S	249
T	108
PLoS	0	4	NNP	PLoS	O	_	_
One	5	8	CD	one	O	_	_
PLoS	9	13	NN	plo	O	_	_
ONE	14	17	CD	one	O	_	_
plos	18	22	NNS	plo	O	_	_
plosone	23	30	VBP	plosone	O	_	_
PLoS	31	35	NN	plo	O	_	_
ONE	36	39	CD	one	O	_	_
1932-6203	40	49	CD	1932-6203	O	_	_
Public	50	56	NNP	Public	O	_	_
Library	57	64	NNP	Library	O	_	_
of	65	67	IN	of	O	_	_
Science	68	75	NNP	Science	O	_	_
San	76	79	NNP	San	O	_	_
Francisco	80	89	NNP	Francisco	O	_	_
,	89	90	,	,	O	_	_
USA	91	94	NNP	USA	O	_	_
24312625	95	103	CD	24312625	O	_	_
3847091	104	111	CD	3847091	O	_	_
PONE-D-13-34101	112	127	NN	pone-d-13-34101	O	_	_
10.1371	128	135	CD	10.1371	O	_	_
/	135	136	:	/	O	_	_
journal.pone	136	148	NN	journal.pone	O	_	_
.0082022	148	156	CD	.0082022	O	_	_
Research	157	165	NNP	Research	O	_	_
Article	166	173	NNP	Article	O	_	_
Phosphorylation	174	189	NN	phosphorylation	O	_	_
of	190	192	IN	of	O	_	_
ASPP2	193	198	NN	aspp2	O	_	_
by	199	201	IN	by	O	_	_
RAS	202	205	NN	ra	B-GENE	_	_
/	205	206	:	/	B-GENE	_	_
MAPK	206	210	NN	mapk	I-GENE	_	_
Pathway	211	218	NN	pathway	O	_	_
Is	219	221	VBZ	be	O	_	_
Critical	222	230	JJ	critical	O	_	_
for	231	234	IN	for	O	_	_
Its	235	238	PRP$	its	O	_	_
Full	239	243	JJ	full	O	_	_
Pro-Apoptotic	244	257	JJ	pro-apoptotic	O	_	_
Function	258	266	NN	function	O	_	_
ASPP2	267	272	NN	aspp2	O	_	_
is	273	275	VBZ	be	O	_	_
Phosphorylated	276	290	VBN	phosphorylate	O	_	_
by	291	293	IN	by	O	_	_
RAS	294	297	NN	ra	B-GENE	_	_
/	297	298	:	/	B-GENE	_	_
MAPK	298	302	NN	mapk	I-GENE	_	_
Pathway	303	310	NN	pathway	O	_	_
Godin-Heymann	311	324	NNP	Godin-Heymann	O	_	_
Nadia	325	330	NNP	Nadia	O	_	_
currency	331	339	NN	currency	O	_	_
Wang	340	344	NNP	Wang	O	_	_
Yihua	345	350	NNP	Yihua	O	_	_
Slee	351	355	NNP	Slee	O	_	_
Elizabeth	356	365	NNP	Elizabeth	O	_	_
Lu	366	368	NNP	Lu	B-GENE	_	_
Xin	369	372	NNP	Xin	I-GENE	_	_
*	373	374	SYM	*	I-GENE	_	_
Ludwig	375	381	NNP	Ludwig	O	_	_
Institute	382	391	NNP	Institute	O	_	_
for	392	395	IN	for	O	_	_
Cancer	396	402	NNP	Cancer	O	_	_
Research	403	411	NNP	Research	O	_	_
Ltd.	412	416	NNP	Ltd.	O	_	_
,	416	417	,	,	O	_	_
Nuffield	418	426	NNP	Nuffield	O	_	_
Department	427	437	NNP	Department	O	_	_
of	438	440	IN	of	O	_	_
Clinical	441	449	JJ	clinical	O	_	_
Medicine	450	458	NN	medicine	O	_	_
,	458	459	,	,	O	_	_
University	460	470	NNP	University	O	_	_
of	471	473	IN	of	O	_	_
Oxford	474	480	NNP	Oxford	O	_	_
,	480	481	,	,	O	_	_
Oxford	482	488	NNP	Oxford	O	_	_
,	488	489	,	,	O	_	_
United	490	496	NNP	United	O	_	_
Kingdom	497	504	NNP	Kingdom	O	_	_
,	504	505	,	,	O	_	_
Zhu	506	509	NNP	Zhu	B-GENE	_	_
Wei-Guo	510	517	NNP	Wei-Guo	I-GENE	_	_
Editor	518	524	NNP	Editor	O	_	_
Peking	525	531	NNP	Peking	O	_	_
University	532	542	NNP	University	O	_	_
Health	543	549	NNP	Health	O	_	_
Science	550	557	NNP	Science	O	_	_
Center	558	564	NNP	Center	O	_	_
,	564	565	,	,	O	_	_
China	566	571	NNP	China	O	_	_
*	572	573	SYM	*	O	_	_
E-mail	574	580	NN	e-mail	O	_	_
:	580	581	:	:	O	_	_
xin.lu@ludwig.ox.ac.uk	582	604	NN	xin.lu@ludwig.ox.ac.uk	O	_	_
Competing	605	614	VBG	compete	O	_	_
Interests	615	624	NNS	interest	O	_	_
:	624	625	:	:	O	_	_
The	626	629	DT	the	O	_	_
authors	630	637	NNS	author	O	_	_
have	638	642	VBP	have	O	_	_
declared	643	651	VBN	declare	O	_	_
that	652	656	IN	that	O	_	_
no	657	659	DT	no	O	_	_
competing	660	669	VBG	compete	O	_	_
interests	670	679	NNS	interest	O	_	_
exist	680	685	VBP	exist	O	_	_
.	685	686	.	.	O	_	_
D	1

107	0	dep
107	1	dep
107	2	dep
107	3	dep
107	4	dep
107	5	dep
107	6	dep
107	7	dep
107	8	dep
107	9	dep
107	10	dep
107	11	dep
107	12	dep
107	13	dep
107	14	dep
107	16	dep
107	17	dep
107	18	dep
107	19	dep
107	20	dep
107	21	dep
107	22	dep
107	23	dep
107	24	dep
107	25	dep
107	26	dep
107	27	dep
107	28	dep
107	29	dep
107	30	dep
107	31	dep
107	32	dep
107	33	dep
107	34	dep
107	35	dep
107	36	dep
107	37	dep
107	38	dep
107	39	dep
107	40	dep
107	41	dep
107	42	dep
107	43	dep
107	44	dep
107	45	dep
107	46	dep
107	47	dep
107	48	dep
107	49	dep
107	50	dep
107	51	dep
107	52	dep
107	53	dep
107	54	dep
107	55	dep
107	56	dep
107	57	dep
107	58	dep
107	59	dep
107	60	dep
107	61	dep
107	62	dep
107	63	dep
107	64	dep
107	66	dep
107	67	dep
107	68	dep
107	69	dep
107	70	dep
107	72	dep
107	73	dep
107	74	dep
107	76	dep
107	78	dep
107	79	dep
107	81	dep
107	82	dep
107	83	dep
107	84	dep
107	85	dep
107	86	dep
107	87	dep
107	88	dep
107	90	dep
107	91	dep
107	92	dep
107	94	dep
107	95	dep
107	96	dep
107	98	dep
107	99	dep
107	100	dep
107	101	dep
107	102	dep
107	103	dep
107	104	dep
107	105	dep
107	106	dep
EOX
Y	1
X	107	0	108	108	X	0	0	1	1	PLoS	0	0	1	0	X	0	1	2	1	One	1	1	2	0	X	0	2	3	1	PLoS	2	2	3	0	X	0	3	4	1	ONE	3	3	4	0	X	0	4	5	1	plos	4	4	5	0	X	0	5	6	1	plosone	5	5	6	0	X	0	6	7	1	PLoS	6	6	7	0	X	0	7	8	1	ONE	7	7	8	0	X	0	8	9	1	1932-6203	8	8	9	0	X	0	9	10	1	Public	9	9	10	0	X	0	10	11	1	Library	10	10	11	0	X	0	11	12	1	of	11	11	12	0	X	0	12	13	1	Science	12	12	13	0	X	0	13	14	1	San	13	13	14	0	X	0	14	15	1	Francisco	14	14	15	0	X	0	15	16	1	,	15	15	16	0	X	0	16	17	1	USA	16	16	17	0	X	0	17	18	1	24312625	17	17	18	0	X	0	18	19	1	3847091	18	18	19	0	X	0	19	20	1	PONE-D-13-34101	19	19	20	0	X	0	20	21	1	10.1371	20	20	21	0	X	0	21	22	1	/	21	21	22	0	X	0	22	23	1	journal.pone	22	22	23	0	X	0	23	24	1	.0082022	23	23	24	0	X	0	24	25	1	Research	24	24	25	0	X	0	25	26	1	Article	25	25	26	0	X	0	26	27	1	Phosphorylation	26	26	27	0	X	0	27	28	1	of	27	27	28	0	X	0	28	29	1	ASPP2	28	28	29	0	X	0	29	30	1	by	29	29	30	0	X	0	30	31	1	RAS	30	30	31	0	X	0	31	32	1	/	31	31	32	0	X	0	32	33	1	MAPK	32	32	33	0	X	0	33	34	1	Pathway	33	33	34	0	X	0	34	35	1	Is	34	34	35	0	X	0	35	36	1	Critical	35	35	36	0	X	0	36	37	1	for	36	36	37	0	X	0	37	38	1	Its	37	37	38	0	X	0	38	39	1	Full	38	38	39	0	X	0	39	40	1	Pro-Apoptotic	39	39	40	0	X	0	40	41	1	Function	40	40	41	0	X	0	41	42	1	ASPP2	41	41	42	0	X	0	42	43	1	is	42	42	43	0	X	0	43	44	1	Phosphorylated	43	43	44	0	X	0	44	45	1	by	44	44	45	0	X	0	45	46	1	RAS	45	45	46	0	X	0	46	47	1	/	46	46	47	0	X	0	47	48	1	MAPK	47	47	48	0	X	0	48	49	1	Pathway	48	48	49	0	X	0	49	50	1	Godin-Heymann	49	49	50	0	X	0	50	51	1	Nadia	50	50	51	0	X	0	51	52	1	currency	51	51	52	0	X	0	52	53	1	Wang	52	52	53	0	X	0	53	54	1	Yihua	53	53	54	0	X	0	54	55	1	Slee	54	54	55	0	X	0	55	56	1	Elizabeth	55	55	56	0	X	0	56	57	1	Lu	56	56	57	0	X	0	57	58	1	Xin	57	57	58	0	X	0	58	59	1	*	58	58	59	0	X	0	59	60	1	Ludwig	59	59	60	0	X	0	60	61	1	Institute	60	60	61	0	X	0	61	62	1	for	61	61	62	0	X	0	62	63	1	Cancer	62	62	63	0	X	0	63	64	1	Research	63	63	64	0	X	0	64	65	1	Ltd.	64	64	65	0	X	0	65	66	1	,	65	65	66	0	X	0	66	67	1	Nuffield	66	66	67	0	X	0	67	68	1	Department	67	67	68	0	X	0	68	69	1	of	68	68	69	0	X	0	69	70	1	Clinical	69	69	70	0	X	0	70	71	1	Medicine	70	70	71	0	X	0	71	72	1	,	71	71	72	0	X	0	72	73	1	University	72	72	73	0	X	0	73	74	1	of	73	73	74	0	X	0	74	75	1	Oxford	74	74	75	0	X	0	75	76	1	,	75	75	76	0	X	0	76	77	1	Oxford	76	76	77	0	X	0	77	78	1	,	77	77	78	0	X	0	78	79	1	United	78	78	79	0	X	0	79	80	1	Kingdom	79	79	80	0	X	0	80	81	1	,	80	80	81	0	X	0	81	82	1	Zhu	81	81	82	0	X	0	82	83	1	Wei-Guo	82	82	83	0	X	0	83	84	1	Editor	83	83	84	0	X	0	84	85	1	Peking	84	84	85	0	X	0	85	86	1	University	85	85	86	0	X	0	86	87	1	Health	86	86	87	0	X	0	87	88	1	Science	87	87	88	0	X	0	88	89	1	Center	88	88	89	0	X	0	89	90	1	,	89	89	90	0	X	0	90	91	1	China	90	90	91	0	X	0	91	92	1	*	91	91	92	0	X	0	92	93	1	E-mail	92	92	93	0	X	0	93	94	1	:	93	93	94	0	X	0	94	95	1	xin.lu@ludwig.ox.ac.uk	94	94	95	0	X	0	95	96	1	Competing	95	95	96	0	X	0	96	97	1	Interests	96	96	97	0	X	0	97	98	1	:	97	97	98	0	X	0	98	99	1	The	98	98	99	0	X	0	99	100	1	authors	99	99	100	0	X	0	100	101	1	have	100	100	101	0	X	0	101	102	1	declared	101	101	102	0	X	0	102	103	1	that	102	102	103	0	X	0	103	104	1	no	103	103	104	0	X	0	104	105	1	competing	104	104	105	0	X	0	105	106	1	interests	105	105	106	0	X	0	106	107	1	exist	106	106	107	0	X	0	107	108	1	.	107	107	108	0
EOS
T	10
Conceived	687	696	VBN	conceive	O	_	_
and	697	700	CC	and	O	_	_
designed	701	709	VBN	design	O	_	_
the	710	713	DT	the	O	_	_
experiments	714	725	NNS	experiment	O	_	_
:	725	726	:	:	O	_	_
NG	727	729	NN	ng	O	_	_
YW	730	732	NNP	YW	O	_	_
XL	733	735	NNP	XL	O	_	_
.	735	736	.	.	O	_	_
D	1
0
0	2	conj_and
0	8	dep
2	4	dobj
4	3	det
8	6	nn
8	7	nn
EOX
Y	1
ROOT	0	0	10	1	SINV	0	0	10	4	S	0	0	5	3	S	0	0	1	1	VP	0	0	1	1	VBN	0	0	1	1	Conceived	0	0	1	0	CC	0	1	2	1	and	1	1	2	0	S	0	2	5	1	VP	0	2	5	2	VBN	0	2	3	1	designed	2	2	3	0	NP	1	3	5	2	DT	0	3	4	1	the	3	3	4	0	NNS	0	4	5	1	experiments	4	4	5	0	:	0	5	6	1	:	5	5	6	0	NP	2	6	9	3	NN	0	6	7	1	NG	6	6	7	0	NNP	0	7	8	1	YW	7	7	8	0	NNP	0	8	9	1	XL	8	8	9	0	.	0	9	10	1	.	9	9	10	0
EOS
T	8
Performed	737	746	VBN	perform	O	_	_
the	747	750	DT	the	O	_	_
experiments	751	762	NNS	experiment	O	_	_
:	762	763	:	:	O	_	_
NG	764	766	NN	ng	O	_	_
YW	767	769	NNP	YW	O	_	_
XL	770	772	NNP	XL	O	_	_
.	772	773	.	.	O	_	_
D	1
0
0	2	dobj
2	1	det
2	6	dep
6	4	nn
6	5	nn
EOX
Y	1
ROOT	0	0	8	1	S	0	0	8	2	VP	0	0	7	2	VBN	0	0	1	1	Performed	0	0	1	0	NP	0	1	7	3	NP	1	1	3	2	DT	0	1	2	1	the	1	1	2	0	NNS	0	2	3	1	experiments	2	2	3	0	:	0	3	4	1	:	3	3	4	0	NP	2	4	7	3	NN	0	4	5	1	NG	4	4	5	0	NNP	0	5	6	1	YW	5	5	6	0	NNP	0	6	7	1	XL	6	6	7	0	.	0	7	8	1	.	7	7	8	0
EOS
T	8
Analyzed	774	782	VBN	analyze	O	_	_
the	783	786	DT	the	O	_	_
data	787	791	NNS	datum	O	_	_
:	791	792	:	:	O	_	_
NG	793	795	NN	ng	O	_	_
YW	796	798	NNP	YW	O	_	_
XL	799	801	NNP	XL	O	_	_
.	801	802	.	.	O	_	_
D	1
0
0	2	dobj
2	1	det
2	6	dep
6	4	nn
6	5	nn
EOX
Y	1
ROOT	0	0	8	1	S	0	0	8	2	VP	0	0	7	2	VBN	0	0	1	1	Analyzed	0	0	1	0	NP	0	1	7	3	NP	1	1	3	2	DT	0	1	2	1	the	1	1	2	0	NNS	0	2	3	1	data	2	2	3	0	:	0	3	4	1	:	3	3	4	0	NP	2	4	7	3	NN	0	4	5	1	NG	4	4	5	0	NNP	0	5	6	1	YW	5	5	6	0	NNP	0	6	7	1	XL	6	6	7	0	.	0	7	8	1	.	7	7	8	0
EOS
T	8
Contributed	803	814	VBN	contribute	O	_	_
reagents	815	823	NNS	reagent	O	_	_
/	823	824	:	/	O	_	_
materials/analysis	824	842	NN	materials/analysis	O	_	_
tools	843	848	NNS	tool	O	_	_
:	848	849	:	:	O	_	_
ES	850	852	NN	e	O	_	_
.	852	853	.	.	O	_	_
D	1
0
0	1	dobj
1	4	dep
4	2	punct
4	3	nn
4	6	dep
EOX
Y	1
ROOT	0	0	8	1	S	0	0	8	2	VP	0	0	7	2	VBN	0	0	1	1	Contributed	0	0	1	0	NP	0	1	7	2	NP	0	1	2	1	NNS	0	1	2	1	reagents	1	1	2	0	PRN	1	2	7	2	:	0	2	3	1	/	2	2	3	0	NP	0	3	7	3	NP	1	3	5	2	NN	0	3	4	1	materials/analysis	3	3	4	0	NNS	0	4	5	1	tools	4	4	5	0	:	0	5	6	1	:	5	5	6	0	NP	0	6	7	1	NN	0	6	7	1	ES	6	6	7	0	.	0	7	8	1	.	7	7	8	0
EOS
T	8
Wrote	854	859	VBD	write	O	_	_
the	860	863	DT	the	O	_	_
manuscript	864	874	NN	manuscript	O	_	_
:	874	875	:	:	O	_	_
NG	876	878	NN	ng	O	_	_
YW	879	881	NNP	YW	O	_	_
XL	882	884	NNP	XL	O	_	_
.	884	885	.	.	O	_	_
D	1
0
0	2	dobj
2	1	det
2	6	dep
6	4	nn
6	5	nn
EOX
Y	1
ROOT	0	0	8	1	S	0	0	8	2	VP	0	0	7	2	VBD	0	0	1	1	Wrote	0	0	1	0	NP	0	1	7	3	NP	1	1	3	2	DT	0	1	2	1	the	1	1	2	0	NN	0	2	3	1	manuscript	2	2	3	0	:	0	3	4	1	:	3	3	4	0	NP	2	4	7	3	NN	0	4	5	1	NG	4	4	5	0	NNP	0	5	6	1	YW	5	5	6	0	NNP	0	6	7	1	XL	6	6	7	0	.	0	7	8	1	.	7	7	8	0
EOS
T	63
currency	886	894	NN	currency	O	_	_
Current	895	902	JJ	current	O	_	_
address	903	910	NN	address	O	_	_
:	910	911	:	:	O	_	_
Cancer	912	918	NNP	Cancer	O	_	_
Research	919	927	NNP	Research	O	_	_
UK	928	930	NNP	UK	O	_	_
,	930	931	,	,	O	_	_
London	932	938	NNP	London	O	_	_
,	938	939	,	,	O	_	_
United	940	946	NNP	United	O	_	_
Kingdom	947	954	NNP	Kingdom	O	_	_
2013	955	959	CD	2013	O	_	_
2	960	961	CD	2	O	_	_
12	962	964	CD	12	O	_	_
2013	965	969	CD	2013	O	_	_
8	970	971	CD	8	O	_	_
12	972	974	CD	12	O	_	_
e82022	975	981	NN	e82022	O	_	_
19	982	984	CD	19	O	_	_
8	985	986	CD	8	O	_	_
2013	987	991	CD	2013	O	_	_
25 10 2013 2013	992	1007	CD	25 10 2013 2013	O	_	_
Godin-Heymann	1008	1021	NNP	Godin-Heymann	O	_	_
et	1022	1024	FW	et	O	_	_
alThis	1025	1031	FW	althis	O	_	_
is	1032	1034	VBZ	be	O	_	_
an	1035	1037	DT	a	O	_	_
open-access	1038	1049	JJ	open-access	O	_	_
article	1050	1057	NN	article	O	_	_
distributed	1058	1069	VBN	distribute	O	_	_
under	1070	1075	IN	under	O	_	_
the	1076	1079	DT	the	O	_	_
terms	1080	1085	NNS	term	O	_	_
of	1086	1088	IN	of	O	_	_
the	1089	1092	DT	the	O	_	_
Creative	1093	1101	NNP	Creative	O	_	_
Commons	1102	1109	NNPS	Commons	O	_	_
Attribution	1110	1121	NNP	Attribution	O	_	_
License	1122	1129	NNP	License	O	_	_
,	1129	1130	,	,	O	_	_
which	1131	1136	WDT	which	O	_	_
permits	1137	1144	VBZ	permit	O	_	_
unrestricted	1145	1157	JJ	unrestricted	O	_	_
use	1158	1161	NN	use	O	_	_
,	1161	1162	,	,	O	_	_
distribution	1163	1175	NN	distribution	O	_	_
,	1175	1176	,	,	O	_	_
and	1177	1180	CC	and	O	_	_
reproduction	1181	1193	NN	reproduction	O	_	_
in	1194	1196	IN	in	O	_	_
any	1197	1200	DT	any	O	_	_
medium	1201	1207	NN	medium	O	_	_
,	1207	1208	,	,	O	_	_
provided	1209	1217	VBD	provide	O	_	_
the	1218	1221	DT	the	O	_	_
original	1222	1230	JJ	original	O	_	_
author	1231	1237	NN	author	O	_	_
and	1238	1241	CC	and	O	_	_
source	1242	1248	NN	source	O	_	_
are	1249	1252	VBP	be	O	_	_
credited	1253	1261	VBN	credit	O	_	_
.	1261	1262	.	.	O	_	_
D	1
54
0	2	dep
2	1	amod
2	11	dep
11	4	nn
11	5	nn
11	6	nn
11	8	appos
11	10	appos
11	12	num
11	14	dep
14	13	number
18	0	dep
18	15	dep
18	16	num
18	17	num
18	20	dep
20	19	number
20	22	dep
22	21	num
23	25	dep
25	24	nn
29	18	dep
29	23	nsubj
29	26	cop
29	27	det
29	28	amod
29	30	vmod
30	33	prep_under
33	32	det
33	39	prep_of
33	42	rcmod
39	35	det
39	36	nn
39	37	nn
39	38	nn
42	41	nsubj
42	44	dobj
44	43	amod
46	49	conj_and
49	52	prep_in
52	51	det
54	29	advcl
54	46	nsubj
54	49	nsubj
54	61	ccomp
57	55	det
57	56	amod
57	59	conj_and
61	57	nsubjpass
61	59	nsubjpass
61	60	auxpass
EOX
Y	1
ROOT	0	0	63	1	S	3	0	63	5	SBAR	1	0	45	2	X	2	0	23	3	NP	0	0	15	2	NP	0	0	1	1	NN	0	0	1	1	currency	0	0	1	0	NP	0	1	15	3	NP	1	1	3	2	JJ	0	1	2	1	Current	1	1	2	0	NN	0	2	3	1	address	2	2	3	0	:	0	3	4	1	:	3	3	4	0	NP	0	4	15	2	NP	7	4	13	9	NNP	0	4	5	1	Cancer	4	4	5	0	NNP	0	5	6	1	Research	5	5	6	0	NNP	0	6	7	1	UK	6	6	7	0	,	0	7	8	1	,	7	7	8	0	NNP	0	8	9	1	London	8	8	9	0	,	0	9	10	1	,	9	9	10	0	NNP	0	10	11	1	United	10	10	11	0	NNP	0	11	12	1	Kingdom	11	11	12	0	CD	0	12	13	1	2013	12	12	13	0	NP	0	13	15	1	QP	1	13	15	2	CD	0	13	14	1	2	13	13	14	0	CD	0	14	15	1	12	14	14	15	0	NP	0	15	16	1	CD	0	15	16	1	2013	15	15	16	0	NP	0	16	23	2	NP	2	16	19	3	CD	0	16	17	1	8	16	16	17	0	CD	0	17	18	1	12	17	17	18	0	NN	0	18	19	1	e82022	18	18	19	0	NP	0	19	23	2	NP	0	19	21	1	QP	1	19	21	2	CD	0	19	20	1	19	19	19	20	0	CD	0	20	21	1	8	20	20	21	0	NP	1	21	23	2	CD	0	21	22	1	2013	21	21	22	0	CD	0	22	23	1	25 10 2013 2013	22	22	23	0	S	1	23	45	2	NP	0	23	26	2	NP	0	23	24	1	NNP	0	23	24	1	Godin-Heymann	23	23	24	0	NP	1	24	26	2	FW	0	24	25	1	et	24	24	25	0	FW	0	25	26	1	alThis	25	25	26	0	VP	1	26	45	2	VBZ	0	26	27	1	is	26	26	27	0	NP	0	27	45	2	NP	2	27	30	3	DT	0	27	28	1	an	27	27	28	0	JJ	0	28	29	1	open-access	28	28	29	0	NN	0	29	30	1	article	29	29	30	0	VP	0	30	45	2	VBN	0	30	31	1	distributed	30	30	31	0	PP	0	31	45	2	IN	0	31	32	1	under	31	31	32	0	NP	0	32	45	4	NP	1	32	34	2	DT	0	32	33	1	the	32	32	33	0	NNS	0	33	34	1	terms	33	33	34	0	PP	0	34	40	2	IN	0	34	35	1	of	34	34	35	0	NP	4	35	40	5	DT	0	35	36	1	the	35	35	36	0	NNP	0	36	37	1	Creative	36	36	37	0	NNPS	0	37	38	1	Commons	37	37	38	0	NNP	0	38	39	1	Attribution	38	38	39	0	NNP	0	39	40	1	License	39	39	40	0	,	0	40	41	1	,	40	40	41	0	SBAR	1	41	45	2	WHNP	0	41	42	1	WDT	0	41	42	1	which	41	41	42	0	S	0	42	45	1	VP	0	42	45	2	VBZ	0	42	43	1	permits	42	42	43	0	NP	1	43	45	2	JJ	0	43	44	1	unrestricted	43	43	44	0	NN	0	44	45	1	use	44	44	45	0	,	0	45	46	1	,	45	45	46	0	NP	0	46	54	5	NP	0	46	47	1	NN	0	46	47	1	distribution	46	46	47	0	,	0	47	48	1	,	47	47	48	0	CC	0	48	49	1	and	48	48	49	0	NP	0	49	53	2	NP	0	49	50	1	NN	0	49	50	1	reproduction	49	49	50	0	PP	0	50	53	2	IN	0	50	51	1	in	50	50	51	0	NP	1	51	53	2	DT	0	51	52	1	any	51	51	52	0	NN	0	52	53	1	medium	52	52	53	0	,	0	53	54	1	,	53	53	54	0	VP	0	54	62	2	VBD	0	54	55	1	provided	54	54	55	0	SBAR	0	55	62	1	S	1	55	62	2	NP	0	55	60	3	NP	2	55	58	3	DT	0	55	56	1	the	55	55	56	0	JJ	0	56	57	1	original	56	56	57	0	NN	0	57	58	1	author	57	57	58	0	CC	0	58	59	1	and	58	58	59	0	NP	0	59	60	1	NN	0	59	60	1	source	59	59	60	0	VP	1	60	62	2	VBP	0	60	61	1	are	60	60	61	0	VP	0	61	62	1	VBN	0	61	62	1	credited	61	61	62	0	.	0	62	63	1	.	62	62	63	0
EOS
T	33
We	1263	1265	PRP	we	O	_	_
reported	1266	1274	VBD	report	O	_	_
recently	1275	1283	RB	recently	O	_	_
that	1284	1288	IN	that	O	_	_
apoptosis	1289	1298	NN	apoptosis	B-GENE	_	_
stimulating	1299	1310	NN	stimulating	I-GENE	_	_
protein	1311	1318	NN	protein	I-GENE	_	_
of	1319	1321	IN	of	O	_	_
p53	1322	1325	NN	p53	B-GENE	_	_
(	1326	1327	CD	(	I-GENE	_	_
ASPP	1327	1331	NN	aspp	I-GENE	_	_
)	1331	1332	NN	)	I-GENE	_	_
2	1333	1334	CD	2	I-GENE	_	_
,	1334	1335	,	,	O	_	_
an	1336	1338	DT	a	O	_	_
activator	1339	1348	NN	activator	O	_	_
of	1349	1351	IN	of	O	_	_
p53	1352	1355	NN	p53	B-GENE	_	_
,	1355	1356	,	,	O	_	_
co-operates	1357	1368	VBZ	co-operate	O	_	_
with	1369	1373	IN	with	O	_	_
oncogenic	1374	1383	JJ	oncogenic	B-GENE	_	_
RAS	1384	1387	NN	ra	I-GENE	_	_
to	1388	1390	TO	to	O	_	_
enhance	1391	1398	VB	enhance	O	_	_
the	1399	1402	DT	the	O	_	_
transcription	1403	1416	NN	transcription	O	_	_
and	1417	1420	CC	and	O	_	_
apoptotic	1421	1430	JJ	apoptotic	O	_	_
function	1431	1439	NN	function	O	_	_
of	1440	1442	IN	of	O	_	_
p53	1443	1446	NN	p53	B-GENE	_	_
.	1446	1447	.	.	O	_	_
D	1
1
1	0	nsubj
1	2	advmod
1	19	ccomp
6	4	nn
6	5	nn
6	11	prep_of
6	15	appos
11	8	nn
11	9	num
11	10	nn
11	12	dep
15	14	det
15	17	prep_of
19	3	mark
19	6	nsubj
19	22	prep_with
19	24	xcomp
22	21	amod
24	23	aux
24	29	dobj
26	28	conj_and
29	25	det
29	26	nn
29	28	nn
29	31	prep_of
EOX
Y	1
ROOT	0	0	33	1	S	1	0	33	3	NP	0	0	1	1	PRP	0	0	1	1	We	0	0	1	0	VP	0	1	32	3	VBD	0	1	2	1	reported	1	1	2	0	ADVP	0	2	3	1	RB	0	2	3	1	recently	2	2	3	0	SBAR	1	3	32	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	32	2	NP	0	4	19	4	NP	0	4	13	2	NP	2	4	7	3	NN	0	4	5	1	apoptosis	4	4	5	0	NN	0	5	6	1	stimulating	5	5	6	0	NN	0	6	7	1	protein	6	6	7	0	PP	0	7	13	2	IN	0	7	8	1	of	7	7	8	0	NP	0	8	13	2	NP	3	8	12	4	NN	0	8	9	1	p53	8	8	9	0	CD	0	9	10	1	(	9	9	10	0	NN	0	10	11	1	ASPP	10	10	11	0	NN	0	11	12	1	)	11	11	12	0	NP	0	12	13	1	CD	0	12	13	1	2	12	12	13	0	,	0	13	14	1	,	13	13	14	0	NP	0	14	18	2	NP	1	14	16	2	DT	0	14	15	1	an	14	14	15	0	NN	0	15	16	1	activator	15	15	16	0	PP	0	16	18	2	IN	0	16	17	1	of	16	16	17	0	NP	0	17	18	1	NN	0	17	18	1	p53	17	17	18	0	,	0	18	19	1	,	18	18	19	0	VP	0	19	32	3	VBZ	0	19	20	1	co-operates	19	19	20	0	PP	0	20	23	2	IN	0	20	21	1	with	20	20	21	0	NP	1	21	23	2	JJ	0	21	22	1	oncogenic	21	21	22	0	NN	0	22	23	1	RAS	22	22	23	0	S	0	23	32	1	VP	1	23	32	2	TO	0	23	24	1	to	23	23	24	0	VP	0	24	32	2	VB	0	24	25	1	enhance	24	24	25	0	NP	0	25	32	2	NP	2	25	30	3	DT	0	25	26	1	the	25	25	26	0	NP	0	26	29	3	NN	0	26	27	1	transcription	26	26	27	0	CC	0	27	28	1	and	27	27	28	0	JJ	0	28	29	1	apoptotic	28	28	29	0	NN	0	29	30	1	function	29	29	30	0	PP	0	30	32	2	IN	0	30	31	1	of	30	30	31	0	NP	0	31	32	1	NN	0	31	32	1	p53	31	31	32	0	.	0	32	33	1	.	32	32	33	0
EOS
T	8
However	1448	1455	RB	however	O	_	_
,	1455	1456	,	,	O	_	_
the	1457	1460	DT	the	O	_	_
detailed	1461	1469	JJ	detailed	O	_	_
mechanism	1470	1479	NN	mechanism	O	_	_
remains	1480	1487	VBZ	remain	O	_	_
unknown	1488	1495	JJ	unknown	O	_	_
.	1495	1496	.	.	O	_	_
D	1
6
4	2	det
4	3	amod
6	0	advmod
6	4	nsubj
6	5	cop
EOX
Y	1
ROOT	0	0	8	1	S	3	0	8	5	ADVP	0	0	1	1	RB	0	0	1	1	However	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	2	2	5	3	DT	0	2	3	1	the	2	2	3	0	JJ	0	3	4	1	detailed	3	3	4	0	NN	0	4	5	1	mechanism	4	4	5	0	VP	1	5	7	2	VBZ	0	5	6	1	remains	5	5	6	0	ADJP	0	6	7	1	JJ	0	6	7	1	unknown	6	6	7	0	.	0	7	8	1	.	7	7	8	0
EOS
T	18
Here	1497	1501	RB	here	O	_	_
we	1502	1504	PRP	we	O	_	_
show	1505	1509	VBP	show	O	_	_
that	1510	1514	IN	that	O	_	_
ASPP2	1515	1520	NN	aspp2	B-GENE	_	_
is	1521	1523	VBZ	be	O	_	_
a	1524	1525	DT	a	O	_	_
novel	1526	1531	JJ	novel	O	_	_
substrate	1532	1541	NN	substrate	O	_	_
of	1542	1544	IN	of	O	_	_
mitogen	1545	1552	NN	mitogen	B-GENE	_	_
activated	1553	1562	VBN	activate	I-GENE	_	_
protein	1563	1570	NN	protein	I-GENE	_	_
kinase	1571	1577	NN	kinase	I-GENE	_	_
(	1578	1579	CD	(	B-GENE	_	_
MAPK	1579	1583	NN	mapk	I-GENE	_	_
)	1583	1584	NN	)	O	_	_
.	1584	1585	.	.	O	_	_
D	1
2
2	0	advmod
2	1	nsubj
2	8	ccomp
8	3	mark
8	4	nsubj
8	5	cop
8	6	det
8	7	amod
8	12	prep_of
12	10	nn
12	11	amod
12	16	dep
16	13	nn
16	14	num
16	15	nn
EOX
Y	1
ROOT	0	0	18	1	S	2	0	18	4	ADVP	0	0	1	1	RB	0	0	1	1	Here	0	0	1	0	NP	0	1	2	1	PRP	0	1	2	1	we	1	1	2	0	VP	0	2	17	2	VBP	0	2	3	1	show	2	2	3	0	SBAR	1	3	17	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	17	2	NP	0	4	5	1	NN	0	4	5	1	ASPP2	4	4	5	0	VP	1	5	17	2	VBZ	0	5	6	1	is	5	5	6	0	NP	0	6	17	2	NP	2	6	9	3	DT	0	6	7	1	a	6	6	7	0	JJ	0	7	8	1	novel	7	7	8	0	NN	0	8	9	1	substrate	8	8	9	0	PP	0	9	17	2	IN	0	9	10	1	of	9	9	10	0	NP	0	10	17	2	NP	2	10	13	3	NN	0	10	11	1	mitogen	10	10	11	0	VBN	0	11	12	1	activated	11	11	12	0	NN	0	12	13	1	protein	12	12	13	0	NP	3	13	17	4	NN	0	13	14	1	kinase	13	13	14	0	CD	0	14	15	1	(	14	14	15	0	NN	0	15	16	1	MAPK	15	15	16	0	NN	0	16	17	1	)	16	16	17	0	.	0	17	18	1	.	17	17	18	0
EOS
T	21
Phosphorylation	1586	1601	NN	phosphorylation	O	_	_
of	1602	1604	IN	of	O	_	_
ASPP2	1605	1610	NN	aspp2	B-GENE	_	_
by	1611	1613	IN	by	O	_	_
MAPK	1614	1618	NN	mapk	B-GENE	_	_
is	1619	1621	VBZ	be	O	_	_
required	1622	1630	VBN	require	O	_	_
for	1631	1634	IN	for	O	_	_
RAS	1635	1638	NN	ra	O	_	_
induced	1639	1646	VBD	induce	O	_	_
increased	1647	1656	VBN	increase	O	_	_
binding	1657	1664	VBG	bind	O	_	_
to	1665	1667	TO	to	O	_	_
p53	1668	1671	NN	p53	B-GENE	_	_
and	1672	1675	CC	and	O	_	_
increased	1676	1685	VBD	increase	O	_	_
transactivation	1686	1701	NN	transactivation	O	_	_
of	1702	1704	IN	of	O	_	_
pro-apoptotic	1705	1718	JJ	pro-apoptotic	O	_	_
genes	1719	1724	NNS	gene	O	_	_
.	1724	1725	.	.	O	_	_
D	1
6
0	2	prep_of
2	4	prep_by
6	0	nsubjpass
6	5	auxpass
6	9	advcl
6	15	advcl
9	7	mark
9	8	nsubj
9	10	dobj
9	15	conj_and
10	11	amod
10	13	prep_to
15	8	nsubj
15	16	dobj
16	19	prep_of
19	18	amod
EOX
Y	1
ROOT	0	0	21	1	S	1	0	21	3	NP	0	0	5	2	NP	0	0	1	1	NN	0	0	1	1	Phosphorylation	0	0	1	0	PP	0	1	5	2	IN	0	1	2	1	of	1	1	2	0	NP	0	2	5	2	NP	0	2	3	1	NN	0	2	3	1	ASPP2	2	2	3	0	PP	0	3	5	2	IN	0	3	4	1	by	3	3	4	0	NP	0	4	5	1	NN	0	4	5	1	MAPK	4	4	5	0	VP	1	5	20	2	VBZ	0	5	6	1	is	5	5	6	0	VP	0	6	20	2	VBN	0	6	7	1	required	6	6	7	0	SBAR	1	7	20	2	IN	0	7	8	1	for	7	7	8	0	S	1	8	20	2	NP	0	8	9	1	NN	0	8	9	1	RAS	8	8	9	0	VP	0	9	20	3	VP	0	9	14	2	VBD	0	9	10	1	induced	9	9	10	0	NP	0	10	14	2	NP	0	10	12	2	VBN	0	10	11	1	increased	10	10	11	0	VBG	0	11	12	1	binding	11	11	12	0	PP	0	12	14	2	TO	0	12	13	1	to	12	12	13	0	NP	0	13	14	1	NN	0	13	14	1	p53	13	13	14	0	CC	0	14	15	1	and	14	14	15	0	VP	0	15	20	2	VBD	0	15	16	1	increased	15	15	16	0	NP	0	16	20	2	NP	0	16	17	1	NN	0	16	17	1	transactivation	16	16	17	0	PP	0	17	20	2	IN	0	17	18	1	of	17	17	18	0	NP	1	18	20	2	JJ	0	18	19	1	pro-apoptotic	18	18	19	0	NNS	0	19	20	1	genes	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	19
In	1726	1728	IN	in	O	_	_
contrast	1729	1737	NN	contrast	O	_	_
,	1737	1738	,	,	O	_	_
an	1739	1741	DT	a	O	_	_
ASPP2	1742	1747	NN	aspp2	B-GENE	_	_
phosphorylation	1748	1763	NN	phosphorylation	O	_	_
mutant	1764	1770	NN	mutant	O	_	_
exhibits	1771	1779	VBZ	exhibit	O	_	_
reduced	1780	1787	VBN	reduce	O	_	_
p53	1788	1791	NN	p53	B-GENE	_	_
binding	1792	1799	NN	binding	O	_	_
and	1800	1803	CC	and	O	_	_
fails	1804	1809	VBZ	fail	O	_	_
to	1810	1812	TO	to	O	_	_
enhance	1813	1820	VB	enhance	O	_	_
transactivation	1821	1836	NN	transactivation	O	_	_
and	1837	1840	CC	and	O	_	_
apoptosis	1841	1850	NN	apoptosis	O	_	_
.	1850	1851	.	.	O	_	_
D	1
7
6	3	det
6	4	nn
6	5	nn
7	1	prep_in
7	6	nsubj
7	8	dep
7	12	conj_and
8	10	dobj
10	9	nn
12	6	nsubj
12	14	xcomp
14	13	aux
14	15	dobj
14	17	dobj
15	17	conj_and
EOX
Y	1
ROOT	0	0	19	1	S	3	0	19	5	PP	0	0	2	2	IN	0	0	1	1	In	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	contrast	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	3	3	7	4	DT	0	3	4	1	an	3	3	4	0	NN	0	4	5	1	ASPP2	4	4	5	0	NN	0	5	6	1	phosphorylation	5	5	6	0	NN	0	6	7	1	mutant	6	6	7	0	VP	0	7	18	3	VP	0	7	11	2	VBZ	0	7	8	1	exhibits	7	7	8	0	VP	0	8	11	2	VBN	0	8	9	1	reduced	8	8	9	0	NP	1	9	11	2	NN	0	9	10	1	p53	9	9	10	0	NN	0	10	11	1	binding	10	10	11	0	CC	0	11	12	1	and	11	11	12	0	VP	0	12	18	2	VBZ	0	12	13	1	fails	12	12	13	0	S	0	13	18	1	VP	1	13	18	2	TO	0	13	14	1	to	13	13	14	0	VP	0	14	18	2	VB	0	14	15	1	enhance	14	14	15	0	NP	0	15	18	3	NN	0	15	16	1	transactivation	15	15	16	0	CC	0	16	17	1	and	16	16	17	0	NN	0	17	18	1	apoptosis	17	17	18	0	.	0	18	19	1	.	18	18	19	0
EOS
T	21
Thus	1852	1856	RB	thus	O	_	_
phosphorylation	1857	1872	NN	phosphorylation	O	_	_
of	1873	1875	IN	of	O	_	_
ASPP2	1876	1881	NN	aspp2	B-GENE	_	_
by	1882	1884	IN	by	O	_	_
RAS	1885	1888	NN	ra	B-GENE	_	_
/	1888	1889	:	/	B-GENE	_	_
MAPK	1889	1893	NN	mapk	I-GENE	_	_
pathway	1894	1901	NN	pathway	O	_	_
provides	1902	1910	VBZ	provide	O	_	_
a	1911	1912	DT	a	O	_	_
novel	1913	1918	JJ	novel	O	_	_
link	1919	1923	NN	link	O	_	_
between	1924	1931	IN	between	O	_	_
RAS	1932	1935	NN	ra	B-GENE	_	_
and	1936	1939	CC	and	O	_	_
p53	1940	1943	NN	p53	B-GENE	_	_
in	1944	1946	IN	in	O	_	_
regulating	1947	1957	VBG	regulate	O	_	_
apoptosis	1958	1967	NN	apoptosis	O	_	_
.	1967	1968	.	.	O	_	_
D	1
1
1	0	advmod
1	3	prep_of
1	5	prep_by
1	6	punct
1	9	dep
8	7	nn
9	8	nsubj
9	12	dobj
9	18	prepc_in
12	10	det
12	11	amod
12	14	prep_between
12	16	prep_between
14	16	conj_and
18	19	dobj
EOX
Y	1
ROOT	0	0	21	1	FRAG	0	0	21	4	NP	0	0	6	2	NP	1	0	4	3	ADVP	0	0	1	1	RB	0	0	1	1	Thus	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	phosphorylation	1	1	2	0	PP	0	2	4	2	IN	0	2	3	1	of	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	ASPP2	3	3	4	0	PP	0	4	6	2	IN	0	4	5	1	by	4	4	5	0	NP	0	5	6	1	NN	0	5	6	1	RAS	5	5	6	0	:	0	6	7	1	/	6	6	7	0	S	1	7	20	2	NP	1	7	9	2	NN	0	7	8	1	MAPK	7	7	8	0	NN	0	8	9	1	pathway	8	8	9	0	VP	0	9	20	3	VBZ	0	9	10	1	provides	9	9	10	0	NP	0	10	17	2	NP	2	10	13	3	DT	0	10	11	1	a	10	10	11	0	JJ	0	11	12	1	novel	11	11	12	0	NN	0	12	13	1	link	12	12	13	0	PP	0	13	17	2	IN	0	13	14	1	between	13	13	14	0	NP	0	14	17	3	NN	0	14	15	1	RAS	14	14	15	0	CC	0	15	16	1	and	15	15	16	0	NN	0	16	17	1	p53	16	16	17	0	PP	0	17	20	2	IN	0	17	18	1	in	17	17	18	0	S	0	18	20	1	VP	0	18	20	2	VBG	0	18	19	1	regulating	18	18	19	0	NP	0	19	20	1	NN	0	19	20	1	apoptosis	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	13
This	1969	1973	DT	this	O	_	_
work	1974	1978	NN	work	O	_	_
is	1979	1981	VBZ	be	O	_	_
supported	1982	1991	VBN	support	O	_	_
by	1992	1994	IN	by	O	_	_
the	1995	1998	DT	the	O	_	_
Ludwig	1999	2005	NNP	Ludwig	O	_	_
Institute	2006	2015	NNP	Institute	O	_	_
for	2016	2019	IN	for	O	_	_
Cancer	2020	2026	NNP	Cancer	O	_	_
Research	2027	2035	NNP	Research	O	_	_
Ltd.	2036	2039	NNP	Ltd.	O	_	_
.	2039	2040	.	.	O	_	_
D	1
3
1	0	det
3	1	nsubjpass
3	2	auxpass
3	7	agent
7	5	det
7	6	nn
7	11	prep_for
11	9	nn
11	10	nn
EOX
Y	1
ROOT	0	0	13	1	S	1	0	13	3	NP	1	0	2	2	DT	0	0	1	1	This	0	0	1	0	NN	0	1	2	1	work	1	1	2	0	VP	1	2	12	2	VBZ	0	2	3	1	is	2	2	3	0	VP	0	3	12	2	VBN	0	3	4	1	supported	3	3	4	0	PP	0	4	12	2	IN	0	4	5	1	by	4	4	5	0	NP	0	5	12	2	NP	2	5	8	3	DT	0	5	6	1	the	5	5	6	0	NNP	0	6	7	1	Ludwig	6	6	7	0	NNP	0	7	8	1	Institute	7	7	8	0	PP	0	8	12	2	IN	0	8	9	1	for	8	8	9	0	NP	2	9	12	3	NNP	0	9	10	1	Cancer	9	9	10	0	NNP	0	10	11	1	Research	10	10	11	0	NNP	0	11	12	1	Ltd.	11	11	12	0	.	0	12	13	1	.	12	12	13	0
EOS
T	24
The	2041	2044	DT	the	O	_	_
funders	2045	2052	NNS	funder	O	_	_
had	2053	2056	VBD	have	O	_	_
no	2057	2059	DT	no	O	_	_
role	2060	2064	NN	role	O	_	_
in	2065	2067	IN	in	O	_	_
study	2068	2073	NN	study	O	_	_
design	2074	2080	NN	design	O	_	_
,	2080	2081	,	,	O	_	_
data	2082	2086	NNS	datum	O	_	_
collection	2087	2097	NN	collection	O	_	_
and	2098	2101	CC	and	O	_	_
analysis	2102	2110	NN	analysis	O	_	_
,	2110	2111	,	,	O	_	_
decision	2112	2120	NN	decision	O	_	_
to	2121	2123	TO	to	O	_	_
publish	2124	2131	VB	publish	O	_	_
,	2131	2132	,	,	O	_	_
or	2133	2135	CC	or	O	_	_
preparation	2136	2147	NN	preparation	O	_	_
of	2148	2150	IN	of	O	_	_
the	2151	2154	DT	the	O	_	_
manuscript	2155	2165	NN	manuscript	O	_	_
.	2165	2166	.	.	O	_	_
D	1
2
1	0	det
2	1	nsubj
2	4	dobj
4	3	det
4	7	prep_in
4	19	prep_in
7	6	nn
7	10	appos
7	12	appos
7	14	appos
7	19	conj_or
10	9	nn
10	12	conj_and
14	16	vmod
16	15	aux
19	22	prep_of
22	21	det
EOX
Y	1
ROOT	0	0	24	1	S	1	0	24	3	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NNS	0	1	2	1	funders	1	1	2	0	VP	0	2	23	2	VBD	0	2	3	1	had	2	2	3	0	NP	0	3	23	2	NP	1	3	5	2	DT	0	3	4	1	no	3	3	4	0	NN	0	4	5	1	role	4	4	5	0	PP	0	5	23	2	IN	0	5	6	1	in	5	5	6	0	NP	0	6	23	4	NP	0	6	17	5	NP	1	6	8	2	NN	0	6	7	1	study	6	6	7	0	NN	0	7	8	1	design	7	7	8	0	,	0	8	9	1	,	8	8	9	0	NP	1	9	13	4	NNS	0	9	10	1	data	9	9	10	0	NN	0	10	11	1	collection	10	10	11	0	CC	0	11	12	1	and	11	11	12	0	NN	0	12	13	1	analysis	12	12	13	0	,	0	13	14	1	,	13	13	14	0	NP	0	14	17	2	NN	0	14	15	1	decision	14	14	15	0	S	0	15	17	1	VP	1	15	17	2	TO	0	15	16	1	to	15	15	16	0	VP	0	16	17	1	VB	0	16	17	1	publish	16	16	17	0	,	0	17	18	1	,	17	17	18	0	CC	0	18	19	1	or	18	18	19	0	NP	0	19	23	2	NP	0	19	20	1	NN	0	19	20	1	preparation	19	19	20	0	PP	0	20	23	2	IN	0	20	21	1	of	20	20	21	0	NP	1	21	23	2	DT	0	21	22	1	the	21	21	22	0	NN	0	22	23	1	manuscript	22	22	23	0	.	0	23	24	1	.	23	23	24	0
EOS
T	14
Introduction	2167	2179	NN	introduction	O	_	_
p53	2180	2183	NN	p53	B-GENE	_	_
is	2184	2186	VBZ	be	O	_	_
the	2187	2190	DT	the	O	_	_
most	2191	2195	RBS	most	O	_	_
commonly	2196	2204	RB	commonly	O	_	_
mutated	2205	2212	VBN	mutate	O	_	_
tumour	2213	2219	NN	tumour	O	_	_
suppressor	2220	2230	NN	suppressor	O	_	_
protein	2231	2238	NN	protein	O	_	_
thus	2239	2243	RB	thus	O	_	_
far	2244	2247	RB	far	O	_	_
identified	2248	2258	VBN	identify	O	_	_
.	2258	2259	.	.	O	_	_
D	1
9
1	0	nn
6	4	advmod
6	5	advmod
9	1	nsubj
9	2	cop
9	3	det
9	6	amod
9	7	nn
9	8	nn
9	12	vmod
11	10	advmod
12	11	advmod
EOX
Y	1
ROOT	0	0	14	1	S	1	0	14	3	NP	1	0	2	2	NN	0	0	1	1	Introduction	0	0	1	0	NN	0	1	2	1	p53	1	1	2	0	VP	1	2	13	2	VBZ	0	2	3	1	is	2	2	3	0	NP	0	3	13	2	NP	4	3	10	5	DT	0	3	4	1	the	3	3	4	0	ADJP	2	4	7	3	RBS	0	4	5	1	most	4	4	5	0	RB	0	5	6	1	commonly	5	5	6	0	VBN	0	6	7	1	mutated	6	6	7	0	NN	0	7	8	1	tumour	7	7	8	0	NN	0	8	9	1	suppressor	8	8	9	0	NN	0	9	10	1	protein	9	9	10	0	VP	1	10	13	2	ADVP	1	10	12	2	RB	0	10	11	1	thus	10	10	11	0	RB	0	11	12	1	far	11	11	12	0	VBN	0	12	13	1	identified	12	12	13	0	.	0	13	14	1	.	13	13	14	0
EOS
T	35
Although	2260	2268	IN	although	O	_	_
p53	2269	2272	NN	p53	B-GENE	_	_
is	2273	2275	VBZ	be	O	_	_
mutated	2276	2283	VBN	mutate	O	_	_
in	2284	2286	IN	in	O	_	_
more	2287	2291	JJR	more	O	_	_
than	2292	2296	IN	than	O	_	_
50	2297	2299	CD	50	O	_	_
%	2299	2300	NN	%	O	_	_
of	2301	2303	IN	of	O	_	_
tumours	2304	2311	NNS	tumour	O	_	_
,	2311	2312	,	,	O	_	_
its	2313	2316	PRP$	its	O	_	_
mutation	2317	2325	NN	mutation	O	_	_
rate	2326	2330	NN	rate	O	_	_
varies	2331	2337	VBZ	vary	O	_	_
significantly	2338	2351	RB	significantly	O	_	_
between	2352	2359	IN	between	O	_	_
different	2360	2369	JJ	different	O	_	_
types	2370	2375	NNS	type	O	_	_
of	2376	2378	IN	of	O	_	_
human	2379	2384	JJ	human	O	_	_
cancer	2385	2391	NN	cancer	O	_	_
,	2391	2392	,	,	O	_	_
with	2393	2397	IN	with	O	_	_
a	2398	2399	DT	a	O	_	_
particularly	2400	2412	RB	particularly	O	_	_
high	2413	2417	JJ	high	O	_	_
incidence	2418	2427	NN	incidence	O	_	_
in	2428	2430	IN	in	O	_	_
colorectal	2431	2441	JJ	colorectal	O	_	_
and	2442	2445	CC	and	O	_	_
pancreatic	2446	2456	JJ	pancreatic	O	_	_
tumours	2457	2464	NNS	tumour	O	_	_
.	2464	2465	.	.	O	_	_
D	1
15
3	0	mark
3	1	nsubjpass
3	2	auxpass
3	8	prep_in
6	5	mwe
7	6	quantmod
8	7	num
8	10	prep_of
14	12	poss
14	13	nn
15	3	advcl
15	14	nsubj
15	16	advmod
15	19	prep_between
15	28	prep_with
19	18	amod
19	22	prep_of
22	21	amod
27	26	advmod
28	25	det
28	27	amod
28	33	prep_in
30	32	conj_and
33	30	amod
33	32	amod
EOX
Y	1
ROOT	0	0	35	1	S	3	0	35	5	SBAR	1	0	11	2	IN	0	0	1	1	Although	0	0	1	0	S	1	1	11	2	NP	0	1	2	1	NN	0	1	2	1	p53	1	1	2	0	VP	1	2	11	2	VBZ	0	2	3	1	is	2	2	3	0	VP	0	3	11	2	VBN	0	3	4	1	mutated	3	3	4	0	PP	0	4	11	2	IN	0	4	5	1	in	4	4	5	0	NP	0	5	11	2	NP	1	5	9	2	QP	1	5	8	2	XS	1	5	7	2	JJR	0	5	6	1	more	5	5	6	0	IN	0	6	7	1	than	6	6	7	0	CD	0	7	8	1	50	7	7	8	0	NN	0	8	9	1	%	8	8	9	0	PP	0	9	11	2	IN	0	9	10	1	of	9	9	10	0	NP	0	10	11	1	NNS	0	10	11	1	tumours	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	2	12	15	3	PRP$	0	12	13	1	its	12	12	13	0	NN	0	13	14	1	mutation	13	13	14	0	NN	0	14	15	1	rate	14	14	15	0	VP	0	15	34	5	VBZ	0	15	16	1	varies	15	15	16	0	ADVP	0	16	17	1	RB	0	16	17	1	significantly	16	16	17	0	PP	0	17	23	2	IN	0	17	18	1	between	17	17	18	0	NP	0	18	23	2	NP	1	18	20	2	JJ	0	18	19	1	different	18	18	19	0	NNS	0	19	20	1	types	19	19	20	0	PP	0	20	23	2	IN	0	20	21	1	of	20	20	21	0	NP	1	21	23	2	JJ	0	21	22	1	human	21	21	22	0	NN	0	22	23	1	cancer	22	22	23	0	,	0	23	24	1	,	23	23	24	0	PP	0	24	34	2	IN	0	24	25	1	with	24	24	25	0	NP	0	25	34	2	NP	2	25	29	3	DT	0	25	26	1	a	25	25	26	0	ADJP	1	26	28	2	RB	0	26	27	1	particularly	26	26	27	0	JJ	0	27	28	1	high	27	27	28	0	NN	0	28	29	1	incidence	28	28	29	0	PP	0	29	34	2	IN	0	29	30	1	in	29	29	30	0	NP	1	30	34	2	ADJP	0	30	33	3	JJ	0	30	31	1	colorectal	30	30	31	0	CC	0	31	32	1	and	31	31	32	0	JJ	0	32	33	1	pancreatic	32	32	33	0	NNS	0	33	34	1	tumours	33	33	34	0	.	0	34	35	1	.	34	34	35	0
EOS
T	18
Interestingly	2466	2479	RB	interestingly	O	_	_
,	2479	2480	,	,	O	_	_
the	2481	2484	DT	the	O	_	_
mediator	2485	2493	NN	mediator	O	_	_
of	2494	2496	IN	of	O	_	_
signal	2497	2503	NN	signal	B-GENE	_	_
transduction	2504	2516	NN	transduction	I-GENE	_	_
RAS	2517	2520	NN	ra	I-GENE	_	_
is	2521	2523	VBZ	be	O	_	_
also	2524	2528	RB	also	O	_	_
commonly	2529	2537	RB	commonly	O	_	_
mutated	2538	2545	VBN	mutate	O	_	_
in	2546	2548	IN	in	O	_	_
these	2549	2554	DT	these	O	_	_
particular	2555	2565	JJ	particular	O	_	_
tumour	2566	2572	NN	tumour	O	_	_
types	2573	2578	NNS	type	O	_	_
.	2578	2579	.	.	O	_	_
D	1
11
3	2	det
3	7	prep_of
7	5	nn
7	6	nn
11	0	advmod
11	3	nsubjpass
11	8	auxpass
11	9	advmod
11	10	advmod
11	16	prep_in
16	13	det
16	14	amod
16	15	nn
EOX
Y	1
ROOT	0	0	18	1	S	3	0	18	5	ADVP	0	0	1	1	RB	0	0	1	1	Interestingly	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	0	2	8	2	NP	1	2	4	2	DT	0	2	3	1	the	2	2	3	0	NN	0	3	4	1	mediator	3	3	4	0	PP	0	4	8	2	IN	0	4	5	1	of	4	4	5	0	NP	2	5	8	3	NN	0	5	6	1	signal	5	5	6	0	NN	0	6	7	1	transduction	6	6	7	0	NN	0	7	8	1	RAS	7	7	8	0	VP	2	8	17	3	VBZ	0	8	9	1	is	8	8	9	0	ADVP	0	9	10	1	RB	0	9	10	1	also	9	9	10	0	VP	1	10	17	3	ADVP	0	10	11	1	RB	0	10	11	1	commonly	10	10	11	0	VBN	0	11	12	1	mutated	11	11	12	0	PP	0	12	17	2	IN	0	12	13	1	in	12	12	13	0	NP	3	13	17	4	DT	0	13	14	1	these	13	13	14	0	JJ	0	14	15	1	particular	14	14	15	0	NN	0	15	16	1	tumour	15	15	16	0	NNS	0	16	17	1	types	16	16	17	0	.	0	17	18	1	.	17	17	18	0
EOS
T	21
It	2580	2582	PRP	it	O	_	_
remains	2583	2590	VBZ	remain	O	_	_
unclear	2591	2598	JJ	unclear	O	_	_
why	2599	2602	WRB	why	O	_	_
there	2603	2608	EX	there	O	_	_
exists	2609	2615	VBZ	exist	O	_	_
such	2616	2620	PDT	such	O	_	_
a	2621	2622	DT	a	O	_	_
tight	2623	2628	JJ	tight	O	_	_
association	2629	2640	NN	association	O	_	_
between	2641	2648	IN	between	O	_	_
the	2649	2652	DT	the	O	_	_
p53	2653	2656	NN	p53	B-GENE	_	_
and	2657	2660	CC	and	I-GENE	_	_
RAS	2661	2664	NN	ra	I-GENE	_	_
mutation	2665	2673	NN	mutation	I-GENE	_	_
status	2674	2680	NN	status	O	_	_
[	2681	2682	CD	[	O	_	_
1	2682	2683	CD	1	O	_	_
]	2683	2684	NN	]	O	_	_
.	2684	2685	.	.	O	_	_
D	1
2
2	0	nsubj
2	1	cop
2	5	advcl
5	3	advmod
5	4	expl
5	9	dobj
5	16	dobj
9	6	dep
9	7	det
9	8	amod
9	12	prep_between
9	16	conj_and
12	11	det
16	14	nn
16	15	nn
16	19	dep
18	17	number
19	18	num
EOX
Y	1
ROOT	0	0	21	1	S	1	0	21	3	NP	0	0	1	1	PRP	0	0	1	1	It	0	0	1	0	VP	1	1	20	3	VBZ	0	1	2	1	remains	1	1	2	0	ADJP	0	2	3	1	JJ	0	2	3	1	unclear	2	2	3	0	SBAR	1	3	20	2	WHADVP	0	3	4	1	WRB	0	3	4	1	why	3	3	4	0	S	1	4	20	2	NP	0	4	5	1	EX	0	4	5	1	there	4	4	5	0	VP	0	5	20	2	VBZ	0	5	6	1	exists	5	5	6	0	NP	1	6	20	4	PDT	0	6	7	1	such	6	6	7	0	NP	0	7	13	2	NP	2	7	10	3	DT	0	7	8	1	a	7	7	8	0	JJ	0	8	9	1	tight	8	8	9	0	NN	0	9	10	1	association	9	9	10	0	PP	0	10	13	2	IN	0	10	11	1	between	10	10	11	0	NP	1	11	13	2	DT	0	11	12	1	the	11	11	12	0	NN	0	12	13	1	p53	12	12	13	0	CC	0	13	14	1	and	13	13	14	0	NP	0	14	20	2	NP	2	14	17	3	NN	0	14	15	1	RAS	14	14	15	0	NN	0	15	16	1	mutation	15	15	16	0	NN	0	16	17	1	status	16	16	17	0	NP	1	17	20	2	QP	1	17	19	2	CD	0	17	18	1	[	17	17	18	0	CD	0	18	19	1	1	18	18	19	0	NN	0	19	20	1	]	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	33
We	2686	2688	PRP	we	O	_	_
reported	2689	2697	VBD	report	O	_	_
recently	2698	2706	RB	recently	O	_	_
that	2707	2711	IN	that	O	_	_
apoptosis	2712	2721	NN	apoptosis	B-GENE	_	_
stimulating	2722	2733	NN	stimulating	I-GENE	_	_
protein	2734	2741	NN	protein	I-GENE	_	_
of	2742	2744	IN	of	O	_	_
p53	2745	2748	NN	p53	B-GENE	_	_
(	2749	2750	CD	(	I-GENE	_	_
ASPP	2750	2754	NN	aspp	I-GENE	_	_
)	2754	2755	NN	)	I-GENE	_	_
2	2756	2757	CD	2	I-GENE	_	_
co-operates	2758	2769	NNS	co-operate	O	_	_
with	2770	2774	IN	with	O	_	_
oncogenic	2775	2784	JJ	oncogenic	B-GENE	_	_
RAS	2785	2788	NN	ra	I-GENE	_	_
to	2789	2791	TO	to	O	_	_
enhance	2792	2799	VB	enhance	O	_	_
the	2800	2803	DT	the	O	_	_
transcription	2804	2817	NN	transcription	O	_	_
and	2818	2821	CC	and	O	_	_
apoptotic	2822	2831	JJ	apoptotic	O	_	_
function	2832	2840	NN	function	O	_	_
of	2841	2843	IN	of	O	_	_
p53	2844	2847	NN	p53	B-GENE	_	_
in	2848	2850	IN	in	O	_	_
cancer	2851	2857	NN	cancer	O	_	_
cells	2858	2863	NNS	cell	O	_	_
[	2864	2865	VBP	[	O	_	_
2	2865	2866	CD	2	O	_	_
]	2866	2867	CD	]	O	_	_
.	2867	2868	.	.	O	_	_
D	1
1
1	0	nsubj
1	2	advmod
1	11	ccomp
1	29	conj_and
6	4	nn
6	5	nn
6	10	prep_of
10	8	nn
10	9	num
11	3	mark
11	6	nsubj
11	13	dobj
11	18	xcomp
13	12	num
13	16	prep_with
16	15	amod
18	17	aux
18	20	dobj
20	19	det
23	22	amod
23	25	prep_of
25	28	prep_in
28	27	nn
29	23	nsubj
29	31	dobj
31	30	number
EOX
Y	1
ROOT	0	0	33	1	S	0	0	33	4	S	1	0	21	2	NP	0	0	1	1	PRP	0	0	1	1	We	0	0	1	0	VP	0	1	21	3	VBD	0	1	2	1	reported	1	1	2	0	ADVP	0	2	3	1	RB	0	2	3	1	recently	2	2	3	0	SBAR	1	3	21	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	21	2	NP	0	4	11	2	NP	2	4	7	3	NN	0	4	5	1	apoptosis	4	4	5	0	NN	0	5	6	1	stimulating	5	5	6	0	NN	0	6	7	1	protein	6	6	7	0	PP	0	7	11	2	IN	0	7	8	1	of	7	7	8	0	NP	2	8	11	3	NN	0	8	9	1	p53	8	8	9	0	CD	0	9	10	1	(	9	9	10	0	NN	0	10	11	1	ASPP	10	10	11	0	VP	0	11	21	3	NN	0	11	12	1	)	11	11	12	0	NP	0	12	17	2	NP	1	12	14	2	CD	0	12	13	1	2	12	12	13	0	NNS	0	13	14	1	co-operates	13	13	14	0	PP	0	14	17	2	IN	0	14	15	1	with	14	14	15	0	NP	1	15	17	2	JJ	0	15	16	1	oncogenic	15	15	16	0	NN	0	16	17	1	RAS	16	16	17	0	S	0	17	21	1	VP	1	17	21	2	TO	0	17	18	1	to	17	17	18	0	VP	0	18	21	2	VB	0	18	19	1	enhance	18	18	19	0	NP	1	19	21	2	DT	0	19	20	1	the	19	19	20	0	NN	0	20	21	1	transcription	20	20	21	0	CC	0	21	22	1	and	21	21	22	0	S	1	22	32	2	NP	0	22	29	2	NP	1	22	24	2	JJ	0	22	23	1	apoptotic	22	22	23	0	NN	0	23	24	1	function	23	23	24	0	PP	0	24	29	2	IN	0	24	25	1	of	24	24	25	0	NP	0	25	29	2	NP	0	25	26	1	NN	0	25	26	1	p53	25	25	26	0	PP	0	26	29	2	IN	0	26	27	1	in	26	26	27	0	NP	1	27	29	2	NN	0	27	28	1	cancer	27	27	28	0	NNS	0	28	29	1	cells	28	28	29	0	VP	0	29	32	2	VBP	0	29	30	1	[	29	29	30	0	NP	0	30	32	1	QP	1	30	32	2	CD	0	30	31	1	2	30	30	31	0	CD	0	31	32	1	]	31	31	32	0	.	0	32	33	1	.	32	32	33	0
EOS
T	28
This	2869	2873	DT	this	O	_	_
may	2874	2877	MD	may	O	_	_
be	2878	2880	VB	be	O	_	_
achieved	2881	2889	VBN	achieve	O	_	_
via	2890	2893	IN	via	O	_	_
the	2894	2897	DT	the	O	_	_
ability	2898	2905	NN	ability	O	_	_
of	2906	2908	IN	of	O	_	_
active	2909	2915	JJ	active	O	_	_
RAS	2916	2919	NN	ra	O	_	_
to	2920	2922	TO	to	O	_	_
induce	2923	2929	VB	induce	O	_	_
ASPP2	2930	2935	NN	aspp2	O	_	_
,	2935	2936	,	,	O	_	_
thereby	2937	2944	RB	thereby	O	_	_
promoting	2945	2954	VBG	promote	O	_	_
ASPP2	2955	2960	NN	aspp2	O	_	_
's	2960	2962	POS	's	O	_	_
interaction	2963	2974	NN	interaction	O	_	_
with	2975	2979	IN	with	O	_	_
p53	2980	2983	NN	p53	B-GENE	_	_
and	2984	2987	CC	and	O	_	_
enhancing	2988	2997	VBG	enhance	O	_	_
the	2998	3001	DT	the	O	_	_
activity	3002	3010	NN	activity	O	_	_
of	3011	3013	IN	of	O	_	_
p53	3014	3017	NN	p53	B-GENE	_	_
.	3017	3018	.	.	O	_	_
D	1
3
3	0	nsubjpass
3	1	aux
3	2	auxpass
3	6	prep_via
3	11	xcomp
3	15	ccomp
3	22	ccomp
6	5	det
6	9	prep_of
9	8	amod
11	10	aux
11	12	dobj
15	14	advmod
15	18	dobj
15	22	conj_and
18	16	poss
18	20	prep_with
22	24	dobj
24	23	det
24	26	prep_of
EOX
Y	1
ROOT	0	0	28	1	S	1	0	28	3	NP	0	0	1	1	DT	0	0	1	1	This	0	0	1	0	VP	1	1	27	2	MD	0	1	2	1	may	1	1	2	0	VP	1	2	27	2	VB	0	2	3	1	be	2	2	3	0	VP	0	3	27	5	VBN	0	3	4	1	achieved	3	3	4	0	PP	0	4	10	2	IN	0	4	5	1	via	4	4	5	0	NP	0	5	10	2	NP	1	5	7	2	DT	0	5	6	1	the	5	5	6	0	NN	0	6	7	1	ability	6	6	7	0	PP	0	7	10	2	IN	0	7	8	1	of	7	7	8	0	NP	1	8	10	2	JJ	0	8	9	1	active	8	8	9	0	NN	0	9	10	1	RAS	9	9	10	0	S	0	10	13	1	VP	1	10	13	2	TO	0	10	11	1	to	10	10	11	0	VP	0	11	13	2	VB	0	11	12	1	induce	11	11	12	0	NP	0	12	13	1	NN	0	12	13	1	ASPP2	12	12	13	0	,	0	13	14	1	,	13	13	14	0	S	1	14	27	2	ADVP	0	14	15	1	RB	0	14	15	1	thereby	14	14	15	0	VP	0	15	27	3	VP	0	15	21	2	VBG	0	15	16	1	promoting	15	15	16	0	NP	0	16	21	2	NP	1	16	19	2	NP	0	16	18	2	NN	0	16	17	1	ASPP2	16	16	17	0	POS	0	17	18	1	's	17	17	18	0	NN	0	18	19	1	interaction	18	18	19	0	PP	0	19	21	2	IN	0	19	20	1	with	19	19	20	0	NP	0	20	21	1	NN	0	20	21	1	p53	20	20	21	0	CC	0	21	22	1	and	21	21	22	0	VP	0	22	27	2	VBG	0	22	23	1	enhancing	22	22	23	0	NP	0	23	27	2	NP	1	23	25	2	DT	0	23	24	1	the	23	23	24	0	NN	0	24	25	1	activity	24	24	25	0	PP	0	25	27	2	IN	0	25	26	1	of	25	25	26	0	NP	0	26	27	1	NN	0	26	27	1	p53	26	26	27	0	.	0	27	28	1	.	27	27	28	0
EOS
T	13
However	3019	3026	RB	however	O	_	_
,	3026	3027	,	,	O	_	_
the	3028	3031	DT	the	O	_	_
detailed	3032	3040	JJ	detailed	O	_	_
mechanism	3041	3050	NN	mechanism	O	_	_
underlying	3051	3061	VBG	underlie	O	_	_
this	3062	3066	DT	this	O	_	_
observation	3067	3078	NN	observation	O	_	_
remains	3079	3086	VBZ	remain	O	_	_
to	3087	3089	TO	to	O	_	_
be	3090	3092	VB	be	O	_	_
elucidated	3093	3103	VBN	elucidate	O	_	_
.	3103	3104	.	.	O	_	_
D	1
8
4	2	det
4	3	amod
4	5	vmod
5	7	dobj
7	6	det
8	0	advmod
8	4	nsubj
8	11	xcomp
11	9	aux
11	10	auxpass
EOX
Y	1
ROOT	0	0	13	1	S	3	0	13	5	ADVP	0	0	1	1	RB	0	0	1	1	However	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	0	2	8	2	NP	2	2	5	3	DT	0	2	3	1	the	2	2	3	0	JJ	0	3	4	1	detailed	3	3	4	0	NN	0	4	5	1	mechanism	4	4	5	0	VP	0	5	8	2	VBG	0	5	6	1	underlying	5	5	6	0	NP	1	6	8	2	DT	0	6	7	1	this	6	6	7	0	NN	0	7	8	1	observation	7	7	8	0	VP	0	8	12	2	VBZ	0	8	9	1	remains	8	8	9	0	S	0	9	12	1	VP	1	9	12	2	TO	0	9	10	1	to	9	9	10	0	VP	1	10	12	2	VB	0	10	11	1	be	10	10	11	0	VP	0	11	12	1	VBN	0	11	12	1	elucidated	11	11	12	0	.	0	12	13	1	.	12	12	13	0
EOS
T	22
Activated	3105	3114	VBN	activate	O	_	_
RAS	3115	3118	NN	ra	B-GENE	_	_
promotes	3119	3127	VBZ	promote	O	_	_
the	3128	3131	DT	the	O	_	_
protein	3132	3139	NN	protein	B-GENE	_	_
kinase	3140	3146	NN	kinase	I-GENE	_	_
activity	3147	3155	NN	activity	O	_	_
of	3156	3158	IN	of	O	_	_
RAF	3159	3162	NN	raf	B-GENE	_	_
,	3162	3163	,	,	O	_	_
which	3164	3169	WDT	which	O	_	_
phosphorylates	3170	3184	VBZ	phosphorylate	O	_	_
and	3185	3188	CC	and	O	_	_
activates	3189	3198	VBZ	activate	O	_	_
MEK	3199	3202	NN	mek	B-GENE	_	_
(	3203	3204	NN	(	O	_	_
also	3204	3208	RB	also	O	_	_
known	3209	3214	VBN	know	O	_	_
as	3215	3217	IN	as	O	_	_
MAPKK	3218	3223	NNP	MAPKK	B-GENE	_	_
)	3223	3224	CD	)	O	_	_
.	3224	3225	.	.	O	_	_
D	1
0
0	1	dobj
0	2	dep
0	6	nsubj
6	3	det
6	4	nn
6	5	nn
6	8	prep_of
6	11	rcmod
6	13	rcmod
11	10	nsubj
11	13	conj_and
11	15	dobj
13	10	nsubj
15	14	nn
15	17	vmod
17	16	advmod
17	19	prep_as
19	20	num
EOX
Y	1
ROOT	0	0	22	1	SINV	0	0	22	4	VP	0	0	2	2	VBN	0	0	1	1	Activated	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	RAS	1	1	2	0	VP	0	2	3	1	VBZ	0	2	3	1	promotes	2	2	3	0	NP	0	3	21	4	NP	3	3	7	4	DT	0	3	4	1	the	3	3	4	0	NN	0	4	5	1	protein	4	4	5	0	NN	0	5	6	1	kinase	5	5	6	0	NN	0	6	7	1	activity	6	6	7	0	PP	0	7	9	2	IN	0	7	8	1	of	7	7	8	0	NP	0	8	9	1	NN	0	8	9	1	RAF	8	8	9	0	,	0	9	10	1	,	9	9	10	0	SBAR	1	10	21	2	WHNP	0	10	11	1	WDT	0	10	11	1	which	10	10	11	0	S	0	11	21	1	VP	0	11	21	4	VBZ	0	11	12	1	phosphorylates	11	11	12	0	CC	0	12	13	1	and	12	12	13	0	VBZ	0	13	14	1	activates	13	13	14	0	NP	0	14	21	2	NP	1	14	16	2	NN	0	14	15	1	MEK	14	14	15	0	NN	0	15	16	1	(	15	15	16	0	VP	1	16	21	3	ADVP	0	16	17	1	RB	0	16	17	1	also	16	16	17	0	VBN	0	17	18	1	known	17	17	18	0	PP	0	18	21	2	IN	0	18	19	1	as	18	18	19	0	NP	0	19	21	2	NNP	0	19	20	1	MAPKK	19	19	20	0	CD	0	20	21	1	)	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	22
MEK	3226	3229	NN	mek	B-GENE	_	_
phosphorylates	3230	3244	VBZ	phosphorylate	O	_	_
and	3245	3248	CC	and	O	_	_
activates	3249	3258	VBZ	activate	O	_	_
a	3259	3260	DT	a	O	_	_
mitogen	3261	3268	NN	mitogen	B-GENE	_	_
activated	3269	3278	VBN	activate	I-GENE	_	_
protein	3279	3286	NN	protein	I-GENE	_	_
kinase	3287	3293	NN	kinase	I-GENE	_	_
(	3294	3295	CD	(	B-GENE	_	_
MAPK	3295	3299	NN	mapk	I-GENE	_	_
/	3299	3300	:	/	B-GENE	_	_
ERK	3300	3303	NN	erk	I-GENE	_	_
)	3303	3304	NN	)	O	_	_
,	3304	3305	,	,	O	_	_
a	3306	3307	DT	a	O	_	_
serine	3308	3314	NN	serine	O	_	_
/	3314	3315	:	/	O	_	_
threonine-selective	3315	3334	JJ	threonine-selective	O	_	_
protein	3335	3342	NN	protein	O	_	_
kinase	3343	3349	NN	kinase	O	_	_
.	3349	3350	.	.	O	_	_
D	1
1
1	0	nsubj
1	3	conj_and
1	5	dobj
3	0	nsubj
5	4	det
5	6	vmod
6	8	dobj
8	7	nn
8	10	dep
10	9	num
10	13	dep
10	20	dep
13	11	punct
13	12	nn
13	16	appos
13	17	punct
16	15	det
20	18	amod
20	19	nn
EOX
Y	1
ROOT	0	0	22	1	S	1	0	22	3	NP	0	0	1	1	NN	0	0	1	1	MEK	0	0	1	0	VP	0	1	21	4	VBZ	0	1	2	1	phosphorylates	1	1	2	0	CC	0	2	3	1	and	2	2	3	0	VBZ	0	3	4	1	activates	3	3	4	0	NP	0	4	21	2	NP	1	4	6	2	DT	0	4	5	1	a	4	4	5	0	NN	0	5	6	1	mitogen	5	5	6	0	VP	0	6	21	2	VBN	0	6	7	1	activated	6	6	7	0	NP	0	7	21	2	NP	1	7	9	2	NN	0	7	8	1	protein	7	7	8	0	NN	0	8	9	1	kinase	8	8	9	0	NP	0	9	21	2	NP	1	9	18	3	CD	0	9	10	1	(	9	9	10	0	NN	0	10	11	1	MAPK	10	10	11	0	PRN	1	11	18	3	:	0	11	12	1	/	11	11	12	0	NP	0	12	17	3	NP	1	12	14	2	NN	0	12	13	1	ERK	12	12	13	0	NN	0	13	14	1	)	13	13	14	0	,	0	14	15	1	,	14	14	15	0	NP	1	15	17	2	DT	0	15	16	1	a	15	15	16	0	NN	0	16	17	1	serine	16	16	17	0	:	0	17	18	1	/	17	17	18	0	NP	2	18	21	3	JJ	0	18	19	1	threonine-selective	18	18	19	0	NN	0	19	20	1	protein	19	19	20	0	NN	0	20	21	1	kinase	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	26
The	3351	3354	DT	the	O	_	_
MAPK	3355	3359	NN	mapk	O	_	_
enzymes	3360	3367	NNS	enzyme	O	_	_
require	3368	3375	VBP	require	O	_	_
a	3376	3377	DT	a	O	_	_
specific	3378	3386	JJ	specific	O	_	_
phosphorylation	3387	3402	NN	phosphorylation	O	_	_
sequence	3403	3411	NN	sequence	O	_	_
where	3412	3417	WRB	where	O	_	_
a	3418	3419	DT	a	O	_	_
serine	3420	3426	NN	serine	O	_	_
or	3427	3429	CC	or	O	_	_
threonine	3430	3439	NN	threonine	O	_	_
is	3440	3442	VBZ	be	O	_	_
followed	3443	3451	VBN	follow	O	_	_
by	3452	3454	IN	by	O	_	_
proline	3455	3462	NN	proline	O	_	_
(	3463	3464	CD	(	O	_	_
S	3464	3465	NN	s	O	_	_
/	3465	3466	:	/	O	_	_
TP	3466	3468	NN	tp	O	_	_
)	3468	3469	CD	)	O	_	_
[	3470	3471	CD	[	O	_	_
3	3471	3472	CD	3	O	_	_
]	3472	3473	NN	]	O	_	_
.	3473	3474	.	.	O	_	_
D	1
3
2	0	det
2	1	nn
3	2	nsubj
3	7	dobj
3	14	advcl
7	4	det
7	5	amod
7	6	nn
10	9	det
10	12	conj_or
14	8	advmod
14	10	nsubjpass
14	12	nsubjpass
14	13	auxpass
14	15	prep
15	16	dep
16	18	dep
16	19	punct
16	20	dep
18	17	num
20	21	num
20	24	dep
23	22	number
24	23	num
EOX
Y	1
ROOT	0	0	26	1	S	1	0	26	3	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	MAPK	1	1	2	0	NNS	0	2	3	1	enzymes	2	2	3	0	VP	0	3	25	3	VBP	0	3	4	1	require	3	3	4	0	NP	3	4	8	4	DT	0	4	5	1	a	4	4	5	0	JJ	0	5	6	1	specific	5	5	6	0	NN	0	6	7	1	phosphorylation	6	6	7	0	NN	0	7	8	1	sequence	7	7	8	0	SBAR	1	8	25	2	WHADVP	0	8	9	1	WRB	0	8	9	1	where	8	8	9	0	S	1	9	25	2	NP	1	9	13	4	DT	0	9	10	1	a	9	9	10	0	NN	0	10	11	1	serine	10	10	11	0	CC	0	11	12	1	or	11	11	12	0	NN	0	12	13	1	threonine	12	12	13	0	VP	1	13	25	2	VBZ	0	13	14	1	is	13	13	14	0	VP	0	14	25	2	VBN	0	14	15	1	followed	14	14	15	0	PP	0	15	25	2	IN	0	15	16	1	by	15	15	16	0	FRAG	0	16	25	3	NP	0	16	19	2	NP	0	16	17	1	NN	0	16	17	1	proline	16	16	17	0	NP	1	17	19	2	CD	0	17	18	1	(	17	17	18	0	NN	0	18	19	1	S	18	18	19	0	:	0	19	20	1	/	19	19	20	0	NP	0	20	25	2	NP	0	20	22	2	NN	0	20	21	1	TP	20	20	21	0	CD	0	21	22	1	)	21	21	22	0	NP	1	22	25	2	QP	1	22	24	2	CD	0	22	23	1	[	22	22	23	0	CD	0	23	24	1	3	23	23	24	0	NN	0	24	25	1	]	24	24	25	0	.	0	25	26	1	.	25	25	26	0
EOS
T	31
It	3475	3477	PRP	it	O	_	_
was	3478	3481	VBD	be	O	_	_
shown	3482	3487	VBN	show	O	_	_
that	3488	3492	IN	that	O	_	_
endogenous	3493	3503	JJ	endogenous	O	_	_
RAS	3504	3507	NN	ra	O	_	_
is	3508	3510	VBZ	be	O	_	_
necessary	3511	3520	JJ	necessary	O	_	_
for	3521	3524	IN	for	O	_	_
the	3525	3528	DT	the	O	_	_
full	3529	3533	JJ	full	O	_	_
apoptotic	3534	3543	JJ	apoptotic	O	_	_
activity	3544	3552	NN	activity	O	_	_
of	3553	3555	IN	of	O	_	_
ASPP2	3556	3561	NN	aspp2	B-GENE	_	_
,	3561	3562	,	,	O	_	_
which	3563	3568	WDT	which	O	_	_
suggests	3569	3577	VBZ	suggest	O	_	_
that	3578	3582	IN	that	O	_	_
RAS	3583	3586	NN	ra	B-GENE	_	_
signalling	3587	3597	NN	signalling	O	_	_
may	3598	3601	MD	may	O	_	_
modify	3602	3608	VB	modify	O	_	_
ASPP2	3609	3614	NN	aspp2	B-GENE	_	_
,	3614	3615	,	,	O	_	_
potentially	3616	3627	RB	potentially	O	_	_
via	3628	3631	IN	via	O	_	_
a	3632	3633	DT	a	O	_	_
phosphorylation	3634	3649	NN	phosphorylation	O	_	_
event	3650	3655	NN	event	O	_	_
.	3655	3656	.	.	O	_	_
D	1
2
2	0	nsubjpass
2	1	auxpass
2	7	ccomp
5	4	amod
7	3	mark
7	5	nsubj
7	6	cop
7	12	prep_for
12	9	det
12	10	amod
12	11	amod
12	14	prep_of
12	29	prep_via
14	17	rcmod
17	16	nsubj
17	22	ccomp
20	19	nn
22	18	mark
22	20	nsubj
22	21	aux
22	23	dobj
22	25	advmod
29	27	det
29	28	nn
EOX
Y	1
ROOT	0	0	31	1	S	1	0	31	3	NP	0	0	1	1	PRP	0	0	1	1	It	0	0	1	0	VP	1	1	30	2	VBD	0	1	2	1	was	1	1	2	0	VP	0	2	30	2	VBN	0	2	3	1	shown	2	2	3	0	SBAR	1	3	30	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	30	2	NP	1	4	6	2	JJ	0	4	5	1	endogenous	4	4	5	0	NN	0	5	6	1	RAS	5	5	6	0	VP	1	6	30	2	VBZ	0	6	7	1	is	6	6	7	0	ADJP	0	7	30	2	JJ	0	7	8	1	necessary	7	7	8	0	PP	0	8	30	2	IN	0	8	9	1	for	8	8	9	0	NP	0	9	30	3	NP	3	9	13	4	DT	0	9	10	1	the	9	9	10	0	JJ	0	10	11	1	full	10	10	11	0	JJ	0	11	12	1	apoptotic	11	11	12	0	NN	0	12	13	1	activity	12	12	13	0	PP	0	13	26	2	IN	0	13	14	1	of	13	13	14	0	NP	0	14	26	3	NP	0	14	15	1	NN	0	14	15	1	ASPP2	14	14	15	0	,	0	15	16	1	,	15	15	16	0	SBAR	1	16	26	2	WHNP	0	16	17	1	WDT	0	16	17	1	which	16	16	17	0	S	0	17	26	1	VP	0	17	26	2	VBZ	0	17	18	1	suggests	17	17	18	0	SBAR	1	18	26	2	IN	0	18	19	1	that	18	18	19	0	S	1	19	26	2	NP	1	19	21	2	NN	0	19	20	1	RAS	19	19	20	0	NN	0	20	21	1	signalling	20	20	21	0	VP	1	21	26	2	MD	0	21	22	1	may	21	21	22	0	VP	0	22	26	4	VB	0	22	23	1	modify	22	22	23	0	NP	0	23	24	1	NN	0	23	24	1	ASPP2	23	23	24	0	,	0	24	25	1	,	24	24	25	0	ADVP	0	25	26	1	RB	0	25	26	1	potentially	25	25	26	0	PP	0	26	30	2	IN	0	26	27	1	via	26	26	27	0	NP	2	27	30	3	DT	0	27	28	1	a	27	27	28	0	NN	0	28	29	1	phosphorylation	28	28	29	0	NN	0	29	30	1	event	29	29	30	0	.	0	30	31	1	.	30	30	31	0
EOS
T	28
Phosphorylation	3657	3672	NN	phosphorylation	O	_	_
by	3673	3675	IN	by	O	_	_
RAS	3676	3679	NN	ra	B-GENE	_	_
/	3679	3680	:	/	B-GENE	_	_
MAPK	3680	3684	NN	mapk	I-GENE	_	_
modulates	3685	3694	VBZ	modulate	O	_	_
the	3695	3698	DT	the	O	_	_
activation	3699	3709	NN	activation	O	_	_
of	3710	3712	IN	of	O	_	_
most	3713	3717	JJS	most	O	_	_
of	3718	3720	IN	of	O	_	_
their	3721	3726	PRP$	they	O	_	_
substrates	3727	3737	NNS	substrate	O	_	_
and	3738	3741	CC	and	O	_	_
in	3742	3744	IN	in	O	_	_
some	3745	3749	DT	some	O	_	_
cases	3750	3755	NNS	case	O	_	_
the	3756	3759	DT	the	O	_	_
phosphorylation	3760	3775	NN	phosphorylation	O	_	_
mediates	3776	3784	VBZ	mediate	O	_	_
changes	3785	3792	NNS	change	O	_	_
in	3793	3795	IN	in	O	_	_
subcellular	3796	3807	JJ	subcellular	O	_	_
localisation	3808	3820	NN	localisation	O	_	_
[	3821	3822	NN	[	O	_	_
4	3822	3823	CD	4	O	_	_
]	3823	3824	NN	]	O	_	_
.	3824	3825	.	.	O	_	_
D	1
0
0	2	prep_by
0	3	punct
0	19	dep
5	4	nsubj
5	5	conj_and
5	7	dobj
5	9	prep_of
5	16	prep_in
5	18	pobj
7	6	det
9	12	prep_of
12	11	poss
16	15	det
18	17	det
19	5	dep
19	20	dobj
19	24	prep_in
19	26	nsubj
24	22	amod
24	23	nn
26	25	num
EOX
Y	1
ROOT	0	0	28	1	FRAG	0	0	28	4	NP	0	0	3	2	NP	0	0	1	1	NN	0	0	1	1	Phosphorylation	0	0	1	0	PP	0	1	3	2	IN	0	1	2	1	by	1	1	2	0	NP	0	2	3	1	NN	0	2	3	1	RAS	2	2	3	0	:	0	3	4	1	/	3	3	4	0	SINV	1	4	27	3	S	1	4	19	2	NP	0	4	5	1	NN	0	4	5	1	MAPK	4	4	5	0	VP	0	5	19	3	VBZ	0	5	6	1	modulates	5	5	6	0	NP	1	6	8	2	DT	0	6	7	1	the	6	6	7	0	NN	0	7	8	1	activation	7	7	8	0	PP	0	8	19	4	PP	0	8	13	2	IN	0	8	9	1	of	8	8	9	0	NP	0	9	13	2	NP	0	9	10	1	JJS	0	9	10	1	most	9	9	10	0	PP	0	10	13	2	IN	0	10	11	1	of	10	10	11	0	NP	1	11	13	2	PRP$	0	11	12	1	their	11	11	12	0	NNS	0	12	13	1	substrates	12	12	13	0	CC	0	13	14	1	and	13	13	14	0	PP	0	14	17	2	IN	0	14	15	1	in	14	14	15	0	NP	1	15	17	2	DT	0	15	16	1	some	15	15	16	0	NNS	0	16	17	1	cases	16	16	17	0	NP	1	17	19	2	DT	0	17	18	1	the	17	17	18	0	NN	0	18	19	1	phosphorylation	18	18	19	0	VP	0	19	25	3	VBZ	0	19	20	1	mediates	19	19	20	0	NP	0	20	21	1	NNS	0	20	21	1	changes	20	20	21	0	PP	0	21	25	2	IN	0	21	22	1	in	21	21	22	0	NP	2	22	25	3	JJ	0	22	23	1	subcellular	22	22	23	0	NN	0	23	24	1	localisation	23	23	24	0	NN	0	24	25	1	[	24	24	25	0	NP	1	25	27	2	CD	0	25	26	1	4	25	25	26	0	NN	0	26	27	1	]	26	26	27	0	.	0	27	28	1	.	27	27	28	0
EOS
T	16
ASPP2	3826	3831	NN	aspp2	B-GENE	_	_
belongs	3832	3839	VBZ	belong	O	_	_
to	3840	3842	TO	to	O	_	_
an	3843	3845	DT	a	O	_	_
evolutionarily	3846	3860	RB	evolutionarily	O	_	_
conserved	3861	3870	VBN	conserve	O	_	_
ASPP	3871	3875	NN	aspp	B-GENE	_	_
family	3876	3882	NN	family	I-GENE	_	_
of	3883	3885	IN	of	O	_	_
proteins	3886	3894	NNS	protein	O	_	_
,	3894	3895	,	,	O	_	_
alongside	3896	3905	IN	alongside	O	_	_
ASPP1	3906	3911	NN	aspp1	O	_	_
and	3912	3915	CC	and	O	_	_
iASPP	3916	3921	NN	iaspp	O	_	_
.	3921	3922	.	.	O	_	_
D	1
1
1	0	nsubj
1	7	prep_to
4	5	dep
7	3	det
7	4	amod
7	6	nn
7	9	prep_of
7	12	prep_alongside
7	14	prep_alongside
12	14	conj_and
EOX
Y	1
ROOT	0	0	16	1	S	1	0	16	3	NP	0	0	1	1	NN	0	0	1	1	ASPP2	0	0	1	0	VP	0	1	15	2	VBZ	0	1	2	1	belongs	1	1	2	0	PP	0	2	15	2	TO	0	2	3	1	to	2	2	3	0	NP	0	3	15	4	NP	3	3	8	4	DT	0	3	4	1	an	3	3	4	0	ADJP	0	4	6	2	RB	0	4	5	1	evolutionarily	4	4	5	0	S	0	5	6	1	VP	0	5	6	1	VBN	0	5	6	1	conserved	5	5	6	0	NN	0	6	7	1	ASPP	6	6	7	0	NN	0	7	8	1	family	7	7	8	0	PP	0	8	10	2	IN	0	8	9	1	of	8	8	9	0	NP	0	9	10	1	NNS	0	9	10	1	proteins	9	9	10	0	,	0	10	11	1	,	10	10	11	0	PP	0	11	15	2	IN	0	11	12	1	alongside	11	11	12	0	NP	0	12	15	3	NN	0	12	13	1	ASPP1	12	12	13	0	CC	0	13	14	1	and	13	13	14	0	NN	0	14	15	1	iASPP	14	14	15	0	.	0	15	16	1	.	15	15	16	0
EOS
T	22
All	3923	3926	DT	all	O	_	_
three	3927	3932	CD	three	O	_	_
contain	3933	3940	VBP	contain	O	_	_
signature	3941	3950	NN	signature	O	_	_
sequences	3951	3960	NNS	sequence	O	_	_
in	3961	3963	IN	in	O	_	_
their	3964	3969	PRP$	they	O	_	_
C-termini	3970	3979	NNS	c-terminus	O	_	_
;	3979	3980	:	;	O	_	_
ankyrin	3981	3988	NN	ankyrin	B-GENE	_	_
repeats	3989	3996	NNS	repeat	O	_	_
,	3996	3997	,	,	O	_	_
SH3	3998	4001	NN	sh3	B-GENE	_	_
domain	4002	4008	NN	domain	I-GENE	_	_
and	4009	4012	CC	and	O	_	_
proline	4013	4020	NN	proline	O	_	_
rich	4021	4025	JJ	rich	O	_	_
sequences	4026	4035	NNS	sequence	O	_	_
[	4036	4037	VBP	[	O	_	_
5	4037	4038	CD	5	O	_	_
]	4038	4039	CD	]	O	_	_
.	4039	4040	.	.	O	_	_
D	1
2
1	0	det
2	1	nsubj
2	4	dobj
2	18	parataxis
4	3	nn
4	7	prep_in
7	6	poss
10	9	nn
10	13	conj_and
10	17	conj_and
13	12	nn
17	15	nn
17	16	amod
18	10	nsubj
18	13	nsubj
18	17	nsubj
18	20	dobj
20	19	number
EOX
Y	1
ROOT	0	0	22	1	S	0	0	22	4	S	1	0	8	2	NP	1	0	2	2	DT	0	0	1	1	All	0	0	1	0	CD	0	1	2	1	three	1	1	2	0	VP	0	2	8	2	VBP	0	2	3	1	contain	2	2	3	0	NP	0	3	8	2	NP	1	3	5	2	NN	0	3	4	1	signature	3	3	4	0	NNS	0	4	5	1	sequences	4	4	5	0	PP	0	5	8	2	IN	0	5	6	1	in	5	5	6	0	NP	1	6	8	2	PRP$	0	6	7	1	their	6	6	7	0	NNS	0	7	8	1	C-termini	7	7	8	0	:	0	8	9	1	;	8	8	9	0	S	1	9	21	2	NP	0	9	18	5	NP	1	9	11	2	NN	0	9	10	1	ankyrin	9	9	10	0	NNS	0	10	11	1	repeats	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	1	12	14	2	NN	0	12	13	1	SH3	12	12	13	0	NN	0	13	14	1	domain	13	13	14	0	CC	0	14	15	1	and	14	14	15	0	NP	2	15	18	3	NN	0	15	16	1	proline	15	15	16	0	JJ	0	16	17	1	rich	16	16	17	0	NNS	0	17	18	1	sequences	17	17	18	0	VP	0	18	21	2	VBP	0	18	19	1	[	18	18	19	0	NP	0	19	21	1	QP	1	19	21	2	CD	0	19	20	1	5	19	19	20	0	CD	0	20	21	1	]	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	11
ASPP2	4041	4046	NN	aspp2	B-GENE	_	_
binds	4047	4052	VBZ	bind	O	_	_
to	4053	4055	TO	to	O	_	_
RAS	4056	4059	NN	ra	O	_	_
through	4060	4067	IN	through	O	_	_
its	4068	4071	PRP$	its	O	_	_
N-terminus	4072	4082	NN	n-terminus	O	_	_
[	4083	4084	CD	[	O	_	_
2,6	4084	4087	CD	2,6	O	_	_
]	4087	4088	NN	]	O	_	_
.	4088	4089	.	.	O	_	_
D	1
1
1	0	nsubj
1	3	prep_to
1	6	prep_through
1	9	dep
6	5	poss
8	7	number
9	8	num
EOX
Y	1
ROOT	0	0	11	1	S	1	0	11	3	NP	0	0	1	1	NN	0	0	1	1	ASPP2	0	0	1	0	VP	0	1	10	3	VBZ	0	1	2	1	binds	1	1	2	0	PP	0	2	4	2	TO	0	2	3	1	to	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	RAS	3	3	4	0	PP	0	4	10	3	IN	0	4	5	1	through	4	4	5	0	NP	1	5	7	2	PRP$	0	5	6	1	its	5	5	6	0	NN	0	6	7	1	N-terminus	6	6	7	0	NP	1	7	10	2	QP	1	7	9	2	CD	0	7	8	1	[	7	7	8	0	CD	0	8	9	1	2,6	8	8	9	0	NN	0	9	10	1	]	9	9	10	0	.	0	10	11	1	.	10	10	11	0
EOS
T	14
The	4090	4093	DT	the	O	_	_
functions	4094	4103	NNS	function	O	_	_
of	4104	4106	IN	of	O	_	_
ASPP2	4107	4112	NN	aspp2	B-GENE	_	_
are	4113	4116	VBP	be	O	_	_
potentially	4117	4128	RB	potentially	O	_	_
controlled	4129	4139	VBN	control	O	_	_
by	4140	4142	IN	by	O	_	_
its	4143	4146	PRP$	its	O	_	_
binding	4147	4154	VBG	bind	O	_	_
partners	4155	4163	NNS	partner	O	_	_
and	4164	4167	CC	and	O	_	_
localisation	4168	4180	NN	localisation	O	_	_
.	4180	4181	.	.	O	_	_
D	1
6
1	0	det
1	3	prep_of
6	1	nsubjpass
6	4	auxpass
6	5	advmod
6	10	agent
6	12	agent
10	8	poss
10	9	amod
10	12	conj_and
EOX
Y	1
ROOT	0	0	14	1	S	1	0	14	3	NP	0	0	4	2	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NNS	0	1	2	1	functions	1	1	2	0	PP	0	2	4	2	IN	0	2	3	1	of	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	ASPP2	3	3	4	0	VP	1	4	13	2	VBP	0	4	5	1	are	4	4	5	0	ADJP	1	5	13	3	RB	0	5	6	1	potentially	5	5	6	0	VBN	0	6	7	1	controlled	6	6	7	0	PP	0	7	13	2	IN	0	7	8	1	by	7	7	8	0	NP	0	8	13	3	NP	2	8	11	3	PRP$	0	8	9	1	its	8	8	9	0	VBG	0	9	10	1	binding	9	9	10	0	NNS	0	10	11	1	partners	10	10	11	0	CC	0	11	12	1	and	11	11	12	0	NP	0	12	13	1	NN	0	12	13	1	localisation	12	12	13	0	.	0	13	14	1	.	13	13	14	0
EOS
T	50
When	4182	4186	WRB	when	O	_	_
ASPP2	4187	4192	NN	aspp2	O	_	_
locates	4193	4200	VBZ	locate	O	_	_
at	4201	4203	IN	at	O	_	_
the	4204	4207	DT	the	O	_	_
cell-cell	4208	4217	JJ	cell-cell	O	_	_
junctions	4218	4227	NNS	junction	O	_	_
,	4227	4228	,	,	O	_	_
it	4229	4231	PRP	it	O	_	_
binds	4232	4237	VBZ	bind	O	_	_
and	4238	4241	CC	and	O	_	_
co-localises	4242	4254	VBZ	co-localise	O	_	_
with	4255	4259	IN	with	O	_	_
PAR3	4260	4264	NN	par3	B-GENE	_	_
via	4265	4268	IN	via	O	_	_
its	4269	4272	PRP$	its	O	_	_
N-terminus	4273	4283	NN	n-terminus	O	_	_
to	4284	4286	TO	to	O	_	_
maintain	4287	4295	VB	maintain	O	_	_
the	4296	4299	DT	the	O	_	_
integrity	4300	4309	NN	integrity	O	_	_
of	4310	4312	IN	of	O	_	_
cell	4313	4317	NN	cell	O	_	_
polarity	4318	4326	NN	polarity	O	_	_
and	4327	4330	CC	and	O	_	_
adherence	4331	4340	NN	adherence	O	_	_
junction	4341	4349	NN	junction	O	_	_
[	4350	4351	CD	[	O	_	_
7,8	4351	4354	CD	7,8	O	_	_
]	4354	4355	NN	]	O	_	_
,	4355	4356	,	,	O	_	_
whereas	4357	4364	IN	whereas	O	_	_
in	4365	4367	IN	in	O	_	_
the	4368	4371	DT	the	O	_	_
cytosol	4372	4379	NN	cytosol	O	_	_
/	4379	4380	:	/	O	_	_
nucleus	4380	4387	NN	nucleus	O	_	_
,	4387	4388	,	,	O	_	_
ASPP2	4389	4394	NN	aspp2	B-GENE	_	_
enhances	4395	4403	VBZ	enhance	O	_	_
p53	4404	4407	NN	p53	B-GENE	_	_
induced	4408	4415	JJ	induced	O	_	_
apoptosis	4416	4425	NN	apoptosis	O	_	_
in	4426	4428	IN	in	O	_	_
cancer	4429	4435	NN	cancer	O	_	_
cells	4436	4441	NNS	cell	O	_	_
[	4442	4443	VBP	[	O	_	_
9	4443	4444	CD	9	O	_	_
]	4444	4445	NN	]	O	_	_
.	4445	4446	.	.	O	_	_
D	1
39
2	0	advmod
2	1	nsubj
2	6	prep_at
6	4	det
6	5	amod
9	2	advcl
9	8	nsubj
9	11	conj_and
9	13	prep_with
11	8	nsubj
13	16	prep_via
16	15	poss
16	18	vmod
18	17	aux
18	20	dobj
20	19	det
20	23	prep_of
20	26	prep_of
23	22	nn
23	26	conj_and
23	29	dep
23	36	dep
26	25	nn
28	27	number
29	28	num
34	32	dep
34	33	det
36	31	mark
36	34	dep
36	35	punct
39	9	ccomp
39	11	ccomp
39	38	nsubj
39	46	ccomp
42	40	nn
42	41	amod
42	45	prep_in
45	44	nn
46	42	nsubj
46	48	dobj
48	47	num
EOX
Y	1
ROOT	0	0	50	1	S	3	0	50	5	S	3	0	37	4	SBAR	1	0	7	2	WHADVP	0	0	1	1	WRB	0	0	1	1	When	0	0	1	0	S	1	1	7	2	NP	0	1	2	1	NN	0	1	2	1	ASPP2	1	1	2	0	VP	0	2	7	2	VBZ	0	2	3	1	locates	2	2	3	0	PP	0	3	7	2	IN	0	3	4	1	at	3	3	4	0	NP	2	4	7	3	DT	0	4	5	1	the	4	4	5	0	JJ	0	5	6	1	cell-cell	5	5	6	0	NNS	0	6	7	1	junctions	6	6	7	0	,	0	7	8	1	,	7	7	8	0	NP	0	8	9	1	PRP	0	8	9	1	it	8	8	9	0	VP	0	9	37	4	VBZ	0	9	10	1	binds	9	9	10	0	CC	0	10	11	1	and	10	10	11	0	VBZ	0	11	12	1	co-localises	11	11	12	0	PP	0	12	37	2	IN	0	12	13	1	with	12	12	13	0	NP	0	13	37	2	NP	0	13	14	1	NN	0	13	14	1	PAR3	13	13	14	0	PP	0	14	37	2	IN	0	14	15	1	via	14	14	15	0	NP	1	15	37	3	PRP$	0	15	16	1	its	15	15	16	0	NN	0	16	17	1	N-terminus	16	16	17	0	S	0	17	37	1	VP	1	17	37	2	TO	0	17	18	1	to	17	17	18	0	VP	0	18	37	2	VB	0	18	19	1	maintain	18	18	19	0	NP	0	19	37	2	NP	1	19	21	2	DT	0	19	20	1	the	19	19	20	0	NN	0	20	21	1	integrity	20	20	21	0	PP	0	21	37	2	IN	0	21	22	1	of	21	21	22	0	NP	0	22	37	3	NP	0	22	30	2	NP	0	22	27	3	NP	1	22	24	2	NN	0	22	23	1	cell	22	22	23	0	NN	0	23	24	1	polarity	23	23	24	0	CC	0	24	25	1	and	24	24	25	0	NP	1	25	27	2	NN	0	25	26	1	adherence	25	25	26	0	NN	0	26	27	1	junction	26	26	27	0	NP	1	27	30	2	QP	1	27	29	2	CD	0	27	28	1	[	27	27	28	0	CD	0	28	29	1	7,8	28	28	29	0	NN	0	29	30	1	]	29	29	30	0	,	0	30	31	1	,	30	30	31	0	SBAR	1	31	37	2	IN	0	31	32	1	whereas	31	31	32	0	FRAG	2	32	37	3	X	1	32	35	2	IN	0	32	33	1	in	32	32	33	0	NP	1	33	35	2	DT	0	33	34	1	the	33	33	34	0	NN	0	34	35	1	cytosol	34	34	35	0	:	0	35	36	1	/	35	35	36	0	NP	0	36	37	1	NN	0	36	37	1	nucleus	36	36	37	0	,	0	37	38	1	,	37	37	38	0	NP	0	38	39	1	NN	0	38	39	1	ASPP2	38	38	39	0	VP	0	39	49	2	VBZ	0	39	40	1	enhances	39	39	40	0	SBAR	0	40	49	1	S	1	40	49	2	NP	0	40	46	2	NP	2	40	43	3	NN	0	40	41	1	p53	40	40	41	0	JJ	0	41	42	1	induced	41	41	42	0	NN	0	42	43	1	apoptosis	42	42	43	0	PP	0	43	46	2	IN	0	43	44	1	in	43	43	44	0	NP	1	44	46	2	NN	0	44	45	1	cancer	44	44	45	0	NNS	0	45	46	1	cells	45	45	46	0	VP	0	46	49	2	VBP	0	46	47	1	[	46	46	47	0	NP	1	47	49	2	CD	0	47	48	1	9	47	47	48	0	NN	0	48	49	1	]	48	48	49	0	.	0	49	50	1	.	49	49	50	0
EOS
T	17
It	4447	4449	PRP	it	O	_	_
also	4450	4454	RB	also	O	_	_
binds	4455	4460	VBZ	bind	O	_	_
ATG5	4461	4465	NN	atg5	B-GENE	_	_
and	4466	4469	CC	and	O	_	_
inhibits	4470	4478	VBZ	inhibit	O	_	_
RAS	4479	4482	NN	ra	O	_	_
induced	4483	4490	VBD	induce	O	_	_
autophagy	4491	4500	NN	autophagy	O	_	_
,	4500	4501	,	,	O	_	_
independently	4502	4515	RB	independently	O	_	_
of	4516	4518	IN	of	O	_	_
p53	4519	4522	NN	p53	B-GENE	_	_
[	4523	4524	CD	[	I-GENE	_	_
10	4524	4526	CD	10	I-GENE	_	_
]	4526	4527	NN	]	I-GENE	_	_
.	4527	4528	.	.	O	_	_
D	1
2
2	0	nsubj
2	1	advmod
2	3	dobj
2	5	conj_and
5	0	nsubj
5	7	ccomp
7	6	nsubj
7	8	dobj
8	15	rcmod
10	12	prep_of
14	13	number
15	10	advmod
15	14	num
EOX
Y	1
ROOT	0	0	17	1	S	2	0	17	4	NP	0	0	1	1	PRP	0	0	1	1	It	0	0	1	0	ADVP	0	1	2	1	RB	0	1	2	1	also	1	1	2	0	VP	0	2	16	3	VP	0	2	4	2	VBZ	0	2	3	1	binds	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	ATG5	3	3	4	0	CC	0	4	5	1	and	4	4	5	0	VP	0	5	16	2	VBZ	0	5	6	1	inhibits	5	5	6	0	SBAR	0	6	16	1	S	1	6	16	2	NP	0	6	7	1	NN	0	6	7	1	RAS	6	6	7	0	VP	0	7	16	2	VBD	0	7	8	1	induced	7	7	8	0	NP	0	8	16	3	NP	0	8	9	1	NN	0	8	9	1	autophagy	8	8	9	0	,	0	9	10	1	,	9	9	10	0	RRC	1	10	16	2	ADVP	0	10	13	2	RB	0	10	11	1	independently	10	10	11	0	PP	0	11	13	2	IN	0	11	12	1	of	11	11	12	0	NP	0	12	13	1	NN	0	12	13	1	p53	12	12	13	0	NP	1	13	16	2	QP	1	13	15	2	CD	0	13	14	1	[	13	13	14	0	CD	0	14	15	1	10	14	14	15	0	NN	0	15	16	1	]	15	15	16	0	.	0	16	17	1	.	16	16	17	0
EOS
T	16
Thus	4529	4533	RB	thus	O	_	_
it	4534	4536	PRP	it	O	_	_
is	4537	4539	VBZ	be	O	_	_
important	4540	4549	JJ	important	O	_	_
to	4550	4552	TO	to	O	_	_
find	4553	4557	VB	find	O	_	_
the	4558	4561	DT	the	O	_	_
molecular	4562	4571	JJ	molecular	O	_	_
event	4572	4577	NN	event	O	_	_
that	4578	4582	WDT	that	O	_	_
controls	4583	4591	VBZ	control	O	_	_
the	4592	4595	DT	the	O	_	_
localisation	4596	4608	NN	localisation	O	_	_
of	4609	4611	IN	of	O	_	_
ASPP2	4612	4617	NN	aspp2	B-GENE	_	_
.	4617	4618	.	.	O	_	_
D	1
3
3	0	advmod
3	1	nsubj
3	2	cop
3	5	xcomp
5	4	aux
5	8	dobj
8	6	det
8	7	amod
8	10	rcmod
10	9	nsubj
10	12	dobj
12	11	det
12	14	prep_of
EOX
Y	1
ROOT	0	0	16	1	S	2	0	16	4	ADVP	0	0	1	1	RB	0	0	1	1	Thus	0	0	1	0	NP	0	1	2	1	PRP	0	1	2	1	it	1	1	2	0	VP	1	2	15	2	VBZ	0	2	3	1	is	2	2	3	0	ADJP	0	3	15	2	JJ	0	3	4	1	important	3	3	4	0	S	0	4	15	1	VP	1	4	15	2	TO	0	4	5	1	to	4	4	5	0	VP	0	5	15	2	VB	0	5	6	1	find	5	5	6	0	NP	0	6	15	2	NP	2	6	9	3	DT	0	6	7	1	the	6	6	7	0	JJ	0	7	8	1	molecular	7	7	8	0	NN	0	8	9	1	event	8	8	9	0	SBAR	1	9	15	2	WHNP	0	9	10	1	WDT	0	9	10	1	that	9	9	10	0	S	0	10	15	1	VP	0	10	15	2	VBZ	0	10	11	1	controls	10	10	11	0	NP	0	11	15	2	NP	1	11	13	2	DT	0	11	12	1	the	11	11	12	0	NN	0	12	13	1	localisation	12	12	13	0	PP	0	13	15	2	IN	0	13	14	1	of	13	13	14	0	NP	0	14	15	1	NN	0	14	15	1	ASPP2	14	14	15	0	.	0	15	16	1	.	15	15	16	0
EOS
T	14
Here	4619	4623	RB	here	O	_	_
we	4624	4626	PRP	we	O	_	_
show	4627	4631	VBP	show	O	_	_
that	4632	4636	IN	that	O	_	_
ASPP2	4637	4642	NN	aspp2	B-GENE	_	_
is	4643	4645	VBZ	be	O	_	_
a	4646	4647	DT	a	O	_	_
novel	4648	4653	JJ	novel	O	_	_
substrate	4654	4663	NN	substrate	O	_	_
of	4664	4666	IN	of	O	_	_
RAS	4667	4670	NN	ra	B-GENE	_	_
/	4670	4671	:	/	B-GENE	_	_
MAPK	4671	4675	NN	mapk	I-GENE	_	_
.	4675	4676	.	.	O	_	_
D	1
2
2	0	advmod
2	1	nsubj
2	8	ccomp
8	3	mark
8	4	nsubj
8	5	cop
8	6	det
8	7	amod
8	10	prep_of
10	12	dep
12	11	punct
EOX
Y	1
ROOT	0	0	14	1	S	2	0	14	4	ADVP	0	0	1	1	RB	0	0	1	1	Here	0	0	1	0	NP	0	1	2	1	PRP	0	1	2	1	we	1	1	2	0	VP	0	2	13	2	VBP	0	2	3	1	show	2	2	3	0	SBAR	1	3	13	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	13	2	NP	0	4	5	1	NN	0	4	5	1	ASPP2	4	4	5	0	VP	1	5	13	2	VBZ	0	5	6	1	is	5	5	6	0	NP	0	6	13	2	NP	2	6	9	3	DT	0	6	7	1	a	6	6	7	0	JJ	0	7	8	1	novel	7	7	8	0	NN	0	8	9	1	substrate	8	8	9	0	PP	0	9	13	2	IN	0	9	10	1	of	9	9	10	0	NP	0	10	13	2	NP	0	10	11	1	NN	0	10	11	1	RAS	10	10	11	0	PRN	1	11	13	2	:	0	11	12	1	/	11	11	12	0	NP	0	12	13	1	NN	0	12	13	1	MAPK	12	12	13	0	.	0	13	14	1	.	13	13	14	0
EOS
T	24
Phosphorylation	4677	4692	NN	phosphorylation	O	_	_
of	4693	4695	IN	of	O	_	_
ASPP2	4696	4701	NN	aspp2	B-GENE	_	_
by	4702	4704	IN	by	O	_	_
MAPK	4705	4709	NN	mapk	B-GENE	_	_
is	4710	4712	VBZ	be	O	_	_
required	4713	4721	VBN	require	O	_	_
for	4722	4725	IN	for	O	_	_
the	4726	4729	DT	the	O	_	_
RAS	4730	4733	NN	ra	O	_	_
induced	4734	4741	VBD	induce	O	_	_
translocation	4742	4755	NN	translocation	O	_	_
of	4756	4758	IN	of	O	_	_
ASPP2	4759	4764	NN	aspp2	B-GENE	_	_
,	4764	4765	,	,	O	_	_
which	4766	4771	WDT	which	O	_	_
results	4772	4779	VBZ	result	O	_	_
in	4780	4782	IN	in	O	_	_
the	4783	4786	DT	the	O	_	_
increased	4787	4796	VBN	increase	O	_	_
binding	4797	4804	NN	binding	O	_	_
to	4805	4807	TO	to	O	_	_
p53	4808	4811	NN	p53	B-GENE	_	_
.	4811	4812	.	.	O	_	_
D	1
6
0	2	prep_of
2	4	prep_by
6	0	nsubjpass
6	5	auxpass
6	10	advcl
9	8	det
10	7	mark
10	9	nsubj
10	11	dobj
11	13	prep_of
13	16	rcmod
16	15	nsubj
16	20	prep_in
20	18	det
20	19	amod
20	22	prep_to
EOX
Y	1
ROOT	0	0	24	1	S	1	0	24	3	NP	0	0	5	2	NP	0	0	1	1	NN	0	0	1	1	Phosphorylation	0	0	1	0	PP	0	1	5	2	IN	0	1	2	1	of	1	1	2	0	NP	0	2	5	2	NP	0	2	3	1	NN	0	2	3	1	ASPP2	2	2	3	0	PP	0	3	5	2	IN	0	3	4	1	by	3	3	4	0	NP	0	4	5	1	NN	0	4	5	1	MAPK	4	4	5	0	VP	1	5	23	2	VBZ	0	5	6	1	is	5	5	6	0	VP	0	6	23	2	VBN	0	6	7	1	required	6	6	7	0	SBAR	1	7	23	2	IN	0	7	8	1	for	7	7	8	0	S	1	8	23	2	NP	1	8	10	2	DT	0	8	9	1	the	8	8	9	0	NN	0	9	10	1	RAS	9	9	10	0	VP	0	10	23	2	VBD	0	10	11	1	induced	10	10	11	0	NP	0	11	23	2	NP	0	11	12	1	NN	0	11	12	1	translocation	11	11	12	0	PP	0	12	23	2	IN	0	12	13	1	of	12	12	13	0	NP	0	13	23	3	NP	0	13	14	1	NN	0	13	14	1	ASPP2	13	13	14	0	,	0	14	15	1	,	14	14	15	0	SBAR	1	15	23	2	WHNP	0	15	16	1	WDT	0	15	16	1	which	15	15	16	0	S	0	16	23	1	VP	0	16	23	2	VBZ	0	16	17	1	results	16	16	17	0	PP	0	17	23	2	IN	0	17	18	1	in	17	17	18	0	NP	0	18	23	2	NP	2	18	21	3	DT	0	18	19	1	the	18	18	19	0	VBN	0	19	20	1	increased	19	19	20	0	NN	0	20	21	1	binding	20	20	21	0	PP	0	21	23	2	TO	0	21	22	1	to	21	21	22	0	NP	0	22	23	1	NN	0	22	23	1	p53	22	22	23	0	.	0	23	24	1	.	23	23	24	0
EOS
T	25
Consequently	4813	4825	RB	consequently	O	_	_
,	4825	4826	,	,	O	_	_
the	4827	4830	DT	the	O	_	_
pro-apoptotic	4831	4844	JJ	pro-apoptotic	O	_	_
activity	4845	4853	NN	activity	O	_	_
of	4854	4856	IN	of	O	_	_
ASPP2	4857	4862	NN	aspp2	B-GENE	_	_
is	4863	4865	VBZ	be	O	_	_
increased	4866	4875	VBN	increase	O	_	_
by	4876	4878	IN	by	O	_	_
the	4879	4882	DT	the	O	_	_
RAS	4883	4886	NN	ra	B-GENE	_	_
/	4886	4887	:	/	I-GENE	_	_
Raf/MAPK	4887	4895	NN	raf/mapk	B-GENE	_	_
signalling	4896	4906	NN	signalling	O	_	_
cascade	4907	4914	NN	cascade	O	_	_
as	4915	4917	IN	as	O	_	_
ASPP2	4918	4923	NN	aspp2	B-GENE	_	_
phosphorylation	4924	4939	NN	phosphorylation	O	_	_
mutant	4940	4946	JJ	mutant	O	_	_
fails	4947	4952	VBZ	fail	O	_	_
to	4953	4955	TO	to	O	_	_
do	4956	4958	VB	do	O	_	_
so	4959	4961	RB	so	O	_	_
.	4961	4962	.	.	O	_	_
D	1
8
4	2	det
4	3	amod
4	6	prep_of
8	0	advmod
8	4	nsubjpass
8	7	auxpass
8	11	agent
11	10	det
11	19	dep
11	20	rcmod
15	13	nn
15	14	nn
15	18	prep_as
18	17	nn
19	12	punct
19	15	dep
20	22	xcomp
22	21	aux
22	23	advmod
EOX
Y	1
ROOT	0	0	25	1	S	3	0	25	5	ADVP	0	0	1	1	RB	0	0	1	1	Consequently	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	0	2	7	2	NP	2	2	5	3	DT	0	2	3	1	the	2	2	3	0	JJ	0	3	4	1	pro-apoptotic	3	3	4	0	NN	0	4	5	1	activity	4	4	5	0	PP	0	5	7	2	IN	0	5	6	1	of	5	5	6	0	NP	0	6	7	1	NN	0	6	7	1	ASPP2	6	6	7	0	VP	1	7	24	2	VBZ	0	7	8	1	is	7	7	8	0	VP	0	8	24	2	VBN	0	8	9	1	increased	8	8	9	0	PP	0	9	24	2	IN	0	9	10	1	by	9	9	10	0	NP	0	10	24	2	NP	0	10	20	2	NP	1	10	12	2	DT	0	10	11	1	the	10	10	11	0	NN	0	11	12	1	RAS	11	11	12	0	PRN	1	12	20	2	:	0	12	13	1	/	12	12	13	0	S	1	13	20	2	NP	0	13	19	2	NP	2	13	16	3	NN	0	13	14	1	Raf/MAPK	13	13	14	0	NN	0	14	15	1	signalling	14	14	15	0	NN	0	15	16	1	cascade	15	15	16	0	PP	0	16	19	2	IN	0	16	17	1	as	16	16	17	0	NP	1	17	19	2	NN	0	17	18	1	ASPP2	17	17	18	0	NN	0	18	19	1	phosphorylation	18	18	19	0	ADJP	0	19	20	1	JJ	0	19	20	1	mutant	19	19	20	0	SBAR	0	20	24	1	S	0	20	24	1	VP	0	20	24	2	VBZ	0	20	21	1	fails	20	20	21	0	S	0	21	24	1	VP	1	21	24	2	TO	0	21	22	1	to	21	21	22	0	VP	0	22	24	2	VB	0	22	23	1	do	22	22	23	0	ADVP	0	23	24	1	RB	0	23	24	1	so	23	23	24	0	.	0	24	25	1	.	24	24	25	0
EOS
T	21
Thus	4963	4967	RB	thus	O	_	_
phosphorylation	4968	4983	NN	phosphorylation	O	_	_
of	4984	4986	IN	of	O	_	_
ASPP2	4987	4992	NN	aspp2	B-GENE	_	_
by	4993	4995	IN	by	O	_	_
RAS	4996	4999	NN	ra	B-GENE	_	_
/	4999	5000	:	/	B-GENE	_	_
MAPK	5000	5004	NN	mapk	I-GENE	_	_
pathway	5005	5012	NN	pathway	O	_	_
provides	5013	5021	VBZ	provide	O	_	_
a	5022	5023	DT	a	O	_	_
novel	5024	5029	JJ	novel	O	_	_
link	5030	5034	NN	link	O	_	_
between	5035	5042	IN	between	O	_	_
RAS	5043	5046	NN	ra	B-GENE	_	_
and	5047	5050	CC	and	O	_	_
p53	5051	5054	NN	p53	B-GENE	_	_
in	5055	5057	IN	in	O	_	_
regulating	5058	5068	VBG	regulate	O	_	_
apoptosis	5069	5078	NN	apoptosis	O	_	_
.	5078	5079	.	.	O	_	_
D	1
1
1	0	advmod
1	3	prep_of
1	5	prep_by
1	6	punct
1	9	dep
8	7	nn
9	8	nsubj
9	12	dobj
9	18	prepc_in
12	10	det
12	11	amod
12	14	prep_between
12	16	prep_between
14	16	conj_and
18	19	dobj
EOX
Y	1
ROOT	0	0	21	1	FRAG	0	0	21	4	NP	0	0	6	2	NP	1	0	4	3	ADVP	0	0	1	1	RB	0	0	1	1	Thus	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	phosphorylation	1	1	2	0	PP	0	2	4	2	IN	0	2	3	1	of	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	ASPP2	3	3	4	0	PP	0	4	6	2	IN	0	4	5	1	by	4	4	5	0	NP	0	5	6	1	NN	0	5	6	1	RAS	5	5	6	0	:	0	6	7	1	/	6	6	7	0	S	1	7	20	2	NP	1	7	9	2	NN	0	7	8	1	MAPK	7	7	8	0	NN	0	8	9	1	pathway	8	8	9	0	VP	0	9	20	3	VBZ	0	9	10	1	provides	9	9	10	0	NP	0	10	17	2	NP	2	10	13	3	DT	0	10	11	1	a	10	10	11	0	JJ	0	11	12	1	novel	11	11	12	0	NN	0	12	13	1	link	12	12	13	0	PP	0	13	17	2	IN	0	13	14	1	between	13	13	14	0	NP	0	14	17	3	NN	0	14	15	1	RAS	14	14	15	0	CC	0	15	16	1	and	15	15	16	0	NN	0	16	17	1	p53	16	16	17	0	PP	0	17	20	2	IN	0	17	18	1	in	17	17	18	0	S	0	18	20	1	VP	0	18	20	2	VBG	0	18	19	1	regulating	18	18	19	0	NP	0	19	20	1	NN	0	19	20	1	apoptosis	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	28
Results	5080	5087	NNS	result	O	_	_
ASPP2	5088	5093	NN	aspp2	B-GENE	_	_
is	5094	5096	VBZ	be	O	_	_
a	5097	5098	DT	a	O	_	_
novel	5099	5104	JJ	novel	O	_	_
substrate	5105	5114	NN	substrate	O	_	_
of	5115	5117	IN	of	O	_	_
MAPK	5118	5122	NN	mapk	O	_	_
It	5123	5125	PRP	it	O	_	_
has	5126	5129	VBZ	have	O	_	_
recently	5130	5138	RB	recently	O	_	_
been	5139	5143	VBN	be	O	_	_
shown	5144	5149	VBN	show	O	_	_
that	5150	5154	IN	that	O	_	_
oncogenic	5155	5164	JJ	oncogenic	O	_	_
RAS	5165	5168	NN	ra	O	_	_
can	5169	5172	MD	can	O	_	_
enhance	5173	5180	VB	enhance	O	_	_
the	5181	5184	DT	the	O	_	_
apoptotic	5185	5194	JJ	apoptotic	O	_	_
function	5195	5203	NN	function	O	_	_
of	5204	5206	IN	of	O	_	_
p53	5207	5210	NN	p53	B-GENE	_	_
via	5211	5214	IN	via	I-GENE	_	_
ASPP1	5215	5220	NN	aspp1	I-GENE	_	_
and	5221	5224	CC	and	O	_	_
ASPP2	5225	5230	NN	aspp2	B-GENE	_	_
.	5230	5231	.	.	O	_	_
D	1
5
1	0	nn
5	1	nsubj
5	2	cop
5	3	det
5	4	amod
5	7	prep_of
5	12	rcmod
12	8	nsubjpass
12	9	aux
12	10	advmod
12	11	auxpass
12	17	ccomp
15	14	amod
17	13	mark
17	15	nsubj
17	16	aux
17	20	dobj
20	18	det
20	19	amod
20	22	prep_of
22	24	prep_via
22	26	prep_via
24	26	conj_and
EOX
Y	1
ROOT	0	0	28	1	S	1	0	28	3	NP	1	0	2	2	NNS	0	0	1	1	Results	0	0	1	0	NN	0	1	2	1	ASPP2	1	1	2	0	VP	1	2	27	2	VBZ	0	2	3	1	is	2	2	3	0	NP	0	3	27	3	NP	2	3	6	3	DT	0	3	4	1	a	3	3	4	0	JJ	0	4	5	1	novel	4	4	5	0	NN	0	5	6	1	substrate	5	5	6	0	PP	0	6	8	2	IN	0	6	7	1	of	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	MAPK	7	7	8	0	SBAR	0	8	27	1	S	1	8	27	2	NP	0	8	9	1	PRP	0	8	9	1	It	8	8	9	0	VP	2	9	27	3	VBZ	0	9	10	1	has	9	9	10	0	ADVP	0	10	11	1	RB	0	10	11	1	recently	10	10	11	0	VP	1	11	27	2	VBN	0	11	12	1	been	11	11	12	0	VP	0	12	27	2	VBN	0	12	13	1	shown	12	12	13	0	SBAR	1	13	27	2	IN	0	13	14	1	that	13	13	14	0	S	1	14	27	2	NP	1	14	16	2	JJ	0	14	15	1	oncogenic	14	14	15	0	NN	0	15	16	1	RAS	15	15	16	0	VP	1	16	27	2	MD	0	16	17	1	can	16	16	17	0	VP	0	17	27	2	VB	0	17	18	1	enhance	17	17	18	0	NP	0	18	27	2	NP	2	18	21	3	DT	0	18	19	1	the	18	18	19	0	JJ	0	19	20	1	apoptotic	19	19	20	0	NN	0	20	21	1	function	20	20	21	0	PP	0	21	27	2	IN	0	21	22	1	of	21	21	22	0	NP	0	22	27	2	NP	0	22	23	1	NN	0	22	23	1	p53	22	22	23	0	PP	0	23	27	2	IN	0	23	24	1	via	23	23	24	0	NP	0	24	27	3	NN	0	24	25	1	ASPP1	24	24	25	0	CC	0	25	26	1	and	25	25	26	0	NN	0	26	27	1	ASPP2	26	26	27	0	.	0	27	28	1	.	27	27	28	0
EOS
T	19
Mechanistically	5232	5247	RB	mechanistically	O	_	_
ASPP1	5248	5253	NN	aspp1	B-GENE	_	_
and	5254	5257	CC	and	O	_	_
ASPP2	5258	5263	NN	aspp2	B-GENE	_	_
bind	5264	5268	VBP	bind	O	_	_
RAS-GTP	5269	5276	NN	ras-gtp	O	_	_
and	5277	5280	CC	and	O	_	_
potentiates	5281	5292	VBZ	potentiate	O	_	_
RAS	5293	5296	NN	ra	B-GENE	_	_
signalling	5297	5307	NN	signalling	O	_	_
to	5308	5310	TO	to	O	_	_
enhance	5311	5318	VB	enhance	O	_	_
p53	5319	5322	NN	p53	B-GENE	_	_
mediated	5323	5331	JJ	mediated	O	_	_
apoptosis	5332	5341	NN	apoptosis	O	_	_
[	5342	5343	NN	[	O	_	_
2	5343	5344	CD	2	O	_	_
]	5344	5345	NN	]	O	_	_
.	5345	5346	.	.	O	_	_
D	1
4
1	3	conj_and
4	0	advmod
4	1	nsubj
4	3	nsubj
4	5	dobj
4	7	conj_and
4	17	dobj
7	1	nsubj
7	9	dobj
7	11	xcomp
9	8	nn
11	10	aux
11	12	dobj
17	13	amod
17	14	nn
17	15	nn
17	16	num
EOX
Y	1
ROOT	0	0	19	1	S	2	0	19	4	ADVP	0	0	1	1	RB	0	0	1	1	Mechanistically	0	0	1	0	NP	0	1	4	3	NN	0	1	2	1	ASPP1	1	1	2	0	CC	0	2	3	1	and	2	2	3	0	NN	0	3	4	1	ASPP2	3	3	4	0	VP	0	4	18	4	VP	0	4	6	2	VBP	0	4	5	1	bind	4	4	5	0	NP	0	5	6	1	NN	0	5	6	1	RAS-GTP	5	5	6	0	CC	0	6	7	1	and	6	6	7	0	VP	0	7	13	3	VBZ	0	7	8	1	potentiates	7	7	8	0	NP	1	8	10	2	NN	0	8	9	1	RAS	8	8	9	0	NN	0	9	10	1	signalling	9	9	10	0	S	0	10	13	1	VP	1	10	13	2	TO	0	10	11	1	to	10	10	11	0	VP	0	11	13	2	VB	0	11	12	1	enhance	11	11	12	0	NP	0	12	13	1	NN	0	12	13	1	p53	12	12	13	0	NP	4	13	18	5	JJ	0	13	14	1	mediated	13	13	14	0	NN	0	14	15	1	apoptosis	14	14	15	0	NN	0	15	16	1	[	15	15	16	0	CD	0	16	17	1	2	16	16	17	0	NN	0	17	18	1	]	17	17	18	0	.	0	18	19	1	.	18	18	19	0
EOS
T	31
As	5347	5349	IN	as	O	_	_
RAS	5350	5353	NN	ra	O	_	_
is	5354	5356	VBZ	be	O	_	_
upstream	5357	5365	JJ	upstream	O	_	_
of	5366	5368	IN	of	O	_	_
several	5369	5376	JJ	several	O	_	_
signalling	5377	5387	NN	signalling	O	_	_
cascades	5388	5396	NNS	cascade	O	_	_
[	5397	5398	VBP	[	O	_	_
13	5398	5400	CD	13	O	_	_
]	5400	5401	CD	]	O	_	_
,	5401	5402	,	,	O	_	_
we	5403	5405	PRP	we	O	_	_
queried	5406	5413	VBD	query	O	_	_
whether	5414	5421	IN	whether	O	_	_
the	5422	5425	DT	the	O	_	_
activity	5426	5434	NN	activity	O	_	_
of	5435	5437	IN	of	O	_	_
ASPP2	5438	5443	NN	aspp2	B-GENE	_	_
is	5444	5446	VBZ	be	O	_	_
regulated	5447	5456	VBN	regulate	O	_	_
by	5457	5459	IN	by	O	_	_
the	5460	5463	DT	the	O	_	_
activation	5464	5474	NN	activation	O	_	_
of	5475	5477	IN	of	O	_	_
a	5478	5479	DT	a	O	_	_
RAS	5480	5483	NN	ra	B-GENE	_	_
mediated	5484	5492	VBD	mediate	O	_	_
signalling	5493	5503	NN	signalling	O	_	_
pathway	5504	5511	NN	pathway	O	_	_
.	5511	5512	.	.	O	_	_
D	1
13
3	0	mark
3	1	nsubj
3	2	cop
3	7	prep_of
3	8	rcmod
7	5	amod
7	6	nn
8	10	dobj
10	9	num
13	3	advcl
13	12	nsubj
13	20	ccomp
16	15	det
16	18	prep_of
20	14	mark
20	16	nsubjpass
20	19	auxpass
20	23	agent
23	22	det
23	26	prep_of
26	25	det
26	27	vmod
27	29	dobj
29	28	nn
EOX
Y	1
ROOT	0	0	31	1	S	3	0	31	5	SBAR	1	0	11	2	IN	0	0	1	1	As	0	0	1	0	S	1	1	11	2	NP	0	1	2	1	NN	0	1	2	1	RAS	1	1	2	0	VP	1	2	11	2	VBZ	0	2	3	1	is	2	2	3	0	NP	0	3	11	3	NP	0	3	4	1	JJ	0	3	4	1	upstream	3	3	4	0	PP	0	4	8	2	IN	0	4	5	1	of	4	4	5	0	NP	2	5	8	3	JJ	0	5	6	1	several	5	5	6	0	NN	0	6	7	1	signalling	6	6	7	0	NNS	0	7	8	1	cascades	7	7	8	0	SBAR	0	8	11	1	S	0	8	11	1	VP	0	8	11	2	VBP	0	8	9	1	[	8	8	9	0	NP	1	9	11	2	CD	0	9	10	1	13	9	9	10	0	CD	0	10	11	1	]	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	0	12	13	1	PRP	0	12	13	1	we	12	12	13	0	VP	0	13	30	2	VBD	0	13	14	1	queried	13	13	14	0	SBAR	1	14	30	2	IN	0	14	15	1	whether	14	14	15	0	S	1	15	30	2	NP	0	15	19	2	NP	1	15	17	2	DT	0	15	16	1	the	15	15	16	0	NN	0	16	17	1	activity	16	16	17	0	PP	0	17	19	2	IN	0	17	18	1	of	17	17	18	0	NP	0	18	19	1	NN	0	18	19	1	ASPP2	18	18	19	0	VP	1	19	30	2	VBZ	0	19	20	1	is	19	19	20	0	VP	0	20	30	2	VBN	0	20	21	1	regulated	20	20	21	0	PP	0	21	30	2	IN	0	21	22	1	by	21	21	22	0	NP	0	22	30	2	NP	1	22	24	2	DT	0	22	23	1	the	22	22	23	0	NN	0	23	24	1	activation	23	23	24	0	PP	0	24	30	2	IN	0	24	25	1	of	24	24	25	0	NP	0	25	30	2	NP	1	25	27	2	DT	0	25	26	1	a	25	25	26	0	NN	0	26	27	1	RAS	26	26	27	0	VP	0	27	30	2	VBD	0	27	28	1	mediated	27	27	28	0	NP	1	28	30	2	NN	0	28	29	1	signalling	28	28	29	0	NN	0	29	30	1	pathway	29	29	30	0	.	0	30	31	1	.	30	30	31	0
EOS
T	15
One	5513	5516	CD	one	O	_	_
of	5517	5519	IN	of	O	_	_
the	5520	5523	DT	the	O	_	_
most	5524	5528	RBS	most	O	_	_
studied	5529	5536	VBN	study	O	_	_
downstream	5537	5547	JJ	downstream	O	_	_
pathways	5548	5556	NNS	pathway	O	_	_
of	5557	5559	IN	of	O	_	_
RAS	5560	5563	NN	ra	O	_	_
signalling	5564	5574	NN	signalling	O	_	_
is	5575	5577	VBZ	be	O	_	_
the	5578	5581	DT	the	O	_	_
Raf-MAPK	5582	5590	NN	raf-mapk	B-GENE	_	_
pathway	5591	5598	NN	pathway	O	_	_
.	5598	5599	.	.	O	_	_
D	1
13
0	2	prep_of
2	3	advmod
2	4	vmod
4	6	dobj
6	5	amod
6	9	prep_of
9	8	nn
13	0	nsubj
13	10	cop
13	11	det
13	12	nn
EOX
Y	1
ROOT	0	0	15	1	S	1	0	15	3	NP	0	0	10	2	NP	0	0	1	1	CD	0	0	1	1	One	0	0	1	0	PP	0	1	10	2	IN	0	1	2	1	of	1	1	2	0	NP	0	2	10	2	NP	0	2	4	2	DT	0	2	3	1	the	2	2	3	0	RBS	0	3	4	1	most	3	3	4	0	VP	0	4	10	2	VBN	0	4	5	1	studied	4	4	5	0	NP	0	5	10	2	NP	1	5	7	2	JJ	0	5	6	1	downstream	5	5	6	0	NNS	0	6	7	1	pathways	6	6	7	0	PP	0	7	10	2	IN	0	7	8	1	of	7	7	8	0	NP	1	8	10	2	NN	0	8	9	1	RAS	8	8	9	0	NN	0	9	10	1	signalling	9	9	10	0	VP	1	10	14	2	VBZ	0	10	11	1	is	10	10	11	0	NP	2	11	14	3	DT	0	11	12	1	the	11	11	12	0	NN	0	12	13	1	Raf-MAPK	12	12	13	0	NN	0	13	14	1	pathway	13	13	14	0	.	0	14	15	1	.	14	14	15	0
EOS
T	15
Interestingly	5600	5613	RB	interestingly	O	_	_
,	5613	5614	,	,	O	_	_
we	5615	5617	PRP	we	O	_	_
observed	5618	5626	VBD	observe	O	_	_
two	5627	5630	CD	two	O	_	_
conserved	5631	5640	VBN	conserve	O	_	_
putative	5641	5649	JJ	putative	O	_	_
MAPK	5650	5654	NN	mapk	B-GENE	_	_
phosphorylation	5655	5670	NN	phosphorylation	O	_	_
sites	5671	5676	NNS	site	O	_	_
in	5677	5679	IN	in	O	_	_
ASPP1	5680	5685	NN	aspp1	B-GENE	_	_
and	5686	5689	CC	and	O	_	_
ASPP2	5690	5695	NN	aspp2	B-GENE	_	_
.	5695	5696	.	.	O	_	_
D	1
3
3	0	advmod
3	2	nsubj
3	4	dobj
4	5	vmod
5	9	dobj
9	6	amod
9	7	nn
9	8	nn
9	11	prep_in
9	13	prep_in
11	13	conj_and
EOX
Y	1
ROOT	0	0	15	1	S	3	0	15	5	ADVP	0	0	1	1	RB	0	0	1	1	Interestingly	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	0	2	3	1	PRP	0	2	3	1	we	2	2	3	0	VP	0	3	14	2	VBD	0	3	4	1	observed	3	3	4	0	NP	0	4	14	2	NP	0	4	5	1	CD	0	4	5	1	two	4	4	5	0	VP	0	5	14	2	VBN	0	5	6	1	conserved	5	5	6	0	NP	0	6	14	2	NP	3	6	10	4	JJ	0	6	7	1	putative	6	6	7	0	NN	0	7	8	1	MAPK	7	7	8	0	NN	0	8	9	1	phosphorylation	8	8	9	0	NNS	0	9	10	1	sites	9	9	10	0	PP	0	10	14	2	IN	0	10	11	1	in	10	10	11	0	NP	0	11	14	3	NN	0	11	12	1	ASPP1	11	11	12	0	CC	0	12	13	1	and	12	12	13	0	NN	0	13	14	1	ASPP2	13	13	14	0	.	0	14	15	1	.	14	14	15	0
EOS
T	21
The	5697	5700	DT	the	O	_	_
ASPP1	5701	5706	NN	aspp1	B-GENE	_	_
sites	5707	5712	NNS	site	I-GENE	_	_
are	5713	5716	VBP	be	O	_	_
at	5717	5719	IN	at	O	_	_
residues	5720	5728	NNS	residue	O	_	_
671	5729	5732	CD	671	O	_	_
and	5733	5736	CC	and	O	_	_
746	5737	5740	CD	746	O	_	_
,	5740	5741	,	,	O	_	_
and	5742	5745	CC	and	O	_	_
the	5746	5749	DT	the	O	_	_
ASPP2	5750	5755	NN	aspp2	B-GENE	_	_
sites	5756	5761	NNS	site	I-GENE	_	_
are	5762	5765	VBP	be	O	_	_
at	5766	5768	IN	at	O	_	_
residues	5769	5777	NNS	residue	O	_	_
698	5778	5781	CD	698	O	_	_
and	5782	5785	CC	and	O	_	_
827	5786	5789	CD	827	O	_	_
.	5801	5802	.	.	O	_	_
D	1
3
2	0	det
2	1	nn
3	2	nsubj
3	5	prep_at
3	8	prep_at
3	14	conj_and
5	6	num
5	8	conj_and
13	11	det
13	12	nn
14	13	nsubj
14	16	prep_at
14	19	prep_at
16	17	num
16	19	conj_and
EOX
Y	1
ROOT	0	0	21	1	S	0	0	21	5	S	1	0	9	2	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	ASPP1	1	1	2	0	NNS	0	2	3	1	sites	2	2	3	0	VP	0	3	9	2	VBP	0	3	4	1	are	3	3	4	0	PP	0	4	9	2	IN	0	4	5	1	at	4	4	5	0	NP	0	5	9	4	NNS	0	5	6	1	residues	5	5	6	0	CD	0	6	7	1	671	6	6	7	0	CC	0	7	8	1	and	7	7	8	0	CD	0	8	9	1	746	8	8	9	0	,	0	9	10	1	,	9	9	10	0	CC	0	10	11	1	and	10	10	11	0	S	1	11	20	2	NP	2	11	14	3	DT	0	11	12	1	the	11	11	12	0	NN	0	12	13	1	ASPP2	12	12	13	0	NNS	0	13	14	1	sites	13	13	14	0	VP	0	14	20	2	VBP	0	14	15	1	are	14	14	15	0	PP	0	15	20	2	IN	0	15	16	1	at	15	15	16	0	NP	0	16	20	4	NNS	0	16	17	1	residues	16	16	17	0	CD	0	17	18	1	698	17	17	18	0	CC	0	18	19	1	and	18	18	19	0	CD	0	19	20	1	827	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	11
We	5803	5805	PRP	we	O	_	_
thus	5806	5810	RB	thus	O	_	_
tested	5811	5817	VBD	test	O	_	_
whether	5818	5825	IN	whether	O	_	_
RAS	5826	5829	NN	ra	B-GENE	_	_
activation	5830	5840	NN	activation	O	_	_
may	5841	5844	MD	may	O	_	_
regulate	5845	5853	VB	regulate	O	_	_
ASPP2	5854	5859	NN	aspp2	B-GENE	_	_
phosphorylation	5860	5875	NN	phosphorylation	O	_	_
.	5875	5876	.	.	O	_	_
D	1
2
2	0	nsubj
2	1	advmod
2	7	ccomp
5	4	nn
7	3	mark
7	5	nsubj
7	6	aux
7	9	dobj
9	8	nn
EOX
Y	1
ROOT	0	0	11	1	S	2	0	11	4	NP	0	0	1	1	PRP	0	0	1	1	We	0	0	1	0	ADVP	0	1	2	1	RB	0	1	2	1	thus	1	1	2	0	VP	0	2	10	2	VBD	0	2	3	1	tested	2	2	3	0	SBAR	1	3	10	2	IN	0	3	4	1	whether	3	3	4	0	S	1	4	10	2	NP	1	4	6	2	NN	0	4	5	1	RAS	4	4	5	0	NN	0	5	6	1	activation	5	5	6	0	VP	1	6	10	2	MD	0	6	7	1	may	6	6	7	0	VP	0	7	10	2	VB	0	7	8	1	regulate	7	7	8	0	NP	1	8	10	2	NN	0	8	9	1	ASPP2	8	8	9	0	NN	0	9	10	1	phosphorylation	9	9	10	0	.	0	10	11	1	.	10	10	11	0
EOS
T	24
An	5877	5879	DT	a	O	_	_
in	5880	5882	FW	in	O	_	_
vitro	5883	5888	FW	vitro	O	_	_
phophorylation	5889	5903	NN	phophorylation	O	_	_
assay	5904	5909	NN	assay	O	_	_
was	5910	5913	VBD	be	O	_	_
performed	5914	5923	VBN	perform	O	_	_
with	5924	5928	IN	with	O	_	_
a	5929	5930	DT	a	O	_	_
purified	5931	5939	VBN	purify	O	_	_
C-terminus	5940	5950	NN	c-terminus	O	_	_
fragment	5951	5959	NN	fragment	O	_	_
of	5960	5962	IN	of	O	_	_
ASPP2	5963	5968	NN	aspp2	O	_	_
(	5969	5970	CD	(	O	_	_
693-1128	5970	5978	CD	693-1128	O	_	_
)	5978	5979	NN	)	O	_	_
containing	5980	5990	VBG	contain	O	_	_
both	5991	5995	CC	both	O	_	_
MAPK	5996	6000	NN	mapk	O	_	_
putative	6001	6009	JJ	putative	O	_	_
phosphorylation	6010	6025	NN	phosphorylation	O	_	_
sites	6026	6031	NNS	site	O	_	_
.	6031	6032	.	.	O	_	_
D	1
6
0	3	rcmod
0	4	dep
2	1	nn
3	2	advmod
6	0	nsubjpass
6	5	auxpass
6	11	prep_with
6	16	nsubjpass
11	8	det
11	9	amod
11	10	nn
11	13	prep_of
13	14	num
16	15	num
16	17	vmod
17	18	prep
18	22	pobj
22	19	nn
22	20	amod
22	21	nn
EOX
Y	1
ROOT	0	0	24	1	S	1	0	24	4	NP	0	0	5	2	NP	0	0	4	2	DT	0	0	1	1	An	0	0	1	0	RRC	1	1	4	2	ADVP	1	1	3	2	FW	0	1	2	1	in	1	1	2	0	FW	0	2	3	1	vitro	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	phophorylation	3	3	4	0	NP	0	4	5	1	NN	0	4	5	1	assay	4	4	5	0	VP	1	5	15	2	VBD	0	5	6	1	was	5	5	6	0	VP	0	6	15	2	VBN	0	6	7	1	performed	6	6	7	0	PP	0	7	15	2	IN	0	7	8	1	with	7	7	8	0	NP	0	8	15	2	NP	3	8	12	4	DT	0	8	9	1	a	8	8	9	0	VBN	0	9	10	1	purified	9	9	10	0	NN	0	10	11	1	C-terminus	10	10	11	0	NN	0	11	12	1	fragment	11	11	12	0	PP	0	12	15	2	IN	0	12	13	1	of	12	12	13	0	NP	0	13	15	2	NN	0	13	14	1	ASPP2	13	13	14	0	CD	0	14	15	1	(	14	14	15	0	NP	0	15	23	2	NP	1	15	17	2	CD	0	15	16	1	693-1128	15	15	16	0	NN	0	16	17	1	)	16	16	17	0	VP	0	17	23	2	VBG	0	17	18	1	containing	17	17	18	0	PP	0	18	23	2	CC	0	18	19	1	both	18	18	19	0	NP	3	19	23	4	NN	0	19	20	1	MAPK	19	19	20	0	JJ	0	20	21	1	putative	20	20	21	0	NN	0	21	22	1	phosphorylation	21	21	22	0	NNS	0	22	23	1	sites	22	22	23	0	.	0	23	24	1	.	23	23	24	0
EOS
T	18
When	6033	6037	WRB	when	O	_	_
compared	6038	6046	VBN	compare	O	_	_
to	6047	6049	TO	to	O	_	_
p38	6050	6053	NN	p38	B-GENE	_	_
SAPK	6054	6058	NN	sapk	I-GENE	_	_
,	6058	6059	,	,	O	_	_
MAPK1	6060	6065	NN	mapk1	B-GENE	_	_
was	6066	6069	VBD	be	O	_	_
clearly	6070	6077	RB	clearly	O	_	_
able	6078	6082	JJ	able	O	_	_
to	6083	6085	TO	to	O	_	_
phosphorylate	6086	6099	VB	phosphorylate	O	_	_
the	6100	6103	DT	the	O	_	_
ASPP2	6104	6109	NN	aspp2	O	_	_
fragment	6110	6118	NN	fragment	O	_	_
in	6119	6121	FW	in	O	_	_
vitro	6122	6127	FW	vitro	O	_	_
.	6163	6164	.	.	O	_	_
D	1
9
1	0	advmod
1	4	prep_to
4	3	nn
9	1	advcl
9	6	nsubj
9	7	cop
9	8	advmod
9	11	xcomp
11	10	aux
11	14	dobj
11	16	advmod
14	12	det
14	13	nn
16	15	nn
EOX
Y	1
ROOT	0	0	18	1	S	3	0	18	5	SBAR	1	0	5	2	WHADVP	0	0	1	1	WRB	0	0	1	1	When	0	0	1	0	S	0	1	5	1	VP	0	1	5	2	VBN	0	1	2	1	compared	1	1	2	0	PP	0	2	5	2	TO	0	2	3	1	to	2	2	3	0	NP	1	3	5	2	NN	0	3	4	1	p38	3	3	4	0	NN	0	4	5	1	SAPK	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	0	6	7	1	NN	0	6	7	1	MAPK1	6	6	7	0	VP	2	7	17	3	VBD	0	7	8	1	was	7	7	8	0	ADVP	0	8	9	1	RB	0	8	9	1	clearly	8	8	9	0	ADJP	0	9	17	2	JJ	0	9	10	1	able	9	9	10	0	S	0	10	17	1	VP	1	10	17	2	TO	0	10	11	1	to	10	10	11	0	VP	0	11	17	3	VB	0	11	12	1	phosphorylate	11	11	12	0	NP	2	12	15	3	DT	0	12	13	1	the	12	12	13	0	NN	0	13	14	1	ASPP2	13	13	14	0	NN	0	14	15	1	fragment	14	14	15	0	ADVP	1	15	17	2	FW	0	15	16	1	in	15	15	16	0	FW	0	16	17	1	vitro	16	16	17	0	.	0	17	18	1	.	17	17	18	0
EOS
T	60
As	6165	6167	IN	as	O	_	_
shown	6168	6173	VBN	show	O	_	_
in	6174	6176	IN	in	O	_	_
,	6186	6187	,	,	O	_	_
histone	6188	6195	NN	histone	B-GENE	_	_
2B	6196	6198	NN	2b	I-GENE	_	_
phosphorylated	6199	6213	VBN	phosphorylate	O	_	_
by	6214	6216	IN	by	O	_	_
p38	6217	6220	NN	p38	B-GENE	_	_
SAPK	6221	6225	NN	sapk	I-GENE	_	_
had	6226	6229	VBD	have	O	_	_
high	6230	6234	JJ	high	O	_	_
levels	6235	6241	NNS	level	O	_	_
of	6242	6244	IN	of	O	_	_
incorporated	6245	6257	JJ	incorporated	O	_	_
32P	6258	6261	NN	32p	O	_	_
,	6261	6262	,	,	O	_	_
suggesting	6263	6273	VBG	suggest	O	_	_
that	6274	6278	IN	that	O	_	_
p38	6279	6282	NN	p38	B-GENE	_	_
SAPK	6283	6287	NN	sapk	O	_	_
was	6288	6291	VBD	be	O	_	_
active	6292	6298	JJ	active	O	_	_
;	6298	6299	:	;	O	_	_
while	6300	6305	IN	while	O	_	_
under	6306	6311	IN	under	O	_	_
the	6312	6315	DT	the	O	_	_
same	6316	6320	JJ	same	O	_	_
conditions	6321	6331	NNS	condition	O	_	_
,	6331	6332	,	,	O	_	_
ASPP2	6333	6338	NN	aspp2	O	_	_
(	6339	6340	CD	(	O	_	_
693-1128	6340	6348	CD	693-1128	O	_	_
)	6348	6349	NN	)	O	_	_
fragment	6350	6358	NN	fragment	O	_	_
phosphorylated	6359	6373	VBN	phosphorylate	O	_	_
by	6374	6376	IN	by	O	_	_
p38	6377	6380	NN	p38	B-GENE	_	_
SAPK	6381	6385	NN	sapk	O	_	_
had	6386	6389	VBD	have	O	_	_
very	6390	6394	RB	very	O	_	_
low	6395	6398	JJ	low	O	_	_
levels	6399	6405	NNS	level	O	_	_
of	6406	6408	IN	of	O	_	_
incorporated	6409	6421	JJ	incorporated	O	_	_
32P	6422	6425	NN	32p	O	_	_
,	6425	6426	,	,	O	_	_
indicating	6427	6437	VBG	indicate	O	_	_
that	6438	6442	IN	that	O	_	_
p38	6443	6446	NN	p38	B-GENE	_	_
SAPK	6447	6451	NN	sapk	I-GENE	_	_
is	6452	6454	VBZ	be	O	_	_
not	6455	6458	RB	not	O	_	_
an	6459	6461	DT	a	O	_	_
efficient	6462	6471	JJ	efficient	O	_	_
kinase	6472	6478	NN	kinase	O	_	_
for	6479	6482	IN	for	O	_	_
ASPP2	6483	6488	NN	aspp2	B-GENE	_	_
phosphorylation	6489	6504	NN	phosphorylation	O	_	_
.	6504	6505	.	.	O	_	_
D	1
10
1	0	mark
1	2	prep
5	4	nn
5	6	vmod
6	9	agent
9	8	nn
10	1	advcl
10	5	nsubj
10	12	dobj
10	17	vmod
12	11	amod
12	15	prep_of
15	14	amod
17	22	ccomp
20	19	nn
22	18	mark
22	20	nsubj
22	21	cop
22	39	parataxis
28	26	det
28	27	amod
28	30	appos
30	31	num
34	32	num
34	33	nn
34	35	vmod
35	38	agent
38	37	nn
39	24	mark
39	28	prep_under
39	34	nsubj
39	42	dobj
39	47	vmod
41	40	advmod
42	41	amod
42	45	prep_of
45	44	amod
47	55	ccomp
50	49	nn
55	48	mark
55	50	nsubj
55	51	cop
55	52	neg
55	53	det
55	54	amod
55	58	prep_for
58	57	nn
EOX
Y	1
ROOT	0	0	60	1	S	3	0	60	5	SBAR	1	0	3	2	IN	0	0	1	1	As	0	0	1	0	S	0	1	3	1	VP	0	1	3	2	VBN	0	1	2	1	shown	1	1	2	0	PP	0	2	3	1	IN	0	2	3	1	in	2	2	3	0	,	0	3	4	1	,	3	3	4	0	NP	0	4	10	2	NP	1	4	6	2	NN	0	4	5	1	histone	4	4	5	0	NN	0	5	6	1	2B	5	5	6	0	VP	0	6	10	2	VBN	0	6	7	1	phosphorylated	6	6	7	0	PP	0	7	10	2	IN	0	7	8	1	by	7	7	8	0	NP	1	8	10	2	NN	0	8	9	1	p38	8	8	9	0	NN	0	9	10	1	SAPK	9	9	10	0	VP	0	10	59	4	VBD	0	10	11	1	had	10	10	11	0	NP	0	11	16	2	NP	1	11	13	2	JJ	0	11	12	1	high	11	11	12	0	NNS	0	12	13	1	levels	12	12	13	0	PP	0	13	16	2	IN	0	13	14	1	of	13	13	14	0	NP	1	14	16	2	JJ	0	14	15	1	incorporated	14	14	15	0	NN	0	15	16	1	32P	15	15	16	0	,	0	16	17	1	,	16	16	17	0	S	0	17	59	1	VP	0	17	59	2	VBG	0	17	18	1	suggesting	17	17	18	0	SBAR	1	18	59	2	IN	0	18	19	1	that	18	18	19	0	S	1	19	59	4	NP	1	19	21	2	NN	0	19	20	1	p38	19	19	20	0	NN	0	20	21	1	SAPK	20	20	21	0	VP	1	21	23	2	VBD	0	21	22	1	was	21	21	22	0	ADJP	0	22	23	1	JJ	0	22	23	1	active	22	22	23	0	:	0	23	24	1	;	23	23	24	0	SBAR	1	24	59	2	IN	0	24	25	1	while	24	24	25	0	S	2	25	59	3	PP	0	25	32	2	IN	0	25	26	1	under	25	25	26	0	NP	0	26	32	3	NP	2	26	29	3	DT	0	26	27	1	the	26	26	27	0	JJ	0	27	28	1	same	27	27	28	0	NNS	0	28	29	1	conditions	28	28	29	0	,	0	29	30	1	,	29	29	30	0	NP	0	30	32	2	NN	0	30	31	1	ASPP2	30	30	31	0	CD	0	31	32	1	(	31	31	32	0	NP	0	32	39	2	NP	2	32	35	3	CD	0	32	33	1	693-1128	32	32	33	0	NN	0	33	34	1	)	33	33	34	0	NN	0	34	35	1	fragment	34	34	35	0	VP	0	35	39	2	VBN	0	35	36	1	phosphorylated	35	35	36	0	PP	0	36	39	2	IN	0	36	37	1	by	36	36	37	0	NP	1	37	39	2	NN	0	37	38	1	p38	37	37	38	0	NN	0	38	39	1	SAPK	38	38	39	0	VP	0	39	59	4	VBD	0	39	40	1	had	39	39	40	0	NP	0	40	46	2	NP	1	40	43	2	ADJP	1	40	42	2	RB	0	40	41	1	very	40	40	41	0	JJ	0	41	42	1	low	41	41	42	0	NNS	0	42	43	1	levels	42	42	43	0	PP	0	43	46	2	IN	0	43	44	1	of	43	43	44	0	NP	1	44	46	2	JJ	0	44	45	1	incorporated	44	44	45	0	NN	0	45	46	1	32P	45	45	46	0	,	0	46	47	1	,	46	46	47	0	S	0	47	59	1	VP	0	47	59	2	VBG	0	47	48	1	indicating	47	47	48	0	SBAR	1	48	59	2	IN	0	48	49	1	that	48	48	49	0	S	1	49	59	2	NP	1	49	51	2	NN	0	49	50	1	p38	49	49	50	0	NN	0	50	51	1	SAPK	50	50	51	0	VP	2	51	59	3	VBZ	0	51	52	1	is	51	51	52	0	RB	0	52	53	1	not	52	52	53	0	NP	0	53	59	2	NP	2	53	56	3	DT	0	53	54	1	an	53	53	54	0	JJ	0	54	55	1	efficient	54	54	55	0	NN	0	55	56	1	kinase	55	55	56	0	PP	0	56	59	2	IN	0	56	57	1	for	56	56	57	0	NP	1	57	59	2	NN	0	57	58	1	ASPP2	57	57	58	0	NN	0	58	59	1	phosphorylation	58	58	59	0	.	0	59	60	1	.	59	59	60	0
EOS
T	22
The	6506	6509	DT	the	O	_	_
phosphorylated	6510	6524	VBN	phosphorylate	B-GENE	_	_
ASPP2	6525	6530	NN	aspp2	I-GENE	_	_
fragment	6531	6539	NN	fragment	I-GENE	_	_
by	6540	6542	IN	by	O	_	_
MAPK1	6543	6548	NN	mapk1	B-GENE	_	_
was	6549	6552	VBD	be	O	_	_
digested	6553	6561	VBN	digest	O	_	_
by	6562	6564	IN	by	O	_	_
trypsin	6565	6572	NN	trypsin	B-GENE	_	_
and	6573	6576	CC	and	O	_	_
fractioned	6577	6587	VBN	fraction	O	_	_
on	6588	6590	IN	on	O	_	_
a	6591	6592	DT	a	O	_	_
high	6593	6597	JJ	high	O	_	_
performance	6598	6609	NN	performance	O	_	_
liquid	6610	6616	JJ	liquid	O	_	_
chromatography	6617	6631	NN	chromatography	O	_	_
(	6632	6633	CD	(	O	_	_
HPLC	6633	6637	NN	hplc	O	_	_
)	6637	6638	NN	)	O	_	_
.	6638	6639	.	.	O	_	_
D	1
7
0	1	vmod
1	3	dobj
1	5	agent
3	2	nn
7	0	nsubjpass
7	6	auxpass
7	9	agent
7	11	conj_and
7	20	dobj
11	0	nsubjpass
11	17	prep_on
17	13	det
17	14	amod
17	15	nn
17	16	amod
20	18	num
20	19	nn
EOX
Y	1
ROOT	0	0	22	1	S	1	0	22	3	NP	0	0	6	2	NP	0	0	1	1	DT	0	0	1	1	The	0	0	1	0	VP	0	1	6	3	VBN	0	1	2	1	phosphorylated	1	1	2	0	NP	1	2	4	2	NN	0	2	3	1	ASPP2	2	2	3	0	NN	0	3	4	1	fragment	3	3	4	0	PP	0	4	6	2	IN	0	4	5	1	by	4	4	5	0	NP	0	5	6	1	NN	0	5	6	1	MAPK1	5	5	6	0	VP	1	6	21	2	VBD	0	6	7	1	was	6	6	7	0	VP	0	7	21	4	VP	0	7	10	2	VBN	0	7	8	1	digested	7	7	8	0	PP	0	8	10	2	IN	0	8	9	1	by	8	8	9	0	NP	0	9	10	1	NN	0	9	10	1	trypsin	9	9	10	0	CC	0	10	11	1	and	10	10	11	0	VP	0	11	18	2	VBN	0	11	12	1	fractioned	11	11	12	0	PP	0	12	18	2	IN	0	12	13	1	on	12	12	13	0	NP	4	13	18	5	DT	0	13	14	1	a	13	13	14	0	JJ	0	14	15	1	high	14	14	15	0	NN	0	15	16	1	performance	15	15	16	0	JJ	0	16	17	1	liquid	16	16	17	0	NN	0	17	18	1	chromatography	17	17	18	0	NP	2	18	21	3	CD	0	18	19	1	(	18	18	19	0	NN	0	19	20	1	HPLC	19	19	20	0	NN	0	20	21	1	)	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	10
Each	6640	6644	DT	each	O	_	_
eluted	6645	6651	VBN	elute	O	_	_
fraction	6652	6660	NN	fraction	O	_	_
was	6661	6664	VBD	be	O	_	_
measured	6665	6673	VBN	measure	O	_	_
for	6674	6677	IN	for	O	_	_
its	6678	6681	PRP$	its	O	_	_
radioactivity	6682	6695	NN	radioactivity	O	_	_
content	6696	6703	NN	content	O	_	_
.	6728	6729	.	.	O	_	_
D	1
4
0	1	vmod
1	2	dobj
4	0	nsubjpass
4	3	auxpass
4	8	prep_for
8	6	poss
8	7	nn
EOX
Y	1
ROOT	0	0	10	1	S	1	0	10	3	NP	0	0	3	2	NP	0	0	1	1	DT	0	0	1	1	Each	0	0	1	0	VP	0	1	3	2	VBN	0	1	2	1	eluted	1	1	2	0	NP	0	2	3	1	NN	0	2	3	1	fraction	2	2	3	0	VP	1	3	9	2	VBD	0	3	4	1	was	3	3	4	0	VP	0	4	9	2	VBN	0	4	5	1	measured	4	4	5	0	PP	0	5	9	2	IN	0	5	6	1	for	5	5	6	0	NP	2	6	9	3	PRP$	0	6	7	1	its	6	6	7	0	NN	0	7	8	1	radioactivity	7	7	8	0	NN	0	8	9	1	content	8	8	9	0	.	0	9	10	1	.	9	9	10	0
EOS
T	12
The	6730	6733	DT	the	O	_	_
fractions	6734	6743	NNS	fraction	O	_	_
representing	6744	6756	VBG	represent	O	_	_
these	6757	6762	DT	these	O	_	_
radioactive	6763	6774	JJ	radioactive	O	_	_
peaks	6775	6780	NNS	peak	O	_	_
were	6781	6785	VBD	be	O	_	_
analysed	6786	6794	VBN	analyse	O	_	_
by	6795	6797	IN	by	O	_	_
mass	6798	6802	NN	mass	O	_	_
spectrometry	6803	6815	NN	spectrometry	O	_	_
.	6815	6816	.	.	O	_	_
D	1
7
1	0	det
1	2	vmod
2	5	dobj
5	3	det
5	4	amod
7	1	nsubjpass
7	6	auxpass
7	10	agent
10	9	nn
EOX
Y	1
ROOT	0	0	12	1	S	1	0	12	3	NP	0	0	6	2	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NNS	0	1	2	1	fractions	1	1	2	0	VP	0	2	6	2	VBG	0	2	3	1	representing	2	2	3	0	NP	2	3	6	3	DT	0	3	4	1	these	3	3	4	0	JJ	0	4	5	1	radioactive	4	4	5	0	NNS	0	5	6	1	peaks	5	5	6	0	VP	1	6	11	2	VBD	0	6	7	1	were	6	6	7	0	VP	0	7	11	2	VBN	0	7	8	1	analysed	7	7	8	0	PP	0	8	11	2	IN	0	8	9	1	by	8	8	9	0	NP	1	9	11	2	NN	0	9	10	1	mass	9	9	10	0	NN	0	10	11	1	spectrometry	10	10	11	0	.	0	11	12	1	.	11	11	12	0
EOS
T	41
Of	6817	6819	IN	of	O	_	_
the	6820	6823	DT	the	O	_	_
two	6824	6827	CD	two	O	_	_
radioactive	6828	6839	JJ	radioactive	O	_	_
peaks	6840	6845	NNS	peak	O	_	_
,	6845	6846	,	,	O	_	_
one	6847	6850	CD	one	O	_	_
represented	6851	6862	VBD	represent	O	_	_
the	6863	6866	DT	the	O	_	_
linker	6867	6873	NN	linker	O	_	_
region	6874	6880	NN	region	O	_	_
between	6881	6888	IN	between	O	_	_
the	6889	6892	DT	the	O	_	_
GST	6893	6896	NN	gst	O	_	_
and	6897	6900	CC	and	O	_	_
our	6901	6904	PRP$	we	O	_	_
ASPP2	6905	6910	NN	aspp2	O	_	_
fragment	6911	6919	NN	fragment	O	_	_
and	6920	6923	CC	and	O	_	_
the	6924	6927	DT	the	O	_	_
other	6928	6933	JJ	other	O	_	_
corresponded	6934	6946	VBD	correspond	O	_	_
to	6947	6949	TO	to	O	_	_
a	6950	6951	DT	a	O	_	_
fragment	6952	6960	NN	fragment	O	_	_
of	6961	6963	IN	of	O	_	_
the	6964	6967	DT	the	O	_	_
same	6968	6972	JJ	same	O	_	_
mass	6973	6977	NN	mass	O	_	_
as	6978	6980	IN	as	O	_	_
that	6981	6985	DT	that	O	_	_
containing	6986	6996	VBG	contain	O	_	_
the	6997	7000	DT	the	O	_	_
second	7001	7007	JJ	second	O	_	_
putative	7008	7016	JJ	putative	O	_	_
phosphorylation	7017	7032	NN	phosphorylation	O	_	_
site	7033	7037	NN	site	O	_	_
,	7037	7038	,	,	O	_	_
serine	7039	7045	NN	serine	O	_	_
827	7046	7049	CD	827	O	_	_
.	7049	7050	.	.	O	_	_
D	1
7
4	1	det
4	2	num
4	3	amod
7	4	prep_of
7	6	nsubj
7	21	ccomp
10	8	det
10	9	nn
10	13	prep_between
10	17	prep_between
13	12	det
13	17	conj_and
13	20	conj_and
17	15	poss
17	16	nn
17	20	conj_and
20	19	det
21	10	nsubj
21	24	prep_to
21	31	prepc_as
24	23	det
24	28	prep_of
28	26	det
28	27	amod
31	30	nsubj
31	36	dobj
36	32	det
36	33	amod
36	34	amod
36	35	nn
36	38	appos
38	39	num
EOX
Y	1
ROOT	0	0	41	1	S	3	0	41	5	PP	0	0	5	2	IN	0	0	1	1	Of	0	0	1	0	NP	3	1	5	4	DT	0	1	2	1	the	1	1	2	0	CD	0	2	3	1	two	2	2	3	0	JJ	0	3	4	1	radioactive	3	3	4	0	NNS	0	4	5	1	peaks	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	0	6	7	1	CD	0	6	7	1	one	6	6	7	0	VP	0	7	40	2	VBD	0	7	8	1	represented	7	7	8	0	SBAR	0	8	40	1	S	1	8	40	2	NP	0	8	21	2	NP	2	8	11	3	DT	0	8	9	1	the	8	8	9	0	NN	0	9	10	1	linker	9	9	10	0	NN	0	10	11	1	region	10	10	11	0	PP	0	11	21	2	IN	0	11	12	1	between	11	11	12	0	NP	0	12	21	3	NP	1	12	14	2	DT	0	12	13	1	the	12	12	13	0	NN	0	13	14	1	GST	13	13	14	0	CC	0	14	15	1	and	14	14	15	0	NP	0	15	21	3	NP	2	15	18	3	PRP$	0	15	16	1	our	15	15	16	0	NN	0	16	17	1	ASPP2	16	16	17	0	NN	0	17	18	1	fragment	17	17	18	0	CC	0	18	19	1	and	18	18	19	0	NP	1	19	21	2	DT	0	19	20	1	the	19	19	20	0	JJ	0	20	21	1	other	20	20	21	0	VP	0	21	40	3	VBD	0	21	22	1	corresponded	21	21	22	0	PP	0	22	29	2	TO	0	22	23	1	to	22	22	23	0	NP	0	23	29	2	NP	1	23	25	2	DT	0	23	24	1	a	23	23	24	0	NN	0	24	25	1	fragment	24	24	25	0	PP	0	25	29	2	IN	0	25	26	1	of	25	25	26	0	NP	2	26	29	3	DT	0	26	27	1	the	26	26	27	0	JJ	0	27	28	1	same	27	27	28	0	NN	0	28	29	1	mass	28	28	29	0	PP	0	29	40	2	IN	0	29	30	1	as	29	29	30	0	S	1	30	40	2	NP	0	30	31	1	DT	0	30	31	1	that	30	30	31	0	VP	0	31	40	2	VBG	0	31	32	1	containing	31	31	32	0	NP	0	32	40	3	NP	4	32	37	5	DT	0	32	33	1	the	32	32	33	0	JJ	0	33	34	1	second	33	33	34	0	JJ	0	34	35	1	putative	34	34	35	0	NN	0	35	36	1	phosphorylation	35	35	36	0	NN	0	36	37	1	site	36	36	37	0	,	0	37	38	1	,	37	37	38	0	NP	0	38	40	2	NN	0	38	39	1	serine	38	38	39	0	CD	0	39	40	1	827	39	39	40	0	.	0	40	41	1	.	40	40	41	0
EOS
T	13
Hence	7051	7056	RB	hence	O	_	_
ASPP2	7057	7062	NN	aspp2	O	_	_
can	7063	7066	MD	can	O	_	_
be	7067	7069	VB	be	O	_	_
phosphorylated	7070	7084	VBN	phosphorylate	O	_	_
at	7085	7087	IN	at	O	_	_
serine	7088	7094	NN	serine	O	_	_
827	7095	7098	CD	827	O	_	_
by	7099	7101	IN	by	O	_	_
MAPK1	7102	7107	NN	mapk1	B-GENE	_	_
in	7108	7110	FW	in	O	_	_
vitro	7111	7116	FW	vitro	O	_	_
.	7116	7117	.	.	O	_	_
D	1
4
4	0	advmod
4	1	nsubjpass
4	2	aux
4	3	auxpass
4	6	prep_at
4	11	advmod
6	7	num
6	9	prep_by
11	10	nn
EOX
Y	1
ROOT	0	0	13	1	S	2	0	13	4	ADVP	0	0	1	1	RB	0	0	1	1	Hence	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	ASPP2	1	1	2	0	VP	1	2	12	2	MD	0	2	3	1	can	2	2	3	0	VP	1	3	12	2	VB	0	3	4	1	be	3	3	4	0	VP	0	4	12	3	VBN	0	4	5	1	phosphorylated	4	4	5	0	PP	0	5	10	2	IN	0	5	6	1	at	5	5	6	0	NP	0	6	10	2	NP	0	6	8	2	NN	0	6	7	1	serine	6	6	7	0	CD	0	7	8	1	827	7	7	8	0	PP	0	8	10	2	IN	0	8	9	1	by	8	8	9	0	NP	0	9	10	1	NN	0	9	10	1	MAPK1	9	9	10	0	ADVP	1	10	12	2	FW	0	10	11	1	in	10	10	11	0	FW	0	11	12	1	vitro	11	11	12	0	.	0	12	13	1	.	12	12	13	0
EOS
T	5
10.1371	7118	7125	CD	10.1371	O	_	_
/	7125	7126	:	/	O	_	_
journal.pone	7126	7138	NN	journal.pone	O	_	_
.0082022	7138	7146	CD	.0082022	O	_	_
.	7146	7147	.	.	O	_	_
D	1
0
0	1	punct
0	2	dep
2	3	dep
EOX
Y	1
ROOT	0	0	5	1	FRAG	0	0	5	4	NP	0	0	1	1	CD	0	0	1	1	10.1371	0	0	1	0	:	0	1	2	1	/	1	1	2	0	FRAG	0	2	4	2	NP	0	2	3	1	NN	0	2	3	1	journal.pone	2	2	3	0	NP	0	3	4	1	CD	0	3	4	1	.0082022	3	3	4	0	.	0	4	5	1	.	4	4	5	0
EOS
T	5
g001	7147	7151	NN	g001	O	_	_
MAPK	7161	7165	NN	mapk	O	_	_
phosphorylates	7166	7180	VBZ	phosphorylate	O	_	_
ASPP2	7181	7186	NN	aspp2	B-GENE	_	_
.	7186	7187	.	.	O	_	_
D	1
2
1	0	nn
2	1	nsubj
2	3	dobj
EOX
Y	1
ROOT	0	0	5	1	S	1	0	5	3	NP	1	0	2	2	NN	0	0	1	1	g001	0	0	1	0	NN	0	1	2	1	MAPK	1	1	2	0	VP	0	2	4	2	VBZ	0	2	3	1	phosphorylates	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	ASPP2	3	3	4	0	.	0	4	5	1	.	4	4	5	0
EOS
T	17
(	7188	7189	NN	(	O	_	_
A	7189	7190	NN	a	O	_	_
)	7190	7191	CD	)	O	_	_
ASPP1	7192	7197	NN	aspp1	B-GENE	_	_
and	7198	7201	CC	and	O	_	_
ASPP2	7202	7207	NN	aspp2	B-GENE	_	_
have	7208	7212	VBP	have	O	_	_
two	7213	7216	CD	two	O	_	_
conserved	7217	7226	VBN	conserve	O	_	_
putative	7227	7235	JJ	putative	O	_	_
MAPK2	7236	7241	NN	mapk2	B-GENE	_	_
phosphorylation	7242	7257	NN	phosphorylation	O	_	_
sites	7258	7263	NNS	site	O	_	_
in	7264	7266	IN	in	O	_	_
their	7267	7272	PRP$	they	O	_	_
C-terminus	7273	7283	NN	c-terminus	O	_	_
.	7283	7284	.	.	O	_	_
D	1
6
1	0	nn
1	3	dep
1	5	conj_and
3	2	num
6	1	nsubj
6	5	nsubj
6	7	dobj
7	8	vmod
8	12	dobj
12	9	amod
12	10	nn
12	11	nn
12	15	prep_in
15	14	poss
EOX
Y	1
ROOT	0	0	17	1	S	1	0	17	3	NP	0	0	6	3	NP	0	0	4	2	NP	1	0	2	2	NN	0	0	1	1	(	0	0	1	0	NN	0	1	2	1	A	1	1	2	0	NP	1	2	4	2	CD	0	2	3	1	)	2	2	3	0	NN	0	3	4	1	ASPP1	3	3	4	0	CC	0	4	5	1	and	4	4	5	0	NP	0	5	6	1	NN	0	5	6	1	ASPP2	5	5	6	0	VP	0	6	16	2	VBP	0	6	7	1	have	6	6	7	0	NP	0	7	16	2	NP	0	7	8	1	CD	0	7	8	1	two	7	7	8	0	VP	0	8	16	2	VBN	0	8	9	1	conserved	8	8	9	0	NP	0	9	16	2	NP	3	9	13	4	JJ	0	9	10	1	putative	9	9	10	0	NN	0	10	11	1	MAPK2	10	10	11	0	NN	0	11	12	1	phosphorylation	11	11	12	0	NNS	0	12	13	1	sites	12	12	13	0	PP	0	13	16	2	IN	0	13	14	1	in	13	13	14	0	NP	1	14	16	2	PRP$	0	14	15	1	their	14	14	15	0	NN	0	15	16	1	C-terminus	15	15	16	0	.	0	16	17	1	.	16	16	17	0
EOS
T	19
(	7285	7286	NN	(	O	_	_
B	7286	7287	NN	b	O	_	_
)	7287	7288	CD	)	O	_	_
The	7289	7292	DT	the	O	_	_
C-terminus	7293	7303	NN	c-terminus	O	_	_
fragment	7304	7312	NN	fragment	O	_	_
of	7313	7315	IN	of	O	_	_
ASPP2	7316	7321	NN	aspp2	B-GENE	_	_
is	7322	7324	VBZ	be	O	_	_
phosphorylated	7325	7339	VBN	phosphorylate	O	_	_
in	7340	7342	FW	in	O	_	_
vitro	7343	7348	FW	vitro	O	_	_
by	7349	7351	IN	by	O	_	_
MAPK1	7352	7357	NN	mapk1	B-GENE	_	_
(	7358	7359	CD	(	O	_	_
left	7359	7363	VBD	leave	O	_	_
panel	7364	7369	NN	panel	O	_	_
)	7369	7370	NN	)	O	_	_
.	7370	7371	.	.	O	_	_
D	1
9
1	0	nn
1	2	dep
1	5	dep
5	3	det
5	4	nn
5	7	prep_of
9	1	nsubjpass
9	8	auxpass
9	11	advmod
9	13	agent
11	10	nn
13	14	num
13	15	vmod
15	17	dobj
17	16	nn
EOX
Y	1
ROOT	0	0	19	1	S	1	0	19	3	NP	0	0	8	3	NP	1	0	2	2	NN	0	0	1	1	(	0	0	1	0	NN	0	1	2	1	B	1	1	2	0	NP	0	2	3	1	CD	0	2	3	1	)	2	2	3	0	NP	0	3	8	2	NP	2	3	6	3	DT	0	3	4	1	The	3	3	4	0	NN	0	4	5	1	C-terminus	4	4	5	0	NN	0	5	6	1	fragment	5	5	6	0	PP	0	6	8	2	IN	0	6	7	1	of	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	ASPP2	7	7	8	0	VP	1	8	18	2	VBZ	0	8	9	1	is	8	8	9	0	VP	0	9	18	3	VBN	0	9	10	1	phosphorylated	9	9	10	0	ADVP	1	10	12	2	FW	0	10	11	1	in	10	10	11	0	FW	0	11	12	1	vitro	11	11	12	0	PP	0	12	18	2	IN	0	12	13	1	by	12	12	13	0	NP	0	13	18	2	NP	0	13	15	2	NN	0	13	14	1	MAPK1	13	13	14	0	CD	0	14	15	1	(	14	14	15	0	VP	0	15	18	2	VBD	0	15	16	1	left	15	15	16	0	NP	1	16	18	2	NN	0	16	17	1	panel	16	16	17	0	NN	0	17	18	1	)	17	17	18	0	.	0	18	19	1	.	18	18	19	0
EOS
T	11
The	7372	7375	DT	the	O	_	_
intensity	7376	7385	NN	intensity	O	_	_
of	7386	7388	IN	of	O	_	_
phosphorylation	7389	7404	NN	phosphorylation	O	_	_
is	7405	7407	VBZ	be	O	_	_
quantified	7408	7418	VBN	quantify	O	_	_
(	7419	7420	RB	(	O	_	_
middle	7420	7426	JJ	middle	O	_	_
panel	7427	7432	NN	panel	O	_	_
)	7432	7433	NN	)	O	_	_
.	7433	7434	.	.	O	_	_
D	1
5
1	0	det
1	3	prep_of
5	1	nsubjpass
5	4	auxpass
5	9	dobj
7	6	advmod
9	7	amod
9	8	nn
EOX
Y	1
ROOT	0	0	11	1	S	1	0	11	3	NP	0	0	4	2	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	intensity	1	1	2	0	PP	0	2	4	2	IN	0	2	3	1	of	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	phosphorylation	3	3	4	0	VP	1	4	10	2	VBZ	0	4	5	1	is	4	4	5	0	VP	0	5	10	2	VBN	0	5	6	1	quantified	5	5	6	0	NP	2	6	10	3	ADJP	1	6	8	2	RB	0	6	7	1	(	6	6	7	0	JJ	0	7	8	1	middle	7	7	8	0	NN	0	8	9	1	panel	8	8	9	0	NN	0	9	10	1	)	9	9	10	0	.	0	10	11	1	.	10	10	11	0
EOS
T	25
The	7435	7438	DT	the	O	_	_
MAPK1	7439	7444	NN	mapk1	O	_	_
phosphorylated	7445	7459	VBN	phosphorylate	B-GENE	_	_
ASPP2	7460	7465	NN	aspp2	I-GENE	_	_
fragment	7466	7474	NN	fragment	I-GENE	_	_
was	7475	7478	VBD	be	O	_	_
digested	7479	7487	VBN	digest	O	_	_
with	7488	7492	IN	with	O	_	_
trypsin	7493	7500	NN	trypsin	O	_	_
and	7501	7504	CC	and	O	_	_
chromatographed	7505	7520	NN	chromatographed	O	_	_
and	7521	7524	CC	and	O	_	_
the	7525	7528	DT	the	O	_	_
radioactive	7529	7540	JJ	radioactive	O	_	_
peptides	7541	7549	NNS	peptide	O	_	_
were	7550	7554	VBD	be	O	_	_
measured	7555	7563	VBN	measure	O	_	_
by	7564	7566	IN	by	O	_	_
mass	7567	7571	NN	mass	O	_	_
spectrometry	7572	7584	NN	spectrometry	O	_	_
(	7585	7586	RB	(	O	_	_
right	7586	7591	JJ	right	O	_	_
panel	7592	7597	NN	panel	O	_	_
)	7597	7598	NN	)	O	_	_
.	7598	7599	.	.	O	_	_
D	1
6
1	0	det
1	2	vmod
2	4	dobj
4	3	nn
6	1	nsubjpass
6	5	auxpass
6	8	prep_with
6	10	prep_with
6	16	conj_and
8	10	conj_and
14	12	det
14	13	amod
16	14	nsubjpass
16	15	auxpass
16	23	agent
19	18	nn
21	20	advmod
23	19	nn
23	21	amod
23	22	nn
EOX
Y	1
ROOT	0	0	25	1	S	0	0	25	4	S	1	0	11	2	NP	0	0	5	2	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	MAPK1	1	1	2	0	VP	0	2	5	2	VBN	0	2	3	1	phosphorylated	2	2	3	0	NP	1	3	5	2	NN	0	3	4	1	ASPP2	3	3	4	0	NN	0	4	5	1	fragment	4	4	5	0	VP	1	5	11	2	VBD	0	5	6	1	was	5	5	6	0	VP	0	6	11	2	VBN	0	6	7	1	digested	6	6	7	0	PP	0	7	11	2	IN	0	7	8	1	with	7	7	8	0	NP	0	8	11	3	NN	0	8	9	1	trypsin	8	8	9	0	CC	0	9	10	1	and	9	9	10	0	NN	0	10	11	1	chromatographed	10	10	11	0	CC	0	11	12	1	and	11	11	12	0	S	1	12	24	2	NP	2	12	15	3	DT	0	12	13	1	the	12	12	13	0	JJ	0	13	14	1	radioactive	13	13	14	0	NNS	0	14	15	1	peptides	14	14	15	0	VP	1	15	24	2	VBD	0	15	16	1	were	15	15	16	0	VP	0	16	24	2	VBN	0	16	17	1	measured	16	16	17	0	PP	0	17	24	2	IN	0	17	18	1	by	17	17	18	0	NP	3	18	24	4	NP	1	18	20	2	NN	0	18	19	1	mass	18	18	19	0	NN	0	19	20	1	spectrometry	19	19	20	0	ADJP	1	20	22	2	RB	0	20	21	1	(	20	20	21	0	JJ	0	21	22	1	right	21	21	22	0	NN	0	22	23	1	panel	22	22	23	0	NN	0	23	24	1	)	23	23	24	0	.	0	24	25	1	.	24	24	25	0
EOS
T	24
The	7600	7603	DT	the	O	_	_
first	7604	7609	JJ	first	O	_	_
peak	7610	7614	NN	peak	O	_	_
represents	7615	7625	VBZ	represent	O	_	_
the	7626	7629	DT	the	O	_	_
GST	7630	7633	NN	gst	O	_	_
linker	7634	7640	NN	linker	O	_	_
region	7641	7647	NN	region	O	_	_
whereas	7648	7655	IN	whereas	O	_	_
the	7656	7659	DT	the	O	_	_
second	7660	7666	JJ	second	O	_	_
presented	7667	7676	VBN	present	O	_	_
a	7677	7678	DT	a	O	_	_
region	7679	7685	NN	region	O	_	_
of	7686	7688	IN	of	O	_	_
equal	7689	7694	JJ	equal	O	_	_
mass	7695	7699	NN	mass	O	_	_
to	7700	7702	TO	to	O	_	_
the	7703	7706	DT	the	O	_	_
fragment	7707	7715	NN	fragment	O	_	_
containing	7716	7726	VBG	contain	O	_	_
serine	7727	7733	NN	serine	O	_	_
827	7734	7737	CD	827	O	_	_
.	7737	7738	.	.	O	_	_
D	1
3
2	0	det
2	1	amod
3	2	nsubj
3	7	dobj
3	11	advcl
7	4	det
7	5	nn
7	6	nn
10	9	det
11	8	mark
11	10	nsubj
11	13	dobj
11	19	prep_to
13	12	det
13	16	prep_of
16	15	amod
19	18	det
19	20	vmod
20	21	dobj
21	22	num
EOX
Y	1
ROOT	0	0	24	1	S	1	0	24	3	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	JJ	0	1	2	1	first	1	1	2	0	NN	0	2	3	1	peak	2	2	3	0	VP	0	3	23	3	VBZ	0	3	4	1	represents	3	3	4	0	NP	3	4	8	4	DT	0	4	5	1	the	4	4	5	0	NN	0	5	6	1	GST	5	5	6	0	NN	0	6	7	1	linker	6	6	7	0	NN	0	7	8	1	region	7	7	8	0	SBAR	1	8	23	2	IN	0	8	9	1	whereas	8	8	9	0	S	1	9	23	2	NP	1	9	11	2	DT	0	9	10	1	the	9	9	10	0	JJ	0	10	11	1	second	10	10	11	0	VP	0	11	23	3	VBN	0	11	12	1	presented	11	11	12	0	NP	0	12	17	2	NP	1	12	14	2	DT	0	12	13	1	a	12	12	13	0	NN	0	13	14	1	region	13	13	14	0	PP	0	14	17	2	IN	0	14	15	1	of	14	14	15	0	NP	1	15	17	2	JJ	0	15	16	1	equal	15	15	16	0	NN	0	16	17	1	mass	16	16	17	0	PP	0	17	23	2	TO	0	17	18	1	to	17	17	18	0	NP	0	18	23	2	NP	1	18	20	2	DT	0	18	19	1	the	18	18	19	0	NN	0	19	20	1	fragment	19	19	20	0	VP	0	20	23	2	VBG	0	20	21	1	containing	20	20	21	0	NP	0	21	23	2	NN	0	21	22	1	serine	21	21	22	0	CD	0	22	23	1	827	22	22	23	0	.	0	23	24	1	.	23	23	24	0
EOS
T	23
(	7739	7740	NN	(	O	_	_
C	7740	7741	NN	c	O	_	_
)	7741	7742	CD	)	O	_	_
An	7743	7745	DT	a	O	_	_
in	7746	7748	FW	in	O	_	_
vitro	7749	7754	FW	vitro	O	_	_
phosphorylation	7755	7770	NN	phosphorylation	O	_	_
assay	7771	7776	NN	assay	O	_	_
was	7777	7780	VBD	be	O	_	_
performed	7781	7790	VBN	perform	O	_	_
on	7791	7793	IN	on	O	_	_
the	7794	7797	DT	the	O	_	_
ASPP2	7798	7803	NN	aspp2	B-GENE	_	_
C-terminus	7804	7814	NN	c-terminus	I-GENE	_	_
fragment	7815	7823	NN	fragment	I-GENE	_	_
with	7824	7828	IN	with	O	_	_
recombinant	7829	7840	JJ	recombinant	B-GENE	_	_
MAPK1	7841	7846	NN	mapk1	I-GENE	_	_
and	7847	7850	CC	and	O	_	_
non	7851	7854	JJ	non	O	_	_
radioactive	7855	7866	JJ	radioactive	O	_	_
ATP	7867	7870	NN	atp	O	_	_
.	7870	7871	.	.	O	_	_
D	1
9
1	0	nn
1	2	dep
1	3	dep
3	7	rcmod
5	4	nn
7	5	advmod
7	6	nn
9	1	nsubjpass
9	8	auxpass
9	14	prep_on
9	17	prep_with
9	21	prep_with
14	11	det
14	12	nn
14	13	nn
17	16	amod
17	21	conj_and
21	19	amod
21	20	amod
EOX
Y	1
ROOT	0	0	23	1	S	1	0	23	3	NP	0	0	8	3	NP	1	0	2	2	NN	0	0	1	1	(	0	0	1	0	NN	0	1	2	1	C	1	1	2	0	NP	0	2	3	1	CD	0	2	3	1	)	2	2	3	0	NP	0	3	8	2	DT	0	3	4	1	An	3	3	4	0	RRC	1	4	8	2	ADVP	1	4	6	2	FW	0	4	5	1	in	4	4	5	0	FW	0	5	6	1	vitro	5	5	6	0	NP	1	6	8	2	NN	0	6	7	1	phosphorylation	6	6	7	0	NN	0	7	8	1	assay	7	7	8	0	VP	1	8	22	2	VBD	0	8	9	1	was	8	8	9	0	VP	0	9	22	3	VBN	0	9	10	1	performed	9	9	10	0	PP	0	10	15	2	IN	0	10	11	1	on	10	10	11	0	NP	3	11	15	4	DT	0	11	12	1	the	11	11	12	0	NN	0	12	13	1	ASPP2	12	12	13	0	NN	0	13	14	1	C-terminus	13	13	14	0	NN	0	14	15	1	fragment	14	14	15	0	PP	0	15	22	2	IN	0	15	16	1	with	15	15	16	0	NP	0	16	22	3	NP	1	16	18	2	JJ	0	16	17	1	recombinant	16	16	17	0	NN	0	17	18	1	MAPK1	17	17	18	0	CC	0	18	19	1	and	18	18	19	0	NP	2	19	22	3	JJ	0	19	20	1	non	19	19	20	0	JJ	0	20	21	1	radioactive	20	20	21	0	NN	0	21	22	1	ATP	21	21	22	0	.	0	22	23	1	.	22	22	23	0
EOS
T	20
The	7872	7875	DT	the	O	_	_
phosphorylation	7876	7891	NN	phosphorylation	O	_	_
status	7892	7898	NN	status	O	_	_
of	7899	7901	IN	of	O	_	_
ASPP2	7902	7907	NN	aspp2	O	_	_
was	7908	7911	VBD	be	O	_	_
assessed	7912	7920	VBN	assess	O	_	_
using	7921	7926	VBG	use	O	_	_
the	7927	7930	DT	the	O	_	_
purified	7931	7939	VBN	purify	O	_	_
NGH.S4	7940	7946	NN	ngh.s4	B-GENE	_	_
phospho	7947	7954	NN	phospho	I-GENE	_	_
specific	7955	7963	JJ	specific	I-GENE	_	_
ASPP2	7964	7969	NN	aspp2	I-GENE	_	_
antibody	7970	7978	NN	antibody	I-GENE	_	_
(	7979	7980	CD	(	O	_	_
upper	7980	7985	JJ	upper	O	_	_
panel	7986	7991	NN	panel	O	_	_
)	7991	7992	NN	)	O	_	_
.	7992	7993	.	.	O	_	_
D	1
6
2	0	det
2	1	nn
2	4	prep_of
6	2	nsubjpass
6	5	auxpass
6	7	ccomp
7	11	dobj
7	14	dep
11	8	det
11	9	amod
11	10	nn
14	12	amod
14	13	nn
14	18	dep
18	15	num
18	16	amod
18	17	nn
EOX
Y	1
ROOT	0	0	20	1	S	1	0	20	3	NP	0	0	5	2	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	phosphorylation	1	1	2	0	NN	0	2	3	1	status	2	2	3	0	PP	0	3	5	2	IN	0	3	4	1	of	3	3	4	0	NP	0	4	5	1	NN	0	4	5	1	ASPP2	4	4	5	0	VP	1	5	19	2	VBD	0	5	6	1	was	5	5	6	0	VP	0	6	19	2	VBN	0	6	7	1	assessed	6	6	7	0	SBAR	0	7	19	1	S	0	7	19	2	VP	0	7	12	2	VBG	0	7	8	1	using	7	7	8	0	NP	3	8	12	4	DT	0	8	9	1	the	8	8	9	0	VBN	0	9	10	1	purified	9	9	10	0	NN	0	10	11	1	NGH.S4	10	10	11	0	NN	0	11	12	1	phospho	11	11	12	0	NP	0	12	19	2	NP	2	12	15	3	JJ	0	12	13	1	specific	12	12	13	0	NN	0	13	14	1	ASPP2	13	13	14	0	NN	0	14	15	1	antibody	14	14	15	0	NP	3	15	19	4	CD	0	15	16	1	(	15	15	16	0	JJ	0	16	17	1	upper	16	16	17	0	NN	0	17	18	1	panel	17	17	18	0	NN	0	18	19	1	)	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	9
Total	7994	7999	JJ	total	O	_	_
ASPP2	8000	8005	NN	aspp2	O	_	_
is	8006	8008	VBZ	be	O	_	_
shown	8009	8014	VBN	show	O	_	_
in	8015	8017	IN	in	O	_	_
the	8018	8021	DT	the	O	_	_
lower	8022	8027	JJR	lower	O	_	_
panel	8028	8033	NN	panel	O	_	_
.	8033	8034	.	.	O	_	_
D	1
3
1	0	amod
3	1	nsubjpass
3	2	auxpass
3	7	prep_in
7	5	det
7	6	amod
EOX
Y	1
ROOT	0	0	9	1	S	1	0	9	3	NP	1	0	2	2	JJ	0	0	1	1	Total	0	0	1	0	NN	0	1	2	1	ASPP2	1	1	2	0	VP	1	2	8	2	VBZ	0	2	3	1	is	2	2	3	0	VP	0	3	8	2	VBN	0	3	4	1	shown	3	3	4	0	PP	0	4	8	2	IN	0	4	5	1	in	4	4	5	0	NP	2	5	8	3	DT	0	5	6	1	the	5	5	6	0	JJR	0	6	7	1	lower	6	6	7	0	NN	0	7	8	1	panel	7	7	8	0	.	0	8	9	1	.	8	8	9	0
EOS
T	14
(	8035	8036	NN	(	O	_	_
D	8036	8037	NN	d	O	_	_
)	8037	8038	CD	)	O	_	_
Saos2	8039	8044	NN	saos2	O	_	_
cells	8045	8050	NNS	cell	O	_	_
were	8051	8055	VBD	be	O	_	_
starved	8056	8063	VBN	starve	O	_	_
then	8064	8068	RB	then	O	_	_
stimulated	8069	8079	VBN	stimulate	O	_	_
with	8080	8084	IN	with	O	_	_
serum	8085	8090	NN	serum	O	_	_
and	8091	8094	CC	and	O	_	_
EGF	8095	8098	NN	egf	B-GENE	_	_
.	8098	8099	.	.	O	_	_
D	1
6
4	0	nn
4	1	nn
4	2	num
4	3	nn
6	4	nsubjpass
6	5	auxpass
6	7	advmod
6	8	dep
8	10	prep_with
8	12	prep_with
10	12	conj_and
EOX
Y	1
ROOT	0	0	14	1	S	1	0	14	3	NP	4	0	5	5	NN	0	0	1	1	(	0	0	1	0	NN	0	1	2	1	D	1	1	2	0	CD	0	2	3	1	)	2	2	3	0	NN	0	3	4	1	Saos2	3	3	4	0	NNS	0	4	5	1	cells	4	4	5	0	VP	1	5	13	2	VBD	0	5	6	1	were	5	5	6	0	VP	0	6	13	3	VBN	0	6	7	1	starved	6	6	7	0	ADVP	0	7	8	1	RB	0	7	8	1	then	7	7	8	0	S	0	8	13	1	VP	0	8	13	2	VBN	0	8	9	1	stimulated	8	8	9	0	PP	0	9	13	2	IN	0	9	10	1	with	9	9	10	0	NP	0	10	13	3	NN	0	10	11	1	serum	10	10	11	0	CC	0	11	12	1	and	11	11	12	0	NN	0	12	13	1	EGF	12	12	13	0	.	0	13	14	1	.	13	13	14	0
EOS
T	32
At	8100	8102	IN	at	O	_	_
the	8103	8106	DT	the	O	_	_
indicated	8107	8116	JJ	indicated	O	_	_
times	8117	8122	NNS	time	O	_	_
the	8123	8126	DT	the	O	_	_
cells	8127	8132	NNS	cell	O	_	_
were	8133	8137	VBD	be	O	_	_
harvested	8138	8147	VBN	harvest	O	_	_
and	8148	8151	CC	and	O	_	_
either	8152	8158	CC	either	O	_	_
blotted	8159	8166	VBN	blot	O	_	_
for	8167	8170	IN	for	O	_	_
phospho	8171	8178	NN	phospho	O	_	_
/	8178	8179	:	/	O	_	_
total	8179	8184	JJ	total	O	_	_
MAPK	8185	8189	NN	mapk	O	_	_
(	8190	8191	NN	(	O	_	_
upper	8191	8196	JJ	upper	O	_	_
panel	8197	8202	NN	panel	O	_	_
)	8202	8203	NN	)	O	_	_
or	8204	8206	CC	or	O	_	_
immunoprecipitated	8207	8225	VBN	immunoprecipitate	O	_	_
for	8226	8229	IN	for	O	_	_
total	8230	8235	JJ	total	O	_	_
ASPP2	8236	8241	NN	aspp2	B-GENE	_	_
and	8242	8245	CC	and	O	_	_
blotted	8246	8253	VBN	blot	O	_	_
with	8254	8258	IN	with	O	_	_
NGH.S4	8259	8265	NN	ngh.s4	B-GENE	_	_
phospho-ASPP2	8266	8279	NN	phospho-aspp2	I-GENE	_	_
antibody	8280	8288	NN	antibody	I-GENE	_	_
.	8288	8289	.	.	O	_	_
D	1
7
3	1	det
3	2	amod
5	4	det
7	3	prep_at
7	5	nsubjpass
7	6	auxpass
7	9	advmod
7	10	conj_and
7	21	conj_and
10	5	nsubjpass
10	12	prep_for
10	16	dep
10	21	conj_or
10	26	conj_or
16	13	punct
16	14	amod
16	15	nn
16	19	dep
19	17	amod
19	18	nn
21	24	prep_for
21	26	conj_and
24	23	amod
26	30	prep_with
30	28	nn
30	29	nn
EOX
Y	1
ROOT	0	0	32	1	S	2	0	32	4	PP	0	0	4	2	IN	0	0	1	1	At	0	0	1	0	NP	2	1	4	3	DT	0	1	2	1	the	1	1	2	0	JJ	0	2	3	1	indicated	2	2	3	0	NNS	0	3	4	1	times	3	3	4	0	NP	1	4	6	2	DT	0	4	5	1	the	4	4	5	0	NNS	0	5	6	1	cells	5	5	6	0	VP	1	6	31	2	VBD	0	6	7	1	were	6	6	7	0	VP	0	7	31	4	VP	0	7	8	1	VBN	0	7	8	1	harvested	7	7	8	0	CC	0	8	9	1	and	8	8	9	0	ADVP	0	9	10	1	CC	0	9	10	1	either	9	9	10	0	VP	0	10	31	3	VP	0	10	20	3	VBN	0	10	11	1	blotted	10	10	11	0	PP	0	11	13	2	IN	0	11	12	1	for	11	11	12	0	NP	0	12	13	1	NN	0	12	13	1	phospho	12	12	13	0	PRN	1	13	20	2	:	0	13	14	1	/	13	13	14	0	NP	0	14	20	2	NP	2	14	17	3	JJ	0	14	15	1	total	14	14	15	0	NN	0	15	16	1	MAPK	15	15	16	0	NN	0	16	17	1	(	16	16	17	0	NP	2	17	20	3	JJ	0	17	18	1	upper	17	17	18	0	NN	0	18	19	1	panel	18	18	19	0	NN	0	19	20	1	)	19	19	20	0	CC	0	20	21	1	or	20	20	21	0	VP	0	21	31	3	VP	0	21	25	2	VBN	0	21	22	1	immunoprecipitated	21	21	22	0	PP	0	22	25	2	IN	0	22	23	1	for	22	22	23	0	NP	1	23	25	2	JJ	0	23	24	1	total	23	23	24	0	NN	0	24	25	1	ASPP2	24	24	25	0	CC	0	25	26	1	and	25	25	26	0	VP	0	26	31	2	VBN	0	26	27	1	blotted	26	26	27	0	PP	0	27	31	2	IN	0	27	28	1	with	27	27	28	0	NP	2	28	31	3	NN	0	28	29	1	NGH.S4	28	28	29	0	NN	0	29	30	1	phospho-ASPP2	29	29	30	0	NN	0	30	31	1	antibody	30	30	31	0	.	0	31	32	1	.	31	31	32	0
EOS
T	27
(	8290	8291	NN	(	O	_	_
E	8291	8292	NN	e	O	_	_
)	8292	8293	CD	)	O	_	_
Total	8294	8299	JJ	total	O	_	_
cell	8300	8304	NN	cell	O	_	_
lysates	8305	8312	NNS	lysate	O	_	_
from	8313	8317	IN	from	O	_	_
HKe3	8318	8322	NN	hke3	B-GENE	_	_
ER	8323	8325	NN	er	I-GENE	_	_
:	8325	8326	:	:	O	_	_
HRASV12	8326	8333	NN	hrasv12	O	_	_
cells	8334	8339	NNS	cell	O	_	_
treated	8340	8347	VBN	treat	O	_	_
with	8348	8352	IN	with	O	_	_
or	8353	8355	CC	or	O	_	_
without	8356	8363	IN	without	O	_	_
4-OHT	8364	8369	NN	4-oht	O	_	_
were	8370	8374	VBD	be	O	_	_
transfected	8375	8386	VBN	transfect	O	_	_
with	8387	8391	IN	with	O	_	_
control	8392	8399	NN	control	O	_	_
siRNA	8400	8405	NN	sirna	O	_	_
or	8406	8408	CC	or	O	_	_
siRNA	8409	8414	NN	sirna	O	_	_
against	8415	8422	IN	against	O	_	_
ASPP2	8423	8428	NN	aspp2	B-GENE	_	_
.	8428	8429	.	.	O	_	_
D	1
18
1	0	nn
1	5	npadvmod
1	8	prep_from
5	2	num
5	3	amod
5	4	nn
8	7	nn
8	11	dep
11	10	nn
11	12	vmod
12	12	conj_or
12	16	prep_with
12	16	prep_without
18	1	nsubjpass
18	17	auxpass
18	21	prep_with
18	23	prep_with
18	25	prep_against
21	20	nn
21	23	conj_or
EOX
Y	1
ROOT	0	0	27	1	S	1	0	27	3	NP	0	0	17	2	NP	1	0	2	2	NN	0	0	1	1	(	0	0	1	0	NN	0	1	2	1	E	1	1	2	0	PP	1	2	17	3	NP	3	2	6	4	CD	0	2	3	1	)	2	2	3	0	JJ	0	3	4	1	Total	3	3	4	0	NN	0	4	5	1	cell	4	4	5	0	NNS	0	5	6	1	lysates	5	5	6	0	IN	0	6	7	1	from	6	6	7	0	NP	0	7	17	3	NP	1	7	9	2	NN	0	7	8	1	HKe3	7	7	8	0	NN	0	8	9	1	ER	8	8	9	0	:	0	9	10	1	:	9	9	10	0	NP	0	10	17	2	NP	1	10	12	2	NN	0	10	11	1	HRASV12	10	10	11	0	NNS	0	11	12	1	cells	11	11	12	0	VP	0	12	17	2	VBN	0	12	13	1	treated	12	12	13	0	PP	0	13	17	4	IN	0	13	14	1	with	13	13	14	0	CC	0	14	15	1	or	14	14	15	0	IN	0	15	16	1	without	15	15	16	0	NP	0	16	17	1	NN	0	16	17	1	4-OHT	16	16	17	0	VP	1	17	26	2	VBD	0	17	18	1	were	17	17	18	0	VP	0	18	26	3	VBN	0	18	19	1	transfected	18	18	19	0	PP	0	19	24	2	IN	0	19	20	1	with	19	19	20	0	NP	1	20	24	4	NN	0	20	21	1	control	20	20	21	0	NN	0	21	22	1	siRNA	21	21	22	0	CC	0	22	23	1	or	22	22	23	0	NN	0	23	24	1	siRNA	23	23	24	0	PP	0	24	26	2	IN	0	24	25	1	against	24	24	25	0	NP	0	25	26	1	NN	0	25	26	1	ASPP2	25	25	26	0	.	0	26	27	1	.	26	26	27	0
EOS
T	12
ASPP2	8430	8435	NN	aspp2	B-GENE	_	_
phosphorylation	8436	8451	NN	phosphorylation	O	_	_
was	8452	8455	VBD	be	O	_	_
detected	8456	8464	VBN	detect	O	_	_
with	8465	8469	IN	with	O	_	_
ES1	8470	8473	NN	es1	B-GENE	_	_
phospho-ASPP2	8474	8487	NN	phospho-aspp2	I-GENE	_	_
antibody	8488	8496	NN	antibody	I-GENE	_	_
and	8497	8500	CC	and	O	_	_
total	8501	8506	JJ	total	O	_	_
ASPP2	8507	8512	NN	aspp2	B-GENE	_	_
.	8512	8513	.	.	O	_	_
D	1
3
1	0	nn
3	1	nsubjpass
3	2	auxpass
3	7	prep_with
3	10	prep_with
7	5	nn
7	6	nn
7	10	conj_and
10	9	amod
EOX
Y	1
ROOT	0	0	12	1	S	1	0	12	3	NP	1	0	2	2	NN	0	0	1	1	ASPP2	0	0	1	0	NN	0	1	2	1	phosphorylation	1	1	2	0	VP	1	2	11	2	VBD	0	2	3	1	was	2	2	3	0	VP	0	3	11	2	VBN	0	3	4	1	detected	3	3	4	0	PP	0	4	11	2	IN	0	4	5	1	with	4	4	5	0	NP	0	5	11	3	NP	2	5	8	3	NN	0	5	6	1	ES1	5	5	6	0	NN	0	6	7	1	phospho-ASPP2	6	6	7	0	NN	0	7	8	1	antibody	7	7	8	0	CC	0	8	9	1	and	8	8	9	0	NP	1	9	11	2	JJ	0	9	10	1	total	9	9	10	0	NN	0	10	11	1	ASPP2	10	10	11	0	.	0	11	12	1	.	11	11	12	0
EOS
T	21
A	8514	8515	DT	a	O	_	_
synthetic	8516	8525	JJ	synthetic	O	_	_
peptide	8526	8533	NN	peptide	O	_	_
encoding	8534	8542	VBG	encode	O	_	_
amino	8543	8548	NN	amino	O	_	_
acids	8549	8554	NNS	acid	O	_	_
824-832	8555	8562	CD	824-832	O	_	_
,	8562	8563	,	,	O	_	_
with	8564	8568	IN	with	O	_	_
a	8569	8570	DT	a	O	_	_
phosphoserine	8571	8584	NN	phosphoserine	O	_	_
at	8585	8587	IN	at	O	_	_
residue	8588	8595	NN	residue	O	_	_
827	8596	8599	CD	827	O	_	_
,	8599	8600	,	,	O	_	_
was	8601	8604	VBD	be	O	_	_
used	8605	8609	VBN	use	O	_	_
to	8610	8612	TO	to	O	_	_
raise	8613	8618	VB	raise	O	_	_
antibodies	8619	8629	NNS	antibody	O	_	_
.	8629	8630	.	.	O	_	_
D	1
16
2	0	det
2	1	amod
2	3	vmod
3	6	xcomp
5	4	nn
6	5	nsubj
6	10	prep_with
10	9	det
10	12	prep_at
12	13	num
16	2	nsubjpass
16	15	auxpass
16	18	xcomp
18	17	aux
18	19	dobj
EOX
Y	1
ROOT	0	0	21	1	S	1	0	21	3	NP	0	0	15	2	NP	2	0	3	3	DT	0	0	1	1	A	0	0	1	0	JJ	0	1	2	1	synthetic	1	1	2	0	NN	0	2	3	1	peptide	2	2	3	0	VP	0	3	15	2	VBG	0	3	4	1	encoding	3	3	4	0	S	1	4	15	2	NP	1	4	6	2	NN	0	4	5	1	amino	4	4	5	0	NNS	0	5	6	1	acids	5	5	6	0	NP	0	6	15	4	NP	0	6	7	1	CD	0	6	7	1	824-832	6	6	7	0	,	0	7	8	1	,	7	7	8	0	PP	0	8	14	2	IN	0	8	9	1	with	8	8	9	0	NP	0	9	14	2	NP	1	9	11	2	DT	0	9	10	1	a	9	9	10	0	NN	0	10	11	1	phosphoserine	10	10	11	0	PP	0	11	14	2	IN	0	11	12	1	at	11	11	12	0	NP	0	12	14	2	NN	0	12	13	1	residue	12	12	13	0	CD	0	13	14	1	827	13	13	14	0	,	0	14	15	1	,	14	14	15	0	VP	1	15	20	2	VBD	0	15	16	1	was	15	15	16	0	VP	0	16	20	2	VBN	0	16	17	1	used	16	16	17	0	S	0	17	20	1	VP	1	17	20	2	TO	0	17	18	1	to	17	17	18	0	VP	0	18	20	2	VB	0	18	19	1	raise	18	18	19	0	NP	0	19	20	1	NNS	0	19	20	1	antibodies	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	11
A	8631	8632	DT	a	O	_	_
polyclonal	8633	8643	JJ	polyclonal	O	_	_
antibody	8644	8652	NN	antibody	O	_	_
NGH.S4	8653	8659	NN	ngh.s4	O	_	_
was	8660	8663	VBD	be	O	_	_
purified	8664	8672	VBN	purify	O	_	_
by	8673	8675	IN	by	O	_	_
affinity	8676	8684	NN	affinity	O	_	_
column	8685	8691	NN	column	O	_	_
purification	8692	8704	NN	purification	O	_	_
.	8704	8705	.	.	O	_	_
D	1
5
3	0	det
3	1	amod
3	2	nn
5	3	nsubjpass
5	4	auxpass
5	9	agent
9	7	nn
9	8	nn
EOX
Y	1
ROOT	0	0	11	1	S	1	0	11	3	NP	3	0	4	4	DT	0	0	1	1	A	0	0	1	0	JJ	0	1	2	1	polyclonal	1	1	2	0	NN	0	2	3	1	antibody	2	2	3	0	NN	0	3	4	1	NGH.S4	3	3	4	0	VP	1	4	10	2	VBD	0	4	5	1	was	4	4	5	0	VP	0	5	10	2	VBN	0	5	6	1	purified	5	5	6	0	PP	0	6	10	2	IN	0	6	7	1	by	6	6	7	0	NP	2	7	10	3	NN	0	7	8	1	affinity	7	7	8	0	NN	0	8	9	1	column	8	8	9	0	NN	0	9	10	1	purification	9	9	10	0	.	0	10	11	1	.	10	10	11	0
EOS
T	32
To	8706	8708	TO	to	O	_	_
test	8709	8713	VB	test	O	_	_
the	8714	8717	DT	the	O	_	_
efficacy	8718	8726	NN	efficacy	O	_	_
of	8727	8729	IN	of	O	_	_
the	8730	8733	DT	the	O	_	_
purified	8734	8742	VBN	purify	O	_	_
phospho	8743	8750	NN	phospho	O	_	_
specific	8751	8759	JJ	specific	O	_	_
antibody	8760	8768	NN	antibody	O	_	_
,	8768	8769	,	,	O	_	_
a	8770	8771	DT	a	O	_	_
non	8772	8775	JJ	non	O	_	_
radioactive	8776	8787	JJ	radioactive	O	_	_
in	8788	8790	FW	in	O	_	_
vitro	8791	8796	FW	vitro	O	_	_
phosphorylation	8797	8812	NN	phosphorylation	O	_	_
assay	8813	8818	NN	assay	O	_	_
was	8819	8822	VBD	be	O	_	_
performed	8823	8832	VBN	perform	O	_	_
on	8833	8835	IN	on	O	_	_
the	8836	8839	DT	the	O	_	_
purified	8840	8848	VBN	purify	O	_	_
GST-ASPP2	8849	8858	NN	gst-aspp2	B-GENE	_	_
fragment	8859	8867	NN	fragment	O	_	_
(	8868	8869	CD	(	O	_	_
693-1128	8869	8877	CD	693-1128	O	_	_
)	8877	8878	NN	)	O	_	_
with	8879	8883	IN	with	O	_	_
recombinant	8884	8895	JJ	recombinant	B-GENE	_	_
MAPK1	8896	8901	NN	mapk1	I-GENE	_	_
.	8901	8902	.	.	O	_	_
D	1
19
1	0	aux
1	3	dobj
3	2	det
3	9	prep_of
9	5	det
9	6	amod
9	7	nn
9	8	amod
9	17	appos
13	15	dep
15	14	nn
17	11	det
17	12	amod
17	13	dep
17	16	nn
19	1	csubjpass
19	18	auxpass
19	24	prep_on
24	21	det
24	22	amod
24	23	nn
24	27	dep
24	30	prep_with
26	25	number
27	26	dep
30	29	amod
EOX
Y	1
ROOT	0	0	32	1	S	1	0	32	3	S	0	0	18	1	VP	1	0	18	2	TO	0	0	1	1	To	0	0	1	0	VP	0	1	18	2	VB	0	1	2	1	test	1	1	2	0	NP	0	2	18	2	NP	1	2	4	2	DT	0	2	3	1	the	2	2	3	0	NN	0	3	4	1	efficacy	3	3	4	0	PP	0	4	18	2	IN	0	4	5	1	of	4	4	5	0	NP	0	5	18	3	NP	4	5	10	5	DT	0	5	6	1	the	5	5	6	0	VBN	0	6	7	1	purified	6	6	7	0	NN	0	7	8	1	phospho	7	7	8	0	JJ	0	8	9	1	specific	8	8	9	0	NN	0	9	10	1	antibody	9	9	10	0	,	0	10	11	1	,	10	10	11	0	NP	4	11	18	5	DT	0	11	12	1	a	11	11	12	0	JJ	0	12	13	1	non	12	12	13	0	NAC	0	13	16	2	NP	0	13	14	1	JJ	0	13	14	1	radioactive	13	13	14	0	ADVP	1	14	16	2	FW	0	14	15	1	in	14	14	15	0	FW	0	15	16	1	vitro	15	15	16	0	NN	0	16	17	1	phosphorylation	16	16	17	0	NN	0	17	18	1	assay	17	17	18	0	VP	1	18	31	2	VBD	0	18	19	1	was	18	18	19	0	VP	0	19	31	2	VBN	0	19	20	1	performed	19	19	20	0	PP	0	20	31	2	IN	0	20	21	1	on	20	20	21	0	NP	0	21	31	2	NP	0	21	28	2	NP	3	21	25	4	DT	0	21	22	1	the	21	21	22	0	VBN	0	22	23	1	purified	22	22	23	0	NN	0	23	24	1	GST-ASPP2	23	23	24	0	NN	0	24	25	1	fragment	24	24	25	0	ADJP	1	25	28	2	QP	1	25	27	2	CD	0	25	26	1	(	25	25	26	0	CD	0	26	27	1	693-1128	26	26	27	0	NN	0	27	28	1	)	27	27	28	0	PP	0	28	31	2	IN	0	28	29	1	with	28	28	29	0	NP	1	29	31	2	JJ	0	29	30	1	recombinant	29	29	30	0	NN	0	30	31	1	MAPK1	30	30	31	0	.	0	31	32	1	.	31	31	32	0
EOS
T	18
shows	8913	8918	NNS	show	O	_	_
that	8919	8923	IN	that	O	_	_
the	8924	8927	DT	the	O	_	_
phospho	8928	8935	NN	phospho	O	_	_
specific	8936	8944	JJ	specific	O	_	_
antibody	8945	8953	NN	antibody	O	_	_
is	8954	8956	VBZ	be	O	_	_
specific	8957	8965	JJ	specific	O	_	_
for	8966	8969	IN	for	O	_	_
the	8970	8973	DT	the	O	_	_
ASPP2	8974	8979	NN	aspp2	B-GENE	_	_
fragment	8980	8988	NN	fragment	I-GENE	_	_
phosphorylated	8989	9003	VBN	phosphorylate	O	_	_
in	9004	9006	FW	in	O	_	_
vitro	9007	9012	FW	vitro	O	_	_
by	9013	9015	IN	by	O	_	_
MAPK	9016	9020	NN	mapk	O	_	_
.	9020	9021	.	.	O	_	_
D	1
12
0	7	dep
5	2	det
5	3	nn
5	4	amod
7	1	mark
7	5	nsubj
7	6	cop
7	11	prep_for
11	9	det
11	10	nn
12	0	nsubj
12	14	advmod
12	16	prep_by
14	13	nn
EOX
Y	1
ROOT	0	0	18	1	S	1	0	18	3	NP	0	0	12	2	NP	0	0	1	1	NNS	0	0	1	1	shows	0	0	1	0	SBAR	1	1	12	2	IN	0	1	2	1	that	1	1	2	0	S	1	2	12	2	NP	3	2	6	4	DT	0	2	3	1	the	2	2	3	0	NN	0	3	4	1	phospho	3	3	4	0	JJ	0	4	5	1	specific	4	4	5	0	NN	0	5	6	1	antibody	5	5	6	0	VP	1	6	12	2	VBZ	0	6	7	1	is	6	6	7	0	ADJP	0	7	12	2	JJ	0	7	8	1	specific	7	7	8	0	PP	0	8	12	2	IN	0	8	9	1	for	8	8	9	0	NP	2	9	12	3	DT	0	9	10	1	the	9	9	10	0	NN	0	10	11	1	ASPP2	10	10	11	0	NN	0	11	12	1	fragment	11	11	12	0	VP	0	12	17	3	VBN	0	12	13	1	phosphorylated	12	12	13	0	ADVP	1	13	15	2	FW	0	13	14	1	in	13	13	14	0	FW	0	14	15	1	vitro	14	14	15	0	PP	0	15	17	2	IN	0	15	16	1	by	15	15	16	0	NP	0	16	17	1	NN	0	16	17	1	MAPK	16	16	17	0	.	0	17	18	1	.	17	17	18	0
EOS
T	47
To	9022	9024	TO	to	O	_	_
test	9025	9029	VB	test	O	_	_
whether	9030	9037	IN	whether	O	_	_
endogenous	9038	9048	JJ	endogenous	O	_	_
ASPP2	9049	9054	NN	aspp2	O	_	_
could	9055	9060	MD	could	O	_	_
be	9061	9063	VB	be	O	_	_
phosphorylated	9064	9078	VBN	phosphorylate	O	_	_
in	9079	9081	IN	in	O	_	_
cells	9082	9087	NNS	cell	O	_	_
,	9087	9088	,	,	O	_	_
Saos2	9089	9094	NN	saos2	O	_	_
cells	9095	9100	NNS	cell	O	_	_
were	9101	9105	VBD	be	O	_	_
grown	9106	9111	VBN	grow	O	_	_
in	9112	9114	IN	in	O	_	_
low	9115	9118	JJ	low	O	_	_
serum	9119	9124	NN	serum	O	_	_
for	9125	9128	IN	for	O	_	_
50	9129	9131	CD	50	O	_	_
hours	9132	9137	NNS	hour	O	_	_
to	9138	9140	TO	to	O	_	_
remove	9141	9147	VB	remove	O	_	_
all	9148	9151	DT	all	O	_	_
background	9152	9162	NN	background	O	_	_
stimulation	9163	9174	NN	stimulation	O	_	_
of	9175	9177	IN	of	O	_	_
RAS	9178	9181	NN	ra	O	_	_
,	9181	9182	,	,	O	_	_
after	9183	9188	IN	after	O	_	_
which	9189	9194	WDT	which	O	_	_
the	9195	9198	DT	the	O	_	_
cells	9199	9204	NNS	cell	O	_	_
were	9205	9209	VBD	be	O	_	_
stimulated	9210	9220	VBN	stimulate	O	_	_
with	9221	9225	IN	with	O	_	_
EGF	9226	9229	NN	egf	O	_	_
and	9230	9233	CC	and	O	_	_
20	9234	9236	CD	20	O	_	_
%	9236	9237	NN	%	O	_	_
fetal	9238	9243	JJ	fetal	O	_	_
calf	9244	9248	NN	calf	O	_	_
serum	9249	9254	NN	serum	O	_	_
(	9255	9256	CD	(	O	_	_
FCS	9256	9259	NN	fc	O	_	_
)	9259	9260	NN	)	O	_	_
.	9260	9261	.	.	O	_	_
D	1
14
1	0	aux
1	7	ccomp
4	3	amod
7	2	mark
7	4	nsubjpass
7	5	aux
7	6	auxpass
7	9	prep_in
12	11	nn
14	1	advcl
14	12	nsubjpass
14	13	auxpass
14	17	prep_in
14	22	xcomp
17	16	amod
17	20	prep_for
20	19	num
22	21	aux
22	25	dobj
25	23	det
25	24	nn
25	27	prep_of
27	34	rcmod
32	31	det
34	30	prep_after
34	32	nsubjpass
34	33	auxpass
34	36	prep_with
34	39	prep_with
36	39	conj_and
39	38	num
39	45	dep
45	40	amod
45	41	nn
45	42	nn
45	43	num
45	44	nn
EOX
Y	1
ROOT	0	0	47	1	S	3	0	47	5	S	0	0	10	1	VP	1	0	10	2	TO	0	0	1	1	To	0	0	1	0	VP	0	1	10	2	VB	0	1	2	1	test	1	1	2	0	SBAR	1	2	10	2	IN	0	2	3	1	whether	2	2	3	0	S	1	3	10	2	NP	1	3	5	2	JJ	0	3	4	1	endogenous	3	3	4	0	NN	0	4	5	1	ASPP2	4	4	5	0	VP	1	5	10	2	MD	0	5	6	1	could	5	5	6	0	VP	1	6	10	2	VB	0	6	7	1	be	6	6	7	0	VP	0	7	10	2	VBN	0	7	8	1	phosphorylated	7	7	8	0	PP	0	8	10	2	IN	0	8	9	1	in	8	8	9	0	NP	0	9	10	1	NNS	0	9	10	1	cells	9	9	10	0	,	0	10	11	1	,	10	10	11	0	NP	1	11	13	2	NN	0	11	12	1	Saos2	11	11	12	0	NNS	0	12	13	1	cells	12	12	13	0	VP	1	13	46	2	VBD	0	13	14	1	were	13	13	14	0	VP	0	14	46	3	VBN	0	14	15	1	grown	14	14	15	0	PP	0	15	21	2	IN	0	15	16	1	in	15	15	16	0	NP	0	16	21	2	NP	1	16	18	2	JJ	0	16	17	1	low	16	16	17	0	NN	0	17	18	1	serum	17	17	18	0	PP	0	18	21	2	IN	0	18	19	1	for	18	18	19	0	NP	1	19	21	2	CD	0	19	20	1	50	19	19	20	0	NNS	0	20	21	1	hours	20	20	21	0	S	0	21	46	1	VP	1	21	46	2	TO	0	21	22	1	to	21	21	22	0	VP	0	22	46	2	VB	0	22	23	1	remove	22	22	23	0	NP	0	23	46	2	NP	2	23	26	3	DT	0	23	24	1	all	23	23	24	0	NN	0	24	25	1	background	24	24	25	0	NN	0	25	26	1	stimulation	25	25	26	0	PP	0	26	46	2	IN	0	26	27	1	of	26	26	27	0	NP	0	27	46	3	NP	0	27	28	1	NN	0	27	28	1	RAS	27	27	28	0	,	0	28	29	1	,	28	28	29	0	SBAR	1	29	46	2	WHPP	0	29	31	2	IN	0	29	30	1	after	29	29	30	0	WHNP	0	30	31	1	WDT	0	30	31	1	which	30	30	31	0	S	1	31	46	2	NP	1	31	33	2	DT	0	31	32	1	the	31	31	32	0	NNS	0	32	33	1	cells	32	32	33	0	VP	1	33	46	2	VBD	0	33	34	1	were	33	33	34	0	VP	0	34	46	2	VBN	0	34	35	1	stimulated	34	34	35	0	PP	0	35	46	2	IN	0	35	36	1	with	35	35	36	0	NP	0	36	46	3	NP	0	36	37	1	NN	0	36	37	1	EGF	36	36	37	0	CC	0	37	38	1	and	37	37	38	0	NP	0	38	46	2	NP	1	38	40	2	CD	0	38	39	1	20	38	38	39	0	NN	0	39	40	1	%	39	39	40	0	NP	5	40	46	6	JJ	0	40	41	1	fetal	40	40	41	0	NN	0	41	42	1	calf	41	41	42	0	NN	0	42	43	1	serum	42	42	43	0	CD	0	43	44	1	(	43	43	44	0	NN	0	44	45	1	FCS	44	44	45	0	NN	0	45	46	1	)	45	45	46	0	.	0	46	47	1	.	46	46	47	0
EOS
T	16
Phosphorylated	9262	9276	VBN	phosphorylate	O	_	_
endogenous	9277	9287	JJ	endogenous	O	_	_
ASPP2	9288	9293	NN	aspp2	O	_	_
was	9294	9297	VBD	be	O	_	_
detected	9298	9306	VBN	detect	O	_	_
by	9307	9309	IN	by	O	_	_
the	9310	9313	DT	the	O	_	_
phospho	9314	9321	NN	phospho	O	_	_
specific	9322	9330	JJ	specific	O	_	_
antibody	9331	9339	NN	antibody	O	_	_
30	9340	9342	CD	30	O	_	_
minutes	9343	9350	NNS	minute	O	_	_
after	9351	9356	IN	after	O	_	_
RAS	9357	9360	NN	ra	B-GENE	_	_
stimulation	9361	9372	NN	stimulation	O	_	_
.	9384	9385	.	.	O	_	_
D	1
0
0	2	dobj
0	4	auxpass
0	9	nsubjpass
2	1	amod
4	3	auxpass
4	7	agent
7	6	det
9	8	amod
9	11	dep
9	14	prep_after
11	10	num
14	13	nn
EOX
Y	1
ROOT	0	0	16	1	SINV	0	0	16	4	VP	0	0	3	2	VBN	0	0	1	1	Phosphorylated	0	0	1	0	NP	1	1	3	2	JJ	0	1	2	1	endogenous	1	1	2	0	NN	0	2	3	1	ASPP2	2	2	3	0	VP	1	3	8	2	VBD	0	3	4	1	was	3	3	4	0	VP	0	4	8	2	VBN	0	4	5	1	detected	4	4	5	0	PP	0	5	8	2	IN	0	5	6	1	by	5	5	6	0	NP	1	6	8	2	DT	0	6	7	1	the	6	6	7	0	NN	0	7	8	1	phospho	7	7	8	0	NP	0	8	15	3	NP	1	8	10	2	JJ	0	8	9	1	specific	8	8	9	0	NN	0	9	10	1	antibody	9	9	10	0	NP	1	10	12	2	CD	0	10	11	1	30	10	10	11	0	NNS	0	11	12	1	minutes	11	11	12	0	PP	0	12	15	2	IN	0	12	13	1	after	12	12	13	0	NP	1	13	15	2	NN	0	13	14	1	RAS	13	13	14	0	NN	0	14	15	1	stimulation	14	14	15	0	.	0	15	16	1	.	15	15	16	0
EOS
T	63
ASPP2	9386	9391	NN	aspp2	B-GENE	_	_
phosphorylation	9392	9407	NN	phosphorylation	O	_	_
was	9408	9411	VBD	be	O	_	_
rapid	9412	9417	JJ	rapid	O	_	_
and	9418	9421	CC	and	O	_	_
transient	9422	9431	JJ	transient	O	_	_
as	9432	9434	IN	as	O	_	_
3	9435	9436	CD	3	O	_	_
hours	9437	9442	NNS	hour	O	_	_
after	9443	9448	IN	after	O	_	_
EGF	9449	9452	NN	egf	B-GENE	_	_
stimulation	9453	9464	NN	stimulation	O	_	_
phosphorylated	9465	9479	VBN	phosphorylate	O	_	_
ASPP2	9480	9485	NN	aspp2	B-GENE	_	_
was	9486	9489	VBD	be	O	_	_
barely	9490	9496	RB	barely	O	_	_
detec	9497	9502	JJ	detec	O	_	_
Moreover	9509	9517	RB	moreover	O	_	_
,	9517	9518	,	,	O	_	_
with	9519	9523	IN	with	O	_	_
another	9524	9531	DT	another	O	_	_
different	9532	9541	JJ	different	O	_	_
phospho-ASPP2	9542	9555	NN	phospho-aspp2	O	_	_
antibody	9556	9564	NN	antibody	O	_	_
,	9564	9565	,	,	O	_	_
ES1	9566	9569	NN	es1	O	_	_
,	9569	9570	,	,	O	_	_
ASPP2	9571	9576	NN	aspp2	B-GENE	_	_
phosphorylation	9577	9592	NN	phosphorylation	O	_	_
was	9593	9596	VBD	be	O	_	_
also	9597	9601	RB	also	O	_	_
observed	9602	9610	VBN	observe	O	_	_
in	9611	9613	IN	in	O	_	_
a	9614	9615	DT	a	O	_	_
human	9616	9621	JJ	human	O	_	_
colon	9622	9627	NN	colon	O	_	_
cancer	9628	9634	NN	cancer	O	_	_
cell	9635	9639	NN	cell	O	_	_
line	9640	9644	NN	line	O	_	_
HKe3	9645	9649	NN	hke3	O	_	_
ER	9650	9652	NN	er	O	_	_
:	9652	9653	:	:	O	_	_
HRASV12	9653	9660	NN	hrasv12	O	_	_
cells	9661	9666	NNS	cell	O	_	_
,	9666	9667	,	,	O	_	_
in	9668	9670	IN	in	O	_	_
which	9671	9676	WDT	which	O	_	_
RAS	9677	9680	NN	ra	B-GENE	_	_
activation	9681	9691	NN	activation	O	_	_
is	9692	9694	VBZ	be	O	_	_
induced	9695	9702	VBN	induce	O	_	_
upon	9703	9707	IN	upon	O	_	_
the	9708	9711	DT	the	O	_	_
addition	9712	9720	NN	addition	O	_	_
of	9721	9723	IN	of	O	_	_
4-hydroxytamoxifen	9724	9742	JJ	4-hydroxytamoxifen	O	_	_
(	9743	9744	NN	(	O	_	_
4-OHT	9744	9749	NN	4-oht	O	_	_
)	9749	9750	CD	)	O	_	_
[	9751	9752	CD	[	O	_	_
2,10,11	9752	9759	CD	2,10,11	O	_	_
]	9759	9760	NN	]	O	_	_
.	9772	9773	.	.	O	_	_
D	1
31
1	0	nn
3	1	nsubj
3	2	cop
3	5	conj_and
3	8	prep_as
3	16	advcl
5	1	nsubj
8	7	num
11	10	nn
11	12	vmod
12	13	dobj
16	9	mark
16	11	nsubj
16	14	cop
16	15	advmod
16	17	advmod
16	23	prep_with
23	20	det
23	21	amod
23	22	nn
23	25	appos
28	27	nn
31	3	ccomp
31	5	ccomp
31	28	nsubjpass
31	29	auxpass
31	30	advmod
31	40	prep_in
40	33	det
40	34	amod
40	35	nn
40	36	nn
40	37	nn
40	38	nn
40	39	nn
40	43	dep
43	42	nn
43	50	rcmod
48	47	nn
50	46	prep_in
50	48	nsubjpass
50	49	auxpass
50	53	prep_upon
53	52	det
53	57	prep_of
57	55	amod
57	56	nn
57	59	dep
59	58	number
59	61	dep
61	60	num
EOX
Y	1
ROOT	0	0	63	1	S	3	0	63	5	S	1	0	26	2	NP	1	0	2	2	NN	0	0	1	1	ASPP2	0	0	1	0	NN	0	1	2	1	phosphorylation	1	1	2	0	VP	1	2	26	4	VBD	0	2	3	1	was	2	2	3	0	ADJP	0	3	6	3	JJ	0	3	4	1	rapid	3	3	4	0	CC	0	4	5	1	and	4	4	5	0	JJ	0	5	6	1	transient	5	5	6	0	PP	0	6	9	2	IN	0	6	7	1	as	6	6	7	0	NP	1	7	9	2	CD	0	7	8	1	3	7	7	8	0	NNS	0	8	9	1	hours	8	8	9	0	SBAR	1	9	26	2	IN	0	9	10	1	after	9	9	10	0	S	1	10	26	2	NP	0	10	14	2	NP	1	10	12	2	NN	0	10	11	1	EGF	10	10	11	0	NN	0	11	12	1	stimulation	11	11	12	0	VP	0	12	14	2	VBN	0	12	13	1	phosphorylated	12	12	13	0	NP	0	13	14	1	NN	0	13	14	1	ASPP2	13	13	14	0	VP	1	14	26	5	VBD	0	14	15	1	was	14	14	15	0	ADJP	1	15	17	2	RB	0	15	16	1	barely	15	15	16	0	JJ	0	16	17	1	detec	16	16	17	0	ADVP	0	17	18	1	RB	0	17	18	1	Moreover	17	17	18	0	,	0	18	19	1	,	18	18	19	0	PP	0	19	26	2	IN	0	19	20	1	with	19	19	20	0	NP	0	20	26	3	NP	3	20	24	4	DT	0	20	21	1	another	20	20	21	0	JJ	0	21	22	1	different	21	21	22	0	NN	0	22	23	1	phospho-ASPP2	22	22	23	0	NN	0	23	24	1	antibody	23	23	24	0	,	0	24	25	1	,	24	24	25	0	NP	0	25	26	1	NN	0	25	26	1	ES1	25	25	26	0	,	0	26	27	1	,	26	26	27	0	NP	1	27	29	2	NN	0	27	28	1	ASPP2	27	27	28	0	NN	0	28	29	1	phosphorylation	28	28	29	0	VP	2	29	62	3	VBD	0	29	30	1	was	29	29	30	0	ADVP	0	30	31	1	RB	0	30	31	1	also	30	30	31	0	VP	0	31	62	2	VBN	0	31	32	1	observed	31	31	32	0	PP	0	32	62	2	IN	0	32	33	1	in	32	32	33	0	NP	0	33	62	3	NP	7	33	41	8	DT	0	33	34	1	a	33	33	34	0	JJ	0	34	35	1	human	34	34	35	0	NN	0	35	36	1	colon	35	35	36	0	NN	0	36	37	1	cancer	36	36	37	0	NN	0	37	38	1	cell	37	37	38	0	NN	0	38	39	1	line	38	38	39	0	NN	0	39	40	1	HKe3	39	39	40	0	NN	0	40	41	1	ER	40	40	41	0	:	0	41	42	1	:	41	41	42	0	NP	0	42	62	3	NP	1	42	44	2	NN	0	42	43	1	HRASV12	42	42	43	0	NNS	0	43	44	1	cells	43	43	44	0	,	0	44	45	1	,	44	44	45	0	SBAR	1	45	62	2	WHPP	0	45	47	2	IN	0	45	46	1	in	45	45	46	0	WHNP	0	46	47	1	WDT	0	46	47	1	which	46	46	47	0	S	1	47	62	2	NP	1	47	49	2	NN	0	47	48	1	RAS	47	47	48	0	NN	0	48	49	1	activation	48	48	49	0	VP	1	49	62	2	VBZ	0	49	50	1	is	49	49	50	0	VP	0	50	62	2	VBN	0	50	51	1	induced	50	50	51	0	PP	0	51	62	2	IN	0	51	52	1	upon	51	51	52	0	NP	0	52	62	2	NP	1	52	54	2	DT	0	52	53	1	the	52	52	53	0	NN	0	53	54	1	addition	53	53	54	0	PP	0	54	62	2	IN	0	54	55	1	of	54	54	55	0	NP	0	55	62	2	NP	2	55	58	3	JJ	0	55	56	1	4-hydroxytamoxifen	55	55	56	0	NN	0	56	57	1	(	56	56	57	0	NN	0	57	58	1	4-OHT	57	57	58	0	NP	0	58	62	2	NP	0	58	60	1	QP	1	58	60	2	CD	0	58	59	1	)	58	58	59	0	CD	0	59	60	1	[	59	59	60	0	NP	1	60	62	2	CD	0	60	61	1	2,10,11	60	60	61	0	NN	0	61	62	1	]	61	61	62	0	.	0	62	63	1	.	62	62	63	0
EOS
T	21
The	9774	9777	DT	the	O	_	_
phospho	9778	9785	NN	phospho	O	_	_
specific	9786	9794	JJ	specific	O	_	_
antibody	9795	9803	NN	antibody	O	_	_
for	9804	9807	IN	for	O	_	_
ASPP2	9808	9813	NN	aspp2	B-GENE	_	_
is	9814	9816	VBZ	be	O	_	_
specific	9817	9825	JJ	specific	O	_	_
as	9826	9828	IN	as	O	_	_
knockdown	9829	9838	NN	knockdown	O	_	_
of	9839	9841	IN	of	O	_	_
ASPP2	9842	9847	NN	aspp2	B-GENE	_	_
resulted	9848	9856	VBD	result	O	_	_
in	9857	9859	IN	in	O	_	_
a	9860	9861	DT	a	O	_	_
lack	9862	9866	NN	lack	O	_	_
of	9867	9869	IN	of	O	_	_
detection	9870	9879	NN	detection	O	_	_
of	9880	9882	IN	of	O	_	_
phospho-ASPP2	9883	9896	NN	phospho-aspp2	O	_	_
.	9896	9897	.	.	O	_	_
D	1
7
3	0	det
3	1	nn
3	2	amod
3	5	prep_for
7	3	nsubj
7	6	cop
7	12	advcl
9	11	prep_of
12	8	mark
12	9	nsubj
12	15	prep_in
15	14	det
15	17	prep_of
17	19	prep_of
EOX
Y	1
ROOT	0	0	21	1	S	1	0	21	3	NP	0	0	6	2	NP	3	0	4	4	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	phospho	1	1	2	0	JJ	0	2	3	1	specific	2	2	3	0	NN	0	3	4	1	antibody	3	3	4	0	PP	0	4	6	2	IN	0	4	5	1	for	4	4	5	0	NP	0	5	6	1	NN	0	5	6	1	ASPP2	5	5	6	0	VP	1	6	20	3	VBZ	0	6	7	1	is	6	6	7	0	ADJP	0	7	8	1	JJ	0	7	8	1	specific	7	7	8	0	SBAR	1	8	20	2	IN	0	8	9	1	as	8	8	9	0	S	1	9	20	2	NP	0	9	12	2	NP	0	9	10	1	NN	0	9	10	1	knockdown	9	9	10	0	PP	0	10	12	2	IN	0	10	11	1	of	10	10	11	0	NP	0	11	12	1	NN	0	11	12	1	ASPP2	11	11	12	0	VP	0	12	20	2	VBD	0	12	13	1	resulted	12	12	13	0	PP	0	13	20	2	IN	0	13	14	1	in	13	13	14	0	NP	0	14	20	2	NP	1	14	16	2	DT	0	14	15	1	a	14	14	15	0	NN	0	15	16	1	lack	15	15	16	0	PP	0	16	20	2	IN	0	16	17	1	of	16	16	17	0	NP	0	17	20	2	NP	0	17	18	1	NN	0	17	18	1	detection	17	17	18	0	PP	0	18	20	2	IN	0	18	19	1	of	18	18	19	0	NP	0	19	20	1	NN	0	19	20	1	phospho-ASPP2	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	24
All	9898	9901	PDT	all	O	_	_
these	9902	9907	DT	these	O	_	_
demonstrate	9908	9919	VBP	demonstrate	O	_	_
that	9920	9924	IN	that	O	_	_
ASPP2	9925	9930	NN	aspp2	B-GENE	_	_
is	9931	9933	VBZ	be	O	_	_
a	9934	9935	DT	a	O	_	_
novel	9936	9941	JJ	novel	O	_	_
substrate	9942	9951	NN	substrate	O	_	_
of	9952	9954	IN	of	O	_	_
MAPK	9955	9959	NN	mapk	O	_	_
and	9960	9963	CC	and	O	_	_
Ser827	9964	9970	NN	ser827	O	_	_
of	9971	9973	IN	of	O	_	_
ASPP2	9974	9979	NN	aspp2	B-GENE	_	_
can	9980	9983	MD	can	O	_	_
be	9984	9986	VB	be	O	_	_
phosphorylated	9987	10001	VBN	phosphorylate	O	_	_
by	10002	10004	IN	by	O	_	_
RAS	10005	10008	NN	ra	B-GENE	_	_
/	10008	10009	:	/	B-GENE	_	_
MAPK	10009	10013	NN	mapk	I-GENE	_	_
pathway	10014	10021	NN	pathway	O	_	_
.	10021	10022	.	.	O	_	_
D	1
2
1	0	predet
2	1	nsubj
2	8	ccomp
2	17	conj_and
8	3	mark
8	4	nsubj
8	5	cop
8	6	det
8	7	amod
8	10	prep_of
12	14	prep_of
17	12	nsubjpass
17	15	aux
17	16	auxpass
17	19	agent
19	22	dep
22	20	punct
22	21	nn
EOX
Y	1
ROOT	0	0	24	1	S	0	0	24	4	S	1	0	11	2	NP	1	0	2	2	PDT	0	0	1	1	All	0	0	1	0	DT	0	1	2	1	these	1	1	2	0	VP	0	2	11	2	VBP	0	2	3	1	demonstrate	2	2	3	0	SBAR	1	3	11	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	11	2	NP	0	4	5	1	NN	0	4	5	1	ASPP2	4	4	5	0	VP	1	5	11	2	VBZ	0	5	6	1	is	5	5	6	0	NP	0	6	11	2	NP	2	6	9	3	DT	0	6	7	1	a	6	6	7	0	JJ	0	7	8	1	novel	7	7	8	0	NN	0	8	9	1	substrate	8	8	9	0	PP	0	9	11	2	IN	0	9	10	1	of	9	9	10	0	NP	0	10	11	1	NN	0	10	11	1	MAPK	10	10	11	0	CC	0	11	12	1	and	11	11	12	0	S	1	12	23	2	NP	0	12	15	2	NP	0	12	13	1	NN	0	12	13	1	Ser827	12	12	13	0	PP	0	13	15	2	IN	0	13	14	1	of	13	13	14	0	NP	0	14	15	1	NN	0	14	15	1	ASPP2	14	14	15	0	VP	1	15	23	2	MD	0	15	16	1	can	15	15	16	0	VP	1	16	23	2	VB	0	16	17	1	be	16	16	17	0	VP	0	17	23	2	VBN	0	17	18	1	phosphorylated	17	17	18	0	PP	0	18	23	2	IN	0	18	19	1	by	18	18	19	0	NP	0	19	23	2	NP	0	19	20	1	NN	0	19	20	1	RAS	19	19	20	0	PRN	1	20	23	2	:	0	20	21	1	/	20	20	21	0	NP	1	21	23	2	NN	0	21	22	1	MAPK	21	21	22	0	NN	0	22	23	1	pathway	22	22	23	0	.	0	23	24	1	.	23	23	24	0
EOS
T	30
Raf	10023	10026	NN	raf	B-GENE	_	_
/	10026	10027	:	/	B-GENE	_	_
MAPK	10027	10031	NN	mapk	I-GENE	_	_
Pathway	10032	10039	NN	pathway	O	_	_
Activates	10040	10049	VBZ	activate	O	_	_
the	10050	10053	DT	the	O	_	_
Pro-Apoptotic	10054	10067	JJ	pro-apoptotic	O	_	_
Function	10068	10076	NN	function	O	_	_
of	10077	10079	IN	of	O	_	_
ASPP2	10080	10085	NNP	ASPP2	B-GENE	_	_
One	10086	10089	CD	one	I-GENE	_	_
of	10090	10092	IN	of	O	_	_
the	10093	10096	DT	the	O	_	_
most	10097	10101	RBS	most	O	_	_
studied	10102	10109	VBN	study	O	_	_
downstream	10110	10120	JJ	downstream	O	_	_
pathways	10121	10129	NNS	pathway	O	_	_
of	10130	10132	IN	of	O	_	_
RAS	10133	10136	NN	ra	O	_	_
signalling	10137	10147	NN	signalling	O	_	_
is	10148	10150	VBZ	be	O	_	_
the	10151	10154	DT	the	O	_	_
Raf	10155	10158	NN	raf	B-GENE	_	_
/	10158	10159	:	/	B-GENE	_	_
MAPK	10159	10163	NN	mapk	I-GENE	_	_
pathway	10164	10171	NN	pathway	O	_	_
[	10172	10173	CD	[	O	_	_
13	10173	10175	CD	13	O	_	_
]	10175	10176	NN	]	O	_	_
.	10176	10177	.	.	O	_	_
D	1
0
0	1	punct
0	4	dep
3	2	nn
4	3	nsubj
4	7	dobj
7	5	det
7	6	amod
7	9	prep_of
7	12	prep_of
9	10	num
12	13	advmod
12	14	vmod
14	28	ccomp
16	15	amod
16	19	prep_of
19	18	nn
25	23	punct
25	24	nn
25	27	dep
27	26	num
28	16	nsubj
28	20	cop
28	21	det
28	22	nn
28	25	dep
EOX
Y	1
ROOT	0	0	30	1	FRAG	0	0	30	4	NP	0	0	1	1	NN	0	0	1	1	Raf	0	0	1	0	:	0	1	2	1	/	1	1	2	0	S	1	2	29	2	NP	1	2	4	2	NN	0	2	3	1	MAPK	2	2	3	0	NN	0	3	4	1	Pathway	3	3	4	0	VP	0	4	29	2	VBZ	0	4	5	1	Activates	4	4	5	0	NP	0	5	29	3	NP	2	5	8	3	DT	0	5	6	1	the	5	5	6	0	JJ	0	6	7	1	Pro-Apoptotic	6	6	7	0	NN	0	7	8	1	Function	7	7	8	0	PP	0	8	11	2	IN	0	8	9	1	of	8	8	9	0	NP	0	9	11	2	NNP	0	9	10	1	ASPP2	9	9	10	0	CD	0	10	11	1	One	10	10	11	0	PP	0	11	29	2	IN	0	11	12	1	of	11	11	12	0	NP	0	12	29	2	NP	0	12	14	2	DT	0	12	13	1	the	12	12	13	0	RBS	0	13	14	1	most	13	13	14	0	VP	0	14	29	2	VBN	0	14	15	1	studied	14	14	15	0	SBAR	0	15	29	1	S	1	15	29	2	NP	0	15	20	2	NP	1	15	17	2	JJ	0	15	16	1	downstream	15	15	16	0	NNS	0	16	17	1	pathways	16	16	17	0	PP	0	17	20	2	IN	0	17	18	1	of	17	17	18	0	NP	1	18	20	2	NN	0	18	19	1	RAS	18	18	19	0	NN	0	19	20	1	signalling	19	19	20	0	VP	1	20	29	2	VBZ	0	20	21	1	is	20	20	21	0	NP	3	21	29	4	DT	0	21	22	1	the	21	21	22	0	NN	0	22	23	1	Raf	22	22	23	0	PRN	1	23	28	2	:	0	23	24	1	/	23	23	24	0	FRAG	0	24	28	2	NP	1	24	26	2	NN	0	24	25	1	MAPK	24	24	25	0	NN	0	25	26	1	pathway	25	25	26	0	NP	1	26	28	2	CD	0	26	27	1	[	26	26	27	0	CD	0	27	28	1	13	27	27	28	0	NN	0	28	29	1	]	28	28	29	0	.	0	29	30	1	.	29	29	30	0
EOS
T	55
Knowing	10178	10185	VBG	know	O	_	_
ASPP2	10186	10191	NN	aspp2	B-GENE	_	_
is	10192	10194	VBZ	be	O	_	_
a	10195	10196	DT	a	O	_	_
substrate	10197	10206	NN	substrate	O	_	_
of	10207	10209	IN	of	O	_	_
MAPK	10210	10214	NN	mapk	B-GENE	_	_
,	10214	10215	,	,	O	_	_
we	10216	10218	PRP	we	O	_	_
thus	10219	10223	RB	thus	O	_	_
tested	10224	10230	VBD	test	O	_	_
whether	10231	10238	IN	whether	O	_	_
activation	10239	10249	NN	activation	O	_	_
of	10250	10252	IN	of	O	_	_
Raf	10253	10256	NN	raf	B-GENE	_	_
/	10256	10257	:	/	B-GENE	_	_
MAPK	10257	10261	NN	mapk	I-GENE	_	_
pathway	10262	10269	NN	pathway	O	_	_
is	10270	10272	VBZ	be	O	_	_
sufficient	10273	10283	JJ	sufficient	O	_	_
to	10284	10286	TO	to	O	_	_
regulate	10287	10295	VB	regulate	O	_	_
ASPP2	10296	10301	NN	aspp2	B-GENE	_	_
activity	10302	10310	NN	activity	O	_	_
using	10311	10316	VBG	use	O	_	_
a	10317	10318	DT	a	O	_	_
mutant	10319	10325	JJ	mutant	B-GENE	_	_
form	10326	10330	NN	form	I-GENE	_	_
of	10331	10333	IN	of	I-GENE	_	_
Raf	10334	10337	NN	raf	I-GENE	_	_
(	10338	10339	CD	(	B-GENE	_	_
Raf	10339	10342	NN	raf	I-GENE	_	_
CAAX	10343	10347	NN	caax	I-GENE	_	_
)	10347	10348	NN	)	O	_	_
,	10348	10349	,	,	O	_	_
which	10350	10355	WDT	which	O	_	_
is	10356	10358	VBZ	be	O	_	_
constitutively	10359	10373	RB	constitutively	O	_	_
present	10374	10381	JJ	present	O	_	_
at	10382	10384	IN	at	O	_	_
the	10385	10388	DT	the	O	_	_
plasma	10389	10395	NN	plasma	O	_	_
membrane	10396	10404	NN	membrane	O	_	_
,	10404	10405	,	,	O	_	_
so	10406	10408	IN	so	O	_	_
the	10409	10412	DT	the	O	_	_
Raf	10413	10416	NN	raf	B-GENE	_	_
pathway	10417	10424	NN	pathway	O	_	_
is	10425	10427	VBZ	be	O	_	_
constitutively	10428	10442	RB	constitutively	O	_	_
active	10443	10449	JJ	active	O	_	_
[	10450	10451	NN	[	O	_	_
14	10451	10453	CD	14	O	_	_
]	10453	10454	NN	]	O	_	_
.	10454	10455	.	.	O	_	_
D	1
4
1	0	amod
4	1	nsubj
4	2	cop
4	3	det
4	6	prep_of
4	10	ccomp
4	44	dep
4	50	ccomp
10	8	nsubj
10	9	advmod
10	19	ccomp
12	14	prep_of
14	17	dep
17	15	punct
17	16	nn
19	11	mark
19	12	nsubj
19	18	cop
19	21	xcomp
21	20	aux
21	23	dobj
23	22	nn
23	24	vmod
24	27	dobj
27	25	det
27	26	amod
27	33	prep_of
27	38	rcmod
33	29	nn
33	30	num
33	31	nn
33	32	nn
38	35	nsubj
38	36	cop
38	37	advmod
38	42	prep_at
42	40	det
42	41	nn
47	45	det
47	46	nn
50	47	nsubj
50	48	cop
50	49	advmod
50	51	iobj
51	53	dep
53	52	num
EOX
Y	1
ROOT	0	0	55	1	S	0	0	55	7	S	1	0	7	2	NP	1	0	2	2	VBG	0	0	1	1	Knowing	0	0	1	0	NN	0	1	2	1	ASPP2	1	1	2	0	VP	1	2	7	2	VBZ	0	2	3	1	is	2	2	3	0	NP	0	3	7	2	NP	1	3	5	2	DT	0	3	4	1	a	3	3	4	0	NN	0	4	5	1	substrate	4	4	5	0	PP	0	5	7	2	IN	0	5	6	1	of	5	5	6	0	NP	0	6	7	1	NN	0	6	7	1	MAPK	6	6	7	0	,	0	7	8	1	,	7	7	8	0	S	2	8	43	3	NP	0	8	9	1	PRP	0	8	9	1	we	8	8	9	0	ADVP	0	9	10	1	RB	0	9	10	1	thus	9	9	10	0	VP	0	10	43	2	VBD	0	10	11	1	tested	10	10	11	0	SBAR	1	11	43	2	IN	0	11	12	1	whether	11	11	12	0	S	1	12	43	2	NP	0	12	18	2	NP	0	12	13	1	NN	0	12	13	1	activation	12	12	13	0	PP	0	13	18	2	IN	0	13	14	1	of	13	13	14	0	NP	0	14	18	2	NP	0	14	15	1	NN	0	14	15	1	Raf	14	14	15	0	PRN	1	15	18	2	:	0	15	16	1	/	15	15	16	0	NP	1	16	18	2	NN	0	16	17	1	MAPK	16	16	17	0	NN	0	17	18	1	pathway	17	17	18	0	VP	1	18	43	2	VBZ	0	18	19	1	is	18	18	19	0	ADJP	0	19	43	2	JJ	0	19	20	1	sufficient	19	19	20	0	S	0	20	43	1	VP	1	20	43	2	TO	0	20	21	1	to	20	20	21	0	VP	0	21	43	2	VB	0	21	22	1	regulate	21	21	22	0	NP	0	22	43	2	NP	1	22	24	2	NN	0	22	23	1	ASPP2	22	22	23	0	NN	0	23	24	1	activity	23	23	24	0	VP	0	24	43	2	VBG	0	24	25	1	using	24	24	25	0	NP	0	25	43	4	NP	2	25	28	3	DT	0	25	26	1	a	25	25	26	0	JJ	0	26	27	1	mutant	26	26	27	0	NN	0	27	28	1	form	27	27	28	0	PP	0	28	34	2	IN	0	28	29	1	of	28	28	29	0	NP	4	29	34	5	NN	0	29	30	1	Raf	29	29	30	0	CD	0	30	31	1	(	30	30	31	0	NN	0	31	32	1	Raf	31	31	32	0	NN	0	32	33	1	CAAX	32	32	33	0	NN	0	33	34	1	)	33	33	34	0	,	0	34	35	1	,	34	34	35	0	SBAR	1	35	43	2	WHNP	0	35	36	1	WDT	0	35	36	1	which	35	35	36	0	S	0	36	43	1	VP	1	36	43	2	VBZ	0	36	37	1	is	36	36	37	0	ADJP	1	37	43	3	RB	0	37	38	1	constitutively	37	37	38	0	JJ	0	38	39	1	present	38	38	39	0	PP	0	39	43	2	IN	0	39	40	1	at	39	39	40	0	NP	2	40	43	3	DT	0	40	41	1	the	40	40	41	0	NN	0	41	42	1	plasma	41	41	42	0	NN	0	42	43	1	membrane	42	42	43	0	,	0	43	44	1	,	43	43	44	0	IN	0	44	45	1	so	44	44	45	0	S	1	45	54	2	NP	2	45	48	3	DT	0	45	46	1	the	45	45	46	0	NN	0	46	47	1	Raf	46	46	47	0	NN	0	47	48	1	pathway	47	47	48	0	VP	1	48	54	3	VBZ	0	48	49	1	is	48	48	49	0	ADJP	1	49	51	2	RB	0	49	50	1	constitutively	49	49	50	0	JJ	0	50	51	1	active	50	50	51	0	NP	0	51	54	2	NP	0	51	52	1	NN	0	51	52	1	[	51	51	52	0	NP	1	52	54	2	CD	0	52	53	1	14	52	52	53	0	NN	0	53	54	1	]	53	53	54	0	.	0	54	55	1	.	54	54	55	0
EOS
T	26
The	10456	10459	DT	the	O	_	_
impact	10460	10466	NN	impact	O	_	_
of	10467	10469	IN	of	O	_	_
co-expression	10470	10483	NN	co-expression	O	_	_
of	10484	10486	IN	of	O	_	_
Raf	10487	10490	NN	raf	B-GENE	_	_
CAAX	10491	10495	NN	caax	I-GENE	_	_
with	10496	10500	IN	with	O	_	_
p53	10501	10504	NN	p53	B-GENE	_	_
and	10505	10508	CC	and	O	_	_
ASPP2	10509	10514	NN	aspp2	B-GENE	_	_
was	10515	10518	VBD	be	O	_	_
tested	10519	10525	VBN	test	O	_	_
by	10526	10528	IN	by	O	_	_
analysing	10529	10538	VBG	analyse	O	_	_
the	10539	10542	DT	the	O	_	_
transcriptional	10543	10558	JJ	transcriptional	O	_	_
activity	10559	10567	NN	activity	O	_	_
of	10568	10570	IN	of	O	_	_
p53	10571	10574	NN	p53	B-GENE	_	_
on	10575	10577	IN	on	O	_	_
the	10578	10581	DT	the	O	_	_
pro-apoptotic	10582	10595	JJ	pro-apoptotic	O	_	_
Bax	10596	10599	NN	bax	O	_	_
reporter	10600	10608	NN	reporter	O	_	_
.	10608	10609	.	.	O	_	_
D	1
12
1	0	det
1	3	prep_of
3	6	prep_of
6	5	nn
6	8	prep_with
6	10	prep_with
8	10	conj_and
12	1	nsubjpass
12	11	auxpass
12	14	agent
14	17	dobj
14	24	prep_on
17	15	det
17	16	amod
17	19	prep_of
24	21	det
24	22	amod
24	23	nn
EOX
Y	1
ROOT	0	0	26	1	S	1	0	26	3	NP	0	0	11	2	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	impact	1	1	2	0	PP	0	2	11	2	IN	0	2	3	1	of	2	2	3	0	NP	0	3	11	2	NP	0	3	4	1	NN	0	3	4	1	co-expression	3	3	4	0	PP	0	4	11	2	IN	0	4	5	1	of	4	4	5	0	NP	0	5	11	2	NP	1	5	7	2	NN	0	5	6	1	Raf	5	5	6	0	NN	0	6	7	1	CAAX	6	6	7	0	PP	0	7	11	2	IN	0	7	8	1	with	7	7	8	0	NP	0	8	11	3	NN	0	8	9	1	p53	8	8	9	0	CC	0	9	10	1	and	9	9	10	0	NN	0	10	11	1	ASPP2	10	10	11	0	VP	1	11	25	2	VBD	0	11	12	1	was	11	11	12	0	VP	0	12	25	2	VBN	0	12	13	1	tested	12	12	13	0	PP	0	13	25	2	IN	0	13	14	1	by	13	13	14	0	S	0	14	25	1	VP	0	14	25	3	VBG	0	14	15	1	analysing	14	14	15	0	NP	0	15	20	2	NP	2	15	18	3	DT	0	15	16	1	the	15	15	16	0	JJ	0	16	17	1	transcriptional	16	16	17	0	NN	0	17	18	1	activity	17	17	18	0	PP	0	18	20	2	IN	0	18	19	1	of	18	18	19	0	NP	0	19	20	1	NN	0	19	20	1	p53	19	19	20	0	PP	0	20	25	2	IN	0	20	21	1	on	20	20	21	0	NP	3	21	25	4	DT	0	21	22	1	the	21	21	22	0	JJ	0	22	23	1	pro-apoptotic	22	22	23	0	NN	0	23	24	1	Bax	23	23	24	0	NN	0	24	25	1	reporter	24	24	25	0	.	0	25	26	1	.	25	25	26	0
EOS
T	22
Raf	10610	10613	NN	raf	B-GENE	_	_
CAAX	10614	10618	NN	caax	I-GENE	_	_
increases	10619	10628	VBZ	increase	O	_	_
Bax-luciferase	10629	10643	JJ	bax-luciferase	B-GENE	_	_
levels	10644	10650	NNS	level	O	_	_
by	10651	10653	IN	by	O	_	_
2.5	10654	10657	CD	2.5	O	_	_
fold	10658	10662	NN	fold	O	_	_
over	10663	10667	IN	over	O	_	_
the	10668	10671	DT	the	O	_	_
baseline	10672	10680	NN	baseline	O	_	_
of	10681	10683	IN	of	O	_	_
p53	10684	10687	NN	p53	B-GENE	_	_
and	10688	10691	CC	and	O	_	_
ASPP2	10692	10697	NN	aspp2	B-GENE	_	_
alone	10698	10703	RB	alone	O	_	_
(	10704	10705	RB	(	O	_	_
P	10705	10706	NN	p	O	_	_
=	10706	10707	JJ	=	O	_	_
0.05	10707	10711	CD	0.05	O	_	_
)	10711	10712	NN	)	O	_	_
.	10712	10713	.	.	O	_	_
D	1
2
1	0	nn
2	1	nsubj
2	4	dobj
2	20	prep_by
4	3	amod
7	6	number
7	10	prep_over
10	9	det
10	12	prep_of
10	14	prep_of
10	15	advmod
10	16	advmod
10	17	dep
12	14	conj_and
18	19	dep
20	7	amod
20	18	amod
EOX
Y	1
ROOT	0	0	22	1	S	1	0	22	3	NP	1	0	2	2	NN	0	0	1	1	Raf	0	0	1	0	NN	0	1	2	1	CAAX	1	1	2	0	VP	0	2	21	3	VBZ	0	2	3	1	increases	2	2	3	0	NP	1	3	5	2	JJ	0	3	4	1	Bax-luciferase	3	3	4	0	NNS	0	4	5	1	levels	4	4	5	0	PP	0	5	21	2	IN	0	5	6	1	by	5	5	6	0	NP	2	6	21	3	ADJP	0	6	18	2	ADJP	1	6	8	2	CD	0	6	7	1	2.5	6	6	7	0	NN	0	7	8	1	fold	7	7	8	0	PP	0	8	18	2	IN	0	8	9	1	over	8	8	9	0	NP	0	9	18	4	NP	0	9	15	2	NP	1	9	11	2	DT	0	9	10	1	the	9	9	10	0	NN	0	10	11	1	baseline	10	10	11	0	PP	0	11	15	2	IN	0	11	12	1	of	11	11	12	0	NP	0	12	15	3	NN	0	12	13	1	p53	12	12	13	0	CC	0	13	14	1	and	13	13	14	0	NN	0	14	15	1	ASPP2	14	14	15	0	RB	0	15	16	1	alone	15	15	16	0	RB	0	16	17	1	(	16	16	17	0	NP	0	17	18	1	NN	0	17	18	1	P	17	17	18	0	ADJP	0	18	20	2	JJ	0	18	19	1	=	18	18	19	0	NP	0	19	20	1	CD	0	19	20	1	0.05	19	19	20	0	NN	0	20	21	1	)	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	21
This	10714	10718	DT	this	O	_	_
effect	10719	10725	NN	effect	O	_	_
is	10726	10728	VBZ	be	O	_	_
likely	10729	10735	JJ	likely	O	_	_
to	10736	10738	TO	to	O	_	_
be	10739	10741	VB	be	O	_	_
mediated	10742	10750	VBN	mediate	O	_	_
by	10751	10753	IN	by	O	_	_
ASPP2	10754	10759	NN	aspp2	B-GENE	_	_
as	10760	10762	IN	as	O	_	_
Raf	10763	10766	NN	raf	B-GENE	_	_
CAAX	10767	10771	NN	caax	I-GENE	_	_
had	10772	10775	VBD	have	O	_	_
little	10776	10782	JJ	little	O	_	_
effect	10783	10789	NN	effect	O	_	_
on	10790	10792	IN	on	O	_	_
p53	10793	10796	NN	p53	B-GENE	_	_
in	10797	10799	IN	in	O	_	_
its	10800	10803	PRP$	its	O	_	_
absence	10804	10811	NN	absence	O	_	_
.	10823	10824	.	.	O	_	_
D	1
3
1	0	det
3	1	nsubj
3	2	cop
3	6	xcomp
6	4	aux
6	5	auxpass
6	8	agent
6	12	advcl
11	10	nn
12	9	mark
12	11	nsubj
12	14	dobj
12	19	prep_in
14	13	amod
14	16	prep_on
19	18	poss
EOX
Y	1
ROOT	0	0	21	1	S	1	0	21	3	NP	1	0	2	2	DT	0	0	1	1	This	0	0	1	0	NN	0	1	2	1	effect	1	1	2	0	VP	1	2	20	2	VBZ	0	2	3	1	is	2	2	3	0	ADJP	0	3	20	2	JJ	0	3	4	1	likely	3	3	4	0	S	0	4	20	1	VP	1	4	20	2	TO	0	4	5	1	to	4	4	5	0	VP	1	5	20	2	VB	0	5	6	1	be	5	5	6	0	VP	0	6	20	3	VBN	0	6	7	1	mediated	6	6	7	0	PP	0	7	9	2	IN	0	7	8	1	by	7	7	8	0	NP	0	8	9	1	NN	0	8	9	1	ASPP2	8	8	9	0	SBAR	1	9	20	2	IN	0	9	10	1	as	9	9	10	0	S	1	10	20	2	NP	1	10	12	2	NN	0	10	11	1	Raf	10	10	11	0	NN	0	11	12	1	CAAX	11	11	12	0	VP	0	12	20	3	VBD	0	12	13	1	had	12	12	13	0	NP	0	13	17	2	NP	1	13	15	2	JJ	0	13	14	1	little	13	13	14	0	NN	0	14	15	1	effect	14	14	15	0	PP	0	15	17	2	IN	0	15	16	1	on	15	15	16	0	NP	0	16	17	1	NN	0	16	17	1	p53	16	16	17	0	PP	0	17	20	2	IN	0	17	18	1	in	17	17	18	0	NP	1	18	20	2	PRP$	0	18	19	1	its	18	18	19	0	NN	0	19	20	1	absence	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	5
10.1371	10825	10832	CD	10.1371	O	_	_
/	10832	10833	:	/	O	_	_
journal.pone	10833	10845	NN	journal.pone	O	_	_
.0082022	10845	10853	CD	.0082022	O	_	_
.	10853	10854	.	.	O	_	_
D	1
0
0	1	punct
0	2	dep
2	3	dep
EOX
Y	1
ROOT	0	0	5	1	FRAG	0	0	5	4	NP	0	0	1	1	CD	0	0	1	1	10.1371	0	0	1	0	:	0	1	2	1	/	1	1	2	0	FRAG	0	2	4	2	NP	0	2	3	1	NN	0	2	3	1	journal.pone	2	2	3	0	NP	0	3	4	1	CD	0	3	4	1	.0082022	3	3	4	0	.	0	4	5	1	.	4	4	5	0
EOS
T	19
g002	10854	10858	NN	g002	B-GENE	_	_
Activated	10868	10877	VBN	activate	O	_	_
Raf	10878	10881	NN	raf	B-GENE	_	_
enhances	10882	10890	VBZ	enhance	O	_	_
the	10891	10894	DT	the	O	_	_
transactivation	10895	10910	NN	transactivation	O	_	_
activity	10911	10919	NN	activity	O	_	_
of	10920	10922	IN	of	O	_	_
ASPP2	10923	10928	NN	aspp2	B-GENE	_	_
and	10929	10932	CC	and	O	_	_
p53	10933	10936	NN	p53	B-GENE	_	_
to	10937	10939	TO	to	O	_	_
the	10940	10943	DT	the	O	_	_
same	10944	10948	JJ	same	O	_	_
extent	10949	10955	NN	extent	O	_	_
as	10956	10958	IN	as	O	_	_
activated	10959	10968	VBN	activate	O	_	_
RAS	10969	10972	NN	ra	O	_	_
.	10972	10973	.	.	O	_	_
D	1
3
0	1	vmod
1	2	dobj
3	0	nsubj
3	6	dobj
3	14	prep_to
6	4	det
6	5	nn
6	8	prep_of
6	10	prep_of
8	10	conj_and
14	12	det
14	13	amod
14	17	prep_as
17	16	amod
EOX
Y	1
ROOT	0	0	19	1	S	1	0	19	3	NP	0	0	3	2	NP	0	0	1	1	NN	0	0	1	1	g002	0	0	1	0	VP	0	1	3	2	VBN	0	1	2	1	Activated	1	1	2	0	NP	0	2	3	1	NN	0	2	3	1	Raf	2	2	3	0	VP	0	3	18	3	VBZ	0	3	4	1	enhances	3	3	4	0	NP	0	4	11	2	NP	2	4	7	3	DT	0	4	5	1	the	4	4	5	0	NN	0	5	6	1	transactivation	5	5	6	0	NN	0	6	7	1	activity	6	6	7	0	PP	0	7	11	2	IN	0	7	8	1	of	7	7	8	0	NP	0	8	11	3	NN	0	8	9	1	ASPP2	8	8	9	0	CC	0	9	10	1	and	9	9	10	0	NN	0	10	11	1	p53	10	10	11	0	PP	0	11	18	2	TO	0	11	12	1	to	11	11	12	0	NP	0	12	18	2	NP	2	12	15	3	DT	0	12	13	1	the	12	12	13	0	JJ	0	13	14	1	same	13	13	14	0	NN	0	14	15	1	extent	14	14	15	0	PP	0	15	18	2	IN	0	15	16	1	as	15	15	16	0	NP	1	16	18	2	VBN	0	16	17	1	activated	16	16	17	0	NN	0	17	18	1	RAS	17	17	18	0	.	0	18	19	1	.	18	18	19	0
EOS
T	19
(	10974	10975	NN	(	O	_	_
A	10975	10976	NN	a	O	_	_
)	10976	10977	CD	)	O	_	_
Saos2	10978	10983	NN	saos2	O	_	_
cells	10984	10989	NNS	cell	O	_	_
were	10990	10994	VBD	be	O	_	_
transfected	10995	11006	VBN	transfect	O	_	_
as	11007	11009	IN	as	O	_	_
indicated	11010	11019	VBN	indicate	O	_	_
with	11020	11024	IN	with	O	_	_
a	11025	11026	DT	a	O	_	_
Bax-luciferase	11027	11041	NN	bax-luciferase	B-GENE	_	_
reporter	11042	11050	NN	reporter	I-GENE	_	_
and	11051	11054	CC	and	O	_	_
the	11055	11058	DT	the	O	_	_
luciferase	11059	11069	NN	luciferase	B-GENE	_	_
activity	11070	11078	NN	activity	O	_	_
shown	11079	11084	VBN	show	O	_	_
.	11084	11085	.	.	O	_	_
D	1
6
4	0	nn
4	1	nn
4	2	num
4	3	nn
6	4	nsubjpass
6	5	auxpass
6	8	advcl
8	7	mark
8	12	prep_with
8	16	prep_with
12	10	det
12	11	nn
12	16	conj_and
16	14	det
16	15	nn
16	17	vmod
EOX
Y	1
ROOT	0	0	19	1	S	1	0	19	3	NP	4	0	5	5	NN	0	0	1	1	(	0	0	1	0	NN	0	1	2	1	A	1	1	2	0	CD	0	2	3	1	)	2	2	3	0	NN	0	3	4	1	Saos2	3	3	4	0	NNS	0	4	5	1	cells	4	4	5	0	VP	1	5	18	2	VBD	0	5	6	1	were	5	5	6	0	VP	0	6	18	2	VBN	0	6	7	1	transfected	6	6	7	0	SBAR	1	7	18	2	IN	0	7	8	1	as	7	7	8	0	S	0	8	18	1	VP	0	8	18	2	VBN	0	8	9	1	indicated	8	8	9	0	PP	0	9	18	2	IN	0	9	10	1	with	9	9	10	0	NP	0	10	18	3	NP	2	10	13	3	DT	0	10	11	1	a	10	10	11	0	NN	0	11	12	1	Bax-luciferase	11	11	12	0	NN	0	12	13	1	reporter	12	12	13	0	CC	0	13	14	1	and	13	13	14	0	NP	0	14	18	2	NP	2	14	17	3	DT	0	14	15	1	the	14	14	15	0	NN	0	15	16	1	luciferase	15	15	16	0	NN	0	16	17	1	activity	16	16	17	0	VP	0	17	18	1	VBN	0	17	18	1	shown	17	17	18	0	.	0	18	19	1	.	18	18	19	0
EOS
T	35
*	11086	11087	SYM	*	O	_	_
P	11088	11089	NN	p	O	_	_
=	11089	11090	JJ	=	O	_	_
0.05	11090	11094	CD	0.05	O	_	_
(	11095	11096	NN	(	O	_	_
B	11096	11097	NN	b	O	_	_
)	11097	11098	CD	)	O	_	_
The	11099	11102	DT	the	O	_	_
value	11103	11108	NN	value	O	_	_
of	11109	11111	IN	of	O	_	_
ASPP2+	11112	11118	JJ	aspp2+	B-GENE	_	_
p53	11118	11121	NN	p53	I-GENE	_	_
was	11122	11125	VBD	be	O	_	_
taken	11126	11131	VBN	take	O	_	_
as	11132	11134	IN	as	O	_	_
1.0	11135	11138	CD	1.0	O	_	_
to	11139	11141	TO	to	O	_	_
reflect	11142	11149	VB	reflect	O	_	_
the	11150	11153	DT	the	O	_	_
fold	11154	11158	JJ	fold	O	_	_
increase	11159	11167	NN	increase	O	_	_
of	11168	11170	IN	of	O	_	_
ASPP2	11171	11176	NN	aspp2	B-GENE	_	_
and	11177	11180	CC	and	O	_	_
p53	11181	11184	NN	p53	B-GENE	_	_
in	11185	11187	IN	in	O	_	_
the	11188	11191	DT	the	O	_	_
presence	11192	11200	NN	presence	O	_	_
of	11201	11203	IN	of	O	_	_
activated	11204	11213	VBN	activate	O	_	_
Raf	11214	11217	NN	raf	B-GENE	_	_
and	11218	11221	CC	and	O	_	_
mutant	11222	11228	JJ	mutant	O	_	_
RAS	11229	11232	NN	ra	O	_	_
.	11232	11233	.	.	O	_	_
D	1
13
1	0	dep
1	2	amod
1	4	dep
4	3	num
5	1	dep
5	6	num
8	5	dep
8	7	det
8	11	prep_of
11	10	amod
13	8	dep
13	12	auxpass
13	15	prep_as
13	17	xcomp
17	16	aux
17	20	dobj
17	27	prep_in
20	18	det
20	19	amod
20	22	prep_of
20	24	prep_of
22	24	conj_and
27	26	det
27	30	prep_of
27	33	prep_of
30	29	amod
30	33	conj_and
33	32	amod
EOX
Y	1
ROOT	0	0	35	1	FRAG	1	0	35	3	X	1	0	12	2	X	1	0	7	2	X	1	0	5	2	X	0	0	1	1	SYM	0	0	1	1	*	0	0	1	0	NP	0	1	5	2	NP	0	1	3	2	NN	0	1	2	1	P	1	1	2	0	JJ	0	2	3	1	=	2	2	3	0	NP	1	3	5	2	CD	0	3	4	1	0.05	3	3	4	0	NN	0	4	5	1	(	4	4	5	0	NP	0	5	7	2	NN	0	5	6	1	B	5	5	6	0	CD	0	6	7	1	)	6	6	7	0	NP	0	7	12	2	NP	1	7	9	2	DT	0	7	8	1	The	7	7	8	0	NN	0	8	9	1	value	8	8	9	0	PP	0	9	12	2	IN	0	9	10	1	of	9	9	10	0	NP	1	10	12	2	JJ	0	10	11	1	ASPP2+	10	10	11	0	NN	0	11	12	1	p53	11	11	12	0	VP	1	12	34	2	VBD	0	12	13	1	was	12	12	13	0	VP	0	13	34	3	VBN	0	13	14	1	taken	13	13	14	0	PP	0	14	16	2	IN	0	14	15	1	as	14	14	15	0	NP	0	15	16	1	CD	0	15	16	1	1.0	15	15	16	0	S	0	16	34	1	VP	1	16	34	2	TO	0	16	17	1	to	16	16	17	0	VP	0	17	34	3	VB	0	17	18	1	reflect	17	17	18	0	NP	0	18	25	2	NP	2	18	21	3	DT	0	18	19	1	the	18	18	19	0	JJ	0	19	20	1	fold	19	19	20	0	NN	0	20	21	1	increase	20	20	21	0	PP	0	21	25	2	IN	0	21	22	1	of	21	21	22	0	NP	0	22	25	3	NN	0	22	23	1	ASPP2	22	22	23	0	CC	0	23	24	1	and	23	23	24	0	NN	0	24	25	1	p53	24	24	25	0	PP	0	25	34	2	IN	0	25	26	1	in	25	25	26	0	NP	0	26	34	2	NP	1	26	28	2	DT	0	26	27	1	the	26	26	27	0	NN	0	27	28	1	presence	27	27	28	0	PP	0	28	34	2	IN	0	28	29	1	of	28	28	29	0	NP	0	29	34	3	NP	1	29	31	2	VBN	0	29	30	1	activated	29	29	30	0	NN	0	30	31	1	Raf	30	30	31	0	CC	0	31	32	1	and	31	31	32	0	NP	1	32	34	2	JJ	0	32	33	1	mutant	32	32	33	0	NN	0	33	34	1	RAS	33	33	34	0	.	0	34	35	1	.	34	34	35	0
EOS
T	10
**	11234	11236	SYM	**	O	_	_
P	11237	11238	NN	p	O	_	_
=	11238	11239	JJ	=	O	_	_
0.0055	11239	11245	CD	0.0055	O	_	_
;	11245	11246	:	;	O	_	_
****	11247	11251	CD	****	O	_	_
P	11252	11253	NN	p	O	_	_
=	11253	11254	JJ	=	O	_	_
0.0001	11254	11260	CD	0.0001	O	_	_
.	11260	11261	.	.	O	_	_
D	1
3
1	0	dep
2	1	dep
3	2	dep
3	6	dep
6	5	num
6	7	amod
7	8	dep
EOX
Y	1
ROOT	0	0	10	1	FRAG	0	0	10	3	FRAG	1	0	4	2	X	1	0	3	2	X	1	0	2	2	X	0	0	1	1	SYM	0	0	1	1	**	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	P	1	1	2	0	NP	0	2	3	1	JJ	0	2	3	1	=	2	2	3	0	NP	0	3	4	1	CD	0	3	4	1	0.0055	3	3	4	0	:	0	4	5	1	;	4	4	5	0	FRAG	0	5	10	2	NP	0	5	9	2	NP	1	5	7	2	CD	0	5	6	1	****	5	5	6	0	NN	0	6	7	1	P	6	6	7	0	ADJP	0	7	9	2	JJ	0	7	8	1	=	7	7	8	0	NP	0	8	9	1	CD	0	8	9	1	0.0001	8	8	9	0	.	0	9	10	1	.	9	9	10	0
EOS
T	20
The	11262	11265	DT	the	O	_	_
effect	11266	11272	NN	effect	O	_	_
of	11273	11275	IN	of	O	_	_
Raf	11276	11279	NN	raf	B-GENE	_	_
CAAX	11280	11284	NN	caax	I-GENE	_	_
on	11285	11287	IN	on	O	_	_
ASPP2	11288	11293	NN	aspp2	B-GENE	_	_
and	11294	11297	CC	and	O	_	_
p53	11298	11301	NN	p53	B-GENE	_	_
was	11302	11305	VBD	be	O	_	_
compared	11306	11314	VBN	compare	O	_	_
to	11315	11317	TO	to	O	_	_
that	11318	11322	DT	that	O	_	_
of	11323	11325	IN	of	O	_	_
HRAS	11326	11330	NNP	HRAS	B-GENE	_	_
V12	11331	11334	NN	v12	I-GENE	_	_
or	11335	11337	CC	or	O	_	_
KRAS	11338	11342	NNP	KRAS	B-GENE	_	_
V12	11343	11346	NN	v12	I-GENE	_	_
.	11346	11347	.	.	O	_	_
D	1
9
1	0	det
1	4	prep_of
4	3	nn
4	6	prep_on
4	8	prep_on
6	8	conj_and
9	1	nsubj
9	11	prepc_compared_to
9	12	pobj
12	15	prep_of
12	18	prep_of
15	14	nn
15	18	conj_or
18	17	nn
EOX
Y	1
ROOT	0	0	20	1	S	1	0	20	3	NP	0	0	9	2	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	effect	1	1	2	0	PP	0	2	9	2	IN	0	2	3	1	of	2	2	3	0	NP	0	3	9	2	NP	1	3	5	2	NN	0	3	4	1	Raf	3	3	4	0	NN	0	4	5	1	CAAX	4	4	5	0	PP	0	5	9	2	IN	0	5	6	1	on	5	5	6	0	NP	0	6	9	3	NN	0	6	7	1	ASPP2	6	6	7	0	CC	0	7	8	1	and	7	7	8	0	NN	0	8	9	1	p53	8	8	9	0	VP	0	9	19	2	VBD	0	9	10	1	was	9	9	10	0	PP	0	10	19	2	VBN	0	10	11	1	compared	10	10	11	0	PP	0	11	19	2	TO	0	11	12	1	to	11	11	12	0	NP	0	12	19	2	NP	0	12	13	1	DT	0	12	13	1	that	12	12	13	0	PP	0	13	19	2	IN	0	13	14	1	of	13	13	14	0	NP	0	14	19	3	NP	1	14	16	2	NNP	0	14	15	1	HRAS	14	14	15	0	NN	0	15	16	1	V12	15	15	16	0	CC	0	16	17	1	or	16	16	17	0	NP	1	17	19	2	NNP	0	17	18	1	KRAS	17	17	18	0	NN	0	18	19	1	V12	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	17
All	11348	11351	DT	all	O	_	_
three	11352	11357	CD	three	O	_	_
activate	11358	11366	VBP	activate	O	_	_
ASPP2	11367	11372	NN	aspp2	B-GENE	_	_
and	11373	11376	CC	and	O	_	_
p53	11377	11380	NN	p53	B-GENE	_	_
transactivation	11381	11396	NN	transactivation	O	_	_
activity	11397	11405	NN	activity	O	_	_
to	11406	11408	TO	to	O	_	_
a	11409	11410	DT	a	O	_	_
similar	11411	11418	JJ	similar	O	_	_
extent	11419	11425	NN	extent	O	_	_
,	11425	11426	,	,	O	_	_
namely	11427	11433	RB	namely	O	_	_
2.5	11434	11437	CD	2.5	O	_	_
fold	11438	11442	NN	fold	O	_	_
.	11454	11455	.	.	O	_	_
D	1
2
1	0	det
2	1	nsubj
2	7	dobj
2	11	prep_to
3	5	conj_and
7	3	nn
7	5	nn
7	6	nn
11	9	det
11	10	amod
11	15	appos
15	13	advmod
15	14	num
EOX
Y	1
ROOT	0	0	17	1	S	1	0	17	3	NP	1	0	2	2	DT	0	0	1	1	All	0	0	1	0	CD	0	1	2	1	three	1	1	2	0	VP	0	2	16	3	VBP	0	2	3	1	activate	2	2	3	0	NP	2	3	8	3	NP	0	3	6	3	NN	0	3	4	1	ASPP2	3	3	4	0	CC	0	4	5	1	and	4	4	5	0	NN	0	5	6	1	p53	5	5	6	0	NN	0	6	7	1	transactivation	6	6	7	0	NN	0	7	8	1	activity	7	7	8	0	PP	0	8	16	2	TO	0	8	9	1	to	8	8	9	0	NP	0	9	16	3	NP	2	9	12	3	DT	0	9	10	1	a	9	9	10	0	JJ	0	10	11	1	similar	10	10	11	0	NN	0	11	12	1	extent	11	11	12	0	,	0	12	13	1	,	12	12	13	0	NP	2	13	16	3	RB	0	13	14	1	namely	13	13	14	0	CD	0	14	15	1	2.5	14	14	15	0	NN	0	15	16	1	fold	15	15	16	0	.	0	16	17	1	.	16	16	17	0
EOS
T	22
This	11456	11460	DT	this	O	_	_
suggests	11461	11469	VBZ	suggest	O	_	_
that	11470	11474	IN	that	O	_	_
the	11475	11478	DT	the	O	_	_
effect	11479	11485	NN	effect	O	_	_
of	11486	11488	IN	of	O	_	_
activated	11489	11498	VBN	activate	O	_	_
RAS	11499	11502	NN	ra	O	_	_
on	11503	11505	IN	on	O	_	_
ASPP2	11506	11511	NN	aspp2	B-GENE	_	_
and	11512	11515	CC	and	O	_	_
p53	11516	11519	NN	p53	B-GENE	_	_
is	11520	11522	VBZ	be	O	_	_
mediated	11523	11531	VBN	mediate	O	_	_
via	11532	11535	IN	via	O	_	_
the	11536	11539	DT	the	O	_	_
downstream	11540	11550	JJ	downstream	O	_	_
Raf	11551	11554	NN	raf	B-GENE	_	_
/	11555	11556	:	/	B-GENE	_	_
MAPK	11556	11560	NN	mapk	I-GENE	_	_
pathway	11561	11568	NN	pathway	O	_	_
.	11568	11569	.	.	O	_	_
D	1
1
1	0	nsubj
1	13	ccomp
4	3	det
4	7	prep_of
7	6	amod
7	9	prep_on
7	11	prep_on
9	11	conj_and
13	2	mark
13	4	nsubjpass
13	12	auxpass
13	17	prep_via
17	15	det
17	16	amod
17	20	dep
20	18	punct
20	19	nn
EOX
Y	1
ROOT	0	0	22	1	S	1	0	22	3	NP	0	0	1	1	DT	0	0	1	1	This	0	0	1	0	VP	0	1	21	2	VBZ	0	1	2	1	suggests	1	1	2	0	SBAR	1	2	21	2	IN	0	2	3	1	that	2	2	3	0	S	1	3	21	2	NP	0	3	12	2	NP	1	3	5	2	DT	0	3	4	1	the	3	3	4	0	NN	0	4	5	1	effect	4	4	5	0	PP	0	5	12	2	IN	0	5	6	1	of	5	5	6	0	NP	0	6	12	2	NP	1	6	8	2	VBN	0	6	7	1	activated	6	6	7	0	NN	0	7	8	1	RAS	7	7	8	0	PP	0	8	12	2	IN	0	8	9	1	on	8	8	9	0	NP	0	9	12	3	NN	0	9	10	1	ASPP2	9	9	10	0	CC	0	10	11	1	and	10	10	11	0	NN	0	11	12	1	p53	11	11	12	0	VP	1	12	21	2	VBZ	0	12	13	1	is	12	12	13	0	VP	0	13	21	2	VBN	0	13	14	1	mediated	13	13	14	0	PP	0	14	21	2	IN	0	14	15	1	via	14	14	15	0	NP	0	15	21	2	NP	2	15	18	3	DT	0	15	16	1	the	15	15	16	0	JJ	0	16	17	1	downstream	16	16	17	0	NN	0	17	18	1	Raf	17	17	18	0	PRN	1	18	21	2	:	0	18	19	1	/	18	18	19	0	NP	1	19	21	2	NN	0	19	20	1	MAPK	19	19	20	0	NN	0	20	21	1	pathway	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	35
ASPP2	11570	11575	NN	aspp2	B-GENE	_	_
phosphorylation	11576	11591	NN	phosphorylation	O	_	_
by	11592	11594	IN	by	O	_	_
MAPK	11595	11599	NN	mapk	O	_	_
is	11600	11602	VBZ	be	O	_	_
necessary	11603	11612	JJ	necessary	O	_	_
for	11613	11616	IN	for	O	_	_
ASPP2	11617	11622	NN	aspp2	B-GENE	_	_
full	11623	11627	JJ	full	O	_	_
pro-apoptotic	11628	11641	JJ	pro-apoptotic	O	_	_
activity	11642	11650	NN	activity	O	_	_
To	11651	11653	TO	to	O	_	_
assess	11654	11660	VB	assess	O	_	_
the	11661	11664	DT	the	O	_	_
effect	11665	11671	NN	effect	O	_	_
of	11672	11674	IN	of	O	_	_
MAPK	11675	11679	NN	mapk	B-GENE	_	_
phosphorylation	11680	11695	NN	phosphorylation	O	_	_
on	11696	11698	IN	on	O	_	_
ASPP2	11699	11704	NN	aspp2	B-GENE	_	_
activity	11705	11713	NN	activity	O	_	_
,	11713	11714	,	,	O	_	_
alanine	11715	11722	NN	alanine	O	_	_
substitution	11723	11735	NN	substitution	O	_	_
mutants	11736	11743	NNS	mutant	O	_	_
of	11744	11746	IN	of	O	_	_
the	11747	11750	DT	the	O	_	_
two	11751	11754	CD	two	O	_	_
putative	11755	11763	JJ	putative	O	_	_
MAPK	11764	11768	NN	mapk	B-GENE	_	_
phosphorylation	11769	11784	NN	phosphorylation	O	_	_
sites	11785	11790	NNS	site	O	_	_
were	11791	11795	VBD	be	O	_	_
constructed	11796	11807	VBN	construct	O	_	_
.	11807	11808	.	.	O	_	_
D	1
33
1	0	nn
1	3	prep_by
5	1	nsubj
5	4	cop
5	10	prep_for
5	12	xcomp
10	7	nn
10	8	amod
10	9	amod
12	11	aux
12	14	dobj
12	20	prep_on
14	13	det
14	17	prep_of
17	16	nn
20	19	nn
24	22	nn
24	23	nn
24	31	prep_of
31	26	det
31	27	num
31	28	amod
31	29	nn
31	30	nn
33	5	ccomp
33	24	nsubjpass
33	32	auxpass
EOX
Y	1
ROOT	0	0	35	1	S	3	0	35	5	S	1	0	21	2	NP	0	0	4	2	NP	1	0	2	2	NN	0	0	1	1	ASPP2	0	0	1	0	NN	0	1	2	1	phosphorylation	1	1	2	0	PP	0	2	4	2	IN	0	2	3	1	by	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	MAPK	3	3	4	0	VP	1	4	21	3	VBZ	0	4	5	1	is	4	4	5	0	ADJP	0	5	11	2	JJ	0	5	6	1	necessary	5	5	6	0	PP	0	6	11	2	IN	0	6	7	1	for	6	6	7	0	NP	3	7	11	4	NN	0	7	8	1	ASPP2	7	7	8	0	JJ	0	8	9	1	full	8	8	9	0	JJ	0	9	10	1	pro-apoptotic	9	9	10	0	NN	0	10	11	1	activity	10	10	11	0	S	0	11	21	1	VP	1	11	21	2	TO	0	11	12	1	To	11	11	12	0	VP	0	12	21	3	VB	0	12	13	1	assess	12	12	13	0	NP	0	13	18	2	NP	1	13	15	2	DT	0	13	14	1	the	13	13	14	0	NN	0	14	15	1	effect	14	14	15	0	PP	0	15	18	2	IN	0	15	16	1	of	15	15	16	0	NP	1	16	18	2	NN	0	16	17	1	MAPK	16	16	17	0	NN	0	17	18	1	phosphorylation	17	17	18	0	PP	0	18	21	2	IN	0	18	19	1	on	18	18	19	0	NP	1	19	21	2	NN	0	19	20	1	ASPP2	19	19	20	0	NN	0	20	21	1	activity	20	20	21	0	,	0	21	22	1	,	21	21	22	0	NP	0	22	32	2	NP	2	22	25	3	NN	0	22	23	1	alanine	22	22	23	0	NN	0	23	24	1	substitution	23	23	24	0	NNS	0	24	25	1	mutants	24	24	25	0	PP	0	25	32	2	IN	0	25	26	1	of	25	25	26	0	NP	5	26	32	6	DT	0	26	27	1	the	26	26	27	0	CD	0	27	28	1	two	27	27	28	0	JJ	0	28	29	1	putative	28	28	29	0	NN	0	29	30	1	MAPK	29	29	30	0	NN	0	30	31	1	phosphorylation	30	30	31	0	NNS	0	31	32	1	sites	31	31	32	0	VP	1	32	34	2	VBD	0	32	33	1	were	32	32	33	0	VP	0	33	34	1	VBN	0	33	34	1	constructed	33	33	34	0	.	0	34	35	1	.	34	34	35	0
EOS
T	29
In	11809	11811	IN	in	O	_	_
conditions	11812	11822	NNS	condition	O	_	_
where	11823	11828	WRB	where	O	_	_
the	11829	11832	DT	the	O	_	_
cells	11833	11838	NNS	cell	O	_	_
were	11839	11843	VBD	be	O	_	_
starved	11844	11851	VBN	starve	O	_	_
of	11852	11854	IN	of	O	_	_
serum	11855	11860	NN	serum	O	_	_
,	11860	11861	,	,	O	_	_
these	11862	11867	DT	these	O	_	_
mutants	11868	11875	NNS	mutant	O	_	_
had	11876	11879	VBD	have	O	_	_
identical	11880	11889	JJ	identical	O	_	_
activity	11890	11898	NN	activity	O	_	_
to	11899	11901	TO	to	O	_	_
wild-type	11902	11911	JJ	wild-type	O	_	_
ASPP2	11912	11917	NN	aspp2	O	_	_
in	11918	11920	IN	in	O	_	_
their	11921	11926	PRP$	they	O	_	_
ability	11927	11934	NN	ability	O	_	_
to	11935	11937	TO	to	O	_	_
enhance	11938	11945	VB	enhance	O	_	_
the	11946	11949	DT	the	O	_	_
transactivation	11950	11965	NN	transactivation	O	_	_
function	11966	11974	NN	function	O	_	_
of	11975	11977	IN	of	O	_	_
p53	11978	11981	NN	p53	B-GENE	_	_
.	11993	11994	.	.	O	_	_
D	1
12
1	6	rcmod
4	3	det
6	2	advmod
6	4	nsubjpass
6	5	auxpass
6	8	prep_of
11	10	det
12	1	prep_in
12	11	nsubj
12	14	dobj
12	20	prep_in
14	13	amod
14	17	prep_to
17	16	amod
20	19	poss
20	22	vmod
22	21	aux
22	25	dobj
25	23	det
25	24	nn
25	27	prep_of
EOX
Y	1
ROOT	0	0	29	1	S	3	0	29	5	PP	0	0	9	2	IN	0	0	1	1	In	0	0	1	0	NP	0	1	9	2	NP	0	1	2	1	NNS	0	1	2	1	conditions	1	1	2	0	SBAR	1	2	9	2	WHADVP	0	2	3	1	WRB	0	2	3	1	where	2	2	3	0	S	1	3	9	2	NP	1	3	5	2	DT	0	3	4	1	the	3	3	4	0	NNS	0	4	5	1	cells	4	4	5	0	VP	1	5	9	2	VBD	0	5	6	1	were	5	5	6	0	VP	0	6	9	2	VBN	0	6	7	1	starved	6	6	7	0	PP	0	7	9	2	IN	0	7	8	1	of	7	7	8	0	NP	0	8	9	1	NN	0	8	9	1	serum	8	8	9	0	,	0	9	10	1	,	9	9	10	0	NP	1	10	12	2	DT	0	10	11	1	these	10	10	11	0	NNS	0	11	12	1	mutants	11	11	12	0	VP	0	12	28	3	VBD	0	12	13	1	had	12	12	13	0	NP	0	13	18	2	NP	1	13	15	2	JJ	0	13	14	1	identical	13	13	14	0	NN	0	14	15	1	activity	14	14	15	0	PP	0	15	18	2	TO	0	15	16	1	to	15	15	16	0	NP	1	16	18	2	JJ	0	16	17	1	wild-type	16	16	17	0	NN	0	17	18	1	ASPP2	17	17	18	0	PP	0	18	28	2	IN	0	18	19	1	in	18	18	19	0	NP	1	19	28	3	PRP$	0	19	20	1	their	19	19	20	0	NN	0	20	21	1	ability	20	20	21	0	S	0	21	28	1	VP	1	21	28	2	TO	0	21	22	1	to	21	21	22	0	VP	0	22	28	2	VB	0	22	23	1	enhance	22	22	23	0	NP	0	23	28	2	NP	2	23	26	3	DT	0	23	24	1	the	23	23	24	0	NN	0	24	25	1	transactivation	24	24	25	0	NN	0	25	26	1	function	25	25	26	0	PP	0	26	28	2	IN	0	26	27	1	of	26	26	27	0	NP	0	27	28	1	NN	0	27	28	1	p53	27	27	28	0	.	0	28	29	1	.	28	28	29	0
EOS
T	35
However	11995	12002	RB	however	O	_	_
,	12002	12003	,	,	O	_	_
whereas	12004	12011	IN	whereas	O	_	_
activated	12012	12021	VBN	activate	O	_	_
Raf	12022	12025	NN	raf	B-GENE	_	_
CAAX	12026	12030	NN	caax	I-GENE	_	_
was	12031	12034	VBD	be	O	_	_
able	12035	12039	JJ	able	O	_	_
to	12040	12042	TO	to	O	_	_
stimulate	12043	12052	VB	stimulate	O	_	_
wild-type	12053	12062	JJ	wild-type	O	_	_
ASPP2	12063	12068	NN	aspp2	O	_	_
and	12069	12072	CC	and	O	_	_
ASPP2	12073	12078	NN	aspp2	O	_	_
(	12079	12080	CD	(	O	_	_
S698A	12080	12085	NN	s698a	O	_	_
)	12085	12086	CD	)	O	_	_
by	12087	12089	IN	by	O	_	_
2.5	12090	12093	CD	2.5	O	_	_
fold	12094	12098	NN	fold	O	_	_
,	12098	12099	,	,	O	_	_
it	12100	12102	PRP	it	O	_	_
was	12103	12106	VBD	be	O	_	_
unable	12107	12113	JJ	unable	O	_	_
to	12114	12116	TO	to	O	_	_
increase	12117	12125	VB	increase	O	_	_
the	12126	12129	DT	the	O	_	_
activity	12130	12138	NN	activity	O	_	_
of	12139	12141	IN	of	O	_	_
mutant	12142	12148	JJ	mutant	O	_	_
ASPP2	12149	12154	NN	aspp2	O	_	_
(	12155	12156	CD	(	O	_	_
S827A	12156	12161	NN	s827a	O	_	_
)	12161	12162	NN	)	O	_	_
.	12174	12175	.	.	O	_	_
D	1
23
5	3	amod
5	4	nn
7	2	mark
7	5	nsubj
7	6	cop
7	9	xcomp
9	8	aux
9	11	dobj
9	13	dobj
9	19	prep_by
11	10	amod
11	13	conj_and
13	14	num
13	15	dep
15	16	num
19	18	num
23	0	advmod
23	7	parataxis
23	21	nsubj
23	22	cop
23	25	xcomp
25	24	aux
25	27	iobj
25	33	dobj
27	26	det
27	30	prep_of
30	29	amod
33	31	num
33	32	nn
EOX
Y	1
ROOT	0	0	35	1	S	3	0	35	5	ADVP	0	0	1	1	RB	0	0	1	1	However	0	0	1	0	PRN	1	1	21	3	,	0	1	2	1	,	1	1	2	0	SBAR	1	2	20	2	IN	0	2	3	1	whereas	2	2	3	0	S	1	3	20	2	NP	2	3	6	3	VBN	0	3	4	1	activated	3	3	4	0	NN	0	4	5	1	Raf	4	4	5	0	NN	0	5	6	1	CAAX	5	5	6	0	VP	1	6	20	2	VBD	0	6	7	1	was	6	6	7	0	ADJP	0	7	20	2	JJ	0	7	8	1	able	7	7	8	0	S	0	8	20	1	VP	1	8	20	2	TO	0	8	9	1	to	8	8	9	0	VP	0	9	20	3	VB	0	9	10	1	stimulate	9	9	10	0	NP	0	10	17	3	NP	1	10	12	2	JJ	0	10	11	1	wild-type	10	10	11	0	NN	0	11	12	1	ASPP2	11	11	12	0	CC	0	12	13	1	and	12	12	13	0	NP	0	13	17	2	NP	0	13	15	2	NN	0	13	14	1	ASPP2	13	13	14	0	CD	0	14	15	1	(	14	14	15	0	NP	0	15	17	2	NN	0	15	16	1	S698A	15	15	16	0	CD	0	16	17	1	)	16	16	17	0	PP	0	17	20	2	IN	0	17	18	1	by	17	17	18	0	NP	1	18	20	2	CD	0	18	19	1	2.5	18	18	19	0	NN	0	19	20	1	fold	19	19	20	0	,	0	20	21	1	,	20	20	21	0	NP	0	21	22	1	PRP	0	21	22	1	it	21	21	22	0	VP	1	22	34	2	VBD	0	22	23	1	was	22	22	23	0	ADJP	0	23	34	2	JJ	0	23	24	1	unable	23	23	24	0	S	0	24	34	1	VP	1	24	34	2	TO	0	24	25	1	to	24	24	25	0	VP	0	25	34	3	VB	0	25	26	1	increase	25	25	26	0	NP	0	26	31	2	NP	1	26	28	2	DT	0	26	27	1	the	26	26	27	0	NN	0	27	28	1	activity	27	27	28	0	PP	0	28	31	2	IN	0	28	29	1	of	28	28	29	0	NP	1	29	31	2	JJ	0	29	30	1	mutant	29	29	30	0	NN	0	30	31	1	ASPP2	30	30	31	0	NP	2	31	34	3	CD	0	31	32	1	(	31	31	32	0	NN	0	32	33	1	S827A	32	32	33	0	NN	0	33	34	1	)	33	33	34	0	.	0	34	35	1	.	34	34	35	0
EOS
T	25
These	12176	12181	DT	these	O	_	_
results	12182	12189	NNS	result	O	_	_
suggest	12190	12197	VBP	suggest	O	_	_
that	12198	12202	IN	that	O	_	_
MAPK	12203	12207	NN	mapk	B-GENE	_	_
phosphorylation	12208	12223	NN	phosphorylation	O	_	_
of	12224	12226	IN	of	O	_	_
ASPP2	12227	12232	NN	aspp2	B-GENE	_	_
Ser827	12233	12239	NN	ser827	O	_	_
is	12240	12242	VBZ	be	O	_	_
necessary	12243	12252	JJ	necessary	O	_	_
for	12253	12256	IN	for	O	_	_
Raf	12257	12260	NN	raf	B-GENE	_	_
CAAX	12261	12265	NN	caax	I-GENE	_	_
to	12266	12268	TO	to	O	_	_
stimulate	12269	12278	VB	stimulate	O	_	_
the	12279	12282	DT	the	O	_	_
full	12283	12287	JJ	full	O	_	_
transcriptional	12288	12303	JJ	transcriptional	O	_	_
activity	12304	12312	NN	activity	O	_	_
of	12313	12315	IN	of	O	_	_
p53	12316	12319	NN	p53	B-GENE	_	_
via	12320	12323	IN	via	I-GENE	_	_
ASPP2	12324	12329	NN	aspp2	I-GENE	_	_
.	12329	12330	.	.	O	_	_
D	1
2
1	0	det
2	1	nsubj
2	10	ccomp
5	4	nn
5	8	prep_of
8	7	nn
10	3	mark
10	5	nsubj
10	9	cop
10	13	prep_for
10	15	xcomp
13	12	nn
15	14	aux
15	19	dobj
19	16	det
19	17	amod
19	18	amod
19	21	prep_of
21	23	prep_via
EOX
Y	1
ROOT	0	0	25	1	S	1	0	25	3	NP	1	0	2	2	DT	0	0	1	1	These	0	0	1	0	NNS	0	1	2	1	results	1	1	2	0	VP	0	2	24	2	VBP	0	2	3	1	suggest	2	2	3	0	SBAR	1	3	24	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	24	2	NP	0	4	9	2	NP	1	4	6	2	NN	0	4	5	1	MAPK	4	4	5	0	NN	0	5	6	1	phosphorylation	5	5	6	0	PP	0	6	9	2	IN	0	6	7	1	of	6	6	7	0	NP	1	7	9	2	NN	0	7	8	1	ASPP2	7	7	8	0	NN	0	8	9	1	Ser827	8	8	9	0	VP	1	9	24	3	VBZ	0	9	10	1	is	9	9	10	0	ADJP	0	10	14	2	JJ	0	10	11	1	necessary	10	10	11	0	PP	0	11	14	2	IN	0	11	12	1	for	11	11	12	0	NP	1	12	14	2	NN	0	12	13	1	Raf	12	12	13	0	NN	0	13	14	1	CAAX	13	13	14	0	S	0	14	24	1	VP	1	14	24	2	TO	0	14	15	1	to	14	14	15	0	VP	0	15	24	2	VB	0	15	16	1	stimulate	15	15	16	0	NP	0	16	24	2	NP	3	16	20	4	DT	0	16	17	1	the	16	16	17	0	JJ	0	17	18	1	full	17	17	18	0	JJ	0	18	19	1	transcriptional	18	18	19	0	NN	0	19	20	1	activity	19	19	20	0	PP	0	20	24	2	IN	0	20	21	1	of	20	20	21	0	NP	0	21	24	2	NP	0	21	22	1	NN	0	21	22	1	p53	21	21	22	0	PP	0	22	24	2	IN	0	22	23	1	via	22	22	23	0	NP	0	23	24	1	NN	0	23	24	1	ASPP2	23	23	24	0	.	0	24	25	1	.	24	24	25	0
EOS
T	5
10.1371	12331	12338	CD	10.1371	O	_	_
/	12338	12339	:	/	O	_	_
journal.pone	12339	12351	NN	journal.pone	O	_	_
.0082022	12351	12359	CD	.0082022	O	_	_
.	12359	12360	.	.	O	_	_
D	1
0
0	1	punct
0	2	dep
2	3	dep
EOX
Y	1
ROOT	0	0	5	1	FRAG	0	0	5	4	NP	0	0	1	1	CD	0	0	1	1	10.1371	0	0	1	0	:	0	1	2	1	/	1	1	2	0	FRAG	0	2	4	2	NP	0	2	3	1	NN	0	2	3	1	journal.pone	2	2	3	0	NP	0	3	4	1	CD	0	3	4	1	.0082022	3	3	4	0	.	0	4	5	1	.	4	4	5	0
EOS
T	15
g003	12360	12364	NN	g003	O	_	_
Phosphorylation	12374	12389	NN	phosphorylation	O	_	_
of	12390	12392	IN	of	O	_	_
ASPP2	12393	12398	NN	aspp2	B-GENE	_	_
by	12399	12401	IN	by	O	_	_
the	12402	12405	DT	the	O	_	_
Raf	12406	12409	NN	raf	B-GENE	_	_
/	12409	12410	:	/	B-GENE	_	_
MAPK	12410	12414	NN	mapk	I-GENE	_	_
pathway	12415	12422	NN	pathway	O	_	_
enhances	12423	12431	VBZ	enhance	O	_	_
p53	12432	12435	NN	p53	B-GENE	_	_
mediated	12436	12444	JJ	mediated	O	_	_
transactivation	12445	12460	NN	transactivation	O	_	_
.	12460	12461	.	.	O	_	_
D	1
1
1	0	nn
1	3	prep_of
1	6	prep_by
1	7	punct
1	10	dep
6	5	det
9	8	nn
10	9	nsubj
10	13	dobj
13	11	nn
13	12	amod
EOX
Y	1
ROOT	0	0	15	1	FRAG	0	0	15	4	NP	0	0	7	3	NP	1	0	2	2	NN	0	0	1	1	g003	0	0	1	0	NN	0	1	2	1	Phosphorylation	1	1	2	0	PP	0	2	4	2	IN	0	2	3	1	of	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	ASPP2	3	3	4	0	PP	0	4	7	2	IN	0	4	5	1	by	4	4	5	0	NP	1	5	7	2	DT	0	5	6	1	the	5	5	6	0	NN	0	6	7	1	Raf	6	6	7	0	:	0	7	8	1	/	7	7	8	0	S	1	8	14	2	NP	1	8	10	2	NN	0	8	9	1	MAPK	8	8	9	0	NN	0	9	10	1	pathway	9	9	10	0	VP	0	10	14	2	VBZ	0	10	11	1	enhances	10	10	11	0	NP	2	11	14	3	NN	0	11	12	1	p53	11	11	12	0	JJ	0	12	13	1	mediated	12	12	13	0	NN	0	13	14	1	transactivation	13	13	14	0	.	0	14	15	1	.	14	14	15	0
EOS
T	23
(	12462	12463	NN	(	O	_	_
A	12463	12464	NN	a	O	_	_
)	12464	12465	CD	)	O	_	_
Saos2	12466	12471	NN	saos2	O	_	_
cells	12472	12477	NNS	cell	O	_	_
were	12478	12482	VBD	be	O	_	_
transfected	12483	12494	VBN	transfect	O	_	_
with	12495	12499	IN	with	O	_	_
p53	12500	12503	NN	p53	B-GENE	_	_
and	12504	12507	CC	and	O	_	_
either	12508	12514	CC	either	O	_	_
wild-type	12515	12524	JJ	wild-type	O	_	_
or	12525	12527	CC	or	O	_	_
mutant	12528	12534	JJ	mutant	O	_	_
ASPP2	12535	12540	NN	aspp2	O	_	_
as	12541	12543	IN	as	O	_	_
indicated	12544	12553	VBN	indicate	O	_	_
together	12554	12562	RB	together	O	_	_
with	12563	12567	IN	with	O	_	_
a	12568	12569	DT	a	O	_	_
Bax-luciferase	12570	12584	NN	bax-luciferase	B-GENE	_	_
reporter	12585	12593	NN	reporter	I-GENE	_	_
.	12593	12594	.	.	O	_	_
D	1
6
4	0	nn
4	1	nn
4	2	num
4	3	nn
6	4	nsubjpass
6	5	auxpass
6	8	prep_with
6	16	conj_and
11	10	preconj
11	14	conj_or
14	13	amod
14	15	amod
16	11	nsubj
16	14	nsubj
16	21	prep_together_with
21	19	det
21	20	nn
EOX
Y	1
ROOT	0	0	23	1	S	0	0	23	4	S	1	0	9	2	NP	4	0	5	5	NN	0	0	1	1	(	0	0	1	0	NN	0	1	2	1	A	1	1	2	0	CD	0	2	3	1	)	2	2	3	0	NN	0	3	4	1	Saos2	3	3	4	0	NNS	0	4	5	1	cells	4	4	5	0	VP	1	5	9	2	VBD	0	5	6	1	were	5	5	6	0	VP	0	6	9	2	VBN	0	6	7	1	transfected	6	6	7	0	PP	0	7	9	2	IN	0	7	8	1	with	7	7	8	0	NP	0	8	9	1	NN	0	8	9	1	p53	8	8	9	0	CC	0	9	10	1	and	9	9	10	0	S	1	10	22	2	NP	1	10	16	4	CC	0	10	11	1	either	10	10	11	0	NP	0	11	12	1	JJ	0	11	12	1	wild-type	11	11	12	0	CC	0	12	13	1	or	12	12	13	0	NP	1	13	16	3	JJ	0	13	14	1	mutant	13	13	14	0	NN	0	14	15	1	ASPP2	14	14	15	0	IN	0	15	16	1	as	15	15	16	0	VP	0	16	22	3	VBN	0	16	17	1	indicated	16	16	17	0	ADVP	0	17	18	1	RB	0	17	18	1	together	17	17	18	0	PP	0	18	22	2	IN	0	18	19	1	with	18	18	19	0	NP	2	19	22	3	DT	0	19	20	1	a	19	19	20	0	NN	0	20	21	1	Bax-luciferase	20	20	21	0	NN	0	21	22	1	reporter	21	21	22	0	.	0	22	23	1	.	22	22	23	0
EOS
T	9
Luciferase	12595	12605	NN	luciferase	B-GENE	_	_
activity	12606	12614	NN	activity	O	_	_
is	12615	12617	VBZ	be	O	_	_
shown	12618	12623	VBN	show	O	_	_
following	12624	12633	VBG	follow	O	_	_
harvesting	12634	12644	NN	harvesting	O	_	_
of	12645	12647	IN	of	O	_	_
cells	12648	12653	NNS	cell	O	_	_
.	12653	12654	.	.	O	_	_
D	1
3
1	0	nn
3	1	nsubjpass
3	2	auxpass
3	5	prep_following
5	7	prep_of
EOX
Y	1
ROOT	0	0	9	1	S	1	0	9	3	NP	1	0	2	2	NN	0	0	1	1	Luciferase	0	0	1	0	NN	0	1	2	1	activity	1	1	2	0	VP	1	2	8	2	VBZ	0	2	3	1	is	2	2	3	0	VP	0	3	8	2	VBN	0	3	4	1	shown	3	3	4	0	PP	0	4	8	2	VBG	0	4	5	1	following	4	4	5	0	NP	0	5	8	2	NP	0	5	6	1	NN	0	5	6	1	harvesting	5	5	6	0	PP	0	6	8	2	IN	0	6	7	1	of	6	6	7	0	NP	0	7	8	1	NNS	0	7	8	1	cells	7	7	8	0	.	0	8	9	1	.	8	8	9	0
EOS
T	9
Values	12655	12661	NNS	value	O	_	_
are	12662	12665	VBP	be	O	_	_
Relative	12666	12674	JJ	relative	O	_	_
Light	12675	12680	JJ	light	O	_	_
Units	12681	12686	NNS	unit	O	_	_
(	12687	12688	VBP	(	O	_	_
RLU	12688	12691	NN	rlu	O	_	_
)	12691	12692	NN	)	O	_	_
.	12692	12693	.	.	O	_	_
D	1
2
2	0	nsubj
2	1	cop
2	5	ccomp
4	3	amod
5	4	nsubj
5	7	dobj
7	6	nn
EOX
Y	1
ROOT	0	0	9	1	S	1	0	9	3	NP	0	0	1	1	NNS	0	0	1	1	Values	0	0	1	0	VP	1	1	8	2	VBP	0	1	2	1	are	1	1	2	0	ADJP	0	2	8	2	JJ	0	2	3	1	Relative	2	2	3	0	SBAR	0	3	8	1	S	1	3	8	2	NP	1	3	5	2	JJ	0	3	4	1	Light	3	3	4	0	NNS	0	4	5	1	Units	4	4	5	0	VP	0	5	8	2	VBP	0	5	6	1	(	5	5	6	0	NP	1	6	8	2	NN	0	6	7	1	RLU	6	6	7	0	NN	0	7	8	1	)	7	7	8	0	.	0	8	9	1	.	8	8	9	0
EOS
T	28
(	12694	12695	NN	(	O	_	_
B	12695	12696	NN	b	O	_	_
)	12696	12697	CD	)	O	_	_
Saos2	12698	12703	NN	saos2	O	_	_
cells	12704	12709	NNS	cell	O	_	_
were	12710	12714	VBD	be	O	_	_
transfected	12715	12726	VBN	transfect	O	_	_
with	12727	12731	IN	with	O	_	_
p53	12732	12735	NN	p53	B-GENE	_	_
,	12735	12736	,	,	O	_	_
constitutively	12737	12751	RB	constitutively	O	_	_
active	12752	12758	JJ	active	O	_	_
Raf	12759	12762	NN	raf	B-GENE	_	_
CAAX	12763	12767	NN	caax	I-GENE	_	_
and	12768	12771	CC	and	O	_	_
either	12772	12778	CC	either	O	_	_
wild-type	12779	12788	JJ	wild-type	O	_	_
or	12789	12791	CC	or	O	_	_
mutant	12792	12798	JJ	mutant	O	_	_
ASPP2	12799	12804	NN	aspp2	O	_	_
as	12805	12807	IN	as	O	_	_
indicated	12808	12817	VBN	indicate	O	_	_
together	12818	12826	RB	together	O	_	_
with	12827	12831	IN	with	O	_	_
a	12832	12833	DT	a	O	_	_
Bax-luciferase	12834	12848	NN	bax-luciferase	B-GENE	_	_
reporter	12849	12857	NN	reporter	I-GENE	_	_
.	12857	12858	.	.	O	_	_
D	1
6
4	0	nn
4	1	nn
4	2	num
4	3	nn
6	4	nsubjpass
6	5	auxpass
6	8	prep_with
6	21	advcl
8	13	appos
8	19	appos
11	10	advmod
13	11	amod
13	12	nn
13	19	conj_and
16	15	preconj
16	18	conj_or
19	16	amod
19	18	amod
21	20	mark
21	26	prep_together_with
26	24	det
26	25	nn
EOX
Y	1
ROOT	0	0	28	1	S	1	0	28	3	NP	4	0	5	5	NN	0	0	1	1	(	0	0	1	0	NN	0	1	2	1	B	1	1	2	0	CD	0	2	3	1	)	2	2	3	0	NN	0	3	4	1	Saos2	3	3	4	0	NNS	0	4	5	1	cells	4	4	5	0	VP	1	5	27	2	VBD	0	5	6	1	were	5	5	6	0	VP	0	6	27	3	VBN	0	6	7	1	transfected	6	6	7	0	PP	0	7	20	2	IN	0	7	8	1	with	7	7	8	0	NP	0	8	20	3	NP	0	8	9	1	NN	0	8	9	1	p53	8	8	9	0	,	0	9	10	1	,	9	9	10	0	NP	0	10	20	3	NP	2	10	14	3	ADJP	1	10	12	2	RB	0	10	11	1	constitutively	10	10	11	0	JJ	0	11	12	1	active	11	11	12	0	NN	0	12	13	1	Raf	12	12	13	0	NN	0	13	14	1	CAAX	13	13	14	0	CC	0	14	15	1	and	14	14	15	0	NP	1	15	20	2	ADJP	1	15	19	4	CC	0	15	16	1	either	15	15	16	0	JJ	0	16	17	1	wild-type	16	16	17	0	CC	0	17	18	1	or	17	17	18	0	JJ	0	18	19	1	mutant	18	18	19	0	NN	0	19	20	1	ASPP2	19	19	20	0	SBAR	1	20	27	2	IN	0	20	21	1	as	20	20	21	0	S	0	21	27	1	VP	0	21	27	3	VBN	0	21	22	1	indicated	21	21	22	0	ADVP	0	22	23	1	RB	0	22	23	1	together	22	22	23	0	PP	0	23	27	2	IN	0	23	24	1	with	23	23	24	0	NP	2	24	27	3	DT	0	24	25	1	a	24	24	25	0	NN	0	25	26	1	Bax-luciferase	25	25	26	0	NN	0	26	27	1	reporter	26	26	27	0	.	0	27	28	1	.	27	27	28	0
EOS
T	36
**	12859	12861	SYM	**	O	_	_
P	12862	12863	NN	p	O	_	_
=	12863	12864	JJ	=	O	_	_
0.013	12864	12869	CD	0.013	O	_	_
;	12869	12870	:	;	O	_	_
****	12871	12875	CD	****	O	_	_
P	12876	12877	NN	p	O	_	_
=	12877	12878	JJ	=	O	_	_
0.0001	12878	12884	CD	0.0001	O	_	_
(	12885	12886	NN	(	O	_	_
C	12886	12887	NN	c	O	_	_
)	12887	12888	CD	)	O	_	_
Saos2	12889	12894	NN	saos2	O	_	_
cells	12895	12900	NNS	cell	O	_	_
were	12901	12905	VBD	be	O	_	_
transfected	12906	12917	VBN	transfect	O	_	_
with	12918	12922	IN	with	O	_	_
a	12923	12924	DT	a	O	_	_
Bax-luciferase	12925	12939	NN	bax-luciferase	B-GENE	_	_
reporter	12940	12948	NN	reporter	I-GENE	_	_
,	12948	12949	,	,	O	_	_
ASPP2	12950	12955	NN	aspp2	B-GENE	_	_
and	12956	12959	CC	and	O	_	_
p53	12960	12963	NN	p53	B-GENE	_	_
and	12964	12967	CC	and	O	_	_
treated	12968	12975	VBN	treat	O	_	_
with	12976	12980	IN	with	O	_	_
20	12981	12983	CD	20	O	_	_
microM	12984	12990	NN	microm	O	_	_
UO126	12991	12996	NN	uo126	O	_	_
or	12997	12999	CC	or	O	_	_
DMSO	13000	13004	NN	dmso	O	_	_
for	13005	13008	IN	for	O	_	_
20	13009	13011	CD	20	O	_	_
hours	13012	13017	NNS	hour	O	_	_
.	13017	13018	.	.	O	_	_
D	1
6
1	0	dep
1	3	dep
3	2	amod
6	1	dep
6	5	num
6	10	rcmod
9	7	amod
9	8	num
10	9	nsubj
10	15	ccomp
10	25	ccomp
13	11	num
13	12	nn
15	13	nsubjpass
15	14	auxpass
15	19	prep_with
15	21	prep_with
15	23	prep_with
15	25	conj_and
19	17	det
19	18	nn
19	21	conj_and
19	23	conj_and
25	13	nsubjpass
25	29	prep_with
25	31	prep_with
25	34	prep_for
29	27	num
29	28	nn
29	31	conj_or
34	33	num
EOX
Y	1
ROOT	0	0	36	1	FRAG	2	0	36	4	X	1	0	4	2	X	0	0	1	1	SYM	0	0	1	1	**	0	0	1	0	NP	0	1	4	2	NP	0	1	2	1	NN	0	1	2	1	P	1	1	2	0	NP	1	2	4	2	JJ	0	2	3	1	=	2	2	3	0	CD	0	3	4	1	0.013	3	3	4	0	:	0	4	5	1	;	4	4	5	0	NP	0	5	35	2	NP	1	5	7	2	CD	0	5	6	1	****	5	5	6	0	NN	0	6	7	1	P	6	6	7	0	SBAR	0	7	35	1	S	1	7	35	2	NP	2	7	10	3	JJ	0	7	8	1	=	7	7	8	0	CD	0	8	9	1	0.0001	8	8	9	0	NN	0	9	10	1	(	9	9	10	0	VP	0	10	35	2	NN	0	10	11	1	C	10	10	11	0	SBAR	0	11	35	1	S	1	11	35	2	NP	2	11	14	3	CD	0	11	12	1	)	11	11	12	0	NN	0	12	13	1	Saos2	12	12	13	0	NNS	0	13	14	1	cells	13	13	14	0	VP	1	14	35	2	VBD	0	14	15	1	were	14	14	15	0	VP	0	15	35	3	VP	0	15	24	2	VBN	0	15	16	1	transfected	15	15	16	0	PP	0	16	24	2	IN	0	16	17	1	with	16	16	17	0	NP	2	17	24	7	DT	0	17	18	1	a	17	17	18	0	NN	0	18	19	1	Bax-luciferase	18	18	19	0	NN	0	19	20	1	reporter	19	19	20	0	,	0	20	21	1	,	20	20	21	0	NN	0	21	22	1	ASPP2	21	21	22	0	CC	0	22	23	1	and	22	22	23	0	NN	0	23	24	1	p53	23	23	24	0	CC	0	24	25	1	and	24	24	25	0	VP	0	25	35	3	VBN	0	25	26	1	treated	25	25	26	0	PP	0	26	32	2	IN	0	26	27	1	with	26	26	27	0	NP	0	27	32	3	NP	2	27	30	3	CD	0	27	28	1	20	27	27	28	0	NN	0	28	29	1	microM	28	28	29	0	NN	0	29	30	1	UO126	29	29	30	0	CC	0	30	31	1	or	30	30	31	0	NP	0	31	32	1	NN	0	31	32	1	DMSO	31	31	32	0	PP	0	32	35	2	IN	0	32	33	1	for	32	32	33	0	NP	1	33	35	2	CD	0	33	34	1	20	33	33	34	0	NNS	0	34	35	1	hours	34	34	35	0	.	0	35	36	1	.	35	35	36	0
EOS
T	21
Luciferase	13019	13029	NN	luciferase	B-GENE	_	_
activity	13030	13038	NN	activity	O	_	_
is	13039	13041	VBZ	be	O	_	_
shown	13042	13047	VBN	show	O	_	_
in	13048	13050	IN	in	O	_	_
the	13051	13054	DT	the	O	_	_
left	13055	13059	JJ	left	O	_	_
panel	13060	13065	NN	panel	O	_	_
and	13066	13069	CC	and	O	_	_
protein	13070	13077	NN	protein	O	_	_
expression	13078	13088	NN	expression	O	_	_
was	13089	13092	VBD	be	O	_	_
verified	13093	13101	VBN	verify	O	_	_
by	13102	13104	IN	by	O	_	_
Western	13105	13112	JJ	western	O	_	_
Blot	13113	13117	NN	blot	O	_	_
(	13118	13119	RB	(	O	_	_
right	13119	13124	JJ	right	O	_	_
panel	13125	13130	NN	panel	O	_	_
)	13130	13131	NN	)	O	_	_
.	13131	13132	.	.	O	_	_
D	1
3
1	0	nn
3	1	nsubjpass
3	2	auxpass
3	7	prep_in
3	12	conj_and
7	5	det
7	6	amod
10	9	nn
12	10	nsubjpass
12	11	auxpass
12	19	agent
15	14	amod
17	16	advmod
19	15	nn
19	17	amod
19	18	nn
EOX
Y	1
ROOT	0	0	21	1	S	0	0	21	4	S	1	0	8	2	NP	1	0	2	2	NN	0	0	1	1	Luciferase	0	0	1	0	NN	0	1	2	1	activity	1	1	2	0	VP	1	2	8	2	VBZ	0	2	3	1	is	2	2	3	0	VP	0	3	8	2	VBN	0	3	4	1	shown	3	3	4	0	PP	0	4	8	2	IN	0	4	5	1	in	4	4	5	0	NP	2	5	8	3	DT	0	5	6	1	the	5	5	6	0	JJ	0	6	7	1	left	6	6	7	0	NN	0	7	8	1	panel	7	7	8	0	CC	0	8	9	1	and	8	8	9	0	S	1	9	20	2	NP	1	9	11	2	NN	0	9	10	1	protein	9	9	10	0	NN	0	10	11	1	expression	10	10	11	0	VP	1	11	20	2	VBD	0	11	12	1	was	11	11	12	0	VP	0	12	20	2	VBN	0	12	13	1	verified	12	12	13	0	PP	0	13	20	2	IN	0	13	14	1	by	13	13	14	0	NP	3	14	20	4	NP	1	14	16	2	JJ	0	14	15	1	Western	14	14	15	0	NN	0	15	16	1	Blot	15	15	16	0	ADJP	1	16	18	2	RB	0	16	17	1	(	16	16	17	0	JJ	0	17	18	1	right	17	17	18	0	NN	0	18	19	1	panel	18	18	19	0	NN	0	19	20	1	)	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	5
****	13133	13137	NN	****	O	_	_
P	13138	13139	NN	p	O	_	_
=	13139	13140	JJ	=	O	_	_
0.0001	13140	13146	CD	0.0001	O	_	_
.	13146	13147	.	.	O	_	_
D	1
1
1	0	nn
1	3	num
3	2	quantmod
EOX
Y	1
ROOT	0	0	5	1	NP	0	0	5	3	NP	1	0	2	2	NN	0	0	1	1	****	0	0	1	0	NN	0	1	2	1	P	1	1	2	0	QP	1	2	4	2	JJ	0	2	3	1	=	2	2	3	0	CD	0	3	4	1	0.0001	3	3	4	0	.	0	4	5	1	.	4	4	5	0
EOS
T	22
To	13148	13150	TO	to	O	_	_
determine	13151	13160	VB	determine	O	_	_
the	13161	13164	DT	the	O	_	_
effect	13165	13171	NN	effect	O	_	_
of	13172	13174	IN	of	O	_	_
MAPK	13175	13179	NN	mapk	B-GENE	_	_
phosphorylation	13180	13195	NN	phosphorylation	O	_	_
on	13196	13198	IN	on	O	_	_
endogenous	13199	13209	JJ	endogenous	O	_	_
ASPP2	13210	13215	NN	aspp2	B-GENE	_	_
activity	13216	13224	NN	activity	O	_	_
,	13224	13225	,	,	O	_	_
cells	13226	13231	NNS	cell	O	_	_
were	13232	13236	VBD	be	O	_	_
treated	13237	13244	VBN	treat	O	_	_
with	13245	13249	IN	with	O	_	_
a	13250	13251	DT	a	O	_	_
MAPK	13252	13256	NN	mapk	B-GENE	_	_
inhibitor	13257	13266	NN	inhibitor	O	_	_
,	13266	13267	,	,	O	_	_
UO126	13268	13273	NN	uo126	O	_	_
.	13273	13274	.	.	O	_	_
D	1
14
1	0	aux
1	3	dobj
1	10	prep_on
3	2	det
3	6	prep_of
6	5	nn
10	8	amod
10	9	nn
14	1	advcl
14	12	nsubjpass
14	13	auxpass
14	18	prep_with
18	16	det
18	17	nn
18	20	appos
EOX
Y	1
ROOT	0	0	22	1	S	3	0	22	5	S	0	0	11	1	VP	1	0	11	2	TO	0	0	1	1	To	0	0	1	0	VP	0	1	11	3	VB	0	1	2	1	determine	1	1	2	0	NP	0	2	7	2	NP	1	2	4	2	DT	0	2	3	1	the	2	2	3	0	NN	0	3	4	1	effect	3	3	4	0	PP	0	4	7	2	IN	0	4	5	1	of	4	4	5	0	NP	1	5	7	2	NN	0	5	6	1	MAPK	5	5	6	0	NN	0	6	7	1	phosphorylation	6	6	7	0	PP	0	7	11	2	IN	0	7	8	1	on	7	7	8	0	NP	2	8	11	3	JJ	0	8	9	1	endogenous	8	8	9	0	NN	0	9	10	1	ASPP2	9	9	10	0	NN	0	10	11	1	activity	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	0	12	13	1	NNS	0	12	13	1	cells	12	12	13	0	VP	1	13	21	2	VBD	0	13	14	1	were	13	13	14	0	VP	0	14	21	2	VBN	0	14	15	1	treated	14	14	15	0	PP	0	15	21	2	IN	0	15	16	1	with	15	15	16	0	NP	0	16	21	3	NP	2	16	19	3	DT	0	16	17	1	a	16	16	17	0	NN	0	17	18	1	MAPK	17	17	18	0	NN	0	18	19	1	inhibitor	18	18	19	0	,	0	19	20	1	,	19	19	20	0	NP	0	20	21	1	NN	0	20	21	1	UO126	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	36
Inhibiting	13275	13285	VBG	inhibit	O	_	_
MAPK	13286	13290	NN	mapk	O	_	_
resulted	13291	13299	VBD	result	O	_	_
in	13300	13302	IN	in	O	_	_
a	13303	13304	DT	a	O	_	_
significant	13305	13316	JJ	significant	O	_	_
decrease	13317	13325	NN	decrease	O	_	_
in	13326	13328	IN	in	O	_	_
the	13329	13332	DT	the	O	_	_
ability	13333	13340	NN	ability	O	_	_
of	13341	13343	IN	of	O	_	_
ASPP2	13344	13349	NN	aspp2	B-GENE	_	_
to	13350	13352	TO	to	O	_	_
enhance	13353	13360	VB	enhance	O	_	_
the	13361	13364	DT	the	O	_	_
transcriptional	13365	13380	JJ	transcriptional	O	_	_
activity	13381	13389	NN	activity	O	_	_
of	13390	13392	IN	of	O	_	_
p53	13393	13396	NN	p53	B-GENE	_	_
compared	13397	13405	VBN	compare	O	_	_
to	13406	13408	TO	to	O	_	_
the	13409	13412	DT	the	O	_	_
control	13413	13420	NN	control	O	_	_
cells	13421	13426	NNS	cell	O	_	_
,	13438	13439	,	,	O	_	_
further	13440	13447	RB	further	O	_	_
validating	13448	13458	VBG	validate	O	_	_
the	13459	13462	DT	the	O	_	_
functional	13463	13473	JJ	functional	O	_	_
role	13474	13478	NN	role	O	_	_
of	13479	13481	IN	of	O	_	_
ASPP2	13482	13487	NN	aspp2	B-GENE	_	_
phosphorylation	13488	13503	NN	phosphorylation	O	_	_
by	13504	13506	IN	by	O	_	_
MAPK	13507	13511	NN	mapk	O	_	_
.	13511	13512	.	.	O	_	_
D	1
2
1	0	amod
2	1	nsubj
2	6	prep_in
2	13	xcomp
2	26	xcomp
6	4	det
6	5	amod
6	9	prep_in
9	8	det
9	11	prep_of
13	12	aux
13	16	dobj
13	20	prepc_compared_to
13	23	pobj
16	14	det
16	15	amod
16	18	prep_of
23	21	det
23	22	nn
26	25	advmod
26	29	dobj
26	34	prep_by
29	27	det
29	28	amod
29	32	prep_of
32	31	nn
EOX
Y	1
ROOT	0	0	36	1	S	1	0	36	3	NP	1	0	2	2	VBG	0	0	1	1	Inhibiting	0	0	1	0	NN	0	1	2	1	MAPK	1	1	2	0	VP	0	2	35	5	VBD	0	2	3	1	resulted	2	2	3	0	PP	0	3	12	2	IN	0	3	4	1	in	3	3	4	0	NP	0	4	12	2	NP	2	4	7	3	DT	0	4	5	1	a	4	4	5	0	JJ	0	5	6	1	significant	5	5	6	0	NN	0	6	7	1	decrease	6	6	7	0	PP	0	7	12	2	IN	0	7	8	1	in	7	7	8	0	NP	0	8	12	2	NP	1	8	10	2	DT	0	8	9	1	the	8	8	9	0	NN	0	9	10	1	ability	9	9	10	0	PP	0	10	12	2	IN	0	10	11	1	of	10	10	11	0	NP	0	11	12	1	NN	0	11	12	1	ASPP2	11	11	12	0	S	0	12	24	1	VP	1	12	24	2	TO	0	12	13	1	to	12	12	13	0	VP	0	13	24	3	VB	0	13	14	1	enhance	13	13	14	0	NP	0	14	19	2	NP	2	14	17	3	DT	0	14	15	1	the	14	14	15	0	JJ	0	15	16	1	transcriptional	15	15	16	0	NN	0	16	17	1	activity	16	16	17	0	PP	0	17	19	2	IN	0	17	18	1	of	17	17	18	0	NP	0	18	19	1	NN	0	18	19	1	p53	18	18	19	0	PP	0	19	24	2	VBN	0	19	20	1	compared	19	19	20	0	PP	0	20	24	2	TO	0	20	21	1	to	20	20	21	0	NP	2	21	24	3	DT	0	21	22	1	the	21	21	22	0	NN	0	22	23	1	control	22	22	23	0	NNS	0	23	24	1	cells	23	23	24	0	,	0	24	25	1	,	24	24	25	0	S	1	25	35	2	ADVP	0	25	26	1	RB	0	25	26	1	further	25	25	26	0	VP	0	26	35	3	VBG	0	26	27	1	validating	26	26	27	0	NP	0	27	33	2	NP	2	27	30	3	DT	0	27	28	1	the	27	27	28	0	ADJP	0	28	29	1	JJ	0	28	29	1	functional	28	28	29	0	NN	0	29	30	1	role	29	29	30	0	PP	0	30	33	2	IN	0	30	31	1	of	30	30	31	0	NP	1	31	33	2	NN	0	31	32	1	ASPP2	31	31	32	0	NN	0	32	33	1	phosphorylation	32	32	33	0	PP	0	33	35	2	IN	0	33	34	1	by	33	33	34	0	NP	0	34	35	1	NN	0	34	35	1	MAPK	34	34	35	0	.	0	35	36	1	.	35	35	36	0
EOS
T	18
Moreover	13513	13521	RB	moreover	O	_	_
,	13521	13522	,	,	O	_	_
another	13523	13530	DT	another	O	_	_
MAPK	13531	13535	NN	mapk	B-GENE	_	_
inhibitor	13536	13545	NN	inhibitor	O	_	_
,	13545	13546	,	,	O	_	_
PD	13547	13549	NN	pd	O	_	_
98059	13550	13555	CD	98059	O	_	_
,	13555	13556	,	,	O	_	_
also	13557	13561	RB	also	O	_	_
inhibited	13562	13571	VBD	inhibit	O	_	_
ASPP2	13572	13577	NN	aspp2	B-GENE	_	_
function	13578	13586	NN	function	O	_	_
to	13587	13589	TO	to	O	_	_
a	13590	13591	DT	a	O	_	_
similar	13592	13599	JJ	similar	O	_	_
extent	13600	13606	NN	extent	O	_	_
.	13618	13619	.	.	O	_	_
D	1
10
4	2	det
4	3	nn
4	6	appos
6	7	num
10	0	advmod
10	4	nsubj
10	9	advmod
10	12	dobj
10	16	prep_to
12	11	nn
16	14	det
16	15	amod
EOX
Y	1
ROOT	0	0	18	1	S	4	0	18	6	ADVP	0	0	1	1	RB	0	0	1	1	Moreover	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	0	2	9	4	NP	2	2	5	3	DT	0	2	3	1	another	2	2	3	0	NN	0	3	4	1	MAPK	3	3	4	0	NN	0	4	5	1	inhibitor	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	0	6	8	2	NN	0	6	7	1	PD	6	6	7	0	CD	0	7	8	1	98059	7	7	8	0	,	0	8	9	1	,	8	8	9	0	ADVP	0	9	10	1	RB	0	9	10	1	also	9	9	10	0	VP	0	10	17	3	VBD	0	10	11	1	inhibited	10	10	11	0	NP	1	11	13	2	NN	0	11	12	1	ASPP2	11	11	12	0	NN	0	12	13	1	function	12	12	13	0	PP	0	13	17	2	TO	0	13	14	1	to	13	13	14	0	NP	2	14	17	3	DT	0	14	15	1	a	14	14	15	0	JJ	0	15	16	1	similar	15	15	16	0	NN	0	16	17	1	extent	16	16	17	0	.	0	17	18	1	.	17	17	18	0
EOS
T	32
Interestingly	13620	13633	RB	interestingly	O	_	_
,	13633	13634	,	,	O	_	_
the	13635	13638	DT	the	O	_	_
endogenous	13639	13649	JJ	endogenous	B-GENE	_	_
ASPP2	13650	13655	NN	aspp2	I-GENE	_	_
protein	13656	13663	NN	protein	I-GENE	_	_
level	13664	13669	NN	level	O	_	_
was	13670	13673	VBD	be	O	_	_
slightly	13674	13682	RB	slightly	O	_	_
decreased	13683	13692	VBN	decrease	O	_	_
following	13693	13702	VBG	follow	O	_	_
RAS	13703	13706	NN	ra	B-GENE	_	_
/	13706	13707	:	/	B-GENE	_	_
MAPK	13707	13711	NN	mapk	I-GENE	_	_
pathway	13712	13719	NN	pathway	O	_	_
inhibition	13720	13730	NN	inhibition	O	_	_
by	13731	13733	IN	by	O	_	_
UO126	13734	13739	NN	uo126	O	_	_
treatment	13740	13749	NN	treatment	O	_	_
while	13775	13780	IN	while	O	_	_
RAS	13781	13784	NN	ra	B-GENE	_	_
/	13784	13785	:	/	B-GENE	_	_
MAPK	13785	13789	NN	mapk	I-GENE	_	_
pathway	13790	13797	NN	pathway	O	_	_
activation	13798	13808	NN	activation	O	_	_
resulted	13809	13817	VBD	result	O	_	_
in	13818	13820	IN	in	O	_	_
the	13821	13824	DT	the	O	_	_
increased	13825	13834	VBN	increase	O	_	_
ASPP2	13835	13840	NN	aspp2	B-GENE	_	_
expression	13841	13851	NN	expression	O	_	_
.	13875	13876	.	.	O	_	_
D	1
9
6	2	det
6	3	amod
6	4	nn
6	5	nn
9	0	advmod
9	6	nsubjpass
9	7	auxpass
9	8	advmod
9	11	prep_following
11	15	dep
11	25	rcmod
15	12	punct
15	13	nn
15	14	nn
15	18	prep_by
15	21	punct
18	17	nn
18	20	prep_while
24	22	nn
24	23	nn
25	24	nsubj
25	30	prep_in
30	27	det
30	28	amod
30	29	nn
EOX
Y	1
ROOT	0	0	32	1	S	3	0	32	5	ADVP	0	0	1	1	RB	0	0	1	1	Interestingly	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	4	2	7	5	DT	0	2	3	1	the	2	2	3	0	JJ	0	3	4	1	endogenous	3	3	4	0	NN	0	4	5	1	ASPP2	4	4	5	0	NN	0	5	6	1	protein	5	5	6	0	NN	0	6	7	1	level	6	6	7	0	VP	2	7	31	3	VBD	0	7	8	1	was	7	7	8	0	ADVP	0	8	9	1	RB	0	8	9	1	slightly	8	8	9	0	VP	0	9	31	2	VBN	0	9	10	1	decreased	9	9	10	0	PP	0	10	31	2	VBG	0	10	11	1	following	10	10	11	0	NP	0	11	31	2	NP	0	11	22	2	NP	0	11	12	1	NN	0	11	12	1	RAS	11	11	12	0	PRN	1	12	22	3	:	0	12	13	1	/	12	12	13	0	NP	0	13	21	2	NP	2	13	16	3	NN	0	13	14	1	MAPK	13	13	14	0	NN	0	14	15	1	pathway	14	14	15	0	NN	0	15	16	1	inhibition	15	15	16	0	PP	0	16	21	2	IN	0	16	17	1	by	16	16	17	0	NP	0	17	21	2	NP	1	17	19	2	NN	0	17	18	1	UO126	17	17	18	0	NN	0	18	19	1	treatment	18	18	19	0	PP	0	19	21	2	IN	0	19	20	1	while	19	19	20	0	NP	0	20	21	1	NN	0	20	21	1	RAS	20	20	21	0	:	0	21	22	1	/	21	21	22	0	SBAR	0	22	31	1	S	1	22	31	2	NP	2	22	25	3	NN	0	22	23	1	MAPK	22	22	23	0	NN	0	23	24	1	pathway	23	23	24	0	NN	0	24	25	1	activation	24	24	25	0	VP	0	25	31	2	VBD	0	25	26	1	resulted	25	25	26	0	PP	0	26	31	2	IN	0	26	27	1	in	26	26	27	0	NP	3	27	31	4	DT	0	27	28	1	the	27	27	28	0	VBN	0	28	29	1	increased	28	28	29	0	NN	0	29	30	1	ASPP2	29	29	30	0	NN	0	30	31	1	expression	30	30	31	0	.	0	31	32	1	.	31	31	32	0
EOS
T	26
The	13877	13880	DT	the	O	_	_
mRNA	13881	13885	NN	mrna	O	_	_
level	13886	13891	NN	level	O	_	_
of	13892	13894	IN	of	O	_	_
ASPP2	13895	13900	NN	aspp2	B-GENE	_	_
was	13901	13904	VBD	be	O	_	_
not	13905	13908	RB	not	O	_	_
affected	13909	13917	VBN	affect	O	_	_
upon	13918	13922	IN	upon	O	_	_
RAS	13923	13926	NN	ra	B-GENE	_	_
/	13926	13927	:	/	B-GENE	_	_
MAPK	13927	13931	NN	mapk	I-GENE	_	_
pathway	13932	13939	NN	pathway	O	_	_
activation	13940	13950	NN	activation	O	_	_
,	13963	13964	,	,	O	_	_
indicating	13965	13975	VBG	indicate	O	_	_
that	13976	13980	IN	that	O	_	_
the	13981	13984	DT	the	O	_	_
regulation	13985	13995	NN	regulation	O	_	_
is	13996	13998	VBZ	be	O	_	_
not	13999	14002	RB	not	O	_	_
at	14003	14005	IN	at	O	_	_
the	14006	14009	DT	the	O	_	_
transcriptional	14010	14025	JJ	transcriptional	O	_	_
level	14026	14031	NN	level	O	_	_
.	14031	14032	.	.	O	_	_
D	1
7
2	0	det
2	1	nn
2	4	prep_of
7	2	nsubjpass
7	5	auxpass
7	6	neg
7	15	prepc_upon
9	12	dep
9	13	dep
12	10	punct
12	11	nn
15	9	nsubj
15	19	ccomp
18	17	det
19	16	mark
19	18	nsubj
19	20	neg
19	24	prep_at
24	22	det
24	23	amod
EOX
Y	1
ROOT	0	0	26	1	S	1	0	26	3	NP	0	0	5	2	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	mRNA	1	1	2	0	NN	0	2	3	1	level	2	2	3	0	PP	0	3	5	2	IN	0	3	4	1	of	3	3	4	0	NP	0	4	5	1	NN	0	4	5	1	ASPP2	4	4	5	0	VP	2	5	25	3	VBD	0	5	6	1	was	5	5	6	0	RB	0	6	7	1	not	6	6	7	0	VP	0	7	25	2	VBN	0	7	8	1	affected	7	7	8	0	PP	0	8	25	2	IN	0	8	9	1	upon	8	8	9	0	S	1	9	25	2	NP	0	9	15	4	NP	0	9	10	1	NN	0	9	10	1	RAS	9	9	10	0	PRN	1	10	13	2	:	0	10	11	1	/	10	10	11	0	NP	1	11	13	2	NN	0	11	12	1	MAPK	11	11	12	0	NN	0	12	13	1	pathway	12	12	13	0	NP	0	13	14	1	NN	0	13	14	1	activation	13	13	14	0	,	0	14	15	1	,	14	14	15	0	VP	0	15	25	2	VBG	0	15	16	1	indicating	15	15	16	0	SBAR	1	16	25	2	IN	0	16	17	1	that	16	16	17	0	S	1	17	25	2	NP	1	17	19	2	DT	0	17	18	1	the	17	17	18	0	NN	0	18	19	1	regulation	18	18	19	0	VP	0	19	25	3	VBZ	0	19	20	1	is	19	19	20	0	RB	0	20	21	1	not	20	20	21	0	PP	0	21	25	2	IN	0	21	22	1	at	21	21	22	0	NP	2	22	25	3	DT	0	22	23	1	the	22	22	23	0	JJ	0	23	24	1	transcriptional	23	23	24	0	NN	0	24	25	1	level	24	24	25	0	.	0	25	26	1	.	25	25	26	0
EOS
T	19
Thus	14033	14037	RB	thus	O	_	_
we	14038	14040	PRP	we	O	_	_
investigated	14041	14053	VBD	investigate	O	_	_
whether	14054	14061	IN	whether	O	_	_
RAS	14062	14065	NNP	RAS	B-GENE	_	_
/	14065	14066	:	/	B-GENE	_	_
MAPK	14066	14070	NN	mapk	I-GENE	_	_
pathway	14071	14078	NN	pathway	O	_	_
activation	14079	14089	NN	activation	O	_	_
could	14090	14095	MD	could	O	_	_
result	14096	14102	VB	result	O	_	_
in	14103	14105	IN	in	O	_	_
the	14106	14109	DT	the	O	_	_
increased	14110	14119	VBN	increase	O	_	_
protein	14120	14127	NN	protein	O	_	_
stability	14128	14137	NN	stability	O	_	_
of	14138	14140	IN	of	O	_	_
ASPP2	14141	14146	NN	aspp2	B-GENE	_	_
.	14146	14147	.	.	O	_	_
D	1
2
2	0	advmod
2	1	nsubj
2	4	dep
4	3	mark
4	5	punct
4	10	dep
8	6	nn
8	7	nn
10	8	nsubj
10	9	aux
10	15	prep_in
15	12	det
15	13	amod
15	14	nn
15	17	prep_of
EOX
Y	1
ROOT	0	0	19	1	S	2	0	19	4	ADVP	0	0	1	1	RB	0	0	1	1	Thus	0	0	1	0	NP	0	1	2	1	PRP	0	1	2	1	we	1	1	2	0	VP	0	2	18	2	VBD	0	2	3	1	investigated	2	2	3	0	SBAR	1	3	18	2	IN	0	3	4	1	whether	3	3	4	0	FRAG	0	4	18	3	NP	0	4	5	1	NNP	0	4	5	1	RAS	4	4	5	0	:	0	5	6	1	/	5	5	6	0	S	1	6	18	2	NP	2	6	9	3	NN	0	6	7	1	MAPK	6	6	7	0	NN	0	7	8	1	pathway	7	7	8	0	NN	0	8	9	1	activation	8	8	9	0	VP	1	9	18	2	MD	0	9	10	1	could	9	9	10	0	VP	0	10	18	2	VB	0	10	11	1	result	10	10	11	0	PP	0	11	18	2	IN	0	11	12	1	in	11	11	12	0	NP	0	12	18	2	NP	3	12	16	4	DT	0	12	13	1	the	12	12	13	0	VBN	0	13	14	1	increased	13	13	14	0	NN	0	14	15	1	protein	14	14	15	0	NN	0	15	16	1	stability	15	15	16	0	PP	0	16	18	2	IN	0	16	17	1	of	16	16	17	0	NP	0	17	18	1	NN	0	17	18	1	ASPP2	17	17	18	0	.	0	18	19	1	.	18	18	19	0
EOS
T	21
The	14148	14151	DT	the	O	_	_
ASPP2	14152	14157	NN	aspp2	B-GENE	_	_
protein	14158	14165	NN	protein	I-GENE	_	_
levels	14166	14172	NNS	level	O	_	_
in	14173	14175	IN	in	O	_	_
the	14176	14179	DT	the	O	_	_
presence	14180	14188	NN	presence	O	_	_
or	14189	14191	CC	or	O	_	_
absence	14192	14199	NN	absence	O	_	_
of	14200	14202	IN	of	O	_	_
oncogenic	14203	14212	JJ	oncogenic	O	_	_
RAS	14213	14216	NN	ra	O	_	_
were	14217	14221	VBD	be	O	_	_
measured	14222	14230	VBN	measure	O	_	_
after	14231	14236	IN	after	O	_	_
cycloheximide	14237	14250	NN	cycloheximide	O	_	_
(	14251	14252	CD	(	O	_	_
CHX	14252	14255	NNP	CHX	O	_	_
)	14255	14256	CD	)	O	_	_
addition	14257	14265	NN	addition	O	_	_
.	14284	14285	.	.	O	_	_
D	1
13
3	0	det
3	1	nn
3	2	nn
3	6	prep_in
3	8	prep_in
6	5	det
6	8	conj_or
6	11	prep_of
11	10	amod
13	3	nsubjpass
13	12	auxpass
13	17	prep_after
17	15	nn
17	16	num
17	19	dep
19	18	num
EOX
Y	1
ROOT	0	0	21	1	S	1	0	21	3	NP	0	0	12	2	NP	3	0	4	4	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	ASPP2	1	1	2	0	NN	0	2	3	1	protein	2	2	3	0	NNS	0	3	4	1	levels	3	3	4	0	PP	0	4	12	2	IN	0	4	5	1	in	4	4	5	0	NP	0	5	12	2	NP	1	5	9	4	DT	0	5	6	1	the	5	5	6	0	NN	0	6	7	1	presence	6	6	7	0	CC	0	7	8	1	or	7	7	8	0	NN	0	8	9	1	absence	8	8	9	0	PP	0	9	12	2	IN	0	9	10	1	of	9	9	10	0	NP	1	10	12	2	JJ	0	10	11	1	oncogenic	10	10	11	0	NN	0	11	12	1	RAS	11	11	12	0	VP	1	12	20	2	VBD	0	12	13	1	were	12	12	13	0	VP	0	13	20	2	VBN	0	13	14	1	measured	13	13	14	0	PP	0	14	20	2	IN	0	14	15	1	after	14	14	15	0	NP	0	15	20	2	NP	2	15	18	3	NN	0	15	16	1	cycloheximide	15	15	16	0	CD	0	16	17	1	(	16	16	17	0	NNP	0	17	18	1	CHX	17	17	18	0	NP	1	18	20	2	CD	0	18	19	1	)	18	18	19	0	NN	0	19	20	1	addition	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	49
ASPP2	14286	14291	NN	aspp2	B-GENE	_	_
was	14292	14295	VBD	be	O	_	_
a	14296	14297	DT	a	O	_	_
bit	14298	14301	NN	bit	O	_	_
more	14302	14306	RBR	more	O	_	_
s	14307	14308	NNS	s	O	_	_
oncogenic	14319	14328	JJ	oncogenic	O	_	_
RAS	14329	14332	NN	ra	O	_	_
is	14333	14335	VBZ	be	O	_	_
induced	14336	14343	VBN	induce	O	_	_
in	14344	14346	IN	in	O	_	_
HKe3	14347	14351	NN	hke3	B-GENE	_	_
ER	14352	14354	NN	er	I-GENE	_	_
:	14354	14355	:	:	O	_	_
HRASV12	14355	14362	NN	hrasv12	O	_	_
cells	14363	14368	NNS	cell	O	_	_
or	14382	14384	CC	or	O	_	_
co	14385	14387	NN	co	O	_	_
transfected	14388	14399	VBN	transfect	O	_	_
in	14400	14402	IN	in	O	_	_
Saos2	14403	14408	NN	saos2	O	_	_
cells	14409	14414	NNS	cell	O	_	_
:	14427	14428	:	:	O	_	_
ASPP2	14429	14434	NN	aspp2	B-GENE	_	_
levels	14435	14441	NNS	level	O	_	_
were	14442	14446	VBD	be	O	_	_
considerably	14447	14459	RB	considerably	O	_	_
decreased	14460	14469	VBN	decrease	O	_	_
without	14470	14477	IN	without	O	_	_
oncogenic	14478	14487	JJ	oncogenic	O	_	_
RAS	14488	14491	NN	ra	O	_	_
,	14491	14492	,	,	O	_	_
while	14493	14498	IN	while	O	_	_
in	14499	14501	IN	in	O	_	_
the	14502	14505	DT	the	O	_	_
presence	14506	14514	NN	presence	O	_	_
of	14515	14517	IN	of	O	_	_
HRAS	14518	14522	NNP	HRAS	B-GENE	_	_
V12	14523	14526	NNP	V12	I-GENE	_	_
,	14526	14527	,	,	O	_	_
ASPP2	14528	14533	NN	aspp2	B-GENE	_	_
protein	14534	14541	NN	protein	I-GENE	_	_
levels	14542	14548	NNS	level	O	_	_
remained	14549	14557	VBD	remain	O	_	_
high	14558	14562	JJ	high	O	_	_
after	14563	14568	IN	after	O	_	_
CHX	14569	14572	NN	chx	O	_	_
treatment	14573	14582	NN	treatment	O	_	_
.	14582	14583	.	.	O	_	_
D	1
5
3	2	det
4	3	npadvmod
5	0	nsubj
5	1	cop
5	4	advmod
5	9	rcmod
5	18	parataxis
5	27	parataxis
7	6	amod
9	7	nsubjpass
9	8	auxpass
9	12	prep_in
12	11	nn
15	14	nn
15	17	conj_or
18	15	nsubj
18	17	nsubj
18	21	prep_in
21	20	nn
24	23	nn
27	24	nsubjpass
27	25	auxpass
27	26	advmod
27	30	prep_without
27	44	advcl
30	29	amod
35	34	det
35	38	prep_of
38	37	nn
42	40	nn
42	41	nn
44	32	mark
44	35	prep_in
44	42	nsubj
44	43	cop
44	47	prep_after
47	46	nn
EOX
Y	1
ROOT	0	0	49	1	S	0	0	49	6	S	1	0	13	2	NP	0	0	1	1	NN	0	0	1	1	ASPP2	0	0	1	0	VP	2	1	13	3	VBD	0	1	2	1	was	1	1	2	0	ADVP	1	2	5	2	NP	1	2	4	2	DT	0	2	3	1	a	2	2	3	0	NN	0	3	4	1	bit	3	3	4	0	RBR	0	4	5	1	more	4	4	5	0	NP	0	5	13	2	NP	0	5	6	1	NNS	0	5	6	1	s	5	5	6	0	SBAR	0	6	13	1	S	1	6	13	2	NP	1	6	8	2	JJ	0	6	7	1	oncogenic	6	6	7	0	NN	0	7	8	1	RAS	7	7	8	0	VP	1	8	13	2	VBZ	0	8	9	1	is	8	8	9	0	VP	0	9	13	2	VBN	0	9	10	1	induced	9	9	10	0	PP	0	10	13	2	IN	0	10	11	1	in	10	10	11	0	NP	1	11	13	2	NN	0	11	12	1	HKe3	11	11	12	0	NN	0	12	13	1	ER	12	12	13	0	:	0	13	14	1	:	13	13	14	0	S	1	14	22	2	NP	1	14	18	4	NN	0	14	15	1	HRASV12	14	14	15	0	NNS	0	15	16	1	cells	15	15	16	0	CC	0	16	17	1	or	16	16	17	0	NN	0	17	18	1	co	17	17	18	0	VP	0	18	22	2	VBN	0	18	19	1	transfected	18	18	19	0	PP	0	19	22	2	IN	0	19	20	1	in	19	19	20	0	NP	1	20	22	2	NN	0	20	21	1	Saos2	20	20	21	0	NNS	0	21	22	1	cells	21	21	22	0	:	0	22	23	1	:	22	22	23	0	S	1	23	48	2	NP	1	23	25	2	NN	0	23	24	1	ASPP2	23	23	24	0	NNS	0	24	25	1	levels	24	24	25	0	VP	1	25	48	2	VBD	0	25	26	1	were	25	25	26	0	VP	1	26	48	5	ADVP	0	26	27	1	RB	0	26	27	1	considerably	26	26	27	0	VBN	0	27	28	1	decreased	27	27	28	0	PP	0	28	31	2	IN	0	28	29	1	without	28	28	29	0	NP	1	29	31	2	JJ	0	29	30	1	oncogenic	29	29	30	0	NN	0	30	31	1	RAS	30	30	31	0	,	0	31	32	1	,	31	31	32	0	SBAR	1	32	48	2	IN	0	32	33	1	while	32	32	33	0	S	3	33	48	4	PP	0	33	39	2	IN	0	33	34	1	in	33	33	34	0	NP	0	34	39	2	NP	1	34	36	2	DT	0	34	35	1	the	34	34	35	0	NN	0	35	36	1	presence	35	35	36	0	PP	0	36	39	2	IN	0	36	37	1	of	36	36	37	0	NP	1	37	39	2	NNP	0	37	38	1	HRAS	37	37	38	0	NNP	0	38	39	1	V12	38	38	39	0	,	0	39	40	1	,	39	39	40	0	NP	2	40	43	3	NN	0	40	41	1	ASPP2	40	40	41	0	NN	0	41	42	1	protein	41	41	42	0	NNS	0	42	43	1	levels	42	42	43	0	VP	1	43	48	3	VBD	0	43	44	1	remained	43	43	44	0	ADJP	0	44	45	1	JJ	0	44	45	1	high	44	44	45	0	PP	0	45	48	2	IN	0	45	46	1	after	45	45	46	0	NP	1	46	48	2	NN	0	46	47	1	CHX	46	46	47	0	NN	0	47	48	1	treatment	47	47	48	0	.	0	48	49	1	.	48	48	49	0
EOS
T	29
These	14584	14589	DT	these	O	_	_
data	14590	14594	NNS	datum	O	_	_
indicate	14595	14603	VBP	indicate	O	_	_
that	14604	14608	IN	that	O	_	_
ASPP2	14609	14614	NN	aspp2	B-GENE	_	_
phosphorylation	14615	14630	NN	phosphorylation	O	_	_
by	14631	14633	IN	by	O	_	_
RAS	14634	14637	NN	ra	B-GENE	_	_
/	14637	14638	:	/	B-GENE	_	_
MAPK	14638	14642	NN	mapk	I-GENE	_	_
is	14643	14645	VBZ	be	O	_	_
necessary	14646	14655	JJ	necessary	O	_	_
for	14656	14659	IN	for	O	_	_
ASPP2	14660	14665	NN	aspp2	B-GENE	_	_
full	14666	14670	JJ	full	O	_	_
pro-apoptotic	14671	14684	JJ	pro-apoptotic	O	_	_
activity	14685	14693	NN	activity	O	_	_
and	14694	14697	CC	and	O	_	_
this	14698	14702	DT	this	O	_	_
may	14703	14706	MD	may	O	_	_
be	14707	14709	VB	be	O	_	_
mediated	14710	14718	VBN	mediate	O	_	_
by	14719	14721	IN	by	O	_	_
the	14722	14725	DT	the	O	_	_
stabilization	14726	14739	NN	stabilization	O	_	_
of	14740	14742	IN	of	O	_	_
ASPP2	14743	14748	NN	aspp2	B-GENE	_	_
protein	14749	14756	NN	protein	I-GENE	_	_
.	14756	14757	.	.	O	_	_
D	1
2
1	0	det
2	1	nsubj
2	21	ccomp
5	4	nn
5	7	prep_by
5	11	dep
11	8	punct
11	9	nsubj
11	10	cop
11	16	prep_for
11	18	prep_for
16	13	nn
16	14	amod
16	15	amod
16	18	conj_and
21	3	mark
21	5	nsubjpass
21	19	aux
21	20	auxpass
21	24	agent
24	23	det
24	27	prep_of
27	26	nn
EOX
Y	1
ROOT	0	0	29	1	S	1	0	29	3	NP	1	0	2	2	DT	0	0	1	1	These	0	0	1	0	NNS	0	1	2	1	data	1	1	2	0	VP	0	2	28	2	VBP	0	2	3	1	indicate	2	2	3	0	SBAR	1	3	28	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	28	2	NP	0	4	19	2	NP	0	4	8	2	NP	1	4	6	2	NN	0	4	5	1	ASPP2	4	4	5	0	NN	0	5	6	1	phosphorylation	5	5	6	0	PP	0	6	8	2	IN	0	6	7	1	by	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	RAS	7	7	8	0	PRN	1	8	19	2	:	0	8	9	1	/	8	8	9	0	S	1	9	19	2	NP	0	9	10	1	NN	0	9	10	1	MAPK	9	9	10	0	VP	1	10	19	2	VBZ	0	10	11	1	is	10	10	11	0	ADJP	0	11	19	2	JJ	0	11	12	1	necessary	11	11	12	0	PP	0	12	19	2	IN	0	12	13	1	for	12	12	13	0	NP	0	13	19	3	NP	3	13	17	4	NN	0	13	14	1	ASPP2	13	13	14	0	JJ	0	14	15	1	full	14	14	15	0	JJ	0	15	16	1	pro-apoptotic	15	15	16	0	NN	0	16	17	1	activity	16	16	17	0	CC	0	17	18	1	and	17	17	18	0	NP	0	18	19	1	DT	0	18	19	1	this	18	18	19	0	VP	1	19	28	2	MD	0	19	20	1	may	19	19	20	0	VP	1	20	28	2	VB	0	20	21	1	be	20	20	21	0	VP	0	21	28	2	VBN	0	21	22	1	mediated	21	21	22	0	PP	0	22	28	2	IN	0	22	23	1	by	22	22	23	0	NP	0	23	28	2	NP	1	23	25	2	DT	0	23	24	1	the	23	23	24	0	NN	0	24	25	1	stabilization	24	24	25	0	PP	0	25	28	2	IN	0	25	26	1	of	25	25	26	0	NP	1	26	28	2	NN	0	26	27	1	ASPP2	26	26	27	0	NN	0	27	28	1	protein	27	27	28	0	.	0	28	29	1	.	28	28	29	0
EOS
T	36
Ser827	14758	14764	NN	ser827	O	_	_
phosphorylation	14765	14780	NN	phosphorylation	O	_	_
is	14781	14783	VBZ	be	O	_	_
required	14784	14792	VBN	require	O	_	_
for	14793	14796	IN	for	O	_	_
RAS	14797	14800	NN	ra	B-GENE	_	_
induced	14801	14808	VBD	induce	O	_	_
translocation	14809	14822	NN	translocation	O	_	_
of	14823	14825	IN	of	O	_	_
ASPP2	14826	14831	NN	aspp2	B-GENE	_	_
It	14832	14834	PRP	it	O	_	_
has	14835	14838	VBZ	have	O	_	_
recently	14839	14847	RB	recently	O	_	_
been	14848	14852	VBN	be	O	_	_
shown	14853	14858	VBN	show	O	_	_
that	14859	14863	IN	that	O	_	_
activation	14864	14874	NN	activation	O	_	_
of	14875	14877	IN	of	O	_	_
RAS	14878	14881	NN	ra	O	_	_
results	14882	14889	VBZ	result	O	_	_
in	14890	14892	IN	in	O	_	_
ASPP2	14893	14898	NN	aspp2	B-GENE	_	_
translocation	14899	14912	NN	translocation	O	_	_
from	14913	14917	IN	from	O	_	_
the	14918	14921	DT	the	O	_	_
plasma	14922	14928	NN	plasma	O	_	_
membrane	14929	14937	NN	membrane	O	_	_
to	14938	14940	TO	to	O	_	_
the	14941	14944	DT	the	O	_	_
cytosol	14945	14952	NN	cytosol	O	_	_
and	14953	14956	CC	and	O	_	_
nucleus	14957	14964	NN	nucleus	O	_	_
[	14965	14966	NN	[	O	_	_
2	14966	14967	CD	2	O	_	_
]	14967	14968	NN	]	O	_	_
.	14968	14969	.	.	O	_	_
D	1
6
1	0	nn
3	1	nsubjpass
3	2	auxpass
3	5	prep_for
6	3	dep
6	7	dobj
6	26	prep_from
6	32	prep_to
6	34	nsubj
7	9	prep_of
7	14	rcmod
14	10	nsubjpass
14	11	aux
14	12	advmod
14	13	auxpass
14	19	ccomp
16	18	prep_of
19	15	mark
19	16	nsubj
19	22	prep_in
22	21	nn
26	24	det
26	25	nn
29	31	conj_and
32	28	det
32	29	nn
32	31	nn
34	33	num
EOX
Y	1
ROOT	0	0	36	1	SINV	1	0	36	4	S	1	0	6	2	NP	1	0	2	2	NN	0	0	1	1	Ser827	0	0	1	0	NN	0	1	2	1	phosphorylation	1	1	2	0	VP	1	2	6	2	VBZ	0	2	3	1	is	2	2	3	0	VP	0	3	6	2	VBN	0	3	4	1	required	3	3	4	0	PP	0	4	6	2	IN	0	4	5	1	for	4	4	5	0	NP	0	5	6	1	NN	0	5	6	1	RAS	5	5	6	0	VP	0	6	33	4	VBD	0	6	7	1	induced	6	6	7	0	NP	0	7	23	3	NP	0	7	8	1	NN	0	7	8	1	translocation	7	7	8	0	PP	0	8	10	2	IN	0	8	9	1	of	8	8	9	0	NP	0	9	10	1	NN	0	9	10	1	ASPP2	9	9	10	0	SBAR	0	10	23	1	S	1	10	23	2	NP	0	10	11	1	PRP	0	10	11	1	It	10	10	11	0	VP	2	11	23	3	VBZ	0	11	12	1	has	11	11	12	0	ADVP	0	12	13	1	RB	0	12	13	1	recently	12	12	13	0	VP	1	13	23	2	VBN	0	13	14	1	been	13	13	14	0	VP	0	14	23	2	VBN	0	14	15	1	shown	14	14	15	0	SBAR	1	15	23	2	IN	0	15	16	1	that	15	15	16	0	S	1	16	23	2	NP	0	16	19	2	NP	0	16	17	1	NN	0	16	17	1	activation	16	16	17	0	PP	0	17	19	2	IN	0	17	18	1	of	17	17	18	0	NP	0	18	19	1	NN	0	18	19	1	RAS	18	18	19	0	VP	0	19	23	2	VBZ	0	19	20	1	results	19	19	20	0	PP	0	20	23	2	IN	0	20	21	1	in	20	20	21	0	NP	1	21	23	2	NN	0	21	22	1	ASPP2	21	21	22	0	NN	0	22	23	1	translocation	22	22	23	0	PP	0	23	27	2	IN	0	23	24	1	from	23	23	24	0	NP	2	24	27	3	DT	0	24	25	1	the	24	24	25	0	NN	0	25	26	1	plasma	25	25	26	0	NN	0	26	27	1	membrane	26	26	27	0	PP	0	27	33	2	TO	0	27	28	1	to	27	27	28	0	NP	2	28	33	3	DT	0	28	29	1	the	28	28	29	0	NP	0	29	32	3	NN	0	29	30	1	cytosol	29	29	30	0	CC	0	30	31	1	and	30	30	31	0	NN	0	31	32	1	nucleus	31	31	32	0	NN	0	32	33	1	[	32	32	33	0	NP	1	33	35	2	CD	0	33	34	1	2	33	33	34	0	NN	0	34	35	1	]	34	34	35	0	.	0	35	36	1	.	35	35	36	0
EOS
T	16
We	14970	14972	PRP	we	O	_	_
therefore	14973	14982	RB	therefore	O	_	_
tested	14983	14989	VBD	test	O	_	_
whether	14990	14997	IN	whether	O	_	_
MAPK	14998	15002	NN	mapk	B-GENE	_	_
phosphorylation	15003	15018	NN	phosphorylation	O	_	_
at	15019	15021	IN	at	O	_	_
Ser827	15022	15028	NN	ser827	O	_	_
could	15029	15034	MD	could	O	_	_
affect	15035	15041	VB	affect	O	_	_
the	15042	15045	DT	the	O	_	_
cellular	15046	15054	JJ	cellular	O	_	_
localization	15055	15067	NN	localization	O	_	_
of	15068	15070	IN	of	O	_	_
ASPP2	15071	15076	NN	aspp2	B-GENE	_	_
.	15076	15077	.	.	O	_	_
D	1
2
2	0	nsubj
2	1	advmod
2	9	ccomp
5	4	nn
5	7	prep_at
9	3	mark
9	5	nsubj
9	8	aux
9	12	dobj
12	10	det
12	11	amod
12	14	prep_of
EOX
Y	1
ROOT	0	0	16	1	S	2	0	16	4	NP	0	0	1	1	PRP	0	0	1	1	We	0	0	1	0	ADVP	0	1	2	1	RB	0	1	2	1	therefore	1	1	2	0	VP	0	2	15	2	VBD	0	2	3	1	tested	2	2	3	0	SBAR	1	3	15	2	IN	0	3	4	1	whether	3	3	4	0	S	1	4	15	2	NP	0	4	8	2	NP	1	4	6	2	NN	0	4	5	1	MAPK	4	4	5	0	NN	0	5	6	1	phosphorylation	5	5	6	0	PP	0	6	8	2	IN	0	6	7	1	at	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	Ser827	7	7	8	0	VP	1	8	15	2	MD	0	8	9	1	could	8	8	9	0	VP	0	9	15	2	VB	0	9	10	1	affect	9	9	10	0	NP	0	10	15	2	NP	2	10	13	3	DT	0	10	11	1	the	10	10	11	0	JJ	0	11	12	1	cellular	11	11	12	0	NN	0	12	13	1	localization	12	12	13	0	PP	0	13	15	2	IN	0	13	14	1	of	13	13	14	0	NP	0	14	15	1	NN	0	14	15	1	ASPP2	14	14	15	0	.	0	15	16	1	.	15	15	16	0
EOS
T	34
Interestingly	15078	15091	RB	interestingly	O	_	_
,	15091	15092	,	,	O	_	_
we	15093	15095	PRP	we	O	_	_
observed	15096	15104	VBD	observe	O	_	_
that	15105	15109	IN	that	O	_	_
in	15110	15112	IN	in	O	_	_
contrast	15113	15121	NN	contrast	O	_	_
to	15122	15124	TO	to	O	_	_
wild	15125	15129	JJ	wild	B-GENE	_	_
type	15130	15134	NN	type	I-GENE	_	_
ASPP2	15135	15140	NN	aspp2	I-GENE	_	_
,	15140	15141	,	,	O	_	_
ASPP2	15142	15147	NN	aspp2	B-GENE	_	_
(	15148	15149	CD	(	I-GENE	_	_
S827A	15149	15154	NN	s827a	I-GENE	_	_
)	15154	15155	NN	)	I-GENE	_	_
remains	15156	15163	VBZ	remain	O	_	_
at	15164	15166	IN	at	O	_	_
the	15167	15170	DT	the	O	_	_
plasma	15171	15177	NN	plasma	O	_	_
membrane	15178	15186	NN	membrane	O	_	_
following	15187	15196	VBG	follow	O	_	_
RAS	15197	15200	NN	ra	O	_	_
activation	15201	15211	NN	activation	O	_	_
by	15212	15214	IN	by	O	_	_
4-OHT	15215	15220	NN	4-oht	O	_	_
in	15221	15223	IN	in	O	_	_
the	15224	15227	DT	the	O	_	_
HKe3	15228	15232	NN	hke3	B-GENE	_	_
ER	15233	15235	NN	er	I-GENE	_	_
:	15235	15236	:	:	O	_	_
HRASV12	15236	15243	NN	hrasv12	O	_	_
system	15244	15250	NN	system	O	_	_
.	15262	15263	.	.	O	_	_
D	1
3
3	0	advmod
3	2	nsubj
3	16	ccomp
6	9	prep_to
9	8	amod
15	10	nn
15	12	dep
15	13	num
15	14	nn
16	4	mark
16	6	prep_in
16	15	nsubj
16	20	prep_at
20	18	det
20	19	nn
20	23	prep_following
23	22	nn
23	25	prep_by
25	29	prep_in
25	32	dep
29	27	det
29	28	nn
32	31	nn
EOX
Y	1
ROOT	0	0	34	1	S	3	0	34	5	ADVP	0	0	1	1	RB	0	0	1	1	Interestingly	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	0	2	3	1	PRP	0	2	3	1	we	2	2	3	0	VP	0	3	33	2	VBD	0	3	4	1	observed	3	3	4	0	SBAR	1	4	33	2	IN	0	4	5	1	that	4	4	5	0	S	2	5	33	3	PP	0	5	10	2	IN	0	5	6	1	in	5	5	6	0	NP	0	6	10	2	NP	0	6	7	1	NN	0	6	7	1	contrast	6	6	7	0	PP	0	7	10	2	TO	0	7	8	1	to	7	7	8	0	NP	1	8	10	2	JJ	0	8	9	1	wild	8	8	9	0	NN	0	9	10	1	type	9	9	10	0	NP	5	10	16	6	NN	0	10	11	1	ASPP2	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NN	0	12	13	1	ASPP2	12	12	13	0	CD	0	13	14	1	(	13	13	14	0	NN	0	14	15	1	S827A	14	14	15	0	NN	0	15	16	1	)	15	15	16	0	VP	0	16	33	2	VBZ	0	16	17	1	remains	16	16	17	0	PP	0	17	33	2	IN	0	17	18	1	at	17	17	18	0	NP	0	18	33	2	NP	2	18	21	3	DT	0	18	19	1	the	18	18	19	0	NN	0	19	20	1	plasma	19	19	20	0	NN	0	20	21	1	membrane	20	20	21	0	PP	0	21	33	2	VBG	0	21	22	1	following	21	21	22	0	NP	0	22	33	2	NP	1	22	24	2	NN	0	22	23	1	RAS	22	22	23	0	NN	0	23	24	1	activation	23	23	24	0	PP	0	24	33	2	IN	0	24	25	1	by	24	24	25	0	NP	0	25	33	3	NP	0	25	30	2	NP	0	25	26	1	NN	0	25	26	1	4-OHT	25	25	26	0	PP	0	26	30	2	IN	0	26	27	1	in	26	26	27	0	NP	2	27	30	3	DT	0	27	28	1	the	27	27	28	0	NN	0	28	29	1	HKe3	28	28	29	0	NN	0	29	30	1	ER	29	29	30	0	:	0	30	31	1	:	30	30	31	0	NP	1	31	33	2	NN	0	31	32	1	HRASV12	31	31	32	0	NN	0	32	33	1	system	32	32	33	0	.	0	33	34	1	.	33	33	34	0
EOS
T	35
This	15264	15268	DT	this	O	_	_
suggests	15269	15277	VBZ	suggest	O	_	_
that	15278	15282	IN	that	O	_	_
ASPP2	15283	15288	NN	aspp2	B-GENE	_	_
binding	15289	15296	NN	binding	O	_	_
to	15297	15299	TO	to	O	_	_
RAS	15300	15303	NN	ra	B-GENE	_	_
at	15304	15306	IN	at	O	_	_
the	15307	15310	DT	the	O	_	_
plasma	15311	15317	NN	plasma	O	_	_
membrane	15318	15326	NN	membrane	O	_	_
occurs	15327	15333	VBZ	occur	O	_	_
prior	15334	15339	RB	prior	O	_	_
to	15340	15342	TO	to	O	_	_
MAPK	15343	15347	NN	mapk	B-GENE	_	_
phosphorylation	15348	15363	NN	phosphorylation	O	_	_
of	15364	15366	IN	of	O	_	_
ASPP2	15367	15372	NN	aspp2	B-GENE	_	_
and	15373	15376	CC	and	O	_	_
that	15377	15381	IN	that	O	_	_
Ser	15382	15385	NN	ser	O	_	_
827	15386	15389	CD	827	O	_	_
phosphorylation	15390	15405	NN	phosphorylation	O	_	_
is	15406	15408	VBZ	be	O	_	_
required	15409	15417	VBN	require	O	_	_
for	15418	15421	IN	for	O	_	_
RAS	15422	15425	NN	ra	B-GENE	_	_
induced	15426	15433	VBD	induce	O	_	_
translocation	15434	15447	NN	translocation	O	_	_
of	15448	15450	IN	of	O	_	_
ASPP2	15451	15456	NN	aspp2	B-GENE	_	_
to	15457	15459	TO	to	O	_	_
the	15460	15463	DT	the	O	_	_
cytosol	15464	15471	NN	cytosol	O	_	_
.	15471	15472	.	.	O	_	_
D	1
1
1	0	nsubj
1	11	ccomp
1	27	ccomp
4	3	nn
4	6	prep_to
6	10	prep_at
10	8	det
10	9	nn
11	2	mark
11	4	nsubj
11	15	prep_prior_to
11	27	conj_and
15	14	nn
15	17	prep_of
20	24	rcmod
22	21	num
24	22	nsubjpass
24	23	auxpass
24	26	prep_for
27	19	mark
27	20	nsubj
27	28	dobj
27	33	prep_to
28	30	prep_of
33	32	det
EOX
Y	1
ROOT	0	0	35	1	S	1	0	35	3	NP	0	0	1	1	DT	0	0	1	1	This	0	0	1	0	VP	0	1	34	2	VBZ	0	1	2	1	suggests	1	1	2	0	SBAR	0	2	34	3	SBAR	1	2	18	2	IN	0	2	3	1	that	2	2	3	0	S	1	3	18	2	NP	0	3	11	2	NP	1	3	5	2	NN	0	3	4	1	ASPP2	3	3	4	0	NN	0	4	5	1	binding	4	4	5	0	PP	0	5	11	2	TO	0	5	6	1	to	5	5	6	0	NP	0	6	11	2	NP	0	6	7	1	NN	0	6	7	1	RAS	6	6	7	0	PP	0	7	11	2	IN	0	7	8	1	at	7	7	8	0	NP	2	8	11	3	DT	0	8	9	1	the	8	8	9	0	NN	0	9	10	1	plasma	9	9	10	0	NN	0	10	11	1	membrane	10	10	11	0	VP	0	11	18	2	VBZ	0	11	12	1	occurs	11	11	12	0	PP	1	12	18	2	RB	0	12	13	1	prior	12	12	13	0	PP	0	13	18	2	TO	0	13	14	1	to	13	13	14	0	NP	0	14	18	2	NP	1	14	16	2	NN	0	14	15	1	MAPK	14	14	15	0	NN	0	15	16	1	phosphorylation	15	15	16	0	PP	0	16	18	2	IN	0	16	17	1	of	16	16	17	0	NP	0	17	18	1	NN	0	17	18	1	ASPP2	17	17	18	0	CC	0	18	19	1	and	18	18	19	0	SBAR	1	19	34	2	IN	0	19	20	1	that	19	19	20	0	S	1	20	34	2	NP	0	20	27	2	NP	0	20	21	1	NN	0	20	21	1	Ser	20	20	21	0	SBAR	0	21	27	1	S	1	21	27	2	NP	1	21	23	2	CD	0	21	22	1	827	21	21	22	0	NN	0	22	23	1	phosphorylation	22	22	23	0	VP	1	23	27	2	VBZ	0	23	24	1	is	23	23	24	0	VP	0	24	27	2	VBN	0	24	25	1	required	24	24	25	0	PP	0	25	27	2	IN	0	25	26	1	for	25	25	26	0	NP	0	26	27	1	NN	0	26	27	1	RAS	26	26	27	0	VP	0	27	34	3	VBD	0	27	28	1	induced	27	27	28	0	NP	0	28	31	2	NP	0	28	29	1	NN	0	28	29	1	translocation	28	28	29	0	PP	0	29	31	2	IN	0	29	30	1	of	29	29	30	0	NP	0	30	31	1	NN	0	30	31	1	ASPP2	30	30	31	0	PP	0	31	34	2	TO	0	31	32	1	to	31	31	32	0	NP	1	32	34	2	DT	0	32	33	1	the	32	32	33	0	NN	0	33	34	1	cytosol	33	33	34	0	.	0	34	35	1	.	34	34	35	0
EOS
T	5
10.1371	15473	15480	CD	10.1371	O	_	_
/	15480	15481	:	/	O	_	_
journal.pone	15481	15493	NN	journal.pone	O	_	_
.0082022	15493	15501	CD	.0082022	O	_	_
.	15501	15502	.	.	O	_	_
D	1
0
0	1	punct
0	2	dep
2	3	dep
EOX
Y	1
ROOT	0	0	5	1	FRAG	0	0	5	4	NP	0	0	1	1	CD	0	0	1	1	10.1371	0	0	1	0	:	0	1	2	1	/	1	1	2	0	FRAG	0	2	4	2	NP	0	2	3	1	NN	0	2	3	1	journal.pone	2	2	3	0	NP	0	3	4	1	CD	0	3	4	1	.0082022	3	3	4	0	.	0	4	5	1	.	4	4	5	0
EOS
T	32
g004	15502	15506	NN	g004	B-GENE	_	_
Wild-type	15516	15525	JJ	wild-type	I-GENE	_	_
ASPP2	15526	15531	NN	aspp2	I-GENE	_	_
,	15531	15532	,	,	O	_	_
but	15533	15536	CC	but	O	_	_
not	15537	15540	RB	not	O	_	_
mutant	15541	15547	JJ	mutant	O	_	_
ASPP2	15548	15553	NN	aspp2	O	_	_
(	15554	15555	CD	(	O	_	_
S827A	15555	15560	NN	s827a	O	_	_
)	15560	15561	NN	)	O	_	_
,	15561	15562	,	,	O	_	_
translocates	15563	15575	VBZ	translocate	O	_	_
to	15576	15578	TO	to	O	_	_
the	15579	15582	DT	the	O	_	_
cytosol	15583	15590	NN	cytosol	O	_	_
and	15591	15594	CC	and	O	_	_
nucleus	15595	15602	NN	nucleus	O	_	_
upon	15603	15607	IN	upon	O	_	_
oncogenic	15608	15617	JJ	oncogenic	O	_	_
RAS	15618	15621	NN	ra	B-GENE	_	_
activation	15622	15632	NN	activation	O	_	_
and	15633	15636	CC	and	O	_	_
this	15637	15641	DT	this	O	_	_
results	15642	15649	VBZ	result	O	_	_
in	15650	15652	IN	in	O	_	_
an	15653	15655	DT	a	O	_	_
increased	15656	15665	VBN	increase	O	_	_
interaction	15666	15677	NN	interaction	O	_	_
with	15678	15682	IN	with	O	_	_
p53	15683	15686	NN	p53	B-GENE	_	_
.	15686	15687	.	.	O	_	_
D	1
12
2	0	nn
2	1	amod
2	7	conj_but
7	5	neg
7	6	amod
7	10	dep
10	8	num
10	9	nn
12	2	nsubj
12	7	nsubj
12	15	prep_to
12	17	prep_to
12	24	conj_and
15	14	det
15	17	conj_and
15	21	prep_upon
21	19	amod
21	20	nn
24	23	nsubj
24	28	prep_in
28	26	det
28	27	amod
28	30	prep_with
EOX
Y	1
ROOT	0	0	32	1	S	0	0	32	4	S	1	0	22	2	NP	0	0	12	5	NP	2	0	3	3	NN	0	0	1	1	g004	0	0	1	0	JJ	0	1	2	1	Wild-type	1	1	2	0	NN	0	2	3	1	ASPP2	2	2	3	0	,	0	3	4	1	,	3	3	4	0	CC	0	4	5	1	but	4	4	5	0	NP	0	5	11	2	NP	2	5	8	3	RB	0	5	6	1	not	5	5	6	0	JJ	0	6	7	1	mutant	6	6	7	0	NN	0	7	8	1	ASPP2	7	7	8	0	NP	2	8	11	3	CD	0	8	9	1	(	8	8	9	0	NN	0	9	10	1	S827A	9	9	10	0	NN	0	10	11	1	)	10	10	11	0	,	0	11	12	1	,	11	11	12	0	VP	0	12	22	2	VBZ	0	12	13	1	translocates	12	12	13	0	PP	0	13	22	2	TO	0	13	14	1	to	13	13	14	0	NP	0	14	22	2	NP	1	14	18	4	DT	0	14	15	1	the	14	14	15	0	NN	0	15	16	1	cytosol	15	15	16	0	CC	0	16	17	1	and	16	16	17	0	NN	0	17	18	1	nucleus	17	17	18	0	PP	0	18	22	2	IN	0	18	19	1	upon	18	18	19	0	NP	2	19	22	3	JJ	0	19	20	1	oncogenic	19	19	20	0	NN	0	20	21	1	RAS	20	20	21	0	NN	0	21	22	1	activation	21	21	22	0	CC	0	22	23	1	and	22	22	23	0	S	1	23	31	2	NP	0	23	24	1	DT	0	23	24	1	this	23	23	24	0	VP	0	24	31	2	VBZ	0	24	25	1	results	24	24	25	0	PP	0	25	31	2	IN	0	25	26	1	in	25	25	26	0	NP	0	26	31	2	NP	2	26	29	3	DT	0	26	27	1	an	26	26	27	0	VBN	0	27	28	1	increased	27	27	28	0	NN	0	28	29	1	interaction	28	28	29	0	PP	0	29	31	2	IN	0	29	30	1	with	29	29	30	0	NP	0	30	31	1	NN	0	30	31	1	p53	30	30	31	0	.	0	31	32	1	.	31	31	32	0
EOS
T	30
(	15688	15689	NN	(	O	_	_
A	15689	15690	NN	a	O	_	_
)	15690	15691	CD	)	O	_	_
RAS	15692	15695	NN	ra	O	_	_
activation	15696	15706	NN	activation	O	_	_
induces	15707	15714	VBZ	induce	O	_	_
cytoplasmic	15715	15726	JJ	cytoplasmic	O	_	_
and	15727	15730	CC	and	O	_	_
nuclear	15731	15738	JJ	nuclear	O	_	_
translocation	15739	15752	NN	translocation	O	_	_
of	15753	15755	IN	of	O	_	_
wild-type	15756	15765	JJ	wild-type	O	_	_
ASPP2	15766	15771	NN	aspp2	O	_	_
but	15772	15775	CC	but	O	_	_
not	15776	15779	RB	not	O	_	_
ASPP2	15780	15785	NN	aspp2	O	_	_
(	15786	15787	CD	(	O	_	_
S827A	15787	15792	NN	s827a	O	_	_
)	15792	15793	NN	)	O	_	_
in	15794	15796	IN	in	O	_	_
HKe3	15797	15801	NN	hke3	B-GENE	_	_
ER	15802	15804	NN	er	I-GENE	_	_
:	15804	15805	:	:	O	_	_
HRAS12	15805	15811	NN	hras12	O	_	_
cells	15812	15817	NNS	cell	O	_	_
as	15818	15820	IN	as	O	_	_
detected	15821	15829	VBN	detect	O	_	_
by	15830	15832	IN	by	O	_	_
immunofluorescence	15833	15851	NN	immunofluorescence	O	_	_
.	15851	15852	.	.	O	_	_
D	1
5
1	0	nn
1	4	dep
4	2	num
4	3	nn
5	1	nsubj
5	9	dobj
5	18	dobj
6	8	conj_and
9	6	amod
9	8	amod
9	12	prep_of
9	18	conj_negcc
12	11	amod
18	15	nn
18	16	num
18	17	nn
18	21	prep_in
18	24	dep
21	20	nn
24	23	nn
24	26	dep
26	25	mark
26	28	prep_by
EOX
Y	1
ROOT	0	0	30	1	S	1	0	30	3	NP	0	0	5	2	NP	1	0	2	2	NN	0	0	1	1	(	0	0	1	0	NN	0	1	2	1	A	1	1	2	0	NP	2	2	5	3	CD	0	2	3	1	)	2	2	3	0	NN	0	3	4	1	RAS	3	3	4	0	NN	0	4	5	1	activation	4	4	5	0	VP	0	5	29	2	VBZ	0	5	6	1	induces	5	5	6	0	NP	0	6	29	3	NP	0	6	13	2	NP	1	6	10	2	ADJP	0	6	9	3	JJ	0	6	7	1	cytoplasmic	6	6	7	0	CC	0	7	8	1	and	7	7	8	0	JJ	0	8	9	1	nuclear	8	8	9	0	NN	0	9	10	1	translocation	9	9	10	0	PP	0	10	13	2	IN	0	10	11	1	of	10	10	11	0	NP	1	11	13	2	JJ	0	11	12	1	wild-type	11	11	12	0	NN	0	12	13	1	ASPP2	12	12	13	0	CONJP	1	13	15	2	CC	0	13	14	1	but	13	13	14	0	RB	0	14	15	1	not	14	14	15	0	NP	0	15	29	3	NP	0	15	22	2	NP	3	15	19	4	NN	0	15	16	1	ASPP2	15	15	16	0	CD	0	16	17	1	(	16	16	17	0	NN	0	17	18	1	S827A	17	17	18	0	NN	0	18	19	1	)	18	18	19	0	PP	0	19	22	2	IN	0	19	20	1	in	19	19	20	0	NP	1	20	22	2	NN	0	20	21	1	HKe3	20	20	21	0	NN	0	21	22	1	ER	21	21	22	0	:	0	22	23	1	:	22	22	23	0	NP	0	23	29	2	NP	1	23	25	2	NN	0	23	24	1	HRAS12	23	23	24	0	NNS	0	24	25	1	cells	24	24	25	0	SBAR	1	25	29	2	IN	0	25	26	1	as	25	25	26	0	S	0	26	29	1	VP	0	26	29	2	VBN	0	26	27	1	detected	26	26	27	0	PP	0	27	29	2	IN	0	27	28	1	by	27	27	28	0	NP	0	28	29	1	NN	0	28	29	1	immunofluorescence	28	28	29	0	.	0	29	30	1	.	29	29	30	0
EOS
T	9
Arrows	15853	15859	NNS	arrow	O	_	_
indicate	15860	15868	VBP	indicate	O	_	_
cell	15869	15873	NN	cell	O	_	_
membrane	15874	15882	NN	membrane	O	_	_
and	15883	15886	CC	and	O	_	_
stars	15887	15892	NNS	star	O	_	_
indicate	15893	15901	VBP	indicate	O	_	_
cytosol	15902	15909	NN	cytosol	O	_	_
.	15909	15910	.	.	O	_	_
D	1
1
1	0	nsubj
1	6	ccomp
3	2	nn
3	5	conj_and
6	3	nsubj
6	5	nsubj
6	7	dobj
EOX
Y	1
ROOT	0	0	9	1	S	1	0	9	3	NP	0	0	1	1	NNS	0	0	1	1	Arrows	0	0	1	0	VP	0	1	8	2	VBP	0	1	2	1	indicate	1	1	2	0	SBAR	0	2	8	1	S	1	2	8	2	NP	0	2	6	3	NP	1	2	4	2	NN	0	2	3	1	cell	2	2	3	0	NN	0	3	4	1	membrane	3	3	4	0	CC	0	4	5	1	and	4	4	5	0	NP	0	5	6	1	NNS	0	5	6	1	stars	5	5	6	0	VP	0	6	8	2	VBP	0	6	7	1	indicate	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	cytosol	7	7	8	0	.	0	8	9	1	.	8	8	9	0
EOS
T	20
(	15911	15912	NN	(	O	_	_
B	15912	15913	NN	b	O	_	_
)	15913	15914	CD	)	O	_	_
RAS	15915	15918	NN	ra	B-GENE	_	_
activation	15919	15929	NN	activation	O	_	_
enhances	15930	15938	VBZ	enhance	O	_	_
the	15939	15942	DT	the	O	_	_
binding	15943	15950	NN	binding	O	_	_
of	15951	15953	IN	of	O	_	_
wild-type	15954	15963	JJ	wild-type	O	_	_
ASPP2	15964	15969	NN	aspp2	O	_	_
but	15970	15973	CC	but	O	_	_
not	15974	15977	RB	not	O	_	_
ASPP2	15978	15983	NN	aspp2	O	_	_
(	15984	15985	CD	(	O	_	_
S827A	15985	15990	NN	s827a	O	_	_
)	15990	15991	NN	)	O	_	_
to	15992	15994	TO	to	O	_	_
p53	15995	15998	NN	p53	B-GENE	_	_
.	15998	15999	.	.	O	_	_
D	1
1
1	0	nn
1	5	rcmod
1	16	conj_negcc
4	2	num
4	3	nn
5	4	nsubj
5	7	dobj
7	6	det
7	10	prep_of
10	9	amod
16	13	nn
16	14	num
16	15	nn
16	18	prep_to
EOX
Y	1
ROOT	0	0	20	1	NP	0	0	20	4	NP	0	0	11	2	NP	1	0	2	2	NN	0	0	1	1	(	0	0	1	0	NN	0	1	2	1	B	1	1	2	0	SBAR	0	2	11	1	S	1	2	11	2	NP	2	2	5	3	CD	0	2	3	1	)	2	2	3	0	NN	0	3	4	1	RAS	3	3	4	0	NN	0	4	5	1	activation	4	4	5	0	VP	0	5	11	2	VBZ	0	5	6	1	enhances	5	5	6	0	NP	0	6	11	2	NP	1	6	8	2	DT	0	6	7	1	the	6	6	7	0	NN	0	7	8	1	binding	7	7	8	0	PP	0	8	11	2	IN	0	8	9	1	of	8	8	9	0	NP	1	9	11	2	JJ	0	9	10	1	wild-type	9	9	10	0	NN	0	10	11	1	ASPP2	10	10	11	0	CONJP	1	11	13	2	CC	0	11	12	1	but	11	11	12	0	RB	0	12	13	1	not	12	12	13	0	NP	0	13	19	2	NP	3	13	17	4	NN	0	13	14	1	ASPP2	13	13	14	0	CD	0	14	15	1	(	14	14	15	0	NN	0	15	16	1	S827A	15	15	16	0	NN	0	16	17	1	)	16	16	17	0	PP	0	17	19	2	TO	0	17	18	1	to	17	17	18	0	NP	0	18	19	1	NN	0	18	19	1	p53	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	27
Total	16000	16005	JJ	total	O	_	_
cell	16006	16010	NN	cell	O	_	_
lysates	16011	16018	NNS	lysate	O	_	_
from	16019	16023	IN	from	O	_	_
HKe3	16024	16028	NN	hke3	B-GENE	_	_
ER	16029	16031	NN	er	I-GENE	_	_
:	16031	16032	:	:	O	_	_
HRASV12	16032	16039	NN	hrasv12	O	_	_
cells	16040	16045	NNS	cell	O	_	_
treated	16046	16053	VBN	treat	O	_	_
with	16054	16058	IN	with	O	_	_
or	16059	16061	CC	or	O	_	_
without	16062	16069	IN	without	O	_	_
4-OHT	16070	16075	NN	4-oht	O	_	_
were	16076	16080	VBD	be	O	_	_
immunoprecipitated	16081	16099	VBN	immunoprecipitate	O	_	_
with	16100	16104	IN	with	O	_	_
an	16105	16107	DT	a	O	_	_
anti	16108	16112	JJ	anti	B-GENE	_	_
p53	16113	16116	NN	p53	I-GENE	_	_
antibody	16117	16125	NN	antibody	I-GENE	_	_
or	16126	16128	CC	or	O	_	_
control	16129	16136	NN	control	B-GENE	_	_
IgG	16137	16140	NN	igg	I-GENE	_	_
as	16141	16143	IN	as	O	_	_
indicated	16144	16153	VBN	indicate	O	_	_
.	16153	16154	.	.	O	_	_
D	1
15
2	0	amod
2	1	nn
2	5	prep_from
5	4	nn
5	8	dep
8	7	nn
8	9	vmod
9	9	conj_or
9	13	prep_with
9	13	prep_without
15	2	nsubjpass
15	14	auxpass
15	20	prep_with
15	23	prep_with
20	17	det
20	18	amod
20	19	nn
20	23	conj_or
20	25	prep_as
23	22	nn
EOX
Y	1
ROOT	0	0	27	1	S	1	0	27	3	NP	0	0	14	2	NP	2	0	3	3	JJ	0	0	1	1	Total	0	0	1	0	NN	0	1	2	1	cell	1	1	2	0	NNS	0	2	3	1	lysates	2	2	3	0	PP	0	3	14	2	IN	0	3	4	1	from	3	3	4	0	NP	0	4	14	3	NP	1	4	6	2	NN	0	4	5	1	HKe3	4	4	5	0	NN	0	5	6	1	ER	5	5	6	0	:	0	6	7	1	:	6	6	7	0	NP	0	7	14	2	NP	1	7	9	2	NN	0	7	8	1	HRASV12	7	7	8	0	NNS	0	8	9	1	cells	8	8	9	0	VP	0	9	14	2	VBN	0	9	10	1	treated	9	9	10	0	PP	0	10	14	4	IN	0	10	11	1	with	10	10	11	0	CC	0	11	12	1	or	11	11	12	0	IN	0	12	13	1	without	12	12	13	0	NP	0	13	14	1	NN	0	13	14	1	4-OHT	13	13	14	0	VP	1	14	26	2	VBD	0	14	15	1	were	14	14	15	0	VP	0	15	26	2	VBN	0	15	16	1	immunoprecipitated	15	15	16	0	PP	0	16	26	2	IN	0	16	17	1	with	16	16	17	0	NP	0	17	26	2	NP	0	17	24	3	NP	3	17	21	4	DT	0	17	18	1	an	17	17	18	0	JJ	0	18	19	1	anti	18	18	19	0	NN	0	19	20	1	p53	19	19	20	0	NN	0	20	21	1	antibody	20	20	21	0	CC	0	21	22	1	or	21	21	22	0	NP	1	22	24	2	NN	0	22	23	1	control	22	22	23	0	NN	0	23	24	1	IgG	23	23	24	0	PP	0	24	26	2	IN	0	24	25	1	as	24	24	25	0	NP	0	25	26	1	VBN	0	25	26	1	indicated	25	25	26	0	.	0	26	27	1	.	26	26	27	0
EOS
T	43
As	16155	16157	IN	as	O	_	_
the	16158	16161	DT	the	O	_	_
translocation	16162	16175	NN	translocation	O	_	_
of	16176	16178	IN	of	O	_	_
wild-type	16179	16188	JJ	wild-type	O	_	_
ASPP2	16189	16194	NN	aspp2	O	_	_
from	16195	16199	IN	from	O	_	_
the	16200	16203	DT	the	O	_	_
plasma	16204	16210	NN	plasma	O	_	_
membrane	16211	16219	NN	membrane	O	_	_
to	16220	16222	TO	to	O	_	_
the	16223	16226	DT	the	O	_	_
cytosol	16227	16234	NN	cytosol	O	_	_
and	16235	16238	CC	and	O	_	_
nucleus	16239	16246	NN	nucleus	O	_	_
results	16247	16254	NNS	result	O	_	_
in	16255	16257	IN	in	O	_	_
increased	16258	16267	VBN	increase	O	_	_
binding	16268	16275	NN	binding	O	_	_
to	16276	16278	TO	to	O	_	_
p53	16279	16282	NN	p53	B-GENE	_	_
[	16283	16284	NN	[	I-GENE	_	_
2	16284	16285	CD	2	I-GENE	_	_
]	16285	16286	NN	]	I-GENE	_	_
,	16286	16287	,	,	O	_	_
we	16288	16290	PRP	we	O	_	_
tested	16291	16297	VBD	test	O	_	_
whether	16298	16305	IN	whether	O	_	_
the	16306	16309	DT	the	O	_	_
p53	16310	16313	NN	p53	B-GENE	_	_
binding	16314	16321	NN	binding	O	_	_
ability	16322	16329	NN	ability	O	_	_
of	16330	16332	IN	of	O	_	_
ASPP2	16333	16338	NN	aspp2	B-GENE	_	_
phosphorylation	16339	16354	NN	phosphorylation	O	_	_
mutant	16355	16361	NN	mutant	O	_	_
would	16362	16367	MD	would	O	_	_
be	16368	16370	VB	be	O	_	_
influenced	16371	16381	VBN	influence	O	_	_
by	16382	16384	IN	by	O	_	_
RAS	16385	16388	NN	ra	B-GENE	_	_
activation	16389	16399	NN	activation	O	_	_
.	16399	16400	.	.	O	_	_
D	1
26
2	1	det
2	5	prep_of
2	18	prep_in
5	4	amod
5	9	prep_from
9	7	det
9	8	nn
9	15	prep_to
12	14	conj_and
15	11	det
15	12	nn
15	14	nn
18	17	amod
18	21	prep_to
21	20	nn
21	23	dep
23	22	num
26	2	prep_as
26	25	nsubj
26	38	ccomp
31	28	det
31	29	nn
31	30	nn
31	35	prep_of
35	33	nn
35	34	nn
38	27	mark
38	31	nsubjpass
38	36	aux
38	37	auxpass
38	41	agent
41	40	nn
EOX
Y	1
ROOT	0	0	43	1	S	3	0	43	5	PP	0	0	24	2	IN	0	0	1	1	As	0	0	1	0	NP	0	1	24	3	NP	1	1	3	2	DT	0	1	2	1	the	1	1	2	0	NN	0	2	3	1	translocation	2	2	3	0	PP	0	3	16	2	IN	0	3	4	1	of	3	3	4	0	NP	0	4	16	2	NP	1	4	6	2	JJ	0	4	5	1	wild-type	4	4	5	0	NN	0	5	6	1	ASPP2	5	5	6	0	PP	0	6	16	2	IN	0	6	7	1	from	6	6	7	0	NP	0	7	16	2	NP	2	7	10	3	DT	0	7	8	1	the	7	7	8	0	NN	0	8	9	1	plasma	8	8	9	0	NN	0	9	10	1	membrane	9	9	10	0	PP	0	10	16	2	TO	0	10	11	1	to	10	10	11	0	NP	2	11	16	3	DT	0	11	12	1	the	11	11	12	0	NP	0	12	15	3	NN	0	12	13	1	cytosol	12	12	13	0	CC	0	13	14	1	and	13	13	14	0	NN	0	14	15	1	nucleus	14	14	15	0	NNS	0	15	16	1	results	15	15	16	0	PP	0	16	24	2	IN	0	16	17	1	in	16	16	17	0	NP	0	17	24	2	NP	1	17	19	2	VBN	0	17	18	1	increased	17	17	18	0	NN	0	18	19	1	binding	18	18	19	0	PP	0	19	24	2	TO	0	19	20	1	to	19	19	20	0	NP	0	20	24	2	NP	1	20	22	2	NN	0	20	21	1	p53	20	20	21	0	NN	0	21	22	1	[	21	21	22	0	NP	1	22	24	2	CD	0	22	23	1	2	22	22	23	0	NN	0	23	24	1	]	23	23	24	0	,	0	24	25	1	,	24	24	25	0	NP	0	25	26	1	PRP	0	25	26	1	we	25	25	26	0	VP	0	26	42	2	VBD	0	26	27	1	tested	26	26	27	0	SBAR	1	27	42	2	IN	0	27	28	1	whether	27	27	28	0	S	1	28	42	2	NP	0	28	36	2	NP	3	28	32	4	DT	0	28	29	1	the	28	28	29	0	NN	0	29	30	1	p53	29	29	30	0	NN	0	30	31	1	binding	30	30	31	0	NN	0	31	32	1	ability	31	31	32	0	PP	0	32	36	2	IN	0	32	33	1	of	32	32	33	0	NP	2	33	36	3	NN	0	33	34	1	ASPP2	33	33	34	0	NN	0	34	35	1	phosphorylation	34	34	35	0	NN	0	35	36	1	mutant	35	35	36	0	VP	1	36	42	2	MD	0	36	37	1	would	36	36	37	0	VP	1	37	42	2	VB	0	37	38	1	be	37	37	38	0	VP	0	38	42	2	VBN	0	38	39	1	influenced	38	38	39	0	PP	0	39	42	2	IN	0	39	40	1	by	39	39	40	0	NP	1	40	42	2	NN	0	40	41	1	RAS	40	40	41	0	NN	0	41	42	1	activation	41	41	42	0	.	0	42	43	1	.	42	42	43	0
EOS
T	33
Indeed	16401	16407	RB	indeed	O	_	_
,	16407	16408	,	,	O	_	_
upon	16409	16413	IN	upon	O	_	_
activation	16414	16424	NN	activation	O	_	_
of	16425	16427	IN	of	O	_	_
RAS	16428	16431	NN	ra	O	_	_
by	16432	16434	IN	by	O	_	_
4-OHT	16435	16440	NN	4-oht	O	_	_
in	16441	16443	IN	in	O	_	_
HKe3	16444	16448	NN	hke3	B-GENE	_	_
ER	16449	16451	NN	er	I-GENE	_	_
:	16451	16452	:	:	O	_	_
HRASV12	16452	16459	NN	hrasv12	O	_	_
cells	16460	16465	NNS	cell	O	_	_
,	16465	16466	,	,	O	_	_
we	16467	16469	PRP	we	O	_	_
observed	16470	16478	VBD	observe	O	_	_
an	16479	16481	DT	a	O	_	_
increase	16482	16490	NN	increase	O	_	_
in	16491	16493	IN	in	O	_	_
the	16494	16497	DT	the	O	_	_
amount	16498	16504	NN	amount	O	_	_
of	16505	16507	IN	of	O	_	_
p53	16508	16511	NN	p53	B-GENE	_	_
co	16512	16514	NN	co	O	_	_
immunoprecipitated	16515	16533	VBN	immunoprecipitate	O	_	_
with	16534	16538	IN	with	O	_	_
transfected	16539	16550	VBN	transfect	O	_	_
V5	16551	16553	NN	v5	O	_	_
tagged	16554	16560	VBD	tag	O	_	_
wild-type	16561	16570	JJ	wild-type	O	_	_
ASPP2	16571	16576	NN	aspp2	O	_	_
.	16611	16612	.	.	O	_	_
D	1
16
3	5	prep_of
7	10	prep_in
7	13	dep
10	9	nn
13	12	nn
16	0	advmod
16	3	prep_upon
16	7	prep_by
16	15	nsubj
16	29	ccomp
18	17	det
18	21	prep_in
21	20	det
21	24	prep_of
24	23	nn
24	25	vmod
25	27	prepc_with
27	28	dobj
29	18	nsubj
29	31	dobj
31	30	amod
EOX
Y	1
ROOT	0	0	33	1	S	5	0	33	7	ADVP	0	0	1	1	RB	0	0	1	1	Indeed	0	0	1	0	,	0	1	2	1	,	1	1	2	0	PP	0	2	14	2	PP	0	2	6	2	IN	0	2	3	1	upon	2	2	3	0	NP	0	3	6	2	NP	0	3	4	1	NN	0	3	4	1	activation	3	3	4	0	PP	0	4	6	2	IN	0	4	5	1	of	4	4	5	0	NP	0	5	6	1	NN	0	5	6	1	RAS	5	5	6	0	PP	0	6	14	2	IN	0	6	7	1	by	6	6	7	0	NP	0	7	14	3	NP	0	7	11	2	NP	0	7	8	1	NN	0	7	8	1	4-OHT	7	7	8	0	PP	0	8	11	2	IN	0	8	9	1	in	8	8	9	0	NP	1	9	11	2	NN	0	9	10	1	HKe3	9	9	10	0	NN	0	10	11	1	ER	10	10	11	0	:	0	11	12	1	:	11	11	12	0	NP	1	12	14	2	NN	0	12	13	1	HRASV12	12	12	13	0	NNS	0	13	14	1	cells	13	13	14	0	,	0	14	15	1	,	14	14	15	0	NP	0	15	16	1	PRP	0	15	16	1	we	15	15	16	0	VP	0	16	32	2	VBD	0	16	17	1	observed	16	16	17	0	SBAR	0	17	32	1	S	1	17	32	2	NP	0	17	29	2	NP	1	17	19	2	DT	0	17	18	1	an	17	17	18	0	NN	0	18	19	1	increase	18	18	19	0	PP	0	19	29	2	IN	0	19	20	1	in	19	19	20	0	NP	0	20	29	2	NP	1	20	22	2	DT	0	20	21	1	the	20	20	21	0	NN	0	21	22	1	amount	21	21	22	0	PP	0	22	29	2	IN	0	22	23	1	of	22	22	23	0	NP	0	23	29	2	NP	1	23	25	2	NN	0	23	24	1	p53	23	23	24	0	NN	0	24	25	1	co	24	24	25	0	VP	0	25	29	2	VBN	0	25	26	1	immunoprecipitated	25	25	26	0	PP	0	26	29	2	IN	0	26	27	1	with	26	26	27	0	S	0	27	29	1	VP	0	27	29	2	VBN	0	27	28	1	transfected	27	27	28	0	NP	0	28	29	1	NN	0	28	29	1	V5	28	28	29	0	VP	0	29	32	2	VBD	0	29	30	1	tagged	29	29	30	0	NP	1	30	32	2	JJ	0	30	31	1	wild-type	30	30	31	0	NN	0	31	32	1	ASPP2	31	31	32	0	.	0	32	33	1	.	32	32	33	0
EOS
T	24
Under	16613	16618	IN	under	O	_	_
the	16619	16622	DT	the	O	_	_
same	16623	16627	JJ	same	O	_	_
conditions	16628	16638	NNS	condition	O	_	_
,	16638	16639	,	,	O	_	_
the	16640	16643	DT	the	O	_	_
amount	16644	16650	NN	amount	O	_	_
of	16651	16653	IN	of	O	_	_
p53	16654	16657	NN	p53	B-GENE	_	_
in	16658	16660	IN	in	O	_	_
complex	16661	16668	NN	complex	O	_	_
with	16669	16673	IN	with	O	_	_
transfected	16674	16685	VBN	transfect	O	_	_
V5-ASPP2	16686	16694	NN	v5-aspp2	O	_	_
(	16695	16696	CD	(	O	_	_
S827A	16696	16701	NN	s827a	O	_	_
)	16701	16702	NN	)	O	_	_
is	16703	16705	VBZ	be	O	_	_
not	16706	16709	RB	not	O	_	_
affected	16710	16718	VBN	affect	O	_	_
by	16719	16721	IN	by	O	_	_
RAS	16722	16725	NN	ra	B-GENE	_	_
activation	16726	16736	NN	activation	O	_	_
.	16771	16772	.	.	O	_	_
D	1
12
3	1	det
3	2	amod
6	5	det
6	8	prep_of
8	10	prep_in
10	11	prep
12	3	prep_under
12	6	nsubj
12	16	dobj
16	13	nn
16	14	num
16	15	nn
16	19	rcmod
19	17	auxpass
19	18	neg
19	22	agent
22	21	nn
EOX
Y	1
ROOT	0	0	24	1	S	3	0	24	5	PP	0	0	4	2	IN	0	0	1	1	Under	0	0	1	0	NP	2	1	4	3	DT	0	1	2	1	the	1	1	2	0	JJ	0	2	3	1	same	2	2	3	0	NNS	0	3	4	1	conditions	3	3	4	0	,	0	4	5	1	,	4	4	5	0	NP	0	5	12	2	NP	1	5	7	2	DT	0	5	6	1	the	5	5	6	0	NN	0	6	7	1	amount	6	6	7	0	PP	0	7	12	2	IN	0	7	8	1	of	7	7	8	0	NP	0	8	12	2	NP	0	8	9	1	NN	0	8	9	1	p53	8	8	9	0	PP	0	9	12	2	IN	0	9	10	1	in	9	9	10	0	NP	0	10	12	2	NP	0	10	11	1	NN	0	10	11	1	complex	10	10	11	0	PP	0	11	12	1	IN	0	11	12	1	with	11	11	12	0	VP	0	12	23	2	VBN	0	12	13	1	transfected	12	12	13	0	NP	0	13	23	2	NP	3	13	17	4	NN	0	13	14	1	V5-ASPP2	13	13	14	0	CD	0	14	15	1	(	14	14	15	0	NN	0	15	16	1	S827A	15	15	16	0	NN	0	16	17	1	)	16	16	17	0	SBAR	0	17	23	1	S	0	17	23	1	VP	2	17	23	3	VBZ	0	17	18	1	is	17	17	18	0	RB	0	18	19	1	not	18	18	19	0	VP	0	19	23	2	VBN	0	19	20	1	affected	19	19	20	0	PP	0	20	23	2	IN	0	20	21	1	by	20	20	21	0	NP	1	21	23	2	NN	0	21	22	1	RAS	21	21	22	0	NN	0	22	23	1	activation	22	22	23	0	.	0	23	24	1	.	23	23	24	0
EOS
T	25
Together	16773	16781	RB	together	O	_	_
these	16782	16787	DT	these	O	_	_
data	16788	16792	NNS	datum	O	_	_
illustrate	16793	16803	VBP	illustrate	O	_	_
that	16804	16808	IN	that	O	_	_
phosphorylation	16809	16824	NN	phosphorylation	O	_	_
of	16825	16827	IN	of	O	_	_
ASPP2	16828	16833	NN	aspp2	B-GENE	_	_
at	16834	16836	IN	at	O	_	_
Ser827	16837	16843	NN	ser827	O	_	_
by	16844	16846	IN	by	O	_	_
MAPK	16847	16851	NN	mapk	O	_	_
is	16852	16854	VBZ	be	O	_	_
necessary	16855	16864	JJ	necessary	O	_	_
for	16865	16868	IN	for	O	_	_
its	16869	16872	PRP$	its	O	_	_
ASPP2	16873	16878	NN	aspp2	O	_	_
to	16879	16881	TO	to	O	_	_
fully	16882	16887	RB	fully	O	_	_
enhance	16888	16895	VB	enhance	O	_	_
p53	16896	16899	NN	p53	B-GENE	_	_
's	16899	16901	POS	's	I-GENE	_	_
pro-apoptotic	16902	16915	JJ	pro-apoptotic	O	_	_
activity	16916	16924	NN	activity	O	_	_
.	16924	16925	.	.	O	_	_
D	1
3
2	1	det
3	0	advmod
3	2	nsubj
3	13	ccomp
5	7	prep_of
7	9	prep_at
9	11	prep_by
13	4	mark
13	5	nsubj
13	12	cop
13	16	prep_for
16	15	poss
16	19	vmod
19	17	aux
19	18	advmod
19	23	dobj
23	20	poss
23	22	amod
EOX
Y	1
ROOT	0	0	25	1	S	2	0	25	4	ADVP	0	0	1	1	RB	0	0	1	1	Together	0	0	1	0	NP	1	1	3	2	DT	0	1	2	1	these	1	1	2	0	NNS	0	2	3	1	data	2	2	3	0	VP	0	3	24	2	VBP	0	3	4	1	illustrate	3	3	4	0	SBAR	1	4	24	2	IN	0	4	5	1	that	4	4	5	0	S	1	5	24	2	NP	0	5	12	2	NP	0	5	6	1	NN	0	5	6	1	phosphorylation	5	5	6	0	PP	0	6	12	2	IN	0	6	7	1	of	6	6	7	0	NP	0	7	12	2	NP	0	7	8	1	NN	0	7	8	1	ASPP2	7	7	8	0	PP	0	8	12	2	IN	0	8	9	1	at	8	8	9	0	NP	0	9	12	2	NP	0	9	10	1	NN	0	9	10	1	Ser827	9	9	10	0	PP	0	10	12	2	IN	0	10	11	1	by	10	10	11	0	NP	0	11	12	1	NN	0	11	12	1	MAPK	11	11	12	0	VP	1	12	24	2	VBZ	0	12	13	1	is	12	12	13	0	ADJP	0	13	24	2	JJ	0	13	14	1	necessary	13	13	14	0	PP	0	14	24	2	IN	0	14	15	1	for	14	14	15	0	NP	1	15	24	3	PRP$	0	15	16	1	its	15	15	16	0	NN	0	16	17	1	ASPP2	16	16	17	0	S	0	17	24	1	VP	1	17	24	2	TO	0	17	18	1	to	17	17	18	0	VP	1	18	24	3	ADVP	0	18	19	1	RB	0	18	19	1	fully	18	18	19	0	VB	0	19	20	1	enhance	19	19	20	0	NP	2	20	24	3	NP	0	20	22	2	NN	0	20	21	1	p53	20	20	21	0	POS	0	21	22	1	's	21	21	22	0	JJ	0	22	23	1	pro-apoptotic	22	22	23	0	NN	0	23	24	1	activity	23	23	24	0	.	0	24	25	1	.	24	24	25	0
EOS
T	29
Discussion	16926	16936	NN	discussion	O	_	_
ASPP2	16937	16942	NN	aspp2	O	_	_
is	16943	16945	VBZ	be	O	_	_
a	16946	16947	DT	a	O	_	_
haploinsufficient	16948	16965	JJ	haploinsufficient	O	_	_
tumor	16966	16971	NN	tumor	O	_	_
suppressor	16972	16982	NN	suppressor	O	_	_
[	16983	16984	CD	[	O	_	_
15	16984	16986	CD	15	O	_	_
]	16986	16987	NN	]	O	_	_
[	16988	16989	CD	[	O	_	_
16	16989	16991	CD	16	O	_	_
]	16991	16992	NN	]	O	_	_
and	16993	16996	CC	and	O	_	_
it	16997	16999	PRP	it	O	_	_
can	17000	17003	MD	can	O	_	_
cooperate	17004	17013	VB	cooperate	O	_	_
with	17014	17018	IN	with	O	_	_
p53	17019	17022	NN	p53	B-GENE	_	_
to	17023	17025	TO	to	O	_	_
suppress	17026	17034	VB	suppress	O	_	_
tumour	17035	17041	NN	tumour	O	_	_
growth	17042	17048	NN	growth	O	_	_
in	17049	17051	FW	in	O	_	_
vivo	17052	17056	FW	vivo	O	_	_
[	17057	17058	FW	[	O	_	_
15	17058	17060	CD	15	O	_	_
]	17060	17061	NN	]	O	_	_
.	17061	17062	.	.	O	_	_
D	1
16
1	0	nn
8	7	number
9	1	nsubj
9	2	cop
9	3	det
9	4	amod
9	5	nn
9	6	nn
9	8	num
9	12	dep
9	14	conj_and
11	10	number
12	11	num
16	9	dep
16	14	dep
16	15	aux
16	18	prep_with
16	20	xcomp
16	27	nsubj
20	19	aux
20	22	dobj
22	21	nn
22	23	prep
23	25	pobj
25	24	nn
27	26	num
EOX
Y	1
ROOT	0	0	29	1	SINV	1	0	29	4	S	1	0	15	2	NP	1	0	2	2	NN	0	0	1	1	Discussion	0	0	1	0	NN	0	1	2	1	ASPP2	1	1	2	0	VP	1	2	15	2	VBZ	0	2	3	1	is	2	2	3	0	NP	0	3	15	4	NP	5	3	10	6	DT	0	3	4	1	a	3	3	4	0	JJ	0	4	5	1	haploinsufficient	4	4	5	0	NN	0	5	6	1	tumor	5	5	6	0	NN	0	6	7	1	suppressor	6	6	7	0	ADJP	0	7	9	1	QP	1	7	9	2	CD	0	7	8	1	[	7	7	8	0	CD	0	8	9	1	15	8	8	9	0	NN	0	9	10	1	]	9	9	10	0	NP	1	10	13	2	QP	1	10	12	2	CD	0	10	11	1	[	10	10	11	0	CD	0	11	12	1	16	11	11	12	0	NN	0	12	13	1	]	12	12	13	0	CC	0	13	14	1	and	13	13	14	0	NP	0	14	15	1	PRP	0	14	15	1	it	14	14	15	0	VP	1	15	26	2	MD	0	15	16	1	can	15	15	16	0	VP	0	16	26	3	VB	0	16	17	1	cooperate	16	16	17	0	PP	0	17	19	2	IN	0	17	18	1	with	17	17	18	0	NP	0	18	19	1	NN	0	18	19	1	p53	18	18	19	0	S	0	19	26	1	VP	1	19	26	2	TO	0	19	20	1	to	19	19	20	0	VP	0	20	26	2	VB	0	20	21	1	suppress	20	20	21	0	NP	0	21	26	2	NP	1	21	23	2	NN	0	21	22	1	tumour	21	21	22	0	NN	0	22	23	1	growth	22	22	23	0	PP	0	23	26	2	FW	0	23	24	1	in	23	23	24	0	NP	1	24	26	2	FW	0	24	25	1	vivo	24	24	25	0	FW	0	25	26	1	[	25	25	26	0	NP	1	26	28	2	CD	0	26	27	1	15	26	26	27	0	NN	0	27	28	1	]	27	27	28	0	.	0	28	29	1	.	28	28	29	0
EOS
T	16
In	17063	17065	IN	in	O	_	_
human	17066	17071	JJ	human	O	_	_
cancer	17072	17078	NN	cancer	O	_	_
,	17078	17079	,	,	O	_	_
ASPP2	17080	17085	NN	aspp2	B-GENE	_	_
expression	17086	17096	NN	expression	O	_	_
is	17097	17099	VBZ	be	O	_	_
down	17100	17104	RB	down	O	_	_
regulated	17105	17114	VBN	regulate	O	_	_
by	17115	17117	IN	by	O	_	_
DNA	17118	17121	NN	dna	O	_	_
methylation	17122	17133	NN	methylation	O	_	_
[	17134	17135	CD	[	O	_	_
9,17-19	17135	17142	CD	9,17-19	O	_	_
]	17142	17143	NN	]	O	_	_
.	17143	17144	.	.	O	_	_
D	1
8
2	1	amod
5	4	nn
8	2	prep_in
8	5	nsubjpass
8	6	auxpass
8	7	advmod
8	11	agent
11	10	nn
11	14	dep
14	12	num
14	13	num
EOX
Y	1
ROOT	0	0	16	1	S	3	0	16	5	PP	0	0	3	2	IN	0	0	1	1	In	0	0	1	0	NP	1	1	3	2	JJ	0	1	2	1	human	1	1	2	0	NN	0	2	3	1	cancer	2	2	3	0	,	0	3	4	1	,	3	3	4	0	NP	1	4	6	2	NN	0	4	5	1	ASPP2	4	4	5	0	NN	0	5	6	1	expression	5	5	6	0	VP	2	6	15	3	VBZ	0	6	7	1	is	6	6	7	0	ADVP	0	7	8	1	RB	0	7	8	1	down	7	7	8	0	VP	0	8	15	2	VBN	0	8	9	1	regulated	8	8	9	0	PP	0	9	15	2	IN	0	9	10	1	by	9	9	10	0	NP	0	10	15	2	NP	1	10	12	2	NN	0	10	11	1	DNA	10	10	11	0	NN	0	11	12	1	methylation	11	11	12	0	NP	2	12	15	3	CD	0	12	13	1	[	12	12	13	0	CD	0	13	14	1	9,17-19	13	13	14	0	NN	0	14	15	1	]	14	14	15	0	.	0	15	16	1	.	15	15	16	0
EOS
T	20
Importantly	17145	17156	RB	importantly	O	_	_
,	17156	17157	,	,	O	_	_
in	17158	17160	IN	in	O	_	_
diffuse	17161	17168	JJ	diffuse	O	_	_
large	17169	17174	JJ	large	O	_	_
B	17175	17176	NN	b	O	_	_
cell	17177	17181	NN	cell	O	_	_
lymphomas	17182	17191	NNS	lymphoma	O	_	_
,	17191	17192	,	,	O	_	_
reduced	17193	17200	VBD	reduce	O	_	_
ASPP2	17201	17206	NN	aspp2	B-GENE	_	_
expression	17207	17217	NN	expression	O	_	_
associates	17218	17228	VBZ	associate	O	_	_
with	17229	17233	IN	with	O	_	_
poor	17234	17238	JJ	poor	O	_	_
prognosis	17239	17248	NN	prognosis	O	_	_
[	17249	17250	CD	[	O	_	_
20	17250	17252	CD	20	O	_	_
]	17252	17253	NN	]	O	_	_
.	17253	17254	.	.	O	_	_
D	1
9
7	3	amod
7	4	amod
7	5	nn
7	6	nn
9	0	advmod
9	7	prep_in
9	12	ccomp
11	10	nn
12	11	nsubj
12	15	prep_with
12	18	dep
15	14	amod
17	16	number
18	17	num
EOX
Y	1
ROOT	0	0	20	1	S	4	0	20	6	ADVP	0	0	1	1	RB	0	0	1	1	Importantly	0	0	1	0	,	0	1	2	1	,	1	1	2	0	PP	0	2	8	2	IN	0	2	3	1	in	2	2	3	0	NP	4	3	8	5	JJ	0	3	4	1	diffuse	3	3	4	0	JJ	0	4	5	1	large	4	4	5	0	NN	0	5	6	1	B	5	5	6	0	NN	0	6	7	1	cell	6	6	7	0	NNS	0	7	8	1	lymphomas	7	7	8	0	,	0	8	9	1	,	8	8	9	0	VP	0	9	19	2	VBD	0	9	10	1	reduced	9	9	10	0	SBAR	0	10	19	1	S	1	10	19	2	NP	1	10	12	2	NN	0	10	11	1	ASPP2	10	10	11	0	NN	0	11	12	1	expression	11	11	12	0	VP	0	12	19	2	VBZ	0	12	13	1	associates	12	12	13	0	PP	0	13	19	3	IN	0	13	14	1	with	13	13	14	0	NP	1	14	16	2	JJ	0	14	15	1	poor	14	14	15	0	NN	0	15	16	1	prognosis	15	15	16	0	NP	1	16	19	2	QP	1	16	18	2	CD	0	16	17	1	[	16	16	17	0	CD	0	17	18	1	20	17	17	18	0	NN	0	18	19	1	]	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	21
ASPP2	17255	17260	NN	aspp2	B-GENE	_	_
expression	17261	17271	NN	expression	O	_	_
is	17272	17274	VBZ	be	O	_	_
also	17275	17279	RB	also	O	_	_
down	17280	17284	RB	down	O	_	_
regulated	17285	17294	VBN	regulate	O	_	_
in	17295	17297	IN	in	O	_	_
both	17298	17302	CC	both	O	_	_
invasive	17303	17311	JJ	invasive	O	_	_
and	17312	17315	CC	and	O	_	_
metastatic	17316	17326	JJ	metastatic	O	_	_
cells	17327	17332	NNS	cell	O	_	_
compared	17333	17341	VBN	compare	O	_	_
with	17342	17346	IN	with	O	_	_
normal	17347	17353	JJ	normal	O	_	_
breast	17354	17360	NN	breast	O	_	_
epithelium	17361	17371	NN	epithelium	O	_	_
[	17372	17373	CD	[	O	_	_
21	17373	17375	CD	21	O	_	_
]	17375	17376	NN	]	O	_	_
.	17376	17377	.	.	O	_	_
D	1
5
1	0	nn
5	1	nsubjpass
5	2	auxpass
5	3	advmod
5	4	advmod
5	11	prep_in
5	13	prepc_compared_with
5	16	pobj
8	7	preconj
8	10	conj_and
11	8	amod
11	10	amod
16	14	amod
16	15	nn
16	19	dep
18	17	number
19	18	num
EOX
Y	1
ROOT	0	0	21	1	S	1	0	21	3	NP	1	0	2	2	NN	0	0	1	1	ASPP2	0	0	1	0	NN	0	1	2	1	expression	1	1	2	0	VP	2	2	20	3	VBZ	0	2	3	1	is	2	2	3	0	ADVP	0	3	4	1	RB	0	3	4	1	also	3	3	4	0	VP	1	4	20	4	ADVP	0	4	5	1	RB	0	4	5	1	down	4	4	5	0	VBN	0	5	6	1	regulated	5	5	6	0	PP	0	6	12	2	IN	0	6	7	1	in	6	6	7	0	NP	1	7	12	2	ADJP	1	7	11	4	CC	0	7	8	1	both	7	7	8	0	JJ	0	8	9	1	invasive	8	8	9	0	CC	0	9	10	1	and	9	9	10	0	JJ	0	10	11	1	metastatic	10	10	11	0	NNS	0	11	12	1	cells	11	11	12	0	PP	0	12	20	2	VBN	0	12	13	1	compared	12	12	13	0	PP	0	13	20	2	IN	0	13	14	1	with	13	13	14	0	NP	0	14	20	2	NP	2	14	17	3	JJ	0	14	15	1	normal	14	14	15	0	NN	0	15	16	1	breast	15	15	16	0	NN	0	16	17	1	epithelium	16	16	17	0	X	0	17	20	1	NP	1	17	20	2	QP	1	17	19	2	CD	0	17	18	1	[	17	17	18	0	CD	0	18	19	1	21	18	18	19	0	NN	0	19	20	1	]	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	15
These	17378	17383	DT	these	O	_	_
findings	17384	17392	NNS	finding	O	_	_
established	17393	17404	VBD	establish	O	_	_
ASPP2	17405	17410	NN	aspp2	O	_	_
as	17411	17413	IN	as	O	_	_
a	17414	17415	DT	a	O	_	_
tumor	17416	17421	NN	tumor	O	_	_
suppressor	17422	17432	NN	suppressor	O	_	_
and	17433	17436	CC	and	O	_	_
an	17437	17439	DT	a	O	_	_
activator	17440	17449	NN	activator	O	_	_
of	17450	17452	IN	of	O	_	_
p53	17453	17456	NN	p53	B-GENE	_	_
family	17457	17463	NN	family	I-GENE	_	_
.	17463	17464	.	.	O	_	_
D	1
2
1	0	det
2	1	nsubj
2	3	dobj
2	7	prep_as
2	10	prep_as
7	5	det
7	6	nn
7	10	conj_and
10	9	det
10	13	prep_of
13	12	nn
EOX
Y	1
ROOT	0	0	15	1	S	1	0	15	3	NP	1	0	2	2	DT	0	0	1	1	These	0	0	1	0	NNS	0	1	2	1	findings	1	1	2	0	VP	0	2	14	3	VBD	0	2	3	1	established	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	ASPP2	3	3	4	0	PP	0	4	14	2	IN	0	4	5	1	as	4	4	5	0	NP	0	5	14	3	NP	2	5	8	3	DT	0	5	6	1	a	5	5	6	0	NN	0	6	7	1	tumor	6	6	7	0	NN	0	7	8	1	suppressor	7	7	8	0	CC	0	8	9	1	and	8	8	9	0	NP	0	9	14	2	NP	1	9	11	2	DT	0	9	10	1	an	9	9	10	0	NN	0	10	11	1	activator	10	10	11	0	PP	0	11	14	2	IN	0	11	12	1	of	11	11	12	0	NP	1	12	14	2	NN	0	12	13	1	p53	12	12	13	0	NN	0	13	14	1	family	13	13	14	0	.	0	14	15	1	.	14	14	15	0
EOS
T	17
ASPP2	17465	17470	NN	aspp2	B-GENE	_	_
is	17471	17473	VBZ	be	O	_	_
involved	17474	17482	VBN	involve	O	_	_
in	17483	17485	IN	in	O	_	_
both	17486	17490	CC	both	O	_	_
senescence	17491	17501	NN	senescence	O	_	_
in	17502	17504	IN	in	O	_	_
fibroblasts	17505	17516	NNS	fibroblast	O	_	_
and	17517	17520	CC	and	O	_	_
apoptosis	17521	17530	NN	apoptosis	O	_	_
in	17531	17533	IN	in	O	_	_
cancer	17534	17540	NN	cancer	O	_	_
cells	17541	17546	NNS	cell	O	_	_
[	17547	17548	VBP	[	O	_	_
2,10	17548	17552	CD	2,10	O	_	_
]	17552	17553	CD	]	O	_	_
.	17553	17554	.	.	O	_	_
D	1
2
2	0	nsubjpass
2	1	auxpass
2	5	prep_in
2	13	conj_and
5	4	dep
5	7	prep_in
9	12	prep_in
12	11	nn
13	9	nsubj
13	15	dobj
15	14	number
EOX
Y	1
ROOT	0	0	17	1	S	0	0	17	4	S	1	0	8	2	NP	0	0	1	1	NN	0	0	1	1	ASPP2	0	0	1	0	VP	1	1	8	2	VBZ	0	1	2	1	is	1	1	2	0	VP	0	2	8	2	VBN	0	2	3	1	involved	2	2	3	0	PP	0	3	8	2	IN	0	3	4	1	in	3	3	4	0	NP	0	4	8	2	NP	1	4	6	2	CC	0	4	5	1	both	4	4	5	0	NN	0	5	6	1	senescence	5	5	6	0	PP	0	6	8	2	IN	0	6	7	1	in	6	6	7	0	NP	0	7	8	1	NNS	0	7	8	1	fibroblasts	7	7	8	0	CC	0	8	9	1	and	8	8	9	0	S	1	9	16	2	NP	0	9	13	2	NP	0	9	10	1	NN	0	9	10	1	apoptosis	9	9	10	0	PP	0	10	13	2	IN	0	10	11	1	in	10	10	11	0	NP	1	11	13	2	NN	0	11	12	1	cancer	11	11	12	0	NNS	0	12	13	1	cells	12	12	13	0	VP	0	13	16	2	VBP	0	13	14	1	[	13	13	14	0	NP	0	14	16	1	QP	1	14	16	2	CD	0	14	15	1	2,10	14	14	15	0	CD	0	15	16	1	]	15	15	16	0	.	0	16	17	1	.	16	16	17	0
EOS
T	11
ASPP2	17555	17560	NN	aspp2	B-GENE	_	_
acts	17561	17565	VBZ	act	O	_	_
at	17566	17568	IN	at	O	_	_
several	17569	17576	JJ	several	O	_	_
steps	17577	17582	NNS	step	O	_	_
in	17583	17585	IN	in	O	_	_
promoting	17586	17595	VBG	promote	O	_	_
senescence	17596	17606	NN	senescence	O	_	_
in	17607	17609	IN	in	O	_	_
fibroblasts	17610	17621	NNS	fibroblast	O	_	_
.	17621	17622	.	.	O	_	_
D	1
1
1	0	nsubj
1	4	prep_at
1	6	prepc_in
4	3	amod
6	7	dobj
6	9	prep_in
EOX
Y	1
ROOT	0	0	11	1	S	1	0	11	3	NP	0	0	1	1	NN	0	0	1	1	ASPP2	0	0	1	0	VP	0	1	10	3	VBZ	0	1	2	1	acts	1	1	2	0	PP	0	2	5	2	IN	0	2	3	1	at	2	2	3	0	NP	1	3	5	2	JJ	0	3	4	1	several	3	3	4	0	NNS	0	4	5	1	steps	4	4	5	0	PP	0	5	10	2	IN	0	5	6	1	in	5	5	6	0	S	0	6	10	1	VP	0	6	10	3	VBG	0	6	7	1	promoting	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	senescence	7	7	8	0	PP	0	8	10	2	IN	0	8	9	1	in	8	8	9	0	NP	0	9	10	1	NNS	0	9	10	1	fibroblasts	9	9	10	0	.	0	10	11	1	.	10	10	11	0
EOS
T	29
It	17623	17625	PRP	it	O	_	_
can	17626	17629	MD	can	O	_	_
do	17630	17632	VB	do	O	_	_
so	17633	17635	RB	so	O	_	_
in	17636	17638	IN	in	O	_	_
a	17639	17640	DT	a	O	_	_
RAS	17641	17644	NN	ra	O	_	_
dependent	17645	17654	JJ	dependent	O	_	_
,	17654	17655	,	,	O	_	_
p53	17656	17659	NN	p53	B-GENE	_	_
independent	17660	17671	JJ	independent	O	_	_
manner	17672	17678	NN	manner	O	_	_
,	17678	17679	,	,	O	_	_
through	17680	17687	IN	through	O	_	_
its	17688	17691	PRP$	its	O	_	_
ability	17692	17699	NN	ability	O	_	_
to	17700	17702	TO	to	O	_	_
bind	17703	17707	VB	bind	O	_	_
ATG5	17708	17712	NN	atg5	O	_	_
and	17713	17716	CC	and	O	_	_
to	17717	17719	TO	to	O	_	_
inhibit	17720	17727	VB	inhibit	O	_	_
RAS	17728	17731	NN	ra	O	_	_
induced	17732	17739	VBN	induce	O	_	_
autophagy	17740	17749	NN	autophagy	O	_	_
[	17750	17751	CD	[	O	_	_
10	17751	17753	CD	10	O	_	_
]	17753	17754	NN	]	O	_	_
.	17754	17755	.	.	O	_	_
D	1
2
2	0	nsubj
2	1	aux
2	3	advmod
2	15	prep_through
3	6	prep_in
6	5	det
6	7	amod
6	11	appos
11	9	nn
11	10	amod
15	14	poss
15	17	dep
15	21	dep
17	16	aux
17	18	dobj
17	21	conj_and
21	20	aux
21	22	dobj
22	23	vmod
23	24	dobj
24	25	num
24	27	dep
27	26	num
EOX
Y	1
ROOT	0	0	29	1	S	1	0	29	3	NP	0	0	1	1	PRP	0	0	1	1	It	0	0	1	0	VP	1	1	28	2	MD	0	1	2	1	can	1	1	2	0	VP	0	2	28	3	VB	0	2	3	1	do	2	2	3	0	ADVP	0	3	13	2	RB	0	3	4	1	so	3	3	4	0	PP	0	4	13	2	IN	0	4	5	1	in	4	4	5	0	NP	0	5	13	4	NP	0	5	8	2	NP	1	5	7	2	DT	0	5	6	1	a	5	5	6	0	NN	0	6	7	1	RAS	6	6	7	0	ADJP	0	7	8	1	JJ	0	7	8	1	dependent	7	7	8	0	,	0	8	9	1	,	8	8	9	0	NP	2	9	12	3	NN	0	9	10	1	p53	9	9	10	0	JJ	0	10	11	1	independent	10	10	11	0	NN	0	11	12	1	manner	11	11	12	0	,	0	12	13	1	,	12	12	13	0	PP	0	13	28	2	IN	0	13	14	1	through	13	13	14	0	NP	1	14	28	3	PRP$	0	14	15	1	its	14	14	15	0	NN	0	15	16	1	ability	15	15	16	0	S	0	16	28	1	VP	0	16	28	3	VP	1	16	19	2	TO	0	16	17	1	to	16	16	17	0	VP	0	17	19	2	VB	0	17	18	1	bind	17	17	18	0	NP	0	18	19	1	NN	0	18	19	1	ATG5	18	18	19	0	CC	0	19	20	1	and	19	19	20	0	VP	1	20	28	2	TO	0	20	21	1	to	20	20	21	0	VP	0	21	28	2	VB	0	21	22	1	inhibit	21	21	22	0	NP	0	22	28	2	NP	0	22	23	1	NN	0	22	23	1	RAS	22	22	23	0	VP	0	23	28	2	VBN	0	23	24	1	induced	23	23	24	0	NP	0	24	28	2	NP	0	24	26	2	NN	0	24	25	1	autophagy	24	24	25	0	CD	0	25	26	1	[	25	25	26	0	NP	1	26	28	2	CD	0	26	27	1	10	26	26	27	0	NN	0	27	28	1	]	27	27	28	0	.	0	28	29	1	.	28	28	29	0
EOS
T	22
Additionally	17756	17768	RB	additionally	O	_	_
,	17768	17769	,	,	O	_	_
it	17770	17772	PRP	it	O	_	_
can	17773	17776	MD	can	O	_	_
bind	17777	17781	VB	bind	O	_	_
active	17782	17788	JJ	active	O	_	_
RAS	17789	17792	NN	ra	O	_	_
directly	17793	17801	RB	directly	O	_	_
leading	17802	17809	VBG	lead	O	_	_
to	17810	17812	TO	to	O	_	_
enhanced	17813	17821	VBN	enhance	O	_	_
activation	17822	17832	NN	activation	O	_	_
of	17833	17835	IN	of	O	_	_
c-Raf	17836	17841	NN	c-raf	B-GENE	_	_
/	17841	17842	:	/	B-GENE	_	_
MAPK	17842	17846	NN	mapk	I-GENE	_	_
mediated	17847	17855	VBD	mediate	O	_	_
senescence	17856	17866	NN	senescence	O	_	_
[	17867	17868	NN	[	O	_	_
6	17868	17869	CD	6	O	_	_
]	17869	17870	NN	]	O	_	_
.	17870	17871	.	.	O	_	_
D	1
4
4	0	advmod
4	2	nsubj
4	3	aux
4	6	dobj
6	5	amod
6	8	vmod
6	16	dep
6	20	dep
8	7	advmod
8	11	prep_to
11	10	amod
11	13	prep_of
16	14	punct
16	15	nsubj
16	18	dobj
18	17	nn
20	19	num
EOX
Y	1
ROOT	0	0	22	1	S	3	0	22	5	ADVP	0	0	1	1	RB	0	0	1	1	Additionally	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	0	2	3	1	PRP	0	2	3	1	it	2	2	3	0	VP	1	3	21	2	MD	0	3	4	1	can	3	3	4	0	VP	0	4	21	2	VB	0	4	5	1	bind	4	4	5	0	NP	0	5	21	3	NP	0	5	14	2	NP	1	5	7	2	JJ	0	5	6	1	active	5	5	6	0	NN	0	6	7	1	RAS	6	6	7	0	VP	1	7	14	3	ADVP	0	7	8	1	RB	0	7	8	1	directly	7	7	8	0	VBG	0	8	9	1	leading	8	8	9	0	PP	0	9	14	2	TO	0	9	10	1	to	9	9	10	0	NP	0	10	14	2	NP	1	10	12	2	VBN	0	10	11	1	enhanced	10	10	11	0	NN	0	11	12	1	activation	11	11	12	0	PP	0	12	14	2	IN	0	12	13	1	of	12	12	13	0	NP	0	13	14	1	NN	0	13	14	1	c-Raf	13	13	14	0	PRN	1	14	19	2	:	0	14	15	1	/	14	14	15	0	S	1	15	19	2	NP	0	15	16	1	NN	0	15	16	1	MAPK	15	15	16	0	VP	0	16	19	2	VBD	0	16	17	1	mediated	16	16	17	0	NP	1	17	19	2	NN	0	17	18	1	senescence	17	17	18	0	NN	0	18	19	1	[	18	18	19	0	NP	1	19	21	2	CD	0	19	20	1	6	19	19	20	0	NN	0	20	21	1	]	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	23
We	17872	17874	PRP	we	O	_	_
and	17875	17878	CC	and	O	_	_
others	17879	17885	NNS	other	O	_	_
have	17886	17890	VBP	have	O	_	_
recently	17891	17899	RB	recently	O	_	_
shown	17900	17905	VBN	show	O	_	_
that	17906	17910	IN	that	O	_	_
ASPP2	17911	17916	NN	aspp2	B-GENE	_	_
can	17917	17920	MD	can	O	_	_
potentiate	17921	17931	VB	potentiate	O	_	_
RAS	17932	17935	NN	ra	O	_	_
signaling	17936	17945	NN	signaling	O	_	_
by	17946	17948	IN	by	O	_	_
binding	17949	17956	VBG	bind	O	_	_
directly	17957	17965	RB	directly	O	_	_
via	17966	17969	IN	via	O	_	_
the	17970	17973	DT	the	O	_	_
ASPP2	17974	17979	NN	aspp2	O	_	_
N-terminus	17980	17990	NN	n-terminus	O	_	_
[	17991	17992	CD	[	O	_	_
2,6	17992	17995	CD	2,6	O	_	_
]	17995	17996	NN	]	O	_	_
.	17996	17997	.	.	O	_	_
D	1
5
0	2	conj_and
5	0	nsubj
5	2	nsubj
5	3	aux
5	4	advmod
5	9	ccomp
9	6	mark
9	7	nsubj
9	8	aux
9	11	dobj
9	13	prep_by
11	10	nn
13	14	advmod
13	18	prep_via
18	16	det
18	17	nn
18	21	dep
20	19	number
21	20	num
EOX
Y	1
ROOT	0	0	23	1	S	1	0	23	3	NP	0	0	3	3	PRP	0	0	1	1	We	0	0	1	0	CC	0	1	2	1	and	1	1	2	0	NNS	0	2	3	1	others	2	2	3	0	VP	2	3	22	3	VBP	0	3	4	1	have	3	3	4	0	ADVP	0	4	5	1	RB	0	4	5	1	recently	4	4	5	0	VP	0	5	22	2	VBN	0	5	6	1	shown	5	5	6	0	SBAR	1	6	22	2	IN	0	6	7	1	that	6	6	7	0	S	1	7	22	2	NP	0	7	8	1	NN	0	7	8	1	ASPP2	7	7	8	0	VP	1	8	22	2	MD	0	8	9	1	can	8	8	9	0	VP	0	9	22	3	VB	0	9	10	1	potentiate	9	9	10	0	NP	1	10	12	2	NN	0	10	11	1	RAS	10	10	11	0	NN	0	11	12	1	signaling	11	11	12	0	PP	0	12	22	2	IN	0	12	13	1	by	12	12	13	0	NP	0	13	22	2	NP	0	13	14	1	VBG	0	13	14	1	binding	13	13	14	0	PP	1	14	22	3	ADVP	0	14	15	1	RB	0	14	15	1	directly	14	14	15	0	IN	0	15	16	1	via	15	15	16	0	NP	0	16	22	2	NP	2	16	19	3	DT	0	16	17	1	the	16	16	17	0	NN	0	17	18	1	ASPP2	17	17	18	0	NN	0	18	19	1	N-terminus	18	18	19	0	NP	1	19	22	2	QP	1	19	21	2	CD	0	19	20	1	[	19	19	20	0	CD	0	20	21	1	2,6	20	20	21	0	NN	0	21	22	1	]	21	21	22	0	.	0	22	23	1	.	22	22	23	0
EOS
T	18
Moreover	17998	18006	RB	moreover	O	_	_
,	18006	18007	,	,	O	_	_
the	18008	18011	DT	the	O	_	_
RAS-ASPP	18012	18020	NN	ras-aspp	O	_	_
interaction	18021	18032	NN	interaction	O	_	_
enhances	18033	18041	VBZ	enhance	O	_	_
the	18042	18045	DT	the	O	_	_
transcription	18046	18059	NN	transcription	O	_	_
function	18060	18068	NN	function	O	_	_
of	18069	18071	IN	of	O	_	_
p53	18072	18075	NN	p53	B-GENE	_	_
in	18076	18078	IN	in	O	_	_
cancer	18079	18085	NN	cancer	O	_	_
cells	18086	18091	NNS	cell	O	_	_
[	18092	18093	VBP	[	O	_	_
2	18093	18094	CD	2	O	_	_
]	18094	18095	CD	]	O	_	_
.	18095	18096	.	.	O	_	_
D	1
5
4	2	det
4	3	nn
5	0	advmod
5	4	nsubj
5	14	ccomp
8	6	det
8	7	nn
8	10	prep_of
10	13	prep_in
13	12	nn
14	8	nsubj
14	16	dobj
16	15	number
EOX
Y	1
ROOT	0	0	18	1	S	3	0	18	5	ADVP	0	0	1	1	RB	0	0	1	1	Moreover	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	2	2	5	3	DT	0	2	3	1	the	2	2	3	0	NN	0	3	4	1	RAS-ASPP	3	3	4	0	NN	0	4	5	1	interaction	4	4	5	0	VP	0	5	17	2	VBZ	0	5	6	1	enhances	5	5	6	0	SBAR	0	6	17	1	S	1	6	17	2	NP	0	6	14	2	NP	2	6	9	3	DT	0	6	7	1	the	6	6	7	0	NN	0	7	8	1	transcription	7	7	8	0	NN	0	8	9	1	function	8	8	9	0	PP	0	9	14	2	IN	0	9	10	1	of	9	9	10	0	NP	0	10	14	2	NP	0	10	11	1	NN	0	10	11	1	p53	10	10	11	0	PP	0	11	14	2	IN	0	11	12	1	in	11	11	12	0	NP	1	12	14	2	NN	0	12	13	1	cancer	12	12	13	0	NNS	0	13	14	1	cells	13	13	14	0	VP	0	14	17	2	VBP	0	14	15	1	[	14	14	15	0	NP	0	15	17	1	QP	1	15	17	2	CD	0	15	16	1	2	15	15	16	0	CD	0	16	17	1	]	16	16	17	0	.	0	17	18	1	.	17	17	18	0
EOS
T	17
Until	18097	18102	IN	until	O	_	_
now	18103	18106	RB	now	O	_	_
,	18106	18107	,	,	O	_	_
it	18108	18110	PRP	it	O	_	_
has	18111	18114	VBZ	have	O	_	_
been	18115	18119	VBN	be	O	_	_
unclear	18120	18127	JJ	unclear	O	_	_
how	18128	18131	WRB	how	O	_	_
RAS	18132	18135	NNP	RAS	B-GENE	_	_
could	18136	18141	MD	could	O	_	_
affect	18142	18148	VB	affect	O	_	_
ASPP2	18149	18154	NN	aspp2	B-GENE	_	_
to	18155	18157	TO	to	O	_	_
enhance	18158	18165	VB	enhance	O	_	_
p53	18166	18169	NN	p53	B-GENE	_	_
function	18170	18178	NN	function	O	_	_
.	18178	18179	.	.	O	_	_
D	1
6
0	1	pobj
6	0	prep
6	3	nsubj
6	4	aux
6	5	cop
6	10	ccomp
10	7	advmod
10	8	nsubj
10	9	aux
10	11	dobj
10	13	xcomp
13	12	aux
13	15	dobj
15	14	nn
EOX
Y	1
ROOT	0	0	17	1	S	3	0	17	5	PP	0	0	2	2	IN	0	0	1	1	Until	0	0	1	0	NP	0	1	2	1	RB	0	1	2	1	now	1	1	2	0	,	0	2	3	1	,	2	2	3	0	NP	0	3	4	1	PRP	0	3	4	1	it	3	3	4	0	VP	1	4	16	2	VBZ	0	4	5	1	has	4	4	5	0	VP	1	5	16	3	VBN	0	5	6	1	been	5	5	6	0	ADJP	0	6	7	1	JJ	0	6	7	1	unclear	6	6	7	0	SBAR	1	7	16	2	WHADVP	0	7	8	1	WRB	0	7	8	1	how	7	7	8	0	S	1	8	16	2	NP	0	8	9	1	NNP	0	8	9	1	RAS	8	8	9	0	VP	1	9	16	2	MD	0	9	10	1	could	9	9	10	0	VP	0	10	16	3	VB	0	10	11	1	affect	10	10	11	0	NP	0	11	12	1	NN	0	11	12	1	ASPP2	11	11	12	0	S	0	12	16	1	VP	1	12	16	2	TO	0	12	13	1	to	12	12	13	0	VP	0	13	16	2	VB	0	13	14	1	enhance	13	13	14	0	NP	1	14	16	2	NN	0	14	15	1	p53	14	14	15	0	NN	0	15	16	1	function	15	15	16	0	.	0	16	17	1	.	16	16	17	0
EOS
T	45
We	18180	18182	PRP	we	O	_	_
show	18183	18187	VBP	show	O	_	_
here	18188	18192	RB	here	O	_	_
that	18193	18197	IN	that	O	_	_
ASPP2	18198	18203	NN	aspp2	B-GENE	_	_
is	18204	18206	VBZ	be	O	_	_
phosphorylated	18207	18221	VBN	phosphorylate	O	_	_
by	18222	18224	IN	by	O	_	_
the	18225	18228	DT	the	O	_	_
RAS	18229	18232	NN	ra	B-GENE	_	_
/	18232	18233	:	/	B-GENE	_	_
Raf/MAPK	18233	18241	NN	raf/mapk	B-GENE	_	_
pathway	18242	18249	NN	pathway	O	_	_
and	18250	18253	CC	and	O	_	_
that	18254	18258	IN	that	O	_	_
this	18259	18263	DT	this	O	_	_
phosphorylation	18264	18279	NN	phosphorylation	O	_	_
leads	18280	18285	VBZ	lead	O	_	_
to	18286	18288	TO	to	O	_	_
its	18289	18292	PRP$	its	O	_	_
increased	18293	18302	VBN	increase	O	_	_
translocation	18303	18316	NN	translocation	O	_	_
to	18317	18319	TO	to	O	_	_
the	18320	18323	DT	the	O	_	_
cytosol	18324	18331	NN	cytosol	O	_	_
/	18331	18332	:	/	O	_	_
nucleus	18332	18339	NN	nucleus	O	_	_
and	18340	18343	CC	and	O	_	_
increased	18344	18353	VBD	increase	O	_	_
binding	18354	18361	NN	binding	O	_	_
to	18362	18364	TO	to	O	_	_
p53	18365	18368	NN	p53	B-GENE	_	_
,	18368	18369	,	,	O	_	_
providing	18370	18379	VBG	provide	O	_	_
an	18380	18382	DT	a	O	_	_
explanation	18383	18394	NN	explanation	O	_	_
of	18395	18397	IN	of	O	_	_
how	18398	18401	WRB	how	O	_	_
RAS	18402	18405	NNP	RAS	B-GENE	_	_
can	18406	18409	MD	can	O	_	_
activate	18410	18418	VB	activate	O	_	_
p53	18419	18422	NN	p53	B-GENE	_	_
pro-apoptotic	18423	18436	JJ	pro-apoptotic	O	_	_
functions	18437	18446	NNS	function	O	_	_
.	18457	18458	.	.	O	_	_
D	1
1
1	0	nsubj
1	2	advmod
1	6	ccomp
6	3	mark
6	4	nsubjpass
6	5	auxpass
6	9	agent
6	31	prep_to
6	33	xcomp
9	8	det
9	17	dep
9	26	dep
9	29	dep
12	11	nn
12	14	conj_and
16	15	det
17	10	punct
17	12	dep
17	14	dep
17	16	nsubj
17	21	prep_to
17	25	punct
21	19	poss
21	20	amod
21	24	prep_to
24	23	det
26	29	conj_and
29	28	amod
33	35	dobj
35	34	det
35	40	prepc_of
40	37	advmod
40	38	nsubj
40	39	aux
40	43	dobj
43	41	nn
43	42	amod
EOX
Y	1
ROOT	0	0	45	1	S	1	0	45	3	NP	0	0	1	1	PRP	0	0	1	1	We	0	0	1	0	VP	0	1	44	3	VBP	0	1	2	1	show	1	1	2	0	ADVP	0	2	3	1	RB	0	2	3	1	here	2	2	3	0	SBAR	1	3	44	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	44	2	NP	0	4	5	1	NN	0	4	5	1	ASPP2	4	4	5	0	VP	1	5	44	2	VBZ	0	5	6	1	is	5	5	6	0	VP	0	6	44	5	VBN	0	6	7	1	phosphorylated	6	6	7	0	PP	0	7	30	2	IN	0	7	8	1	by	7	7	8	0	NP	0	8	30	3	NP	1	8	10	2	DT	0	8	9	1	the	8	8	9	0	NN	0	9	10	1	RAS	9	9	10	0	PRN	1	10	26	3	:	0	10	11	1	/	10	10	11	0	SBAR	1	11	25	2	NP	0	11	15	3	NP	1	11	13	2	NN	0	11	12	1	Raf/MAPK	11	11	12	0	NN	0	12	13	1	pathway	12	12	13	0	CC	0	13	14	1	and	13	13	14	0	ADJP	0	14	15	1	IN	0	14	15	1	that	14	14	15	0	S	1	15	25	2	NP	1	15	17	2	DT	0	15	16	1	this	15	15	16	0	NN	0	16	17	1	phosphorylation	16	16	17	0	VP	0	17	25	2	VBZ	0	17	18	1	leads	17	17	18	0	PP	0	18	25	2	TO	0	18	19	1	to	18	18	19	0	NP	0	19	25	2	NP	2	19	22	3	PRP$	0	19	20	1	its	19	19	20	0	VBN	0	20	21	1	increased	20	20	21	0	NN	0	21	22	1	translocation	21	21	22	0	PP	0	22	25	2	TO	0	22	23	1	to	22	22	23	0	NP	1	23	25	2	DT	0	23	24	1	the	23	23	24	0	NN	0	24	25	1	cytosol	24	24	25	0	:	0	25	26	1	/	25	25	26	0	NP	0	26	30	3	NP	0	26	27	1	NN	0	26	27	1	nucleus	26	26	27	0	CC	0	27	28	1	and	27	27	28	0	NP	1	28	30	2	VBD	0	28	29	1	increased	28	28	29	0	NN	0	29	30	1	binding	29	29	30	0	PP	0	30	32	2	TO	0	30	31	1	to	30	30	31	0	NP	0	31	32	1	NN	0	31	32	1	p53	31	31	32	0	,	0	32	33	1	,	32	32	33	0	S	0	33	44	1	VP	0	33	44	2	VBG	0	33	34	1	providing	33	33	34	0	NP	0	34	44	2	NP	1	34	36	2	DT	0	34	35	1	an	34	34	35	0	NN	0	35	36	1	explanation	35	35	36	0	PP	0	36	44	2	IN	0	36	37	1	of	36	36	37	0	SBAR	1	37	44	2	WHADVP	0	37	38	1	WRB	0	37	38	1	how	37	37	38	0	S	1	38	44	2	NP	0	38	39	1	NNP	0	38	39	1	RAS	38	38	39	0	VP	1	39	44	2	MD	0	39	40	1	can	39	39	40	0	VP	0	40	44	2	VB	0	40	41	1	activate	40	40	41	0	NP	2	41	44	3	NN	0	41	42	1	p53	41	41	42	0	JJ	0	42	43	1	pro-apoptotic	42	42	43	0	NNS	0	43	44	1	functions	43	43	44	0	.	0	44	45	1	.	44	44	45	0
EOS
T	20
Additionally	18459	18471	RB	additionally	O	_	_
,	18471	18472	,	,	O	_	_
RAS	18473	18476	NN	ra	B-GENE	_	_
/	18476	18477	:	/	B-GENE	_	_
Raf/MAPK	18477	18485	NN	raf/mapk	B-GENE	_	_
pathway	18486	18493	NN	pathway	O	_	_
activation	18494	18504	NN	activation	O	_	_
stabilizes	18505	18515	VBZ	stabilize	O	_	_
ASPP2	18516	18521	NN	aspp2	B-GENE	_	_
protein	18522	18529	NN	protein	I-GENE	_	_
,	18529	18530	,	,	O	_	_
although	18531	18539	IN	although	O	_	_
the	18540	18543	DT	the	O	_	_
underlying	18544	18554	VBG	underlie	O	_	_
mechanism	18555	18564	NN	mechanism	O	_	_
remains	18565	18572	VBZ	remain	O	_	_
to	18573	18575	TO	to	O	_	_
be	18576	18578	VB	be	O	_	_
investigated	18579	18591	VBN	investigate	O	_	_
.	18591	18592	.	.	O	_	_
D	1
7
2	4	dep
4	3	punct
4	6	dep
6	5	nn
7	0	advmod
7	2	nsubj
7	9	dobj
7	15	advcl
9	8	nn
14	12	det
14	13	amod
15	11	mark
15	14	nsubj
15	18	xcomp
18	16	aux
18	17	auxpass
EOX
Y	1
ROOT	0	0	20	1	S	3	0	20	5	ADVP	0	0	1	1	RB	0	0	1	1	Additionally	0	0	1	0	,	0	1	2	1	,	1	1	2	0	NP	0	2	7	2	NP	0	2	3	1	NN	0	2	3	1	RAS	2	2	3	0	PRN	1	3	7	2	:	0	3	4	1	/	3	3	4	0	NP	0	4	7	2	NP	0	4	5	1	NN	0	4	5	1	Raf/MAPK	4	4	5	0	NP	1	5	7	2	NN	0	5	6	1	pathway	5	5	6	0	NN	0	6	7	1	activation	6	6	7	0	VP	0	7	19	4	VBZ	0	7	8	1	stabilizes	7	7	8	0	NP	1	8	10	2	NN	0	8	9	1	ASPP2	8	8	9	0	NN	0	9	10	1	protein	9	9	10	0	,	0	10	11	1	,	10	10	11	0	SBAR	1	11	19	2	IN	0	11	12	1	although	11	11	12	0	S	1	12	19	2	NP	2	12	15	3	DT	0	12	13	1	the	12	12	13	0	VBG	0	13	14	1	underlying	13	13	14	0	NN	0	14	15	1	mechanism	14	14	15	0	VP	0	15	19	2	VBZ	0	15	16	1	remains	15	15	16	0	S	0	16	19	1	VP	1	16	19	2	TO	0	16	17	1	to	16	16	17	0	VP	1	17	19	2	VB	0	17	18	1	be	17	17	18	0	VP	0	18	19	1	VBN	0	18	19	1	investigated	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	5
10.1371	18593	18600	CD	10.1371	O	_	_
/	18600	18601	:	/	O	_	_
journal.pone	18601	18613	NN	journal.pone	O	_	_
.0082022	18613	18621	CD	.0082022	O	_	_
.	18621	18622	.	.	O	_	_
D	1
0
0	1	punct
0	2	dep
2	3	dep
EOX
Y	1
ROOT	0	0	5	1	FRAG	0	0	5	4	NP	0	0	1	1	CD	0	0	1	1	10.1371	0	0	1	0	:	0	1	2	1	/	1	1	2	0	FRAG	0	2	4	2	NP	0	2	3	1	NN	0	2	3	1	journal.pone	2	2	3	0	NP	0	3	4	1	CD	0	3	4	1	.0082022	3	3	4	0	.	0	4	5	1	.	4	4	5	0
EOS
T	10
g005	18622	18626	NN	g005	O	_	_
Diagram	18636	18643	NN	diagram	O	_	_
summarizes	18644	18654	VBZ	summarize	O	_	_
the	18655	18658	DT	the	O	_	_
inter-regulation	18659	18675	NN	inter-regulation	O	_	_
between	18676	18683	IN	between	O	_	_
ASPP2	18684	18689	NN	aspp2	B-GENE	_	_
and	18690	18693	CC	and	O	_	_
RAS	18694	18697	NN	ra	B-GENE	_	_
.	18697	18698	.	.	O	_	_
D	1
2
1	0	nn
2	1	nsubj
2	4	dobj
4	3	det
4	6	prep_between
4	8	prep_between
6	8	conj_and
EOX
Y	1
ROOT	0	0	10	1	S	1	0	10	3	NP	1	0	2	2	NN	0	0	1	1	g005	0	0	1	0	NN	0	1	2	1	Diagram	1	1	2	0	VP	0	2	9	2	VBZ	0	2	3	1	summarizes	2	2	3	0	NP	0	3	9	2	NP	1	3	5	2	DT	0	3	4	1	the	3	3	4	0	NN	0	4	5	1	inter-regulation	4	4	5	0	PP	0	5	9	2	IN	0	5	6	1	between	5	5	6	0	NP	0	6	9	3	NN	0	6	7	1	ASPP2	6	6	7	0	CC	0	7	8	1	and	7	7	8	0	NN	0	8	9	1	RAS	8	8	9	0	.	0	9	10	1	.	9	9	10	0
EOS
T	22
ASPP2	18699	18704	NN	aspp2	B-GENE	_	_
binds	18705	18710	VBZ	bind	O	_	_
active	18711	18717	JJ	active	O	_	_
RAS	18718	18721	NN	ra	O	_	_
at	18722	18724	IN	at	O	_	_
the	18725	18728	DT	the	O	_	_
plasma	18729	18735	NN	plasma	O	_	_
membrane	18736	18744	NN	membrane	O	_	_
,	18744	18745	,	,	O	_	_
thereby	18746	18753	RB	thereby	O	_	_
increasing	18754	18764	VBG	increase	O	_	_
RAS	18765	18768	NN	ra	O	_	_
signaling	18769	18778	NN	signaling	O	_	_
to	18779	18781	TO	to	O	_	_
its	18782	18785	PRP$	its	O	_	_
downstream	18786	18796	JJ	downstream	O	_	_
pathway	18797	18804	NN	pathway	O	_	_
effectors	18805	18814	NNS	effector	O	_	_
Raf	18815	18818	NN	raf	B-GENE	_	_
/	18818	18819	:	/	B-GENE	_	_
MAPK	18819	18823	NN	mapk	I-GENE	_	_
.	18823	18824	.	.	O	_	_
D	1
1
1	0	nsubj
1	3	dobj
1	7	prep_at
1	10	vmod
3	2	amod
7	5	det
7	6	nn
10	9	advmod
10	12	dobj
10	18	prep_to
12	11	nn
18	14	poss
18	15	amod
18	16	nn
18	17	nn
18	20	dep
20	19	punct
EOX
Y	1
ROOT	0	0	22	1	S	1	0	22	3	NP	0	0	1	1	NN	0	0	1	1	ASPP2	0	0	1	0	VP	0	1	21	5	VBZ	0	1	2	1	binds	1	1	2	0	NP	1	2	4	2	JJ	0	2	3	1	active	2	2	3	0	NN	0	3	4	1	RAS	3	3	4	0	PP	0	4	8	2	IN	0	4	5	1	at	4	4	5	0	NP	2	5	8	3	DT	0	5	6	1	the	5	5	6	0	NN	0	6	7	1	plasma	6	6	7	0	NN	0	7	8	1	membrane	7	7	8	0	,	0	8	9	1	,	8	8	9	0	S	1	9	21	2	ADVP	0	9	10	1	RB	0	9	10	1	thereby	9	9	10	0	VP	0	10	21	3	VBG	0	10	11	1	increasing	10	10	11	0	NP	1	11	13	2	NN	0	11	12	1	RAS	11	11	12	0	NN	0	12	13	1	signaling	12	12	13	0	PP	0	13	21	2	TO	0	13	14	1	to	13	13	14	0	NP	0	14	21	2	NP	4	14	19	5	PRP$	0	14	15	1	its	14	14	15	0	JJ	0	15	16	1	downstream	15	15	16	0	NN	0	16	17	1	pathway	16	16	17	0	NNS	0	17	18	1	effectors	17	17	18	0	NN	0	18	19	1	Raf	18	18	19	0	PRN	1	19	21	2	:	0	19	20	1	/	19	19	20	0	NP	0	20	21	1	NN	0	20	21	1	MAPK	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	17
Activated	18825	18834	VBN	activate	O	_	_
MAPK	18835	18839	NN	mapk	O	_	_
phosphorylates	18840	18854	VBZ	phosphorylate	O	_	_
ASPP2	18855	18860	NN	aspp2	B-GENE	_	_
which	18861	18866	WDT	which	O	_	_
can	18867	18870	MD	can	O	_	_
then	18871	18875	RB	then	O	_	_
relocate	18876	18884	VB	relocate	O	_	_
to	18885	18887	TO	to	O	_	_
the	18888	18891	DT	the	O	_	_
nucleus	18892	18899	NN	nucleus	O	_	_
and	18900	18903	CC	and	O	_	_
activate	18904	18912	VBP	activate	O	_	_
p53	18913	18916	NN	p53	B-GENE	_	_
pro-apoptotic	18917	18930	JJ	pro-apoptotic	O	_	_
signaling	18931	18940	NN	signaling	O	_	_
.	18940	18941	.	.	O	_	_
D	1
0
0	1	dobj
0	2	dep
0	3	nsubj
3	7	ccomp
3	12	ccomp
7	4	nsubj
7	5	aux
7	6	advmod
7	10	prep_to
7	12	conj_and
10	9	det
12	4	nsubj
12	15	dobj
15	13	nn
15	14	amod
EOX
Y	1
ROOT	0	0	17	1	SINV	0	0	17	4	VP	0	0	2	2	VBN	0	0	1	1	Activated	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	MAPK	1	1	2	0	VP	0	2	3	1	VBZ	0	2	3	1	phosphorylates	2	2	3	0	NP	0	3	16	2	NN	0	3	4	1	ASPP2	3	3	4	0	SBAR	1	4	16	2	WHNP	0	4	5	1	WDT	0	4	5	1	which	4	4	5	0	S	0	5	16	1	VP	0	5	16	3	VP	2	5	11	3	MD	0	5	6	1	can	5	5	6	0	RB	0	6	7	1	then	6	6	7	0	VP	0	7	11	2	VB	0	7	8	1	relocate	7	7	8	0	PP	0	8	11	2	TO	0	8	9	1	to	8	8	9	0	NP	1	9	11	2	DT	0	9	10	1	the	9	9	10	0	NN	0	10	11	1	nucleus	10	10	11	0	CC	0	11	12	1	and	11	11	12	0	VP	0	12	16	2	VBP	0	12	13	1	activate	12	12	13	0	NP	2	13	16	3	NN	0	13	14	1	p53	13	13	14	0	JJ	0	14	15	1	pro-apoptotic	14	14	15	0	NN	0	15	16	1	signaling	15	15	16	0	.	0	16	17	1	.	16	16	17	0
EOS
T	30
Thus	18942	18946	RB	thus	O	_	_
ASPP2	18947	18952	NN	aspp2	O	_	_
is	18953	18955	VBZ	be	O	_	_
both	18956	18960	DT	both	O	_	_
upstream	18961	18969	JJ	upstream	O	_	_
of	18970	18972	IN	of	O	_	_
RAS	18973	18976	NN	ra	B-GENE	_	_
,	18976	18977	,	,	O	_	_
by	18978	18980	IN	by	O	_	_
binding	18981	18988	VBG	bind	O	_	_
active	18989	18995	JJ	active	O	_	_
RAS	18996	18999	NN	ra	O	_	_
and	19000	19003	CC	and	O	_	_
enhancing	19004	19013	VBG	enhance	O	_	_
its	19014	19017	PRP$	its	O	_	_
downstream	19018	19028	JJ	downstream	O	_	_
pathway	19029	19036	NN	pathway	O	_	_
activity	19037	19045	NN	activity	O	_	_
,	19045	19046	,	,	O	_	_
as	19047	19049	RB	as	O	_	_
well	19050	19054	RB	well	O	_	_
as	19055	19057	IN	as	O	_	_
downstream	19058	19068	JJ	downstream	O	_	_
of	19069	19071	IN	of	O	_	_
the	19072	19075	DT	the	O	_	_
RAS	19076	19079	NN	ra	B-GENE	_	_
/	19079	19080	:	/	B-GENE	_	_
RAF/MAPK	19080	19088	NN	raf/mapk	B-GENE	_	_
pathway	19089	19096	NN	pathway	O	_	_
.	19096	19097	.	.	O	_	_
D	1
4
4	0	advmod
4	1	nsubj
4	2	cop
4	3	det
4	6	prep_of
4	11	prep_by
4	13	conj_and
11	9	amod
11	10	amod
13	1	nsubj
13	17	dobj
13	22	dobj
17	14	poss
17	15	amod
17	16	nn
17	22	conj_and
22	25	prep_of
25	24	det
25	28	dep
28	26	punct
28	27	nn
EOX
Y	1
ROOT	0	0	30	1	S	0	0	30	4	S	2	0	12	3	ADVP	0	0	1	1	RB	0	0	1	1	Thus	0	0	1	0	NP	0	1	2	1	NN	0	1	2	1	ASPP2	1	1	2	0	VP	1	2	12	4	VBZ	0	2	3	1	is	2	2	3	0	NP	0	3	7	2	NP	1	3	5	2	DT	0	3	4	1	both	3	3	4	0	JJ	0	4	5	1	upstream	4	4	5	0	PP	0	5	7	2	IN	0	5	6	1	of	5	5	6	0	NP	0	6	7	1	NN	0	6	7	1	RAS	6	6	7	0	,	0	7	8	1	,	7	7	8	0	PP	0	8	12	2	IN	0	8	9	1	by	8	8	9	0	NP	2	9	12	3	VBG	0	9	10	1	binding	9	9	10	0	JJ	0	10	11	1	active	10	10	11	0	NN	0	11	12	1	RAS	11	11	12	0	CC	0	12	13	1	and	12	12	13	0	S	0	13	29	1	VP	0	13	29	2	VBG	0	13	14	1	enhancing	13	13	14	0	NP	0	14	29	4	NP	3	14	18	4	PRP$	0	14	15	1	its	14	14	15	0	JJ	0	15	16	1	downstream	15	15	16	0	NN	0	16	17	1	pathway	16	16	17	0	NN	0	17	18	1	activity	17	17	18	0	,	0	18	19	1	,	18	18	19	0	CONJP	1	19	22	3	RB	0	19	20	1	as	19	19	20	0	RB	0	20	21	1	well	20	20	21	0	IN	0	21	22	1	as	21	21	22	0	NP	0	22	29	2	NP	0	22	23	1	JJ	0	22	23	1	downstream	22	22	23	0	PP	0	23	29	2	IN	0	23	24	1	of	23	23	24	0	NP	0	24	29	2	NP	1	24	26	2	DT	0	24	25	1	the	24	24	25	0	NN	0	25	26	1	RAS	25	25	26	0	PRN	1	26	29	2	:	0	26	27	1	/	26	26	27	0	NP	1	27	29	2	NN	0	27	28	1	RAF/MAPK	27	27	28	0	NN	0	28	29	1	pathway	28	28	29	0	.	0	29	30	1	.	29	29	30	0
EOS
T	15
It	19098	19100	PRP	it	O	_	_
is	19101	19103	VBZ	be	O	_	_
likely	19104	19110	JJ	likely	O	_	_
that	19111	19115	IN	that	O	_	_
this	19116	19120	DT	this	O	_	_
possible	19121	19129	JJ	possible	O	_	_
feedback	19130	19138	NN	feedback	O	_	_
loop	19139	19143	NN	loop	O	_	_
leads	19144	19149	VBZ	lead	O	_	_
to	19150	19152	TO	to	O	_	_
an	19153	19155	DT	a	O	_	_
amplified	19156	19165	VBN	amplify	O	_	_
pro-apoptotic	19166	19179	JJ	pro-apoptotic	O	_	_
signal	19180	19186	NN	signal	O	_	_
.	19186	19187	.	.	O	_	_
D	1
2
2	0	nsubj
2	1	cop
2	8	ccomp
7	4	det
7	5	amod
7	6	nn
8	3	mark
8	7	nsubj
8	13	prep_to
13	10	det
13	11	amod
13	12	amod
EOX
Y	1
ROOT	0	0	15	1	S	1	0	15	3	NP	0	0	1	1	PRP	0	0	1	1	It	0	0	1	0	VP	1	1	14	3	VBZ	0	1	2	1	is	1	1	2	0	ADJP	0	2	3	1	JJ	0	2	3	1	likely	2	2	3	0	SBAR	1	3	14	2	IN	0	3	4	1	that	3	3	4	0	S	1	4	14	2	NP	3	4	8	4	DT	0	4	5	1	this	4	4	5	0	JJ	0	5	6	1	possible	5	5	6	0	NN	0	6	7	1	feedback	6	6	7	0	NN	0	7	8	1	loop	7	7	8	0	VP	0	8	14	2	VBZ	0	8	9	1	leads	8	8	9	0	PP	0	9	14	2	TO	0	9	10	1	to	9	9	10	0	NP	3	10	14	4	DT	0	10	11	1	an	10	10	11	0	VBN	0	11	12	1	amplified	11	11	12	0	JJ	0	12	13	1	pro-apoptotic	12	12	13	0	NN	0	13	14	1	signal	13	13	14	0	.	0	14	15	1	.	14	14	15	0
EOS
T	24
In	19188	19190	IN	in	O	_	_
a	19191	19192	DT	a	O	_	_
scenario	19193	19201	NN	scenario	O	_	_
where	19202	19207	WRB	where	O	_	_
RAS	19208	19211	NNP	RAS	O	_	_
is	19212	19214	VBZ	be	O	_	_
mutated	19215	19222	VBN	mutate	O	_	_
and	19223	19226	CC	and	O	_	_
thereby	19227	19234	RB	thereby	O	_	_
constitutively	19235	19249	RB	constitutively	O	_	_
active	19250	19256	JJ	active	O	_	_
,	19256	19257	,	,	O	_	_
it	19258	19260	PRP	it	O	_	_
binds	19261	19266	VBZ	bind	O	_	_
ASPP2	19267	19272	NN	aspp2	B-GENE	_	_
,	19272	19273	,	,	O	_	_
resulting	19274	19283	VBG	result	O	_	_
in	19284	19286	IN	in	O	_	_
increased	19287	19296	VBN	increase	O	_	_
RAS	19297	19300	NN	ra	B-GENE	_	_
/	19300	19301	:	/	B-GENE	_	_
MAPK	19301	19305	NN	mapk	I-GENE	_	_
signaling	19306	19315	NN	signaling	O	_	_
.	19315	19316	.	.	O	_	_
D	1
13
2	1	det
2	5	rcmod
5	3	advmod
5	4	nsubj
5	6	dep
5	8	dep
5	10	dep
6	8	conj_and
6	10	conj_and
10	9	advmod
13	2	prep_in
13	12	nsubj
13	14	dobj
13	16	vmod
16	19	prep_in
19	18	amod
19	22	dep
22	20	punct
22	21	nn
EOX
Y	1
ROOT	0	0	24	1	S	3	0	24	5	PP	0	0	11	2	IN	0	0	1	1	In	0	0	1	0	NP	0	1	11	2	NP	1	1	3	2	DT	0	1	2	1	a	1	1	2	0	NN	0	2	3	1	scenario	2	2	3	0	SBAR	1	3	11	2	WHADVP	0	3	4	1	WRB	0	3	4	1	where	3	3	4	0	S	1	4	11	2	NP	0	4	5	1	NNP	0	4	5	1	RAS	4	4	5	0	VP	0	5	11	2	VBZ	0	5	6	1	is	5	5	6	0	UCP	0	6	11	4	VP	0	6	7	1	VBN	0	6	7	1	mutated	6	6	7	0	CC	0	7	8	1	and	7	7	8	0	ADVP	0	8	9	1	RB	0	8	9	1	thereby	8	8	9	0	ADJP	1	9	11	2	RB	0	9	10	1	constitutively	9	9	10	0	JJ	0	10	11	1	active	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	0	12	13	1	PRP	0	12	13	1	it	12	12	13	0	VP	0	13	23	4	VBZ	0	13	14	1	binds	13	13	14	0	NP	0	14	15	1	NN	0	14	15	1	ASPP2	14	14	15	0	,	0	15	16	1	,	15	15	16	0	S	0	16	23	1	VP	0	16	23	2	VBG	0	16	17	1	resulting	16	16	17	0	PP	0	17	23	2	IN	0	17	18	1	in	17	17	18	0	NP	0	18	23	2	NP	1	18	20	2	VBN	0	18	19	1	increased	18	18	19	0	NN	0	19	20	1	RAS	19	19	20	0	PRN	1	20	23	2	:	0	20	21	1	/	20	20	21	0	NP	1	21	23	2	NN	0	21	22	1	MAPK	21	21	22	0	NN	0	22	23	1	signaling	22	22	23	0	.	0	23	24	1	.	23	23	24	0
EOS
T	18
This	19317	19321	DT	this	O	_	_
in	19322	19324	IN	in	O	_	_
turn	19325	19329	NN	turn	O	_	_
activates	19330	19339	VBZ	activate	O	_	_
ASPP2	19340	19345	NN	aspp2	B-GENE	_	_
via	19346	19349	IN	via	O	_	_
MAPK	19350	19354	NN	mapk	B-GENE	_	_
phosphorylation	19355	19370	NN	phosphorylation	O	_	_
which	19371	19376	WDT	which	O	_	_
will	19377	19381	MD	will	O	_	_
translocate	19382	19393	VB	translocate	O	_	_
and	19394	19397	CC	and	O	_	_
activate	19398	19406	VB	activate	O	_	_
p53	19407	19410	NN	p53	B-GENE	_	_
to	19411	19413	TO	to	O	_	_
promote	19414	19421	VB	promote	O	_	_
apoptosis	19422	19431	NN	apoptosis	O	_	_
.	19431	19432	.	.	O	_	_
D	1
3
0	2	prep_in
3	0	nsubj
3	4	dobj
4	7	prep_via
4	10	rcmod
4	12	rcmod
7	6	nn
10	8	nsubj
10	9	aux
10	12	conj_and
10	13	dobj
10	15	xcomp
12	8	nsubj
15	14	aux
15	16	dobj
EOX
Y	1
ROOT	0	0	18	1	S	1	0	18	3	NP	0	0	3	2	NP	0	0	1	1	DT	0	0	1	1	This	0	0	1	0	PP	0	1	3	2	IN	0	1	2	1	in	1	1	2	0	NP	0	2	3	1	NN	0	2	3	1	turn	2	2	3	0	VP	0	3	17	2	VBZ	0	3	4	1	activates	3	3	4	0	NP	0	4	17	3	NP	0	4	5	1	NN	0	4	5	1	ASPP2	4	4	5	0	PP	0	5	8	2	IN	0	5	6	1	via	5	5	6	0	NP	1	6	8	2	NN	0	6	7	1	MAPK	6	6	7	0	NN	0	7	8	1	phosphorylation	7	7	8	0	SBAR	1	8	17	2	WHNP	0	8	9	1	WDT	0	8	9	1	which	8	8	9	0	S	0	9	17	1	VP	1	9	17	2	MD	0	9	10	1	will	9	9	10	0	VP	0	10	17	5	VB	0	10	11	1	translocate	10	10	11	0	CC	0	11	12	1	and	11	11	12	0	VB	0	12	13	1	activate	12	12	13	0	NP	0	13	14	1	NN	0	13	14	1	p53	13	13	14	0	S	0	14	17	1	VP	1	14	17	2	TO	0	14	15	1	to	14	14	15	0	VP	0	15	17	2	VB	0	15	16	1	promote	15	15	16	0	NP	0	16	17	1	NN	0	16	17	1	apoptosis	16	16	17	0	.	0	17	18	1	.	17	17	18	0
EOS
T	19
ASPP2	19433	19438	NN	aspp2	B-GENE	_	_
will	19439	19443	MD	will	O	_	_
also	19444	19448	RB	also	O	_	_
continue	19449	19457	VB	continue	O	_	_
to	19458	19460	TO	to	O	_	_
bind	19461	19465	VB	bind	O	_	_
active	19466	19472	JJ	active	O	_	_
RAS	19473	19476	NN	ra	O	_	_
,	19476	19477	,	,	O	_	_
thereby	19478	19485	RB	thereby	O	_	_
propagating	19486	19497	VBG	propagate	O	_	_
the	19498	19501	DT	the	O	_	_
pro-apoptotic	19502	19515	JJ	pro-apoptotic	O	_	_
signal	19516	19522	NN	signal	O	_	_
from	19523	19527	IN	from	O	_	_
RAS	19528	19531	NN	ra	O	_	_
to	19532	19534	TO	to	O	_	_
p53	19535	19538	NN	p53	B-GENE	_	_
.	19538	19539	.	.	O	_	_
D	1
3
3	0	nsubj
3	1	aux
3	2	advmod
3	5	xcomp
5	4	aux
5	7	dobj
5	10	vmod
7	6	amod
10	9	advmod
10	13	dobj
10	15	prep_from
10	17	prep_to
13	11	det
13	12	amod
EOX
Y	1
ROOT	0	0	19	1	S	1	0	19	3	NP	0	0	1	1	NN	0	0	1	1	ASPP2	0	0	1	0	VP	2	1	18	3	MD	0	1	2	1	will	1	1	2	0	ADVP	0	2	3	1	RB	0	2	3	1	also	2	2	3	0	VP	0	3	18	2	VB	0	3	4	1	continue	3	3	4	0	S	0	4	18	1	VP	1	4	18	2	TO	0	4	5	1	to	4	4	5	0	VP	0	5	18	4	VB	0	5	6	1	bind	5	5	6	0	NP	1	6	8	2	JJ	0	6	7	1	active	6	6	7	0	NN	0	7	8	1	RAS	7	7	8	0	,	0	8	9	1	,	8	8	9	0	S	1	9	18	2	ADVP	0	9	10	1	RB	0	9	10	1	thereby	9	9	10	0	VP	0	10	18	4	VBG	0	10	11	1	propagating	10	10	11	0	NP	2	11	14	3	DT	0	11	12	1	the	11	11	12	0	JJ	0	12	13	1	pro-apoptotic	12	12	13	0	NN	0	13	14	1	signal	13	13	14	0	PP	0	14	16	2	IN	0	14	15	1	from	14	14	15	0	NP	0	15	16	1	NN	0	15	16	1	RAS	15	15	16	0	PP	0	16	18	2	TO	0	16	17	1	to	16	16	17	0	NP	0	17	18	1	NN	0	17	18	1	p53	17	17	18	0	.	0	18	19	1	.	18	18	19	0
EOS
T	43
If	19540	19542	IN	if	O	_	_
RAS	19543	19546	NN	ra	O	_	_
is	19547	19549	VBZ	be	O	_	_
only	19550	19554	RB	only	O	_	_
temporarily	19555	19566	RB	temporarily	O	_	_
active	19567	19573	JJ	active	O	_	_
,	19573	19574	,	,	O	_	_
as	19575	19577	IN	as	O	_	_
happens	19578	19585	VBZ	happen	O	_	_
in	19586	19588	IN	in	O	_	_
natural	19589	19596	JJ	natural	O	_	_
growth	19597	19603	NN	growth	O	_	_
conditions	19604	19614	NNS	condition	O	_	_
,	19614	19615	,	,	O	_	_
one	19616	19619	CD	one	O	_	_
could	19620	19625	MD	could	O	_	_
hypothesize	19626	19637	VB	hypothesize	O	_	_
that	19638	19642	IN	that	O	_	_
ASPP2	19643	19648	NN	aspp2	B-GENE	_	_
would	19649	19654	MD	would	O	_	_
bind	19655	19659	VB	bind	O	_	_
active	19660	19666	JJ	active	O	_	_
RAS	19667	19670	NN	ra	O	_	_
,	19670	19671	,	,	O	_	_
potentiate	19672	19682	VB	potentiate	O	_	_
its	19683	19686	PRP$	its	O	_	_
downstream	19687	19697	JJ	downstream	O	_	_
pathways	19698	19706	NNS	pathway	O	_	_
,	19706	19707	,	,	O	_	_
and	19708	19711	CC	and	O	_	_
MAPK	19712	19716	NN	mapk	B-GENE	_	_
mediated	19717	19725	VBD	mediate	O	_	_
phosphorylation	19726	19741	NN	phosphorylation	O	_	_
of	19742	19744	IN	of	O	_	_
ASPP2	19745	19750	NN	aspp2	B-GENE	_	_
would	19751	19756	MD	would	O	_	_
lead	19757	19761	VB	lead	O	_	_
to	19762	19764	TO	to	O	_	_
increased	19765	19774	VBN	increase	O	_	_
binding	19775	19782	NN	binding	O	_	_
to	19783	19785	TO	to	O	_	_
p53	19786	19789	NN	p53	B-GENE	_	_
.	19789	19790	.	.	O	_	_
D	1
16
5	0	mark
5	1	nsubj
5	2	cop
5	3	advmod
5	4	advmod
5	8	advcl
8	7	mark
8	12	prep_in
12	10	amod
12	11	nn
16	5	advcl
16	14	nsubj
16	15	aux
16	20	ccomp
16	31	conj_and
20	17	mark
20	18	nsubj
20	19	aux
20	22	dobj
20	24	dep
22	21	amod
24	27	dobj
27	25	poss
27	26	amod
31	30	nsubj
31	36	ccomp
32	34	prep_of
36	32	nsubj
36	35	aux
36	39	prep_to
39	38	amod
39	41	prep_to
EOX
Y	1
ROOT	0	0	43	1	S	0	0	43	5	S	3	0	28	4	SBAR	1	0	13	2	IN	0	0	1	1	If	0	0	1	0	S	1	1	13	2	NP	0	1	2	1	NN	0	1	2	1	RAS	1	1	2	0	VP	2	2	13	5	VBZ	0	2	3	1	is	2	2	3	0	ADVP	0	3	4	1	RB	0	3	4	1	only	3	3	4	0	ADJP	1	4	6	2	RB	0	4	5	1	temporarily	4	4	5	0	JJ	0	5	6	1	active	5	5	6	0	,	0	6	7	1	,	6	6	7	0	SBAR	1	7	13	2	IN	0	7	8	1	as	7	7	8	0	S	0	8	13	1	VP	0	8	13	2	VBZ	0	8	9	1	happens	8	8	9	0	PP	0	9	13	2	IN	0	9	10	1	in	9	9	10	0	NP	2	10	13	3	JJ	0	10	11	1	natural	10	10	11	0	NN	0	11	12	1	growth	11	11	12	0	NNS	0	12	13	1	conditions	12	12	13	0	,	0	13	14	1	,	13	13	14	0	NP	0	14	15	1	CD	0	14	15	1	one	14	14	15	0	VP	1	15	28	2	MD	0	15	16	1	could	15	15	16	0	VP	0	16	28	2	VB	0	16	17	1	hypothesize	16	16	17	0	SBAR	1	17	28	2	IN	0	17	18	1	that	17	17	18	0	S	1	18	28	2	NP	0	18	19	1	NN	0	18	19	1	ASPP2	18	18	19	0	VP	1	19	28	4	MD	0	19	20	1	would	19	19	20	0	VP	0	20	23	2	VB	0	20	21	1	bind	20	20	21	0	NP	1	21	23	2	JJ	0	21	22	1	active	21	21	22	0	NN	0	22	23	1	RAS	22	22	23	0	,	0	23	24	1	,	23	23	24	0	VP	0	24	28	2	VB	0	24	25	1	potentiate	24	24	25	0	NP	2	25	28	3	PRP$	0	25	26	1	its	25	25	26	0	JJ	0	26	27	1	downstream	26	26	27	0	NNS	0	27	28	1	pathways	27	27	28	0	,	0	28	29	1	,	28	28	29	0	CC	0	29	30	1	and	29	29	30	0	S	1	30	42	2	NP	0	30	31	1	NN	0	30	31	1	MAPK	30	30	31	0	VP	0	31	42	2	VBD	0	31	32	1	mediated	31	31	32	0	SBAR	0	32	42	1	S	1	32	42	2	NP	0	32	35	2	NP	0	32	33	1	NN	0	32	33	1	phosphorylation	32	32	33	0	PP	0	33	35	2	IN	0	33	34	1	of	33	33	34	0	NP	0	34	35	1	NN	0	34	35	1	ASPP2	34	34	35	0	VP	1	35	42	2	MD	0	35	36	1	would	35	35	36	0	VP	0	36	42	2	VB	0	36	37	1	lead	36	36	37	0	PP	0	37	42	2	TO	0	37	38	1	to	37	37	38	0	NP	0	38	42	2	NP	1	38	40	2	VBN	0	38	39	1	increased	38	38	39	0	NN	0	39	40	1	binding	39	39	40	0	PP	0	40	42	2	TO	0	40	41	1	to	40	40	41	0	NP	0	41	42	1	NN	0	41	42	1	p53	41	41	42	0	.	0	42	43	1	.	42	42	43	0
EOS
T	31
However	19791	19798	RB	however	O	_	_
,	19798	19799	,	,	O	_	_
once	19800	19804	RB	once	O	_	_
RAS	19805	19808	NNP	RAS	B-GENE	_	_
reverts	19809	19816	VBZ	revert	O	_	_
to	19817	19819	TO	to	O	_	_
its	19820	19823	PRP$	its	O	_	_
inactive	19824	19832	JJ	inactive	O	_	_
state	19833	19838	NN	state	O	_	_
,	19838	19839	,	,	O	_	_
it	19840	19842	PRP	it	O	_	_
would	19843	19848	MD	would	O	_	_
be	19849	19851	VB	be	O	_	_
unable	19852	19858	JJ	unable	O	_	_
to	19859	19861	TO	to	O	_	_
bind	19862	19866	VB	bind	O	_	_
to	19867	19869	TO	to	O	_	_
ASPP2	19870	19875	NN	aspp2	B-GENE	_	_
and	19876	19879	CC	and	O	_	_
would	19880	19885	MD	would	O	_	_
therefore	19886	19895	RB	therefore	O	_	_
be	19896	19898	VB	be	O	_	_
unable	19899	19905	JJ	unable	O	_	_
to	19906	19908	TO	to	O	_	_
amplify	19909	19916	VB	amplify	O	_	_
the	19917	19920	DT	the	O	_	_
RAS	19921	19924	NN	ra	O	_	_
signal	19925	19931	NN	signal	O	_	_
to	19932	19934	TO	to	O	_	_
p53	19935	19938	NN	p53	B-GENE	_	_
.	19938	19939	.	.	O	_	_
D	1
13
4	2	advmod
4	3	nsubj
4	8	prep_to
8	6	poss
8	7	amod
13	0	advmod
13	4	advcl
13	10	nsubj
13	11	aux
13	12	cop
13	15	xcomp
13	22	conj_and
15	14	aux
15	17	prep_to
22	10	nsubj
22	19	aux
22	20	advmod
22	21	cop
22	24	xcomp
24	23	aux
24	27	dobj
24	29	prep_to
27	25	det
27	26	nn
EOX
Y	1
ROOT	0	0	31	1	S	5	0	31	7	ADVP	0	0	1	1	RB	0	0	1	1	However	0	0	1	0	,	0	1	2	1	,	1	1	2	0	SBAR	1	2	9	2	RB	0	2	3	1	once	2	2	3	0	S	1	3	9	2	NP	0	3	4	1	NNP	0	3	4	1	RAS	3	3	4	0	VP	0	4	9	2	VBZ	0	4	5	1	reverts	4	4	5	0	PP	0	5	9	2	TO	0	5	6	1	to	5	5	6	0	NP	2	6	9	3	PRP$	0	6	7	1	its	6	6	7	0	JJ	0	7	8	1	inactive	7	7	8	0	NN	0	8	9	1	state	8	8	9	0	,	0	9	10	1	,	9	9	10	0	NP	0	10	11	1	PRP	0	10	11	1	it	10	10	11	0	VP	0	11	30	3	VP	1	11	18	2	MD	0	11	12	1	would	11	11	12	0	VP	1	12	18	2	VB	0	12	13	1	be	12	12	13	0	ADJP	0	13	18	2	JJ	0	13	14	1	unable	13	13	14	0	S	0	14	18	1	VP	1	14	18	2	TO	0	14	15	1	to	14	14	15	0	VP	0	15	18	2	VB	0	15	16	1	bind	15	15	16	0	PP	0	16	18	2	TO	0	16	17	1	to	16	16	17	0	NP	0	17	18	1	NN	0	17	18	1	ASPP2	17	17	18	0	CC	0	18	19	1	and	18	18	19	0	VP	2	19	30	3	MD	0	19	20	1	would	19	19	20	0	ADVP	0	20	21	1	RB	0	20	21	1	therefore	20	20	21	0	VP	1	21	30	2	VB	0	21	22	1	be	21	21	22	0	ADJP	0	22	30	2	JJ	0	22	23	1	unable	22	22	23	0	S	0	23	30	1	VP	1	23	30	2	TO	0	23	24	1	to	23	23	24	0	VP	0	24	30	3	VB	0	24	25	1	amplify	24	24	25	0	NP	2	25	28	3	DT	0	25	26	1	the	25	25	26	0	NN	0	26	27	1	RAS	26	26	27	0	NN	0	27	28	1	signal	27	27	28	0	PP	0	28	30	2	TO	0	28	29	1	to	28	28	29	0	NP	0	29	30	1	NN	0	29	30	1	p53	29	29	30	0	.	0	30	31	1	.	30	30	31	0
EOS
T	27
Only	19940	19944	RB	only	O	_	_
in	19945	19947	IN	in	O	_	_
conditions	19948	19958	NNS	condition	O	_	_
where	19959	19964	WRB	where	O	_	_
RAS	19965	19968	NN	ra	O	_	_
is	19969	19971	VBZ	be	O	_	_
constitutively	19972	19986	RB	constitutively	O	_	_
active	19987	19993	JJ	active	O	_	_
would	19994	19999	MD	would	O	_	_
the	20000	20003	DT	the	O	_	_
ASPP2	20004	20009	NN	aspp2	O	_	_
feedback	20010	20018	NN	feedback	O	_	_
loop	20019	20023	NN	loop	O	_	_
reach	20024	20029	VBP	reach	O	_	_
a	20030	20031	DT	a	O	_	_
threshold	20032	20041	NN	threshold	O	_	_
of	20042	20044	IN	of	O	_	_
signaling	20045	20054	VBG	signal	O	_	_
high	20055	20059	JJ	high	O	_	_
enough	20060	20066	JJ	enough	O	_	_
to	20067	20069	TO	to	O	_	_
result	20070	20076	VB	result	O	_	_
in	20077	20079	IN	in	O	_	_
p53	20080	20083	NN	p53	B-GENE	_	_
dependent	20084	20093	JJ	dependent	O	_	_
apoptosis	20094	20103	NN	apoptosis	O	_	_
.	20103	20104	.	.	O	_	_
D	1
13
0	2	prep_in
2	7	rcmod
7	3	advmod
7	4	nsubj
7	5	cop
7	6	advmod
7	8	ccomp
12	9	det
12	10	nn
12	11	nn
13	0	advmod
13	12	nsubj
13	19	xcomp
15	14	det
15	17	prepc_of
17	18	acomp
19	15	nsubj
19	21	xcomp
21	20	aux
21	25	prep_in
25	23	nn
25	24	amod
EOX
Y	1
ROOT	0	0	27	1	S	2	0	27	4	ADVP	0	0	9	2	RB	0	0	1	1	Only	0	0	1	0	PP	0	1	9	2	IN	0	1	2	1	in	1	1	2	0	NP	0	2	9	2	NP	0	2	3	1	NNS	0	2	3	1	conditions	2	2	3	0	SBAR	1	3	9	2	WHADVP	0	3	4	1	WRB	0	3	4	1	where	3	3	4	0	S	1	4	9	2	NP	0	4	5	1	NN	0	4	5	1	RAS	4	4	5	0	VP	1	5	9	2	VBZ	0	5	6	1	is	5	5	6	0	ADJP	1	6	9	3	RB	0	6	7	1	constitutively	6	6	7	0	JJ	0	7	8	1	active	7	7	8	0	SBAR	0	8	9	1	S	0	8	9	1	VP	0	8	9	1	MD	0	8	9	1	would	8	8	9	0	NP	3	9	13	4	DT	0	9	10	1	the	9	9	10	0	NN	0	10	11	1	ASPP2	10	10	11	0	NN	0	11	12	1	feedback	11	11	12	0	NN	0	12	13	1	loop	12	12	13	0	VP	0	13	26	2	VBP	0	13	14	1	reach	13	13	14	0	S	1	14	26	2	NP	0	14	19	2	NP	1	14	16	2	DT	0	14	15	1	a	14	14	15	0	NN	0	15	16	1	threshold	15	15	16	0	PP	0	16	19	2	IN	0	16	17	1	of	16	16	17	0	S	0	17	19	1	VP	0	17	19	2	VBG	0	17	18	1	signaling	17	17	18	0	ADJP	0	18	19	1	JJ	0	18	19	1	high	18	18	19	0	ADJP	0	19	26	2	JJ	0	19	20	1	enough	19	19	20	0	S	0	20	26	1	VP	1	20	26	2	TO	0	20	21	1	to	20	20	21	0	VP	0	21	26	2	VB	0	21	22	1	result	21	21	22	0	PP	0	22	26	2	IN	0	22	23	1	in	22	22	23	0	NP	2	23	26	3	NN	0	23	24	1	p53	23	23	24	0	JJ	0	24	25	1	dependent	24	24	25	0	NN	0	25	26	1	apoptosis	25	25	26	0	.	0	26	27	1	.	26	26	27	0
EOS
T	32
The	20105	20108	DT	the	O	_	_
ability	20109	20116	NN	ability	O	_	_
of	20117	20119	IN	of	O	_	_
oncogenic	20120	20129	JJ	oncogenic	O	_	_
RAS	20130	20133	NN	ra	O	_	_
to	20134	20136	TO	to	O	_	_
stimulate	20137	20146	VB	stimulate	O	_	_
apoptosis	20147	20156	NN	apoptosis	O	_	_
allows	20157	20163	VBZ	allow	O	_	_
the	20164	20167	DT	the	O	_	_
cell	20168	20172	NN	cell	O	_	_
to	20173	20175	TO	to	O	_	_
have	20176	20180	VB	have	O	_	_
a	20181	20182	DT	a	O	_	_
fail-proof	20183	20193	JJ	fail-proof	O	_	_
mechanism	20194	20203	NN	mechanism	O	_	_
:	20203	20204	:	:	O	_	_
mutated	20205	20212	VBN	mutate	O	_	_
RAS	20213	20216	NN	ra	O	_	_
signals	20217	20224	NNS	signal	O	_	_
to	20225	20227	TO	to	O	_	_
p53	20228	20231	NN	p53	B-GENE	_	_
via	20232	20235	IN	via	O	_	_
ASPP2	20236	20241	NN	aspp2	B-GENE	_	_
to	20242	20244	TO	to	O	_	_
induce	20245	20251	VB	induce	O	_	_
apoptosis	20252	20261	NN	apoptosis	O	_	_
instead	20262	20269	RB	instead	O	_	_
of	20270	20272	IN	of	O	_	_
uncontrolled	20273	20285	JJ	uncontrolled	O	_	_
proliferation	20286	20299	NN	proliferation	O	_	_
.	20299	20300	.	.	O	_	_
D	1
8
1	0	det
1	4	prep_of
4	3	amod
4	6	vmod
6	5	aux
6	7	dobj
8	1	nsubj
8	10	dobj
10	9	det
10	12	vmod
12	11	aux
12	15	dobj
15	13	det
15	14	amod
15	17	vmod
17	19	dobj
17	21	prep_to
17	25	xcomp
19	18	nn
21	23	prep_via
25	24	aux
25	26	dobj
26	30	prep_instead_of
30	29	amod
EOX
Y	1
ROOT	0	0	32	1	S	1	0	32	3	NP	0	0	8	2	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	ability	1	1	2	0	PP	0	2	8	2	IN	0	2	3	1	of	2	2	3	0	NP	1	3	8	3	JJ	0	3	4	1	oncogenic	3	3	4	0	NN	0	4	5	1	RAS	4	4	5	0	S	0	5	8	1	VP	1	5	8	2	TO	0	5	6	1	to	5	5	6	0	VP	0	6	8	2	VB	0	6	7	1	stimulate	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	apoptosis	7	7	8	0	VP	0	8	31	2	VBZ	0	8	9	1	allows	8	8	9	0	NP	1	9	31	3	DT	0	9	10	1	the	9	9	10	0	NN	0	10	11	1	cell	10	10	11	0	S	0	11	31	1	VP	1	11	31	2	TO	0	11	12	1	to	11	11	12	0	VP	0	12	31	2	VB	0	12	13	1	have	12	12	13	0	NP	0	13	31	3	NP	2	13	16	3	DT	0	13	14	1	a	13	13	14	0	JJ	0	14	15	1	fail-proof	14	14	15	0	NN	0	15	16	1	mechanism	15	15	16	0	:	0	16	17	1	:	16	16	17	0	VP	0	17	31	4	VBN	0	17	18	1	mutated	17	17	18	0	NP	1	18	20	2	NN	0	18	19	1	RAS	18	18	19	0	NNS	0	19	20	1	signals	19	19	20	0	PP	0	20	24	2	TO	0	20	21	1	to	20	20	21	0	NP	0	21	24	2	NP	0	21	22	1	NN	0	21	22	1	p53	21	21	22	0	PP	0	22	24	2	IN	0	22	23	1	via	22	22	23	0	NP	0	23	24	1	NN	0	23	24	1	ASPP2	23	23	24	0	S	0	24	31	1	VP	1	24	31	2	TO	0	24	25	1	to	24	24	25	0	VP	0	25	31	2	VB	0	25	26	1	induce	25	25	26	0	NP	0	26	31	2	NP	0	26	27	1	NN	0	26	27	1	apoptosis	26	26	27	0	PP	1	27	31	3	RB	0	27	28	1	instead	27	27	28	0	IN	0	28	29	1	of	28	28	29	0	NP	1	29	31	2	JJ	0	29	30	1	uncontrolled	29	29	30	0	NN	0	30	31	1	proliferation	30	30	31	0	.	0	31	32	1	.	31	31	32	0
EOS
T	40
However	20301	20308	RB	however	O	_	_
,	20308	20309	,	,	O	_	_
under	20310	20315	IN	under	O	_	_
normal	20316	20322	JJ	normal	O	_	_
conditions	20323	20333	NNS	condition	O	_	_
,	20333	20334	,	,	O	_	_
growth	20335	20341	NN	growth	O	_	_
factors	20342	20349	NNS	factor	O	_	_
or	20350	20352	CC	or	O	_	_
growth	20353	20359	NN	growth	O	_	_
receptors	20360	20369	NNS	receptor	O	_	_
would	20370	20375	MD	would	O	_	_
only	20376	20380	RB	only	O	_	_
activate	20381	20389	VB	activate	O	_	_
RAS	20390	20393	NN	ra	B-GENE	_	_
for	20394	20397	IN	for	O	_	_
short	20398	20403	JJ	short	O	_	_
periods	20404	20411	NNS	period	O	_	_
of	20412	20414	IN	of	O	_	_
time	20415	20419	NN	time	O	_	_
,	20419	20420	,	,	O	_	_
preventing	20421	20431	VBG	prevent	O	_	_
the	20432	20435	DT	the	O	_	_
amplification	20436	20449	NN	amplification	O	_	_
of	20450	20452	IN	of	O	_	_
ASPP2	20453	20458	NN	aspp2	B-GENE	_	_
signaling	20459	20468	NN	signaling	O	_	_
to	20469	20471	TO	to	O	_	_
p53	20472	20475	NN	p53	B-GENE	_	_
via	20476	20479	IN	via	O	_	_
the	20480	20483	DT	the	O	_	_
feedback	20484	20492	NN	feedback	O	_	_
loop	20493	20497	NN	loop	O	_	_
,	20497	20498	,	,	O	_	_
thereby	20499	20506	RB	thereby	O	_	_
eliminating	20507	20518	VBG	eliminate	O	_	_
the	20519	20522	DT	the	O	_	_
apoptotic	20523	20532	JJ	apoptotic	O	_	_
stimulus	20533	20541	NN	stimulus	O	_	_
.	20541	20542	.	.	O	_	_
D	1
13
4	3	amod
7	6	nn
7	10	conj_or
10	9	nn
13	0	advmod
13	4	prep_under
13	7	nsubj
13	10	nsubj
13	11	aux
13	12	advmod
13	14	dobj
13	17	prep_for
13	21	vmod
13	35	xcomp
17	16	amod
17	19	prep_of
21	23	dobj
21	28	prep_to
23	22	det
23	26	prep_of
26	25	nn
28	32	prep_via
32	30	det
32	31	nn
35	34	advmod
35	38	dobj
38	36	det
38	37	amod
EOX
Y	1
ROOT	0	0	40	1	S	5	0	40	7	ADVP	0	0	1	1	RB	0	0	1	1	However	0	0	1	0	,	0	1	2	1	,	1	1	2	0	PP	0	2	5	2	IN	0	2	3	1	under	2	2	3	0	NP	1	3	5	2	JJ	0	3	4	1	normal	3	3	4	0	NNS	0	4	5	1	conditions	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	0	6	11	3	NP	1	6	8	2	NN	0	6	7	1	growth	6	6	7	0	NNS	0	7	8	1	factors	7	7	8	0	CC	0	8	9	1	or	8	8	9	0	NP	1	9	11	2	NN	0	9	10	1	growth	9	9	10	0	NNS	0	10	11	1	receptors	10	10	11	0	VP	2	11	39	3	MD	0	11	12	1	would	11	11	12	0	ADVP	0	12	13	1	RB	0	12	13	1	only	12	12	13	0	VP	0	13	39	7	VB	0	13	14	1	activate	13	13	14	0	NP	0	14	15	1	NN	0	14	15	1	RAS	14	14	15	0	PP	0	15	20	2	IN	0	15	16	1	for	15	15	16	0	NP	0	16	20	2	NP	1	16	18	2	JJ	0	16	17	1	short	16	16	17	0	NNS	0	17	18	1	periods	17	17	18	0	PP	0	18	20	2	IN	0	18	19	1	of	18	18	19	0	NP	0	19	20	1	NN	0	19	20	1	time	19	19	20	0	,	0	20	21	1	,	20	20	21	0	S	0	21	33	1	VP	0	21	33	3	VBG	0	21	22	1	preventing	21	21	22	0	NP	0	22	27	2	NP	1	22	24	2	DT	0	22	23	1	the	22	22	23	0	NN	0	23	24	1	amplification	23	23	24	0	PP	0	24	27	2	IN	0	24	25	1	of	24	24	25	0	NP	1	25	27	2	NN	0	25	26	1	ASPP2	25	25	26	0	NN	0	26	27	1	signaling	26	26	27	0	PP	0	27	33	2	TO	0	27	28	1	to	27	27	28	0	NP	0	28	33	2	NP	0	28	29	1	NN	0	28	29	1	p53	28	28	29	0	PP	0	29	33	2	IN	0	29	30	1	via	29	29	30	0	NP	2	30	33	3	DT	0	30	31	1	the	30	30	31	0	NN	0	31	32	1	feedback	31	31	32	0	NN	0	32	33	1	loop	32	32	33	0	,	0	33	34	1	,	33	33	34	0	S	1	34	39	2	ADVP	0	34	35	1	RB	0	34	35	1	thereby	34	34	35	0	VP	0	35	39	2	VBG	0	35	36	1	eliminating	35	35	36	0	NP	2	36	39	3	DT	0	36	37	1	the	36	36	37	0	JJ	0	37	38	1	apoptotic	37	37	38	0	NN	0	38	39	1	stimulus	38	38	39	0	.	0	39	40	1	.	39	39	40	0
EOS
T	39
The	20543	20546	DT	the	O	_	_
novel	20547	20552	JJ	novel	O	_	_
RAS	20553	20556	NN	ra	B-GENE	_	_
/	20556	20557	:	/	I-GENE	_	_
Raf/MAPK	20557	20565	NN	raf/mapk	B-GENE	_	_
/	20565	20566	:	/	B-GENE	_	_
ASPP2	20566	20571	NN	aspp2	I-GENE	_	_
pathway	20572	20579	NN	pathway	O	_	_
is	20580	20582	VBZ	be	O	_	_
thus	20583	20587	RB	thus	O	_	_
involved	20588	20596	VBN	involve	O	_	_
in	20597	20599	IN	in	O	_	_
an	20600	20602	DT	a	O	_	_
important	20603	20612	JJ	important	O	_	_
feedback	20613	20621	NN	feedback	O	_	_
loop	20622	20626	NN	loop	O	_	_
between	20627	20634	IN	between	O	_	_
RAS	20635	20638	NN	ra	B-GENE	_	_
and	20639	20642	CC	and	O	_	_
p53	20643	20646	NN	p53	B-GENE	_	_
,	20646	20647	,	,	O	_	_
and	20648	20651	CC	and	O	_	_
is	20652	20654	VBZ	be	O	_	_
an	20655	20657	DT	a	O	_	_
effective	20658	20667	JJ	effective	O	_	_
way	20668	20671	NN	way	O	_	_
for	20672	20675	IN	for	O	_	_
mutant	20676	20682	JJ	mutant	O	_	_
RAS	20683	20686	NN	ra	O	_	_
to	20687	20689	TO	to	O	_	_
induce	20690	20696	VB	induce	O	_	_
apoptosis	20697	20706	NN	apoptosis	O	_	_
in	20707	20709	IN	in	O	_	_
cancer	20710	20716	NN	cancer	O	_	_
cells	20717	20722	NNS	cell	O	_	_
with	20723	20727	IN	with	O	_	_
wild-type	20728	20737	JJ	wild-type	B-GENE	_	_
p53	20738	20741	NN	p53	I-GENE	_	_
.	20741	20742	.	.	O	_	_
D	1
2
2	0	det
2	1	amod
2	3	punct
2	10	dep
2	25	dep
4	7	dep
7	5	punct
7	6	nn
10	4	nsubjpass
10	8	auxpass
10	9	advmod
10	15	prep_in
10	25	conj_and
15	12	det
15	13	amod
15	14	nn
15	17	prep_between
15	19	prep_between
17	19	conj_and
25	22	cop
25	23	det
25	24	amod
25	28	prep_for
25	30	vmod
28	27	amod
30	29	aux
30	31	dobj
30	37	prep_with
31	34	prep_in
34	33	nn
37	36	amod
EOX
Y	1
ROOT	0	0	39	1	FRAG	0	0	39	4	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	JJ	0	1	2	1	novel	1	1	2	0	NN	0	2	3	1	RAS	2	2	3	0	:	0	3	4	1	/	3	3	4	0	S	1	4	38	2	NP	0	4	8	2	NP	0	4	5	1	NN	0	4	5	1	Raf/MAPK	4	4	5	0	PRN	1	5	8	2	:	0	5	6	1	/	5	5	6	0	NP	1	6	8	2	NN	0	6	7	1	ASPP2	6	6	7	0	NN	0	7	8	1	pathway	7	7	8	0	VP	0	8	38	4	VP	2	8	20	3	VBZ	0	8	9	1	is	8	8	9	0	ADVP	0	9	10	1	RB	0	9	10	1	thus	9	9	10	0	VP	0	10	20	2	VBN	0	10	11	1	involved	10	10	11	0	PP	0	11	20	2	IN	0	11	12	1	in	11	11	12	0	NP	0	12	20	2	NP	3	12	16	4	DT	0	12	13	1	an	12	12	13	0	JJ	0	13	14	1	important	13	13	14	0	NN	0	14	15	1	feedback	14	14	15	0	NN	0	15	16	1	loop	15	15	16	0	PP	0	16	20	2	IN	0	16	17	1	between	16	16	17	0	NP	0	17	20	3	NN	0	17	18	1	RAS	17	17	18	0	CC	0	18	19	1	and	18	18	19	0	NN	0	19	20	1	p53	19	19	20	0	,	0	20	21	1	,	20	20	21	0	CC	0	21	22	1	and	21	21	22	0	VP	1	22	38	2	VBZ	0	22	23	1	is	22	22	23	0	NP	0	23	38	3	NP	2	23	26	3	DT	0	23	24	1	an	23	23	24	0	JJ	0	24	25	1	effective	24	24	25	0	NN	0	25	26	1	way	25	25	26	0	PP	0	26	29	2	IN	0	26	27	1	for	26	26	27	0	NP	1	27	29	2	JJ	0	27	28	1	mutant	27	27	28	0	NN	0	28	29	1	RAS	28	28	29	0	S	0	29	38	1	VP	1	29	38	2	TO	0	29	30	1	to	29	29	30	0	VP	0	30	38	3	VB	0	30	31	1	induce	30	30	31	0	NP	0	31	35	2	NP	0	31	32	1	NN	0	31	32	1	apoptosis	31	31	32	0	PP	0	32	35	2	IN	0	32	33	1	in	32	32	33	0	NP	1	33	35	2	NN	0	33	34	1	cancer	33	33	34	0	NNS	0	34	35	1	cells	34	34	35	0	PP	0	35	38	2	IN	0	35	36	1	with	35	35	36	0	NP	1	36	38	2	JJ	0	36	37	1	wild-type	36	36	37	0	NN	0	37	38	1	p53	37	37	38	0	.	0	38	39	1	.	38	38	39	0
EOS
T	25
Materials	20743	20752	NNPS	Materials	O	_	_
and	20753	20756	CC	and	O	_	_
Methods	20757	20764	NNS	method	O	_	_
Cell	20765	20769	NN	cell	O	_	_
culture	20770	20777	NN	culture	O	_	_
,	20777	20778	,	,	O	_	_
plasmids	20779	20787	NNS	plasmid	O	_	_
and	20788	20791	CC	and	O	_	_
siRNA	20792	20797	NN	sirna	O	_	_
Saos2	20798	20803	NN	saos2	O	_	_
cells	20804	20809	NNS	cell	O	_	_
were	20810	20814	VBD	be	O	_	_
obtained	20815	20823	VBN	obtain	O	_	_
from	20824	20828	IN	from	O	_	_
the	20829	20832	DT	the	O	_	_
American	20833	20841	JJ	american	O	_	_
Type	20842	20846	NN	type	O	_	_
Culture	20847	20854	NN	culture	O	_	_
Collection	20855	20865	NN	collection	O	_	_
(	20866	20867	CD	(	O	_	_
Manassas	20867	20875	NNP	Manassas	O	_	_
,	20875	20876	,	,	O	_	_
VA	20877	20879	NNP	VA	O	_	_
)	20879	20880	CD	)	O	_	_
.	20880	20881	.	.	O	_	_
D	1
12
0	4	conj_and
0	6	conj_and
0	10	conj_and
4	2	nn
4	3	nn
4	6	conj_and
4	10	conj_and
10	8	nn
10	9	nn
12	0	nsubjpass
12	4	nsubjpass
12	11	auxpass
12	17	prep_from
12	20	dobj
17	14	det
17	15	amod
17	16	nn
20	18	nn
20	19	num
20	22	appos
22	23	num
EOX
Y	1
ROOT	0	0	25	1	S	1	0	25	3	NP	0	0	11	3	NP	0	0	1	1	NNPS	0	0	1	1	Materials	0	0	1	0	CC	0	1	2	1	and	1	1	2	0	NP	0	2	11	5	NP	2	2	5	3	NNS	0	2	3	1	Methods	2	2	3	0	NN	0	3	4	1	Cell	3	3	4	0	NN	0	4	5	1	culture	4	4	5	0	,	0	5	6	1	,	5	5	6	0	NP	0	6	7	1	NNS	0	6	7	1	plasmids	6	6	7	0	CC	0	7	8	1	and	7	7	8	0	NP	2	8	11	3	NN	0	8	9	1	siRNA	8	8	9	0	NN	0	9	10	1	Saos2	9	9	10	0	NNS	0	10	11	1	cells	10	10	11	0	VP	1	11	24	2	VBD	0	11	12	1	were	11	11	12	0	VP	0	12	24	3	VBN	0	12	13	1	obtained	12	12	13	0	PP	0	13	18	2	IN	0	13	14	1	from	13	13	14	0	NP	3	14	18	4	DT	0	14	15	1	the	14	14	15	0	JJ	0	15	16	1	American	15	15	16	0	NN	0	16	17	1	Type	16	16	17	0	NN	0	17	18	1	Culture	17	17	18	0	NP	0	18	24	3	NP	2	18	21	3	NN	0	18	19	1	Collection	18	18	19	0	CD	0	19	20	1	(	19	19	20	0	NNP	0	20	21	1	Manassas	20	20	21	0	,	0	21	22	1	,	21	21	22	0	NP	0	22	24	2	NNP	0	22	23	1	VA	22	22	23	0	CD	0	23	24	1	)	23	23	24	0	.	0	24	25	1	.	24	24	25	0
EOS
T	16
HKe3	20882	20886	NN	hke3	B-GENE	_	_
ER	20887	20889	NN	er	O	_	_
:	20889	20890	:	:	O	_	_
HRASV12	20890	20897	NN	hrasv12	O	_	_
cells	20898	20903	NNS	cell	O	_	_
were	20904	20908	VBD	be	O	_	_
kindly	20909	20915	RB	kindly	O	_	_
provided	20916	20924	VBN	provide	O	_	_
by	20925	20927	IN	by	O	_	_
Dr	20928	20930	NNP	Dr	O	_	_
Julian	20931	20937	NNP	Julian	O	_	_
Downward	20938	20946	NNP	Downward	O	_	_
[	20947	20948	CD	[	O	_	_
2,10,11	20948	20955	CD	2,10,11	O	_	_
]	20955	20956	NN	]	O	_	_
.	20956	20957	.	.	O	_	_
D	1
1
1	0	nn
1	7	dep
4	3	nn
7	4	nsubjpass
7	5	auxpass
7	6	advmod
7	11	agent
7	14	dep
11	9	nn
11	10	nn
13	12	number
14	13	num
EOX
Y	1
ROOT	0	0	16	1	FRAG	0	0	16	4	NP	1	0	2	2	NN	0	0	1	1	HKe3	0	0	1	0	NN	0	1	2	1	ER	1	1	2	0	:	0	2	3	1	:	2	2	3	0	S	1	3	15	2	NP	1	3	5	2	NN	0	3	4	1	HRASV12	3	3	4	0	NNS	0	4	5	1	cells	4	4	5	0	VP	2	5	15	3	VBD	0	5	6	1	were	5	5	6	0	ADVP	0	6	7	1	RB	0	6	7	1	kindly	6	6	7	0	VP	0	7	15	2	VBN	0	7	8	1	provided	7	7	8	0	PP	0	8	15	3	IN	0	8	9	1	by	8	8	9	0	NP	2	9	12	3	NNP	0	9	10	1	Dr	9	9	10	0	NNP	0	10	11	1	Julian	10	10	11	0	NNP	0	11	12	1	Downward	11	11	12	0	NP	1	12	15	2	QP	1	12	14	2	CD	0	12	13	1	[	12	12	13	0	CD	0	13	14	1	2,10,11	13	13	14	0	NN	0	14	15	1	]	14	14	15	0	.	0	15	16	1	.	15	15	16	0
EOS
T	29
Cells	20958	20963	NNS	cell	O	_	_
were	20964	20968	VBD	be	O	_	_
cultured	20969	20977	VBN	culture	O	_	_
in	20978	20980	IN	in	O	_	_
DMEM	20981	20985	NNP	DMEM	O	_	_
supplemented	20986	20998	VBN	supplement	O	_	_
with	20999	21003	IN	with	O	_	_
10	21004	21006	CD	10	O	_	_
%	21006	21007	NN	%	O	_	_
fetal	21008	21013	JJ	fetal	O	_	_
bovine	21014	21020	JJ	bovine	O	_	_
serum	21021	21026	NN	serum	O	_	_
(	21027	21028	CD	(	O	_	_
FBS	21028	21031	NN	fb	O	_	_
)	21031	21032	NN	)	O	_	_
and	21033	21036	CC	and	O	_	_
penicillin	21037	21047	NN	penicillin	O	_	_
streptomycin	21048	21060	NN	streptomycin	O	_	_
(	21061	21062	CD	(	O	_	_
Gibco-BRL	21062	21071	NNP	Gibco-BRL	O	_	_
,	21071	21072	,	,	O	_	_
Invitrogen	21073	21083	NNP	Invitrogen	O	_	_
Ltd	21084	21087	NNP	Ltd	O	_	_
,	21087	21088	,	,	O	_	_
Paisley	21089	21096	NNP	Paisley	O	_	_
,	21096	21097	,	,	O	_	_
UK	21098	21100	NNP	UK	O	_	_
)	21100	21101	CD	)	O	_	_
.	21101	21102	.	.	O	_	_
D	1
2
2	0	nsubjpass
2	1	auxpass
2	4	prep_in
4	5	vmod
5	11	prep_with
5	16	prep_with
8	7	number
11	8	amod
11	9	amod
11	10	amod
11	14	dep
11	16	conj_and
14	12	num
14	13	nn
16	19	dep
19	17	nn
19	18	num
19	26	appos
26	21	nn
26	22	nn
26	24	appos
26	27	num
EOX
Y	1
ROOT	0	0	29	1	S	1	0	29	3	NP	0	0	1	1	NNS	0	0	1	1	Cells	0	0	1	0	VP	1	1	28	2	VBD	0	1	2	1	were	1	1	2	0	VP	0	2	28	2	VBN	0	2	3	1	cultured	2	2	3	0	PP	0	3	28	2	IN	0	3	4	1	in	3	3	4	0	NP	0	4	28	2	NP	0	4	5	1	NNP	0	4	5	1	DMEM	4	4	5	0	VP	0	5	28	2	VBN	0	5	6	1	supplemented	5	5	6	0	PP	0	6	28	2	IN	0	6	7	1	with	6	6	7	0	NP	0	7	28	3	NP	0	7	15	2	NP	3	7	12	4	ADJP	1	7	9	2	CD	0	7	8	1	10	7	7	8	0	NN	0	8	9	1	%	8	8	9	0	JJ	0	9	10	1	fetal	9	9	10	0	JJ	0	10	11	1	bovine	10	10	11	0	NN	0	11	12	1	serum	11	11	12	0	NP	2	12	15	3	CD	0	12	13	1	(	12	12	13	0	NN	0	13	14	1	FBS	13	13	14	0	NN	0	14	15	1	)	14	14	15	0	CC	0	15	16	1	and	15	15	16	0	NP	0	16	28	2	NP	0	16	17	1	NN	0	16	17	1	penicillin	16	16	17	0	NP	0	17	28	3	NP	2	17	20	3	NN	0	17	18	1	streptomycin	17	17	18	0	CD	0	18	19	1	(	18	18	19	0	NNP	0	19	20	1	Gibco-BRL	19	19	20	0	,	0	20	21	1	,	20	20	21	0	NP	5	21	28	7	NNP	0	21	22	1	Invitrogen	21	21	22	0	NNP	0	22	23	1	Ltd	22	22	23	0	,	0	23	24	1	,	23	23	24	0	NNP	0	24	25	1	Paisley	24	24	25	0	,	0	25	26	1	,	25	25	26	0	NNP	0	26	27	1	UK	26	26	27	0	CD	0	27	28	1	)	27	27	28	0	.	0	28	29	1	.	28	28	29	0
EOS
T	42
For	21103	21106	IN	for	O	_	_
growth	21107	21113	NN	growth	O	_	_
factor	21114	21120	NN	factor	O	_	_
stimulation	21121	21132	NN	stimulation	O	_	_
,	21132	21133	,	,	O	_	_
cells	21134	21139	NNS	cell	O	_	_
were	21140	21144	VBD	be	O	_	_
serum	21145	21150	NN	serum	O	_	_
starved	21151	21158	VBN	starve	O	_	_
for	21159	21162	IN	for	O	_	_
indicated	21163	21172	JJ	indicated	O	_	_
time	21173	21177	NN	time	O	_	_
,	21177	21178	,	,	O	_	_
followed	21179	21187	VBN	follow	O	_	_
by	21188	21190	IN	by	O	_	_
stimulation	21191	21202	NN	stimulation	O	_	_
with	21203	21207	IN	with	O	_	_
20	21208	21210	CD	20	O	_	_
%	21210	21211	NN	%	O	_	_
serum	21212	21217	NN	serum	O	_	_
plus	21218	21222	CC	plus	O	_	_
epidermal	21223	21232	JJ	epidermal	B-GENE	_	_
growth	21233	21239	NN	growth	I-GENE	_	_
factor	21240	21246	NN	factor	I-GENE	_	_
(	21247	21248	CD	(	B-GENE	_	_
EGF	21248	21251	NN	egf	I-GENE	_	_
)	21251	21252	NN	)	O	_	_
,	21252	21253	,	,	O	_	_
EGF	21254	21257	NN	egf	B-GENE	_	_
alone	21258	21263	RB	alone	O	_	_
or	21264	21266	CC	or	O	_	_
insulin	21267	21274	NN	insulin	B-GENE	_	_
(	21275	21276	CD	(	O	_	_
Sigma	21276	21281	NNP	Sigma	O	_	_
,	21281	21282	,	,	O	_	_
Dorset	21283	21289	NNP	Dorset	O	_	_
,	21289	21290	,	,	O	_	_
UK	21291	21293	NNP	UK	O	_	_
)	21293	21294	CD	)	O	_	_
as	21295	21297	IN	as	O	_	_
indicated	21298	21307	VBN	indicate	O	_	_
.	21307	21308	.	.	O	_	_
D	1
7
3	1	nn
3	2	nn
7	3	prep_for
7	5	nsubj
7	6	cop
7	8	vmod
8	11	prep_for
11	10	amod
11	13	vmod
13	15	agent
13	37	dobj
15	19	prep_with
18	17	number
19	18	amod
19	20	prep
20	26	pobj
20	28	pobj
20	31	pobj
26	21	amod
26	22	nn
26	23	nn
26	24	num
26	25	nn
26	28	conj_or
26	31	conj_or
28	29	advmod
31	32	num
37	33	nn
37	35	appos
37	38	num
37	40	prep_as
EOX
Y	1
ROOT	0	0	42	1	S	3	0	42	5	PP	0	0	4	2	IN	0	0	1	1	For	0	0	1	0	NP	2	1	4	3	NN	0	1	2	1	growth	1	1	2	0	NN	0	2	3	1	factor	2	2	3	0	NN	0	3	4	1	stimulation	3	3	4	0	,	0	4	5	1	,	4	4	5	0	NP	0	5	6	1	NNS	0	5	6	1	cells	5	5	6	0	VP	1	6	41	2	VBD	0	6	7	1	were	6	6	7	0	NP	0	7	41	2	NP	0	7	8	1	NN	0	7	8	1	serum	7	7	8	0	VP	0	8	41	2	VBN	0	8	9	1	starved	8	8	9	0	PP	0	9	41	2	IN	0	9	10	1	for	9	9	10	0	NP	0	10	41	3	NP	1	10	12	2	JJ	0	10	11	1	indicated	10	10	11	0	NN	0	11	12	1	time	11	11	12	0	,	0	12	13	1	,	12	12	13	0	VP	0	13	41	3	VBN	0	13	14	1	followed	13	13	14	0	PP	0	14	33	2	IN	0	14	15	1	by	14	14	15	0	NP	0	15	33	2	NP	0	15	16	1	NN	0	15	16	1	stimulation	15	15	16	0	PP	0	16	33	2	IN	0	16	17	1	with	16	16	17	0	NP	0	17	33	2	NP	1	17	20	2	ADJP	1	17	19	2	CD	0	17	18	1	20	17	17	18	0	NN	0	18	19	1	%	18	18	19	0	NN	0	19	20	1	serum	19	19	20	0	PP	0	20	33	2	CC	0	20	21	1	plus	20	20	21	0	NP	0	21	33	5	NP	5	21	27	6	JJ	0	21	22	1	epidermal	21	21	22	0	NN	0	22	23	1	growth	22	22	23	0	NN	0	23	24	1	factor	23	23	24	0	CD	0	24	25	1	(	24	24	25	0	NN	0	25	26	1	EGF	25	25	26	0	NN	0	26	27	1	)	26	26	27	0	,	0	27	28	1	,	27	27	28	0	NP	0	28	30	2	NN	0	28	29	1	EGF	28	28	29	0	RB	0	29	30	1	alone	29	29	30	0	CC	0	30	31	1	or	30	30	31	0	NP	0	31	33	2	NN	0	31	32	1	insulin	31	31	32	0	CD	0	32	33	1	(	32	32	33	0	NP	0	33	41	2	NP	4	33	39	6	NNP	0	33	34	1	Sigma	33	33	34	0	,	0	34	35	1	,	34	34	35	0	NNP	0	35	36	1	Dorset	35	35	36	0	,	0	36	37	1	,	36	36	37	0	NNP	0	37	38	1	UK	37	37	38	0	CD	0	38	39	1	)	38	38	39	0	PP	0	39	41	2	IN	0	39	40	1	as	39	39	40	0	NP	0	40	41	1	VBN	0	40	41	1	indicated	40	40	41	0	.	0	41	42	1	.	41	41	42	0
EOS
T	13
Full-length	21309	21320	JJ	full-length	O	_	_
ASPP2	21321	21326	NN	aspp2	O	_	_
and	21327	21330	CC	and	O	_	_
ASPP2	21331	21336	NN	aspp2	O	_	_
(	21337	21338	CD	(	O	_	_
693-1128	21338	21346	CD	693-1128	O	_	_
)	21346	21347	NN	)	O	_	_
was	21348	21351	VBD	be	O	_	_
tagged	21352	21358	VBN	tag	O	_	_
with	21359	21363	IN	with	O	_	_
the	21364	21367	DT	the	O	_	_
V5-epitope	21368	21378	NN	v5-epitope	O	_	_
.	21378	21379	.	.	O	_	_
D	1
8
1	0	amod
1	3	conj_and
1	6	dep
5	4	number
6	5	dep
8	1	nsubjpass
8	3	nsubjpass
8	7	auxpass
8	11	prep_with
11	10	det
EOX
Y	1
ROOT	0	0	13	1	S	1	0	13	3	NP	0	0	7	2	NP	1	0	4	4	JJ	0	0	1	1	Full-length	0	0	1	0	NN	0	1	2	1	ASPP2	1	1	2	0	CC	0	2	3	1	and	2	2	3	0	NN	0	3	4	1	ASPP2	3	3	4	0	ADJP	1	4	7	2	QP	1	4	6	2	CD	0	4	5	1	(	4	4	5	0	CD	0	5	6	1	693-1128	5	5	6	0	NN	0	6	7	1	)	6	6	7	0	VP	1	7	12	2	VBD	0	7	8	1	was	7	7	8	0	VP	0	8	12	2	VBN	0	8	9	1	tagged	8	8	9	0	PP	0	9	12	2	IN	0	9	10	1	with	9	9	10	0	NP	1	10	12	2	DT	0	10	11	1	the	10	10	11	0	NN	0	11	12	1	V5-epitope	11	11	12	0	.	0	12	13	1	.	12	12	13	0
EOS
T	13
HRASV12	21380	21387	NN	hrasv12	O	_	_
and	21388	21391	CC	and	O	_	_
KRASV12	21392	21399	NN	krasv12	O	_	_
were	21400	21404	VBD	be	O	_	_
tagged	21405	21411	VBN	tag	O	_	_
with	21412	21416	IN	with	O	_	_
the	21417	21420	DT	the	O	_	_
haemagglutinin	21421	21435	NN	haemagglutinin	B-GENE	_	_
(	21436	21437	CD	(	I-GENE	_	_
HA	21437	21439	NNP	HA	I-GENE	_	_
)	21439	21440	CD	)	I-GENE	_	_
epitope	21441	21448	NN	epitope	I-GENE	_	_
.	21448	21449	.	.	O	_	_
D	1
4
0	2	conj_and
4	0	nsubjpass
4	2	nsubjpass
4	3	auxpass
4	7	prep_with
4	11	xcomp
7	6	det
11	8	num
11	9	nn
11	10	num
EOX
Y	1
ROOT	0	0	13	1	S	1	0	13	3	NP	0	0	3	3	NN	0	0	1	1	HRASV12	0	0	1	0	CC	0	1	2	1	and	1	1	2	0	NN	0	2	3	1	KRASV12	2	2	3	0	VP	1	3	12	2	VBD	0	3	4	1	were	3	3	4	0	VP	0	4	12	3	VBN	0	4	5	1	tagged	4	4	5	0	PP	0	5	8	2	IN	0	5	6	1	with	5	5	6	0	NP	1	6	8	2	DT	0	6	7	1	the	6	6	7	0	NN	0	7	8	1	haemagglutinin	7	7	8	0	S	0	8	12	1	NP	3	8	12	4	CD	0	8	9	1	(	8	8	9	0	NNP	0	9	10	1	HA	9	9	10	0	CD	0	10	11	1	)	10	10	11	0	NN	0	11	12	1	epitope	11	11	12	0	.	0	12	13	1	.	12	12	13	0
EOS
T	33
All	21450	21453	DT	all	O	_	_
expression	21454	21464	NN	expression	O	_	_
plasmids	21465	21473	NNS	plasmid	O	_	_
used	21474	21478	VBN	use	O	_	_
in	21479	21481	IN	in	O	_	_
this	21482	21486	DT	this	O	_	_
study	21487	21492	NN	study	O	_	_
were	21493	21497	VBD	be	O	_	_
driven	21498	21504	VBN	drive	O	_	_
by	21505	21507	IN	by	O	_	_
the	21508	21511	DT	the	O	_	_
cytomegalovirus	21512	21527	NN	cytomegalovirus	B-GENE	_	_
immediate-early	21528	21543	JJ	immediate-early	I-GENE	_	_
promoter	21544	21552	NN	promoter	I-GENE	_	_
,	21552	21553	,	,	O	_	_
with	21554	21558	IN	with	O	_	_
the	21559	21562	DT	the	O	_	_
exception	21563	21572	NN	exception	O	_	_
of	21573	21575	IN	of	O	_	_
the	21576	21579	DT	the	O	_	_
RAS	21580	21583	NN	ra	B-GENE	_	_
and	21584	21587	CC	and	O	_	_
Raf	21588	21591	NN	raf	B-GENE	_	_
CAAX	21592	21596	NN	caax	I-GENE	_	_
plasmids	21597	21605	NNS	plasmid	O	_	_
which	21606	21611	WDT	which	O	_	_
were	21612	21616	VBD	be	O	_	_
driven	21617	21623	VBN	drive	O	_	_
by	21624	21626	IN	by	O	_	_
the	21627	21630	DT	the	O	_	_
EF1a	21631	21635	NN	ef1a	B-GENE	_	_
promoter	21636	21644	NN	promoter	I-GENE	_	_
.	21644	21645	.	.	O	_	_
D	1
8
2	0	det
2	1	nn
2	3	vmod
3	6	prep_in
6	5	det
8	2	nsubjpass
8	7	auxpass
8	13	agent
8	17	prep_with
13	10	det
13	11	nn
13	12	amod
17	16	det
17	20	prep_of
17	24	prep_of
17	27	rcmod
20	19	det
20	24	conj_and
24	22	nn
24	23	nn
27	25	nsubjpass
27	26	auxpass
27	31	agent
31	29	det
31	30	nn
EOX
Y	1
ROOT	0	0	33	1	S	1	0	33	3	NP	0	0	7	2	NP	2	0	3	3	DT	0	0	1	1	All	0	0	1	0	NN	0	1	2	1	expression	1	1	2	0	NNS	0	2	3	1	plasmids	2	2	3	0	VP	0	3	7	2	VBN	0	3	4	1	used	3	3	4	0	PP	0	4	7	2	IN	0	4	5	1	in	4	4	5	0	NP	1	5	7	2	DT	0	5	6	1	this	5	5	6	0	NN	0	6	7	1	study	6	6	7	0	VP	1	7	32	2	VBD	0	7	8	1	were	7	7	8	0	VP	0	8	32	4	VBN	0	8	9	1	driven	8	8	9	0	PP	0	9	14	2	IN	0	9	10	1	by	9	9	10	0	NP	3	10	14	4	DT	0	10	11	1	the	10	10	11	0	NN	0	11	12	1	cytomegalovirus	11	11	12	0	JJ	0	12	13	1	immediate-early	12	12	13	0	NN	0	13	14	1	promoter	13	13	14	0	,	0	14	15	1	,	14	14	15	0	PP	0	15	32	2	IN	0	15	16	1	with	15	15	16	0	NP	0	16	32	3	NP	1	16	18	2	DT	0	16	17	1	the	16	16	17	0	NN	0	17	18	1	exception	17	17	18	0	PP	0	18	25	2	IN	0	18	19	1	of	18	18	19	0	NP	0	19	25	3	NP	1	19	21	2	DT	0	19	20	1	the	19	19	20	0	NN	0	20	21	1	RAS	20	20	21	0	CC	0	21	22	1	and	21	21	22	0	NP	2	22	25	3	NN	0	22	23	1	Raf	22	22	23	0	NN	0	23	24	1	CAAX	23	23	24	0	NNS	0	24	25	1	plasmids	24	24	25	0	SBAR	1	25	32	2	WHNP	0	25	26	1	WDT	0	25	26	1	which	25	25	26	0	S	0	26	32	1	VP	1	26	32	2	VBD	0	26	27	1	were	26	26	27	0	VP	0	27	32	2	VBN	0	27	28	1	driven	27	27	28	0	PP	0	28	32	2	IN	0	28	29	1	by	28	28	29	0	NP	2	29	32	3	DT	0	29	30	1	the	29	29	30	0	NN	0	30	31	1	EF1a	30	30	31	0	NN	0	31	32	1	promoter	31	31	32	0	.	0	32	33	1	.	32	32	33	0
EOS
T	16
The	21646	21649	DT	the	O	_	_
ASPP2	21650	21655	NN	aspp2	B-GENE	_	_
mutants	21656	21663	NNS	mutant	I-GENE	_	_
were	21664	21668	VBD	be	O	_	_
constructed	21669	21680	VBN	construct	O	_	_
using	21681	21686	VBG	use	O	_	_
the	21687	21690	DT	the	O	_	_
QuickChange	21691	21702	NNP	QuickChange	O	_	_
Site	21703	21707	NN	site	O	_	_
Directed	21708	21716	NNP	Directed	O	_	_
Mutagenesis	21717	21728	NN	mutagenesis	O	_	_
Kit	21729	21732	NN	kit	O	_	_
(	21733	21734	CD	(	O	_	_
Stratagene	21734	21744	JJ	stratagene	O	_	_
)	21744	21745	NN	)	O	_	_
.	21745	21746	.	.	O	_	_
D	1
4
2	0	det
2	1	nn
4	2	nsubjpass
4	3	auxpass
4	5	xcomp
5	11	xcomp
8	6	det
8	7	nn
11	8	nsubj
11	9	nn
11	10	nn
11	14	amod
14	12	number
14	13	dep
EOX
Y	1
ROOT	0	0	16	1	S	1	0	16	3	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	ASPP2	1	1	2	0	NNS	0	2	3	1	mutants	2	2	3	0	VP	1	3	15	2	VBD	0	3	4	1	were	3	3	4	0	VP	0	4	15	2	VBN	0	4	5	1	constructed	4	4	5	0	S	0	5	15	1	VP	0	5	15	2	VBG	0	5	6	1	using	5	5	6	0	S	1	6	15	2	NP	2	6	9	3	DT	0	6	7	1	the	6	6	7	0	NNP	0	7	8	1	QuickChange	7	7	8	0	NN	0	8	9	1	Site	8	8	9	0	NP	0	9	15	2	NP	2	9	12	3	NNP	0	9	10	1	Directed	9	9	10	0	NN	0	10	11	1	Mutagenesis	10	10	11	0	NN	0	11	12	1	Kit	11	11	12	0	ADJP	2	12	15	3	CD	0	12	13	1	(	12	12	13	0	JJ	0	13	14	1	Stratagene	13	13	14	0	NN	0	14	15	1	)	14	14	15	0	.	0	15	16	1	.	15	15	16	0
EOS
T	9
siRNA	21747	21752	NN	sirna	O	_	_
oligos	21753	21759	NNS	oligo	O	_	_
against	21760	21767	IN	against	O	_	_
ASPP2	21768	21773	NN	aspp2	O	_	_
were	21774	21778	VBD	be	O	_	_
purchased	21779	21788	VBN	purchase	O	_	_
from	21789	21793	IN	from	O	_	_
Dharmacon	21794	21803	NNP	Dharmacon	O	_	_
.	21803	21804	.	.	O	_	_
D	1
5
1	0	nn
1	3	prep_against
5	1	nsubjpass
5	4	auxpass
5	7	prep_from
EOX
Y	1
ROOT	0	0	9	1	S	1	0	9	3	NP	0	0	4	2	NP	1	0	2	2	NN	0	0	1	1	siRNA	0	0	1	0	NNS	0	1	2	1	oligos	1	1	2	0	PP	0	2	4	2	IN	0	2	3	1	against	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	ASPP2	3	3	4	0	VP	1	4	8	2	VBD	0	4	5	1	were	4	4	5	0	VP	0	5	8	2	VBN	0	5	6	1	purchased	5	5	6	0	PP	0	6	8	2	IN	0	6	7	1	from	6	6	7	0	NP	0	7	8	1	NNP	0	7	8	1	Dharmacon	7	7	8	0	.	0	8	9	1	.	8	8	9	0
EOS
T	9
Sequences	21805	21814	NNS	sequence	O	_	_
are	21815	21818	VBP	be	O	_	_
available	21819	21828	JJ	available	O	_	_
from	21829	21833	IN	from	O	_	_
Dharmacon	21834	21843	NNP	Dharmacon	O	_	_
or	21844	21846	CC	or	O	_	_
upon	21847	21851	IN	upon	O	_	_
request	21852	21859	NN	request	O	_	_
.	21859	21860	.	.	O	_	_
D	1
2
2	0	nsubj
2	1	cop
2	2	conj_or
2	4	prep_from
2	7	prep_upon
EOX
Y	1
ROOT	0	0	9	1	S	1	0	9	3	NP	0	0	1	1	NNS	0	0	1	1	Sequences	0	0	1	0	VP	1	1	8	2	VBP	0	1	2	1	are	1	1	2	0	ADJP	0	2	8	2	JJ	0	2	3	1	available	2	2	3	0	PP	0	3	8	3	PP	0	3	5	2	IN	0	3	4	1	from	3	3	4	0	NP	0	4	5	1	NNP	0	4	5	1	Dharmacon	4	4	5	0	CC	0	5	6	1	or	5	5	6	0	PP	0	6	8	2	IN	0	6	7	1	upon	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	request	7	7	8	0	.	0	8	9	1	.	8	8	9	0
EOS
T	20
We	21861	21863	PRP	we	O	_	_
used	21864	21868	VBD	use	O	_	_
siGENOME	21869	21877	NN	sigenome	B-GENE	_	_
RISC-Free	21878	21887	JJ	risc-free	I-GENE	_	_
siRNA	21888	21893	NN	sirna	I-GENE	_	_
(	21894	21895	CD	(	O	_	_
Dharmacon	21895	21904	NNP	Dharmacon	O	_	_
,	21904	21905	,	,	O	_	_
Lafayette	21906	21915	NNP	Lafayette	O	_	_
,	21915	21916	,	,	O	_	_
CO	21917	21919	NNP	CO	O	_	_
,	21919	21920	,	,	O	_	_
United	21921	21927	NNP	United	O	_	_
States	21928	21934	NNPS	States	O	_	_
)	21934	21935	RB	)	O	_	_
as	21936	21938	IN	as	O	_	_
a	21939	21940	DT	a	O	_	_
negative	21941	21949	JJ	negative	O	_	_
control	21950	21957	NN	control	O	_	_
.	21957	21958	.	.	O	_	_
D	1
1
1	0	nsubj
1	2	dobj
1	6	dep
1	14	advmod
1	18	prep_as
2	3	amod
6	4	nn
6	5	num
6	8	appos
6	10	appos
6	13	appos
13	12	nn
18	16	det
18	17	amod
EOX
Y	1
ROOT	0	0	20	1	S	1	0	20	3	NP	0	0	1	1	PRP	0	0	1	1	We	0	0	1	0	VP	0	1	19	4	VBD	0	1	2	1	used	1	1	2	0	NP	0	2	4	2	NN	0	2	3	1	siGENOME	2	2	3	0	JJ	0	3	4	1	RISC-Free	3	3	4	0	FRAG	0	4	14	1	NP	0	4	14	7	NP	2	4	7	3	NN	0	4	5	1	siRNA	4	4	5	0	CD	0	5	6	1	(	5	5	6	0	NNP	0	6	7	1	Dharmacon	6	6	7	0	,	0	7	8	1	,	7	7	8	0	NP	0	8	9	1	NNP	0	8	9	1	Lafayette	8	8	9	0	,	0	9	10	1	,	9	9	10	0	NP	0	10	11	1	NNP	0	10	11	1	CO	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	1	12	14	2	NNP	0	12	13	1	United	12	12	13	0	NNPS	0	13	14	1	States	13	13	14	0	PP	1	14	19	3	ADVP	0	14	15	1	RB	0	14	15	1	)	14	14	15	0	IN	0	15	16	1	as	15	15	16	0	NP	2	16	19	3	DT	0	16	17	1	a	16	16	17	0	JJ	0	17	18	1	negative	17	17	18	0	NN	0	18	19	1	control	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	36
Cells	21959	21964	NNS	cell	O	_	_
were	21965	21969	VBD	be	O	_	_
transfected	21970	21981	VBN	transfect	O	_	_
with	21982	21986	IN	with	O	_	_
the	21987	21990	DT	the	O	_	_
indicated	21991	22000	VBN	indicate	O	_	_
siRNA	22001	22006	NN	sirna	O	_	_
oligos	22007	22013	NNS	oligo	O	_	_
at	22014	22016	IN	at	O	_	_
a	22017	22018	DT	a	O	_	_
final	22019	22024	JJ	final	O	_	_
concentration	22025	22038	NN	concentration	O	_	_
of	22039	22041	IN	of	O	_	_
35nM	22042	22046	NN	35nm	O	_	_
using	22047	22052	VBG	use	O	_	_
Dharmafect	22053	22063	NN	dharmafect	O	_	_
1	22064	22065	CD	1	O	_	_
reagent	22066	22073	NN	reagent	O	_	_
(	22074	22075	CD	(	O	_	_
Dharmacon	22075	22084	NNP	Dharmacon	O	_	_
,	22084	22085	,	,	O	_	_
Lafayette	22086	22095	NNP	Lafayette	O	_	_
,	22095	22096	,	,	O	_	_
CO	22097	22099	NNP	CO	O	_	_
,	22099	22100	,	,	O	_	_
United	22101	22107	NNP	United	O	_	_
States	22108	22114	NNPS	States	O	_	_
)	22114	22115	NN	)	O	_	_
,	22115	22116	,	,	O	_	_
according	22117	22126	VBG	accord	O	_	_
to	22127	22129	TO	to	O	_	_
the	22130	22133	DT	the	O	_	_
manufacturer	22134	22146	NN	manufacturer	O	_	_
's	22146	22148	POS	's	O	_	_
instructions	22149	22161	NNS	instruction	O	_	_
.	22161	22162	.	.	O	_	_
D	1
2
2	0	nsubjpass
2	1	auxpass
2	7	prep_with
2	11	prep_at
2	30	prepc_according_to
2	34	pobj
7	4	det
7	5	amod
7	6	nn
11	9	det
11	10	amod
11	13	prep_of
13	14	vmod
14	17	dobj
14	27	dep
17	15	nn
17	16	num
27	18	num
27	19	nn
27	21	appos
27	23	appos
27	25	appos
27	26	nn
32	31	det
34	32	poss
EOX
Y	1
ROOT	0	0	36	1	S	1	0	36	3	NP	0	0	1	1	NNS	0	0	1	1	Cells	0	0	1	0	VP	1	1	35	2	VBD	0	1	2	1	were	1	1	2	0	VP	0	2	35	5	VBN	0	2	3	1	transfected	2	2	3	0	PP	0	3	8	2	IN	0	3	4	1	with	3	3	4	0	NP	3	4	8	4	DT	0	4	5	1	the	4	4	5	0	VBN	0	5	6	1	indicated	5	5	6	0	NN	0	6	7	1	siRNA	6	6	7	0	NNS	0	7	8	1	oligos	7	7	8	0	PP	0	8	28	2	IN	0	8	9	1	at	8	8	9	0	NP	0	9	28	2	NP	2	9	12	3	DT	0	9	10	1	a	9	9	10	0	JJ	0	10	11	1	final	10	10	11	0	NN	0	11	12	1	concentration	11	11	12	0	PP	0	12	28	2	IN	0	12	13	1	of	12	12	13	0	NP	0	13	28	2	NP	0	13	14	1	NN	0	13	14	1	35nM	13	13	14	0	VP	0	14	28	3	VBG	0	14	15	1	using	14	14	15	0	NP	2	15	18	3	NN	0	15	16	1	Dharmafect	15	15	16	0	CD	0	16	17	1	1	16	16	17	0	NN	0	17	18	1	reagent	17	17	18	0	S	0	18	28	1	NP	9	18	28	10	CD	0	18	19	1	(	18	18	19	0	NNP	0	19	20	1	Dharmacon	19	19	20	0	,	0	20	21	1	,	20	20	21	0	NNP	0	21	22	1	Lafayette	21	21	22	0	,	0	22	23	1	,	22	22	23	0	NNP	0	23	24	1	CO	23	23	24	0	,	0	24	25	1	,	24	24	25	0	NNP	0	25	26	1	United	25	25	26	0	NNPS	0	26	27	1	States	26	26	27	0	NN	0	27	28	1	)	27	27	28	0	,	0	28	29	1	,	28	28	29	0	PP	0	29	35	2	VBG	0	29	30	1	according	29	29	30	0	PP	0	30	35	2	TO	0	30	31	1	to	30	30	31	0	NP	1	31	35	2	NP	1	31	34	3	DT	0	31	32	1	the	31	31	32	0	NN	0	32	33	1	manufacturer	32	32	33	0	POS	0	33	34	1	's	33	33	34	0	NNS	0	34	35	1	instructions	34	34	35	0	.	0	35	36	1	.	35	35	36	0
EOS
T	38
Generation	22163	22173	NN	generation	O	_	_
of	22174	22176	IN	of	O	_	_
Phosphor-ASPP2	22177	22191	NN	phosphor-aspp2	O	_	_
Antibody	22192	22200	NN	antibody	O	_	_
Using	22201	22206	VBG	use	O	_	_
the	22207	22210	DT	the	O	_	_
peptide	22211	22218	NN	peptide	O	_	_
CPAPSpPGLDY	22219	22230	NN	cpapsppgldy	O	_	_
(	22231	22232	CD	(	O	_	_
representing	22232	22244	VBG	represent	O	_	_
residues	22245	22253	NNS	residue	O	_	_
824-832	22254	22261	CD	824-832	O	_	_
)	22261	22262	CD	)	O	_	_
with	22263	22267	IN	with	O	_	_
the	22268	22271	DT	the	O	_	_
serine	22272	22278	NN	serine	O	_	_
phosphorylated	22279	22293	VBN	phosphorylate	O	_	_
as	22294	22296	IN	as	O	_	_
an	22297	22299	DT	a	O	_	_
immunogen	22300	22309	NN	immunogen	O	_	_
,	22309	22310	,	,	O	_	_
a	22311	22312	DT	a	O	_	_
rabbit	22313	22319	NN	rabbit	B-GENE	_	_
polyclonal	22320	22330	JJ	polyclonal	I-GENE	_	_
antibody	22331	22339	NN	antibody	I-GENE	_	_
NGH.S4	22340	22346	NN	ngh.s4	I-GENE	_	_
which	22347	22352	WDT	which	O	_	_
specifically	22353	22365	RB	specifically	O	_	_
recognizes	22366	22376	VBZ	recognize	O	_	_
phosphorylated	22377	22391	VBN	phosphorylate	O	_	_
ASPP2	22392	22397	NN	aspp2	B-GENE	_	_
at	22398	22400	IN	at	O	_	_
amino	22401	22406	NN	amino	O	_	_
acid	22407	22411	NN	acid	O	_	_
827	22412	22415	CD	827	O	_	_
was	22416	22419	VBD	be	O	_	_
raised	22420	22426	VBN	raise	O	_	_
.	22426	22427	.	.	O	_	_
D	1
36
0	3	prep_of
3	2	nn
3	4	vmod
4	7	dobj
4	9	vmod
7	5	det
7	6	nn
7	8	num
9	10	dobj
9	12	npadvmod
9	15	prep_with
12	11	num
15	14	det
15	16	vmod
16	19	prep_as
19	18	det
19	25	appos
25	21	det
25	22	nn
25	23	amod
25	24	nn
25	28	rcmod
28	26	nsubj
28	27	advmod
28	29	dep
29	30	dobj
29	33	prep_at
33	32	nn
33	34	num
36	0	nsubjpass
36	35	auxpass
EOX
Y	1
ROOT	0	0	38	1	S	1	0	38	3	NP	0	0	35	2	NP	0	0	1	1	NN	0	0	1	1	Generation	0	0	1	0	PP	0	1	35	2	IN	0	1	2	1	of	1	1	2	0	NP	0	2	35	2	NP	1	2	4	2	NN	0	2	3	1	Phosphor-ASPP2	2	2	3	0	NN	0	3	4	1	Antibody	3	3	4	0	VP	0	4	35	3	VBG	0	4	5	1	Using	4	4	5	0	NP	2	5	9	4	DT	0	5	6	1	the	5	5	6	0	NN	0	6	7	1	peptide	6	6	7	0	NN	0	7	8	1	CPAPSpPGLDY	7	7	8	0	CD	0	8	9	1	(	8	8	9	0	S	0	9	35	1	VP	0	9	35	3	VBG	0	9	10	1	representing	9	9	10	0	NP	0	10	11	1	NNS	0	10	11	1	residues	10	10	11	0	PP	1	11	35	3	NP	1	11	13	2	CD	0	11	12	1	824-832	11	11	12	0	CD	0	12	13	1	)	12	12	13	0	IN	0	13	14	1	with	13	13	14	0	NP	0	14	35	2	NP	1	14	16	2	DT	0	14	15	1	the	14	14	15	0	NN	0	15	16	1	serine	15	15	16	0	VP	0	16	35	2	VBN	0	16	17	1	phosphorylated	16	16	17	0	PP	0	17	35	2	IN	0	17	18	1	as	17	17	18	0	NP	0	18	35	3	NP	1	18	20	2	DT	0	18	19	1	an	18	18	19	0	NN	0	19	20	1	immunogen	19	19	20	0	,	0	20	21	1	,	20	20	21	0	NP	0	21	35	2	NP	4	21	26	5	DT	0	21	22	1	a	21	21	22	0	NN	0	22	23	1	rabbit	22	22	23	0	JJ	0	23	24	1	polyclonal	23	23	24	0	NN	0	24	25	1	antibody	24	24	25	0	NN	0	25	26	1	NGH.S4	25	25	26	0	SBAR	1	26	35	2	WHNP	0	26	27	1	WDT	0	26	27	1	which	26	26	27	0	S	1	27	35	2	ADVP	0	27	28	1	RB	0	27	28	1	specifically	27	27	28	0	VP	0	28	35	2	VBZ	0	28	29	1	recognizes	28	28	29	0	VP	0	29	35	3	VBN	0	29	30	1	phosphorylated	29	29	30	0	NP	0	30	31	1	NN	0	30	31	1	ASPP2	30	30	31	0	PP	0	31	35	2	IN	0	31	32	1	at	31	31	32	0	NP	1	32	35	3	NN	0	32	33	1	amino	32	32	33	0	NN	0	33	34	1	acid	33	33	34	0	CD	0	34	35	1	827	34	34	35	0	VP	1	35	37	2	VBD	0	35	36	1	was	35	35	36	0	VP	0	36	37	1	VBN	0	36	37	1	raised	36	36	37	0	.	0	37	38	1	.	37	37	38	0
EOS
T	24
An	22428	22430	DT	a	O	_	_
affinity	22431	22439	NN	affinity	O	_	_
column	22440	22446	NN	column	O	_	_
was	22447	22450	VBD	be	O	_	_
made	22451	22455	VBN	make	O	_	_
by	22456	22458	IN	by	O	_	_
cross	22459	22464	NN	cross	O	_	_
linking	22465	22472	VBG	link	O	_	_
the	22473	22476	DT	the	O	_	_
phospho-peptide	22477	22492	NN	phospho-peptide	O	_	_
to	22493	22495	TO	to	O	_	_
epoxy-sepharose-6B	22496	22514	NN	epoxy-sepharose-6b	O	_	_
(	22515	22516	CD	(	O	_	_
Amersham	22516	22524	NNP	Amersham	O	_	_
Pharmacia	22525	22534	NNP	Pharmacia	O	_	_
Biotech	22535	22542	NNP	Biotech	O	_	_
)	22542	22543	CD	)	O	_	_
according	22544	22553	VBG	accord	O	_	_
to	22554	22556	TO	to	O	_	_
the	22557	22560	DT	the	O	_	_
manufacturer	22561	22573	NN	manufacturer	O	_	_
's	22573	22575	POS	's	O	_	_
instructions	22576	22588	NNS	instruction	O	_	_
.	22588	22589	.	.	O	_	_
D	1
4
2	0	det
2	1	nn
4	2	nsubjpass
4	3	auxpass
4	6	agent
4	7	xcomp
4	18	prepc_according_to
4	22	pobj
7	9	dobj
7	11	prep_to
7	15	dobj
9	8	det
11	12	num
15	13	nn
15	14	nn
15	16	dep
20	19	det
22	20	poss
EOX
Y	1
ROOT	0	0	24	1	S	1	0	24	3	NP	2	0	3	3	DT	0	0	1	1	An	0	0	1	0	NN	0	1	2	1	affinity	1	1	2	0	NN	0	2	3	1	column	2	2	3	0	VP	1	3	23	2	VBD	0	3	4	1	was	3	3	4	0	VP	0	4	23	4	VBN	0	4	5	1	made	4	4	5	0	PP	0	5	7	2	IN	0	5	6	1	by	5	5	6	0	NP	0	6	7	1	NN	0	6	7	1	cross	6	6	7	0	S	0	7	17	1	VP	0	7	17	4	VBG	0	7	8	1	linking	7	7	8	0	NP	1	8	10	2	DT	0	8	9	1	the	8	8	9	0	NN	0	9	10	1	phospho-peptide	9	9	10	0	PP	0	10	13	2	TO	0	10	11	1	to	10	10	11	0	NP	0	11	13	2	NN	0	11	12	1	epoxy-sepharose-6B	11	11	12	0	CD	0	12	13	1	(	12	12	13	0	NP	0	13	17	2	NP	2	13	16	3	NNP	0	13	14	1	Amersham	13	13	14	0	NNP	0	14	15	1	Pharmacia	14	14	15	0	NNP	0	15	16	1	Biotech	15	15	16	0	NP	0	16	17	1	CD	0	16	17	1	)	16	16	17	0	PP	0	17	23	2	VBG	0	17	18	1	according	17	17	18	0	PP	0	18	23	2	TO	0	18	19	1	to	18	18	19	0	NP	1	19	23	2	NP	1	19	22	3	DT	0	19	20	1	the	19	19	20	0	NN	0	20	21	1	manufacturer	20	20	21	0	POS	0	21	22	1	's	21	21	22	0	NNS	0	22	23	1	instructions	22	22	23	0	.	0	23	24	1	.	23	23	24	0
EOS
T	40
Serum	22590	22595	NN	serum	O	_	_
from	22596	22600	IN	from	O	_	_
the	22601	22604	DT	the	O	_	_
final	22605	22610	JJ	final	O	_	_
bleed	22611	22616	VB	bleed	O	_	_
was	22617	22620	VBD	be	O	_	_
clarified	22621	22630	VBN	clarify	O	_	_
by	22631	22633	IN	by	O	_	_
centrifugation	22634	22648	NN	centrifugation	O	_	_
and	22649	22652	CC	and	O	_	_
filtration	22653	22663	NN	filtration	O	_	_
through	22664	22671	IN	through	O	_	_
a	22672	22673	DT	a	O	_	_
0.45	22674	22678	CD	0.45	O	_	_
mum	22678	22681	NN	mum	O	_	_
filter	22682	22688	NN	filter	O	_	_
and	22689	22692	CC	and	O	_	_
was	22693	22696	VBD	be	O	_	_
supplemented	22697	22709	VBN	supplement	O	_	_
with	22710	22714	IN	with	O	_	_
1X	22715	22717	NN	1x	O	_	_
TTBS	22718	22722	NN	ttb	O	_	_
(	22723	22724	CD	(	O	_	_
0.5	22724	22727	CD	0.5	O	_	_
M	22728	22729	NN	m	O	_	_
NaCl	22730	22734	NN	nacl	O	_	_
,	22734	22735	,	,	O	_	_
20	22736	22738	CD	20	O	_	_
mM	22739	22741	NN	mm	O	_	_
Tris	22742	22746	NNP	Tris	O	_	_
[	22747	22748	CD	[	O	_	_
pH	22748	22750	NN	ph	O	_	_
8.0	22751	22754	CD	8.0	O	_	_
]	22754	22755	NN	]	O	_	_
,	22755	22756	,	,	O	_	_
0.1	22757	22760	CD	0.1	O	_	_
%	22760	22761	NN	%	O	_	_
Tween-20	22762	22770	NN	tween-20	O	_	_
)	22770	22771	NN	)	O	_	_
.	22771	22772	.	.	O	_	_
D	1
4
0	3	prep_from
3	2	det
4	0	nsubj
4	6	dep
4	18	dep
4	38	dobj
6	5	auxpass
6	8	agent
6	10	agent
6	15	prep_through
6	18	conj_and
6	25	dobj
6	33	nsubjpass
8	10	conj_and
15	12	det
15	13	num
15	14	nn
18	17	auxpass
18	21	prep_with
18	33	nsubjpass
21	20	nn
23	22	number
25	23	num
25	24	nn
25	29	appos
29	27	num
29	28	nn
33	30	num
33	31	nn
33	32	num
36	35	number
38	36	amod
38	37	nn
EOX
Y	1
ROOT	0	0	40	1	S	1	0	40	3	NP	0	0	4	2	NP	0	0	1	1	NN	0	0	1	1	Serum	0	0	1	0	PP	0	1	4	2	IN	0	1	2	1	from	1	1	2	0	NP	1	2	4	2	DT	0	2	3	1	the	2	2	3	0	JJ	0	3	4	1	final	3	3	4	0	VP	0	4	39	3	VP	0	4	34	2	VB	0	4	5	1	bleed	4	4	5	0	SBAR	0	5	34	1	SINV	0	5	34	2	VP	1	5	30	2	VBD	0	5	6	1	was	5	5	6	0	VP	0	6	30	4	VP	0	6	16	3	VBN	0	6	7	1	clarified	6	6	7	0	PP	0	7	11	2	IN	0	7	8	1	by	7	7	8	0	NP	0	8	11	3	NN	0	8	9	1	centrifugation	8	8	9	0	CC	0	9	10	1	and	9	9	10	0	NN	0	10	11	1	filtration	10	10	11	0	PP	0	11	16	2	IN	0	11	12	1	through	11	11	12	0	NP	3	12	16	4	DT	0	12	13	1	a	12	12	13	0	CD	0	13	14	1	0.45	13	13	14	0	NN	0	14	15	1	mum	14	14	15	0	NN	0	15	16	1	filter	15	15	16	0	CC	0	16	17	1	and	16	16	17	0	VP	1	17	22	2	VBD	0	17	18	1	was	17	17	18	0	VP	0	18	22	2	VBN	0	18	19	1	supplemented	18	18	19	0	PP	0	19	22	2	IN	0	19	20	1	with	19	19	20	0	NP	1	20	22	2	NN	0	20	21	1	1X	20	20	21	0	NN	0	21	22	1	TTBS	21	21	22	0	NP	0	22	30	3	NP	2	22	26	3	QP	1	22	24	2	CD	0	22	23	1	(	22	22	23	0	CD	0	23	24	1	0.5	23	23	24	0	NN	0	24	25	1	M	24	24	25	0	NN	0	25	26	1	NaCl	25	25	26	0	,	0	26	27	1	,	26	26	27	0	NP	2	27	30	3	CD	0	27	28	1	20	27	27	28	0	NN	0	28	29	1	mM	28	28	29	0	NNP	0	29	30	1	Tris	29	29	30	0	NP	3	30	34	4	CD	0	30	31	1	[	30	30	31	0	NN	0	31	32	1	pH	31	31	32	0	CD	0	32	33	1	8.0	32	32	33	0	NN	0	33	34	1	]	33	33	34	0	,	0	34	35	1	,	34	34	35	0	NP	2	35	39	3	ADJP	1	35	37	2	CD	0	35	36	1	0.1	35	35	36	0	NN	0	36	37	1	%	36	36	37	0	NN	0	37	38	1	Tween-20	37	37	38	0	NN	0	38	39	1	)	38	38	39	0	.	0	39	40	1	.	39	39	40	0
EOS
T	20
This	22773	22777	DT	this	O	_	_
was	22778	22781	VBD	be	O	_	_
passed	22782	22788	VBN	pass	O	_	_
over	22789	22793	IN	over	O	_	_
the	22794	22797	DT	the	O	_	_
affinity	22798	22806	NN	affinity	O	_	_
column	22807	22813	NN	column	O	_	_
and	22814	22817	CC	and	O	_	_
washed	22818	22824	VBN	wash	O	_	_
with	22825	22829	IN	with	O	_	_
TTBS	22830	22834	NN	ttb	O	_	_
until	22835	22840	IN	until	O	_	_
the	22841	22844	DT	the	O	_	_
flow-through	22845	22857	JJ	flow-through	O	_	_
had	22858	22861	VBD	have	O	_	_
an	22862	22864	DT	a	O	_	_
OD280nm	22865	22872	NN	od280nm	O	_	_
<	22873	22874	JJR	<	O	_	_
0.01	22874	22878	CD	0.01	O	_	_
.	22878	22879	.	.	O	_	_
D	1
2
2	0	nsubjpass
2	1	auxpass
2	6	prep_over
2	8	conj_and
2	18	dobj
6	4	det
6	5	nn
8	0	nsubjpass
8	10	prep_with
8	14	advcl
13	12	det
14	11	mark
14	13	nsubj
14	17	dobj
17	15	det
17	16	dep
EOX
Y	1
ROOT	0	0	20	1	S	1	0	20	3	NP	0	0	1	1	DT	0	0	1	1	This	0	0	1	0	VP	1	1	19	2	VBD	0	1	2	1	was	1	1	2	0	VP	0	2	19	4	VP	0	2	7	2	VBN	0	2	3	1	passed	2	2	3	0	PP	0	3	7	2	IN	0	3	4	1	over	3	3	4	0	NP	2	4	7	3	DT	0	4	5	1	the	4	4	5	0	NN	0	5	6	1	affinity	5	5	6	0	NN	0	6	7	1	column	6	6	7	0	CC	0	7	8	1	and	7	7	8	0	VP	0	8	18	3	VBN	0	8	9	1	washed	8	8	9	0	PP	0	9	11	2	IN	0	9	10	1	with	9	9	10	0	NP	0	10	11	1	NN	0	10	11	1	TTBS	10	10	11	0	SBAR	1	11	18	2	IN	0	11	12	1	until	11	11	12	0	S	1	12	18	2	NP	1	12	14	2	DT	0	12	13	1	the	12	12	13	0	JJ	0	13	14	1	flow-through	13	13	14	0	VP	0	14	18	2	VBD	0	14	15	1	had	14	14	15	0	NP	2	15	18	3	DT	0	15	16	1	an	15	15	16	0	NN	0	16	17	1	OD280nm	16	16	17	0	JJR	0	17	18	1	<	17	17	18	0	NP	0	18	19	1	CD	0	18	19	1	0.01	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	22
The	22880	22883	DT	the	O	_	_
antibody	22884	22892	NN	antibody	O	_	_
was	22893	22896	VBD	be	O	_	_
then	22897	22901	RB	then	O	_	_
eluted	22902	22908	VBN	elute	O	_	_
with	22909	22913	IN	with	O	_	_
0.2	22914	22917	CD	0.2	O	_	_
M	22917	22918	NN	m	O	_	_
glycine	22919	22926	NN	glycine	O	_	_
(	22927	22928	CD	(	O	_	_
pH	22928	22930	NN	ph	O	_	_
2.8	22931	22934	CD	2.8	O	_	_
)	22934	22935	NN	)	O	_	_
and	22936	22939	CC	and	O	_	_
neutralized	22940	22951	VBD	neutralize	O	_	_
with	22952	22956	IN	with	O	_	_
Tris-HCl	22957	22965	NN	tris-hcl	O	_	_
(	22966	22967	CD	(	O	_	_
pH	22967	22969	NN	ph	O	_	_
8.0	22970	22973	CD	8.0	O	_	_
)	22973	22974	NN	)	O	_	_
.	22974	22975	.	.	O	_	_
D	1
4
1	0	det
4	1	dep
4	2	auxpass
4	3	advmod
4	8	prep_with
4	12	nsubjpass
4	14	conj_and
8	6	num
8	7	nn
12	9	num
12	10	nn
12	11	num
14	16	prep_with
14	20	nsubj
20	17	num
20	18	nn
20	19	num
EOX
Y	1
ROOT	0	0	22	1	SINV	0	0	22	4	SINV	1	0	13	3	FRAG	0	0	2	1	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	antibody	1	1	2	0	VP	2	2	9	3	VBD	0	2	3	1	was	2	2	3	0	RB	0	3	4	1	then	3	3	4	0	VP	0	4	9	2	VBN	0	4	5	1	eluted	4	4	5	0	PP	0	5	9	2	IN	0	5	6	1	with	5	5	6	0	NP	2	6	9	3	CD	0	6	7	1	0.2	6	6	7	0	NN	0	7	8	1	M	7	7	8	0	NN	0	8	9	1	glycine	8	8	9	0	NP	3	9	13	4	CD	0	9	10	1	(	9	9	10	0	NN	0	10	11	1	pH	10	10	11	0	CD	0	11	12	1	2.8	11	11	12	0	NN	0	12	13	1	)	12	12	13	0	CC	0	13	14	1	and	13	13	14	0	SINV	0	14	21	2	VP	0	14	17	2	VBD	0	14	15	1	neutralized	14	14	15	0	PP	0	15	17	2	IN	0	15	16	1	with	15	15	16	0	NP	0	16	17	1	NN	0	16	17	1	Tris-HCl	16	16	17	0	NP	3	17	21	4	CD	0	17	18	1	(	17	17	18	0	NN	0	18	19	1	pH	18	18	19	0	CD	0	19	20	1	8.0	19	19	20	0	NN	0	20	21	1	)	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	33
A	22976	22977	DT	a	O	_	_
second	22978	22984	JJ	second	O	_	_
phospho	22985	22992	NN	phospho	O	_	_
specific	22993	23001	JJ	specific	O	_	_
antibody	23002	23010	NN	antibody	O	_	_
ES1	23011	23014	NN	es1	O	_	_
was	23015	23018	VBD	be	O	_	_
raised	23019	23025	VBN	raise	O	_	_
against	23026	23033	IN	against	O	_	_
the	23034	23037	DT	the	O	_	_
peptide	23038	23045	NN	peptide	O	_	_
SDMPAPS	23046	23053	NNP	SDMPAPS	O	_	_
[	23053	23054	CD	[	O	_	_
P	23054	23055	NN	p	O	_	_
]	23055	23056	CD	]	O	_	_
PGLDYE	23056	23062	NN	pgldye	O	_	_
where	23063	23068	WRB	where	O	_	_
S	23069	23070	NN	s	O	_	_
[	23070	23071	CD	[	O	_	_
P	23071	23072	NN	p	O	_	_
]	23072	23073	NN	]	O	_	_
is	23074	23076	VBZ	be	O	_	_
the	23077	23080	DT	the	O	_	_
phosphorylated	23081	23095	VBN	phosphorylate	O	_	_
serine	23096	23102	NN	serine	O	_	_
827	23103	23106	CD	827	O	_	_
,	23106	23107	,	,	O	_	_
and	23108	23111	CC	and	O	_	_
was	23112	23115	VBD	be	O	_	_
conjugated	23116	23126	VBN	conjugate	O	_	_
to	23127	23129	TO	to	O	_	_
KLH	23130	23133	NNP	KLH	O	_	_
.	23133	23134	.	.	O	_	_
D	1
7
2	0	det
2	1	amod
2	5	dep
5	3	amod
5	4	nn
7	2	nsubjpass
7	6	auxpass
7	11	prep_against
7	15	dobj
7	29	conj_and
11	9	det
11	10	nn
11	12	num
15	13	nn
15	14	num
15	22	rcmod
17	16	advmod
20	18	num
20	19	nn
22	17	dobj
22	20	nsubj
22	21	cop
22	23	vmod
23	24	dobj
24	25	num
29	2	nsubjpass
29	28	auxpass
29	31	prep_to
EOX
Y	1
ROOT	0	0	33	1	S	1	0	33	3	NP	0	0	6	2	NP	2	0	3	3	DT	0	0	1	1	A	0	0	1	0	JJ	0	1	2	1	second	1	1	2	0	NN	0	2	3	1	phospho	2	2	3	0	NP	2	3	6	3	JJ	0	3	4	1	specific	3	3	4	0	NN	0	4	5	1	antibody	4	4	5	0	NN	0	5	6	1	ES1	5	5	6	0	VP	0	6	32	4	VP	1	6	26	2	VBD	0	6	7	1	was	6	6	7	0	VP	0	7	26	3	VBN	0	7	8	1	raised	7	7	8	0	PP	0	8	13	2	IN	0	8	9	1	against	8	8	9	0	NP	2	9	13	4	DT	0	9	10	1	the	9	9	10	0	NN	0	10	11	1	peptide	10	10	11	0	NNP	0	11	12	1	SDMPAPS	11	11	12	0	CD	0	12	13	1	[	12	12	13	0	NP	0	13	26	2	NP	2	13	16	3	NN	0	13	14	1	P	13	13	14	0	CD	0	14	15	1	]	14	14	15	0	NN	0	15	16	1	PGLDYE	15	15	16	0	SBAR	1	16	26	2	WHNP	1	16	18	2	WHADVP	0	16	17	1	WRB	0	16	17	1	where	16	16	17	0	NN	0	17	18	1	S	17	17	18	0	S	1	18	26	2	NP	2	18	21	3	CD	0	18	19	1	[	18	18	19	0	NN	0	19	20	1	P	19	19	20	0	NN	0	20	21	1	]	20	20	21	0	VP	1	21	26	2	VBZ	0	21	22	1	is	21	21	22	0	NP	0	22	26	2	NP	0	22	23	1	DT	0	22	23	1	the	22	22	23	0	VP	0	23	26	2	VBN	0	23	24	1	phosphorylated	23	23	24	0	NP	0	24	26	2	NN	0	24	25	1	serine	24	24	25	0	CD	0	25	26	1	827	25	25	26	0	,	0	26	27	1	,	26	26	27	0	CC	0	27	28	1	and	27	27	28	0	VP	1	28	32	2	VBD	0	28	29	1	was	28	28	29	0	VP	0	29	32	2	VBN	0	29	30	1	conjugated	29	29	30	0	PP	0	30	32	2	TO	0	30	31	1	to	30	30	31	0	NP	0	31	32	1	NNP	0	31	32	1	KLH	31	31	32	0	.	0	32	33	1	.	32	32	33	0
EOS
T	13
The	23135	23138	DT	the	O	_	_
serum	23139	23144	NN	serum	O	_	_
was	23145	23148	VBD	be	O	_	_
double	23149	23155	JJ	double	O	_	_
affinity	23156	23164	NN	affinity	O	_	_
purified	23165	23173	VBN	purify	O	_	_
against	23174	23181	IN	against	O	_	_
the	23182	23185	DT	the	O	_	_
non	23186	23189	JJ	non	O	_	_
phosphorylated	23190	23204	JJ	phosphorylated	O	_	_
peptide	23205	23212	NN	peptide	O	_	_
SDMPAPSPGLDYE	23213	23226	NNP	SDMPAPSPGLDYE	O	_	_
.	23226	23227	.	.	O	_	_
D	1
4
1	0	det
4	1	nsubj
4	2	cop
4	3	amod
4	5	vmod
5	10	prep_against
10	7	det
10	8	amod
10	9	amod
10	11	appos
EOX
Y	1
ROOT	0	0	13	1	S	1	0	13	3	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	serum	1	1	2	0	VP	1	2	12	2	VBD	0	2	3	1	was	2	2	3	0	NP	0	3	12	2	NP	1	3	5	2	JJ	0	3	4	1	double	3	3	4	0	NN	0	4	5	1	affinity	4	4	5	0	VP	0	5	12	2	VBN	0	5	6	1	purified	5	5	6	0	PP	0	6	12	2	IN	0	6	7	1	against	6	6	7	0	NP	0	7	12	2	NP	3	7	11	4	DT	0	7	8	1	the	7	7	8	0	JJ	0	8	9	1	non	8	8	9	0	JJ	0	9	10	1	phosphorylated	9	9	10	0	NN	0	10	11	1	peptide	10	10	11	0	NP	0	11	12	1	NNP	0	11	12	1	SDMPAPSPGLDYE	11	11	12	0	.	0	12	13	1	.	12	12	13	0
EOS
T	20
Transactivation	23228	23243	NN	transactivation	O	_	_
Assay	23244	23249	NN	assay	O	_	_
Saos2	23250	23255	NN	saos2	O	_	_
cells	23256	23261	NNS	cell	O	_	_
(	23262	23263	VBP	(	O	_	_
7	23263	23264	CD	7	O	_	_
x	23265	23266	CC	x	O	_	_
105	23267	23270	CD	105	O	_	_
)	23270	23271	NN	)	O	_	_
were	23272	23276	VBD	be	O	_	_
plated	23277	23283	VBN	plate	O	_	_
24	23284	23286	CD	24	O	_	_
hours	23287	23292	NNS	hour	O	_	_
prior	23293	23298	RB	prior	O	_	_
to	23299	23301	TO	to	O	_	_
transfection	23302	23314	NN	transfection	O	_	_
in	23315	23317	IN	in	O	_	_
6-cm-diameter	23318	23331	JJ	6-cm-diameter	O	_	_
dishes	23332	23338	NNS	dish	O	_	_
.	23338	23339	.	.	O	_	_
D	1
4
3	0	nn
3	1	nn
3	2	nn
4	3	nsubj
4	10	ccomp
5	8	conj_x
8	7	num
10	5	nsubjpass
10	8	nsubjpass
10	9	auxpass
10	12	npadvmod
10	15	prep_prior_to
12	11	num
15	18	prep_in
18	17	amod
EOX
Y	1
ROOT	0	0	20	1	S	1	0	20	3	NP	3	0	4	4	NN	0	0	1	1	Transactivation	0	0	1	0	NN	0	1	2	1	Assay	1	1	2	0	NN	0	2	3	1	Saos2	2	2	3	0	NNS	0	3	4	1	cells	3	3	4	0	VP	0	4	19	2	VBP	0	4	5	1	(	4	4	5	0	SBAR	0	5	19	1	S	1	5	19	2	NP	0	5	9	3	NP	0	5	6	1	CD	0	5	6	1	7	5	5	6	0	CC	0	6	7	1	x	6	6	7	0	NP	1	7	9	2	CD	0	7	8	1	105	7	7	8	0	NN	0	8	9	1	)	8	8	9	0	VP	1	9	19	2	VBD	0	9	10	1	were	9	9	10	0	VP	0	10	19	2	VBN	0	10	11	1	plated	10	10	11	0	PP	1	11	19	3	ADVP	1	11	14	2	NP	1	11	13	2	CD	0	11	12	1	24	11	11	12	0	NNS	0	12	13	1	hours	12	12	13	0	RB	0	13	14	1	prior	13	13	14	0	TO	0	14	15	1	to	14	14	15	0	NP	0	15	19	2	NP	0	15	16	1	NN	0	15	16	1	transfection	15	15	16	0	PP	0	16	19	2	IN	0	16	17	1	in	16	16	17	0	NP	1	17	19	2	JJ	0	17	18	1	6-cm-diameter	17	17	18	0	NNS	0	18	19	1	dishes	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	10
All	23340	23343	DT	all	O	_	_
transactivation	23344	23359	NN	transactivation	O	_	_
assays	23360	23366	NNS	assay	O	_	_
contained	23367	23376	VBD	contain	O	_	_
1	23377	23378	CD	1	O	_	_
mug	23379	23382	NN	mug	O	_	_
of	23383	23385	IN	of	O	_	_
reporter	23386	23394	NN	reporter	O	_	_
plasmid	23395	23402	NN	plasmid	O	_	_
.	23402	23403	.	.	O	_	_
D	1
3
2	0	det
2	1	nn
3	2	nsubj
3	5	dobj
5	4	num
5	8	prep_of
8	7	nn
EOX
Y	1
ROOT	0	0	10	1	S	1	0	10	3	NP	2	0	3	3	DT	0	0	1	1	All	0	0	1	0	NN	0	1	2	1	transactivation	1	1	2	0	NNS	0	2	3	1	assays	2	2	3	0	VP	0	3	9	2	VBD	0	3	4	1	contained	3	3	4	0	NP	0	4	9	2	NP	1	4	6	2	CD	0	4	5	1	1	4	4	5	0	NN	0	5	6	1	mug	5	5	6	0	PP	0	6	9	2	IN	0	6	7	1	of	6	6	7	0	NP	1	7	9	2	NN	0	7	8	1	reporter	7	7	8	0	NN	0	8	9	1	plasmid	8	8	9	0	.	0	9	10	1	.	9	9	10	0
EOS
T	27
50	23404	23406	CD	50	O	_	_
ng	23407	23409	NN	ng	O	_	_
of	23410	23412	IN	of	O	_	_
p53	23413	23416	NN	p53	B-GENE	_	_
,	23416	23417	,	,	I-GENE	_	_
4	23418	23419	CD	4	I-GENE	_	_
mug	23420	23423	NN	mug	I-GENE	_	_
of	23424	23426	IN	of	I-GENE	_	_
ASPP2	23427	23432	NN	aspp2	I-GENE	_	_
,	23432	23433	,	,	I-GENE	_	_
and	23434	23437	CC	and	I-GENE	_	_
1.5	23438	23441	CD	1.5	I-GENE	_	_
mug	23442	23445	NN	mug	I-GENE	_	_
of	23446	23448	IN	of	I-GENE	_	_
HRASV12	23449	23456	NN	hrasv12	I-GENE	_	_
or	23457	23459	CC	or	I-GENE	_	_
KRASV12	23460	23467	NN	krasv12	I-GENE	_	_
or	23468	23470	CC	or	O	_	_
Raf	23471	23474	NN	raf	B-GENE	_	_
CAAX	23475	23479	NN	caax	I-GENE	_	_
expression	23480	23490	NN	expression	O	_	_
plasmids	23491	23499	NNS	plasmid	O	_	_
were	23500	23504	VBD	be	O	_	_
used	23505	23509	VBN	use	O	_	_
as	23510	23512	IN	as	O	_	_
indicated	23513	23522	VBN	indicate	O	_	_
.	23522	23523	.	.	O	_	_
D	1
23
1	0	num
1	3	prep_of
1	6	conj_and
1	12	conj_and
6	5	num
6	8	prep_of
12	11	num
12	14	prep_of
12	16	prep_of
12	21	prep_of
14	16	conj_or
14	21	conj_or
21	18	nn
21	19	nn
21	20	nn
23	1	nsubjpass
23	6	nsubjpass
23	12	nsubjpass
23	22	auxpass
23	25	prep_as
EOX
Y	1
ROOT	0	0	27	1	S	1	0	27	3	NP	0	0	22	6	NP	0	0	4	2	NP	1	0	2	2	CD	0	0	1	1	50	0	0	1	0	NN	0	1	2	1	ng	1	1	2	0	PP	0	2	4	2	IN	0	2	3	1	of	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	p53	3	3	4	0	,	0	4	5	1	,	4	4	5	0	NP	0	5	9	2	NP	1	5	7	2	CD	0	5	6	1	4	5	5	6	0	NN	0	6	7	1	mug	6	6	7	0	PP	0	7	9	2	IN	0	7	8	1	of	7	7	8	0	NP	0	8	9	1	NN	0	8	9	1	ASPP2	8	8	9	0	,	0	9	10	1	,	9	9	10	0	CC	0	10	11	1	and	10	10	11	0	NP	0	11	22	2	NP	1	11	13	2	CD	0	11	12	1	1.5	11	11	12	0	NN	0	12	13	1	mug	12	12	13	0	PP	0	13	22	2	IN	0	13	14	1	of	13	13	14	0	NP	0	14	22	3	NP	0	14	17	3	NN	0	14	15	1	HRASV12	14	14	15	0	CC	0	15	16	1	or	15	15	16	0	NN	0	16	17	1	KRASV12	16	16	17	0	CC	0	17	18	1	or	17	17	18	0	NP	3	18	22	4	NN	0	18	19	1	Raf	18	18	19	0	NN	0	19	20	1	CAAX	19	19	20	0	NN	0	20	21	1	expression	20	20	21	0	NNS	0	21	22	1	plasmids	21	21	22	0	VP	1	22	26	2	VBD	0	22	23	1	were	22	22	23	0	VP	0	23	26	2	VBN	0	23	24	1	used	23	23	24	0	PP	0	24	26	2	IN	0	24	25	1	as	24	24	25	0	NP	0	25	26	1	VBN	0	25	26	1	indicated	25	25	26	0	.	0	26	27	1	.	26	26	27	0
EOS
T	24
Cells	23524	23529	NNS	cell	O	_	_
were	23530	23534	VBD	be	O	_	_
lysed	23535	23540	VBN	lyse	O	_	_
in	23541	23543	IN	in	O	_	_
reporter	23544	23552	NN	reporter	O	_	_
lysis	23553	23558	NN	lysis	O	_	_
buffer	23559	23565	NN	buffer	O	_	_
16	23566	23568	CD	16	O	_	_
to	23569	23571	TO	to	O	_	_
24	23572	23574	CD	24	O	_	_
hours	23575	23580	NNS	hour	O	_	_
after	23581	23586	IN	after	O	_	_
transfection	23587	23599	NN	transfection	O	_	_
and	23600	23603	CC	and	O	_	_
assayed	23604	23611	VBN	assay	O	_	_
using	23612	23617	VBG	use	O	_	_
the	23618	23621	DT	the	O	_	_
luciferase	23622	23632	NN	luciferase	B-GENE	_	_
assay	23633	23638	NN	assay	O	_	_
kit	23639	23642	NN	kit	O	_	_
(	23643	23644	CD	(	O	_	_
Promega	23644	23651	NNP	Promega	O	_	_
)	23651	23652	CD	)	O	_	_
.	23652	23653	.	.	O	_	_
D	1
2
2	0	nsubjpass
2	1	auxpass
2	6	prep_in
2	10	npadvmod
2	12	prep_after
2	14	conj_and
6	4	nn
6	5	nn
9	7	number
9	8	dep
10	9	num
14	0	nsubjpass
14	15	xcomp
15	19	dobj
19	16	det
19	17	nn
19	18	nn
19	21	dep
21	20	num
21	22	num
EOX
Y	1
ROOT	0	0	24	1	S	1	0	24	3	NP	0	0	1	1	NNS	0	0	1	1	Cells	0	0	1	0	VP	1	1	23	2	VBD	0	1	2	1	were	1	1	2	0	VP	0	2	23	3	VP	0	2	13	3	VBN	0	2	3	1	lysed	2	2	3	0	PP	0	3	7	2	IN	0	3	4	1	in	3	3	4	0	NP	2	4	7	3	NN	0	4	5	1	reporter	4	4	5	0	NN	0	5	6	1	lysis	5	5	6	0	NN	0	6	7	1	buffer	6	6	7	0	PP	1	7	13	3	NP	1	7	11	2	QP	2	7	10	3	CD	0	7	8	1	16	7	7	8	0	TO	0	8	9	1	to	8	8	9	0	CD	0	9	10	1	24	9	9	10	0	NNS	0	10	11	1	hours	10	10	11	0	IN	0	11	12	1	after	11	11	12	0	NP	0	12	13	1	NN	0	12	13	1	transfection	12	12	13	0	CC	0	13	14	1	and	13	13	14	0	VP	0	14	23	2	VBN	0	14	15	1	assayed	14	14	15	0	S	0	15	23	1	VP	0	15	23	2	VBG	0	15	16	1	using	15	15	16	0	NP	0	16	23	2	NP	3	16	20	4	DT	0	16	17	1	the	16	16	17	0	NN	0	17	18	1	luciferase	17	17	18	0	NN	0	18	19	1	assay	18	18	19	0	NN	0	19	20	1	kit	19	19	20	0	NP	1	20	23	3	CD	0	20	21	1	(	20	20	21	0	NNP	0	21	22	1	Promega	21	21	22	0	CD	0	22	23	1	)	22	22	23	0	.	0	23	24	1	.	23	23	24	0
EOS
T	38
The	23654	23657	DT	the	O	_	_
fold	23658	23662	JJ	fold	O	_	_
increase	23663	23671	NN	increase	O	_	_
of	23672	23674	IN	of	O	_	_
p53	23675	23678	NN	p53	B-GENE	_	_
and	23679	23682	CC	and	O	_	_
ASPP	23683	23687	NN	aspp	B-GENE	_	_
by	23688	23690	IN	by	O	_	_
HRASV12	23691	23698	NN	hrasv12	B-GENE	_	_
/	23698	23699	:	/	B-GENE	_	_
KRASV12/Raf	23699	23710	NN	krasv12/raf	B-GENE	_	_
CAAX	23711	23715	NN	caax	O	_	_
was	23716	23719	VBD	be	O	_	_
determined	23720	23730	VBN	determine	O	_	_
by	23731	23733	IN	by	O	_	_
the	23734	23737	DT	the	O	_	_
activity	23738	23746	NN	activity	O	_	_
of	23747	23749	IN	of	O	_	_
p53	23750	23753	NN	p53	B-GENE	_	_
and	23754	23757	CC	and	O	_	_
ASPP	23758	23762	NN	aspp	B-GENE	_	_
in	23763	23765	IN	in	O	_	_
combination	23766	23777	NN	combination	O	_	_
with	23778	23782	IN	with	O	_	_
RASV12	23783	23789	NN	rasv12	B-GENE	_	_
/	23789	23790	:	/	I-GENE	_	_
Raf	23790	23793	NN	raf	I-GENE	_	_
CAAX	23794	23798	NN	caax	I-GENE	_	_
divided	23799	23806	VBN	divide	O	_	_
by	23807	23809	IN	by	O	_	_
the	23810	23813	DT	the	O	_	_
activity	23814	23822	NN	activity	O	_	_
of	23823	23825	IN	of	O	_	_
p53	23826	23829	NN	p53	B-GENE	_	_
and	23830	23833	CC	and	O	_	_
ASPP	23834	23838	NN	aspp	B-GENE	_	_
alone	23839	23844	RB	alone	O	_	_
.	23844	23845	.	.	O	_	_
D	1
28
2	0	det
2	1	amod
2	4	prep_of
2	6	prep_of
2	8	prep_by
2	13	dep
2	27	dep
4	6	conj_and
11	10	nn
13	9	punct
13	11	nsubjpass
13	12	auxpass
13	16	agent
13	22	prep_in
13	24	prep_with
13	25	punct
16	15	det
16	18	prep_of
16	20	prep_of
18	20	conj_and
27	26	nn
28	2	nsubj
28	31	prep_by
28	36	advmod
31	30	det
31	33	prep_of
31	35	prep_of
33	35	conj_and
EOX
Y	1
ROOT	0	0	38	1	S	1	0	38	3	NP	0	0	28	3	NP	0	0	9	3	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	JJ	0	1	2	1	fold	1	1	2	0	NN	0	2	3	1	increase	2	2	3	0	PP	0	3	7	2	IN	0	3	4	1	of	3	3	4	0	NP	0	4	7	3	NN	0	4	5	1	p53	4	4	5	0	CC	0	5	6	1	and	5	5	6	0	NN	0	6	7	1	ASPP	6	6	7	0	PP	0	7	9	2	IN	0	7	8	1	by	7	7	8	0	NP	0	8	9	1	NN	0	8	9	1	HRASV12	8	8	9	0	PRN	1	9	26	3	:	0	9	10	1	/	9	9	10	0	S	1	10	25	2	NP	1	10	12	2	NN	0	10	11	1	KRASV12/Raf	10	10	11	0	NN	0	11	12	1	CAAX	11	11	12	0	VP	1	12	25	2	VBD	0	12	13	1	was	12	12	13	0	VP	0	13	25	4	VBN	0	13	14	1	determined	13	13	14	0	PP	0	14	21	2	IN	0	14	15	1	by	14	14	15	0	NP	0	15	21	2	NP	1	15	17	2	DT	0	15	16	1	the	15	15	16	0	NN	0	16	17	1	activity	16	16	17	0	PP	0	17	21	2	IN	0	17	18	1	of	17	17	18	0	NP	0	18	21	3	NN	0	18	19	1	p53	18	18	19	0	CC	0	19	20	1	and	19	19	20	0	NN	0	20	21	1	ASPP	20	20	21	0	PP	0	21	23	2	IN	0	21	22	1	in	21	21	22	0	NP	0	22	23	1	NN	0	22	23	1	combination	22	22	23	0	PP	0	23	25	2	IN	0	23	24	1	with	23	23	24	0	NP	0	24	25	1	NN	0	24	25	1	RASV12	24	24	25	0	:	0	25	26	1	/	25	25	26	0	NP	1	26	28	2	NN	0	26	27	1	Raf	26	26	27	0	NN	0	27	28	1	CAAX	27	27	28	0	VP	0	28	37	3	VBN	0	28	29	1	divided	28	28	29	0	PP	0	29	36	2	IN	0	29	30	1	by	29	29	30	0	NP	0	30	36	2	NP	1	30	32	2	DT	0	30	31	1	the	30	30	31	0	NN	0	31	32	1	activity	31	31	32	0	PP	0	32	36	2	IN	0	32	33	1	of	32	32	33	0	NP	0	33	36	3	NN	0	33	34	1	p53	33	33	34	0	CC	0	34	35	1	and	34	34	35	0	NN	0	35	36	1	ASPP	35	35	36	0	ADVP	0	36	37	1	RB	0	36	37	1	alone	36	36	37	0	.	0	37	38	1	.	37	37	38	0
EOS
T	100
Western	23846	23853	NN	western	O	_	_
blot	23854	23858	NN	blot	O	_	_
analysis	23859	23867	NN	analysis	O	_	_
For	23868	23871	IN	for	O	_	_
Western	23872	23879	NN	western	O	_	_
blotting	23880	23888	NN	blotting	O	_	_
,	23888	23889	,	,	O	_	_
cells	23890	23895	NNS	cell	O	_	_
were	23896	23900	VBD	be	O	_	_
lysed	23901	23906	VBN	lyse	O	_	_
in	23907	23909	IN	in	O	_	_
either	23910	23916	CC	either	O	_	_
NP40	23917	23921	NN	np40	O	_	_
lysis	23922	23927	NN	lysis	O	_	_
buffer	23928	23934	NN	buffer	O	_	_
(	23935	23936	NN	(	O	_	_
1	23936	23937	CD	1	O	_	_
%	23937	23938	NN	%	O	_	_
Nonidet	23939	23946	NNP	Nonidet	O	_	_
P40	23947	23950	NN	p40	O	_	_
,	23950	23951	,	,	O	_	_
50	23952	23954	CD	50	O	_	_
mM	23955	23957	NN	mm	O	_	_
Tris	23958	23962	NNP	Tris	O	_	_
[	23963	23964	CD	[	O	_	_
pH	23964	23966	NN	ph	O	_	_
8.0	23967	23970	CD	8.0	O	_	_
]	23970	23971	NN	]	O	_	_
,	23971	23972	,	,	O	_	_
150	23973	23976	CD	150	O	_	_
mM	23977	23979	NN	mm	O	_	_
NaCl	23980	23984	NN	nacl	O	_	_
,	23984	23985	,	,	O	_	_
and	23986	23989	CC	and	O	_	_
1	23990	23991	CD	1	O	_	_
mM	23992	23994	NN	mm	O	_	_
EDTA	23995	23999	NN	edta	O	_	_
)	23999	24000	NN	)	O	_	_
,	24000	24001	,	,	O	_	_
RIPA	24002	24006	NN	ripa	O	_	_
buffer	24007	24013	NN	buffer	O	_	_
(	24014	24015	NN	(	O	_	_
150	24015	24018	CD	150	O	_	_
mM	24019	24021	NN	mm	O	_	_
NaCl	24022	24026	NN	nacl	O	_	_
,	24026	24027	,	,	O	_	_
1	24028	24029	CD	1	O	_	_
%	24029	24030	NN	%	O	_	_
Nonidet	24031	24038	NNP	Nonidet	O	_	_
P40	24039	24042	NN	p40	O	_	_
,	24042	24043	,	,	O	_	_
0.5	24044	24047	CD	0.5	O	_	_
%	24047	24048	NN	%	O	_	_
sodium	24049	24055	NN	sodium	O	_	_
deoxycholate	24056	24068	NN	deoxycholate	O	_	_
,	24068	24069	,	,	O	_	_
0.1	24070	24073	CD	0.1	O	_	_
%	24073	24074	NN	%	O	_	_
sodium	24075	24081	NN	sodium	O	_	_
dodecyl	24082	24089	NN	dodecyl	O	_	_
sulfate	24090	24097	NN	sulfate	O	_	_
,	24097	24098	,	,	O	_	_
50	24099	24101	CD	50	O	_	_
mM	24102	24104	NN	mm	O	_	_
Tris-HCl	24105	24113	NN	tris-hcl	O	_	_
[	24114	24115	CD	[	O	_	_
pH	24115	24117	NN	ph	O	_	_
8.0	24118	24121	CD	8.0	O	_	_
]	24121	24122	CD	]	O	_	_
)	24122	24123	NN	)	O	_	_
,	24123	24124	,	,	O	_	_
Urea	24125	24129	NN	urea	O	_	_
solution	24130	24138	NN	solution	O	_	_
(	24139	24140	CD	(	O	_	_
8	24140	24141	CD	8	O	_	_
M	24142	24143	NN	m	O	_	_
Urea	24144	24148	NN	urea	O	_	_
,	24148	24149	,	,	O	_	_
1	24150	24151	CD	1	O	_	_
M	24152	24153	NN	m	O	_	_
Thiourea	24154	24162	NN	thiourea	O	_	_
,	24162	24163	,	,	O	_	_
0.5	24164	24167	CD	0.5	O	_	_
%	24167	24168	NN	%	O	_	_
CHAPS	24169	24174	NNS	chap	O	_	_
,	24174	24175	,	,	O	_	_
50	24176	24178	CD	50	O	_	_
mM	24179	24181	NN	mm	O	_	_
DTT	24182	24185	NN	dtt	O	_	_
,	24185	24186	,	,	O	_	_
and	24187	24190	CC	and	O	_	_
24	24191	24193	CD	24	O	_	_
mM	24194	24196	NN	mm	O	_	_
Spermine	24197	24205	NN	spermine	O	_	_
)	24205	24206	CD	)	O	_	_
or	24207	24209	CC	or	O	_	_
luciferase	24210	24220	NN	luciferase	B-GENE	_	_
lysis	24221	24226	NN	lysis	I-GENE	_	_
buffer	24227	24233	NN	buffer	I-GENE	_	_
.	24233	24234	.	.	O	_	_
D	1

99	0	dep
99	1	dep
99	2	dep
99	3	dep
99	4	dep
99	5	dep
99	7	dep
99	8	dep
99	9	dep
99	10	dep
99	11	dep
99	12	dep
99	13	dep
99	14	dep
99	16	dep
99	17	dep
99	18	dep
99	19	dep
99	21	dep
99	22	dep
99	23	dep
99	24	dep
99	25	dep
99	26	dep
99	27	dep
99	29	dep
99	30	dep
99	31	dep
99	33	dep
99	34	dep
99	35	dep
99	36	dep
99	39	dep
99	40	dep
99	42	dep
99	43	dep
99	44	dep
99	46	dep
99	47	dep
99	48	dep
99	49	dep
99	51	dep
99	52	dep
99	53	dep
99	54	dep
99	56	dep
99	57	dep
99	58	dep
99	59	dep
99	60	dep
99	62	dep
99	63	dep
99	64	dep
99	65	dep
99	66	dep
99	67	dep
99	68	dep
99	71	dep
99	72	dep
99	74	dep
99	75	dep
99	76	dep
99	78	dep
99	79	dep
99	80	dep
99	82	dep
99	83	dep
99	84	dep
99	86	dep
99	87	dep
99	88	dep
99	90	dep
99	91	dep
99	92	dep
99	93	dep
99	95	dep
99	96	dep
99	97	dep
99	98	dep
EOX
Y	1
X	99	0	100	100	X	0	0	1	1	Western	0	0	1	0	X	0	1	2	1	blot	1	1	2	0	X	0	2	3	1	analysis	2	2	3	0	X	0	3	4	1	For	3	3	4	0	X	0	4	5	1	Western	4	4	5	0	X	0	5	6	1	blotting	5	5	6	0	X	0	6	7	1	,	6	6	7	0	X	0	7	8	1	cells	7	7	8	0	X	0	8	9	1	were	8	8	9	0	X	0	9	10	1	lysed	9	9	10	0	X	0	10	11	1	in	10	10	11	0	X	0	11	12	1	either	11	11	12	0	X	0	12	13	1	NP40	12	12	13	0	X	0	13	14	1	lysis	13	13	14	0	X	0	14	15	1	buffer	14	14	15	0	X	0	15	16	1	-LRB-	15	15	16	0	X	0	16	17	1	1	16	16	17	0	X	0	17	18	1	%	17	17	18	0	X	0	18	19	1	Nonidet	18	18	19	0	X	0	19	20	1	P40	19	19	20	0	X	0	20	21	1	,	20	20	21	0	X	0	21	22	1	50	21	21	22	0	X	0	22	23	1	mM	22	22	23	0	X	0	23	24	1	Tris	23	23	24	0	X	0	24	25	1	[	24	24	25	0	X	0	25	26	1	pH	25	25	26	0	X	0	26	27	1	8.0	26	26	27	0	X	0	27	28	1	]	27	27	28	0	X	0	28	29	1	,	28	28	29	0	X	0	29	30	1	150	29	29	30	0	X	0	30	31	1	mM	30	30	31	0	X	0	31	32	1	NaCl	31	31	32	0	X	0	32	33	1	,	32	32	33	0	X	0	33	34	1	and	33	33	34	0	X	0	34	35	1	1	34	34	35	0	X	0	35	36	1	mM	35	35	36	0	X	0	36	37	1	EDTA	36	36	37	0	X	0	37	38	1	-RRB-	37	37	38	0	X	0	38	39	1	,	38	38	39	0	X	0	39	40	1	RIPA	39	39	40	0	X	0	40	41	1	buffer	40	40	41	0	X	0	41	42	1	-LRB-	41	41	42	0	X	0	42	43	1	150	42	42	43	0	X	0	43	44	1	mM	43	43	44	0	X	0	44	45	1	NaCl	44	44	45	0	X	0	45	46	1	,	45	45	46	0	X	0	46	47	1	1	46	46	47	0	X	0	47	48	1	%	47	47	48	0	X	0	48	49	1	Nonidet	48	48	49	0	X	0	49	50	1	P40	49	49	50	0	X	0	50	51	1	,	50	50	51	0	X	0	51	52	1	0.5	51	51	52	0	X	0	52	53	1	%	52	52	53	0	X	0	53	54	1	sodium	53	53	54	0	X	0	54	55	1	deoxycholate	54	54	55	0	X	0	55	56	1	,	55	55	56	0	X	0	56	57	1	0.1	56	56	57	0	X	0	57	58	1	%	57	57	58	0	X	0	58	59	1	sodium	58	58	59	0	X	0	59	60	1	dodecyl	59	59	60	0	X	0	60	61	1	sulfate	60	60	61	0	X	0	61	62	1	,	61	61	62	0	X	0	62	63	1	50	62	62	63	0	X	0	63	64	1	mM	63	63	64	0	X	0	64	65	1	Tris-HCl	64	64	65	0	X	0	65	66	1	[	65	65	66	0	X	0	66	67	1	pH	66	66	67	0	X	0	67	68	1	8.0	67	67	68	0	X	0	68	69	1	]	68	68	69	0	X	0	69	70	1	-RRB-	69	69	70	0	X	0	70	71	1	,	70	70	71	0	X	0	71	72	1	Urea	71	71	72	0	X	0	72	73	1	solution	72	72	73	0	X	0	73	74	1	-LRB-	73	73	74	0	X	0	74	75	1	8	74	74	75	0	X	0	75	76	1	M	75	75	76	0	X	0	76	77	1	Urea	76	76	77	0	X	0	77	78	1	,	77	77	78	0	X	0	78	79	1	1	78	78	79	0	X	0	79	80	1	M	79	79	80	0	X	0	80	81	1	Thiourea	80	80	81	0	X	0	81	82	1	,	81	81	82	0	X	0	82	83	1	0.5	82	82	83	0	X	0	83	84	1	%	83	83	84	0	X	0	84	85	1	CHAPS	84	84	85	0	X	0	85	86	1	,	85	85	86	0	X	0	86	87	1	50	86	86	87	0	X	0	87	88	1	mM	87	87	88	0	X	0	88	89	1	DTT	88	88	89	0	X	0	89	90	1	,	89	89	90	0	X	0	90	91	1	and	90	90	91	0	X	0	91	92	1	24	91	91	92	0	X	0	92	93	1	mM	92	92	93	0	X	0	93	94	1	Spermine	93	93	94	0	X	0	94	95	1	-RRB-	94	94	95	0	X	0	95	96	1	or	95	95	96	0	X	0	96	97	1	luciferase	96	96	97	0	X	0	97	98	1	lysis	97	97	98	0	X	0	98	99	1	buffer	98	98	99	0	X	0	99	100	1	.	99	99	100	0
EOS
T	19
Between	24235	24242	IN	between	O	_	_
35	24243	24245	CD	35	O	_	_
and	24246	24249	CC	and	O	_	_
150	24250	24253	CD	150	O	_	_
mug	24254	24257	NN	mug	O	_	_
of	24258	24260	IN	of	O	_	_
extract	24261	24268	NN	extract	O	_	_
was	24269	24272	VBD	be	O	_	_
mixed	24273	24278	VBN	mix	O	_	_
with	24279	24283	IN	with	O	_	_
6x	24284	24286	JJ	6x	O	_	_
sample	24287	24293	NN	sample	O	_	_
buffer	24294	24300	NN	buffer	O	_	_
and	24301	24304	CC	and	O	_	_
loaded	24305	24311	VBN	load	O	_	_
on	24312	24314	IN	on	O	_	_
SDS-PAGE	24315	24323	NN	sds-page	O	_	_
gels	24324	24328	NNS	gel	O	_	_
.	24328	24329	.	.	O	_	_
D	1
8
1	0	amod
1	3	conj_and
4	1	num
4	3	num
4	6	prep_of
8	4	nsubjpass
8	7	auxpass
8	12	prep_with
8	14	conj_and
12	10	amod
12	11	nn
14	4	nsubjpass
14	17	prep_on
17	16	nn
EOX
Y	1
ROOT	0	0	19	1	S	1	0	19	3	NP	0	0	7	2	NP	1	0	5	2	QP	0	0	4	3	NP	1	0	2	2	IN	0	0	1	1	Between	0	0	1	0	CD	0	1	2	1	35	1	1	2	0	CC	0	2	3	1	and	2	2	3	0	NP	0	3	4	1	CD	0	3	4	1	150	3	3	4	0	NN	0	4	5	1	mug	4	4	5	0	PP	0	5	7	2	IN	0	5	6	1	of	5	5	6	0	NP	0	6	7	1	NN	0	6	7	1	extract	6	6	7	0	VP	1	7	18	2	VBD	0	7	8	1	was	7	7	8	0	VP	0	8	18	3	VP	0	8	13	2	VBN	0	8	9	1	mixed	8	8	9	0	PP	0	9	13	2	IN	0	9	10	1	with	9	9	10	0	NP	2	10	13	3	JJ	0	10	11	1	6x	10	10	11	0	NN	0	11	12	1	sample	11	11	12	0	NN	0	12	13	1	buffer	12	12	13	0	CC	0	13	14	1	and	13	13	14	0	VP	0	14	18	2	VBN	0	14	15	1	loaded	14	14	15	0	PP	0	15	18	2	IN	0	15	16	1	on	15	15	16	0	NP	1	16	18	2	NN	0	16	17	1	SDS-PAGE	16	16	17	0	NNS	0	17	18	1	gels	17	17	18	0	.	0	18	19	1	.	18	18	19	0
EOS
T	35
The	24330	24333	DT	the	O	_	_
gels	24334	24338	NNS	gel	O	_	_
were	24339	24343	VBD	be	O	_	_
wet	24344	24347	JJ	wet	O	_	_
transferred	24348	24359	VBN	transfer	O	_	_
onto	24360	24364	IN	onto	O	_	_
Protran	24365	24372	NNP	Protran	O	_	_
nitrocellulose	24373	24387	NN	nitrocellulose	O	_	_
membrane	24388	24396	NN	membrane	O	_	_
and	24397	24400	CC	and	O	_	_
the	24401	24404	DT	the	O	_	_
resulting	24405	24414	VBG	result	O	_	_
blots	24415	24420	NNS	blot	O	_	_
were	24421	24425	VBD	be	O	_	_
blocked	24426	24433	VBN	block	O	_	_
and	24434	24437	CC	and	O	_	_
incubated	24438	24447	VBN	incubate	O	_	_
first	24448	24453	RB	first	O	_	_
in	24454	24456	IN	in	O	_	_
primary	24457	24464	JJ	primary	O	_	_
antibody	24465	24473	NN	antibody	O	_	_
and	24474	24477	CC	and	O	_	_
then	24478	24482	RB	then	O	_	_
with	24483	24487	IN	with	O	_	_
the	24488	24491	DT	the	O	_	_
appropriate	24492	24503	JJ	appropriate	O	_	_
secondary	24504	24513	JJ	secondary	O	_	_
horseradish	24514	24525	NN	horseradish	B-GENE	_	_
peroxidase	24526	24536	NN	peroxidase	I-GENE	_	_
conjugated	24537	24547	VBN	conjugate	I-GENE	_	_
antibody	24548	24556	NN	antibody	I-GENE	_	_
(	24557	24558	CD	(	O	_	_
Dako	24558	24562	NNP	Dako	O	_	_
)	24562	24563	CD	)	O	_	_
.	24563	24564	.	.	O	_	_
D	1
3
1	0	det
3	1	nsubj
3	2	cop
3	4	ccomp
3	14	conj_and
3	16	conj_and
4	8	prep_onto
8	6	nn
8	7	nn
12	10	det
12	11	amod
14	12	nsubjpass
14	13	auxpass
14	14	conj_and
14	16	conj_and
14	17	advmod
14	20	prep_in
14	22	advmod
14	28	prep_with
16	12	nsubjpass
20	19	amod
28	24	det
28	25	amod
28	26	amod
28	27	nn
28	29	vmod
29	30	dobj
30	31	num
30	32	dep
32	33	num
EOX
Y	1
ROOT	0	0	35	1	S	0	0	35	4	S	1	0	9	2	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NNS	0	1	2	1	gels	1	1	2	0	VP	1	2	9	2	VBD	0	2	3	1	were	2	2	3	0	ADJP	0	3	9	2	JJ	0	3	4	1	wet	3	3	4	0	SBAR	0	4	9	1	S	0	4	9	1	VP	0	4	9	2	VBN	0	4	5	1	transferred	4	4	5	0	PP	0	5	9	2	IN	0	5	6	1	onto	5	5	6	0	NP	2	6	9	3	NNP	0	6	7	1	Protran	6	6	7	0	NN	0	7	8	1	nitrocellulose	7	7	8	0	NN	0	8	9	1	membrane	8	8	9	0	CC	0	9	10	1	and	9	9	10	0	S	1	10	34	2	NP	2	10	13	3	DT	0	10	11	1	the	10	10	11	0	VBG	0	11	12	1	resulting	11	11	12	0	NNS	0	12	13	1	blots	12	12	13	0	VP	1	13	34	2	VBD	0	13	14	1	were	13	13	14	0	VP	0	14	34	4	VBN	0	14	15	1	blocked	14	14	15	0	CC	0	15	16	1	and	15	15	16	0	VBN	0	16	17	1	incubated	16	16	17	0	PP	1	17	34	4	RB	0	17	18	1	first	17	17	18	0	PP	0	18	21	2	IN	0	18	19	1	in	18	18	19	0	NP	1	19	21	2	JJ	0	19	20	1	primary	19	19	20	0	NN	0	20	21	1	antibody	20	20	21	0	CC	0	21	22	1	and	21	21	22	0	PP	1	22	34	3	RB	0	22	23	1	then	22	22	23	0	IN	0	23	24	1	with	23	23	24	0	NP	0	24	34	2	NP	4	24	29	5	DT	0	24	25	1	the	24	24	25	0	JJ	0	25	26	1	appropriate	25	25	26	0	JJ	0	26	27	1	secondary	26	26	27	0	NN	0	27	28	1	horseradish	27	27	28	0	NN	0	28	29	1	peroxidase	28	28	29	0	VP	0	29	34	2	VBN	0	29	30	1	conjugated	29	29	30	0	NP	0	30	34	2	NP	0	30	32	2	NN	0	30	31	1	antibody	30	30	31	0	CD	0	31	32	1	(	31	31	32	0	NP	0	32	34	2	NNP	0	32	33	1	Dako	32	32	33	0	CD	0	33	34	1	)	33	33	34	0	.	0	34	35	1	.	34	34	35	0
EOS
T	20
The	24565	24568	DT	the	O	_	_
blot	24569	24573	NN	blot	O	_	_
was	24574	24577	VBD	be	O	_	_
exposed	24578	24585	VBN	expose	O	_	_
to	24586	24588	TO	to	O	_	_
hyperfilm	24589	24598	NN	hyperfilm	O	_	_
following	24599	24608	VBG	follow	O	_	_
the	24609	24612	DT	the	O	_	_
use	24613	24616	NN	use	O	_	_
of	24617	24619	IN	of	O	_	_
enhanced	24620	24628	VBN	enhance	O	_	_
chemiluminescence	24629	24646	NN	chemiluminescence	O	_	_
substrate	24647	24656	NN	substrate	O	_	_
solution	24657	24665	NN	solution	O	_	_
(	24666	24667	CD	(	O	_	_
Amersham	24667	24675	NNP	Amersham	O	_	_
Life	24676	24680	NNP	Life	O	_	_
Science	24681	24688	NNP	Science	O	_	_
)	24688	24689	CD	)	O	_	_
.	24689	24690	.	.	O	_	_
D	1
3
1	0	det
3	1	nsubjpass
3	2	auxpass
3	5	prep_to
5	6	vmod
6	8	iobj
6	17	dobj
8	7	det
8	12	prep_of
12	10	amod
12	11	nn
17	13	nn
17	14	num
17	15	nn
17	16	nn
17	18	dep
EOX
Y	1
ROOT	0	0	20	1	S	1	0	20	3	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	blot	1	1	2	0	VP	1	2	19	2	VBD	0	2	3	1	was	2	2	3	0	VP	0	3	19	2	VBN	0	3	4	1	exposed	3	3	4	0	PP	0	4	19	2	TO	0	4	5	1	to	4	4	5	0	NP	0	5	19	2	NP	0	5	6	1	NN	0	5	6	1	hyperfilm	5	5	6	0	VP	0	6	19	3	VBG	0	6	7	1	following	6	6	7	0	NP	0	7	13	2	NP	1	7	9	2	DT	0	7	8	1	the	7	7	8	0	NN	0	8	9	1	use	8	8	9	0	PP	0	9	13	2	IN	0	9	10	1	of	9	9	10	0	NP	2	10	13	3	VBN	0	10	11	1	enhanced	10	10	11	0	NN	0	11	12	1	chemiluminescence	11	11	12	0	NN	0	12	13	1	substrate	12	12	13	0	NP	0	13	19	2	NP	4	13	18	5	NN	0	13	14	1	solution	13	13	14	0	CD	0	14	15	1	(	14	14	15	0	NNP	0	15	16	1	Amersham	15	15	16	0	NNP	0	16	17	1	Life	16	16	17	0	NNP	0	17	18	1	Science	17	17	18	0	NP	0	18	19	1	CD	0	18	19	1	)	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	55
Primary	24691	24698	JJ	primary	O	_	_
antibodies	24699	24709	NNS	antibody	O	_	_
were	24710	24714	VBD	be	O	_	_
from	24715	24719	IN	from	O	_	_
:	24719	24720	:	:	O	_	_
Abcam	24721	24726	NNP	Abcam	O	_	_
Inc.	24727	24731	NNP	Inc.	O	_	_
,	24731	24732	,	,	O	_	_
Cambridge	24733	24742	NNP	Cambridge	O	_	_
,	24742	24743	,	,	O	_	_
MA	24744	24746	NNP	MA	O	_	_
,	24746	24747	,	,	O	_	_
USA	24748	24751	NNP	USA	O	_	_
(	24752	24753	CD	(	B-GENE	_	_
beta-actin	24753	24763	NN	beta-actin	I-GENE	_	_
,	24763	24764	,	,	O	_	_
beta-Tubulin	24765	24777	NN	beta-tubulin	B-GENE	_	_
)	24777	24778	NN	)	O	_	_
,	24778	24779	,	,	O	_	_
Upstate	24780	24787	NNP	Upstate	O	_	_
Millipore	24788	24797	NNP	Millipore	O	_	_
Corporate	24798	24807	NNP	Corporate	O	_	_
Headquarters	24808	24820	NN	headquarters	O	_	_
,	24820	24821	,	,	O	_	_
Billerica	24822	24831	NNP	Billerica	O	_	_
,	24831	24832	,	,	O	_	_
MA	24833	24835	NNP	MA	O	_	_
USA	24836	24839	NNP	USA	O	_	_
(	24840	24841	CD	(	O	_	_
RAS	24841	24844	NNP	RAS	O	_	_
Clone	24845	24850	NN	clone	O	_	_
10	24851	24853	CD	10	O	_	_
)	24853	24854	NN	)	O	_	_
,	24854	24855	,	,	O	_	_
Cell	24856	24860	NN	cell	O	_	_
Signaling	24861	24870	NN	signaling	O	_	_
Technology	24871	24881	NN	technology	O	_	_
,	24881	24882	,	,	O	_	_
Inc.	24883	24887	NNP	Inc.	O	_	_
,	24887	24888	,	,	O	_	_
Danvers	24889	24896	NNP	Danvers	O	_	_
,	24896	24897	,	,	O	_	_
MA	24898	24900	NNP	MA	O	_	_
,	24900	24901	,	,	O	_	_
USA	24902	24905	NNP	USA	O	_	_
(	24906	24907	CD	(	O	_	_
Phospho-ERK	24907	24918	NN	phospho-erk	B-GENE	_	_
/	24918	24919	:	/	B-GENE	_	_
MAPK	24919	24923	NN	mapk	I-GENE	_	_
,	24923	24924	,	,	O	_	_
ERK	24925	24928	NN	erk	B-GENE	_	_
/	24928	24929	:	/	B-GENE	_	_
MAPK	24929	24933	NN	mapk	I-GENE	_	_
)	24933	24934	NN	)	O	_	_
.	24934	24935	.	.	O	_	_
D	1
2
1	0	amod
2	1	nsubj
2	3	prep
2	53	dep
6	5	nn
6	8	appos
6	10	appos
6	14	appos
6	17	appos
6	22	appos
6	24	appos
6	29	appos
14	12	nn
14	13	num
17	16	nn
22	19	nn
22	20	nn
22	21	nn
29	26	nn
29	27	nn
29	28	num
30	31	num
32	6	dep
32	30	dep
32	36	appos
32	38	appos
32	40	appos
32	42	appos
32	44	appos
32	50	appos
36	34	nn
36	35	nn
44	46	dep
46	45	num
46	48	dep
48	47	punct
53	32	dep
53	51	punct
53	52	nn
EOX
Y	1
ROOT	0	0	55	1	S	0	0	55	4	S	1	0	4	2	NP	1	0	2	2	JJ	0	0	1	1	Primary	0	0	1	0	NNS	0	1	2	1	antibodies	1	1	2	0	VP	0	2	4	2	VBD	0	2	3	1	were	2	2	3	0	PP	0	3	4	1	IN	0	3	4	1	from	3	3	4	0	:	0	4	5	1	:	4	4	5	0	FRAG	2	5	54	3	X	2	5	51	3	NP	0	5	30	15	NP	1	5	7	2	NNP	0	5	6	1	Abcam	5	5	6	0	NNP	0	6	7	1	Inc.	6	6	7	0	,	0	7	8	1	,	7	7	8	0	NP	0	8	9	1	NNP	0	8	9	1	Cambridge	8	8	9	0	,	0	9	10	1	,	9	9	10	0	NP	0	10	11	1	NNP	0	10	11	1	MA	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	2	12	15	3	NNP	0	12	13	1	USA	12	12	13	0	CD	0	13	14	1	(	13	13	14	0	NN	0	14	15	1	beta-actin	14	14	15	0	,	0	15	16	1	,	15	15	16	0	NP	1	16	18	2	NN	0	16	17	1	beta-Tubulin	16	16	17	0	NN	0	17	18	1	)	17	17	18	0	,	0	18	19	1	,	18	18	19	0	NP	3	19	23	4	NNP	0	19	20	1	Upstate	19	19	20	0	NNP	0	20	21	1	Millipore	20	20	21	0	NNP	0	21	22	1	Corporate	21	21	22	0	NN	0	22	23	1	Headquarters	22	22	23	0	,	0	23	24	1	,	23	23	24	0	NP	0	24	25	1	NNP	0	24	25	1	Billerica	24	24	25	0	,	0	25	26	1	,	25	25	26	0	NP	3	26	30	4	NNP	0	26	27	1	MA	26	26	27	0	NNP	0	27	28	1	USA	27	27	28	0	CD	0	28	29	1	(	28	28	29	0	NNP	0	29	30	1	RAS	29	29	30	0	NP	0	30	32	2	NN	0	30	31	1	Clone	30	30	31	0	CD	0	31	32	1	10	31	31	32	0	NP	0	32	51	13	NP	0	32	33	1	NN	0	32	33	1	)	32	32	33	0	,	0	33	34	1	,	33	33	34	0	NP	2	34	37	3	NN	0	34	35	1	Cell	34	34	35	0	NN	0	35	36	1	Signaling	35	35	36	0	NN	0	36	37	1	Technology	36	36	37	0	,	0	37	38	1	,	37	37	38	0	NP	0	38	39	1	NNP	0	38	39	1	Inc.	38	38	39	0	,	0	39	40	1	,	39	39	40	0	NP	0	40	41	1	NNP	0	40	41	1	Danvers	40	40	41	0	,	0	41	42	1	,	41	41	42	0	NP	0	42	43	1	NNP	0	42	43	1	MA	42	42	43	0	,	0	43	44	1	,	43	43	44	0	NP	0	44	49	2	NP	0	44	45	1	NNP	0	44	45	1	USA	44	44	45	0	NP	1	45	49	3	CD	0	45	46	1	(	45	45	46	0	NN	0	46	47	1	Phospho-ERK	46	46	47	0	PRN	1	47	49	2	:	0	47	48	1	/	47	47	48	0	NP	0	48	49	1	NN	0	48	49	1	MAPK	48	48	49	0	,	0	49	50	1	,	49	49	50	0	NP	0	50	51	1	NN	0	50	51	1	ERK	50	50	51	0	:	0	51	52	1	/	51	51	52	0	NP	1	52	54	2	NN	0	52	53	1	MAPK	52	52	53	0	NN	0	53	54	1	)	53	53	54	0	.	0	54	55	1	.	54	54	55	0
EOS
T	42
The	24936	24939	DT	the	O	_	_
V5	24940	24942	NN	v5	O	_	_
epitope	24943	24950	NN	epitope	O	_	_
is	24951	24953	VBZ	be	O	_	_
recognized	24954	24964	VBN	recognize	O	_	_
by	24965	24967	IN	by	O	_	_
the	24968	24971	DT	the	O	_	_
mouse	24972	24977	NN	mouse	B-GENE	_	_
monoclonal	24978	24988	JJ	monoclonal	I-GENE	_	_
anti	24989	24993	JJ	anti	I-GENE	_	_
V5	24994	24996	NN	v5	I-GENE	_	_
antibody	24997	25005	NN	antibody	I-GENE	_	_
(	25006	25007	CD	(	O	_	_
Invitrogen	25007	25017	NNP	Invitrogen	O	_	_
,	25017	25018	,	,	O	_	_
Paisley	25019	25026	NNP	Paisley	O	_	_
,	25026	25027	,	,	O	_	_
UK	25028	25030	NNP	UK	O	_	_
)	25030	25031	NNP	)	O	_	_
and	25032	25035	CC	and	O	_	_
the	25036	25039	DT	the	O	_	_
haemagglutinin	25040	25054	NN	haemagglutinin	B-GENE	_	_
epitope	25055	25062	NN	epitope	O	_	_
is	25063	25065	VBZ	be	O	_	_
recognized	25066	25076	VBN	recognize	O	_	_
by	25077	25079	IN	by	O	_	_
the	25080	25083	DT	the	O	_	_
anti	25084	25088	JJ	anti	B-GENE	_	_
HA	25089	25091	NN	ha	I-GENE	_	_
antibody	25092	25100	NN	antibody	I-GENE	_	_
(	25101	25102	CD	(	B-GENE	_	_
mAb	25102	25105	NN	mab	I-GENE	_	_
)	25105	25106	CD	)	O	_	_
(	25107	25108	CD	(	O	_	_
Covance	25108	25115	NNP	Covance	O	_	_
,	25115	25116	,	,	O	_	_
Princeton	25117	25126	NNP	Princeton	O	_	_
,	25126	25127	,	,	O	_	_
NJ	25128	25130	NNP	NJ	O	_	_
USA	25131	25134	NNP	USA	O	_	_
)	25134	25135	NN	)	O	_	_
.	25135	25136	.	.	O	_	_
D	1
4
2	0	det
2	1	nn
4	2	nsubjpass
4	3	auxpass
4	7	agent
4	10	dobj
7	6	det
10	8	amod
10	9	amod
10	24	rcmod
13	11	nn
13	12	num
13	15	conj_and
13	18	conj_and
13	22	conj_and
18	17	nn
22	20	det
22	21	nn
24	13	nsubjpass
24	15	nsubjpass
24	18	nsubjpass
24	22	nsubjpass
24	23	auxpass
24	29	agent
29	26	det
29	27	amod
29	28	nn
29	31	dep
29	33	dep
29	40	appos
31	30	num
33	32	number
33	36	dep
36	34	nn
40	38	nn
40	39	nn
EOX
Y	1
ROOT	0	0	42	1	S	1	0	42	3	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	V5	1	1	2	0	NN	0	2	3	1	epitope	2	2	3	0	VP	1	3	41	2	VBZ	0	3	4	1	is	3	3	4	0	VP	0	4	41	3	VBN	0	4	5	1	recognized	4	4	5	0	PP	0	5	8	2	IN	0	5	6	1	by	5	5	6	0	NP	1	6	8	2	DT	0	6	7	1	the	6	6	7	0	NN	0	7	8	1	mouse	7	7	8	0	NP	0	8	41	2	NP	2	8	11	3	JJ	0	8	9	1	monoclonal	8	8	9	0	JJ	0	9	10	1	anti	9	9	10	0	NN	0	10	11	1	V5	10	10	11	0	SBAR	0	11	41	1	S	1	11	41	2	NP	0	11	23	7	NP	2	11	14	3	NN	0	11	12	1	antibody	11	11	12	0	CD	0	12	13	1	(	12	12	13	0	NNP	0	13	14	1	Invitrogen	13	13	14	0	,	0	14	15	1	,	14	14	15	0	NP	0	15	16	1	NNP	0	15	16	1	Paisley	15	15	16	0	,	0	16	17	1	,	16	16	17	0	NP	1	17	19	2	NNP	0	17	18	1	UK	17	17	18	0	NNP	0	18	19	1	)	18	18	19	0	CC	0	19	20	1	and	19	19	20	0	NP	2	20	23	3	DT	0	20	21	1	the	20	20	21	0	NN	0	21	22	1	haemagglutinin	21	21	22	0	NN	0	22	23	1	epitope	22	22	23	0	VP	1	23	41	2	VBZ	0	23	24	1	is	23	23	24	0	VP	0	24	41	2	VBN	0	24	25	1	recognized	24	24	25	0	PP	0	25	41	2	IN	0	25	26	1	by	25	25	26	0	NP	0	26	41	4	NP	0	26	32	2	NP	3	26	30	4	DT	0	26	27	1	the	26	26	27	0	JJ	0	27	28	1	anti	27	27	28	0	NN	0	28	29	1	HA	28	28	29	0	NN	0	29	30	1	antibody	29	29	30	0	NP	1	30	32	2	CD	0	30	31	1	(	30	30	31	0	NN	0	31	32	1	mAb	31	31	32	0	NP	0	32	37	2	NP	0	32	34	1	QP	1	32	34	2	CD	0	32	33	1	)	32	32	33	0	CD	0	33	34	1	(	33	33	34	0	NP	2	34	37	3	NNP	0	34	35	1	Covance	34	34	35	0	,	0	35	36	1	,	35	35	36	0	NNP	0	36	37	1	Princeton	36	36	37	0	,	0	37	38	1	,	37	37	38	0	NP	2	38	41	3	NNP	0	38	39	1	NJ	38	38	39	0	NNP	0	39	40	1	USA	39	39	40	0	NN	0	40	41	1	)	40	40	41	0	.	0	41	42	1	.	41	41	42	0
EOS
T	20
To	25137	25139	TO	to	O	_	_
detect	25140	25146	VB	detect	O	_	_
RAS	25147	25150	NN	ra	B-GENE	_	_
by	25151	25153	IN	by	O	_	_
immunoprecipitation	25154	25173	NN	immunoprecipitation	O	_	_
the	25174	25177	DT	the	O	_	_
rat	25178	25181	NN	rat	B-GENE	_	_
monoclonal	25182	25192	JJ	monoclonal	I-GENE	_	_
antibody	25193	25201	NN	antibody	I-GENE	_	_
238	25202	25205	CD	238	I-GENE	_	_
was	25206	25209	VBD	be	O	_	_
used	25210	25214	VBN	use	O	_	_
(	25215	25216	CD	(	O	_	_
Santa	25216	25221	NNP	Santa	O	_	_
Cruz	25222	25226	NNP	Cruz	O	_	_
,	25226	25227	,	,	O	_	_
CA	25228	25230	NNP	CA	B-GENE	_	_
USA	25231	25234	NNP	USA	I-GENE	_	_
)	25234	25235	NN	)	O	_	_
.	25235	25236	.	.	O	_	_
D	1
11
1	0	aux
1	2	dobj
1	4	prep_by
6	5	det
6	7	amod
7	8	dep
8	9	num
11	1	dep
11	6	nsubjpass
11	10	auxpass
11	14	dobj
14	12	num
14	13	nn
14	18	appos
18	16	nn
18	17	nn
EOX
Y	1
ROOT	0	0	20	1	S	2	0	20	4	S	0	0	5	1	VP	1	0	5	2	TO	0	0	1	1	To	0	0	1	0	VP	0	1	5	3	VB	0	1	2	1	detect	1	1	2	0	NP	0	2	3	1	NN	0	2	3	1	RAS	2	2	3	0	PP	0	3	5	2	IN	0	3	4	1	by	3	3	4	0	NP	0	4	5	1	NN	0	4	5	1	immunoprecipitation	4	4	5	0	NP	0	5	10	2	NP	1	5	7	2	DT	0	5	6	1	the	5	5	6	0	NN	0	6	7	1	rat	6	6	7	0	ADJP	0	7	10	2	JJ	0	7	8	1	monoclonal	7	7	8	0	NP	0	8	10	2	NN	0	8	9	1	antibody	8	8	9	0	CD	0	9	10	1	238	9	9	10	0	VP	1	10	19	2	VBD	0	10	11	1	was	10	10	11	0	VP	0	11	19	2	VBN	0	11	12	1	used	11	11	12	0	NP	0	12	19	3	NP	2	12	15	3	CD	0	12	13	1	(	12	12	13	0	NNP	0	13	14	1	Santa	13	13	14	0	NNP	0	14	15	1	Cruz	14	14	15	0	,	0	15	16	1	,	15	15	16	0	NP	2	16	19	3	NNP	0	16	17	1	CA	16	16	17	0	NNP	0	17	18	1	USA	17	17	18	0	NN	0	18	19	1	)	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	31
The	25237	25240	DT	the	O	_	_
mouse	25241	25246	NN	mouse	O	_	_
and	25247	25250	CC	and	O	_	_
rabbit	25251	25257	NN	rabbit	O	_	_
antibodies	25258	25268	NNS	antibody	O	_	_
to	25269	25271	TO	to	O	_	_
ASPP2	25272	25277	NN	aspp2	B-GENE	_	_
were	25278	25282	VBD	be	O	_	_
described	25283	25292	VBN	describe	O	_	_
previously	25293	25303	RB	previously	O	_	_
[	25304	25305	CD	[	O	_	_
9	25305	25306	CD	9	O	_	_
]	25306	25307	NN	]	O	_	_
:	25307	25308	:	:	O	_	_
rabbit	25309	25315	NN	rabbit	O	_	_
anti	25316	25320	JJ	anti	O	_	_
ASPP2	25321	25326	NN	aspp2	B-GENE	_	_
polyclonal	25327	25337	JJ	polyclonal	I-GENE	_	_
antibody	25338	25346	NN	antibody	I-GENE	_	_
ASPP2	25347	25352	NN	aspp2	I-GENE	_	_
/	25352	25353	:	/	I-GENE	_	_
77	25353	25355	CD	77	I-GENE	_	_
and	25356	25359	CC	and	O	_	_
mouse	25360	25365	NN	mouse	B-GENE	_	_
monoclonal	25366	25376	JJ	monoclonal	I-GENE	_	_
anti	25377	25381	JJ	anti	I-GENE	_	_
ASPP2	25382	25387	NN	aspp2	I-GENE	_	_
antibody	25388	25396	NN	antibody	I-GENE	_	_
DX54	25397	25401	NN	dx54	O	_	_
.10	25401	25404	CD	.10	O	_	_
.	25404	25405	.	.	O	_	_
D	1
8
1	3	conj_and
4	0	det
4	1	nn
4	3	nn
4	6	prep_to
8	4	nsubjpass
8	7	auxpass
8	9	advmod
8	12	dobj
11	10	number
12	11	num
12	16	dep
12	28	dep
16	14	nn
16	15	amod
16	19	dep
19	17	amod
19	18	nn
21	27	conj_and
27	23	nn
27	24	amod
27	25	amod
27	26	nn
28	20	punct
28	21	dep
28	27	dep
28	29	num
EOX
Y	1
ROOT	0	0	31	1	S	1	0	31	3	NP	0	0	7	2	NP	2	0	5	3	DT	0	0	1	1	The	0	0	1	0	NP	0	1	4	3	NN	0	1	2	1	mouse	1	1	2	0	CC	0	2	3	1	and	2	2	3	0	NN	0	3	4	1	rabbit	3	3	4	0	NNS	0	4	5	1	antibodies	4	4	5	0	PP	0	5	7	2	TO	0	5	6	1	to	5	5	6	0	NP	0	6	7	1	NN	0	6	7	1	ASPP2	6	6	7	0	VP	1	7	30	2	VBD	0	7	8	1	were	7	7	8	0	VP	0	8	30	3	VBN	0	8	9	1	described	8	8	9	0	ADVP	0	9	10	1	RB	0	9	10	1	previously	9	9	10	0	NP	0	10	30	2	NP	1	10	20	2	QP	1	10	12	2	CD	0	10	11	1	[	10	10	11	0	CD	0	11	12	1	9	11	11	12	0	NX	0	12	20	3	NP	0	12	13	1	NN	0	12	13	1	]	12	12	13	0	:	0	13	14	1	:	13	13	14	0	NP	0	14	20	2	NP	2	14	17	3	NN	0	14	15	1	rabbit	14	14	15	0	JJ	0	15	16	1	anti	15	15	16	0	NN	0	16	17	1	ASPP2	16	16	17	0	NP	2	17	20	3	JJ	0	17	18	1	polyclonal	17	17	18	0	NN	0	18	19	1	antibody	18	18	19	0	NN	0	19	20	1	ASPP2	19	19	20	0	PRN	1	20	30	2	:	0	20	21	1	/	20	20	21	0	S	1	21	30	2	NP	0	21	28	3	NP	0	21	22	1	CD	0	21	22	1	77	21	21	22	0	CC	0	22	23	1	and	22	22	23	0	NP	4	23	28	5	NN	0	23	24	1	mouse	23	23	24	0	JJ	0	24	25	1	monoclonal	24	24	25	0	JJ	0	25	26	1	anti	25	25	26	0	NN	0	26	27	1	ASPP2	26	26	27	0	NN	0	27	28	1	antibody	27	27	28	0	NP	0	28	30	2	NN	0	28	29	1	DX54	28	28	29	0	CD	0	29	30	1	.10	29	29	30	0	.	0	30	31	1	.	30	30	31	0
EOS
T	9
The	25406	25409	DT	the	O	_	_
mouse	25410	25415	NN	mouse	B-GENE	_	_
monoclonal	25416	25426	JJ	monoclonal	I-GENE	_	_
DO-1	25427	25431	NN	do-1	I-GENE	_	_
is	25432	25434	VBZ	be	O	_	_
specific	25435	25443	JJ	specific	O	_	_
to	25444	25446	TO	to	O	_	_
p53	25447	25450	NN	p53	B-GENE	_	_
.	25450	25451	.	.	O	_	_
D	1
5
3	0	det
3	1	nn
3	2	amod
5	3	nsubj
5	4	cop
5	7	prep_to
EOX
Y	1
ROOT	0	0	9	1	S	1	0	9	3	NP	3	0	4	4	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	mouse	1	1	2	0	JJ	0	2	3	1	monoclonal	2	2	3	0	NN	0	3	4	1	DO-1	3	3	4	0	VP	1	4	8	2	VBZ	0	4	5	1	is	4	4	5	0	ADJP	0	5	8	2	JJ	0	5	6	1	specific	5	5	6	0	PP	0	6	8	2	TO	0	6	7	1	to	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	p53	7	7	8	0	.	0	8	9	1	.	8	8	9	0
EOS
T	21
Signals	25452	25459	NNS	signal	O	_	_
were	25460	25464	VBD	be	O	_	_
detected	25465	25473	VBN	detect	O	_	_
using	25474	25479	VBG	use	O	_	_
ECL	25480	25483	NN	ecl	O	_	_
detection	25484	25493	NN	detection	O	_	_
system	25494	25500	NN	system	O	_	_
(	25501	25502	CD	(	O	_	_
GE	25502	25504	NNP	GE	O	_	_
Healthcare	25505	25515	NNP	Healthcare	O	_	_
,	25515	25516	,	,	O	_	_
Pollards	25517	25525	NNP	Pollards	O	_	_
Wood	25526	25530	NNP	Wood	O	_	_
,	25530	25531	,	,	O	_	_
Chalfont	25532	25540	NNP	Chalfont	O	_	_
,	25540	25541	,	,	O	_	_
Buckinghamshire	25542	25557	NNP	Buckinghamshire	O	_	_
,	25557	25558	,	,	O	_	_
UK	25559	25561	NNP	UK	O	_	_
)	25561	25562	CD	)	O	_	_
.	25562	25563	.	.	O	_	_
D	1
2
2	0	nsubjpass
2	1	auxpass
2	3	xcomp
3	6	dobj
6	4	nn
6	5	nn
6	9	dep
9	7	num
9	8	nn
9	18	appos
18	11	nn
18	12	nn
18	14	appos
18	16	appos
18	19	num
EOX
Y	1
ROOT	0	0	21	1	S	1	0	21	3	NP	0	0	1	1	NNS	0	0	1	1	Signals	0	0	1	0	VP	1	1	20	2	VBD	0	1	2	1	were	1	1	2	0	VP	0	2	20	2	VBN	0	2	3	1	detected	2	2	3	0	S	0	3	20	1	VP	0	3	20	2	VBG	0	3	4	1	using	3	3	4	0	NP	0	4	20	2	NP	2	4	7	3	NN	0	4	5	1	ECL	4	4	5	0	NN	0	5	6	1	detection	5	5	6	0	NN	0	6	7	1	system	6	6	7	0	NP	0	7	20	3	NP	2	7	10	3	CD	0	7	8	1	(	7	7	8	0	NNP	0	8	9	1	GE	8	8	9	0	NNP	0	9	10	1	Healthcare	9	9	10	0	,	0	10	11	1	,	10	10	11	0	NP	7	11	20	9	NNP	0	11	12	1	Pollards	11	11	12	0	NNP	0	12	13	1	Wood	12	12	13	0	,	0	13	14	1	,	13	13	14	0	NNP	0	14	15	1	Chalfont	14	14	15	0	,	0	15	16	1	,	15	15	16	0	NNP	0	16	17	1	Buckinghamshire	16	16	17	0	,	0	17	18	1	,	17	17	18	0	NNP	0	18	19	1	UK	18	18	19	0	CD	0	19	20	1	)	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	56
Immunofluorescence	25564	25582	NN	immunofluorescence	O	_	_
Cells	25583	25588	NNS	cell	O	_	_
were	25589	25593	VBD	be	O	_	_
fixed	25594	25599	VBN	fix	O	_	_
in	25600	25602	IN	in	O	_	_
4	25603	25604	CD	4	O	_	_
%	25604	25605	NN	%	O	_	_
PBS-paraformaldeyde	25606	25625	NN	pbs-paraformaldeyde	O	_	_
for	25626	25629	IN	for	O	_	_
15	25630	25632	CD	15	O	_	_
min	25633	25636	NN	min	O	_	_
,	25636	25637	,	,	O	_	_
incubated	25638	25647	VBN	incubate	O	_	_
in	25648	25650	IN	in	O	_	_
0.2	25651	25654	CD	0.2	O	_	_
%	25654	25655	NN	%	O	_	_
Triton-X-100	25656	25668	NN	triton-x-100	O	_	_
for	25669	25672	IN	for	O	_	_
5	25673	25674	CD	5	O	_	_
min	25675	25678	NN	min	O	_	_
,	25678	25679	,	,	O	_	_
then	25680	25684	RB	then	O	_	_
in	25685	25687	IN	in	O	_	_
0.2	25688	25691	CD	0.2	O	_	_
%	25691	25692	NN	%	O	_	_
Fish	25693	25697	NN	fish	O	_	_
Skin	25698	25702	NN	skin	O	_	_
Gelatine	25703	25711	NN	gelatine	O	_	_
in	25712	25714	IN	in	O	_	_
PBS	25715	25718	NNP	PBS	O	_	_
for	25719	25722	IN	for	O	_	_
10	25723	25725	CD	10	O	_	_
min	25726	25729	NN	min	O	_	_
and	25730	25733	CC	and	O	_	_
stained	25734	25741	VBN	stain	O	_	_
for	25742	25745	IN	for	O	_	_
1	25746	25747	CD	1	O	_	_
hr	25748	25750	NN	hr	O	_	_
with	25751	25755	IN	with	O	_	_
anti	25756	25760	JJ	anti	O	_	_
V5	25761	25763	NN	v5	O	_	_
(	25764	25765	CD	(	O	_	_
Invitrogen	25765	25775	NNP	Invitrogen	O	_	_
,	25775	25776	,	,	O	_	_
Paisley	25777	25784	NNP	Paisley	O	_	_
,	25784	25785	,	,	O	_	_
UK	25786	25788	NNP	UK	O	_	_
)	25788	25789	CD	)	O	_	_
or	25790	25792	CC	or	O	_	_
with	25793	25797	IN	with	O	_	_
anti	25798	25802	JJ	anti	B-GENE	_	_
ASPP2	25803	25808	NN	aspp2	I-GENE	_	_
with	25809	25813	IN	with	O	_	_
DX54	25814	25818	NN	dx54	B-GENE	_	_
.10	25818	25821	CD	.10	I-GENE	_	_
.	25821	25822	.	.	O	_	_
D	1
3
1	0	nn
3	1	nsubjpass
3	2	auxpass
3	7	prep_in
3	12	conj_and
3	34	conj_and
6	5	number
7	6	amod
7	10	prep_for
10	9	num
12	1	nsubjpass
12	16	prep_in
12	32	prep_for
15	14	number
16	15	amod
16	19	prep_for
16	21	advmod
16	27	dep
19	18	num
21	24	prep_in
24	23	num
27	25	nn
27	26	nn
27	29	prep_in
32	31	num
34	1	nsubjpass
34	34	conj_or
34	37	prep_for
34	51	prep_with
34	53	prep_with
37	36	num
37	40	prep_with
40	39	amod
40	41	num
40	46	dep
46	42	nn
46	44	appos
46	47	num
51	50	amod
53	54	num
EOX
Y	1
ROOT	0	0	56	1	S	1	0	56	3	NP	1	0	2	2	NN	0	0	1	1	Immunofluorescence	0	0	1	0	NNS	0	1	2	1	Cells	1	1	2	0	VP	1	2	55	2	VBD	0	2	3	1	were	2	2	3	0	VP	0	3	55	5	VP	0	3	11	2	VBN	0	3	4	1	fixed	3	3	4	0	PP	0	4	11	2	IN	0	4	5	1	in	4	4	5	0	NP	0	5	11	2	NP	1	5	8	2	ADJP	1	5	7	2	CD	0	5	6	1	4	5	5	6	0	NN	0	6	7	1	%	6	6	7	0	NN	0	7	8	1	PBS-paraformaldeyde	7	7	8	0	PP	0	8	11	2	IN	0	8	9	1	for	8	8	9	0	NP	1	9	11	2	CD	0	9	10	1	15	9	9	10	0	NN	0	10	11	1	min	10	10	11	0	,	0	11	12	1	,	11	11	12	0	VP	0	12	33	3	VBN	0	12	13	1	incubated	12	12	13	0	PP	0	13	30	2	IN	0	13	14	1	in	13	13	14	0	NP	0	14	30	4	NP	0	14	20	2	NP	1	14	17	2	ADJP	1	14	16	2	CD	0	14	15	1	0.2	14	14	15	0	NN	0	15	16	1	%	15	15	16	0	NN	0	16	17	1	Triton-X-100	16	16	17	0	PP	0	17	20	2	IN	0	17	18	1	for	17	17	18	0	NP	1	18	20	2	CD	0	18	19	1	5	18	18	19	0	NN	0	19	20	1	min	19	19	20	0	,	0	20	21	1	,	20	20	21	0	ADVP	0	21	25	2	RB	0	21	22	1	then	21	21	22	0	PP	0	22	25	2	IN	0	22	23	1	in	22	22	23	0	NP	1	23	25	2	CD	0	23	24	1	0.2	23	23	24	0	NN	0	24	25	1	%	24	24	25	0	NP	0	25	30	2	NP	2	25	28	3	NN	0	25	26	1	Fish	25	25	26	0	NN	0	26	27	1	Skin	26	26	27	0	NN	0	27	28	1	Gelatine	27	27	28	0	PP	0	28	30	2	IN	0	28	29	1	in	28	28	29	0	NP	0	29	30	1	NNP	0	29	30	1	PBS	29	29	30	0	PP	0	30	33	2	IN	0	30	31	1	for	30	30	31	0	NP	1	31	33	2	CD	0	31	32	1	10	31	31	32	0	NN	0	32	33	1	min	32	32	33	0	CC	0	33	34	1	and	33	33	34	0	VP	0	34	55	3	VBN	0	34	35	1	stained	34	34	35	0	PP	0	35	52	3	PP	0	35	48	2	IN	0	35	36	1	for	35	35	36	0	NP	0	36	48	2	NP	1	36	38	2	CD	0	36	37	1	1	36	36	37	0	NN	0	37	38	1	hr	37	37	38	0	PP	0	38	48	2	IN	0	38	39	1	with	38	38	39	0	NP	0	39	48	2	NP	1	39	42	3	JJ	0	39	40	1	anti	39	39	40	0	NN	0	40	41	1	V5	40	40	41	0	CD	0	41	42	1	(	41	41	42	0	NP	4	42	48	6	NNP	0	42	43	1	Invitrogen	42	42	43	0	,	0	43	44	1	,	43	43	44	0	NNP	0	44	45	1	Paisley	44	44	45	0	,	0	45	46	1	,	45	45	46	0	NNP	0	46	47	1	UK	46	46	47	0	CD	0	47	48	1	)	47	47	48	0	CC	0	48	49	1	or	48	48	49	0	PP	0	49	52	2	IN	0	49	50	1	with	49	49	50	0	NP	1	50	52	2	JJ	0	50	51	1	anti	50	50	51	0	NN	0	51	52	1	ASPP2	51	51	52	0	PP	0	52	55	2	IN	0	52	53	1	with	52	52	53	0	NP	0	53	55	2	NN	0	53	54	1	DX54	53	53	54	0	CD	0	54	55	1	.10	54	54	55	0	.	0	55	56	1	.	55	55	56	0
EOS
T	15
Antibodies	25823	25833	NNS	antibody	O	_	_
were	25834	25838	VBD	be	O	_	_
used	25839	25843	VBN	use	O	_	_
at	25844	25846	IN	at	O	_	_
1:100	25847	25852	CD	1:100	O	_	_
dilution	25853	25861	NN	dilution	O	_	_
in	25862	25864	IN	in	O	_	_
0.2	25865	25868	CD	0.2	O	_	_
%	25868	25869	NN	%	O	_	_
Fish	25870	25874	NN	fish	O	_	_
Skin	25875	25879	NN	skin	O	_	_
Gelatine-PBS	25880	25892	NN	gelatine-pb	O	_	_
,	25892	25893	,	,	O	_	_
respectively	25894	25906	RB	respectively	O	_	_
.	25906	25907	.	.	O	_	_
D	1
2
2	0	nsubjpass
2	1	auxpass
2	5	prep_at
2	13	advmod
5	4	num
5	8	prep_in
8	7	num
8	11	dep
11	9	nn
11	10	nn
EOX
Y	1
ROOT	0	0	15	1	S	1	0	15	3	NP	0	0	1	1	NNS	0	0	1	1	Antibodies	0	0	1	0	VP	1	1	14	2	VBD	0	1	2	1	were	1	1	2	0	VP	0	2	14	4	VBN	0	2	3	1	used	2	2	3	0	PP	0	3	12	2	IN	0	3	4	1	at	3	3	4	0	NP	0	4	12	2	NP	1	4	6	2	CD	0	4	5	1	1:100	4	4	5	0	NN	0	5	6	1	dilution	5	5	6	0	PP	0	6	12	2	IN	0	6	7	1	in	6	6	7	0	NP	0	7	12	2	NP	1	7	9	2	CD	0	7	8	1	0.2	7	7	8	0	NN	0	8	9	1	%	8	8	9	0	NP	2	9	12	3	NN	0	9	10	1	Fish	9	9	10	0	NN	0	10	11	1	Skin	10	10	11	0	NN	0	11	12	1	Gelatine-PBS	11	11	12	0	,	0	12	13	1	,	12	12	13	0	ADVP	0	13	14	1	RB	0	13	14	1	respectively	13	13	14	0	.	0	14	15	1	.	14	14	15	0
EOS
T	23
Staining	25908	25916	VBG	stain	O	_	_
with	25917	25921	IN	with	O	_	_
the	25922	25925	DT	the	O	_	_
secondary	25926	25935	JJ	secondary	O	_	_
antibody	25936	25944	NN	antibody	O	_	_
and	25945	25948	CC	and	O	_	_
Hoechst	25949	25956	NNP	Hoechst	O	_	_
was	25957	25960	VBD	be	O	_	_
performed	25961	25970	VBN	perform	O	_	_
as	25971	25973	IN	as	O	_	_
described	25974	25983	VBN	describe	O	_	_
[	25984	25985	NN	[	O	_	_
2	25985	25986	CD	2	O	_	_
]	25986	25987	NN	]	O	_	_
,	25987	25988	,	,	O	_	_
followed	25989	25997	VBN	follow	O	_	_
by	25998	26000	IN	by	O	_	_
visualisation	26001	26014	NN	visualisation	O	_	_
under	26015	26020	IN	under	O	_	_
a	26021	26022	DT	a	O	_	_
fluorescence	26023	26035	NN	fluorescence	O	_	_
microscope	26036	26046	NN	microscope	O	_	_
.	26046	26047	.	.	O	_	_
D	1
0
0	4	prep_with
0	6	prep_with
0	8	aux
0	13	nsubj
4	2	det
4	3	amod
4	6	conj_and
8	7	auxpass
8	11	prep_as
11	10	amod
13	12	num
13	15	vmod
15	17	agent
15	21	prep_under
21	19	det
21	20	nn
EOX
Y	1
ROOT	0	0	23	1	SINV	0	0	23	4	VP	0	0	7	2	VBG	0	0	1	1	Staining	0	0	1	0	PP	0	1	7	2	IN	0	1	2	1	with	1	1	2	0	NP	0	2	7	3	NP	2	2	5	3	DT	0	2	3	1	the	2	2	3	0	JJ	0	3	4	1	secondary	3	3	4	0	NN	0	4	5	1	antibody	4	4	5	0	CC	0	5	6	1	and	5	5	6	0	NP	0	6	7	1	NNP	0	6	7	1	Hoechst	6	6	7	0	VP	1	7	12	2	VBD	0	7	8	1	was	7	7	8	0	VP	0	8	12	2	VBN	0	8	9	1	performed	8	8	9	0	PP	0	9	12	2	IN	0	9	10	1	as	9	9	10	0	NP	1	10	12	2	VBN	0	10	11	1	described	10	10	11	0	NN	0	11	12	1	[	11	11	12	0	NP	0	12	22	3	NP	1	12	14	2	CD	0	12	13	1	2	12	12	13	0	NN	0	13	14	1	]	13	13	14	0	,	0	14	15	1	,	14	14	15	0	VP	0	15	22	3	VBN	0	15	16	1	followed	15	15	16	0	PP	0	16	18	2	IN	0	16	17	1	by	16	16	17	0	NP	0	17	18	1	NN	0	17	18	1	visualisation	17	17	18	0	PP	0	18	22	2	IN	0	18	19	1	under	18	18	19	0	NP	2	19	22	3	DT	0	19	20	1	a	19	19	20	0	NN	0	20	21	1	fluorescence	20	20	21	0	NN	0	21	22	1	microscope	21	21	22	0	.	0	22	23	1	.	22	22	23	0
EOS
T	59
Immunoprecipitation	26048	26067	NN	immunoprecipitation	O	_	_
For	26068	26071	IN	for	O	_	_
immunoprecipitation	26072	26091	NN	immunoprecipitation	O	_	_
,	26091	26092	,	,	O	_	_
cells	26093	26098	NNS	cell	O	_	_
were	26099	26103	VBD	be	O	_	_
lysed	26104	26109	VBN	lyse	O	_	_
in	26110	26112	IN	in	O	_	_
IP	26113	26115	NNP	IP	O	_	_
buffer	26116	26122	NN	buffer	O	_	_
(	26123	26124	CD	(	O	_	_
20	26124	26126	CD	20	O	_	_
mM	26127	26129	NN	mm	O	_	_
Trish-HCl	26130	26139	NN	trish-hcl	O	_	_
[	26140	26141	CD	[	O	_	_
pH	26141	26143	NN	ph	O	_	_
7.5	26144	26147	CD	7.5	O	_	_
]	26147	26148	NN	]	O	_	_
,	26148	26149	,	,	O	_	_
1	26150	26151	CD	1	O	_	_
mM	26152	26154	NN	mm	O	_	_
EDTA	26155	26159	NN	edta	O	_	_
,	26159	26160	,	,	O	_	_
1	26161	26162	CD	1	O	_	_
M	26163	26164	NN	m	O	_	_
KCl	26165	26168	NN	kcl	O	_	_
,	26168	26169	,	,	O	_	_
5	26170	26171	CD	5	O	_	_
mM	26172	26174	NN	mm	O	_	_
MgCl2	26175	26180	NN	mgcl2	O	_	_
,	26181	26182	,	,	O	_	_
10	26183	26185	CD	10	O	_	_
%	26185	26186	NN	%	O	_	_
v	26187	26188	LS	v	O	_	_
/	26188	26189	:	/	O	_	_
v	26189	26190	LS	v	O	_	_
glycerol	26191	26199	NN	glycerol	O	_	_
,	26199	26200	,	,	O	_	_
1	26201	26202	CD	1	O	_	_
%	26202	26203	NN	%	O	_	_
v	26204	26205	LS	v	O	_	_
/	26205	26206	:	/	O	_	_
v	26206	26207	LS	v	O	_	_
Triton	26208	26214	NNP	Triton	O	_	_
X-100	26215	26220	NN	x-100	O	_	_
,	26220	26221	,	,	O	_	_
0.05	26222	26226	CD	0.05	O	_	_
%	26226	26227	NN	%	O	_	_
v	26228	26229	LS	v	O	_	_
/	26229	26230	:	/	O	_	_
v	26230	26231	LS	v	O	_	_
2-Mercaptoethanol	26232	26249	NN	2-mercaptoethanol	O	_	_
and	26250	26253	CC	and	O	_	_
protease	26254	26262	NN	protease	O	_	_
and	26263	26266	CC	and	O	_	_
phosphatase	26267	26278	NN	phosphatase	O	_	_
inhibitors	26279	26289	NNS	inhibitor	O	_	_
)	26289	26290	NN	)	O	_	_
.	26290	26291	.	.	O	_	_
D	1
6
6	0	npadvmod
6	2	prep_for
6	4	nsubjpass
6	5	auxpass
6	9	prep_in
6	15	dep
6	21	dep
9	8	nn
11	10	number
15	11	num
15	12	nn
15	13	nn
15	14	num
15	17	amod
17	16	number
21	19	num
21	20	nn
21	25	appos
21	29	appos
21	32	appos
21	33	dep
21	34	punct
21	36	dep
21	40	dep
21	41	punct
21	44	dep
21	48	dep
21	49	punct
21	57	dep
25	23	num
25	24	nn
29	27	num
29	28	nn
32	31	num
36	35	dep
36	39	dep
39	38	num
44	42	dep
44	43	nn
44	47	dep
47	46	num
50	51	dep
50	53	dep
50	56	dep
51	53	conj_and
51	56	conj_and
56	55	nn
57	50	prep
EOX
Y	1
ROOT	0	0	59	1	S	2	0	59	6	PP	1	0	3	3	NP	0	0	1	1	NN	0	0	1	1	Immunoprecipitation	0	0	1	0	IN	0	1	2	1	For	1	1	2	0	NP	0	2	3	1	NN	0	2	3	1	immunoprecipitation	2	2	3	0	,	0	3	4	1	,	3	3	4	0	S	1	4	18	2	NP	0	4	5	1	NNS	0	4	5	1	cells	4	4	5	0	VP	1	5	18	2	VBD	0	5	6	1	were	5	5	6	0	VP	0	6	18	2	VBN	0	6	7	1	lysed	6	6	7	0	PP	0	7	18	3	IN	0	7	8	1	in	7	7	8	0	NP	1	8	10	2	NNP	0	8	9	1	IP	8	8	9	0	NN	0	9	10	1	buffer	9	9	10	0	NP	0	10	18	2	NP	4	10	16	5	QP	1	10	12	2	CD	0	10	11	1	(	10	10	11	0	CD	0	11	12	1	20	11	11	12	0	NN	0	12	13	1	mM	12	12	13	0	NN	0	13	14	1	Trish-HCl	13	13	14	0	CD	0	14	15	1	[	14	14	15	0	NN	0	15	16	1	pH	15	15	16	0	ADJP	1	16	18	2	CD	0	16	17	1	7.5	16	16	17	0	NN	0	17	18	1	]	17	17	18	0	,	0	18	19	1	,	18	18	19	0	FRAG	0	19	58	3	FRAG	0	19	49	4	FRAG	0	19	41	4	FRAG	0	19	34	2	NP	0	19	33	7	NP	2	19	22	3	CD	0	19	20	1	1	19	19	20	0	NN	0	20	21	1	mM	20	20	21	0	NN	0	21	22	1	EDTA	21	21	22	0	,	0	22	23	1	,	22	22	23	0	NP	2	23	26	3	CD	0	23	24	1	1	23	23	24	0	NN	0	24	25	1	M	24	24	25	0	NN	0	25	26	1	KCl	25	25	26	0	,	0	26	27	1	,	26	26	27	0	NP	2	27	30	3	CD	0	27	28	1	5	27	27	28	0	NN	0	28	29	1	mM	28	28	29	0	NN	0	29	30	1	MgCl2	29	29	30	0	,	0	30	31	1	,	30	30	31	0	NP	1	31	33	2	CD	0	31	32	1	10	31	31	32	0	NN	0	32	33	1	%	32	32	33	0	LS	0	33	34	1	v	33	33	34	0	:	0	34	35	1	/	34	34	35	0	FRAG	0	35	40	3	NP	1	35	37	2	LS	0	35	36	1	v	35	35	36	0	NN	0	36	37	1	glycerol	36	36	37	0	,	0	37	38	1	,	37	37	38	0	NP	1	38	40	2	CD	0	38	39	1	1	38	38	39	0	NN	0	39	40	1	%	39	39	40	0	LS	0	40	41	1	v	40	40	41	0	:	0	41	42	1	/	41	41	42	0	FRAG	0	42	48	3	NP	2	42	45	3	LS	0	42	43	1	v	42	42	43	0	NNP	0	43	44	1	Triton	43	43	44	0	NN	0	44	45	1	X-100	44	44	45	0	,	0	45	46	1	,	45	45	46	0	NP	1	46	48	2	CD	0	46	47	1	0.05	46	46	47	0	NN	0	47	48	1	%	47	47	48	0	LS	0	48	49	1	v	48	48	49	0	:	0	49	50	1	/	49	49	50	0	FRAG	1	50	58	2	PP	0	50	57	2	LS	0	50	51	1	v	50	50	51	0	NP	0	51	57	3	NP	0	51	54	3	NN	0	51	52	1	2-Mercaptoethanol	51	51	52	0	CC	0	52	53	1	and	52	52	53	0	NN	0	53	54	1	protease	53	53	54	0	CC	0	54	55	1	and	54	54	55	0	NP	1	55	57	2	NN	0	55	56	1	phosphatase	55	55	56	0	NNS	0	56	57	1	inhibitors	56	56	57	0	NP	0	57	58	1	NN	0	57	58	1	)	57	57	58	0	.	0	58	59	1	.	58	58	59	0
EOS
T	33
1-4	26292	26295	CD	1-4	O	_	_
mg	26296	26298	NN	mg	O	_	_
of	26299	26301	IN	of	O	_	_
lysate	26302	26308	NN	lysate	O	_	_
was	26309	26312	VBD	be	O	_	_
pre	26313	26316	JJ	pre	O	_	_
cleared	26317	26324	VBN	clear	O	_	_
with	26325	26329	IN	with	O	_	_
protein	26330	26337	NN	protein	O	_	_
G	26338	26339	NN	g	O	_	_
beads	26340	26345	NNS	bead	O	_	_
for	26346	26349	IN	for	O	_	_
30	26350	26352	CD	30	O	_	_
min	26353	26356	NN	min	O	_	_
at	26357	26359	IN	at	O	_	_
4degreesC	26360	26369	NN	4degreesc	O	_	_
and	26370	26373	CC	and	O	_	_
subsequently	26374	26386	RB	subsequently	O	_	_
incubated	26387	26396	VBN	incubate	O	_	_
with	26397	26401	IN	with	O	_	_
antibody	26402	26410	NN	antibody	O	_	_
pre	26411	26414	JJ	pre	O	_	_
bound	26415	26420	VBN	bind	O	_	_
to	26421	26423	TO	to	O	_	_
protein	26424	26431	NN	protein	O	_	_
G	26432	26433	NN	g	O	_	_
beads	26434	26439	NNS	bead	O	_	_
for	26440	26443	IN	for	O	_	_
2-16	26444	26448	CD	2-16	O	_	_
hrs	26449	26452	NNS	hr	O	_	_
at	26453	26455	IN	at	O	_	_
4degreesC	26456	26465	NN	4degreesc	O	_	_
.	26465	26466	.	.	O	_	_
D	1
5
1	0	num
1	3	prep_of
5	1	nsubj
5	4	cop
5	6	ccomp
5	18	ccomp
6	10	prep_with
6	13	prep_for
6	15	prep_at
6	18	conj_and
10	8	nn
10	9	nn
13	12	num
18	17	advmod
18	20	prep_with
20	21	amod
20	22	vmod
22	26	prep_to
22	29	prep_for
26	24	nn
26	25	nn
29	28	num
29	31	prep_at
EOX
Y	1
ROOT	0	0	33	1	S	1	0	33	3	NP	0	0	4	2	NP	1	0	2	2	CD	0	0	1	1	1-4	0	0	1	0	NN	0	1	2	1	mg	1	1	2	0	PP	0	2	4	2	IN	0	2	3	1	of	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	lysate	3	3	4	0	VP	1	4	32	2	VBD	0	4	5	1	was	4	4	5	0	ADJP	0	5	32	2	JJ	0	5	6	1	pre	5	5	6	0	SBAR	0	6	32	1	S	0	6	32	3	S	0	6	16	1	VP	0	6	16	4	VBN	0	6	7	1	cleared	6	6	7	0	PP	0	7	11	2	IN	0	7	8	1	with	7	7	8	0	NP	2	8	11	3	NN	0	8	9	1	protein	8	8	9	0	NN	0	9	10	1	G	9	9	10	0	NNS	0	10	11	1	beads	10	10	11	0	PP	0	11	14	2	IN	0	11	12	1	for	11	11	12	0	NP	1	12	14	2	CD	0	12	13	1	30	12	12	13	0	NN	0	13	14	1	min	13	13	14	0	PP	0	14	16	2	IN	0	14	15	1	at	14	14	15	0	NP	0	15	16	1	NN	0	15	16	1	4degreesC	15	15	16	0	CC	0	16	17	1	and	16	16	17	0	S	1	17	32	2	ADVP	0	17	18	1	RB	0	17	18	1	subsequently	17	17	18	0	VP	0	18	32	2	VBN	0	18	19	1	incubated	18	18	19	0	PP	0	19	32	2	IN	0	19	20	1	with	19	19	20	0	NP	0	20	32	2	NP	0	20	22	2	NN	0	20	21	1	antibody	20	20	21	0	JJ	0	21	22	1	pre	21	21	22	0	VP	0	22	32	3	VBN	0	22	23	1	bound	22	22	23	0	PP	0	23	27	2	TO	0	23	24	1	to	23	23	24	0	NP	2	24	27	3	NN	0	24	25	1	protein	24	24	25	0	NN	0	25	26	1	G	25	25	26	0	NNS	0	26	27	1	beads	26	26	27	0	PP	0	27	32	2	IN	0	27	28	1	for	27	27	28	0	NP	0	28	32	2	NP	1	28	30	2	CD	0	28	29	1	2-16	28	28	29	0	NNS	0	29	30	1	hrs	29	29	30	0	PP	0	30	32	2	IN	0	30	31	1	at	30	30	31	0	NP	0	31	32	1	NN	0	31	32	1	4degreesC	31	31	32	0	.	0	32	33	1	.	32	32	33	0
EOS
T	10
The	26467	26470	DT	the	O	_	_
beads	26471	26476	NNS	bead	O	_	_
were	26477	26481	VBD	be	O	_	_
washed	26482	26488	VBN	wash	O	_	_
three	26489	26494	CD	three	O	_	_
times	26495	26500	NNS	time	O	_	_
with	26501	26505	IN	with	O	_	_
NP40	26506	26510	NN	np40	O	_	_
buffer	26511	26517	NN	buffer	O	_	_
.	26517	26518	.	.	O	_	_
D	1
3
1	0	det
3	1	nsubjpass
3	2	auxpass
3	5	dobj
3	8	prep_with
5	4	num
8	7	nn
EOX
Y	1
ROOT	0	0	10	1	S	1	0	10	3	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NNS	0	1	2	1	beads	1	1	2	0	VP	1	2	9	2	VBD	0	2	3	1	were	2	2	3	0	VP	0	3	9	3	VBN	0	3	4	1	washed	3	3	4	0	NP	1	4	6	2	CD	0	4	5	1	three	4	4	5	0	NNS	0	5	6	1	times	5	5	6	0	PP	0	6	9	2	IN	0	6	7	1	with	6	6	7	0	NP	1	7	9	2	NN	0	7	8	1	NP40	7	7	8	0	NN	0	8	9	1	buffer	8	8	9	0	.	0	9	10	1	.	9	9	10	0
EOS
T	15
The	26519	26522	DT	the	O	_	_
immunoprecipitation	26523	26542	NN	immunoprecipitation	O	_	_
beads	26543	26548	NNS	bead	O	_	_
were	26549	26553	VBD	be	O	_	_
mixed	26554	26559	VBN	mix	O	_	_
with	26560	26564	IN	with	O	_	_
6x	26565	26567	JJ	6x	O	_	_
sample	26568	26574	NN	sample	O	_	_
buffer	26575	26581	NN	buffer	O	_	_
and	26582	26585	CC	and	O	_	_
loaded	26586	26592	VBN	load	O	_	_
on	26593	26595	IN	on	O	_	_
SDS-PAGE	26596	26604	NN	sds-page	O	_	_
gels	26605	26609	NNS	gel	O	_	_
.	26609	26610	.	.	O	_	_
D	1
4
2	0	det
2	1	nn
4	2	nsubjpass
4	3	auxpass
4	8	prep_with
4	10	conj_and
8	6	amod
8	7	nn
10	2	nsubjpass
10	13	prep_on
13	12	nn
EOX
Y	1
ROOT	0	0	15	1	S	1	0	15	3	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	immunoprecipitation	1	1	2	0	NNS	0	2	3	1	beads	2	2	3	0	VP	1	3	14	2	VBD	0	3	4	1	were	3	3	4	0	VP	0	4	14	3	VP	0	4	9	2	VBN	0	4	5	1	mixed	4	4	5	0	PP	0	5	9	2	IN	0	5	6	1	with	5	5	6	0	NP	2	6	9	3	JJ	0	6	7	1	6x	6	6	7	0	NN	0	7	8	1	sample	7	7	8	0	NN	0	8	9	1	buffer	8	8	9	0	CC	0	9	10	1	and	9	9	10	0	VP	0	10	14	2	VBN	0	10	11	1	loaded	10	10	11	0	PP	0	11	14	2	IN	0	11	12	1	on	11	11	12	0	NP	1	12	14	2	NN	0	12	13	1	SDS-PAGE	12	12	13	0	NNS	0	13	14	1	gels	13	13	14	0	.	0	14	15	1	.	14	14	15	0
EOS
T	73
In	26611	26613	FW	in	O	_	_
vitro	26614	26619	FW	vitro	O	_	_
phosphorylation	26620	26635	NN	phosphorylation	O	_	_
assay	26636	26641	NN	assay	O	_	_
2	26642	26643	CD	2	O	_	_
mug	26644	26647	NN	mug	O	_	_
of	26648	26650	IN	of	O	_	_
GST-ASPP2	26651	26660	NN	gst-aspp2	O	_	_
(	26661	26662	CD	(	O	_	_
693-1128	26662	26670	CD	693-1128	O	_	_
)	26670	26671	NN	)	O	_	_
expressed	26672	26681	VBN	express	O	_	_
in	26682	26684	IN	in	O	_	_
E.	26685	26687	FW	e.	O	_	_
coli	26688	26692	FW	coli	O	_	_
,	26692	26693	,	,	O	_	_
2	26694	26695	CD	2	O	_	_
mug	26696	26699	NN	mug	O	_	_
of	26700	26702	IN	of	O	_	_
1mg	26703	26706	JJ	1mg	O	_	_
/	26706	26707	:	/	O	_	_
ml	26707	26709	NN	ml	O	_	_
recombinant	26710	26721	JJ	recombinant	O	_	_
Histone	26722	26729	NN	histone	O	_	_
2B	26730	26732	NN	2b	O	_	_
or	26733	26735	CC	or	O	_	_
2	26736	26737	CD	2	O	_	_
mul	26738	26741	NN	mul	O	_	_
of	26742	26744	IN	of	O	_	_
water	26745	26750	NN	water	O	_	_
was	26751	26754	VBD	be	O	_	_
incubated	26755	26764	VBN	incubate	O	_	_
in	26765	26767	IN	in	O	_	_
30	26768	26770	CD	30	O	_	_
mul	26771	26774	NN	mul	O	_	_
of	26775	26777	IN	of	O	_	_
reaction	26778	26786	NN	reaction	O	_	_
mixture	26787	26794	NN	mixture	O	_	_
containing	26795	26805	VBG	contain	O	_	_
50	26806	26808	CD	50	O	_	_
mM	26809	26811	NN	mm	O	_	_
Tris-HCl	26812	26820	NN	tris-hcl	O	_	_
,	26820	26821	,	,	O	_	_
pH	26822	26824	NN	ph	O	_	_
7.5	26825	26828	CD	7.5	O	_	_
,	26828	26829	,	,	O	_	_
0.1	26830	26833	CD	0.1	O	_	_
%	26833	26834	NN	%	O	_	_
2-mercaptoethanol	26835	26852	NN	2-mercaptoethanol	O	_	_
,	26852	26853	,	,	O	_	_
1	26854	26855	CD	1	O	_	_
muM	26856	26859	NN	mum	O	_	_
microcystine	26860	26872	NN	microcystine	O	_	_
and	26873	26876	CC	and	O	_	_
100	26877	26880	CD	100	O	_	_
muM	26881	26884	JJ	mum	O	_	_
[	26885	26886	NN	[	O	_	_
gamma-32P	26886	26895	NN	gamma-32p	O	_	_
]	26895	26896	CD	]	O	_	_
ATP	26896	26899	NN	atp	O	_	_
(	26900	26901	NN	(	O	_	_
10	26901	26903	CD	10	O	_	_
000	26904	26907	CD	000	O	_	_
c.p.m.	26908	26914	NN	c.p.m.	O	_	_
/	26914	26915	:	/	O	_	_
pmol	26915	26919	NN	pmol	O	_	_
)	26919	26920	NN	)	O	_	_
at	26921	26923	IN	at	O	_	_
30degreesC	26924	26934	NNP	30degreesC	O	_	_
for	26935	26938	IN	for	O	_	_
30	26939	26941	CD	30	O	_	_
min	26942	26945	NN	min	O	_	_
.	26945	26946	.	.	O	_	_
D	1
11
3	0	nn
3	1	nn
3	2	nn
3	5	dep
3	10	dep
5	4	num
5	7	prep_of
7	8	num
10	9	num
11	3	nsubj
11	14	prep_in
11	17	dobj
14	13	nn
17	16	num
17	19	prep_of
17	21	dep
17	66	dep
21	20	punct
21	31	rcmod
21	64	punct
24	22	amod
24	23	nn
24	27	conj_or
27	26	num
27	29	prep_of
31	24	nsubjpass
31	27	nsubjpass
31	30	auxpass
31	34	prep_in
31	38	xcomp
34	33	num
34	37	prep_of
37	36	nn
38	41	dobj
38	43	dobj
38	48	dobj
38	52	dobj
38	57	dobj
41	39	num
41	40	nn
41	43	conj_and
41	48	conj_and
41	52	conj_and
41	57	conj_and
43	44	num
48	46	num
48	47	nn
52	50	num
52	51	nn
57	54	num
57	55	amod
57	56	nn
57	60	dep
60	58	num
60	59	nn
60	63	dep
62	61	number
63	62	num
66	65	nn
66	68	prep_at
68	71	prep_for
71	70	num
EOX
Y	1
ROOT	0	0	73	1	S	1	0	73	3	NP	0	0	11	2	NP	0	0	9	2	NP	3	0	4	4	FW	0	0	1	1	In	0	0	1	0	FW	0	1	2	1	vitro	1	1	2	0	NN	0	2	3	1	phosphorylation	2	2	3	0	NN	0	3	4	1	assay	3	3	4	0	NP	0	4	9	2	NP	1	4	6	2	CD	0	4	5	1	2	4	4	5	0	NN	0	5	6	1	mug	5	5	6	0	PP	0	6	9	2	IN	0	6	7	1	of	6	6	7	0	NP	0	7	9	2	NN	0	7	8	1	GST-ASPP2	7	7	8	0	CD	0	8	9	1	(	8	8	9	0	NP	1	9	11	2	CD	0	9	10	1	693-1128	9	9	10	0	NN	0	10	11	1	)	10	10	11	0	VP	0	11	72	3	VP	0	11	15	2	VBN	0	11	12	1	expressed	11	11	12	0	PP	0	12	15	2	IN	0	12	13	1	in	12	12	13	0	NP	1	13	15	2	FW	0	13	14	1	E.	13	13	14	0	FW	0	14	15	1	coli	14	14	15	0	,	0	15	16	1	,	15	15	16	0	NP	0	16	72	4	NP	1	16	18	2	CD	0	16	17	1	2	16	16	17	0	NN	0	17	18	1	mug	17	17	18	0	PP	0	18	20	2	IN	0	18	19	1	of	18	18	19	0	NP	0	19	20	1	JJ	0	19	20	1	1mg	19	19	20	0	PRN	1	20	65	3	:	0	20	21	1	/	20	20	21	0	NP	0	21	64	2	NP	0	21	22	1	NN	0	21	22	1	ml	21	21	22	0	SBAR	0	22	64	1	S	1	22	64	2	NP	0	22	30	3	NP	2	22	25	3	JJ	0	22	23	1	recombinant	22	22	23	0	NN	0	23	24	1	Histone	23	23	24	0	NN	0	24	25	1	2B	24	24	25	0	CC	0	25	26	1	or	25	25	26	0	NP	0	26	30	2	NP	1	26	28	2	CD	0	26	27	1	2	26	26	27	0	NN	0	27	28	1	mul	27	27	28	0	PP	0	28	30	2	IN	0	28	29	1	of	28	28	29	0	NP	0	29	30	1	NN	0	29	30	1	water	29	29	30	0	VP	1	30	64	2	VBD	0	30	31	1	was	30	30	31	0	VP	0	31	64	3	VBN	0	31	32	1	incubated	31	31	32	0	PP	0	32	38	2	IN	0	32	33	1	in	32	32	33	0	NP	0	33	38	2	NP	1	33	35	2	CD	0	33	34	1	30	33	33	34	0	NN	0	34	35	1	mul	34	34	35	0	PP	0	35	38	2	IN	0	35	36	1	of	35	35	36	0	NP	1	36	38	2	NN	0	36	37	1	reaction	36	36	37	0	NN	0	37	38	1	mixture	37	37	38	0	S	0	38	64	1	VP	0	38	64	2	VBG	0	38	39	1	containing	38	38	39	0	NP	0	39	64	9	NP	2	39	42	3	CD	0	39	40	1	50	39	39	40	0	NN	0	40	41	1	mM	40	40	41	0	NN	0	41	42	1	Tris-HCl	41	41	42	0	,	0	42	43	1	,	42	42	43	0	NP	0	43	45	2	NN	0	43	44	1	pH	43	43	44	0	CD	0	44	45	1	7.5	44	44	45	0	,	0	45	46	1	,	45	45	46	0	NP	2	46	49	3	CD	0	46	47	1	0.1	46	46	47	0	NN	0	47	48	1	%	47	47	48	0	NN	0	48	49	1	2-mercaptoethanol	48	48	49	0	,	0	49	50	1	,	49	49	50	0	NP	2	50	53	3	CD	0	50	51	1	1	50	50	51	0	NN	0	51	52	1	muM	51	51	52	0	NN	0	52	53	1	microcystine	52	52	53	0	CC	0	53	54	1	and	53	53	54	0	NP	0	54	64	2	NP	3	54	58	4	CD	0	54	55	1	100	54	54	55	0	JJ	0	55	56	1	muM	55	55	56	0	NN	0	56	57	1	[	56	56	57	0	NN	0	57	58	1	gamma-32P	57	57	58	0	NP	0	58	64	2	NP	2	58	61	3	CD	0	58	59	1	]	58	58	59	0	NN	0	59	60	1	ATP	59	59	60	0	NN	0	60	61	1	(	60	60	61	0	NP	1	61	64	2	QP	1	61	63	2	CD	0	61	62	1	10	61	61	62	0	CD	0	62	63	1	000	62	62	63	0	NN	0	63	64	1	c.p.m.	63	63	64	0	:	0	64	65	1	/	64	64	65	0	NP	0	65	72	2	NP	1	65	67	2	NN	0	65	66	1	pmol	65	65	66	0	NN	0	66	67	1	)	66	66	67	0	PP	0	67	72	2	IN	0	67	68	1	at	67	67	68	0	NP	0	68	72	2	NP	0	68	69	1	NNP	0	68	69	1	30degreesC	68	68	69	0	PP	0	69	72	2	IN	0	69	70	1	for	69	69	70	0	NP	1	70	72	2	CD	0	70	71	1	30	70	70	71	0	NN	0	71	72	1	min	71	71	72	0	.	0	72	73	1	.	72	72	73	0
EOS
T	11
0.35	26947	26951	CD	0.35	B-GENE	_	_
units	26952	26957	NNS	unit	I-GENE	_	_
MAPK1	26958	26963	NN	mapk1	I-GENE	_	_
or	26964	26966	CC	or	I-GENE	_	_
0.1	26967	26970	CD	0.1	I-GENE	_	_
units	26971	26976	NNS	unit	I-GENE	_	_
p38	26977	26980	NN	p38	I-GENE	_	_
SAPK	26981	26985	NN	sapk	I-GENE	_	_
were	26986	26990	VBD	be	O	_	_
used	26991	26995	VBN	use	O	_	_
.	26995	26996	.	.	O	_	_
D	1
9
1	0	num
1	2	dep
1	5	conj_or
5	4	num
5	7	dep
7	6	nn
9	1	nsubjpass
9	5	nsubjpass
9	8	auxpass
EOX
Y	1
ROOT	0	0	11	1	S	1	0	11	3	NP	0	0	8	3	NP	0	0	3	2	NP	1	0	2	2	CD	0	0	1	1	0.35	0	0	1	0	NNS	0	1	2	1	units	1	1	2	0	NP	0	2	3	1	NN	0	2	3	1	MAPK1	2	2	3	0	CC	0	3	4	1	or	3	3	4	0	NP	0	4	8	2	NP	1	4	6	2	CD	0	4	5	1	0.1	4	4	5	0	NNS	0	5	6	1	units	5	5	6	0	NP	1	6	8	2	NN	0	6	7	1	p38	6	6	7	0	NN	0	7	8	1	SAPK	7	7	8	0	VP	1	8	10	2	VBD	0	8	9	1	were	8	8	9	0	VP	0	9	10	1	VBN	0	9	10	1	used	9	9	10	0	.	0	10	11	1	.	10	10	11	0
EOS
T	27
The	26997	27000	DT	the	O	_	_
reactions	27001	27010	NNS	reaction	O	_	_
were	27011	27015	VBD	be	O	_	_
terminated	27016	27026	VBN	terminate	O	_	_
as	27027	27029	IN	as	O	_	_
described	27030	27039	VBN	describe	O	_	_
[	27040	27041	NN	[	O	_	_
12	27041	27043	CD	12	O	_	_
]	27043	27044	NN	]	O	_	_
and	27045	27048	CC	and	O	_	_
analyzed	27049	27057	VBN	analyze	O	_	_
by	27058	27060	IN	by	O	_	_
chromatography	27061	27075	NN	chromatography	O	_	_
on	27076	27078	IN	on	O	_	_
a	27079	27080	DT	a	O	_	_
C18	27081	27084	NN	c18	O	_	_
column	27085	27091	NN	column	O	_	_
or	27092	27094	CC	or	O	_	_
resolved	27095	27103	VBN	resolve	O	_	_
on	27104	27106	IN	on	O	_	_
SDS-PAGE	27107	27115	NN	sds-page	O	_	_
gels	27116	27120	NNS	gel	O	_	_
and	27121	27124	CC	and	O	_	_
visualized	27125	27135	VBN	visualize	O	_	_
by	27136	27138	IN	by	O	_	_
autoradiograph	27139	27153	NN	autoradiograph	O	_	_
.	27153	27154	.	.	O	_	_
D	1
3
1	0	det
3	1	nsubjpass
3	2	auxpass
3	5	advcl
3	10	advcl
3	18	advcl
3	23	advcl
5	4	mark
5	8	dobj
5	10	conj_and
5	18	conj_or
5	23	conj_and
8	6	nn
8	7	num
10	12	prep_by
12	16	prep_on
16	14	det
16	15	nn
18	21	prep_on
21	20	nn
23	25	prep_by
EOX
Y	1
ROOT	0	0	27	1	S	1	0	27	3	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NNS	0	1	2	1	reactions	1	1	2	0	VP	1	2	26	2	VBD	0	2	3	1	were	2	2	3	0	VP	0	3	26	2	VBN	0	3	4	1	terminated	3	3	4	0	SBAR	1	4	26	2	IN	0	4	5	1	as	4	4	5	0	S	0	5	26	3	S	0	5	22	1	VP	0	5	22	5	VP	0	5	9	2	VBN	0	5	6	1	described	5	5	6	0	NP	2	6	9	3	NN	0	6	7	1	[	6	6	7	0	CD	0	7	8	1	12	7	7	8	0	NN	0	8	9	1	]	8	8	9	0	CC	0	9	10	1	and	9	9	10	0	VP	0	10	17	2	VBN	0	10	11	1	analyzed	10	10	11	0	PP	0	11	17	2	IN	0	11	12	1	by	11	11	12	0	NP	0	12	17	2	NP	0	12	13	1	NN	0	12	13	1	chromatography	12	12	13	0	PP	0	13	17	2	IN	0	13	14	1	on	13	13	14	0	NP	2	14	17	3	DT	0	14	15	1	a	14	14	15	0	NN	0	15	16	1	C18	15	15	16	0	NN	0	16	17	1	column	16	16	17	0	CC	0	17	18	1	or	17	17	18	0	VP	0	18	22	2	VBN	0	18	19	1	resolved	18	18	19	0	PP	0	19	22	2	IN	0	19	20	1	on	19	19	20	0	NP	1	20	22	2	NN	0	20	21	1	SDS-PAGE	20	20	21	0	NNS	0	21	22	1	gels	21	21	22	0	CC	0	22	23	1	and	22	22	23	0	S	0	23	26	1	VP	0	23	26	2	VBN	0	23	24	1	visualized	23	23	24	0	PP	0	24	26	2	IN	0	24	25	1	by	24	24	25	0	NP	0	25	26	1	NN	0	25	26	1	autoradiograph	25	25	26	0	.	0	26	27	1	.	26	26	27	0
EOS
T	37
Quantitative	27155	27167	JJ	quantitative	O	_	_
reverse	27168	27175	JJ	reverse	O	_	_
transcription-PCR	27176	27193	NN	transcription-pcr	O	_	_
Real-time	27194	27203	JJ	real-time	O	_	_
reverse	27204	27211	JJ	reverse	B-GENE	_	_
transcriptase-PCR	27212	27229	NN	transcriptase-pcr	I-GENE	_	_
was	27230	27233	VBD	be	O	_	_
performed	27234	27243	VBN	perform	O	_	_
using	27244	27249	VBG	use	O	_	_
gene	27250	27254	NN	gene	O	_	_
specific	27255	27263	JJ	specific	O	_	_
primers	27264	27271	NNS	primer	O	_	_
(	27272	27273	VBP	(	O	_	_
QuantiTect	27273	27283	NNP	QuantiTect	O	_	_
Primer	27284	27290	NN	primer	O	_	_
Assays	27291	27297	NNS	assay	O	_	_
)	27297	27298	VBP	)	O	_	_
for	27299	27302	IN	for	O	_	_
human	27303	27308	JJ	human	B-GENE	_	_
ASPP2	27309	27314	NN	aspp2	I-GENE	_	_
or	27315	27317	CC	or	O	_	_
GAPDH	27318	27323	NN	gapdh	B-GENE	_	_
with	27324	27328	IN	with	O	_	_
the	27329	27332	DT	the	O	_	_
QuantiTect	27333	27343	NNP	QuantiTect	O	_	_
SYBR	27344	27348	NNP	SYBR	O	_	_
Green	27349	27354	NNP	Green	O	_	_
RT-PCR	27355	27361	NN	rt-pcr	O	_	_
Kit	27362	27365	NN	kit	O	_	_
(	27366	27367	CD	(	O	_	_
Qiagen	27367	27373	NNP	Qiagen	O	_	_
,	27373	27374	,	,	O	_	_
Hilden	27375	27381	NNP	Hilden	O	_	_
,	27381	27382	,	,	O	_	_
Germany	27383	27390	NNP	Germany	O	_	_
)	27390	27391	CD	)	O	_	_
.	27391	27392	.	.	O	_	_
D	1
12
2	0	amod
2	1	amod
2	5	dep
5	3	amod
5	4	amod
7	2	nsubjpass
7	6	auxpass
7	8	xcomp
8	11	dobj
11	9	nn
11	10	amod
12	7	dep
12	16	ccomp
12	30	nsubj
15	13	nn
15	14	nn
16	15	nsubj
16	19	prep_for
16	21	prep_for
16	27	prep_with
19	18	amod
19	21	conj_or
27	23	det
27	24	nn
27	25	nn
27	26	nn
30	28	nn
30	29	num
30	32	appos
32	34	appos
34	35	num
EOX
Y	1
ROOT	0	0	37	1	SINV	1	0	37	4	S	1	0	12	2	NP	0	0	6	2	NP	2	0	3	3	JJ	0	0	1	1	Quantitative	0	0	1	0	JJ	0	1	2	1	reverse	1	1	2	0	NN	0	2	3	1	transcription-PCR	2	2	3	0	NP	2	3	6	3	JJ	0	3	4	1	Real-time	3	3	4	0	JJ	0	4	5	1	reverse	4	4	5	0	NN	0	5	6	1	transcriptase-PCR	5	5	6	0	VP	1	6	12	2	VBD	0	6	7	1	was	6	6	7	0	VP	0	7	12	2	VBN	0	7	8	1	performed	7	7	8	0	S	0	8	12	1	VP	0	8	12	2	VBG	0	8	9	1	using	8	8	9	0	NP	2	9	12	3	NN	0	9	10	1	gene	9	9	10	0	JJ	0	10	11	1	specific	10	10	11	0	NNS	0	11	12	1	primers	11	11	12	0	VP	0	12	28	2	VBP	0	12	13	1	(	12	12	13	0	SBAR	0	13	28	1	S	1	13	28	2	NP	2	13	16	3	NNP	0	13	14	1	QuantiTect	13	13	14	0	NN	0	14	15	1	Primer	14	14	15	0	NNS	0	15	16	1	Assays	15	15	16	0	VP	0	16	28	3	VBP	0	16	17	1	)	16	16	17	0	PP	0	17	22	2	IN	0	17	18	1	for	17	17	18	0	NP	1	18	22	4	JJ	0	18	19	1	human	18	18	19	0	NN	0	19	20	1	ASPP2	19	19	20	0	CC	0	20	21	1	or	20	20	21	0	NN	0	21	22	1	GAPDH	21	21	22	0	PP	0	22	28	2	IN	0	22	23	1	with	22	22	23	0	NP	4	23	28	5	DT	0	23	24	1	the	23	23	24	0	NNP	0	24	25	1	QuantiTect	24	24	25	0	NNP	0	25	26	1	SYBR	25	25	26	0	NNP	0	26	27	1	Green	26	26	27	0	NN	0	27	28	1	RT-PCR	27	27	28	0	NP	0	28	36	3	NP	2	28	31	3	NN	0	28	29	1	Kit	28	28	29	0	CD	0	29	30	1	(	29	29	30	0	NNP	0	30	31	1	Qiagen	30	30	31	0	,	0	31	32	1	,	31	31	32	0	NP	0	32	36	3	NP	0	32	33	1	NNP	0	32	33	1	Hilden	32	32	33	0	,	0	33	34	1	,	33	33	34	0	NP	0	34	36	2	NNP	0	34	35	1	Germany	34	34	35	0	CD	0	35	36	1	)	35	35	36	0	.	0	36	37	1	.	36	36	37	0
EOS
T	12
Relative	27393	27401	JJ	relative	O	_	_
transcript	27402	27412	NN	transcript	O	_	_
levels	27413	27419	NNS	level	O	_	_
of	27420	27422	IN	of	O	_	_
ASPP2	27423	27428	NN	aspp2	B-GENE	_	_
were	27429	27433	VBD	be	O	_	_
normalized	27434	27444	VBN	normalize	O	_	_
to	27445	27447	TO	to	O	_	_
GAPDH	27448	27453	NN	gapdh	B-GENE	_	_
mRNA	27454	27458	NN	mrna	I-GENE	_	_
levels	27459	27465	NNS	level	O	_	_
.	27465	27466	.	.	O	_	_
D	1
6
2	0	amod
2	1	nn
2	4	prep_of
6	2	nsubjpass
6	5	auxpass
6	10	prep_to
10	8	nn
10	9	nn
EOX
Y	1
ROOT	0	0	12	1	S	1	0	12	3	NP	0	0	5	2	NP	2	0	3	3	JJ	0	0	1	1	Relative	0	0	1	0	NN	0	1	2	1	transcript	1	1	2	0	NNS	0	2	3	1	levels	2	2	3	0	PP	0	3	5	2	IN	0	3	4	1	of	3	3	4	0	NP	0	4	5	1	NN	0	4	5	1	ASPP2	4	4	5	0	VP	1	5	11	2	VBD	0	5	6	1	were	5	5	6	0	VP	0	6	11	2	VBN	0	6	7	1	normalized	6	6	7	0	PP	0	7	11	2	TO	0	7	8	1	to	7	7	8	0	NP	2	8	11	3	NN	0	8	9	1	GAPDH	8	8	9	0	NN	0	9	10	1	mRNA	9	9	10	0	NNS	0	10	11	1	levels	10	10	11	0	.	0	11	12	1	.	11	11	12	0
EOS
T	16
Statistical	27467	27478	JJ	statistical	O	_	_
analysis	27479	27487	NN	analysis	O	_	_
SPSS	27488	27492	NNS	spss	O	_	_
for	27493	27496	IN	for	O	_	_
Windows	27497	27504	NNP	Windows	O	_	_
(	27505	27506	CD	(	O	_	_
SPSS	27506	27510	NNP	SPSS	O	_	_
Inc.	27511	27515	NNP	Inc.	O	_	_
)	27515	27516	NN	)	O	_	_
was	27517	27520	VBD	be	O	_	_
used	27521	27525	VBN	use	O	_	_
to	27526	27528	TO	to	O	_	_
analyze	27529	27536	VB	analyze	O	_	_
the	27537	27540	DT	the	O	_	_
data	27541	27545	NNS	datum	O	_	_
.	27545	27546	.	.	O	_	_
D	1
10
2	0	amod
2	1	nn
2	4	prep_for
8	5	num
8	6	nn
8	7	nn
10	2	nsubjpass
10	8	nsubjpass
10	9	auxpass
10	12	xcomp
12	11	aux
12	14	dobj
14	13	det
EOX
Y	1
ROOT	0	0	16	1	S	2	0	16	4	NP	0	0	5	2	NP	2	0	3	3	JJ	0	0	1	1	Statistical	0	0	1	0	NN	0	1	2	1	analysis	1	1	2	0	NNS	0	2	3	1	SPSS	2	2	3	0	PP	0	3	5	2	IN	0	3	4	1	for	3	3	4	0	NP	0	4	5	1	NNP	0	4	5	1	Windows	4	4	5	0	NP	3	5	9	4	CD	0	5	6	1	(	5	5	6	0	NNP	0	6	7	1	SPSS	6	6	7	0	NNP	0	7	8	1	Inc.	7	7	8	0	NN	0	8	9	1	)	8	8	9	0	VP	1	9	15	2	VBD	0	9	10	1	was	9	9	10	0	VP	0	10	15	2	VBN	0	10	11	1	used	10	10	11	0	S	0	11	15	1	VP	1	11	15	2	TO	0	11	12	1	to	11	11	12	0	VP	0	12	15	2	VB	0	12	13	1	analyze	12	12	13	0	NP	1	13	15	2	DT	0	13	14	1	the	13	13	14	0	NNS	0	14	15	1	data	14	14	15	0	.	0	15	16	1	.	15	15	16	0
EOS
T	22
A	27547	27548	DT	a	O	_	_
two	27549	27552	CD	two	O	_	_
tailed	27553	27559	VBD	tail	O	_	_
unpaired	27560	27568	JJ	unpaired	O	_	_
t-test	27569	27575	NN	t-test	O	_	_
was	27576	27579	VBD	be	O	_	_
used	27580	27584	VBN	use	O	_	_
to	27585	27587	TO	to	O	_	_
compare	27588	27595	VB	compare	O	_	_
the	27596	27599	DT	the	O	_	_
statistical	27600	27611	JJ	statistical	O	_	_
significance	27612	27624	NN	significance	O	_	_
of	27625	27627	IN	of	O	_	_
the	27628	27631	DT	the	O	_	_
differences	27632	27643	NNS	difference	O	_	_
in	27644	27646	IN	in	O	_	_
data	27647	27651	NNS	datum	O	_	_
from	27652	27656	IN	from	O	_	_
the	27657	27660	DT	the	O	_	_
two	27661	27664	CD	two	O	_	_
groups	27665	27671	NNS	group	O	_	_
.	27671	27672	.	.	O	_	_
D	1
2
1	0	det
2	1	nsubj
2	6	ccomp
4	3	amod
6	4	nsubjpass
6	5	auxpass
6	8	xcomp
8	7	aux
8	11	dobj
8	20	prep_from
11	9	det
11	10	amod
11	14	prep_of
14	13	det
14	16	prep_in
20	18	det
20	19	num
EOX
Y	1
ROOT	0	0	22	1	S	1	0	22	3	NP	1	0	2	2	DT	0	0	1	1	A	0	0	1	0	CD	0	1	2	1	two	1	1	2	0	VP	0	2	21	2	VBD	0	2	3	1	tailed	2	2	3	0	SBAR	0	3	21	1	S	1	3	21	2	NP	1	3	5	2	JJ	0	3	4	1	unpaired	3	3	4	0	NN	0	4	5	1	t-test	4	4	5	0	VP	1	5	21	2	VBD	0	5	6	1	was	5	5	6	0	VP	0	6	21	2	VBN	0	6	7	1	used	6	6	7	0	S	0	7	21	1	VP	1	7	21	2	TO	0	7	8	1	to	7	7	8	0	VP	0	8	21	3	VB	0	8	9	1	compare	8	8	9	0	NP	0	9	17	2	NP	2	9	12	3	DT	0	9	10	1	the	9	9	10	0	JJ	0	10	11	1	statistical	10	10	11	0	NN	0	11	12	1	significance	11	11	12	0	PP	0	12	17	2	IN	0	12	13	1	of	12	12	13	0	NP	0	13	17	2	NP	1	13	15	2	DT	0	13	14	1	the	13	13	14	0	NNS	0	14	15	1	differences	14	14	15	0	PP	0	15	17	2	IN	0	15	16	1	in	15	15	16	0	NP	0	16	17	1	NNS	0	16	17	1	data	16	16	17	0	PP	0	17	21	2	IN	0	17	18	1	from	17	17	18	0	NP	2	18	21	3	DT	0	18	19	1	the	18	18	19	0	CD	0	19	20	1	two	19	19	20	0	NNS	0	20	21	1	groups	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	13
Supporting	27673	27683	VBG	support	O	_	_
Information	27684	27695	NN	information	B-GENE	_	_
p38	27706	27709	NN	p38	I-GENE	_	_
SAPK	27710	27714	NN	sapk	I-GENE	_	_
is	27715	27717	VBZ	be	O	_	_
not	27718	27721	RB	not	O	_	_
an	27722	27724	DT	a	O	_	_
efficient	27725	27734	JJ	efficient	O	_	_
kinase	27735	27741	NN	kinase	O	_	_
for	27742	27745	IN	for	O	_	_
ASPP2	27746	27751	NN	aspp2	B-GENE	_	_
phosphorylation	27752	27767	NN	phosphorylation	O	_	_
.	27767	27768	.	.	O	_	_
D	1
8
0	3	dobj
3	1	nn
3	2	nn
8	0	csubj
8	4	cop
8	5	neg
8	6	det
8	7	amod
8	11	prep_for
11	10	nn
EOX
Y	1
ROOT	0	0	13	1	S	1	0	13	3	S	0	0	4	1	VP	0	0	4	2	VBG	0	0	1	1	Supporting	0	0	1	0	NP	2	1	4	3	NN	0	1	2	1	Information	1	1	2	0	NN	0	2	3	1	p38	2	2	3	0	NN	0	3	4	1	SAPK	3	3	4	0	VP	2	4	12	3	VBZ	0	4	5	1	is	4	4	5	0	RB	0	5	6	1	not	5	5	6	0	NP	0	6	12	2	NP	2	6	9	3	DT	0	6	7	1	an	6	6	7	0	JJ	0	7	8	1	efficient	7	7	8	0	NN	0	8	9	1	kinase	8	8	9	0	PP	0	9	12	2	IN	0	9	10	1	for	9	9	10	0	NP	1	10	12	2	NN	0	10	11	1	ASPP2	10	10	11	0	NN	0	11	12	1	phosphorylation	11	11	12	0	.	0	12	13	1	.	12	12	13	0
EOS
T	22
ASPP2	27769	27774	NN	aspp2	O	_	_
(	27775	27776	CD	(	O	_	_
693-1128	27776	27784	CD	693-1128	O	_	_
)	27784	27785	NN	)	O	_	_
fragment	27786	27794	NN	fragment	O	_	_
was	27795	27798	VBD	be	O	_	_
used	27799	27803	VBN	use	O	_	_
as	27804	27806	IN	as	O	_	_
a	27807	27808	DT	a	O	_	_
substrate	27809	27818	NN	substrate	O	_	_
for	27819	27822	IN	for	O	_	_
an	27823	27825	DT	a	O	_	_
in	27826	27828	FW	in	O	_	_
vitro	27829	27834	FW	vitro	O	_	_
phosphorylation	27835	27850	NN	phosphorylation	O	_	_
assay	27851	27856	NN	assay	O	_	_
by	27857	27859	IN	by	O	_	_
the	27860	27863	DT	the	O	_	_
kinase	27864	27870	NN	kinase	O	_	_
p38	27871	27874	NN	p38	B-GENE	_	_
SAPK	27875	27879	NN	sapk	O	_	_
.	27879	27880	.	.	O	_	_
D	1
6
0	1	num
0	4	dep
4	2	num
4	3	nn
6	0	nsubjpass
6	5	auxpass
6	9	prep_as
9	8	det
9	20	prep_for
13	12	nn
13	16	dep
15	14	nn
16	15	dep
16	19	pobj
19	17	det
19	18	nn
20	11	det
20	13	dep
EOX
Y	1
ROOT	0	0	22	1	S	1	0	22	3	NP	0	0	5	2	NP	0	0	2	2	NN	0	0	1	1	ASPP2	0	0	1	0	CD	0	1	2	1	(	1	1	2	0	NP	2	2	5	3	CD	0	2	3	1	693-1128	2	2	3	0	NN	0	3	4	1	)	3	3	4	0	NN	0	4	5	1	fragment	4	4	5	0	VP	1	5	21	2	VBD	0	5	6	1	was	5	5	6	0	VP	0	6	21	2	VBN	0	6	7	1	used	6	6	7	0	PP	0	7	21	2	IN	0	7	8	1	as	7	7	8	0	NP	0	8	21	2	NP	1	8	10	2	DT	0	8	9	1	a	8	8	9	0	NN	0	9	10	1	substrate	9	9	10	0	PP	0	10	21	2	IN	0	10	11	1	for	10	10	11	0	NP	2	11	21	3	DT	0	11	12	1	an	11	11	12	0	UCP	0	12	20	2	ADVP	1	12	14	2	FW	0	12	13	1	in	12	12	13	0	FW	0	13	14	1	vitro	13	13	14	0	PP	1	14	20	2	NP	1	14	16	2	NN	0	14	15	1	phosphorylation	14	14	15	0	NN	0	15	16	1	assay	15	15	16	0	PP	0	16	20	2	IN	0	16	17	1	by	16	16	17	0	NP	2	17	20	3	DT	0	17	18	1	the	17	17	18	0	NN	0	18	19	1	kinase	18	18	19	0	NN	0	19	20	1	p38	19	19	20	0	NN	0	20	21	1	SAPK	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	19
As	27881	27883	IN	as	O	_	_
a	27884	27885	DT	a	O	_	_
negative	27886	27894	JJ	negative	O	_	_
control	27895	27902	NN	control	O	_	_
no	27903	27905	DT	no	O	_	_
substrate	27906	27915	NN	substrate	O	_	_
was	27916	27919	VBD	be	O	_	_
used	27920	27924	VBN	use	O	_	_
and	27925	27928	CC	and	O	_	_
Histone	27929	27936	NN	histone	O	_	_
2B	27937	27939	NN	2b	O	_	_
was	27940	27943	VBD	be	O	_	_
the	27944	27947	DT	the	O	_	_
substrate	27948	27957	NN	substrate	O	_	_
for	27958	27961	IN	for	O	_	_
the	27962	27965	DT	the	O	_	_
positive	27966	27974	JJ	positive	O	_	_
control	27975	27982	NN	control	O	_	_
.	27982	27983	.	.	O	_	_
D	1
7
3	1	det
3	2	amod
5	4	det
7	3	prep_as
7	5	nsubjpass
7	6	auxpass
7	13	conj_and
10	9	nn
13	10	nsubj
13	11	cop
13	12	det
13	17	prep_for
17	15	det
17	16	amod
EOX
Y	1
ROOT	0	0	19	1	S	0	0	19	4	S	2	0	8	3	PP	0	0	4	2	IN	0	0	1	1	As	0	0	1	0	NP	2	1	4	3	DT	0	1	2	1	a	1	1	2	0	JJ	0	2	3	1	negative	2	2	3	0	NN	0	3	4	1	control	3	3	4	0	NP	1	4	6	2	DT	0	4	5	1	no	4	4	5	0	NN	0	5	6	1	substrate	5	5	6	0	VP	1	6	8	2	VBD	0	6	7	1	was	6	6	7	0	VP	0	7	8	1	VBN	0	7	8	1	used	7	7	8	0	CC	0	8	9	1	and	8	8	9	0	S	1	9	18	2	NP	1	9	11	2	NN	0	9	10	1	Histone	9	9	10	0	NN	0	10	11	1	2B	10	10	11	0	VP	1	11	18	2	VBD	0	11	12	1	was	11	11	12	0	NP	0	12	18	2	NP	1	12	14	2	DT	0	12	13	1	the	12	12	13	0	NN	0	13	14	1	substrate	13	13	14	0	PP	0	14	18	2	IN	0	14	15	1	for	14	14	15	0	NP	2	15	18	3	DT	0	15	16	1	the	15	15	16	0	JJ	0	16	17	1	positive	16	16	17	0	NN	0	17	18	1	control	17	17	18	0	.	0	18	19	1	.	18	18	19	0
EOS
T	23
32P	27984	27987	NN	32p	O	_	_
labelled	27988	27996	VBN	label	O	_	_
ATP	27997	28000	NN	atp	O	_	_
was	28001	28004	VBD	be	O	_	_
added	28005	28010	VBN	add	O	_	_
to	28011	28013	TO	to	O	_	_
the	28014	28017	DT	the	O	_	_
kinase	28018	28024	NN	kinase	O	_	_
assay	28025	28030	NN	assay	O	_	_
and	28031	28034	CC	and	O	_	_
the	28035	28038	DT	the	O	_	_
labelled	28039	28047	JJ	labelled	O	_	_
proteins	28048	28056	NNS	protein	O	_	_
were	28057	28061	VBD	be	O	_	_
resolved	28062	28070	VBN	resolve	O	_	_
on	28071	28073	IN	on	O	_	_
SDS-PAGE	28074	28082	NN	sds-page	O	_	_
gels	28083	28087	NNS	gel	O	_	_
and	28088	28091	CC	and	O	_	_
visualized	28092	28102	VBN	visualize	O	_	_
by	28103	28105	IN	by	O	_	_
autoradiograph	28106	28120	NN	autoradiograph	O	_	_
.	28120	28121	.	.	O	_	_
D	1
4
0	1	vmod
1	2	dobj
4	0	nsubjpass
4	3	auxpass
4	8	prep_to
4	14	conj_and
4	19	conj_and
8	6	det
8	7	nn
12	10	det
12	11	amod
14	12	nsubjpass
14	13	auxpass
14	17	prep_on
14	19	conj_and
17	16	nn
19	12	nsubjpass
19	21	prep_by
EOX
Y	1
ROOT	0	0	23	1	S	0	0	23	4	S	1	0	9	2	NP	0	0	3	2	NP	0	0	1	1	NN	0	0	1	1	32P	0	0	1	0	VP	0	1	3	2	VBN	0	1	2	1	labelled	1	1	2	0	NP	0	2	3	1	NN	0	2	3	1	ATP	2	2	3	0	VP	1	3	9	2	VBD	0	3	4	1	was	3	3	4	0	VP	0	4	9	2	VBN	0	4	5	1	added	4	4	5	0	PP	0	5	9	2	TO	0	5	6	1	to	5	5	6	0	NP	2	6	9	3	DT	0	6	7	1	the	6	6	7	0	NN	0	7	8	1	kinase	7	7	8	0	NN	0	8	9	1	assay	8	8	9	0	CC	0	9	10	1	and	9	9	10	0	S	1	10	22	2	NP	2	10	13	3	DT	0	10	11	1	the	10	10	11	0	JJ	0	11	12	1	labelled	11	11	12	0	NNS	0	12	13	1	proteins	12	12	13	0	VP	1	13	22	2	VBD	0	13	14	1	were	13	13	14	0	VP	0	14	22	3	VP	0	14	18	2	VBN	0	14	15	1	resolved	14	14	15	0	PP	0	15	18	2	IN	0	15	16	1	on	15	15	16	0	NP	1	16	18	2	NN	0	16	17	1	SDS-PAGE	16	16	17	0	NNS	0	17	18	1	gels	17	17	18	0	CC	0	18	19	1	and	18	18	19	0	VP	0	19	22	2	VBN	0	19	20	1	visualized	19	19	20	0	PP	0	20	22	2	IN	0	20	21	1	by	20	20	21	0	NP	0	21	22	1	NN	0	21	22	1	autoradiograph	21	21	22	0	.	0	22	23	1	.	22	22	23	0
EOS
T	10
(	28122	28123	NN	(	B-GENE	_	_
TIF	28123	28126	NN	tif	I-GENE	_	_
)	28126	28127	CD	)	O	_	_
Click	28128	28133	VB	click	O	_	_
here	28134	28138	RB	here	O	_	_
for	28139	28142	IN	for	O	_	_
additional	28143	28153	JJ	additional	O	_	_
data	28154	28158	NNS	datum	O	_	_
file	28159	28163	NN	file	O	_	_
.	28163	28164	.	.	O	_	_
D	1
8
1	0	nn
1	3	rcmod
3	2	nsubj
3	4	advmod
3	7	prep_for
7	6	amod
8	1	nsubj
EOX
Y	1
ROOT	0	0	10	1	S	1	0	10	3	NP	0	0	8	2	NP	1	0	2	2	NN	0	0	1	1	(	0	0	1	0	NN	0	1	2	1	TIF	1	1	2	0	SBAR	0	2	8	1	S	1	2	8	2	NP	0	2	3	1	CD	0	2	3	1	)	2	2	3	0	VP	0	3	8	3	VB	0	3	4	1	Click	3	3	4	0	ADVP	0	4	5	1	RB	0	4	5	1	here	4	4	5	0	PP	0	5	8	2	IN	0	5	6	1	for	5	5	6	0	NP	1	6	8	2	JJ	0	6	7	1	additional	6	6	7	0	NNS	0	7	8	1	data	7	7	8	0	VP	0	8	9	1	NN	0	8	9	1	file	8	8	9	0	.	0	9	10	1	.	9	9	10	0
EOS
T	14
Phosphorylation	28175	28190	NN	phosphorylation	O	_	_
of	28191	28193	IN	of	O	_	_
ASPP2	28194	28199	NN	aspp2	B-GENE	_	_
by	28200	28202	IN	by	O	_	_
the	28203	28206	DT	the	O	_	_
Raf	28207	28210	NN	raf	B-GENE	_	_
/	28210	28211	:	/	B-GENE	_	_
MAPK	28211	28215	NN	mapk	I-GENE	_	_
pathway	28216	28223	NN	pathway	O	_	_
enhances	28224	28232	VBZ	enhance	O	_	_
p53	28233	28236	NN	p53	B-GENE	_	_
mediated	28237	28245	JJ	mediated	O	_	_
transactivation	28246	28261	NN	transactivation	O	_	_
.	28261	28262	.	.	O	_	_
D	1
0
0	2	prep_of
0	5	prep_by
0	6	punct
0	9	dep
5	4	det
8	7	nn
9	8	nsubj
9	12	dobj
12	10	nn
12	11	amod
EOX
Y	1
ROOT	0	0	14	1	FRAG	0	0	14	4	NP	0	0	6	3	NP	0	0	1	1	NN	0	0	1	1	Phosphorylation	0	0	1	0	PP	0	1	3	2	IN	0	1	2	1	of	1	1	2	0	NP	0	2	3	1	NN	0	2	3	1	ASPP2	2	2	3	0	PP	0	3	6	2	IN	0	3	4	1	by	3	3	4	0	NP	1	4	6	2	DT	0	4	5	1	the	4	4	5	0	NN	0	5	6	1	Raf	5	5	6	0	:	0	6	7	1	/	6	6	7	0	S	1	7	13	2	NP	1	7	9	2	NN	0	7	8	1	MAPK	7	7	8	0	NN	0	8	9	1	pathway	8	8	9	0	VP	0	9	13	2	VBZ	0	9	10	1	enhances	9	9	10	0	NP	2	10	13	3	NN	0	10	11	1	p53	10	10	11	0	JJ	0	11	12	1	mediated	11	11	12	0	NN	0	12	13	1	transactivation	12	12	13	0	.	0	13	14	1	.	13	13	14	0
EOS
T	25
Saos2	28263	28268	NN	saos2	O	_	_
cells	28269	28274	NNS	cell	O	_	_
were	28275	28279	VBD	be	O	_	_
transfected	28280	28291	VBN	transfect	O	_	_
with	28292	28296	IN	with	O	_	_
a	28297	28298	DT	a	O	_	_
Bax-luciferase	28299	28313	NN	bax-luciferase	B-GENE	_	_
reporter	28314	28322	NN	reporter	I-GENE	_	_
,	28322	28323	,	,	O	_	_
ASPP2	28324	28329	NN	aspp2	B-GENE	_	_
and	28330	28333	CC	and	O	_	_
p53	28334	28337	NN	p53	B-GENE	_	_
and	28338	28341	CC	and	O	_	_
treated	28342	28349	VBN	treat	O	_	_
with	28350	28354	IN	with	O	_	_
100	28355	28358	CD	100	O	_	_
muM	28359	28362	NN	mum	O	_	_
PD	28363	28365	NN	pd	O	_	_
98059	28366	28371	CD	98059	O	_	_
or	28372	28374	CC	or	O	_	_
DMSO	28375	28379	NN	dmso	O	_	_
for	28380	28383	IN	for	O	_	_
20	28384	28386	CD	20	O	_	_
hours	28387	28392	NNS	hour	O	_	_
.	28392	28393	.	.	O	_	_
D	1
3
1	0	nn
3	1	nsubjpass
3	2	auxpass
3	7	prep_with
3	9	prep_with
3	11	prep_with
3	13	conj_and
7	5	det
7	6	nn
7	9	conj_and
7	11	conj_and
13	1	nsubjpass
13	17	prep_with
13	20	prep_with
17	15	num
17	16	nn
17	18	dep
17	20	conj_or
20	23	prep_for
23	22	num
EOX
Y	1
ROOT	0	0	25	1	S	1	0	25	3	NP	1	0	2	2	NN	0	0	1	1	Saos2	0	0	1	0	NNS	0	1	2	1	cells	1	1	2	0	VP	1	2	24	2	VBD	0	2	3	1	were	2	2	3	0	VP	0	3	24	3	VP	0	3	12	2	VBN	0	3	4	1	transfected	3	3	4	0	PP	0	4	12	2	IN	0	4	5	1	with	4	4	5	0	NP	2	5	12	7	DT	0	5	6	1	a	5	5	6	0	NN	0	6	7	1	Bax-luciferase	6	6	7	0	NN	0	7	8	1	reporter	7	7	8	0	,	0	8	9	1	,	8	8	9	0	NN	0	9	10	1	ASPP2	9	9	10	0	CC	0	10	11	1	and	10	10	11	0	NN	0	11	12	1	p53	11	11	12	0	CC	0	12	13	1	and	12	12	13	0	VP	0	13	24	2	VBN	0	13	14	1	treated	13	13	14	0	PP	0	14	24	2	IN	0	14	15	1	with	14	14	15	0	NP	0	15	24	3	NP	0	15	19	2	NP	2	15	18	3	CD	0	15	16	1	100	15	15	16	0	NN	0	16	17	1	muM	16	16	17	0	NN	0	17	18	1	PD	17	17	18	0	NP	0	18	19	1	CD	0	18	19	1	98059	18	18	19	0	CC	0	19	20	1	or	19	19	20	0	NP	0	20	24	2	NP	0	20	21	1	NN	0	20	21	1	DMSO	20	20	21	0	PP	0	21	24	2	IN	0	21	22	1	for	21	21	22	0	NP	1	22	24	2	CD	0	22	23	1	20	22	22	23	0	NNS	0	23	24	1	hours	23	23	24	0	.	0	24	25	1	.	24	24	25	0
EOS
T	9
The	28394	28397	DT	the	O	_	_
cells	28398	28403	NNS	cell	O	_	_
were	28404	28408	VBD	be	O	_	_
harvested	28409	28418	VBN	harvest	O	_	_
,	28418	28419	,	,	O	_	_
luciferase	28420	28430	NN	luciferase	B-GENE	_	_
activity	28431	28439	NN	activity	O	_	_
shown	28440	28445	VBN	show	O	_	_
.	28445	28446	.	.	O	_	_
D	1
3
1	0	det
3	1	nsubjpass
3	2	auxpass
3	6	dobj
6	5	nn
6	7	vmod
EOX
Y	1
ROOT	0	0	9	1	S	1	0	9	3	NP	1	0	2	2	DT	0	0	1	1	The	0	0	1	0	NNS	0	1	2	1	cells	1	1	2	0	VP	1	2	8	2	VBD	0	2	3	1	were	2	2	3	0	VP	0	3	8	3	VBN	0	3	4	1	harvested	3	3	4	0	,	0	4	5	1	,	4	4	5	0	NP	0	5	8	2	NP	1	5	7	2	NN	0	5	6	1	luciferase	5	5	6	0	NN	0	6	7	1	activity	6	6	7	0	VP	0	7	8	1	VBN	0	7	8	1	shown	7	7	8	0	.	0	8	9	1	.	8	8	9	0
EOS
T	10
(	28447	28448	NN	(	B-GENE	_	_
TIF	28448	28451	NN	tif	I-GENE	_	_
)	28451	28452	CD	)	O	_	_
Click	28453	28458	VB	click	O	_	_
here	28459	28463	RB	here	O	_	_
for	28464	28467	IN	for	O	_	_
additional	28468	28478	JJ	additional	O	_	_
data	28479	28483	NNS	datum	O	_	_
file	28484	28488	NN	file	O	_	_
.	28488	28489	.	.	O	_	_
D	1
8
1	0	nn
1	3	rcmod
3	2	nsubj
3	4	advmod
3	7	prep_for
7	6	amod
8	1	nsubj
EOX
Y	1
ROOT	0	0	10	1	S	1	0	10	3	NP	0	0	8	2	NP	1	0	2	2	NN	0	0	1	1	(	0	0	1	0	NN	0	1	2	1	TIF	1	1	2	0	SBAR	0	2	8	1	S	1	2	8	2	NP	0	2	3	1	CD	0	2	3	1	)	2	2	3	0	VP	0	3	8	3	VB	0	3	4	1	Click	3	3	4	0	ADVP	0	4	5	1	RB	0	4	5	1	here	4	4	5	0	PP	0	5	8	2	IN	0	5	6	1	for	5	5	6	0	NP	1	6	8	2	JJ	0	6	7	1	additional	6	6	7	0	NNS	0	7	8	1	data	7	7	8	0	VP	0	8	9	1	NN	0	8	9	1	file	8	8	9	0	.	0	9	10	1	.	9	9	10	0
EOS
T	5
Oncogenic	28500	28509	JJ	oncogenic	O	_	_
RAS	28510	28513	NN	ra	O	_	_
stabilizes	28514	28524	VBZ	stabilize	O	_	_
ASPP2	28525	28530	NN	aspp2	B-GENE	_	_
.	28530	28531	.	.	O	_	_
D	1
2
1	0	amod
2	1	nsubj
2	3	dobj
EOX
Y	1
ROOT	0	0	5	1	S	1	0	5	3	NP	1	0	2	2	JJ	0	0	1	1	Oncogenic	0	0	1	0	NN	0	1	2	1	RAS	1	1	2	0	VP	0	2	4	2	VBZ	0	2	3	1	stabilizes	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	ASPP2	3	3	4	0	.	0	4	5	1	.	4	4	5	0
EOS
T	20
(	28532	28533	NN	(	O	_	_
A	28533	28534	NN	a	O	_	_
)	28534	28535	CD	)	O	_	_
Quantitative	28536	28548	JJ	quantitative	O	_	_
RT-PCR	28549	28555	NN	rt-pcr	O	_	_
analysis	28556	28564	NN	analysis	O	_	_
of	28565	28567	IN	of	O	_	_
ASPP2	28568	28573	NN	aspp2	B-GENE	_	_
mRNA	28574	28578	NN	mrna	I-GENE	_	_
levels	28579	28585	NNS	level	O	_	_
in	28586	28588	IN	in	O	_	_
HKe3	28589	28593	NN	hke3	B-GENE	_	_
ER	28594	28596	NN	er	I-GENE	_	_
:	28596	28597	:	:	O	_	_
HRASV12	28597	28604	NN	hrasv12	O	_	_
cells	28605	28610	NNS	cell	O	_	_
with	28611	28615	IN	with	O	_	_
indicated	28616	28625	JJ	indicated	O	_	_
treatment	28626	28635	NN	treatment	O	_	_
.	28635	28636	.	.	O	_	_
D	1
1
1	0	nn
1	5	dep
1	15	dep
5	2	num
5	3	amod
5	4	nn
5	9	prep_of
9	7	nn
9	8	nn
9	12	prep_in
12	11	nn
15	14	nn
15	18	prep_with
18	17	amod
EOX
Y	1
ROOT	0	0	20	1	NP	0	0	20	4	NP	0	0	13	2	NP	1	0	2	2	NN	0	0	1	1	(	0	0	1	0	NN	0	1	2	1	A	1	1	2	0	NP	0	2	13	2	NP	3	2	6	4	CD	0	2	3	1	)	2	2	3	0	JJ	0	3	4	1	Quantitative	3	3	4	0	NN	0	4	5	1	RT-PCR	4	4	5	0	NN	0	5	6	1	analysis	5	5	6	0	PP	0	6	13	2	IN	0	6	7	1	of	6	6	7	0	NP	0	7	13	2	NP	2	7	10	3	NN	0	7	8	1	ASPP2	7	7	8	0	NN	0	8	9	1	mRNA	8	8	9	0	NNS	0	9	10	1	levels	9	9	10	0	PP	0	10	13	2	IN	0	10	11	1	in	10	10	11	0	NP	1	11	13	2	NN	0	11	12	1	HKe3	11	11	12	0	NN	0	12	13	1	ER	12	12	13	0	:	0	13	14	1	:	13	13	14	0	NP	0	14	19	2	NP	1	14	16	2	NN	0	14	15	1	HRASV12	14	14	15	0	NNS	0	15	16	1	cells	15	15	16	0	PP	0	16	19	2	IN	0	16	17	1	with	16	16	17	0	NP	1	17	19	2	JJ	0	17	18	1	indicated	17	17	18	0	NN	0	18	19	1	treatment	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	26
(	28637	28638	NN	(	O	_	_
B	28638	28639	NN	b	O	_	_
)	28639	28640	CD	)	O	_	_
HKe3	28641	28645	NN	hke3	B-GENE	_	_
ER	28646	28648	NN	er	O	_	_
:	28648	28649	:	:	O	_	_
HRASV12	28649	28656	NN	hrasv12	O	_	_
cells	28657	28662	NNS	cell	O	_	_
were	28663	28667	VBD	be	O	_	_
transfected	28668	28679	VBN	transfect	O	_	_
with	28680	28684	IN	with	O	_	_
ASPP2	28685	28690	NN	aspp2	B-GENE	_	_
wild-type	28691	28700	JJ	wild-type	I-GENE	_	_
(	28701	28702	NN	(	I-GENE	_	_
wt	28702	28704	JJ	wt	I-GENE	_	_
)	28704	28705	NN	)	I-GENE	_	_
expression	28706	28716	NN	expression	O	_	_
plasmid	28717	28724	NN	plasmid	O	_	_
in	28725	28727	IN	in	O	_	_
the	28728	28731	DT	the	O	_	_
presence	28732	28740	NN	presence	O	_	_
or	28741	28743	CC	or	O	_	_
absence	28744	28751	NN	absence	O	_	_
of	28752	28754	IN	of	O	_	_
4-OHT	28755	28760	NN	4-oht	O	_	_
.	28760	28761	.	.	O	_	_
D	1
1
1	0	nn
1	4	dep
1	7	dep
4	2	num
4	3	nn
7	6	nn
7	9	rcmod
9	8	auxpass
9	13	prep_with
9	20	prep_in
9	22	prep_in
13	11	nn
13	12	amod
13	17	dep
17	14	amod
17	15	nn
17	16	nn
20	19	det
20	22	conj_or
20	24	prep_of
EOX
Y	1
ROOT	0	0	26	1	NP	0	0	26	4	NP	0	0	5	2	NP	1	0	2	2	NN	0	0	1	1	(	0	0	1	0	NN	0	1	2	1	B	1	1	2	0	NP	2	2	5	3	CD	0	2	3	1	)	2	2	3	0	NN	0	3	4	1	HKe3	3	3	4	0	NN	0	4	5	1	ER	4	4	5	0	:	0	5	6	1	:	5	5	6	0	NP	0	6	25	2	NP	1	6	8	2	NN	0	6	7	1	HRASV12	6	6	7	0	NNS	0	7	8	1	cells	7	7	8	0	SBAR	0	8	25	1	S	0	8	25	1	VP	1	8	25	2	VBD	0	8	9	1	were	8	8	9	0	VP	0	9	25	3	VBN	0	9	10	1	transfected	9	9	10	0	PP	0	10	18	2	IN	0	10	11	1	with	10	10	11	0	NP	0	11	18	2	NP	2	11	14	3	NN	0	11	12	1	ASPP2	11	11	12	0	JJ	0	12	13	1	wild-type	12	12	13	0	NN	0	13	14	1	(	13	13	14	0	NP	3	14	18	4	JJ	0	14	15	1	wt	14	14	15	0	NN	0	15	16	1	)	15	15	16	0	NN	0	16	17	1	expression	16	16	17	0	NN	0	17	18	1	plasmid	17	17	18	0	PP	0	18	25	2	IN	0	18	19	1	in	18	18	19	0	NP	0	19	25	2	NP	1	19	23	4	DT	0	19	20	1	the	19	19	20	0	NN	0	20	21	1	presence	20	20	21	0	CC	0	21	22	1	or	21	21	22	0	NN	0	22	23	1	absence	22	22	23	0	PP	0	23	25	2	IN	0	23	24	1	of	23	23	24	0	NP	0	24	25	1	NN	0	24	25	1	4-OHT	24	24	25	0	.	0	25	26	1	.	25	25	26	0
EOS
T	23
16	28762	28764	CD	16	O	_	_
hours	28765	28770	NNS	hour	O	_	_
after	28771	28776	IN	after	O	_	_
transfection	28777	28789	NN	transfection	O	_	_
,	28789	28790	,	,	O	_	_
10	28791	28793	CD	10	O	_	_
mug	28794	28797	NN	mug	O	_	_
/	28797	28798	:	/	O	_	_
ml	28798	28800	NN	ml	O	_	_
cycloheximide	28801	28814	NN	cycloheximide	O	_	_
(	28815	28816	CD	(	O	_	_
CHX	28816	28819	NN	chx	O	_	_
)	28819	28820	NN	)	O	_	_
was	28821	28824	VBD	be	O	_	_
added	28825	28830	VBN	add	O	_	_
to	28831	28833	TO	to	O	_	_
the	28834	28837	DT	the	O	_	_
cells	28838	28843	NNS	cell	O	_	_
for	28844	28847	IN	for	O	_	_
the	28848	28851	DT	the	O	_	_
time	28852	28856	NN	time	O	_	_
indicated	28857	28866	VBD	indicate	O	_	_
.	28866	28867	.	.	O	_	_
D	1
1
1	0	num
1	3	prep_after
1	7	punct
1	21	dep
3	6	appos
6	5	num
9	8	nn
9	14	rcmod
12	10	num
12	11	nn
14	12	nsubjpass
14	13	auxpass
14	17	prep_to
17	16	det
17	20	prep_for
20	19	det
21	9	nsubj
EOX
Y	1
ROOT	0	0	23	1	FRAG	0	0	23	4	NP	0	0	7	2	NP	1	0	2	2	CD	0	0	1	1	16	0	0	1	0	NNS	0	1	2	1	hours	1	1	2	0	PP	0	2	7	2	IN	0	2	3	1	after	2	2	3	0	NP	0	3	7	3	NP	0	3	4	1	NN	0	3	4	1	transfection	3	3	4	0	,	0	4	5	1	,	4	4	5	0	NP	1	5	7	2	CD	0	5	6	1	10	5	5	6	0	NN	0	6	7	1	mug	6	6	7	0	:	0	7	8	1	/	7	7	8	0	S	1	8	22	2	NP	0	8	21	2	NP	1	8	10	2	NN	0	8	9	1	ml	8	8	9	0	NN	0	9	10	1	cycloheximide	9	9	10	0	SBAR	0	10	21	1	S	1	10	21	2	NP	2	10	13	3	CD	0	10	11	1	(	10	10	11	0	NN	0	11	12	1	CHX	11	11	12	0	NN	0	12	13	1	)	12	12	13	0	VP	1	13	21	2	VBD	0	13	14	1	was	13	13	14	0	VP	0	14	21	2	VBN	0	14	15	1	added	14	14	15	0	PP	0	15	21	2	TO	0	15	16	1	to	15	15	16	0	NP	0	16	21	2	NP	1	16	18	2	DT	0	16	17	1	the	16	16	17	0	NNS	0	17	18	1	cells	17	17	18	0	PP	0	18	21	2	IN	0	18	19	1	for	18	18	19	0	NP	1	19	21	2	DT	0	19	20	1	the	19	19	20	0	NN	0	20	21	1	time	20	20	21	0	VP	0	21	22	1	VBD	0	21	22	1	indicated	21	21	22	0	.	0	22	23	1	.	22	22	23	0
EOS
T	12
The	28868	28871	DT	the	O	_	_
protein	28872	28879	NN	protein	O	_	_
levels	28880	28886	NNS	level	O	_	_
of	28887	28889	IN	of	O	_	_
V5-ASPP2	28890	28898	NN	v5-aspp2	O	_	_
were	28899	28903	VBD	be	O	_	_
determined	28904	28914	VBN	determine	O	_	_
by	28915	28917	IN	by	O	_	_
western	28918	28925	NN	western	O	_	_
blot	28926	28930	NN	blot	O	_	_
analysis	28931	28939	NN	analysis	O	_	_
.	28939	28940	.	.	O	_	_
D	1
6
2	0	det
2	1	nn
2	4	prep_of
6	2	nsubjpass
6	5	auxpass
6	10	agent
10	8	nn
10	9	nn
EOX
Y	1
ROOT	0	0	12	1	S	1	0	12	3	NP	0	0	5	2	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	protein	1	1	2	0	NNS	0	2	3	1	levels	2	2	3	0	PP	0	3	5	2	IN	0	3	4	1	of	3	3	4	0	NP	0	4	5	1	NN	0	4	5	1	V5-ASPP2	4	4	5	0	VP	1	5	11	2	VBD	0	5	6	1	were	5	5	6	0	VP	0	6	11	2	VBN	0	6	7	1	determined	6	6	7	0	PP	0	7	11	2	IN	0	7	8	1	by	7	7	8	0	NP	2	8	11	3	NN	0	8	9	1	western	8	8	9	0	NN	0	9	10	1	blot	9	9	10	0	NN	0	10	11	1	analysis	10	10	11	0	.	0	11	12	1	.	11	11	12	0
EOS
T	8
beta-Tubulin	28941	28953	NN	beta-tubulin	B-GENE	_	_
was	28954	28957	VBD	be	O	_	_
used	28958	28962	VBN	use	O	_	_
as	28963	28965	IN	as	O	_	_
a	28966	28967	DT	a	O	_	_
loading	28968	28975	VBG	load	O	_	_
control	28976	28983	NN	control	O	_	_
.	28983	28984	.	.	O	_	_
D	1
2
2	0	nsubjpass
2	1	auxpass
2	6	prep_as
6	4	det
6	5	amod
EOX
Y	1
ROOT	0	0	8	1	S	1	0	8	3	NP	0	0	1	1	NN	0	0	1	1	beta-Tubulin	0	0	1	0	VP	1	1	7	2	VBD	0	1	2	1	was	1	1	2	0	VP	0	2	7	2	VBN	0	2	3	1	used	2	2	3	0	PP	0	3	7	2	IN	0	3	4	1	as	3	3	4	0	NP	2	4	7	3	DT	0	4	5	1	a	4	4	5	0	VBG	0	5	6	1	loading	5	5	6	0	NN	0	6	7	1	control	6	6	7	0	.	0	7	8	1	.	7	7	8	0
EOS
T	23
(	28985	28986	NN	(	O	_	_
C	28986	28987	NN	c	O	_	_
)	28987	28988	CD	)	O	_	_
Saos2	28989	28994	NN	saos2	O	_	_
cells	28995	29000	NNS	cell	O	_	_
were	29001	29005	VBD	be	O	_	_
transfected	29006	29017	VBN	transfect	O	_	_
with	29018	29022	IN	with	O	_	_
ASPP2	29023	29028	NN	aspp2	B-GENE	_	_
wt	29029	29031	JJ	wt	O	_	_
expression	29032	29042	NN	expression	O	_	_
plasmid	29043	29050	NN	plasmid	O	_	_
in	29051	29053	IN	in	O	_	_
the	29054	29057	DT	the	O	_	_
presence	29058	29066	NN	presence	O	_	_
or	29067	29069	CC	or	O	_	_
absence	29070	29077	NN	absence	O	_	_
of	29078	29080	IN	of	O	_	_
co	29081	29083	NN	co	O	_	_
transfected	29084	29095	VBN	transfect	O	_	_
HRAS	29096	29100	NNP	HRAS	O	_	_
V12	29101	29104	NN	v12	O	_	_
.	29104	29105	.	.	O	_	_
D	1
6
4	0	nn
4	1	nn
4	2	num
4	3	nn
6	4	nsubjpass
6	5	auxpass
6	11	prep_with
6	14	prep_in
6	16	prep_in
11	8	nn
11	9	amod
11	10	nn
14	13	det
14	16	conj_or
14	18	prep_of
18	19	vmod
19	21	dobj
21	20	nn
EOX
Y	1
ROOT	0	0	23	1	S	1	0	23	3	NP	4	0	5	5	NN	0	0	1	1	(	0	0	1	0	NN	0	1	2	1	C	1	1	2	0	CD	0	2	3	1	)	2	2	3	0	NN	0	3	4	1	Saos2	3	3	4	0	NNS	0	4	5	1	cells	4	4	5	0	VP	1	5	22	2	VBD	0	5	6	1	were	5	5	6	0	VP	0	6	22	3	VBN	0	6	7	1	transfected	6	6	7	0	PP	0	7	12	2	IN	0	7	8	1	with	7	7	8	0	NP	3	8	12	4	NN	0	8	9	1	ASPP2	8	8	9	0	JJ	0	9	10	1	wt	9	9	10	0	NN	0	10	11	1	expression	10	10	11	0	NN	0	11	12	1	plasmid	11	11	12	0	PP	0	12	22	2	IN	0	12	13	1	in	12	12	13	0	NP	0	13	22	2	NP	1	13	17	4	DT	0	13	14	1	the	13	13	14	0	NN	0	14	15	1	presence	14	14	15	0	CC	0	15	16	1	or	15	15	16	0	NN	0	16	17	1	absence	16	16	17	0	PP	0	17	22	2	IN	0	17	18	1	of	17	17	18	0	NP	0	18	22	2	NP	0	18	19	1	NN	0	18	19	1	co	18	18	19	0	VP	0	19	22	2	VBN	0	19	20	1	transfected	19	19	20	0	NP	1	20	22	2	NNP	0	20	21	1	HRAS	20	20	21	0	NN	0	21	22	1	V12	21	21	22	0	.	0	22	23	1	.	22	22	23	0
EOS
T	20
16	29106	29108	CD	16	O	_	_
hours	29109	29114	NNS	hour	O	_	_
after	29115	29120	IN	after	O	_	_
transfection	29121	29133	NN	transfection	O	_	_
,	29133	29134	,	,	O	_	_
50	29135	29137	CD	50	O	_	_
mug	29138	29141	NN	mug	O	_	_
/	29141	29142	:	/	O	_	_
ml	29142	29144	NN	ml	O	_	_
CHX	29145	29148	NN	chx	O	_	_
was	29149	29152	VBD	be	O	_	_
added	29153	29158	VBN	add	O	_	_
to	29159	29161	TO	to	O	_	_
the	29162	29165	DT	the	O	_	_
cells	29166	29171	NNS	cell	O	_	_
for	29172	29175	IN	for	O	_	_
the	29176	29179	DT	the	O	_	_
time	29180	29184	NN	time	O	_	_
indicated	29185	29194	VBD	indicate	O	_	_
.	29194	29195	.	.	O	_	_
D	1
18
1	0	num
6	5	num
6	11	dep
9	8	nn
11	7	punct
11	9	nsubjpass
11	10	auxpass
11	14	prep_to
14	13	det
14	17	prep_for
17	16	det
18	1	npadvmod
18	3	prep_after
18	6	nsubj
EOX
Y	1
ROOT	0	0	20	1	S	3	0	20	5	PP	1	0	4	3	NP	1	0	2	2	CD	0	0	1	1	16	0	0	1	0	NNS	0	1	2	1	hours	1	1	2	0	IN	0	2	3	1	after	2	2	3	0	NP	0	3	4	1	NN	0	3	4	1	transfection	3	3	4	0	,	0	4	5	1	,	4	4	5	0	NP	0	5	18	2	NP	1	5	7	2	CD	0	5	6	1	50	5	5	6	0	NN	0	6	7	1	mug	6	6	7	0	PRN	1	7	18	2	:	0	7	8	1	/	7	7	8	0	S	1	8	18	2	NP	1	8	10	2	NN	0	8	9	1	ml	8	8	9	0	NN	0	9	10	1	CHX	9	9	10	0	VP	1	10	18	2	VBD	0	10	11	1	was	10	10	11	0	VP	0	11	18	2	VBN	0	11	12	1	added	11	11	12	0	PP	0	12	18	2	TO	0	12	13	1	to	12	12	13	0	NP	0	13	18	2	NP	1	13	15	2	DT	0	13	14	1	the	13	13	14	0	NNS	0	14	15	1	cells	14	14	15	0	PP	0	15	18	2	IN	0	15	16	1	for	15	15	16	0	NP	1	16	18	2	DT	0	16	17	1	the	16	16	17	0	NN	0	17	18	1	time	17	17	18	0	VP	0	18	19	1	VBD	0	18	19	1	indicated	18	18	19	0	.	0	19	20	1	.	19	19	20	0
EOS
T	15
The	29196	29199	DT	the	O	_	_
protein	29200	29207	NN	protein	O	_	_
levels	29208	29214	NNS	level	O	_	_
of	29215	29217	IN	of	O	_	_
V5-ASPP2	29218	29226	NN	v5-aspp2	B-GENE	_	_
or	29227	29229	CC	or	O	_	_
HRAS	29230	29234	NN	hra	B-GENE	_	_
V12	29235	29238	NN	v12	I-GENE	_	_
were	29239	29243	VBD	be	O	_	_
determined	29244	29254	VBN	determine	O	_	_
by	29255	29257	IN	by	O	_	_
western	29258	29265	NN	western	O	_	_
blot	29266	29270	NN	blot	O	_	_
analysis	29271	29279	NN	analysis	O	_	_
.	29279	29280	.	.	O	_	_
D	1
9
2	0	det
2	1	nn
2	7	prep_of
4	6	conj_or
7	4	nn
7	6	nn
9	2	nsubjpass
9	8	auxpass
9	13	agent
13	11	nn
13	12	nn
EOX
Y	1
ROOT	0	0	15	1	S	1	0	15	3	NP	0	0	8	2	NP	2	0	3	3	DT	0	0	1	1	The	0	0	1	0	NN	0	1	2	1	protein	1	1	2	0	NNS	0	2	3	1	levels	2	2	3	0	PP	0	3	8	2	IN	0	3	4	1	of	3	3	4	0	NP	1	4	8	2	NP	0	4	7	3	NN	0	4	5	1	V5-ASPP2	4	4	5	0	CC	0	5	6	1	or	5	5	6	0	NN	0	6	7	1	HRAS	6	6	7	0	NN	0	7	8	1	V12	7	7	8	0	VP	1	8	14	2	VBD	0	8	9	1	were	8	8	9	0	VP	0	9	14	2	VBN	0	9	10	1	determined	9	9	10	0	PP	0	10	14	2	IN	0	10	11	1	by	10	10	11	0	NP	2	11	14	3	NN	0	11	12	1	western	11	11	12	0	NN	0	12	13	1	blot	12	12	13	0	NN	0	13	14	1	analysis	13	13	14	0	.	0	14	15	1	.	14	14	15	0
EOS
T	8
beta-actin	29281	29291	NN	beta-actin	B-GENE	_	_
was	29292	29295	VBD	be	O	_	_
used	29296	29300	VBN	use	O	_	_
as	29301	29303	IN	as	O	_	_
a	29304	29305	DT	a	O	_	_
loading	29306	29313	VBG	load	O	_	_
control	29314	29321	NN	control	O	_	_
.	29321	29322	.	.	O	_	_
D	1
2
2	0	nsubjpass
2	1	auxpass
2	6	prep_as
6	4	det
6	5	amod
EOX
Y	1
ROOT	0	0	8	1	S	1	0	8	3	NP	0	0	1	1	NN	0	0	1	1	beta-actin	0	0	1	0	VP	1	1	7	2	VBD	0	1	2	1	was	1	1	2	0	VP	0	2	7	2	VBN	0	2	3	1	used	2	2	3	0	PP	0	3	7	2	IN	0	3	4	1	as	3	3	4	0	NP	2	4	7	3	DT	0	4	5	1	a	4	4	5	0	VBG	0	5	6	1	loading	5	5	6	0	NN	0	6	7	1	control	6	6	7	0	.	0	7	8	1	.	7	7	8	0
EOS
T	10
(	29323	29324	NN	(	B-GENE	_	_
TIF	29324	29327	NN	tif	I-GENE	_	_
)	29327	29328	CD	)	O	_	_
Click	29329	29334	VB	click	O	_	_
here	29335	29339	RB	here	O	_	_
for	29340	29343	IN	for	O	_	_
additional	29344	29354	JJ	additional	O	_	_
data	29355	29359	NNS	datum	O	_	_
file	29360	29364	NN	file	O	_	_
.	29364	29365	.	.	O	_	_
D	1
8
1	0	nn
1	3	rcmod
3	2	nsubj
3	4	advmod
3	7	prep_for
7	6	amod
8	1	nsubj
EOX
Y	1
ROOT	0	0	10	1	S	1	0	10	3	NP	0	0	8	2	NP	1	0	2	2	NN	0	0	1	1	(	0	0	1	0	NN	0	1	2	1	TIF	1	1	2	0	SBAR	0	2	8	1	S	1	2	8	2	NP	0	2	3	1	CD	0	2	3	1	)	2	2	3	0	VP	0	3	8	3	VB	0	3	4	1	Click	3	3	4	0	ADVP	0	4	5	1	RB	0	4	5	1	here	4	4	5	0	PP	0	5	8	2	IN	0	5	6	1	for	5	5	6	0	NP	1	6	8	2	JJ	0	6	7	1	additional	6	6	7	0	NNS	0	7	8	1	data	7	7	8	0	VP	0	8	9	1	NN	0	8	9	1	file	8	8	9	0	.	0	9	10	1	.	9	9	10	0
EOS
T	11
We	29366	29368	PRP	we	O	_	_
thank	29369	29374	VBP	thank	O	_	_
Kimberley	29375	29384	NNP	Kimberley	O	_	_
Bryon-Dodd	29385	29395	NNP	Bryon-Dodd	O	_	_
for	29396	29399	IN	for	O	_	_
critical	29400	29408	JJ	critical	O	_	_
reading	29409	29416	NN	reading	O	_	_
of	29417	29419	IN	of	O	_	_
the	29420	29423	DT	the	O	_	_
manuscript	29424	29434	NN	manuscript	O	_	_
.	29434	29435	.	.	O	_	_
D	1
1
1	0	nsubj
1	3	dobj
3	2	nn
3	6	prep_for
6	5	amod
6	9	prep_of
9	8	det
EOX
Y	1
ROOT	0	0	11	1	S	1	0	11	3	NP	0	0	1	1	PRP	0	0	1	1	We	0	0	1	0	VP	0	1	10	2	VBP	0	1	2	1	thank	1	1	2	0	NP	0	2	10	2	NP	1	2	4	2	NNP	0	2	3	1	Kimberley	2	2	3	0	NNP	0	3	4	1	Bryon-Dodd	3	3	4	0	PP	0	4	10	2	IN	0	4	5	1	for	4	4	5	0	NP	0	5	10	2	NP	1	5	7	2	JJ	0	5	6	1	critical	5	5	6	0	NN	0	6	7	1	reading	6	6	7	0	PP	0	7	10	2	IN	0	7	8	1	of	7	7	8	0	NP	1	8	10	2	DT	0	8	9	1	the	8	8	9	0	NN	0	9	10	1	manuscript	9	9	10	0	.	0	10	11	1	.	10	10	11	0
EOS
T	14
We	29436	29438	PRP	we	O	_	_
thank	29439	29444	VBP	thank	O	_	_
Dario	29445	29450	NNP	Dario	O	_	_
Alessi	29451	29457	NNP	Alessi	O	_	_
for	29458	29461	IN	for	O	_	_
his	29462	29465	PRP$	he	O	_	_
help	29466	29470	NN	help	O	_	_
with	29471	29475	IN	with	O	_	_
the	29476	29479	DT	the	O	_	_
in	29480	29482	FW	in	O	_	_
vitro	29483	29488	FW	vitro	O	_	_
phosphorylation	29489	29504	NN	phosphorylation	O	_	_
data	29505	29509	NNS	datum	O	_	_
.	29509	29510	.	.	O	_	_
D	1
1
1	0	nsubj
1	3	dobj
3	2	nn
3	6	prep_for
3	7	amod
3	8	dep
6	5	poss
8	12	rcmod
10	9	nn
12	10	advmod
12	11	nn
EOX
Y	1
ROOT	0	0	14	1	S	1	0	14	3	NP	0	0	1	1	PRP	0	0	1	1	We	0	0	1	0	VP	0	1	13	2	VBP	0	1	2	1	thank	1	1	2	0	NP	0	2	13	3	NP	0	2	7	2	NP	1	2	4	2	NNP	0	2	3	1	Dario	2	2	3	0	NNP	0	3	4	1	Alessi	3	3	4	0	PP	0	4	7	2	IN	0	4	5	1	for	4	4	5	0	NP	1	5	7	2	PRP$	0	5	6	1	his	5	5	6	0	NN	0	6	7	1	help	6	6	7	0	IN	0	7	8	1	with	7	7	8	0	NP	0	8	13	2	DT	0	8	9	1	the	8	8	9	0	RRC	1	9	13	2	ADVP	1	9	11	2	FW	0	9	10	1	in	9	9	10	0	FW	0	10	11	1	vitro	10	10	11	0	NP	1	11	13	2	NN	0	11	12	1	phosphorylation	11	11	12	0	NNS	0	12	13	1	data	12	12	13	0	.	0	13	14	1	.	13	13	14	0
EOS
T	21
We	29511	29513	PRP	we	O	_	_
are	29514	29517	VBP	be	O	_	_
grateful	29518	29526	JJ	grateful	O	_	_
to	29527	29529	TO	to	O	_	_
Dr	29530	29532	VB	dr	O	_	_
Julian	29533	29539	NNP	Julian	O	_	_
Downward	29540	29548	NNP	Downward	O	_	_
for	29549	29552	IN	for	O	_	_
providing	29553	29562	VBG	provide	O	_	_
HKe3	29563	29567	NN	hke3	B-GENE	_	_
ER	29568	29570	NN	er	I-GENE	_	_
:	29570	29571	:	:	O	_	_
HRASV12	29571	29578	NN	hrasv12	O	_	_
cells	29579	29584	NNS	cell	O	_	_
and	29585	29588	CC	and	O	_	_
Senji	29589	29594	NNP	Senji	O	_	_
Shirasawa	29595	29604	NNP	Shirasawa	O	_	_
for	29605	29608	IN	for	O	_	_
HKe3	29609	29613	NN	hke3	O	_	_
cells	29614	29619	NNS	cell	O	_	_
.	29619	29620	.	.	O	_	_
D	1
2
2	0	nsubj
2	1	cop
2	4	xcomp
4	3	aux
4	6	dobj
6	5	nn
6	8	prepc_for
8	10	dobj
8	19	prep_for
10	9	nn
10	13	dep
10	16	dep
13	12	nn
13	16	conj_and
16	15	nn
19	18	nn
EOX
Y	1
ROOT	0	0	21	1	S	1	0	21	3	NP	0	0	1	1	PRP	0	0	1	1	We	0	0	1	0	VP	1	1	20	2	VBP	0	1	2	1	are	1	1	2	0	ADJP	0	2	20	2	JJ	0	2	3	1	grateful	2	2	3	0	S	0	3	20	1	VP	1	3	20	2	TO	0	3	4	1	to	3	3	4	0	VP	0	4	20	2	VB	0	4	5	1	Dr	4	4	5	0	NP	0	5	20	2	NP	1	5	7	2	NNP	0	5	6	1	Julian	5	5	6	0	NNP	0	6	7	1	Downward	6	6	7	0	PP	0	7	20	2	IN	0	7	8	1	for	7	7	8	0	S	0	8	20	1	VP	0	8	20	3	VBG	0	8	9	1	providing	8	8	9	0	NP	0	9	17	3	NP	1	9	11	2	NN	0	9	10	1	HKe3	9	9	10	0	NN	0	10	11	1	ER	10	10	11	0	:	0	11	12	1	:	11	11	12	0	NP	0	12	17	3	NP	1	12	14	2	NN	0	12	13	1	HRASV12	12	12	13	0	NNS	0	13	14	1	cells	13	13	14	0	CC	0	14	15	1	and	14	14	15	0	NP	1	15	17	2	NNP	0	15	16	1	Senji	15	15	16	0	NNP	0	16	17	1	Shirasawa	16	16	17	0	PP	0	17	20	2	IN	0	17	18	1	for	17	17	18	0	NP	1	18	20	2	NN	0	18	19	1	HKe3	18	18	19	0	NNS	0	19	20	1	cells	19	19	20	0	.	0	20	21	1	.	20	20	21	0
EOS
T	22
We	29621	29623	PRP	we	O	_	_
thank	29624	29629	VBP	thank	O	_	_
Richard	29630	29637	NNP	Richard	O	_	_
Marais	29638	29644	NNP	Marais	O	_	_
and	29645	29648	CC	and	O	_	_
Chris	29649	29654	NNP	Chris	O	_	_
Marshall	29655	29663	NNP	Marshall	O	_	_
for	29664	29667	IN	for	O	_	_
providing	29668	29677	VBG	provide	O	_	_
us	29678	29680	PRP	we	O	_	_
with	29681	29685	IN	with	O	_	_
the	29686	29689	DT	the	O	_	_
expression	29690	29700	NN	expression	O	_	_
plasmids	29701	29709	NNS	plasmid	O	_	_
for	29710	29713	IN	for	O	_	_
HRAS	29714	29718	NNP	HRAS	O	_	_
,	29718	29719	,	,	O	_	_
KRAS	29720	29724	NNP	KRAS	O	_	_
and	29725	29728	CC	and	O	_	_
HRAS	29729	29733	NNP	HRAS	O	_	_
V12	29734	29737	NN	v12	O	_	_
.	29737	29738	.	.	O	_	_
D	1
1
1	0	nsubj
1	3	dobj
1	6	dobj
1	8	prepc_for
3	2	nn
3	6	conj_and
6	5	nn
8	9	dobj
8	20	prep_with
13	12	nn
13	15	prep_for
13	17	prep_for
13	19	prep_for
15	17	conj_and
15	19	conj_and
20	11	det
20	13	nn
EOX
Y	1
ROOT	0	0	22	1	S	1	0	22	3	NP	0	0	1	1	PRP	0	0	1	1	We	0	0	1	0	VP	0	1	21	3	VBP	0	1	2	1	thank	1	1	2	0	NP	0	2	7	3	NP	1	2	4	2	NNP	0	2	3	1	Richard	2	2	3	0	NNP	0	3	4	1	Marais	3	3	4	0	CC	0	4	5	1	and	4	4	5	0	NP	1	5	7	2	NNP	0	5	6	1	Chris	5	5	6	0	NNP	0	6	7	1	Marshall	6	6	7	0	PP	0	7	21	2	IN	0	7	8	1	for	7	7	8	0	S	0	8	21	1	VP	0	8	21	3	VBG	0	8	9	1	providing	8	8	9	0	NP	0	9	10	1	PRP	0	9	10	1	us	9	9	10	0	PP	0	10	21	2	IN	0	10	11	1	with	10	10	11	0	NP	2	11	21	3	DT	0	11	12	1	the	11	11	12	0	NP	0	12	20	2	NP	1	12	14	2	NN	0	12	13	1	expression	12	12	13	0	NNS	0	13	14	1	plasmids	13	13	14	0	PP	0	14	20	2	IN	0	14	15	1	for	14	14	15	0	NP	0	15	20	5	NNP	0	15	16	1	HRAS	15	15	16	0	,	0	16	17	1	,	16	16	17	0	NNP	0	17	18	1	KRAS	17	17	18	0	CC	0	18	19	1	and	18	18	19	0	NNP	0	19	20	1	HRAS	19	19	20	0	NN	0	20	21	1	V12	20	20	21	0	.	0	21	22	1	.	21	21	22	0
EOS
T	39
References	29739	29749	NNS	reference	O	_	_
1	29750	29751	CD	1	O	_	_
Russo	29752	29757	NNP	Russo	O	_	_
A	29758	29759	NNP	A	O	_	_
,	29760	29761	,	,	O	_	_
Bazan	29762	29767	NNP	Bazan	O	_	_
V	29768	29769	NNP	V	O	_	_
,	29770	29771	,	,	O	_	_
Agnese	29772	29778	NNP	Agnese	O	_	_
V	29779	29780	NNP	V	O	_	_
,	29781	29782	,	,	O	_	_
Rodolico	29783	29791	NNP	Rodolico	O	_	_
V	29792	29793	NNP	V	O	_	_
,	29794	29795	,	,	O	_	_
Gebbia	29796	29802	NNP	Gebbia	O	_	_
N	29803	29804	NNP	N	O	_	_
(	29805	29806	CD	(	O	_	_
2005	29807	29811	CD	2005	O	_	_
)	29812	29813	CD	)	O	_	_
Prognostic	29815	29825	NNP	Prognostic	O	_	_
and	29826	29829	CC	and	O	_	_
predictive	29830	29840	JJ	predictive	O	_	_
factors	29841	29848	NNS	factor	O	_	_
in	29849	29851	IN	in	O	_	_
colorectal	29852	29862	JJ	colorectal	O	_	_
cancer	29863	29869	NN	cancer	O	_	_
:	29869	29870	:	:	O	_	_
Kirsten	29871	29878	NNP	Kirsten	O	_	_
Ras	29879	29882	NN	ra	O	_	_
in	29883	29885	IN	in	O	_	_
CRC	29886	29889	NN	crc	O	_	_
(	29890	29891	CD	(	O	_	_
RASCAL	29891	29897	NN	rascal	O	_	_
)	29897	29898	NN	)	O	_	_
and	29899	29902	CC	and	O	_	_
TP53CRC	29903	29910	NN	tp53crc	B-GENE	_	_
collaborative	29911	29924	JJ	collaborative	O	_	_
studies	29925	29932	NNS	study	O	_	_
.	29933	29934	.	.	O	_	_
D	1
0
0	3	dep
0	6	dep
0	9	dep
0	12	dep
0	15	dep
0	37	dep
3	1	num
3	2	nn
3	6	conj_and
3	9	conj_and
3	12	conj_and
3	15	conj_and
3	37	conj_and
6	5	nn
9	8	nn
12	11	nn
15	14	nn
15	19	dep
15	22	dep
15	28	dep
17	16	number
19	17	num
19	18	num
19	22	conj_and
19	25	prep_in
22	21	amod
25	24	amod
28	27	nn
28	33	prep_in
33	30	nn
33	31	num
33	32	nn
37	35	nn
37	36	amod
EOX
Y	1
ROOT	0	0	39	1	NP	0	0	39	3	NP	0	0	1	1	NNS	0	0	1	1	References	0	0	1	0	NP	0	1	38	11	NP	2	1	4	3	CD	0	1	2	1	1	1	1	2	0	NNP	0	2	3	1	Russo	2	2	3	0	NNP	0	3	4	1	A	3	3	4	0	,	0	4	5	1	,	4	4	5	0	NP	1	5	7	2	NNP	0	5	6	1	Bazan	5	5	6	0	NNP	0	6	7	1	V	6	6	7	0	,	0	7	8	1	,	7	7	8	0	NP	1	8	10	2	NNP	0	8	9	1	Agnese	8	8	9	0	NNP	0	9	10	1	V	9	9	10	0	,	0	10	11	1	,	10	10	11	0	NP	1	11	13	2	NNP	0	11	12	1	Rodolico	11	11	12	0	NNP	0	12	13	1	V	12	12	13	0	,	0	13	14	1	,	13	13	14	0	NP	0	14	34	3	NP	0	14	26	2	NP	1	14	16	2	NNP	0	14	15	1	Gebbia	14	14	15	0	NNP	0	15	16	1	N	15	15	16	0	VP	0	16	26	2	NP	0	16	23	3	NP	2	16	20	3	QP	1	16	18	2	CD	0	16	17	1	(	16	16	17	0	CD	0	17	18	1	2005	17	17	18	0	CD	0	18	19	1	)	18	18	19	0	NNP	0	19	20	1	Prognostic	19	19	20	0	CC	0	20	21	1	and	20	20	21	0	NP	1	21	23	2	JJ	0	21	22	1	predictive	21	21	22	0	NNS	0	22	23	1	factors	22	22	23	0	PP	0	23	26	2	IN	0	23	24	1	in	23	23	24	0	NP	1	24	26	2	JJ	0	24	25	1	colorectal	24	24	25	0	NN	0	25	26	1	cancer	25	25	26	0	:	0	26	27	1	:	26	26	27	0	NP	0	27	34	2	NP	1	27	29	2	NNP	0	27	28	1	Kirsten	27	27	28	0	NN	0	28	29	1	Ras	28	28	29	0	PP	0	29	34	2	IN	0	29	30	1	in	29	29	30	0	NP	3	30	34	4	NN	0	30	31	1	CRC	30	30	31	0	CD	0	31	32	1	(	31	31	32	0	NN	0	32	33	1	RASCAL	32	32	33	0	NN	0	33	34	1	)	33	33	34	0	CC	0	34	35	1	and	34	34	35	0	NP	2	35	38	3	NN	0	35	36	1	TP53CRC	35	35	36	0	JJ	0	36	37	1	collaborative	36	36	37	0	NNS	0	37	38	1	studies	37	37	38	0	.	0	38	39	1	.	38	38	39	0
EOS
T	52
Ann	29935	29938	NNP	Ann	O	_	_
Oncol	29939	29944	NNP	Oncol	O	_	_
16	29945	29947	CD	16	O	_	_
Suppl	29948	29953	NNP	Suppl	O	_	_
4	29954	29955	CD	4	O	_	_
:	29956	29957	:	:	O	_	_
iv44	29958	29962	CD	iv44	O	_	_
-	29963	29964	:	-	O	_	_
iv49	29965	29969	CD	iv49	O	_	_
PubMed	29970	29976	NNP	PubMed	O	_	_
:	29976	29977	:	:	O	_	_
15923428	29978	29986	CD	15923428	O	_	_
15923428	29987	29995	CD	15923428	O	_	_
2	29996	29997	CD	2	O	_	_
Wang	29998	30002	NNP	Wang	O	_	_
Y	30003	30004	NN	y	O	_	_
,	30005	30006	,	,	O	_	_
Godin-Heymann	30007	30020	NNP	Godin-Heymann	O	_	_
N	30021	30022	NNP	N	O	_	_
,	30023	30024	,	,	O	_	_
Dan	30025	30028	NNP	Dan	O	_	_
Wang	30029	30033	NNP	Wang	O	_	_
X	30034	30035	NNP	X	O	_	_
,	30036	30037	,	,	O	_	_
Bergamaschi	30038	30049	NNP	Bergamaschi	O	_	_
D	30050	30051	NNP	D	O	_	_
,	30052	30053	,	,	O	_	_
Llanos	30054	30060	NNP	Llanos	O	_	_
S	30061	30062	NNP	S	O	_	_
et	30063	30065	FW	et	O	_	_
al.	30066	30069	FW	al.	O	_	_
(	30070	30071	FW	(	O	_	_
2013	30072	30076	CD	2013	O	_	_
)	30077	30078	CD	)	O	_	_
ASPP1	30080	30085	NN	aspp1	B-GENE	_	_
and	30086	30089	CC	and	O	_	_
ASPP2	30090	30095	NN	aspp2	B-GENE	_	_
bind	30096	30100	VBP	bind	O	_	_
active	30101	30107	JJ	active	O	_	_
RAS	30108	30111	NN	ra	O	_	_
,	30111	30112	,	,	O	_	_
potentiate	30113	30123	VB	potentiate	O	_	_
RAS	30124	30127	NN	ra	O	_	_
signalling	30128	30138	NN	signalling	O	_	_
and	30139	30142	CC	and	O	_	_
enhance	30143	30150	VBP	enhance	O	_	_
p53	30151	30154	NN	p53	B-GENE	_	_
activity	30155	30163	NN	activity	O	_	_
in	30164	30166	IN	in	O	_	_
cancer	30167	30173	NN	cancer	O	_	_
cells	30174	30179	NNS	cell	O	_	_
.	30180	30181	.	.	O	_	_
D	1
37
1	0	nn
1	3	dep
1	8	dep
1	12	dep
1	18	appos
1	22	appos
1	25	appos
1	28	appos
1	36	appos
3	2	num
3	4	num
8	6	num
8	9	appos
12	11	number
12	15	dep
15	13	num
15	14	nn
18	17	nn
18	22	conj_and
18	25	conj_and
18	28	conj_and
18	36	conj_and
22	20	nn
22	21	nn
25	24	nn
28	27	nn
28	31	dep
28	34	dep
31	29	nn
31	30	nn
34	32	num
34	33	num
37	1	nsubj
37	39	dobj
37	41	conj_and
37	45	conj_and
39	38	amod
41	1	nsubj
41	43	dobj
43	42	nn
45	1	nsubj
45	47	dobj
45	50	prep_in
47	46	nn
50	49	nn
EOX
Y	1
ROOT	0	0	52	1	S	1	0	52	3	NP	0	0	37	3	NP	0	0	16	5	NP	0	0	5	2	NP	1	0	2	2	NNP	0	0	1	1	Ann	0	0	1	0	NNP	0	1	2	1	Oncol	1	1	2	0	NP	1	2	5	3	CD	0	2	3	1	16	2	2	3	0	NNP	0	3	4	1	Suppl	3	3	4	0	CD	0	4	5	1	4	4	4	5	0	:	0	5	6	1	:	5	5	6	0	NP	0	6	10	2	NP	2	6	9	3	CD	0	6	7	1	iv44	6	6	7	0	:	0	7	8	1	-	7	7	8	0	CD	0	8	9	1	iv49	8	8	9	0	NP	0	9	10	1	NNP	0	9	10	1	PubMed	9	9	10	0	:	0	10	11	1	:	10	10	11	0	NP	0	11	16	2	NP	0	11	13	1	QP	0	11	13	2	CD	0	11	12	1	15923428	11	11	12	0	CD	0	12	13	1	15923428	12	12	13	0	NP	2	13	16	3	CD	0	13	14	1	2	13	13	14	0	NNP	0	14	15	1	Wang	14	14	15	0	NN	0	15	16	1	Y	15	15	16	0	,	0	16	17	1	,	16	16	17	0	NP	0	17	37	9	NP	1	17	19	2	NNP	0	17	18	1	Godin-Heymann	17	17	18	0	NNP	0	18	19	1	N	18	18	19	0	,	0	19	20	1	,	19	19	20	0	NP	2	20	23	3	NNP	0	20	21	1	Dan	20	20	21	0	NNP	0	21	22	1	Wang	21	21	22	0	NNP	0	22	23	1	X	22	22	23	0	,	0	23	24	1	,	23	23	24	0	NP	1	24	26	2	NNP	0	24	25	1	Bergamaschi	24	24	25	0	NNP	0	25	26	1	D	25	25	26	0	,	0	26	27	1	,	26	26	27	0	NP	0	27	35	3	NP	1	27	29	2	NNP	0	27	28	1	Llanos	27	27	28	0	NNP	0	28	29	1	S	28	28	29	0	NP	2	29	32	3	FW	0	29	30	1	et	29	29	30	0	FW	0	30	31	1	al.	30	30	31	0	FW	0	31	32	1	(	31	31	32	0	NP	2	32	35	3	CD	0	32	33	1	2013	32	32	33	0	CD	0	33	34	1	)	33	33	34	0	NN	0	34	35	1	ASPP1	34	34	35	0	CC	0	35	36	1	and	35	35	36	0	NP	0	36	37	1	NN	0	36	37	1	ASPP2	36	36	37	0	VP	0	37	51	5	VP	0	37	40	2	VBP	0	37	38	1	bind	37	37	38	0	NP	1	38	40	2	JJ	0	38	39	1	active	38	38	39	0	NN	0	39	40	1	RAS	39	39	40	0	,	0	40	41	1	,	40	40	41	0	VP	0	41	44	2	VB	0	41	42	1	potentiate	41	41	42	0	NP	1	42	44	2	NN	0	42	43	1	RAS	42	42	43	0	NN	0	43	44	1	signalling	43	43	44	0	CC	0	44	45	1	and	44	44	45	0	VP	0	45	51	3	VBP	0	45	46	1	enhance	45	45	46	0	NP	1	46	48	2	NN	0	46	47	1	p53	46	46	47	0	NN	0	47	48	1	activity	47	47	48	0	PP	0	48	51	2	IN	0	48	49	1	in	48	48	49	0	NP	1	49	51	2	NN	0	49	50	1	cancer	49	49	50	0	NNS	0	50	51	1	cells	50	50	51	0	.	0	51	52	1	.	51	51	52	0
EOS
T	38
Cell	30182	30186	NN	cell	O	_	_
Death	30187	30192	NNP	Death	O	_	_
Differ	30193	30199	NNP	Differ	O	_	_
20	30200	30202	CD	20	O	_	_
:	30203	30204	:	:	O	_	_
525	30205	30208	CD	525	O	_	_
-	30209	30210	:	-	O	_	_
534	30211	30214	CD	534	O	_	_
.10.1038	30215	30223	CD	.10.1038	O	_	_
/	30223	30224	:	/	O	_	_
cdd	30224	30227	NN	cdd	O	_	_
.2013.3	30227	30234	CD	.2013.3	O	_	_
PubMed	30235	30241	NNP	PubMed	O	_	_
:	30241	30242	:	:	O	_	_
23392125	30243	30251	CD	23392125	O	_	_
23392125	30252	30260	CD	23392125	O	_	_
3	30261	30262	CD	3	O	_	_
Yoon	30263	30267	NNP	Yoon	O	_	_
S	30268	30269	NN	s	O	_	_
,	30270	30271	,	,	O	_	_
Seger	30272	30277	NNP	Seger	O	_	_
R	30278	30279	NNP	R	O	_	_
(	30280	30281	CD	(	O	_	_
2006	30282	30286	CD	2006	O	_	_
)	30287	30288	CD	)	O	_	_
The	30290	30293	DT	the	O	_	_
extracellular	30294	30307	JJ	extracellular	B-GENE	_	_
signal	30308	30314	NN	signal	I-GENE	_	_
regulated	30315	30324	VBN	regulate	I-GENE	_	_
kinase	30325	30331	NN	kinase	I-GENE	_	_
:	30331	30332	:	:	O	_	_
multiple	30333	30341	JJ	multiple	O	_	_
substrates	30342	30352	NNS	substrate	O	_	_
regulate	30353	30361	VBP	regulate	O	_	_
diverse	30362	30369	JJ	diverse	O	_	_
cellular	30370	30378	JJ	cellular	O	_	_
functions	30379	30388	NNS	function	O	_	_
.	30389	30390	.	.	O	_	_
D	1
2
2	0	nn
2	1	nn
2	3	dep
2	5	dep
2	15	dep
2	21	appos
2	33	dep
5	8	dep
5	12	dep
8	7	number
8	9	punct
12	10	nn
12	11	num
15	14	number
15	18	dep
18	16	num
18	17	nn
21	20	nn
21	22	num
21	24	dep
21	27	dep
21	28	vmod
24	23	num
27	25	det
27	26	amod
28	29	dobj
32	31	amod
33	32	nsubj
33	36	dobj
36	34	amod
36	35	amod
EOX
Y	1
ROOT	0	0	38	1	FRAG	0	0	38	4	NP	0	0	30	3	NP	0	0	19	5	NP	0	0	4	2	NP	2	0	3	3	NN	0	0	1	1	Cell	0	0	1	0	NNP	0	1	2	1	Death	1	1	2	0	NNP	0	2	3	1	Differ	2	2	3	0	NP	0	3	4	1	CD	0	3	4	1	20	3	3	4	0	:	0	4	5	1	:	4	4	5	0	NP	0	5	13	3	NP	0	5	6	1	CD	0	5	6	1	525	5	5	6	0	PRN	1	6	10	3	:	0	6	7	1	-	6	6	7	0	NP	0	7	9	1	QP	1	7	9	2	CD	0	7	8	1	534	7	7	8	0	CD	0	8	9	1	.10.1038	8	8	9	0	:	0	9	10	1	/	9	9	10	0	NP	2	10	13	3	NN	0	10	11	1	cdd	10	10	11	0	CD	0	11	12	1	.2013.3	11	11	12	0	NNP	0	12	13	1	PubMed	12	12	13	0	:	0	13	14	1	:	13	13	14	0	NP	0	14	19	2	NP	0	14	16	1	QP	0	14	16	2	CD	0	14	15	1	23392125	14	14	15	0	CD	0	15	16	1	23392125	15	15	16	0	NP	2	16	19	3	CD	0	16	17	1	3	16	16	17	0	NNP	0	17	18	1	Yoon	17	17	18	0	NN	0	18	19	1	S	18	18	19	0	,	0	19	20	1	,	19	19	20	0	NP	0	20	30	2	NP	0	20	28	3	NP	1	20	23	3	NNP	0	20	21	1	Seger	20	20	21	0	NNP	0	21	22	1	R	21	21	22	0	CD	0	22	23	1	(	22	22	23	0	NP	1	23	25	2	CD	0	23	24	1	2006	23	23	24	0	CD	0	24	25	1	)	24	24	25	0	NP	2	25	28	3	DT	0	25	26	1	The	25	25	26	0	JJ	0	26	27	1	extracellular	26	26	27	0	NN	0	27	28	1	signal	27	27	28	0	VP	0	28	30	2	VBN	0	28	29	1	regulated	28	28	29	0	NP	0	29	30	1	NN	0	29	30	1	kinase	29	29	30	0	:	0	30	31	1	:	30	30	31	0	S	1	31	37	2	NP	1	31	33	2	JJ	0	31	32	1	multiple	31	31	32	0	NNS	0	32	33	1	substrates	32	32	33	0	VP	0	33	37	2	VBP	0	33	34	1	regulate	33	33	34	0	NP	2	34	37	3	JJ	0	34	35	1	diverse	34	34	35	0	JJ	0	35	36	1	cellular	35	35	36	0	NNS	0	36	37	1	functions	36	36	37	0	.	0	37	38	1	.	37	37	38	0
EOS
T	39
Growth	30391	30397	NN	growth	O	_	_
Factors	30398	30405	NNS	factor	O	_	_
24	30406	30408	CD	24	O	_	_
:	30409	30410	:	:	O	_	_
21	30411	30413	CD	21	O	_	_
-	30414	30415	:	-	O	_	_
44	30416	30418	CD	44	O	_	_
.10.1080	30419	30427	CD	.10.1080	O	_	_
/	30427	30428	:	/	O	_	_
02699050500284218	30428	30445	CD	02699050500284218	O	_	_
PubMed	30446	30452	NNP	PubMed	O	_	_
:	30452	30453	:	:	O	_	_
16393692	30454	30462	CD	16393692	O	_	_
16393692	30463	30471	CD	16393692	O	_	_
4	30472	30473	CD	4	O	_	_
Cargnello	30474	30483	NNP	Cargnello	O	_	_
M	30484	30485	NN	m	O	_	_
,	30486	30487	,	,	O	_	_
Roux	30488	30492	NNP	Roux	O	_	_
PP	30493	30495	NNP	PP	O	_	_
(	30496	30497	CD	(	O	_	_
2011	30498	30502	CD	2011	O	_	_
)	30503	30504	CD	)	O	_	_
Activation	30506	30516	NN	activation	O	_	_
and	30517	30520	CC	and	O	_	_
function	30521	30529	NN	function	O	_	_
of	30530	30532	IN	of	O	_	_
the	30533	30536	DT	the	O	_	_
MAPKs	30537	30542	NNS	mapk	O	_	_
and	30543	30546	CC	and	O	_	_
their	30547	30552	PRP$	they	O	_	_
substrates	30553	30563	NNS	substrate	O	_	_
,	30563	30564	,	,	O	_	_
the	30565	30568	DT	the	O	_	_
MAPK	30569	30573	NN	mapk	B-GENE	_	_
activated	30574	30583	VBN	activate	O	_	_
protein	30584	30591	NN	protein	O	_	_
kinases	30592	30599	NNS	kinase	O	_	_
.	30600	30601	.	.	O	_	_
D	1
1
1	0	nn
1	4	dep
1	7	dep
4	2	num
7	6	number
7	9	dep
7	19	dep
7	25	dep
7	28	prep_of
7	31	prep_of
9	8	punct
9	10	appos
9	13	dep
9	19	conj_and
9	25	conj_and
13	12	number
13	16	dep
16	14	num
16	15	nn
19	18	nn
19	21	dep
19	23	dep
21	20	num
23	22	num
28	27	det
28	31	conj_and
31	30	poss
31	34	appos
34	33	det
34	35	vmod
35	37	dobj
37	36	nn
EOX
Y	1
ROOT	0	0	39	1	NP	0	0	39	4	NP	0	0	5	2	NP	1	0	2	2	NN	0	0	1	1	Growth	0	0	1	0	NNS	0	1	2	1	Factors	1	1	2	0	NP	2	2	5	3	CD	0	2	3	1	24	2	2	3	0	:	0	3	4	1	:	3	3	4	0	CD	0	4	5	1	21	4	4	5	0	:	0	5	6	1	-	5	5	6	0	NP	0	6	38	3	NP	0	6	8	1	QP	1	6	8	2	CD	0	6	7	1	44	6	6	7	0	CD	0	7	8	1	.10.1080	7	7	8	0	PRN	1	8	26	2	:	0	8	9	1	/	8	8	9	0	NP	0	9	26	5	NP	0	9	17	3	NP	0	9	11	2	NP	0	9	10	1	CD	0	9	10	1	02699050500284218	9	9	10	0	NP	0	10	11	1	NNP	0	10	11	1	PubMed	10	10	11	0	:	0	11	12	1	:	11	11	12	0	NP	0	12	17	2	NP	0	12	14	1	QP	0	12	14	2	CD	0	12	13	1	16393692	12	12	13	0	CD	0	13	14	1	16393692	13	13	14	0	NP	2	14	17	3	CD	0	14	15	1	4	14	14	15	0	NNP	0	15	16	1	Cargnello	15	15	16	0	NN	0	16	17	1	M	16	16	17	0	,	0	17	18	1	,	17	17	18	0	NP	0	18	24	3	NP	1	18	20	2	NNP	0	18	19	1	Roux	18	18	19	0	NNP	0	19	20	1	PP	19	19	20	0	NP	1	20	22	2	CD	0	20	21	1	(	20	20	21	0	CD	0	21	22	1	2011	21	21	22	0	NP	1	22	24	2	CD	0	22	23	1	)	22	22	23	0	NN	0	23	24	1	Activation	23	23	24	0	CC	0	24	25	1	and	24	24	25	0	NP	0	25	26	1	NN	0	25	26	1	function	25	25	26	0	PP	0	26	38	2	IN	0	26	27	1	of	26	26	27	0	NP	0	27	38	3	NP	1	27	29	2	DT	0	27	28	1	the	27	27	28	0	NNS	0	28	29	1	MAPKs	28	28	29	0	CC	0	29	30	1	and	29	29	30	0	NP	0	30	38	3	NP	1	30	32	2	PRP$	0	30	31	1	their	30	30	31	0	NNS	0	31	32	1	substrates	31	31	32	0	,	0	32	33	1	,	32	32	33	0	NP	0	33	38	2	NP	1	33	35	2	DT	0	33	34	1	the	33	33	34	0	NN	0	34	35	1	MAPK	34	34	35	0	VP	0	35	38	2	VBN	0	35	36	1	activated	35	35	36	0	NP	1	36	38	2	NN	0	36	37	1	protein	36	36	37	0	NNS	0	37	38	1	kinases	37	37	38	0	.	0	38	39	1	.	38	38	39	0
EOS
T	32
Microbiol	30602	30611	NNP	Microbiol	O	_	_
Mol	30612	30615	NNP	Mol	O	_	_
Biol	30616	30620	NNP	Biol	O	_	_
Rev	30621	30624	NN	rev	O	_	_
75	30625	30627	CD	75	O	_	_
:	30628	30629	:	:	O	_	_
50	30630	30632	CD	50	O	_	_
-	30633	30634	:	-	O	_	_
83	30635	30637	CD	83	O	_	_
.10.1128	30638	30646	CD	.10.1128	O	_	_
/	30646	30647	:	/	O	_	_
MMBR.00031-10	30647	30660	NN	mmbr.00031-10	O	_	_
PubMed	30661	30667	NNP	PubMed	O	_	_
:	30667	30668	:	:	O	_	_
21372320	30669	30677	CD	21372320	O	_	_
21372320	30678	30686	CD	21372320	O	_	_
5	30687	30688	CD	5	O	_	_
Trigiante	30689	30698	NNP	Trigiante	O	_	_
G	30699	30700	NNP	G	O	_	_
,	30701	30702	,	,	O	_	_
Lu	30703	30705	NNP	Lu	O	_	_
X	30706	30707	NNP	X	O	_	_
(	30708	30709	CD	(	O	_	_
2006	30710	30714	CD	2006	O	_	_
)	30715	30716	CD	)	O	_	_
ASPP	30718	30722	NN	aspp	O	_	_
[	30723	30724	CD	[	O	_	_
corrected	30724	30733	VBN	correct	O	_	_
]	30733	30734	NN	]	O	_	_
and	30735	30738	CC	and	O	_	_
cancer	30739	30745	NN	cancer	O	_	_
.	30746	30747	.	.	O	_	_
D	1
27
2	0	nn
2	1	nn
2	3	dep
2	6	dep
2	18	dep
2	26	dep
3	4	num
6	9	dep
6	12	dep
9	8	number
9	10	punct
12	11	nn
18	14	num
18	15	num
18	16	num
18	17	nn
18	21	appos
21	20	nn
21	23	dep
21	25	dep
23	22	num
25	24	num
27	2	nsubj
27	28	dobj
27	30	dobj
28	30	conj_and
EOX
Y	1
ROOT	0	0	32	1	S	1	0	32	3	NP	0	0	27	2	NP	0	0	26	5	NP	0	0	5	2	NP	2	0	3	3	NNP	0	0	1	1	Microbiol	0	0	1	0	NNP	0	1	2	1	Mol	1	1	2	0	NNP	0	2	3	1	Biol	2	2	3	0	NP	0	3	5	2	NN	0	3	4	1	Rev	3	3	4	0	CD	0	4	5	1	75	4	4	5	0	:	0	5	6	1	:	5	5	6	0	NP	0	6	13	3	NP	0	6	7	1	CD	0	6	7	1	50	6	6	7	0	PRN	1	7	11	3	:	0	7	8	1	-	7	7	8	0	NP	0	8	10	1	QP	1	8	10	2	CD	0	8	9	1	83	8	8	9	0	CD	0	9	10	1	.10.1128	9	9	10	0	:	0	10	11	1	/	10	10	11	0	NP	1	11	13	2	NN	0	11	12	1	MMBR.00031-10	11	11	12	0	NNP	0	12	13	1	PubMed	12	12	13	0	:	0	13	14	1	:	13	13	14	0	NP	0	14	26	3	NP	4	14	19	5	CD	0	14	15	1	21372320	14	14	15	0	CD	0	15	16	1	21372320	15	15	16	0	CD	0	16	17	1	5	16	16	17	0	NNP	0	17	18	1	Trigiante	17	17	18	0	NNP	0	18	19	1	G	18	18	19	0	,	0	19	20	1	,	19	19	20	0	NP	0	20	26	3	NP	1	20	22	2	NNP	0	20	21	1	Lu	20	20	21	0	NNP	0	21	22	1	X	21	21	22	0	NP	1	22	24	2	CD	0	22	23	1	(	22	22	23	0	CD	0	23	24	1	2006	23	23	24	0	NP	1	24	26	2	CD	0	24	25	1	)	24	24	25	0	NN	0	25	26	1	ASPP	25	25	26	0	NP	0	26	27	1	CD	0	26	27	1	[	26	26	27	0	VP	0	27	31	2	VBN	0	27	28	1	corrected	27	27	28	0	NP	0	28	31	3	NN	0	28	29	1	]	28	28	29	0	CC	0	29	30	1	and	29	29	30	0	NN	0	30	31	1	cancer	30	30	31	0	.	0	31	32	1	.	31	31	32	0
EOS
T	57
Nat	30748	30751	NNP	Nat	B-GENE	_	_
Rev	30752	30755	NN	rev	I-GENE	_	_
Cancer	30756	30762	NN	cancer	I-GENE	_	_
6	30763	30764	CD	6	I-GENE	_	_
:	30765	30766	:	:	O	_	_
217	30767	30770	CD	217	O	_	_
-	30771	30772	:	-	O	_	_
226	30773	30776	CD	226	O	_	_
.10.1038	30777	30785	CD	.10.1038	O	_	_
/	30785	30786	:	/	O	_	_
nrc1818	30786	30793	CD	nrc1818	O	_	_
PubMed	30794	30800	NNP	PubMed	O	_	_
:	30800	30801	:	:	O	_	_
16498444	30802	30810	CD	16498444	O	_	_
16498444	30811	30819	CD	16498444	O	_	_
6	30820	30821	CD	6	O	_	_
Wang	30822	30826	NNP	Wang	O	_	_
Z	30827	30828	NN	z	O	_	_
,	30829	30830	,	,	O	_	_
Liu	30831	30834	NNP	Liu	O	_	_
Y	30835	30836	NN	y	O	_	_
,	30837	30838	,	,	O	_	_
Takahashi	30839	30848	NNP	Takahashi	O	_	_
M	30849	30850	NNP	M	O	_	_
,	30851	30852	,	,	O	_	_
Van	30853	30856	NNP	Van	O	_	_
Hook	30857	30861	NNP	Hook	O	_	_
K	30862	30863	NNP	K	O	_	_
,	30864	30865	,	,	O	_	_
Kampa-Schittenhelm	30866	30884	NNP	Kampa-Schittenhelm	O	_	_
KM	30885	30887	NNP	KM	O	_	_
et	30888	30890	FW	et	O	_	_
al.	30891	30894	FW	al.	O	_	_
(	30895	30896	FW	(	O	_	_
2013	30897	30901	CD	2013	O	_	_
)	30902	30903	CD	)	O	_	_
N	30905	30906	NN	n	O	_	_
terminus	30907	30915	NN	terminus	O	_	_
of	30916	30918	IN	of	O	_	_
ASPP2	30919	30924	NN	aspp2	B-GENE	_	_
binds	30925	30930	VBZ	bind	O	_	_
to	30931	30933	TO	to	O	_	_
Ras	30934	30937	NN	ra	B-GENE	_	_
and	30938	30941	CC	and	O	_	_
enhances	30942	30950	VBZ	enhance	O	_	_
Ras	30951	30954	NN	ra	B-GENE	_	_
/	30954	30955	:	/	B-GENE	_	_
Raf/MEK	30955	30962	NN	raf/mek	B-GENE	_	_
/	30962	30963	:	/	B-GENE	_	_
ERK	30963	30966	NN	erk	I-GENE	_	_
activation	30967	30977	NN	activation	O	_	_
to	30978	30980	TO	to	O	_	_
promote	30981	30988	VB	promote	O	_	_
oncogene	30989	30997	NN	oncogene	O	_	_
induced	30998	31005	VBN	induce	O	_	_
senescence	31006	31016	NN	senescence	O	_	_
.	31017	31018	.	.	O	_	_
D	1
2
2	0	nn
2	1	nn
2	3	dep
2	5	dep
2	9	punct
2	40	dep
2	44	dep
5	8	dep
8	7	number
11	10	num
11	14	dep
11	37	dep
11	39	prep_of
14	13	number
17	15	num
17	16	nn
17	20	appos
17	23	appos
17	27	appos
17	29	appos
20	19	nn
23	22	nn
27	25	nn
27	26	nn
33	17	dep
33	30	dep
33	31	nn
33	32	nn
33	35	dep
35	34	num
37	33	dep
37	36	nn
40	11	nsubj
40	42	prep_to
40	44	conj_and
44	11	nsubj
44	45	dobj
45	47	dep
45	52	vmod
47	46	punct
47	48	punct
50	49	nn
52	50	nsubj
52	51	aux
52	53	dobj
53	54	vmod
54	55	dobj
EOX
Y	1
ROOT	0	0	57	1	FRAG	0	0	57	4	NP	0	0	9	3	NP	0	0	4	2	NP	2	0	3	3	NNP	0	0	1	1	Nat	0	0	1	0	NN	0	1	2	1	Rev	1	1	2	0	NN	0	2	3	1	Cancer	2	2	3	0	NP	0	3	4	1	CD	0	3	4	1	6	3	3	4	0	:	0	4	5	1	:	4	4	5	0	NP	0	5	9	3	NP	0	5	6	1	CD	0	5	6	1	217	5	5	6	0	:	0	6	7	1	-	6	6	7	0	NP	0	7	9	1	QP	1	7	9	2	CD	0	7	8	1	226	7	7	8	0	CD	0	8	9	1	.10.1038	8	8	9	0	:	0	9	10	1	/	9	9	10	0	S	1	10	56	2	NP	0	10	40	2	NP	0	10	38	4	NP	1	10	12	2	CD	0	10	11	1	nrc1818	10	10	11	0	NNP	0	11	12	1	PubMed	11	11	12	0	:	0	12	13	1	:	12	12	13	0	NP	0	13	15	1	QP	0	13	15	2	CD	0	13	14	1	16498444	13	13	14	0	CD	0	14	15	1	16498444	14	14	15	0	X	1	15	38	2	X	2	15	36	3	NP	0	15	30	9	NP	2	15	18	3	CD	0	15	16	1	6	15	15	16	0	NNP	0	16	17	1	Wang	16	16	17	0	NN	0	17	18	1	Z	17	17	18	0	,	0	18	19	1	,	18	18	19	0	NP	1	19	21	2	NNP	0	19	20	1	Liu	19	19	20	0	NN	0	20	21	1	Y	20	20	21	0	,	0	21	22	1	,	21	21	22	0	NP	1	22	24	2	NNP	0	22	23	1	Takahashi	22	22	23	0	NNP	0	23	24	1	M	23	23	24	0	,	0	24	25	1	,	24	24	25	0	NP	2	25	28	3	NNP	0	25	26	1	Van	25	25	26	0	NNP	0	26	27	1	Hook	26	26	27	0	NNP	0	27	28	1	K	27	27	28	0	,	0	28	29	1	,	28	28	29	0	NP	0	29	30	1	NNP	0	29	30	1	Kampa-Schittenhelm	29	29	30	0	NP	0	30	31	1	NNP	0	30	31	1	KM	30	30	31	0	NP	0	31	36	2	NP	2	31	34	3	FW	0	31	32	1	et	31	31	32	0	FW	0	32	33	1	al.	32	32	33	0	FW	0	33	34	1	(	33	33	34	0	NP	1	34	36	2	CD	0	34	35	1	2013	34	34	35	0	CD	0	35	36	1	)	35	35	36	0	NP	1	36	38	2	NN	0	36	37	1	N	36	36	37	0	NN	0	37	38	1	terminus	37	37	38	0	PP	0	38	40	2	IN	0	38	39	1	of	38	38	39	0	NP	0	39	40	1	NN	0	39	40	1	ASPP2	39	39	40	0	VP	0	40	56	3	VP	0	40	43	2	VBZ	0	40	41	1	binds	40	40	41	0	PP	0	41	43	2	TO	0	41	42	1	to	41	41	42	0	NP	0	42	43	1	NN	0	42	43	1	Ras	42	42	43	0	CC	0	43	44	1	and	43	43	44	0	VP	0	44	56	2	VBZ	0	44	45	1	enhances	44	44	45	0	NP	0	45	56	3	NP	0	45	46	1	NN	0	45	46	1	Ras	45	45	46	0	PRN	1	46	49	3	:	0	46	47	1	/	46	46	47	0	NP	0	47	48	1	NN	0	47	48	1	Raf/MEK	47	47	48	0	:	0	48	49	1	/	48	48	49	0	SBAR	0	49	56	1	S	1	49	56	2	NP	1	49	51	2	NN	0	49	50	1	ERK	49	49	50	0	NN	0	50	51	1	activation	50	50	51	0	VP	1	51	56	2	TO	0	51	52	1	to	51	51	52	0	VP	0	52	56	2	VB	0	52	53	1	promote	52	52	53	0	NP	0	53	56	2	NP	0	53	54	1	NN	0	53	54	1	oncogene	53	53	54	0	VP	0	54	56	2	VBN	0	54	55	1	induced	54	54	55	0	NP	0	55	56	1	NN	0	55	56	1	senescence	55	55	56	0	.	0	56	57	1	.	56	56	57	0
EOS
T	50
Proc	31019	31023	NNP	Proc	O	_	_
Natl	31024	31028	NNP	Natl	O	_	_
Acad	31029	31033	NNP	Acad	O	_	_
Sci	31034	31037	NNP	Sci	O	_	_
U	31038	31039	NNP	U	O	_	_
S	31040	31041	NNP	S	O	_	_
A	31042	31043	NNP	A	O	_	_
110	31044	31047	CD	110	O	_	_
:	31048	31049	:	:	O	_	_
312	31050	31053	CD	312	O	_	_
-	31054	31055	:	-	O	_	_
317	31056	31059	CD	317	O	_	_
.10.1073	31060	31068	CD	.10.1073	O	_	_
/	31068	31069	:	/	O	_	_
pnas	31069	31073	NNS	pna	O	_	_
.1201514110	31073	31084	CD	.1201514110	O	_	_
PubMed	31085	31091	NNP	PubMed	O	_	_
:	31091	31092	:	:	O	_	_
23248303	31093	31101	CD	23248303	O	_	_
23248303	31102	31110	CD	23248303	O	_	_
7	31111	31112	CD	7	O	_	_
Cong	31113	31117	NNP	Cong	O	_	_
W	31118	31119	NNP	W	O	_	_
,	31120	31121	,	,	O	_	_
Hirose	31122	31128	NNP	Hirose	O	_	_
T	31129	31130	NN	t	O	_	_
,	31131	31132	,	,	O	_	_
Harita	31133	31139	FW	harita	O	_	_
Y	31140	31141	NN	y	O	_	_
,	31142	31143	,	,	O	_	_
Yamashita	31144	31153	NNP	Yamashita	O	_	_
A	31154	31155	NNP	A	O	_	_
,	31156	31157	,	,	O	_	_
Mizuno	31158	31164	NNP	Mizuno	O	_	_
K	31165	31166	NNP	K	O	_	_
et	31167	31169	FW	et	O	_	_
al.	31170	31173	FW	al.	O	_	_
(	31174	31175	FW	(	O	_	_
2010	31176	31180	CD	2010	O	_	_
)	31181	31182	CD	)	O	_	_
ASPP2	31184	31189	NN	aspp2	O	_	_
regulates	31190	31199	VBZ	regulate	O	_	_
epithelial	31200	31210	JJ	epithelial	O	_	_
cell	31211	31215	NN	cell	O	_	_
polarity	31216	31224	NN	polarity	O	_	_
through	31225	31232	IN	through	O	_	_
the	31233	31236	DT	the	O	_	_
PAR	31237	31240	NN	par	O	_	_
complex	31241	31248	NN	complex	O	_	_
.	31249	31250	.	.	O	_	_
D	1
6
6	0	nn
6	1	nn
6	2	nn
6	3	nn
6	4	nn
6	5	nn
6	7	num
6	9	dep
6	13	punct
6	41	dep
9	12	dep
12	11	number
14	16	dep
14	22	dep
16	15	num
22	18	num
22	19	num
22	20	num
22	21	nn
22	25	appos
22	27	dep
22	28	dep
25	24	nn
28	31	appos
28	34	appos
31	30	nn
34	33	nn
34	37	dep
34	40	dep
37	35	nn
37	36	nn
40	38	num
40	39	num
41	14	nsubj
41	44	dobj
41	48	prep_through
44	42	amod
44	43	nn
48	46	det
48	47	nn
EOX
Y	1
ROOT	0	0	50	1	FRAG	0	0	50	4	NP	0	0	13	3	NP	6	0	8	8	NNP	0	0	1	1	Proc	0	0	1	0	NNP	0	1	2	1	Natl	1	1	2	0	NNP	0	2	3	1	Acad	2	2	3	0	NNP	0	3	4	1	Sci	3	3	4	0	NNP	0	4	5	1	U	4	4	5	0	NNP	0	5	6	1	S	5	5	6	0	NNP	0	6	7	1	A	6	6	7	0	CD	0	7	8	1	110	7	7	8	0	:	0	8	9	1	:	8	8	9	0	NP	0	9	13	3	NP	0	9	10	1	CD	0	9	10	1	312	9	9	10	0	:	0	10	11	1	-	10	10	11	0	NP	0	11	13	1	QP	1	11	13	2	CD	0	11	12	1	317	11	11	12	0	CD	0	12	13	1	.10.1073	12	12	13	0	:	0	13	14	1	/	13	13	14	0	S	1	14	49	2	NP	0	14	41	3	NP	0	14	15	1	NNS	0	14	15	1	pnas	14	14	15	0	NP	1	15	17	2	CD	0	15	16	1	.1201514110	15	15	16	0	NNP	0	16	17	1	PubMed	16	16	17	0	NP	1	17	41	5	:	0	17	18	1	:	17	17	18	0	NP	0	18	26	3	NP	4	18	23	5	CD	0	18	19	1	23248303	18	18	19	0	CD	0	19	20	1	23248303	19	19	20	0	CD	0	20	21	1	7	20	20	21	0	NNP	0	21	22	1	Cong	21	21	22	0	NNP	0	22	23	1	W	22	22	23	0	,	0	23	24	1	,	23	23	24	0	NP	1	24	26	2	NNP	0	24	25	1	Hirose	24	24	25	0	NN	0	25	26	1	T	25	25	26	0	,	0	26	27	1	,	26	26	27	0	FW	0	27	28	1	Harita	27	27	28	0	NP	0	28	41	5	NP	0	28	29	1	NN	0	28	29	1	Y	28	28	29	0	,	0	29	30	1	,	29	29	30	0	NP	1	30	32	2	NNP	0	30	31	1	Yamashita	30	30	31	0	NNP	0	31	32	1	A	31	31	32	0	,	0	32	33	1	,	32	32	33	0	NP	0	33	41	3	NP	1	33	35	2	NNP	0	33	34	1	Mizuno	33	33	34	0	NNP	0	34	35	1	K	34	34	35	0	NP	2	35	38	3	FW	0	35	36	1	et	35	35	36	0	FW	0	36	37	1	al.	36	36	37	0	FW	0	37	38	1	(	37	37	38	0	NP	2	38	41	3	CD	0	38	39	1	2010	38	38	39	0	CD	0	39	40	1	)	39	39	40	0	NN	0	40	41	1	ASPP2	40	40	41	0	VP	0	41	49	3	VBZ	0	41	42	1	regulates	41	41	42	0	NP	2	42	45	3	JJ	0	42	43	1	epithelial	42	42	43	0	NN	0	43	44	1	cell	43	43	44	0	NN	0	44	45	1	polarity	44	44	45	0	PP	0	45	49	2	IN	0	45	46	1	through	45	45	46	0	NP	2	46	49	3	DT	0	46	47	1	the	46	46	47	0	NN	0	47	48	1	PAR	47	47	48	0	NN	0	48	49	1	complex	48	48	49	0	.	0	49	50	1	.	49	49	50	0
EOS
T	51
Curr	31251	31255	NNP	Curr	O	_	_
Biol	31256	31260	NNP	Biol	O	_	_
20	31261	31263	CD	20	O	_	_
:	31264	31265	:	:	O	_	_
1408	31266	31270	CD	1408	O	_	_
-	31271	31272	:	-	O	_	_
1414	31273	31277	CD	1414	O	_	_
.10.1016	31278	31286	CD	.10.1016	O	_	_
/	31286	31287	:	/	O	_	_
j.cub	31287	31292	NN	j.cub	O	_	_
.2010.06.024	31292	31304	CD	.2010.06.024	O	_	_
PubMed	31305	31311	NNP	PubMed	O	_	_
:	31311	31312	:	:	O	_	_
20619648	31313	31321	CD	20619648	O	_	_
20619648	31322	31330	CD	20619648	O	_	_
8	31331	31332	CD	8	O	_	_
Sottocornola	31333	31345	NN	sottocornolum	O	_	_
R	31346	31347	NN	r	O	_	_
,	31348	31349	,	,	O	_	_
Royer	31350	31355	NNP	Royer	O	_	_
C	31356	31357	NNP	C	O	_	_
,	31358	31359	,	,	O	_	_
Vives	31360	31365	NNP	Vives	O	_	_
V	31366	31367	NNP	V	O	_	_
,	31368	31369	,	,	O	_	_
Tordella	31370	31378	NNP	Tordella	O	_	_
L	31379	31380	NNP	L	O	_	_
,	31381	31382	,	,	O	_	_
Zhong	31383	31388	NNP	Zhong	O	_	_
S	31389	31390	NNP	S	O	_	_
et	31391	31393	FW	et	O	_	_
al.	31394	31397	FW	al.	O	_	_
(	31398	31399	FW	(	O	_	_
2010	31400	31404	CD	2010	O	_	_
)	31405	31406	CD	)	O	_	_
ASPP2	31408	31413	NN	aspp2	B-GENE	_	_
binds	31414	31419	VBZ	bind	O	_	_
Par-3	31420	31425	NN	par-3	O	_	_
and	31426	31429	CC	and	O	_	_
controls	31430	31438	VBZ	control	O	_	_
the	31439	31442	DT	the	O	_	_
polarity	31443	31451	NN	polarity	O	_	_
and	31452	31455	CC	and	O	_	_
proliferation	31456	31469	NN	proliferation	O	_	_
of	31470	31472	IN	of	O	_	_
neural	31473	31479	JJ	neural	O	_	_
progenitors	31480	31491	NNS	progenitor	O	_	_
during	31492	31498	IN	during	O	_	_
CNS	31499	31502	NN	cn	O	_	_
development	31503	31514	NN	development	O	_	_
.	31515	31516	.	.	O	_	_
D	1
36
1	0	nn
1	2	dep
1	4	dep
1	14	dep
1	20	appos
4	7	dep
4	11	dep
7	6	number
7	8	punct
11	9	nn
11	10	num
14	13	number
14	17	dep
17	15	num
17	16	nn
20	19	nn
20	23	appos
20	26	appos
20	29	appos
23	22	nn
26	25	nn
29	28	nn
29	32	dep
29	35	dep
32	30	nn
32	31	nn
35	33	num
35	34	num
36	1	nsubj
36	37	dobj
36	39	conj_and
39	1	nsubj
39	41	dobj
39	43	dobj
39	49	prep_during
41	40	det
41	43	conj_and
41	46	prep_of
46	45	amod
49	48	nn
EOX
Y	1
ROOT	0	0	51	1	S	1	0	51	3	NP	0	0	36	3	NP	0	0	18	5	NP	0	0	3	2	NP	1	0	2	2	NNP	0	0	1	1	Curr	0	0	1	0	NNP	0	1	2	1	Biol	1	1	2	0	NP	0	2	3	1	CD	0	2	3	1	20	2	2	3	0	:	0	3	4	1	:	3	3	4	0	NP	0	4	12	3	NP	0	4	5	1	CD	0	4	5	1	1408	4	4	5	0	PRN	1	5	9	3	:	0	5	6	1	-	5	5	6	0	NP	0	6	8	1	QP	1	6	8	2	CD	0	6	7	1	1414	6	6	7	0	CD	0	7	8	1	.10.1016	7	7	8	0	:	0	8	9	1	/	8	8	9	0	NP	2	9	12	3	NN	0	9	10	1	j.cub	9	9	10	0	CD	0	10	11	1	.2010.06.024	10	10	11	0	NNP	0	11	12	1	PubMed	11	11	12	0	:	0	12	13	1	:	12	12	13	0	NP	0	13	18	2	NP	0	13	15	1	QP	0	13	15	2	CD	0	13	14	1	20619648	13	13	14	0	CD	0	14	15	1	20619648	14	14	15	0	NP	2	15	18	3	CD	0	15	16	1	8	15	15	16	0	NN	0	16	17	1	Sottocornola	16	16	17	0	NN	0	17	18	1	R	17	17	18	0	,	0	18	19	1	,	18	18	19	0	NP	0	19	36	7	NP	1	19	21	2	NNP	0	19	20	1	Royer	19	19	20	0	NNP	0	20	21	1	C	20	20	21	0	,	0	21	22	1	,	21	21	22	0	NP	1	22	24	2	NNP	0	22	23	1	Vives	22	22	23	0	NNP	0	23	24	1	V	23	23	24	0	,	0	24	25	1	,	24	24	25	0	NP	1	25	27	2	NNP	0	25	26	1	Tordella	25	25	26	0	NNP	0	26	27	1	L	26	26	27	0	,	0	27	28	1	,	27	27	28	0	NP	0	28	36	3	NP	1	28	30	2	NNP	0	28	29	1	Zhong	28	28	29	0	NNP	0	29	30	1	S	29	29	30	0	NP	2	30	33	3	FW	0	30	31	1	et	30	30	31	0	FW	0	31	32	1	al.	31	31	32	0	FW	0	32	33	1	(	32	32	33	0	NP	2	33	36	3	CD	0	33	34	1	2010	33	33	34	0	CD	0	34	35	1	)	34	34	35	0	NN	0	35	36	1	ASPP2	35	35	36	0	VP	0	36	50	3	VP	0	36	38	2	VBZ	0	36	37	1	binds	36	36	37	0	NP	0	37	38	1	NN	0	37	38	1	Par-3	37	37	38	0	CC	0	38	39	1	and	38	38	39	0	VP	0	39	50	3	VBZ	0	39	40	1	controls	39	39	40	0	NP	0	40	47	2	NP	1	40	44	4	DT	0	40	41	1	the	40	40	41	0	NN	0	41	42	1	polarity	41	41	42	0	CC	0	42	43	1	and	42	42	43	0	NN	0	43	44	1	proliferation	43	43	44	0	PP	0	44	47	2	IN	0	44	45	1	of	44	44	45	0	NP	1	45	47	2	JJ	0	45	46	1	neural	45	45	46	0	NNS	0	46	47	1	progenitors	46	46	47	0	PP	0	47	50	2	IN	0	47	48	1	during	47	47	48	0	NP	1	48	50	2	NN	0	48	49	1	CNS	48	48	49	0	NN	0	49	50	1	development	49	49	50	0	.	0	50	51	1	.	50	50	51	0
EOS
T	45
Dev	31517	31520	NNP	Dev	O	_	_
Cell	31521	31525	NNP	Cell	O	_	_
19	31526	31528	CD	19	O	_	_
:	31529	31530	:	:	O	_	_
126	31531	31534	CD	126	O	_	_
-	31535	31536	:	-	O	_	_
137	31537	31540	CD	137	O	_	_
.10.1016	31541	31549	CD	.10.1016	O	_	_
/	31549	31550	:	/	O	_	_
j.devcel	31550	31558	NN	j.devcel	O	_	_
.2010.06.003	31558	31570	CD	.2010.06.003	O	_	_
PubMed	31571	31577	NNP	PubMed	O	_	_
:	31577	31578	:	:	O	_	_
20619750	31579	31587	CD	20619750	O	_	_
20619750	31588	31596	CD	20619750	O	_	_
9	31597	31598	CD	9	O	_	_
Samuels-Lev	31599	31610	NNP	Samuels-Lev	O	_	_
Y	31611	31612	NN	y	O	_	_
,	31613	31614	,	,	O	_	_
O'Connor	31615	31623	NNP	O'Connor	O	_	_
DJ	31624	31626	NNP	DJ	O	_	_
,	31627	31628	,	,	O	_	_
Bergamaschi	31629	31640	NNP	Bergamaschi	O	_	_
D	31641	31642	NNP	D	O	_	_
,	31643	31644	,	,	O	_	_
Trigiante	31645	31654	NNP	Trigiante	O	_	_
G	31655	31656	NNP	G	O	_	_
,	31657	31658	,	,	O	_	_
Hsieh	31659	31664	NNP	Hsieh	O	_	_
JK	31665	31667	NNP	JK	O	_	_
et	31668	31670	FW	et	O	_	_
al.	31671	31674	FW	al.	O	_	_
(	31675	31676	FW	(	O	_	_
2001	31677	31681	CD	2001	O	_	_
)	31682	31683	CD	)	O	_	_
ASPP	31685	31689	NN	aspp	O	_	_
proteins	31690	31698	NNS	protein	O	_	_
specifically	31699	31711	RB	specifically	O	_	_
stimulate	31712	31721	VBP	stimulate	O	_	_
the	31722	31725	DT	the	O	_	_
apoptotic	31726	31735	JJ	apoptotic	O	_	_
function	31736	31744	NN	function	O	_	_
of	31745	31747	IN	of	O	_	_
p53	31748	31751	NN	p53	B-GENE	_	_
.	31752	31753	.	.	O	_	_
D	1
1
1	0	nn
1	2	dep
1	4	dep
1	8	punct
1	38	dep
4	7	dep
7	6	number
11	9	nn
11	10	num
11	14	dep
11	32	dep
11	37	advmod
14	13	number
17	15	num
17	16	nn
17	20	appos
17	23	appos
17	26	appos
17	28	appos
20	19	nn
23	22	nn
26	25	nn
32	17	dep
32	29	dep
32	30	nn
32	31	nn
32	33	dep
33	36	dep
36	34	num
36	35	nn
38	11	nsubj
38	41	dobj
41	39	det
41	40	amod
41	43	prep_of
EOX
Y	1
ROOT	0	0	45	1	FRAG	0	0	45	4	NP	0	0	8	3	NP	0	0	3	2	NP	1	0	2	2	NNP	0	0	1	1	Dev	0	0	1	0	NNP	0	1	2	1	Cell	1	1	2	0	NP	0	2	3	1	CD	0	2	3	1	19	2	2	3	0	:	0	3	4	1	:	3	3	4	0	NP	0	4	8	3	NP	0	4	5	1	CD	0	4	5	1	126	4	4	5	0	:	0	5	6	1	-	5	5	6	0	NP	0	6	8	1	QP	1	6	8	2	CD	0	6	7	1	137	6	6	7	0	CD	0	7	8	1	.10.1016	7	7	8	0	:	0	8	9	1	/	8	8	9	0	S	1	9	44	2	NP	0	9	38	2	NP	0	9	37	4	NP	2	9	12	3	NN	0	9	10	1	j.devcel	9	9	10	0	CD	0	10	11	1	.2010.06.003	10	10	11	0	NNP	0	11	12	1	PubMed	11	11	12	0	:	0	12	13	1	:	12	12	13	0	NP	0	13	15	1	QP	0	13	15	2	CD	0	13	14	1	20619750	13	13	14	0	CD	0	14	15	1	20619750	14	14	15	0	X	2	15	37	3	NP	0	15	29	9	NP	2	15	18	3	CD	0	15	16	1	9	15	15	16	0	NNP	0	16	17	1	Samuels-Lev	16	16	17	0	NN	0	17	18	1	Y	17	17	18	0	,	0	18	19	1	,	18	18	19	0	NP	1	19	21	2	NNP	0	19	20	1	O'Connor	19	19	20	0	NNP	0	20	21	1	DJ	20	20	21	0	,	0	21	22	1	,	21	21	22	0	NP	1	22	24	2	NNP	0	22	23	1	Bergamaschi	22	22	23	0	NNP	0	23	24	1	D	23	23	24	0	,	0	24	25	1	,	24	24	25	0	NP	1	25	27	2	NNP	0	25	26	1	Trigiante	25	25	26	0	NNP	0	26	27	1	G	26	26	27	0	,	0	27	28	1	,	27	27	28	0	NP	0	28	29	1	NNP	0	28	29	1	Hsieh	28	28	29	0	NP	0	29	30	1	NNP	0	29	30	1	JK	29	29	30	0	NP	0	30	37	2	NP	2	30	33	3	FW	0	30	31	1	et	30	30	31	0	FW	0	31	32	1	al.	31	31	32	0	FW	0	32	33	1	(	32	32	33	0	NP	0	33	37	2	NP	0	33	34	1	CD	0	33	34	1	2001	33	33	34	0	NP	2	34	37	3	CD	0	34	35	1	)	34	34	35	0	NN	0	35	36	1	ASPP	35	35	36	0	NNS	0	36	37	1	proteins	36	36	37	0	ADVP	0	37	38	1	RB	0	37	38	1	specifically	37	37	38	0	VP	0	38	44	2	VBP	0	38	39	1	stimulate	38	38	39	0	NP	0	39	44	2	NP	2	39	42	3	DT	0	39	40	1	the	39	39	40	0	JJ	0	40	41	1	apoptotic	40	40	41	0	NN	0	41	42	1	function	41	41	42	0	PP	0	42	44	2	IN	0	42	43	1	of	42	42	43	0	NP	0	43	44	1	NN	0	43	44	1	p53	43	43	44	0	.	0	44	45	1	.	44	44	45	0
EOS
T	48
Mol	31754	31757	NNP	Mol	O	_	_
Cell	31758	31762	NNP	Cell	O	_	_
8	31763	31764	CD	8	O	_	_
:	31765	31766	:	:	O	_	_
781	31767	31770	CD	781	O	_	_
-	31771	31772	:	-	O	_	_
794	31773	31776	CD	794	O	_	_
.10.1016	31777	31785	CD	.10.1016	O	_	_
/	31785	31786	:	/	O	_	_
S1097-2765	31786	31796	CD	s1097-2765	O	_	_
(	31796	31797	CD	(	O	_	_
01	31797	31799	CD	01	O	_	_
)	31799	31800	NN	)	O	_	_
00367-7	31800	31807	CD	00367-7	O	_	_
PubMed	31808	31814	NNP	PubMed	O	_	_
:	31814	31815	:	:	O	_	_
11684014	31816	31824	CD	11684014	O	_	_
11684014	31825	31833	CD	11684014	O	_	_
10	31834	31836	CD	10	O	_	_
Wang	31837	31841	NNP	Wang	O	_	_
Y	31842	31843	NN	y	O	_	_
,	31844	31845	,	,	O	_	_
Wang	31846	31850	NNP	Wang	O	_	_
XD	31851	31853	NNP	XD	O	_	_
,	31854	31855	,	,	O	_	_
Lapi	31856	31860	NNP	Lapi	O	_	_
E	31861	31862	NNP	E	O	_	_
,	31863	31864	,	,	O	_	_
Sullivan	31865	31873	NNP	Sullivan	O	_	_
A	31874	31875	NNP	A	O	_	_
,	31876	31877	,	,	O	_	_
Jia	31878	31881	NNP	Jia	O	_	_
W	31882	31883	NNP	W	O	_	_
et	31884	31886	FW	et	O	_	_
al.	31887	31890	FW	al.	O	_	_
(	31891	31892	FW	(	O	_	_
2012	31893	31897	CD	2012	O	_	_
)	31898	31899	CD	)	O	_	_
Autophagic	31901	31911	NN	autophagic	O	_	_
activity	31912	31920	NN	activity	O	_	_
dictates	31921	31929	VBZ	dictate	O	_	_
the	31930	31933	DT	the	O	_	_
cellular	31934	31942	JJ	cellular	O	_	_
response	31943	31951	NN	response	O	_	_
to	31952	31954	TO	to	O	_	_
oncogenic	31955	31964	JJ	oncogenic	O	_	_
RAS	31965	31968	NN	ra	O	_	_
.	31969	31970	.	.	O	_	_
D	1
40
1	0	nn
1	2	dep
1	4	dep
1	8	punct
1	9	dep
4	7	dep
7	6	num
9	11	dep
11	10	number
11	14	dep
11	17	dep
14	12	nn
14	13	num
17	16	number
17	20	dep
20	18	num
20	19	nn
23	22	nn
26	25	nn
26	29	appos
26	31	appos
29	28	nn
35	26	dep
35	32	dep
35	33	nn
35	34	nn
35	36	dep
39	37	num
39	38	nn
40	1	dep
40	23	nsubj
40	35	dep
40	39	nsubj
40	43	dobj
40	46	prep_to
43	41	det
43	42	amod
46	45	amod
EOX
Y	1
ROOT	0	0	48	1	S	6	0	48	8	FRAG	0	0	21	3	FRAG	0	0	8	3	NP	0	0	3	2	NP	1	0	2	2	NNP	0	0	1	1	Mol	0	0	1	0	NNP	0	1	2	1	Cell	1	1	2	0	NP	0	2	3	1	CD	0	2	3	1	8	2	2	3	0	:	0	3	4	1	:	3	3	4	0	NP	0	4	8	3	NP	0	4	5	1	CD	0	4	5	1	781	4	4	5	0	:	0	5	6	1	-	5	5	6	0	NP	1	6	8	2	CD	0	6	7	1	794	6	6	7	0	CD	0	7	8	1	.10.1016	7	7	8	0	:	0	8	9	1	/	8	8	9	0	FRAG	0	9	21	2	NP	0	9	10	1	CD	0	9	10	1	S1097-2765	9	9	10	0	NP	0	10	21	3	NP	0	10	15	2	NP	0	10	12	1	QP	1	10	12	2	CD	0	10	11	1	(	10	10	11	0	CD	0	11	12	1	01	11	11	12	0	NP	2	12	15	3	NN	0	12	13	1	)	12	12	13	0	CD	0	13	14	1	00367-7	13	13	14	0	NNP	0	14	15	1	PubMed	14	14	15	0	:	0	15	16	1	:	15	15	16	0	NP	0	16	21	2	NP	0	16	18	1	QP	0	16	18	2	CD	0	16	17	1	11684014	16	16	17	0	CD	0	17	18	1	11684014	17	17	18	0	NP	2	18	21	3	CD	0	18	19	1	10	18	18	19	0	NNP	0	19	20	1	Wang	19	19	20	0	NN	0	20	21	1	Y	20	20	21	0	,	0	21	22	1	,	21	21	22	0	NP	1	22	24	2	NNP	0	22	23	1	Wang	22	22	23	0	NNP	0	23	24	1	XD	23	23	24	0	,	0	24	25	1	,	24	24	25	0	X	2	25	37	3	NP	0	25	32	5	NP	1	25	27	2	NNP	0	25	26	1	Lapi	25	25	26	0	NNP	0	26	27	1	E	26	26	27	0	,	0	27	28	1	,	27	27	28	0	NP	1	28	30	2	NNP	0	28	29	1	Sullivan	28	28	29	0	NNP	0	29	30	1	A	29	29	30	0	,	0	30	31	1	,	30	30	31	0	NP	0	31	32	1	NNP	0	31	32	1	Jia	31	31	32	0	NP	0	32	33	1	NNP	0	32	33	1	W	32	32	33	0	NP	0	33	37	2	NP	2	33	36	3	FW	0	33	34	1	et	33	33	34	0	FW	0	34	35	1	al.	34	34	35	0	FW	0	35	36	1	(	35	35	36	0	NP	0	36	37	1	CD	0	36	37	1	2012	36	36	37	0	NP	2	37	40	3	CD	0	37	38	1	)	37	37	38	0	NN	0	38	39	1	Autophagic	38	38	39	0	NN	0	39	40	1	activity	39	39	40	0	VP	0	40	47	3	VBZ	0	40	41	1	dictates	40	40	41	0	NP	2	41	44	3	DT	0	41	42	1	the	41	41	42	0	JJ	0	42	43	1	cellular	42	42	43	0	NN	0	43	44	1	response	43	43	44	0	PP	0	44	47	2	TO	0	44	45	1	to	44	44	45	0	NP	1	45	47	2	JJ	0	45	46	1	oncogenic	45	45	46	0	NN	0	46	47	1	RAS	46	46	47	0	.	0	47	48	1	.	47	47	48	0
EOS
T	56
Proc	31971	31975	NNP	Proc	O	_	_
Natl	31976	31980	NNP	Natl	O	_	_
Acad	31981	31985	NNP	Acad	O	_	_
Sci	31986	31989	NNP	Sci	O	_	_
U	31990	31991	NNP	U	O	_	_
S	31992	31993	NNP	S	O	_	_
A	31994	31995	NNP	A	O	_	_
109	31996	31999	CD	109	O	_	_
:	32000	32001	:	:	O	_	_
13325	32002	32007	CD	13325	O	_	_
-	32008	32009	:	-	O	_	_
13330	32010	32015	CD	13330	O	_	_
.10.1073	32016	32024	CD	.10.1073	O	_	_
/	32024	32025	:	/	O	_	_
pnas	32025	32029	NNS	pna	O	_	_
.1120193109	32029	32040	CD	.1120193109	O	_	_
PubMed	32041	32047	NNP	PubMed	O	_	_
:	32047	32048	:	:	O	_	_
22847423	32049	32057	CD	22847423	O	_	_
22847423	32058	32066	CD	22847423	O	_	_
11	32067	32069	CD	11	O	_	_
Wang	32070	32074	NNP	Wang	O	_	_
Y	32075	32076	NN	y	O	_	_
,	32077	32078	,	,	O	_	_
Ngo	32079	32082	NNP	Ngo	O	_	_
VN	32083	32085	NNP	VN	O	_	_
,	32086	32087	,	,	O	_	_
Marani	32088	32094	NNP	Marani	O	_	_
M	32095	32096	NNP	M	O	_	_
,	32097	32098	,	,	O	_	_
Yang	32099	32103	NNP	Yang	O	_	_
Y	32104	32105	NN	y	O	_	_
,	32106	32107	,	,	O	_	_
Wright	32108	32114	NNP	Wright	O	_	_
G	32115	32116	NNP	G	O	_	_
et	32117	32119	FW	et	O	_	_
al.	32120	32123	FW	al.	O	_	_
(	32124	32125	FW	(	O	_	_
2010	32126	32130	CD	2010	O	_	_
)	32131	32132	CD	)	O	_	_
Critical	32134	32142	JJ	critical	O	_	_
role	32143	32147	NN	role	O	_	_
for	32148	32151	IN	for	O	_	_
transcriptional	32152	32167	JJ	transcriptional	O	_	_
repressor	32168	32177	NN	repressor	O	_	_
Snail2	32178	32184	NN	snail2	B-GENE	_	_
in	32185	32187	IN	in	O	_	_
transformation	32188	32202	NN	transformation	O	_	_
by	32203	32205	IN	by	O	_	_
oncogenic	32206	32215	JJ	oncogenic	B-GENE	_	_
RAS	32216	32219	NN	ra	I-GENE	_	_
in	32220	32222	IN	in	O	_	_
colorectal	32223	32233	JJ	colorectal	O	_	_
carcinoma	32234	32243	NN	carcinoma	O	_	_
cells	32244	32249	NNS	cell	O	_	_
.	32250	32251	.	.	O	_	_
D	1
6
6	0	nn
6	1	nn
6	2	nn
6	3	nn
6	4	nn
6	5	nn
6	7	dep
6	12	dep
7	9	dep
12	11	num
12	13	punct
12	14	dep
14	16	dep
14	50	prep_by
14	54	prep_in
16	15	num
16	19	dep
16	41	dep
19	18	number
22	20	num
22	21	nn
22	25	appos
22	28	appos
22	31	appos
22	33	appos
25	24	nn
28	27	nn
31	30	nn
37	22	dep
37	34	dep
37	35	nn
37	36	nn
37	39	dep
39	38	num
41	37	dep
41	40	amod
41	45	prep_for
45	43	amod
45	44	nn
45	47	prep_in
50	49	amod
54	52	amod
54	53	nn
EOX
Y	1
ROOT	0	0	56	1	FRAG	0	0	56	3	FRAG	0	0	10	2	NP	6	0	7	7	NNP	0	0	1	1	Proc	0	0	1	0	NNP	0	1	2	1	Natl	1	1	2	0	NNP	0	2	3	1	Acad	2	2	3	0	NNP	0	3	4	1	Sci	3	3	4	0	NNP	0	4	5	1	U	4	4	5	0	NNP	0	5	6	1	S	5	5	6	0	NNP	0	6	7	1	A	6	6	7	0	NP	0	7	10	3	NP	0	7	8	1	CD	0	7	8	1	109	7	7	8	0	:	0	8	9	1	:	8	8	9	0	NP	0	9	10	1	CD	0	9	10	1	13325	9	9	10	0	:	0	10	11	1	-	10	10	11	0	FRAG	0	11	56	4	NP	1	11	13	2	CD	0	11	12	1	13330	11	11	12	0	CD	0	12	13	1	.10.1073	12	12	13	0	:	0	13	14	1	/	13	13	14	0	FRAG	0	14	55	3	NP	0	14	48	2	NP	0	14	15	1	NNS	0	14	15	1	pnas	14	14	15	0	NP	0	15	48	4	NP	1	15	17	2	CD	0	15	16	1	.1120193109	15	15	16	0	NNP	0	16	17	1	PubMed	16	16	17	0	:	0	17	18	1	:	17	17	18	0	NP	0	18	20	1	QP	0	18	20	2	CD	0	18	19	1	22847423	18	18	19	0	CD	0	19	20	1	22847423	19	19	20	0	X	1	20	48	2	X	2	20	40	3	NP	0	20	34	9	NP	2	20	23	3	CD	0	20	21	1	11	20	20	21	0	NNP	0	21	22	1	Wang	21	21	22	0	NN	0	22	23	1	Y	22	22	23	0	,	0	23	24	1	,	23	23	24	0	NP	1	24	26	2	NNP	0	24	25	1	Ngo	24	24	25	0	NNP	0	25	26	1	VN	25	25	26	0	,	0	26	27	1	,	26	26	27	0	NP	1	27	29	2	NNP	0	27	28	1	Marani	27	27	28	0	NNP	0	28	29	1	M	28	28	29	0	,	0	29	30	1	,	29	29	30	0	NP	1	30	32	2	NNP	0	30	31	1	Yang	30	30	31	0	NN	0	31	32	1	Y	31	31	32	0	,	0	32	33	1	,	32	32	33	0	NP	0	33	34	1	NNP	0	33	34	1	Wright	33	33	34	0	NP	0	34	35	1	NNP	0	34	35	1	G	34	34	35	0	NP	0	35	40	2	NP	2	35	38	3	FW	0	35	36	1	et	35	35	36	0	FW	0	36	37	1	al.	36	36	37	0	FW	0	37	38	1	(	37	37	38	0	NP	1	38	40	2	CD	0	38	39	1	2010	38	38	39	0	CD	0	39	40	1	)	39	39	40	0	NP	0	40	48	2	NP	1	40	42	2	JJ	0	40	41	1	Critical	40	40	41	0	NN	0	41	42	1	role	41	41	42	0	PP	0	42	48	2	IN	0	42	43	1	for	42	42	43	0	NP	0	43	48	2	NP	2	43	46	3	JJ	0	43	44	1	transcriptional	43	43	44	0	NN	0	44	45	1	repressor	44	44	45	0	NN	0	45	46	1	Snail2	45	45	46	0	PP	0	46	48	2	IN	0	46	47	1	in	46	46	47	0	NP	0	47	48	1	NN	0	47	48	1	transformation	47	47	48	0	PP	0	48	51	2	IN	0	48	49	1	by	48	48	49	0	NP	1	49	51	2	JJ	0	49	50	1	oncogenic	49	49	50	0	NN	0	50	51	1	RAS	50	50	51	0	PP	0	51	55	2	IN	0	51	52	1	in	51	51	52	0	NP	2	52	55	3	JJ	0	52	53	1	colorectal	52	52	53	0	NN	0	53	54	1	carcinoma	53	53	54	0	NNS	0	54	55	1	cells	54	54	55	0	.	0	55	56	1	.	55	55	56	0
EOS
T	65
Oncogene	32252	32260	NN	oncogene	O	_	_
29	32261	32263	CD	29	O	_	_
:	32264	32265	:	:	O	_	_
4658	32266	32270	CD	4658	O	_	_
-	32271	32272	:	-	O	_	_
4670	32273	32277	CD	4670	O	_	_
.10.1038	32278	32286	CD	.10.1038	O	_	_
/	32286	32287	:	/	O	_	_
onc	32287	32290	JJ	onc	O	_	_
.2010.218	32290	32299	CD	.2010.218	O	_	_
PubMed	32300	32306	NNP	PubMed	O	_	_
:	32306	32307	:	:	O	_	_
20562906	32308	32316	CD	20562906	O	_	_
20562906	32317	32325	CD	20562906	O	_	_
12	32326	32328	CD	12	O	_	_
Sapkota	32329	32336	NNP	Sapkota	O	_	_
GP	32337	32339	NN	gp	O	_	_
,	32340	32341	,	,	O	_	_
Boudeau	32342	32349	NNP	Boudeau	O	_	_
J	32350	32351	NNP	J	O	_	_
,	32352	32353	,	,	O	_	_
Deak	32354	32358	NNP	Deak	O	_	_
M	32359	32360	NNP	M	O	_	_
,	32361	32362	,	,	O	_	_
Kieloch	32363	32370	NNP	Kieloch	O	_	_
A	32371	32372	NNP	A	O	_	_
,	32373	32374	,	,	O	_	_
Morrice	32375	32382	NNP	Morrice	O	_	_
N	32383	32384	NNP	N	O	_	_
et	32385	32387	FW	et	O	_	_
al.	32388	32391	FW	al.	O	_	_
(	32392	32393	FW	(	O	_	_
2002	32394	32398	CD	2002	O	_	_
)	32399	32400	CD	)	O	_	_
Identification	32402	32416	NN	identification	O	_	_
and	32417	32420	CC	and	O	_	_
characterization	32421	32437	NN	characterization	O	_	_
of	32438	32440	IN	of	O	_	_
four	32441	32445	CD	four	O	_	_
novel	32446	32451	JJ	novel	O	_	_
phosphorylation	32452	32467	NN	phosphorylation	O	_	_
sites	32468	32473	NNS	site	O	_	_
(	32474	32475	VBP	(	O	_	_
Ser31	32475	32480	NN	ser31	O	_	_
,	32480	32481	,	,	O	_	_
Ser325	32482	32488	NN	ser325	O	_	_
,	32488	32489	,	,	O	_	_
Thr336	32490	32496	NN	thr336	O	_	_
and	32497	32500	CC	and	O	_	_
Thr366	32501	32507	NN	thr366	O	_	_
)	32507	32508	NN	)	O	_	_
on	32509	32511	IN	on	O	_	_
LKB1	32512	32516	NN	lkb1	B-GENE	_	_
/	32516	32517	:	/	B-GENE	_	_
STK11	32517	32522	NN	stk11	I-GENE	_	_
,	32522	32523	,	,	O	_	_
the	32524	32527	DT	the	O	_	_
protein	32528	32535	NN	protein	O	_	_
kinase	32536	32542	NN	kinase	O	_	_
mutated	32543	32550	VBN	mutate	O	_	_
in	32551	32553	IN	in	O	_	_
Peutz-Jeghers	32554	32567	NNP	Peutz-Jeghers	O	_	_
cancer	32568	32574	NN	cancer	O	_	_
syndrome	32575	32583	NN	syndrome	O	_	_
.	32584	32585	.	.	O	_	_
D	1
0
0	1	num
0	3	dep
3	6	dep
3	9	dep
3	54	dep
6	5	number
9	7	punct
9	8	amod
9	42	rcmod
9	53	punct
10	13	dep
10	31	dep
10	41	prep_of
13	12	number
16	14	num
16	15	nn
16	19	appos
16	22	appos
16	25	appos
16	27	appos
19	18	nn
22	21	nn
25	24	nn
31	16	dep
31	28	dep
31	29	nn
31	30	nn
31	34	dep
31	36	dep
34	32	num
34	33	num
34	36	conj_and
41	38	num
41	39	amod
41	40	nn
42	10	nsubj
42	50	dobj
42	52	prep_on
43	45	conj_and
43	47	conj_and
43	49	conj_and
50	43	nn
50	45	nn
50	47	nn
50	49	nn
54	58	appos
58	56	det
58	57	nn
58	59	vmod
59	63	prep_in
63	61	nn
63	62	nn
EOX
Y	1
ROOT	0	0	65	1	NP	0	0	65	4	NP	0	0	2	2	NN	0	0	1	1	Oncogene	0	0	1	0	CD	0	1	2	1	29	1	1	2	0	:	0	2	3	1	:	2	2	3	0	NP	0	3	64	2	NP	0	3	54	2	NP	0	3	7	3	NP	0	3	4	1	CD	0	3	4	1	4658	3	3	4	0	:	0	4	5	1	-	4	4	5	0	NP	0	5	7	1	QP	1	5	7	2	CD	0	5	6	1	4670	5	5	6	0	CD	0	6	7	1	.10.1038	6	6	7	0	PRN	1	7	54	3	:	0	7	8	1	/	7	7	8	0	NP	0	8	53	2	NP	1	8	10	2	JJ	0	8	9	1	onc	8	8	9	0	CD	0	9	10	1	.2010.218	9	9	10	0	SBAR	0	10	53	1	S	1	10	53	2	NP	0	10	42	2	NP	0	10	37	4	NP	0	10	11	1	NNP	0	10	11	1	PubMed	10	10	11	0	:	0	11	12	1	:	11	11	12	0	NP	0	12	14	1	QP	0	12	14	2	CD	0	12	13	1	20562906	12	12	13	0	CD	0	13	14	1	20562906	13	13	14	0	X	2	14	37	3	NP	0	14	28	9	NP	2	14	17	3	CD	0	14	15	1	12	14	14	15	0	NNP	0	15	16	1	Sapkota	15	15	16	0	NN	0	16	17	1	GP	16	16	17	0	,	0	17	18	1	,	17	17	18	0	NP	1	18	20	2	NNP	0	18	19	1	Boudeau	18	18	19	0	NNP	0	19	20	1	J	19	19	20	0	,	0	20	21	1	,	20	20	21	0	NP	1	21	23	2	NNP	0	21	22	1	Deak	21	21	22	0	NNP	0	22	23	1	M	22	22	23	0	,	0	23	24	1	,	23	23	24	0	NP	1	24	26	2	NNP	0	24	25	1	Kieloch	24	24	25	0	NNP	0	25	26	1	A	25	25	26	0	,	0	26	27	1	,	26	26	27	0	NP	0	27	28	1	NNP	0	27	28	1	Morrice	27	27	28	0	NP	0	28	29	1	NNP	0	28	29	1	N	28	28	29	0	NP	0	29	37	2	NP	2	29	32	3	FW	0	29	30	1	et	29	29	30	0	FW	0	30	31	1	al.	30	30	31	0	FW	0	31	32	1	(	31	31	32	0	NP	0	32	37	3	NP	2	32	35	3	CD	0	32	33	1	2002	32	32	33	0	CD	0	33	34	1	)	33	33	34	0	NN	0	34	35	1	Identification	34	34	35	0	CC	0	35	36	1	and	35	35	36	0	NP	0	36	37	1	NN	0	36	37	1	characterization	36	36	37	0	PP	0	37	42	2	IN	0	37	38	1	of	37	37	38	0	NP	3	38	42	4	CD	0	38	39	1	four	38	38	39	0	JJ	0	39	40	1	novel	39	39	40	0	NN	0	40	41	1	phosphorylation	40	40	41	0	NNS	0	41	42	1	sites	41	41	42	0	VP	0	42	53	3	VBP	0	42	43	1	(	42	42	43	0	NP	1	43	51	2	NP	0	43	50	7	NN	0	43	44	1	Ser31	43	43	44	0	,	0	44	45	1	,	44	44	45	0	NN	0	45	46	1	Ser325	45	45	46	0	,	0	46	47	1	,	46	46	47	0	NN	0	47	48	1	Thr336	47	47	48	0	CC	0	48	49	1	and	48	48	49	0	NN	0	49	50	1	Thr366	49	49	50	0	NN	0	50	51	1	)	50	50	51	0	PP	0	51	53	2	IN	0	51	52	1	on	51	51	52	0	NP	0	52	53	1	NN	0	52	53	1	LKB1	52	52	53	0	:	0	53	54	1	/	53	53	54	0	NP	0	54	64	3	NP	0	54	55	1	NN	0	54	55	1	STK11	54	54	55	0	,	0	55	56	1	,	55	55	56	0	NP	0	56	64	2	NP	2	56	59	3	DT	0	56	57	1	the	56	56	57	0	NN	0	57	58	1	protein	57	57	58	0	NN	0	58	59	1	kinase	58	58	59	0	VP	0	59	64	2	VBN	0	59	60	1	mutated	59	59	60	0	PP	0	60	64	2	IN	0	60	61	1	in	60	60	61	0	NP	2	61	64	3	NNP	0	61	62	1	Peutz-Jeghers	61	61	62	0	NN	0	62	63	1	cancer	62	62	63	0	NN	0	63	64	1	syndrome	63	63	64	0	.	0	64	65	1	.	64	64	65	0
EOS
T	29
Biochem	32586	32593	NNP	Biochem	O	_	_
J	32594	32595	NNP	J	O	_	_
362	32596	32599	CD	362	O	_	_
:	32600	32601	:	:	O	_	_
481	32602	32605	CD	481	O	_	_
-	32606	32607	:	-	O	_	_
490	32608	32611	CD	490	O	_	_
.10.1042	32612	32620	CD	.10.1042	O	_	_
/	32620	32621	:	/	O	_	_
0264-6021	32621	32630	CD	0264-6021	O	_	_
:3620481	32630	32638	CD	:3620481	O	_	_
PubMed	32639	32645	NNP	PubMed	O	_	_
:	32645	32646	:	:	O	_	_
11853558	32647	32655	CD	11853558	O	_	_
11853558	32656	32664	CD	11853558	O	_	_
13	32665	32667	CD	13	O	_	_
Downward	32668	32676	JJ	downward	O	_	_
J	32677	32678	NN	j	O	_	_
(	32679	32680	CD	(	O	_	_
2003	32681	32685	CD	2003	O	_	_
)	32686	32687	CD	)	O	_	_
Targeting	32689	32698	NN	targeting	O	_	_
RAS	32699	32702	NN	ra	O	_	_
signalling	32703	32713	NN	signalling	O	_	_
pathways	32714	32722	NNS	pathway	O	_	_
in	32723	32725	IN	in	O	_	_
cancer	32726	32732	NN	cancer	O	_	_
therapy	32733	32740	NN	therapy	O	_	_
.	32741	32742	.	.	O	_	_
D	1
1
1	0	nn
1	2	dep
1	4	dep
1	8	punct
1	10	dep
4	7	dep
7	6	number
10	9	num
10	11	dep
11	14	dep
11	24	dep
14	13	number
17	15	num
17	16	amod
17	19	dep
19	18	num
21	20	num
24	17	dep
24	21	dep
24	22	nn
24	23	nn
24	27	prep_in
27	26	nn
EOX
Y	1
ROOT	0	0	29	1	FRAG	0	0	29	4	NP	0	0	8	3	NP	0	0	3	2	NP	1	0	2	2	NNP	0	0	1	1	Biochem	0	0	1	0	NNP	0	1	2	1	J	1	1	2	0	NP	0	2	3	1	CD	0	2	3	1	362	2	2	3	0	:	0	3	4	1	:	3	3	4	0	NP	0	4	8	3	NP	0	4	5	1	CD	0	4	5	1	481	4	4	5	0	:	0	5	6	1	-	5	5	6	0	NP	0	6	8	1	QP	1	6	8	2	CD	0	6	7	1	490	6	6	7	0	CD	0	7	8	1	.10.1042	7	7	8	0	:	0	8	9	1	/	8	8	9	0	NP	0	9	28	2	NP	1	9	11	2	CD	0	9	10	1	0264-6021	9	9	10	0	CD	0	10	11	1	:3620481	10	10	11	0	NP	0	11	28	4	NP	0	11	12	1	NNP	0	11	12	1	PubMed	11	11	12	0	:	0	12	13	1	:	12	12	13	0	NP	0	13	15	1	QP	0	13	15	2	CD	0	13	14	1	11853558	13	13	14	0	CD	0	14	15	1	11853558	14	14	15	0	X	2	15	28	3	NP	0	15	20	2	NP	2	15	18	3	CD	0	15	16	1	13	15	15	16	0	JJ	0	16	17	1	Downward	16	16	17	0	NN	0	17	18	1	J	17	17	18	0	NP	1	18	20	2	CD	0	18	19	1	(	18	18	19	0	CD	0	19	20	1	2003	19	19	20	0	NP	1	20	22	2	CD	0	20	21	1	)	20	20	21	0	NN	0	21	22	1	Targeting	21	21	22	0	NP	0	22	28	2	NP	2	22	25	3	NN	0	22	23	1	RAS	22	22	23	0	NN	0	23	24	1	signalling	23	23	24	0	NNS	0	24	25	1	pathways	24	24	25	0	PP	0	25	28	2	IN	0	25	26	1	in	25	25	26	0	NP	1	26	28	2	NN	0	26	27	1	cancer	26	26	27	0	NN	0	27	28	1	therapy	27	27	28	0	.	0	28	29	1	.	28	28	29	0
EOS
T	36
Nat	32743	32746	NNP	Nat	O	_	_
Rev	32747	32750	NN	rev	O	_	_
Cancer	32751	32757	NN	cancer	O	_	_
3	32758	32759	CD	3	O	_	_
:	32760	32761	:	:	O	_	_
11	32762	32764	CD	11	O	_	_
-	32765	32766	:	-	O	_	_
22	32767	32769	CD	22	O	_	_
.10.1038	32770	32778	CD	.10.1038	O	_	_
/	32778	32779	:	/	O	_	_
nri979	32779	32785	CD	nri979	O	_	_
PubMed	32786	32792	NNP	PubMed	O	_	_
:	32792	32793	:	:	O	_	_
12509763	32794	32802	CD	12509763	O	_	_
12509763	32803	32811	CD	12509763	O	_	_
14	32812	32814	CD	14	O	_	_
Sridhar	32815	32822	NNP	Sridhar	O	_	_
SS	32823	32825	NNP	SS	O	_	_
,	32826	32827	,	,	O	_	_
Hedley	32828	32834	NNP	Hedley	O	_	_
D	32835	32836	NNP	D	O	_	_
,	32837	32838	,	,	O	_	_
Siu	32839	32842	NNP	Siu	B-GENE	_	_
LL	32843	32845	NNP	LL	I-GENE	_	_
(	32846	32847	CD	(	I-GENE	_	_
2005	32848	32852	CD	2005	I-GENE	_	_
)	32853	32854	CD	)	I-GENE	_	_
Raf	32856	32859	NN	raf	I-GENE	_	_
kinase	32860	32866	NN	kinase	I-GENE	_	_
as	32867	32869	IN	as	O	_	_
a	32870	32871	DT	a	O	_	_
target	32872	32878	NN	target	O	_	_
for	32879	32882	IN	for	O	_	_
anticancer	32883	32893	JJ	anticancer	O	_	_
therapeutics	32894	32906	NNS	therapeutics	O	_	_
.	32907	32908	.	.	O	_	_
D	1
2
2	0	nn
2	1	nn
2	3	dep
2	5	dep
2	9	punct
2	10	dep
5	8	dep
8	7	num
10	11	appos
10	17	dep
17	13	num
17	14	num
17	15	num
17	16	nn
17	20	appos
17	23	appos
20	19	nn
23	22	nn
23	25	rcmod
25	24	num
25	28	dobj
25	34	prep_for
28	26	num
28	27	nn
28	31	prep_as
31	30	det
34	33	amod
EOX
Y	1
ROOT	0	0	36	1	FRAG	0	0	36	4	FRAG	0	0	9	3	NP	0	0	4	2	NP	2	0	3	3	NNP	0	0	1	1	Nat	0	0	1	0	NN	0	1	2	1	Rev	1	1	2	0	NN	0	2	3	1	Cancer	2	2	3	0	NP	0	3	4	1	CD	0	3	4	1	3	3	3	4	0	:	0	4	5	1	:	4	4	5	0	NP	0	5	9	3	NP	0	5	6	1	CD	0	5	6	1	11	5	5	6	0	:	0	6	7	1	-	6	6	7	0	NP	1	7	9	2	CD	0	7	8	1	22	7	7	8	0	CD	0	8	9	1	.10.1038	8	8	9	0	:	0	9	10	1	/	9	9	10	0	FRAG	0	10	35	3	NP	0	10	12	2	NP	0	10	11	1	CD	0	10	11	1	nri979	10	10	11	0	NP	0	11	12	1	NNP	0	11	12	1	PubMed	11	11	12	0	:	0	12	13	1	:	12	12	13	0	NP	0	13	35	5	NP	4	13	18	5	CD	0	13	14	1	12509763	13	13	14	0	CD	0	14	15	1	12509763	14	14	15	0	CD	0	15	16	1	14	15	15	16	0	NNP	0	16	17	1	Sridhar	16	16	17	0	NNP	0	17	18	1	SS	17	17	18	0	,	0	18	19	1	,	18	18	19	0	NP	1	19	21	2	NNP	0	19	20	1	Hedley	19	19	20	0	NNP	0	20	21	1	D	20	20	21	0	,	0	21	22	1	,	21	21	22	0	NP	0	22	35	2	NP	1	22	24	2	NNP	0	22	23	1	Siu	22	22	23	0	NNP	0	23	24	1	LL	23	23	24	0	SBAR	0	24	35	1	S	0	24	35	1	VP	0	24	35	3	NP	1	24	26	2	CD	0	24	25	1	(	24	24	25	0	CD	0	25	26	1	2005	25	25	26	0	NP	0	26	32	2	NP	2	26	29	3	CD	0	26	27	1	)	26	26	27	0	NN	0	27	28	1	Raf	27	27	28	0	NN	0	28	29	1	kinase	28	28	29	0	PP	0	29	32	2	IN	0	29	30	1	as	29	29	30	0	NP	1	30	32	2	DT	0	30	31	1	a	30	30	31	0	NN	0	31	32	1	target	31	31	32	0	PP	0	32	35	2	IN	0	32	33	1	for	32	32	33	0	NP	1	33	35	2	JJ	0	33	34	1	anticancer	33	33	34	0	NNS	0	34	35	1	therapeutics	34	34	35	0	.	0	35	36	1	.	35	35	36	0
EOS
T	12
Mol	32909	32912	NNP	Mol	O	_	_
Cancer	32913	32919	NNP	Cancer	O	_	_
Ther	32920	32924	NNP	Ther	O	_	_
4	32925	32926	CD	4	O	_	_
:	32927	32928	:	:	O	_	_
677	32929	32932	CD	677	O	_	_
-	32933	32934	:	-	O	_	_
685	32935	32938	CD	685	O	_	_
.10.1158	32939	32947	CD	.10.1158	O	_	_
/	32947	32948	:	/	O	_	_
1535-7163	32948	32957	CD	1535-7163	O	_	_
.	32957	32958	.	.	O	_	_
D	1
2
2	0	nn
2	1	nn
2	3	dep
2	8	dep
3	5	dep
8	7	num
8	9	punct
8	10	dep
EOX
Y	1
ROOT	0	0	12	1	FRAG	0	0	12	3	FRAG	0	0	6	2	NP	2	0	3	3	NNP	0	0	1	1	Mol	0	0	1	0	NNP	0	1	2	1	Cancer	1	1	2	0	NNP	0	2	3	1	Ther	2	2	3	0	NP	0	3	6	3	NP	0	3	4	1	CD	0	3	4	1	4	3	3	4	0	:	0	4	5	1	:	4	4	5	0	NP	0	5	6	1	CD	0	5	6	1	677	5	5	6	0	:	0	6	7	1	-	6	6	7	0	FRAG	0	7	12	4	NP	1	7	9	2	CD	0	7	8	1	685	7	7	8	0	CD	0	8	9	1	.10.1158	8	8	9	0	:	0	9	10	1	/	9	9	10	0	NP	0	10	11	1	CD	0	10	11	1	1535-7163	10	10	11	0	.	0	11	12	1	.	11	11	12	0
EOS
T	40
MCT-04-0297	32958	32969	NN	mct-04-0297	O	_	_
PubMed	32970	32976	NNP	PubMed	O	_	_
:	32976	32977	:	:	O	_	_
15827342	32978	32986	CD	15827342	O	_	_
15827342	32987	32995	CD	15827342	O	_	_
15	32996	32998	CD	15	O	_	_
Vives	32999	33004	NNS	vive	O	_	_
V	33005	33006	NN	v	O	_	_
,	33007	33008	,	,	O	_	_
Su	33009	33011	FW	su	B-GENE	_	_
J	33012	33013	NN	j	I-GENE	_	_
,	33014	33015	,	,	O	_	_
Zhong	33016	33021	NNP	Zhong	B-GENE	_	_
S	33022	33023	NNP	S	I-GENE	_	_
,	33024	33025	,	,	I-GENE	_	_
Ratnayaka	33026	33035	NNP	Ratnayaka	I-GENE	_	_
I	33036	33037	NNP	I	I-GENE	_	_
,	33038	33039	,	,	O	_	_
Slee	33040	33044	NNP	Slee	O	_	_
E	33045	33046	NNP	E	O	_	_
et	33047	33049	FW	et	O	_	_
al.	33050	33053	FW	al.	O	_	_
(	33054	33055	FW	(	O	_	_
2006	33056	33060	CD	2006	O	_	_
)	33061	33062	CD	)	O	_	_
ASPP2	33064	33069	NN	aspp2	B-GENE	_	_
is	33070	33072	VBZ	be	O	_	_
a	33073	33074	DT	a	O	_	_
haploinsufficient	33075	33092	JJ	haploinsufficient	O	_	_
tumor	33093	33098	NN	tumor	O	_	_
suppressor	33099	33109	NN	suppressor	O	_	_
that	33110	33114	WDT	that	O	_	_
cooperates	33115	33125	VBZ	cooperate	O	_	_
with	33126	33130	IN	with	O	_	_
p53	33131	33134	NN	p53	B-GENE	_	_
to	33135	33137	TO	to	O	_	_
suppress	33138	33146	VB	suppress	O	_	_
tumor	33147	33152	NN	tumor	O	_	_
growth	33153	33159	NN	growth	O	_	_
.	33160	33161	.	.	O	_	_
D	1
30
0	1	appos
0	6	dep
4	3	number
6	4	num
6	5	num
6	7	dep
6	9	dep
6	10	dep
10	13	appos
10	16	appos
10	19	appos
13	12	nn
16	15	nn
19	18	nn
19	22	dep
19	25	dep
22	20	nn
22	21	nn
25	23	num
25	24	num
30	0	nsubj
30	26	cop
30	27	det
30	28	amod
30	29	nn
30	32	rcmod
32	31	nsubj
32	34	prep_with
32	36	xcomp
36	35	aux
36	38	dobj
38	37	nn
EOX
Y	1
ROOT	0	0	40	1	S	1	0	40	3	NP	0	0	26	3	NP	0	0	1	1	NN	0	0	1	1	MCT-04-0297	0	0	1	0	NP	0	1	2	1	NNP	0	1	2	1	PubMed	1	1	2	0	NP	1	2	26	5	:	0	2	3	1	:	2	2	3	0	NP	0	3	8	2	NP	2	3	7	3	QP	0	3	5	2	CD	0	3	4	1	15827342	3	3	4	0	CD	0	4	5	1	15827342	4	4	5	0	CD	0	5	6	1	15	5	5	6	0	NNS	0	6	7	1	Vives	6	6	7	0	NP	0	7	8	1	NN	0	7	8	1	V	7	7	8	0	,	0	8	9	1	,	8	8	9	0	FW	0	9	10	1	Su	9	9	10	0	NP	0	10	26	7	NP	0	10	11	1	NN	0	10	11	1	J	10	10	11	0	,	0	11	12	1	,	11	11	12	0	NP	1	12	14	2	NNP	0	12	13	1	Zhong	12	12	13	0	NNP	0	13	14	1	S	13	13	14	0	,	0	14	15	1	,	14	14	15	0	NP	1	15	17	2	NNP	0	15	16	1	Ratnayaka	15	15	16	0	NNP	0	16	17	1	I	16	16	17	0	,	0	17	18	1	,	17	17	18	0	NP	0	18	26	3	NP	1	18	20	2	NNP	0	18	19	1	Slee	18	18	19	0	NNP	0	19	20	1	E	19	19	20	0	NP	2	20	23	3	FW	0	20	21	1	et	20	20	21	0	FW	0	21	22	1	al.	21	21	22	0	FW	0	22	23	1	(	22	22	23	0	NP	2	23	26	3	CD	0	23	24	1	2006	23	23	24	0	CD	0	24	25	1	)	24	24	25	0	NN	0	25	26	1	ASPP2	25	25	26	0	VP	1	26	39	2	VBZ	0	26	27	1	is	26	26	27	0	NP	0	27	39	2	NP	3	27	31	4	DT	0	27	28	1	a	27	27	28	0	JJ	0	28	29	1	haploinsufficient	28	28	29	0	NN	0	29	30	1	tumor	29	29	30	0	NN	0	30	31	1	suppressor	30	30	31	0	SBAR	1	31	39	2	WHNP	0	31	32	1	WDT	0	31	32	1	that	31	31	32	0	S	0	32	39	1	VP	0	32	39	3	VBZ	0	32	33	1	cooperates	32	32	33	0	PP	0	33	35	2	IN	0	33	34	1	with	33	33	34	0	NP	0	34	35	1	NN	0	34	35	1	p53	34	34	35	0	S	0	35	39	1	VP	1	35	39	2	TO	0	35	36	1	to	35	35	36	0	VP	0	36	39	2	VB	0	36	37	1	suppress	36	36	37	0	NP	1	37	39	2	NN	0	37	38	1	tumor	37	37	38	0	NN	0	38	39	1	growth	38	38	39	0	.	0	39	40	1	.	39	39	40	0
EOS
T	55
Genes	33162	33167	NNS	gene	O	_	_
Dev	33168	33171	JJ	dev	O	_	_
20	33172	33174	CD	20	O	_	_
:	33175	33176	:	:	O	_	_
1262	33177	33181	CD	1262	O	_	_
-	33182	33183	:	-	O	_	_
1267	33184	33188	CD	1267	O	_	_
.10.1101	33189	33197	CD	.10.1101	O	_	_
/	33197	33198	:	/	O	_	_
gad	33198	33201	NN	gad	O	_	_
.374006	33201	33208	CD	.374006	O	_	_
PubMed	33209	33215	NNP	PubMed	O	_	_
:	33215	33216	:	:	O	_	_
16702401	33217	33225	CD	16702401	O	_	_
16702401	33226	33234	CD	16702401	O	_	_
16	33235	33237	CD	16	O	_	_
Kampa	33238	33243	NNP	Kampa	O	_	_
KM	33244	33246	NNP	KM	O	_	_
,	33247	33248	,	,	O	_	_
Acoba	33249	33254	NNP	Acoba	O	_	_
JD	33255	33257	NNP	JD	O	_	_
,	33258	33259	,	,	O	_	_
Chen	33260	33264	NNP	Chen	O	_	_
D	33265	33266	NNP	D	O	_	_
,	33267	33268	,	,	O	_	_
Gay	33269	33272	NNS	gay	O	_	_
J	33273	33274	NN	j	O	_	_
,	33275	33276	,	,	O	_	_
Lee	33277	33280	NNP	Lee	O	_	_
H	33281	33282	NNP	H	O	_	_
et	33283	33285	FW	et	O	_	_
al.	33286	33289	FW	al.	O	_	_
(	33290	33291	FW	(	O	_	_
2009	33292	33296	CD	2009	O	_	_
)	33297	33298	CD	)	O	_	_
Apoptosis	33300	33309	NN	apoptosis	O	_	_
stimulating	33310	33321	NN	stimulating	O	_	_
protein	33322	33329	NN	protein	O	_	_
of	33330	33332	IN	of	O	_	_
p53	33333	33336	NN	p53	B-GENE	_	_
(	33337	33338	CD	(	B-GENE	_	_
ASPP2	33338	33343	NN	aspp2	I-GENE	_	_
)	33343	33344	NN	)	O	_	_
heterozygous	33345	33357	JJ	heterozygous	O	_	_
mice	33358	33362	NNS	mouse	O	_	_
are	33363	33366	VBP	be	O	_	_
tumor-prone	33367	33378	JJ	tumor-prone	O	_	_
and	33379	33382	CC	and	O	_	_
have	33383	33387	VBP	have	O	_	_
attenuated	33388	33398	VBN	attenuate	O	_	_
cellular	33399	33407	JJ	cellular	O	_	_
damage	33408	33414	NN	damage	O	_	_
response	33415	33423	NN	response	O	_	_
thresholds	33424	33434	NNS	threshold	O	_	_
.	33435	33436	.	.	O	_	_
D	1
0
0	1	amod
0	4	dep
1	2	dep
4	7	dep
4	46	rcmod
4	49	rcmod
7	6	number
7	8	punct
9	10	num
9	11	appos
9	17	dep
17	13	num
17	14	num
17	15	num
17	16	nn
17	20	appos
17	23	appos
17	26	appos
20	19	nn
23	22	nn
26	25	nn
29	28	nn
29	32	dep
32	30	nn
32	31	nn
37	29	dep
37	33	dep
37	34	num
37	35	nn
37	36	nn
37	42	prep_of
42	39	nn
42	40	num
42	41	nn
44	43	amod
46	9	dep
46	37	dep
46	44	nsubj
46	45	cop
46	49	conj_and
49	44	nsubj
49	48	aux
49	53	dobj
53	50	amod
53	51	nn
53	52	nn
EOX
Y	1
ROOT	0	0	55	1	NP	0	0	55	4	NP	0	0	3	2	NP	0	0	1	1	NNS	0	0	1	1	Genes	0	0	1	0	ADJP	0	1	3	2	JJ	0	1	2	1	Dev	1	1	2	0	NP	0	2	3	1	CD	0	2	3	1	20	2	2	3	0	:	0	3	4	1	:	3	3	4	0	NP	0	4	54	3	NP	0	4	5	1	CD	0	4	5	1	1262	4	4	5	0	PRN	1	5	9	3	:	0	5	6	1	-	5	5	6	0	NP	0	6	8	1	QP	1	6	8	2	CD	0	6	7	1	1267	6	6	7	0	CD	0	7	8	1	.10.1101	7	7	8	0	:	0	8	9	1	/	8	8	9	0	SBAR	0	9	54	1	S	4	9	54	5	FRAG	0	9	27	3	NP	0	9	12	2	NP	0	9	11	2	NN	0	9	10	1	gad	9	9	10	0	CD	0	10	11	1	.374006	10	10	11	0	NP	0	11	12	1	NNP	0	11	12	1	PubMed	11	11	12	0	:	0	12	13	1	:	12	12	13	0	NP	0	13	27	7	NP	4	13	18	5	CD	0	13	14	1	16702401	13	13	14	0	CD	0	14	15	1	16702401	14	14	15	0	CD	0	15	16	1	16	15	15	16	0	NNP	0	16	17	1	Kampa	16	16	17	0	NNP	0	17	18	1	KM	17	17	18	0	,	0	18	19	1	,	18	18	19	0	NP	1	19	21	2	NNP	0	19	20	1	Acoba	19	19	20	0	NNP	0	20	21	1	JD	20	20	21	0	,	0	21	22	1	,	21	21	22	0	NP	1	22	24	2	NNP	0	22	23	1	Chen	22	22	23	0	NNP	0	23	24	1	D	23	23	24	0	,	0	24	25	1	,	24	24	25	0	NP	1	25	27	2	NNS	0	25	26	1	Gay	25	25	26	0	NN	0	26	27	1	J	26	26	27	0	,	0	27	28	1	,	27	27	28	0	X	2	28	43	3	NP	0	28	33	2	NP	1	28	30	2	NNP	0	28	29	1	Lee	28	28	29	0	NNP	0	29	30	1	H	29	29	30	0	NP	2	30	33	3	FW	0	30	31	1	et	30	30	31	0	FW	0	31	32	1	al.	31	31	32	0	FW	0	32	33	1	(	32	32	33	0	NP	0	33	34	1	CD	0	33	34	1	2009	33	33	34	0	NP	0	34	43	2	NP	3	34	38	4	CD	0	34	35	1	)	34	34	35	0	NN	0	35	36	1	Apoptosis	35	35	36	0	NN	0	36	37	1	stimulating	36	36	37	0	NN	0	37	38	1	protein	37	37	38	0	PP	0	38	43	2	IN	0	38	39	1	of	38	38	39	0	NP	3	39	43	4	NN	0	39	40	1	p53	39	39	40	0	CD	0	40	41	1	(	40	40	41	0	NN	0	41	42	1	ASPP2	41	41	42	0	NN	0	42	43	1	)	42	42	43	0	NP	1	43	45	2	JJ	0	43	44	1	heterozygous	43	43	44	0	NNS	0	44	45	1	mice	44	44	45	0	VP	0	45	54	3	VP	1	45	47	2	VBP	0	45	46	1	are	45	45	46	0	ADJP	0	46	47	1	JJ	0	46	47	1	tumor-prone	46	46	47	0	CC	0	47	48	1	and	47	47	48	0	VP	1	48	54	2	VBP	0	48	49	1	have	48	48	49	0	VP	0	49	54	2	VBN	0	49	50	1	attenuated	49	49	50	0	NP	3	50	54	4	JJ	0	50	51	1	cellular	50	50	51	0	NN	0	51	52	1	damage	51	51	52	0	NN	0	52	53	1	response	52	52	53	0	NNS	0	53	54	1	thresholds	53	53	54	0	.	0	54	55	1	.	54	54	55	0
EOS
T	71
Proc	33437	33441	NNP	Proc	O	_	_
Natl	33442	33446	NNP	Natl	O	_	_
Acad	33447	33451	NNP	Acad	O	_	_
Sci	33452	33455	NNP	Sci	O	_	_
U	33456	33457	NNP	U	O	_	_
S	33458	33459	NNP	S	O	_	_
A	33460	33461	NNP	A	O	_	_
106	33462	33465	CD	106	O	_	_
:	33466	33467	:	:	O	_	_
4390	33468	33472	CD	4390	O	_	_
-	33473	33474	:	-	O	_	_
4395	33475	33479	CD	4395	O	_	_
.10.1073	33480	33488	CD	.10.1073	O	_	_
/	33488	33489	:	/	O	_	_
pnas	33489	33493	NNS	pna	O	_	_
.0809080106	33493	33504	CD	.0809080106	O	_	_
PubMed	33505	33511	NNP	PubMed	O	_	_
:	33511	33512	:	:	O	_	_
19251665	33513	33521	CD	19251665	O	_	_
19251665	33522	33530	CD	19251665	O	_	_
17	33531	33533	CD	17	O	_	_
Zhao	33534	33538	NNP	Zhao	O	_	_
J	33539	33540	NNP	J	O	_	_
,	33541	33542	,	,	O	_	_
Wu	33543	33545	NNP	Wu	B-GENE	_	_
G	33546	33547	NNP	G	I-GENE	_	_
,	33548	33549	,	,	I-GENE	_	_
Bu	33550	33552	NNP	Bu	I-GENE	_	_
F	33553	33554	NN	f	I-GENE	_	_
,	33555	33556	,	,	O	_	_
Lu	33557	33559	NN	lu	B-GENE	_	_
B	33560	33561	NN	b	I-GENE	_	_
,	33562	33563	,	,	O	_	_
Liang	33564	33569	NNP	Liang	O	_	_
A	33570	33571	NNP	A	O	_	_
et	33572	33574	FW	et	O	_	_
al.	33575	33578	FW	al.	O	_	_
(	33579	33580	FW	(	O	_	_
2010	33581	33585	CD	2010	O	_	_
)	33586	33587	CD	)	O	_	_
Epigenetic	33589	33599	JJ	epigenetic	O	_	_
silence	33600	33607	NN	silence	O	_	_
of	33608	33610	IN	of	O	_	_
ankyrin-repeat	33611	33625	NN	ankyrin-repeat	B-GENE	_	_
containing	33626	33636	VBG	contain	O	_	_
,	33636	33637	,	,	O	_	_
SH3-domain	33638	33648	JJ	sh3-domain	B-GENE	_	_
containing	33649	33659	VBG	contain	O	_	_
,	33659	33660	,	,	O	_	_
and	33661	33664	CC	and	O	_	_
proline-rich-region-	33665	33685	NN	proline-rich-region-_NN	O	_	_
containing	33686	33696	VBG	contain	O	_	_
protein	33697	33704	NN	protein	B-GENE	_	_
1	33705	33706	CD	1	I-GENE	_	_
(	33707	33708	CD	(	B-GENE	_	_
ASPP1	33708	33713	NN	aspp1	I-GENE	_	_
)	33713	33714	NN	)	O	_	_
and	33715	33718	CC	and	O	_	_
ASPP2	33719	33724	NN	aspp2	B-GENE	_	_
genes	33725	33730	NNS	gene	I-GENE	_	_
promotes	33731	33739	VBZ	promote	O	_	_
tumor	33740	33745	NN	tumor	O	_	_
growth	33746	33752	NN	growth	O	_	_
in	33753	33755	IN	in	O	_	_
hepatitis	33756	33765	NN	hepatitis	O	_	_
B	33766	33767	NN	b	O	_	_
virus	33768	33773	NN	virus	O	_	_
positive	33774	33782	JJ	positive	O	_	_
hepatocellular	33783	33797	JJ	hepatocellular	O	_	_
carcinoma	33798	33807	NN	carcinoma	O	_	_
.	33808	33809	.	.	O	_	_
D	1
6
6	0	nn
6	1	nn
6	2	nn
6	3	nn
6	4	nn
6	5	nn
6	9	dep
6	12	dep
6	46	dep
6	50	dep
9	7	num
12	11	number
12	14	dep
12	43	prep_of
12	46	conj_and
12	50	conj_and
14	13	punct
14	16	dep
14	22	dep
16	15	num
22	18	num
22	19	num
22	20	num
22	21	nn
22	25	appos
22	28	appos
22	31	appos
22	34	appos
25	24	nn
28	27	nn
31	30	nn
34	33	nn
34	37	dep
37	35	nn
37	36	nn
37	41	dep
39	38	number
41	39	num
41	40	amod
43	44	vmod
46	47	vmod
50	51	vmod
51	52	iobj
51	54	dobj
54	53	number
54	60	rcmod
54	69	dep
56	55	nn
56	59	conj_and
59	58	nn
60	56	nsubj
60	59	nsubj
60	62	dobj
62	61	nn
62	66	prep_in
66	64	nn
66	65	nn
69	67	amod
69	68	amod
EOX
Y	1
ROOT	0	0	71	1	NP	0	0	71	4	NP	0	0	10	2	NP	6	0	7	7	NNP	0	0	1	1	Proc	0	0	1	0	NNP	0	1	2	1	Natl	1	1	2	0	NNP	0	2	3	1	Acad	2	2	3	0	NNP	0	3	4	1	Sci	3	3	4	0	NNP	0	4	5	1	U	4	4	5	0	NNP	0	5	6	1	S	5	5	6	0	NNP	0	6	7	1	A	6	6	7	0	NP	2	7	10	3	CD	0	7	8	1	106	7	7	8	0	:	0	8	9	1	:	8	8	9	0	CD	0	9	10	1	4390	9	9	10	0	:	0	10	11	1	-	10	10	11	0	NP	0	11	70	6	NP	0	11	45	3	NP	0	11	13	1	QP	1	11	13	2	CD	0	11	12	1	4395	11	11	12	0	CD	0	12	13	1	.10.1073	12	12	13	0	PRN	1	13	42	2	:	0	13	14	1	/	13	13	14	0	FRAG	0	14	42	3	NP	0	14	17	2	NP	0	14	15	1	NNS	0	14	15	1	pnas	14	14	15	0	NP	1	15	17	2	CD	0	15	16	1	.0809080106	15	15	16	0	NNP	0	16	17	1	PubMed	16	16	17	0	:	0	17	18	1	:	17	17	18	0	NP	0	18	42	9	NP	4	18	23	5	CD	0	18	19	1	19251665	18	18	19	0	CD	0	19	20	1	19251665	19	19	20	0	CD	0	20	21	1	17	20	20	21	0	NNP	0	21	22	1	Zhao	21	21	22	0	NNP	0	22	23	1	J	22	22	23	0	,	0	23	24	1	,	23	23	24	0	NP	1	24	26	2	NNP	0	24	25	1	Wu	24	24	25	0	NNP	0	25	26	1	G	25	25	26	0	,	0	26	27	1	,	26	26	27	0	NP	1	27	29	2	NNP	0	27	28	1	Bu	27	27	28	0	NN	0	28	29	1	F	28	28	29	0	,	0	29	30	1	,	29	29	30	0	NP	1	30	32	2	NN	0	30	31	1	Lu	30	30	31	0	NN	0	31	32	1	B	31	31	32	0	,	0	32	33	1	,	32	32	33	0	NP	0	33	42	2	NP	1	33	35	2	NNP	0	33	34	1	Liang	33	33	34	0	NNP	0	34	35	1	A	34	34	35	0	NP	0	35	42	2	NP	2	35	38	3	FW	0	35	36	1	et	35	35	36	0	FW	0	36	37	1	al.	36	36	37	0	FW	0	37	38	1	(	37	37	38	0	NP	2	38	42	3	QP	1	38	40	2	CD	0	38	39	1	2010	38	38	39	0	CD	0	39	40	1	)	39	39	40	0	JJ	0	40	41	1	Epigenetic	40	40	41	0	NN	0	41	42	1	silence	41	41	42	0	PP	0	42	45	2	IN	0	42	43	1	of	42	42	43	0	NP	0	43	45	2	NP	0	43	44	1	NN	0	43	44	1	ankyrin-repeat	43	43	44	0	VP	0	44	45	1	VBG	0	44	45	1	containing	44	44	45	0	,	0	45	46	1	,	45	45	46	0	NP	0	46	48	2	NP	0	46	47	1	JJ	0	46	47	1	SH3-domain	46	46	47	0	VP	0	47	48	1	VBG	0	47	48	1	containing	47	47	48	0	,	0	48	49	1	,	48	48	49	0	CC	0	49	50	1	and	49	49	50	0	NP	0	50	70	2	NP	0	50	51	1	NN	0	50	51	1	proline-rich-region-	50	50	51	0	VP	0	51	70	3	VBG	0	51	52	1	containing	51	51	52	0	NP	0	52	53	1	NN	0	52	53	1	protein	52	52	53	0	NP	0	53	70	2	NP	0	53	67	2	NP	0	53	55	1	QP	1	53	55	2	CD	0	53	54	1	1	53	53	54	0	CD	0	54	55	1	(	54	54	55	0	SBAR	0	55	67	1	S	1	55	67	2	NP	0	55	60	3	NP	1	55	57	2	NN	0	55	56	1	ASPP1	55	55	56	0	NN	0	56	57	1	)	56	56	57	0	CC	0	57	58	1	and	57	57	58	0	NP	1	58	60	2	NN	0	58	59	1	ASPP2	58	58	59	0	NNS	0	59	60	1	genes	59	59	60	0	VP	0	60	67	2	VBZ	0	60	61	1	promotes	60	60	61	0	NP	0	61	67	2	NP	1	61	63	2	NN	0	61	62	1	tumor	61	61	62	0	NN	0	62	63	1	growth	62	62	63	0	PP	0	63	67	2	IN	0	63	64	1	in	63	63	64	0	NP	2	64	67	3	NN	0	64	65	1	hepatitis	64	64	65	0	NN	0	65	66	1	B	65	65	66	0	NN	0	66	67	1	virus	66	66	67	0	NP	2	67	70	3	JJ	0	67	68	1	positive	67	67	68	0	JJ	0	68	69	1	hepatocellular	68	68	69	0	NN	0	69	70	1	carcinoma	69	69	70	0	.	0	70	71	1	.	70	70	71	0
EOS
T	57
Hepatology	33810	33820	NNP	Hepatology	O	_	_
51	33821	33823	CD	51	O	_	_
:	33824	33825	:	:	O	_	_
142	33826	33829	CD	142	O	_	_
-	33830	33831	:	-	O	_	_
153	33832	33835	CD	153	O	_	_
.10.1002	33836	33844	CD	.10.1002	O	_	_
/	33844	33845	:	/	O	_	_
hep	33845	33848	NN	hep	O	_	_
.23247	33848	33854	CD	.23247	O	_	_
PubMed	33855	33861	NNP	PubMed	O	_	_
:	33861	33862	:	:	O	_	_
20034025	33863	33871	CD	20034025	O	_	_
20034025	33872	33880	CD	20034025	O	_	_
18	33881	33883	CD	18	O	_	_
Liu	33884	33887	NNP	Liu	O	_	_
ZJ	33888	33890	NNP	ZJ	O	_	_
,	33891	33892	,	,	O	_	_
Lu	33893	33895	NNP	Lu	B-GENE	_	_
X	33896	33897	NNP	X	I-GENE	_	_
,	33898	33899	,	,	I-GENE	_	_
Zhang	33900	33905	NNP	Zhang	I-GENE	_	_
Y	33906	33907	NN	y	I-GENE	_	_
,	33908	33909	,	,	O	_	_
Zhong	33910	33915	NNP	Zhong	B-GENE	_	_
S	33916	33917	NNP	S	I-GENE	_	_
,	33918	33919	,	,	O	_	_
Gu	33920	33922	NNP	Gu	O	_	_
SZ	33923	33925	NNP	SZ	O	_	_
et	33926	33928	FW	et	O	_	_
al.	33929	33932	FW	al.	O	_	_
(	33933	33934	FW	(	O	_	_
2005	33935	33939	CD	2005	O	_	_
)	33940	33941	CD	)	O	_	_
Downregulated	33943	33956	VBN	downregulate	O	_	_
mRNA	33957	33961	NN	mrna	O	_	_
expression	33962	33972	NN	expression	O	_	_
of	33973	33975	IN	of	O	_	_
ASPP	33976	33980	NN	aspp	O	_	_
and	33981	33984	CC	and	O	_	_
the	33985	33988	DT	the	O	_	_
hypermethylation	33989	34005	NN	hypermethylation	O	_	_
of	34006	34008	IN	of	O	_	_
the	34009	34012	DT	the	O	_	_
5	34013	34014	CD	5	O	_	_
'	34014	34015	''	'	O	_	_
-	34015	34016	:	-	O	_	_
untranslated	34016	34028	JJ	untranslated	O	_	_
region	34029	34035	NN	region	O	_	_
in	34036	34038	IN	in	O	_	_
cancer	34039	34045	NN	cancer	O	_	_
cell	34046	34050	NN	cell	O	_	_
lines	34051	34056	NNS	line	O	_	_
retaining	34057	34066	VBG	retain	O	_	_
wild-type	34067	34076	JJ	wild-type	B-GENE	_	_
p53	34077	34080	NN	p53	I-GENE	_	_
.	34081	34082	.	.	O	_	_
D	1
0
0	1	num
0	3	dep
0	6	dep
0	41	dep
3	6	conj_and
3	41	conj_and
6	5	number
6	8	dep
6	34	vmod
8	7	punct
8	9	num
8	10	appos
8	16	dep
16	12	num
16	13	num
16	14	num
16	15	nn
16	19	appos
16	22	appos
16	25	appos
16	28	appos
19	18	nn
22	21	nn
25	24	nn
28	27	nn
28	31	dep
28	33	dep
31	29	nn
31	30	nn
33	32	num
34	36	dobj
36	35	nn
36	38	prep_of
41	40	det
41	44	prep_of
44	43	det
44	48	dep
48	47	amod
48	52	prep_in
52	50	nn
52	51	nn
52	53	vmod
53	55	dobj
55	54	amod
EOX
Y	1
ROOT	0	0	57	1	NP	0	0	57	4	NP	0	0	2	2	NNP	0	0	1	1	Hepatology	0	0	1	0	CD	0	1	2	1	51	1	1	2	0	:	0	2	3	1	:	2	2	3	0	NP	0	3	56	5	NP	0	3	4	1	CD	0	3	4	1	142	3	3	4	0	:	0	4	5	1	-	4	4	5	0	NP	0	5	39	2	NP	0	5	34	2	NP	0	5	7	1	QP	1	5	7	2	CD	0	5	6	1	153	5	5	6	0	CD	0	6	7	1	.10.1002	6	6	7	0	PRN	1	7	34	2	:	0	7	8	1	/	7	7	8	0	FRAG	0	8	34	3	NP	0	8	11	2	NP	0	8	10	2	NN	0	8	9	1	hep	8	8	9	0	CD	0	9	10	1	.23247	9	9	10	0	NP	0	10	11	1	NNP	0	10	11	1	PubMed	10	10	11	0	:	0	11	12	1	:	11	11	12	0	NP	0	12	34	9	NP	4	12	17	5	CD	0	12	13	1	20034025	12	12	13	0	CD	0	13	14	1	20034025	13	13	14	0	CD	0	14	15	1	18	14	14	15	0	NNP	0	15	16	1	Liu	15	15	16	0	NNP	0	16	17	1	ZJ	16	16	17	0	,	0	17	18	1	,	17	17	18	0	NP	1	18	20	2	NNP	0	18	19	1	Lu	18	18	19	0	NNP	0	19	20	1	X	19	19	20	0	,	0	20	21	1	,	20	20	21	0	NP	1	21	23	2	NNP	0	21	22	1	Zhang	21	21	22	0	NN	0	22	23	1	Y	22	22	23	0	,	0	23	24	1	,	23	23	24	0	NP	1	24	26	2	NNP	0	24	25	1	Zhong	24	24	25	0	NNP	0	25	26	1	S	25	25	26	0	,	0	26	27	1	,	26	26	27	0	NP	0	27	34	3	NP	1	27	29	2	NNP	0	27	28	1	Gu	27	27	28	0	NNP	0	28	29	1	SZ	28	28	29	0	NP	2	29	32	3	FW	0	29	30	1	et	29	29	30	0	FW	0	30	31	1	al.	30	30	31	0	FW	0	31	32	1	(	31	31	32	0	NP	1	32	34	2	CD	0	32	33	1	2005	32	32	33	0	CD	0	33	34	1	)	33	33	34	0	VP	0	34	39	2	VBN	0	34	35	1	Downregulated	34	34	35	0	NP	0	35	39	2	NP	1	35	37	2	NN	0	35	36	1	mRNA	35	35	36	0	NN	0	36	37	1	expression	36	36	37	0	PP	0	37	39	2	IN	0	37	38	1	of	37	37	38	0	NP	0	38	39	1	NN	0	38	39	1	ASPP	38	38	39	0	CC	0	39	40	1	and	39	39	40	0	NP	0	40	56	2	NP	1	40	42	2	DT	0	40	41	1	the	40	40	41	0	NN	0	41	42	1	hypermethylation	41	41	42	0	PP	0	42	56	2	IN	0	42	43	1	of	42	42	43	0	NP	1	43	56	5	DT	0	43	44	1	the	43	43	44	0	NP	0	44	45	1	CD	0	44	45	1	5	44	44	45	0	''	0	45	46	1	'	45	45	46	0	:	0	46	47	1	-	46	46	47	0	NP	0	47	56	2	NP	1	47	49	2	JJ	0	47	48	1	untranslated	47	47	48	0	NN	0	48	49	1	region	48	48	49	0	PP	0	49	56	2	IN	0	49	50	1	in	49	49	50	0	NP	0	50	56	2	NP	2	50	53	3	NN	0	50	51	1	cancer	50	50	51	0	NN	0	51	52	1	cell	51	51	52	0	NNS	0	52	53	1	lines	52	52	53	0	VP	0	53	56	2	VBG	0	53	54	1	retaining	53	53	54	0	NP	1	54	56	2	JJ	0	54	55	1	wild-type	54	54	55	0	NN	0	55	56	1	p53	55	55	56	0	.	0	56	57	1	.	56	56	57	0
EOS
T	44
FEBS	34083	34087	NNP	FEBS	O	_	_
Lett	34088	34092	NNP	Lett	O	_	_
579	34093	34096	CD	579	O	_	_
:	34097	34098	:	:	O	_	_
1587	34099	34103	CD	1587	O	_	_
-	34104	34105	:	-	O	_	_
1590	34106	34110	CD	1590	O	_	_
.10.1016	34111	34119	CD	.10.1016	O	_	_
/	34119	34120	:	/	O	_	_
j.febslet	34120	34129	JJ	j.febslet	O	_	_
.2005.01.069	34129	34141	CD	.2005.01.069	O	_	_
PubMed	34142	34148	NNP	PubMed	O	_	_
:	34148	34149	:	:	O	_	_
15757645	34150	34158	CD	15757645	O	_	_
15757645	34159	34167	CD	15757645	O	_	_
19	34168	34170	CD	19	O	_	_
Sarraf	34171	34177	NNP	Sarraf	O	_	_
SA	34178	34180	NNP	SA	O	_	_
,	34181	34182	,	,	O	_	_
Stancheva	34183	34192	NNP	Stancheva	O	_	_
I	34193	34194	PRP	I	O	_	_
(	34195	34196	VBP	(	O	_	_
2004	34197	34201	CD	2004	O	_	_
)	34202	34203	CD	)	O	_	_
Methyl-CpG	34205	34215	NN	methyl-cpg	O	_	_
binding	34216	34223	NN	binding	O	_	_
protein	34224	34231	NN	protein	B-GENE	_	_
MBD1	34232	34236	NN	mbd1	I-GENE	_	_
couples	34237	34244	NNS	couple	I-GENE	_	_
histone	34245	34252	NN	histone	I-GENE	_	_
H3	34253	34255	NN	h3	I-GENE	_	_
methylation	34256	34267	NN	methylation	O	_	_
at	34268	34270	IN	at	O	_	_
lysine	34271	34277	NN	lysine	O	_	_
9	34278	34279	CD	9	O	_	_
by	34280	34282	IN	by	O	_	_
SETDB1	34283	34289	NN	setdb1	O	_	_
to	34290	34292	TO	to	O	_	_
DNA	34293	34296	NN	dna	O	_	_
replication	34297	34308	NN	replication	O	_	_
and	34309	34312	CC	and	O	_	_
chromatin	34313	34322	NN	chromatin	O	_	_
assembly	34323	34331	NN	assembly	O	_	_
.	34332	34333	.	.	O	_	_
D	1
28
1	0	nn
1	2	dep
1	4	dep
1	17	dep
1	21	rcmod
4	7	dep
4	9	amod
4	11	appos
7	6	number
7	8	punct
9	10	dep
17	13	num
17	14	num
17	15	num
17	16	nn
17	19	appos
21	20	nsubj
21	23	dobj
23	22	num
28	1	nsubj
28	24	nn
28	25	nn
28	26	nn
28	27	nn
28	31	dobj
28	36	prep_by
31	29	nn
31	30	nn
31	33	prep_at
33	34	num
36	39	prep_to
36	42	prep_to
39	38	nn
39	42	conj_and
42	41	nn
EOX
Y	1
ROOT	0	0	44	1	S	1	0	44	3	NP	0	0	24	2	NP	0	0	20	5	NP	0	0	3	2	NP	1	0	2	2	NNP	0	0	1	1	FEBS	0	0	1	0	NNP	0	1	2	1	Lett	1	1	2	0	NP	0	2	3	1	CD	0	2	3	1	579	2	2	3	0	:	0	3	4	1	:	3	3	4	0	NP	0	4	12	2	NP	0	4	11	2	NP	0	4	9	2	NP	0	4	5	1	CD	0	4	5	1	1587	4	4	5	0	PRN	1	5	9	3	:	0	5	6	1	-	5	5	6	0	NP	0	6	8	1	QP	1	6	8	2	CD	0	6	7	1	1590	6	6	7	0	CD	0	7	8	1	.10.1016	7	7	8	0	:	0	8	9	1	/	8	8	9	0	ADJP	0	9	11	2	JJ	0	9	10	1	j.febslet	9	9	10	0	NP	0	10	11	1	CD	0	10	11	1	.2005.01.069	10	10	11	0	NP	0	11	12	1	NNP	0	11	12	1	PubMed	11	11	12	0	:	0	12	13	1	:	12	12	13	0	NP	0	13	20	3	NP	4	13	18	5	CD	0	13	14	1	15757645	13	13	14	0	CD	0	14	15	1	15757645	14	14	15	0	CD	0	15	16	1	19	15	15	16	0	NNP	0	16	17	1	Sarraf	16	16	17	0	NNP	0	17	18	1	SA	17	17	18	0	,	0	18	19	1	,	18	18	19	0	NP	0	19	20	1	NNP	0	19	20	1	Stancheva	19	19	20	0	SBAR	0	20	24	1	S	1	20	24	2	NP	0	20	21	1	PRP	0	20	21	1	I	20	20	21	0	VP	0	21	24	2	VBP	0	21	22	1	(	21	21	22	0	NP	1	22	24	2	CD	0	22	23	1	2004	22	22	23	0	CD	0	23	24	1	)	23	23	24	0	VP	0	24	43	3	NP	4	24	29	5	NN	0	24	25	1	Methyl-CpG	24	24	25	0	NN	0	25	26	1	binding	25	25	26	0	NN	0	26	27	1	protein	26	26	27	0	NN	0	27	28	1	MBD1	27	27	28	0	NNS	0	28	29	1	couples	28	28	29	0	NP	0	29	35	2	NP	2	29	32	3	NN	0	29	30	1	histone	29	29	30	0	NN	0	30	31	1	H3	30	30	31	0	NN	0	31	32	1	methylation	31	31	32	0	PP	0	32	35	2	IN	0	32	33	1	at	32	32	33	0	NP	0	33	35	2	NN	0	33	34	1	lysine	33	33	34	0	CD	0	34	35	1	9	34	34	35	0	PP	0	35	43	2	IN	0	35	36	1	by	35	35	36	0	NP	0	36	43	2	NP	0	36	37	1	NN	0	36	37	1	SETDB1	36	36	37	0	PP	0	37	43	2	TO	0	37	38	1	to	37	37	38	0	NP	0	38	43	3	NP	1	38	40	2	NN	0	38	39	1	DNA	38	38	39	0	NN	0	39	40	1	replication	39	39	40	0	CC	0	40	41	1	and	40	40	41	0	NP	1	41	43	2	NN	0	41	42	1	chromatin	41	41	42	0	NN	0	42	43	1	assembly	42	42	43	0	.	0	43	44	1	.	43	43	44	0
EOS
T	54
Mol	34334	34337	NNP	Mol	O	_	_
Cell	34338	34342	NNP	Cell	O	_	_
15	34343	34345	CD	15	O	_	_
:	34346	34347	:	:	O	_	_
595	34348	34351	CD	595	O	_	_
-	34352	34353	:	-	O	_	_
605	34354	34357	CD	605	O	_	_
.10.1016	34358	34366	CD	.10.1016	O	_	_
/	34366	34367	:	/	O	_	_
j.molcel	34367	34375	NN	j.molcel	O	_	_
.2004.06.043	34375	34387	CD	.2004.06.043	O	_	_
PubMed	34388	34394	NNP	PubMed	O	_	_
:	34394	34395	:	:	O	_	_
15327775	34396	34404	CD	15327775	O	_	_
15327775	34405	34413	CD	15327775	O	_	_
20	34414	34416	CD	20	O	_	_
Lossos	34417	34423	NNP	Lossos	O	_	_
IS	34424	34426	VBZ	be	O	_	_
,	34427	34428	,	,	O	_	_
Natkunam	34429	34437	NNP	Natkunam	O	_	_
Y	34438	34439	NN	y	O	_	_
,	34440	34441	,	,	O	_	_
Levy	34442	34446	NNP	Levy	O	_	_
R	34447	34448	NNP	R	O	_	_
,	34449	34450	,	,	O	_	_
Lopez	34451	34456	NNP	Lopez	O	_	_
CD	34457	34459	NNP	CD	O	_	_
(	34460	34461	CD	(	O	_	_
2002	34462	34466	CD	2002	O	_	_
)	34467	34468	CD	)	O	_	_
Apoptosis	34470	34479	NN	apoptosis	O	_	_
stimulating	34480	34491	NN	stimulating	O	_	_
protein	34492	34499	NN	protein	O	_	_
of	34500	34502	IN	of	O	_	_
p53	34503	34506	NN	p53	B-GENE	_	_
(	34507	34508	CD	(	B-GENE	_	_
ASPP2	34508	34513	NN	aspp2	I-GENE	_	_
)	34513	34514	NN	)	O	_	_
expression	34515	34525	NN	expression	O	_	_
differs	34526	34533	VBZ	differ	O	_	_
in	34534	34536	IN	in	O	_	_
diffuse	34537	34544	JJ	diffuse	O	_	_
large	34545	34550	JJ	large	O	_	_
B-cell	34551	34557	NN	b-cell	O	_	_
and	34558	34561	CC	and	O	_	_
follicular	34562	34572	JJ	follicular	O	_	_
center	34573	34579	NN	center	O	_	_
lymphoma	34580	34588	NN	lymphoma	O	_	_
:	34588	34589	:	:	O	_	_
correlation	34590	34601	NN	correlation	O	_	_
with	34602	34606	IN	with	O	_	_
clinical	34607	34615	JJ	clinical	O	_	_
outcome	34616	34623	NN	outcome	O	_	_
.	34624	34625	.	.	O	_	_
D	1
39
1	0	nn
1	2	dep
1	6	dep
2	4	dep
6	7	dep
6	8	punct
6	11	dep
11	9	nn
11	10	num
11	14	dep
14	13	number
14	15	dep
20	1	dep
20	16	nsubj
20	17	cop
20	19	nn
20	23	appos
23	22	nn
32	25	nn
32	26	nn
32	27	num
32	28	num
32	29	num
32	30	nn
32	31	nn
38	34	nn
38	35	num
38	36	nn
38	37	nn
39	20	ccomp
39	32	nsubj
39	38	prep_of
39	43	prep_in
39	47	prep_in
39	49	dobj
43	41	amod
43	42	amod
43	47	conj_and
47	45	amod
47	46	nn
49	52	prep_with
52	51	amod
EOX
Y	1
ROOT	0	0	54	1	S	4	0	54	6	S	2	0	24	3	FRAG	0	0	16	3	FRAG	0	0	5	2	NP	1	0	2	2	NNP	0	0	1	1	Mol	0	0	1	0	NNP	0	1	2	1	Cell	1	1	2	0	NP	0	2	5	3	NP	0	2	3	1	CD	0	2	3	1	15	2	2	3	0	:	0	3	4	1	:	3	3	4	0	NP	0	4	5	1	CD	0	4	5	1	595	4	4	5	0	:	0	5	6	1	-	5	5	6	0	FRAG	0	6	16	3	NP	0	6	8	2	NP	0	6	7	1	CD	0	6	7	1	605	6	6	7	0	NP	0	7	8	1	CD	0	7	8	1	.10.1016	7	7	8	0	:	0	8	9	1	/	8	8	9	0	NP	0	9	16	3	NP	2	9	12	3	NN	0	9	10	1	j.molcel	9	9	10	0	CD	0	10	11	1	.2004.06.043	10	10	11	0	NNP	0	11	12	1	PubMed	11	11	12	0	:	0	12	13	1	:	12	12	13	0	NP	0	13	16	2	NP	0	13	15	1	QP	0	13	15	2	CD	0	13	14	1	15327775	13	13	14	0	CD	0	14	15	1	15327775	14	14	15	0	NP	0	15	16	1	CD	0	15	16	1	20	15	15	16	0	NP	0	16	17	1	NNP	0	16	17	1	Lossos	16	16	17	0	VP	2	17	24	3	VBZ	0	17	18	1	IS	17	17	18	0	,	0	18	19	1	,	18	18	19	0	NP	0	19	24	3	NP	1	19	21	2	NNP	0	19	20	1	Natkunam	19	19	20	0	NN	0	20	21	1	Y	20	20	21	0	,	0	21	22	1	,	21	21	22	0	NP	1	22	24	2	NNP	0	22	23	1	Levy	22	22	23	0	NNP	0	23	24	1	R	23	23	24	0	,	0	24	25	1	,	24	24	25	0	NP	7	25	33	8	NNP	0	25	26	1	Lopez	25	25	26	0	NNP	0	26	27	1	CD	26	26	27	0	CD	0	27	28	1	(	27	27	28	0	CD	0	28	29	1	2002	28	28	29	0	CD	0	29	30	1	)	29	29	30	0	NN	0	30	31	1	Apoptosis	30	30	31	0	NN	0	31	32	1	stimulating	31	31	32	0	NN	0	32	33	1	protein	32	32	33	0	PP	0	33	39	2	IN	0	33	34	1	of	33	33	34	0	NP	4	34	39	5	NN	0	34	35	1	p53	34	34	35	0	CD	0	35	36	1	(	35	35	36	0	NN	0	36	37	1	ASPP2	36	36	37	0	NN	0	37	38	1	)	37	37	38	0	NN	0	38	39	1	expression	38	38	39	0	VP	0	39	53	4	VBZ	0	39	40	1	differs	39	39	40	0	PP	0	40	48	2	IN	0	40	41	1	in	40	40	41	0	NP	0	41	48	3	NP	2	41	44	3	JJ	0	41	42	1	diffuse	41	41	42	0	JJ	0	42	43	1	large	42	42	43	0	NN	0	43	44	1	B-cell	43	43	44	0	CC	0	44	45	1	and	44	44	45	0	NP	2	45	48	3	JJ	0	45	46	1	follicular	45	45	46	0	NN	0	46	47	1	center	46	46	47	0	NN	0	47	48	1	lymphoma	47	47	48	0	:	0	48	49	1	:	48	48	49	0	NP	0	49	53	2	NP	0	49	50	1	NN	0	49	50	1	correlation	49	49	50	0	PP	0	50	53	2	IN	0	50	51	1	with	50	50	51	0	NP	1	51	53	2	JJ	0	51	52	1	clinical	51	51	52	0	NN	0	52	53	1	outcome	52	52	53	0	.	0	53	54	1	.	53	53	54	0
EOS
T	46
Leuk	34626	34630	NNP	Leuk	O	_	_
Lymphoma	34631	34639	NNP	Lymphoma	O	_	_
43	34640	34642	CD	43	O	_	_
:	34643	34644	:	:	O	_	_
2309	34645	34649	CD	2309	O	_	_
-	34650	34651	:	-	O	_	_
2317	34652	34656	CD	2317	O	_	_
.10.1080	34657	34665	CD	.10.1080	O	_	_
/	34665	34666	:	/	O	_	_
1042819021000040017	34666	34685	CD	1042819021000040017	O	_	_
PubMed	34686	34692	NNP	PubMed	O	_	_
:	34692	34693	:	:	O	_	_
12613517	34694	34702	CD	12613517	O	_	_
12613517	34703	34711	CD	12613517	O	_	_
21	34712	34714	CD	21	O	_	_
Sgroi	34715	34720	NNP	Sgroi	O	_	_
DC	34721	34723	NNP	DC	O	_	_
,	34724	34725	,	,	O	_	_
Teng	34726	34730	NNP	Teng	B-GENE	_	_
S	34731	34732	NN	s	I-GENE	_	_
,	34733	34734	,	,	O	_	_
Robinson	34735	34743	NNP	Robinson	B-GENE	_	_
G	34744	34745	NNP	G	I-GENE	_	_
,	34746	34747	,	,	O	_	_
LeVangie	34748	34756	NNP	LeVangie	B-GENE	_	_
R	34757	34758	NNP	R	I-GENE	_	_
,	34759	34760	,	,	O	_	_
Hudson	34761	34767	NNP	Hudson	O	_	_
JR	34768	34770	NNP	JR	O	_	_
Jr.et	34771	34776	NNP	Jr.et	O	_	_
al.	34777	34780	FW	al.	O	_	_
(	34781	34782	FW	(	O	_	_
1999	34783	34787	CD	1999	O	_	_
)	34788	34789	CD	)	O	_	_
In	34791	34793	FW	in	O	_	_
vivo	34794	34798	FW	vivo	O	_	_
gene	34799	34803	NN	gene	O	_	_
expression	34804	34814	NN	expression	O	_	_
profile	34815	34822	NN	profile	O	_	_
analysis	34823	34831	NN	analysis	O	_	_
of	34832	34834	IN	of	O	_	_
human	34835	34840	JJ	human	O	_	_
breast	34841	34847	NN	breast	O	_	_
cancer	34848	34854	NN	cancer	O	_	_
progression	34855	34866	NN	progression	O	_	_
.	34867	34868	.	.	O	_	_
D	1
1
1	0	nn
1	2	dep
1	4	dep
1	8	punct
1	9	dep
4	7	dep
7	6	num
9	10	appos
9	16	dep
16	12	num
16	13	num
16	14	num
16	15	nn
16	19	appos
16	22	appos
16	25	appos
16	29	appos
19	18	nn
22	21	nn
25	24	nn
29	27	nn
29	28	nn
29	31	dep
29	33	dep
31	30	nn
33	32	num
33	37	dep
33	39	dep
37	34	nn
37	35	nn
37	36	nn
39	38	nn
39	44	prep_of
44	41	amod
44	42	nn
44	43	nn
EOX
Y	1
ROOT	0	0	46	1	FRAG	0	0	46	4	FRAG	0	0	8	3	NP	0	0	3	2	NP	1	0	2	2	NNP	0	0	1	1	Leuk	0	0	1	0	NNP	0	1	2	1	Lymphoma	1	1	2	0	NP	0	2	3	1	CD	0	2	3	1	43	2	2	3	0	:	0	3	4	1	:	3	3	4	0	NP	0	4	8	3	NP	0	4	5	1	CD	0	4	5	1	2309	4	4	5	0	:	0	5	6	1	-	5	5	6	0	NP	1	6	8	2	CD	0	6	7	1	2317	6	6	7	0	CD	0	7	8	1	.10.1080	7	7	8	0	:	0	8	9	1	/	8	8	9	0	FRAG	0	9	45	3	NP	0	9	11	2	NP	0	9	10	1	CD	0	9	10	1	1042819021000040017	9	9	10	0	NP	0	10	11	1	NNP	0	10	11	1	PubMed	10	10	11	0	:	0	11	12	1	:	11	11	12	0	NP	0	12	45	9	NP	4	12	17	5	CD	0	12	13	1	12613517	12	12	13	0	CD	0	13	14	1	12613517	13	13	14	0	CD	0	14	15	1	21	14	14	15	0	NNP	0	15	16	1	Sgroi	15	15	16	0	NNP	0	16	17	1	DC	16	16	17	0	,	0	17	18	1	,	17	17	18	0	NP	1	18	20	2	NNP	0	18	19	1	Teng	18	18	19	0	NN	0	19	20	1	S	19	19	20	0	,	0	20	21	1	,	20	20	21	0	NP	1	21	23	2	NNP	0	21	22	1	Robinson	21	21	22	0	NNP	0	22	23	1	G	22	22	23	0	,	0	23	24	1	,	23	23	24	0	NP	1	24	26	2	NNP	0	24	25	1	LeVangie	24	24	25	0	NNP	0	25	26	1	R	25	25	26	0	,	0	26	27	1	,	26	26	27	0	NP	0	27	45	2	NP	0	27	32	2	NP	2	27	30	3	NNP	0	27	28	1	Hudson	27	27	28	0	NNP	0	28	29	1	JR	28	28	29	0	NNP	0	29	30	1	Jr.et	29	29	30	0	NP	1	30	32	2	FW	0	30	31	1	al.	30	30	31	0	FW	0	31	32	1	(	31	31	32	0	NP	0	32	45	2	NP	0	32	38	2	NP	1	32	34	2	CD	0	32	33	1	1999	32	32	33	0	CD	0	33	34	1	)	33	33	34	0	NP	3	34	38	4	FW	0	34	35	1	In	34	34	35	0	FW	0	35	36	1	vivo	35	35	36	0	NN	0	36	37	1	gene	36	36	37	0	NN	0	37	38	1	expression	37	37	38	0	NP	0	38	45	2	NP	1	38	40	2	NN	0	38	39	1	profile	38	38	39	0	NN	0	39	40	1	analysis	39	39	40	0	PP	0	40	45	2	IN	0	40	41	1	of	40	40	41	0	NP	3	41	45	4	JJ	0	41	42	1	human	41	41	42	0	NN	0	42	43	1	breast	42	42	43	0	NN	0	43	44	1	cancer	43	43	44	0	NN	0	44	45	1	progression	44	44	45	0	.	0	45	46	1	.	45	45	46	0
EOS
T	11
Cancer	34869	34875	NN	cancer	O	_	_
Res	34876	34879	NNP	Res	O	_	_
59	34880	34882	CD	59	O	_	_
:	34883	34884	:	:	O	_	_
5656	34885	34889	CD	5656	O	_	_
-	34890	34891	:	-	O	_	_
5661	34892	34896	CD	5661	O	_	_
PubMed	34897	34903	NNP	PubMed	O	_	_
:	34903	34904	:	:	O	_	_
10582678	34905	34913	CD	10582678	O	_	_
10582678	34914	34922	CD	10582678	O	_	_
D	1
0
0	1	dep
0	4	dep
1	2	num
4	6	dep
4	10	dep
6	7	appos
10	9	num
EOX
Y	1
ROOT	0	0	11	1	FRAG	0	0	11	3	NP	0	0	3	2	NP	0	0	1	1	NN	0	0	1	1	Cancer	0	0	1	0	NP	0	1	3	2	NNP	0	1	2	1	Res	1	1	2	0	CD	0	2	3	1	59	2	2	3	0	:	0	3	4	1	:	3	3	4	0	NP	0	4	11	5	NP	0	4	5	1	CD	0	4	5	1	5656	4	4	5	0	:	0	5	6	1	-	5	5	6	0	NP	0	6	8	2	NP	0	6	7	1	CD	0	6	7	1	5661	6	6	7	0	NP	0	7	8	1	NNP	0	7	8	1	PubMed	7	7	8	0	:	0	8	9	1	:	8	8	9	0	NP	0	9	11	2	CD	0	9	10	1	10582678	9	9	10	0	CD	0	10	11	1	10582678	10	10	11	0
EOS
C	1537
55	3	2	4	288
243	59	58	60	1528
244	8	8	11	1579
7	21	21	22	39
204	3	1	4	906
135	10	10	14	104
236	16	15	48	1447
1	8	6	9	8
246	2	2	5	1613
231	35	34	36	1367
7	6	4	18	41
207	5	4	6	387
245	39	38	43	1608
111	10	10	11	498
103	16	14	19	418
247	7	6	8	1635
131	4	3	5	716
238	19	18	20	1490
98	4	0	5	520
59	7	4	8	269
19	31	30	32	106
89	1	0	4	54
155	1	0	2	372
20	16	16	18	110
203	0	0	5	1178
171	20	18	21	959
194	2	0	3	1121
155	4	3	5	332
47	34	32	39	250
55	7	7	16	289
90	4	3	5	324
166	7	5	9	922
183	15	15	16	862
147	13	11	14	786
60	2	2	3	260
237	54	54	64	1479
160	20	19	25	888
227	9	9	10	1295
203	9	8	21	1180
234	41	39	44	208
182	42	42	43	1019
198	32	32	36	1161
35	20	18	23	56
120	8	7	14	332
84	5	5	7	293
227	47	46	48	992
60	1	0	8	314
102	6	5	7	54
77	33	29	34	409
247	21	21	22	1628
51	15	15	16	274
31	48	47	49	179
182	8	8	9	1018
92	13	12	14	400
134	21	19	22	160
143	28	27	29	751
137	35	34	44	758
188	32	31	33	1084
229	1	0	39	1323
235	36	36	37	1438
232	48	46	49	1386
198	34	34	36	1163
32	8	8	16	182
191	4	4	5	332
237	41	38	42	1476
109	21	20	22	324
92	19	16	24	501
137	9	8	30	749
120	2	0	14	652
228	32	31	33	1321
169	18	18	19	951
236	37	35	40	1456
246	7	7	8	1596
188	46	42	48	860
36	18	17	19	54
239	8	7	9	1498
247	37	34	38	1646
149	27	25	28	806
148	39	38	42	56
148	27	25	28	222
228	8	7	9	1314
149	10	10	11	360
213	20	19	25	1222
97	7	6	8	519
228	36	34	37	1322
110	27	26	28	556
165	7	4	8	908
100	7	5	8	535
107	1	1	2	570
234	32	30	37	1418
11	6	3	7	59
14	19	19	23	77
182	22	19	23	1022
146	0	0	3	792
19	25	25	29	104
143	22	22	29	780
243	14	14	17	1553
0	30	30	32	1
26	20	20	21	145
16	33	30	34	86
197	8	6	9	1150
6	49	49	53	30
208	23	22	24	533
47	38	37	39	241
226	15	14	34	1284
157	35	35	36	880
84	10	10	11	392
9	16	13	17	53
114	28	28	31	191
233	32	30	33	1221
73	61	60	62	378
46	14	12	15	237
239	22	22	23	1494
58	8	8	11	303
243	22	18	42	1555
149	3	3	4	360
195	21	21	64	1130
137	26	26	30	756
74	3	0	6	379
237	28	28	29	1299
234	26	25	27	1347
81	3	3	4	284
67	2	0	14	338
23	16	15	17	124
180	12	10	13	1003
18	19	17	20	96
22	15	14	21	115
47	50	49	51	241
175	1	0	22	976
16	14	12	15	82
132	15	14	28	722
182	40	40	41	1029
207	12	10	13	509
101	1	0	5	528
33	8	6	15	183
20	18	16	21	109
42	2	2	3	216
154	4	2	11	840
6	39	35	40	28
231	8	7	9	1356
247	2	2	3	1633
247	29	27	45	1643
55	15	14	16	291
117	1	0	5	636
176	21	20	23	986
247	25	24	26	1623
6	33	32	45	27
133	20	19	21	731
109	5	5	13	580
78	17	15	20	418
60	14	11	15	237
25	12	9	30	133
159	11	8	12	882
69	3	2	18	348
83	4	0	5	438
20	24	23	27	111
197	12	12	17	1151
114	33	32	34	176
80	1	0	2	427
231	37	36	38	1368
122	10	9	11	372
31	42	40	46	177
14	14	14	17	76
238	11	11	28	1487
51	24	23	29	276
185	1	1	4	1058
201	14	13	17	1172
57	1	0	4	298
203	4	2	5	353
113	25	25	33	616
23	9	9	10	49
96	1	0	2	441
40	3	3	11	213
163	0	0	1	150
114	10	8	11	410
71	9	9	10	332
243	62	61	67	1569
190	21	19	22	1099
137	24	23	25	176
29	5	5	6	155
246	38	34	39	1625
14	1	0	2	70
180	32	32	34	1006
75	22	21	23	64
229	28	27	38	1334
227	43	42	44	135
109	3	2	4	579
97	4	3	5	518
5	2	1	7	15
65	5	2	6	330
234	36	34	37	1420
145	12	12	13	787
6	10	10	11	37
10	19	18	20	58
141	7	5	8	410
234	28	28	29	1416
85	8	8	9	456
228	18	16	19	1317
238	4	4	8	1484
26	0	0	3	63
110	5	4	19	591
236	12	11	13	1445
235	26	25	32	1432
219	4	4	7	1245
141	18	14	21	772
114	4	3	11	620
241	12	12	13	1514
106	12	11	13	64
150	12	9	13	808
164	18	16	19	906
6	14	13	15	19
151	19	18	20	814
32	0	0	1	158
234	1	0	8	1405
237	19	18	20	1468
153	4	4	8	831
224	19	18	20	1266
123	3	1	4	247
50	5	3	6	265
178	98	97	99	983
226	19	16	23	1285
214	17	16	21	1228
238	27	26	28	1493
182	13	13	14	49
234	7	6	8	1408
73	8	7	9	367
172	10	7	12	964
195	71	70	72	1114
47	9	8	10	241
26	11	11	12	142
40	29	28	30	220
244	36	35	39	1588
136	8	8	9	360
30	1	0	4	161
236	34	34	35	1347
124	20	20	22	521
156	11	7	28	854
225	0	0	1	1251
40	12	12	13	216
12	1	0	6	63
73	1	0	2	54
237	31	29	37	1473
136	3	3	4	744
88	17	15	21	475
175	14	14	22	979
129	7	5	14	707
61	11	11	15	319
65	11	10	17	332
89	31	26	32	483
231	17	15	30	1359
73	43	42	62	373
6	4	4	5	35
232	14	14	41	1375
233	49	48	50	1404
229	7	6	38	1325
166	19	18	35	926
226	28	27	34	1288
14	10	9	13	75
224	13	12	17	1263
6	57	55	60	31
212	15	14	19	1217
145	19	18	23	790
139	0	0	1	283
244	19	19	23	1348
105	20	20	22	1
237	16	14	28	1466
47	55	53	59	241
239	5	5	9	1497
184	7	7	10	1050
192	26	24	27	1113
86	17	17	18	458
243	54	53	70	1565
243	31	30	32	1558
67	10	9	14	342
71	27	27	46	360
117	21	20	22	372
87	7	3	8	434
207	8	7	9	64
181	8	7	13	1009
231	33	31	36	1366
34	1	1	2	185
133	2	2	3	711
232	12	11	13	1374
177	4	4	7	990
202	3	1	4	1175
79	3	3	4	420
33	12	11	15	184
195	37	36	38	1133
88	9	9	12	205
235	14	12	15	1376
74	15	14	20	381
99	3	2	4	527
113	10	9	11	610
236	33	33	34	1454
25	29	27	30	136
58	4	3	5	237
134	0	0	3	732
195	60	58	64	1140
182	36	34	37	1027
218	17	16	18	871
160	17	16	32	887
68	9	7	10	346
37	5	5	7	1
214	20	19	21	871
14	4	3	23	71
174	8	7	9	974
228	26	26	27	1308
168	29	27	30	943
179	3	3	4	999
6	22	21	23	20
246	32	25	33	1624
137	21	19	25	660
67	6	6	14	340
152	26	25	27	824
153	17	17	20	66
36	15	13	19	197
167	11	11	13	932
31	16	15	37	168
235	17	16	21	1429
69	9	5	18	349
152	38	36	39	827
76	7	5	29	391
28	4	3	8	150
151	21	21	24	209
225	17	17	18	458
92	21	21	24	209
159	0	0	3	883
15	9	3	13	79
195	19	19	20	1129
38	24	24	27	210
103	1	0	2	543
18	12	11	13	79
58	14	12	15	304
30	8	8	9	158
244	6	5	39	1578
245	7	6	8	1596
12	5	5	7	1
152	28	28	33	825
148	25	25	26	786
182	29	26	30	360
213	4	2	5	372
24	10	9	13	128
37	14	14	17	66
88	4	3	12	472
242	32	30	33	1221
144	7	4	8	785
244	16	12	34	1581
195	63	61	64	1141
229	9	9	26	1326
233	2	2	3	1389
219	2	0	8	1243
47	42	40	46	252
91	33	31	34	495
235	7	6	8	1425
113	32	31	33	618
108	17	15	20	575
0	45	45	47	1
80	18	18	19	400
188	7	5	11	1077
191	21	19	33	1103
56	17	16	18	297
94	1	0	7	506
244	0	0	57	1576
92	1	0	2	497
76	10	10	11	388
120	5	4	14	331
191	29	27	30	1106
119	1	0	20	645
221	1	0	8	1193
233	4	4	12	1390
137	19	19	20	684
165	26	26	27	905
125	9	3	15	691
231	53	53	56	1371
240	5	5	6	1510
76	0	0	2	387
235	35	33	37	1437
6	6	6	7	34
246	15	15	16	1389
237	13	12	14	1465
109	12	11	13	372
76	16	15	20	222
244	24	24	25	1514
140	6	6	9	205
165	34	31	35	913
132	27	26	28	180
15	1	0	2	79
245	31	29	35	1605
67	19	19	20	344
110	7	7	9	1
111	29	29	32	604
138	4	4	7	761
230	25	24	26	1350
27	12	12	15	149
44	9	8	10	54
122	3	3	6	218
164	13	12	14	905
31	13	13	37	167
153	31	31	35	177
59	2	0	3	307
195	27	26	30	1131
9	1	1	2	40
244	33	32	34	1587
195	48	46	49	1137
36	12	12	13	119
176	6	4	7	983
121	9	7	16	661
166	15	14	35	925
13	1	0	2	67
116	28	26	31	635
130	9	9	13	177
86	6	6	9	205
115	0	0	1	283
188	1	0	2	640
242	11	11	12	1295
43	13	11	14	227
4	1	1	7	13
85	3	3	4	454
239	2	0	4	1495
179	17	16	18	1000
232	34	33	41	1383
226	3	1	38	1279
150	15	14	19	809
242	39	39	41	1527
123	16	13	23	680
239	10	10	12	1499
241	13	13	17	1399
61	18	15	19	322
234	20	19	21	1413
45	11	8	15	237
237	58	56	64	1480
230	21	20	26	1348
240	10	10	11	1512
167	16	16	17	260
121	18	17	24	664
229	30	30	31	1324
149	8	6	9	803
51	38	38	40	279
195	10	9	11	239
232	31	30	32	1382
238	1	0	8	1482
43	16	16	20	232
35	13	13	23	110
113	2	2	3	606
59	13	12	17	310
217	4	0	5	1233
122	18	17	29	675
199	2	0	5	1164
35	0	0	5	54
89	14	13	18	479
165	32	31	34	914
235	29	28	30	1434
223	12	11	13	1259
84	15	15	16	447
150	2	2	9	484
181	12	10	13	1010
201	16	16	17	11
157	3	1	4	867
19	6	4	11	42
28	6	6	7	149
102	18	16	21	541
208	17	15	24	1203
106	18	17	19	567
217	14	13	22	1235
109	15	14	18	582
203	20	11	21	1181
204	13	12	18	243
154	6	6	7	842
160	31	29	32	891
114	20	20	27	624
142	15	13	16	776
138	2	2	7	760
184	16	16	17	314
94	6	5	7	387
245	4	4	12	1595
49	6	6	7	261
243	6	0	71	1549
183	13	11	23	1038
170	12	9	13	954
66	1	0	2	54
192	1	0	4	1112
35	9	8	10	187
123	6	5	12	678
4	4	3	7	14
235	11	10	21	1427
195	14	13	15	1127
51	17	15	21	272
241	30	27	39	1516
64	5	4	6	324
236	49	49	50	39
87	15	13	16	469
244	54	54	55	512
93	0	0	1	283
229	23	22	24	637
245	2	2	3	1594
23	5	4	21	120
77	23	22	43	407
181	5	5	19	1008
245	19	19	20	1601
28	13	12	14	155
124	15	15	16	684
90	20	19	28	487
167	22	19	23	913
74	17	17	20	382
67	12	12	14	343
107	4	4	6	1
236	14	14	48	1446
38	5	3	27	205
164	0	0	1	899
229	31	30	38	141
130	12	11	13	105
142	3	3	16	110
180	8	6	9	1002
227	22	20	23	1300
35	11	11	23	191
177	33	33	36	990
227	3	2	5	1293
132	6	5	12	719
247	4	4	8	1634
89	20	19	21	478
182	6	5	30	1016
225	6	5	7	1270
228	24	23	25	1312
244	3	3	56	1577
231	11	10	40	1357
217	18	18	22	1236
7	26	26	29	46
89	10	7	11	478
188	37	36	48	1085
125	22	21	26	694
29	6	5	7	158
244	44	43	56	1590
175	6	4	17	975
31	45	44	46	105
69	24	21	31	353
7	29	25	32	45
165	17	15	18	911
217	21	20	22	464
84	8	7	12	446
227	18	17	37	1298
86	1	0	9	459
89	24	22	32	482
242	37	34	43	1542
156	19	17	28	858
109	38	37	39	464
153	25	23	38	835
27	9	9	10	148
236	7	7	10	1443
213	13	11	18	1221
51	36	32	40	279
225	19	19	20	457
26	18	17	19	63
243	34	33	42	1559
183	7	6	8	1037
13	11	9	12	69
177	8	8	11	987
191	36	35	37	1107
164	8	8	9	903
228	21	20	30	1318
24	20	20	25	131
237	9	8	53	1463
195	3	0	11	1123
242	44	43	45	1544
10	10	10	14	56
145	22	21	23	791
70	5	2	6	350
237	27	27	28	1471
232	6	0	13	1372
39	9	8	10	135
230	26	26	27	1096
82	14	12	18	436
236	19	18	20	1448
3	6	4	7	8
36	4	2	7	195
23	10	9	21	122
192	20	20	32	1115
234	29	29	30	1417
203	15	14	16	317
6	23	23	26	24
6	5	5	6	36
181	17	13	19	1011
109	24	23	25	573
241	19	18	26	1522
166	12	11	13	924
160	6	5	7	885
164	10	10	11	904
121	25	25	26	666
237	3	3	64	1461
141	14	14	15	734
124	23	20	24	689
239	20	19	21	1503
45	0	0	5	236
123	10	10	12	679
183	40	38	41	1045
102	12	12	13	332
241	25	23	26	1524
134	11	10	12	734
235	20	18	21	1430
247	10	10	11	1295
243	66	64	67	1570
225	9	9	10	1251
111	32	28	33	603
114	22	21	23	625
76	27	26	28	397
183	22	20	23	1042
161	8	6	9	893
47	28	26	32	247
84	22	22	25	205
228	12	10	13	1295
237	0	0	65	1460
244	52	50	56	1591
247	9	9	11	1636
110	1	0	2	11
233	41	40	47	1402
233	26	25	27	1398
106	24	22	25	568
6	8	8	9	33
129	10	9	14	709
116	23	23	24	619
161	11	9	15	894
128	11	7	12	704
11	10	9	11	56
170	20	17	21	955
99	13	11	14	520
78	6	5	11	416
77	53	52	54	413
29	9	7	10	160
35	2	2	5	55
86	18	17	19	465
217	11	8	12	1234
198	18	18	19	1155
187	12	12	13	1072
157	40	40	41	658
116	2	0	11	630
82	8	8	11	205
203	19	17	20	1183
6	15	15	16	20
51	28	26	29	277
40	10	9	11	215
245	11	11	12	1295
109	35	34	39	585
237	22	21	23	1469
6	11	4	15	18
42	11	11	14	210
190	13	12	22	106
164	6	4	14	901
16	12	12	13	79
167	15	13	17	933
246	14	13	16	1618
208	1	0	2	324
197	16	14	17	1152
137	29	28	30	664
180	30	30	34	1005
242	42	39	43	649
105	3	3	4	555
105	15	13	21	560
230	3	3	5	1342
108	6	5	12	574
86	15	14	19	463
244	28	27	34	1585
177	18	18	21	990
187	16	16	17	1070
77	4	3	7	401
235	1	0	3	1422
40	23	22	30	218
247	18	18	19	1627
23	8	7	21	121
90	11	10	12	482
38	8	8	9	205
121	41	40	42	218
20	0	0	1	107
72	14	13	15	365
248	10	9	11	1653
166	25	21	35	927
105	30	27	31	563
229	37	36	38	1340
244	41	40	56	1589
182	10	10	11	1019
168	38	35	39	946
45	22	19	23	227
16	10	10	11	81
238	2	2	3	1483
231	45	45	56	1369
245	17	13	20	1599
105	11	11	31	559
195	57	54	64	1139
47	30	30	32	238
77	12	12	18	404
205	17	16	18	1000
209	6	5	8	441
169	0	0	1	947
37	12	10	17	65
241	6	2	26	1518
177	16	15	21	992
233	7	6	8	1391
154	22	22	24	847
122	21	20	29	676
58	19	18	20	266
87	3	3	6	205
165	27	18	28	912
159	7	6	8	884
205	8	6	9	1190
243	43	43	45	1562
243	9	7	10	1550
158	11	10	12	881
176	19	16	23	985
26	2	2	4	1
242	7	6	8	1531
174	5	4	9	973
230	2	0	27	1341
111	1	0	2	498
195	68	68	72	1143
231	23	22	24	1362
77	14	14	18	405
184	14	12	19	1054
187	11	11	12	1073
47	5	4	10	243
175	25	25	26	658
248	7	7	8	1295
9	8	6	17	51
96	5	5	8	515
72	7	6	8	319
157	5	5	6	332
56	1	0	8	293
205	0	0	3	1189
167	20	19	22	914
122	7	7	14	671
145	4	4	5	360
31	20	19	37	170
199	10	8	11	1165
168	3	2	4	938
136	1	1	2	744
204	10	9	11	243
152	23	22	27	823
42	9	6	14	227
195	7	7	9	1125
224	6	5	20	1261
56	13	13	18	296
103	23	21	24	547
100	1	0	2	441
88	7	6	12	473
154	17	14	18	844
227	8	6	10	1294
120	18	18	19	650
184	6	5	10	1053
234	17	15	29	1411
238	14	13	15	1488
73	28	27	29	54
241	22	20	23	1221
61	2	0	5	320
83	16	14	18	441
28	7	6	8	151
245	1	0	24	1593
246	11	9	16	1617
230	9	8	10	1344
50	1	0	6	264
223	0	0	1	1251
117	18	15	29	638
79	10	9	18	424
214	3	3	7	1224
1	4	3	5	7
243	25	25	29	1347
21	7	6	8	113
233	1	0	36	1387
190	6	6	7	1095
2	6	4	7	8
188	16	14	30	1079
168	0	0	4	937
226	37	35	38	1290
226	9	8	10	1282
246	23	22	24	1623
177	11	10	12	991
148	32	32	35	498
188	29	29	30	1083
23	6	6	9	48
77	30	30	31	49
10	2	2	5	55
102	3	2	7	479
67	5	4	6	339
80	19	18	20	429
82	0	0	3	433
239	23	22	35	1504
206	1	0	8	1193
185	4	0	7	1057
42	4	4	14	226
227	31	29	32	1221
182	53	52	54	1026
58	23	18	24	305
120	25	25	26	658
24	18	17	19	130
214	9	8	21	1226
208	18	18	19	1205
90	1	1	9	484
196	1	0	8	1147
74	9	9	12	380
32	15	13	16	180
49	8	6	9	262
173	8	7	9	969
138	6	5	7	404
228	3	3	4	1312
191	51	51	57	1109
136	15	14	16	739
46	4	3	5	241
234	23	22	24	1301
243	46	46	48	1563
165	13	13	28	910
238	24	22	28	1492
243	12	11	70	1551
121	31	28	36	667
235	39	37	40	1439
181	18	18	19	260
156	14	12	15	856
236	28	27	29	1452
60	7	6	8	317
223	3	2	13	1255
228	5	5	13	1313
144	13	10	14	786
235	2	2	3	22
218	14	13	18	1228
240	8	7	9	1511
132	14	14	15	711
17	7	5	8	88
218	1	0	2	1223
12	8	7	9	64
138	9	8	10	556
135	13	12	14	105
232	9	9	13	1373
215	10	8	11	1231
124	7	7	12	685
236	39	38	40	1457
236	9	9	10	1444
225	3	2	7	1268
226	22	21	23	1287
124	16	15	24	687
192	10	8	11	1113
198	27	23	28	1158
198	30	28	36	1159
191	56	55	57	1111
245	42	41	43	1610
40	16	15	19	195
165	23	23	24	904
51	20	19	21	275
34	10	10	13	187
236	22	20	34	1449
175	21	18	22	980
26	26	25	27	146
19	10	8	11	101
246	49	49	53	1626
226	33	30	34	1289
234	14	13	15	1410
72	11	10	12	364
105	18	17	21	561
182	32	32	51	1026
210	2	2	3	260
55	1	0	6	286
188	53	53	55	1063
205	12	10	13	1191
76	9	9	11	392
229	4	2	5	1324
209	1	0	2	324
168	15	12	16	940
96	7	7	8	332
226	12	11	13	1283
191	44	42	45	1108
19	11	9	13	38
28	17	15	18	156
152	17	16	20	821
86	4	3	9	416
152	7	6	11	818
234	4	4	8	1407
188	19	18	20	1081
218	6	5	18	1239
153	7	6	8	832
182	30	30	32	1025
10	16	16	20	57
100	10	9	11	536
183	2	0	3	1036
127	18	16	19	702
23	11	11	12	119
43	5	5	9	230
191	15	10	18	1102
99	6	5	35	528
173	15	15	19	971
183	33	32	37	1045
18	9	6	20	92
90	25	23	28	489
95	11	10	16	511
157	21	21	22	864
82	17	16	18	437
247	39	38	45	1647
242	29	28	33	1539
109	37	37	38	457
142	10	9	11	756
31	8	8	9	158
182	1	0	2	1015
229	16	14	17	1330
194	13	12	14	1000
130	7	7	8	712
168	33	30	34	945
40	26	25	30	219
237	34	32	37	1474
156	22	22	23	861
239	28	26	32	1505
91	27	26	31	407
79	20	6	21	423
242	23	22	24	1537
120	20	17	26	655
191	25	23	26	1105
70	11	9	12	237
78	24	21	25	419
143	25	24	29	760
103	29	27	33	548
98	13	10	20	522
132	22	22	28	724
77	27	25	43	408
228	2	0	30	1310
237	63	61	64	1481
176	0	0	1	332
221	7	6	8	1195
23	13	12	17	123
19	13	12	17	102
129	13	12	14	710
241	1	1	2	1295
71	20	19	21	359
198	15	13	16	1157
14	7	6	23	72
38	22	22	27	209
73	48	47	49	218
64	3	1	4	326
70	0	0	12	354
107	8	6	9	404
31	34	33	35	176
202	11	10	12	54
243	16	15	17	1554
231	29	29	30	1364
115	3	3	4	284
110	16	13	19	592
112	0	0	1	606
134	18	16	22	736
153	2	0	3	830
171	11	9	13	957
244	31	29	32	1221
200	2	0	5	1166
246	1	0	2	1422
7	11	8	13	43
230	28	28	31	1352
116	10	8	11	495
41	9	8	10	135
184	18	16	19	1055
233	35	33	36	1385
200	14	13	15	11
98	8	8	20	521
64	30	28	31	328
41	13	11	14	221
51	10	8	21	269
245	10	10	11	1597
19	20	19	21	46
192	29	28	32	1117
152	10	9	11	820
234	33	33	37	1419
85	2	2	3	453
59	19	18	23	311
3	2	1	7	11
92	5	4	9	498
223	6	5	7	1256
197	1	0	2	1149
26	16	15	17	143
77	1	0	2	401
240	2	0	3	1508
157	33	33	34	879
31	29	27	30	175
50	10	9	11	266
49	0	0	3	261
222	3	2	10	1252
66	7	5	11	336
54	1	0	2	285
222	0	0	1	1251
160	13	10	14	886
237	25	24	26	1470
56	5	3	8	237
153	3	3	4	119
160	24	22	25	890
143	17	14	29	779
81	0	0	1	283
216	6	4	7	1232
127	7	3	8	700
132	11	9	12	720
233	20	19	36	1395
168	25	22	30	942
30	10	8	13	162
111	7	7	23	598
45	13	13	15	238
231	14	13	15	1358
71	32	31	33	324
126	11	10	15	698
248	0	0	3	1648
246	34	34	36	1527
225	20	11	21	1272
179	4	0	7	997
228	15	14	19	1316
169	17	15	18	950
26	12	11	13	141
137	12	11	15	750
99	34	33	35	533
65	21	20	24	333
91	5	3	6	490
114	15	14	18	498
157	23	22	24	865
18	14	13	16	90
187	18	11	20	1069
77	8	8	9	403
89	17	16	18	54
122	15	15	16	666
2	2	1	7	9
150	25	23	26	810
213	1	0	26	1218
91	13	13	17	491
183	30	30	31	49
224	10	9	17	1262
145	2	1	11	787
65	8	7	17	331
162	7	7	8	896
125	14	14	15	690
91	15	15	17	492
156	4	4	28	853
193	5	4	6	1119
188	10	9	11	1078
125	1	0	2	690
247	33	32	45	1645
244	10	10	11	1295
138	14	12	15	112
232	40	38	41	1385
44	0	0	1	216
167	2	0	3	930
41	6	5	10	222
201	1	0	2	1170
204	17	15	18	1188
9	14	14	15	49
246	20	19	24	1621
236	6	0	7	1372
237	10	10	42	1464
183	31	30	32	1044
212	12	11	13	372
193	8	7	9	1120
6	18	16	23	21
77	47	45	48	411
77	26	26	27	59
108	3	0	12	573
126	5	4	6	563
146	7	6	8	54
112	5	4	8	607
114	0	0	1	619
242	33	33	34	1389
157	19	17	33	873
87	11	9	16	468
83	12	10	18	439
190	4	2	7	1093
113	23	22	33	615
167	9	8	10	931
124	2	1	3	11
56	2	2	3	260
214	6	5	7	1128
228	27	25	28	1320
139	3	3	4	284
227	25	24	26	1301
24	7	4	8	127
231	2	0	9	1354
195	43	43	45	1102
36	11	10	24	196
242	20	19	21	1536
99	19	17	24	530
245	33	33	35	1606
243	56	55	60	1566
183	18	17	19	1041
91	19	18	20	469
208	20	20	24	1206
120	23	22	24	657
109	42	40	43	573
117	24	23	29	640
241	10	10	26	1519
111	16	16	19	218
39	1	1	4	210
169	6	4	7	930
151	15	13	31	813
238	17	15	20	1489
85	6	5	9	455
13	7	5	12	68
170	1	0	2	921
84	1	1	5	443
65	1	0	17	329
143	14	14	15	777
55	14	14	15	286
76	25	24	26	64
77	51	51	54	411
31	23	22	37	171
188	42	42	43	863
155	11	9	12	850
170	8	6	9	953
166	3	2	35	921
92	8	7	9	384
118	3	2	6	642
28	20	19	21	157
197	21	20	22	1000
104	6	6	8	551
169	13	12	14	949
37	1	0	6	63
219	13	11	14	1231
239	11	11	12	1295
16	19	18	23	84
31	6	4	7	165
84	20	18	25	448
79	4	3	5	422
232	28	28	41	1379
21	4	2	8	112
7	15	14	18	42
157	37	33	41	877
226	6	5	7	1281
195	41	39	64	1134
242	53	50	54	1545
12	12	10	17	65
180	28	24	34	1004
232	25	24	26	1379
129	1	0	2	706
188	54	54	55	1075
239	31	30	32	1506
227	34	32	35	1304
134	13	13	22	735
94	13	11	14	509
219	7	4	8	1244
239	34	33	35	1507
113	8	8	9	609
43	2	0	3	227
124	9	9	12	686
207	0	0	6	506
79	1	0	2	400
227	15	13	16	1297
165	19	19	20	896
185	12	10	30	1059
76	3	2	4	64
88	0	0	1	471
125	27	26	28	691
38	1	0	2	205
137	43	41	44	759
0	57	57	59	4
184	17	17	18	1031
103	32	31	33	54
177	26	25	28	988
76	28	21	29	395
242	26	25	27	1538
8	4	2	5	47
137	16	15	17	684
143	4	3	7	777
227	12	11	16	1296
110	18	18	19	594
154	20	18	24	845
185	21	21	28	1061
73	40	33	62	372
235	23	22	24	1431
75	19	19	23	385
182	46	45	49	1032
123	22	21	23	218
103	9	8	12	545
238	7	6	8	1485
53	0	0	1	283
131	9	9	10	712
185	28	28	30	1063
165	25	25	26	37
75	8	6	11	383
201	11	9	17	1171
218	9	8	10	1240
111	26	24	27	410
0	56	56	57	3
196	2	1	8	1146
104	12	11	13	391
231	20	19	21	1361
233	23	22	24	1397
157	24	24	25	49
24	24	22	25	132
25	14	14	26	110
231	5	5	9	1355
182	24	24	25	1023
192	13	12	14	1114
180	1	0	2	1000
173	12	11	13	970
0	82	82	83	6
195	66	65	72	1142
189	11	9	12	1092
227	1	0	37	1291
188	27	25	30	1080
164	2	2	4	900
242	4	4	54	1530
121	21	20	24	665
156	0	0	1	332
247	24	24	25	1630
103	6	4	12	544
76	19	18	20	135
86	12	12	19	462
177	2	0	28	989
246	6	6	8	1615
17	3	2	8	87
229	34	33	38	1339
237	50	43	51	1477
221	2	2	3	260
95	21	19	22	440
242	2	2	3	1389
182	38	38	39	1028
206	7	6	8	1195
114	6	6	11	621
237	6	5	7	1462
166	33	32	35	929
84	4	3	5	444
196	0	0	1	1145
105	6	2	7	558
224	0	0	1	1251
182	14	12	15	1020
79	12	12	15	209
146	4	4	17	793
27	7	3	15	147
31	26	25	27	174
201	20	18	21	1174
63	4	0	5	324
206	2	2	3	260
226	0	0	39	1278
188	50	50	51	650
163	4	4	5	896
86	14	14	15	457
247	1	0	3	1632
60	3	3	8	316
189	0	0	1	344
63	10	10	13	325
121	35	33	36	59
6	20	19	23	22
241	38	37	39	1526
239	17	13	35	1501
210	1	0	8	1193
200	4	4	5	1167
229	10	10	11	1295
191	9	8	10	1101
108	19	18	20	376
40	7	5	8	214
215	2	0	5	1230
22	6	3	21	114
51	6	6	7	268
240	3	3	6	1509
165	21	21	22	903
156	16	16	28	857
148	12	10	13	796
166	10	10	11	230
137	38	38	39	360
125	12	10	13	692
233	14	13	18	1389
244	25	24	26	1399
20	6	5	10	108
99	1	1	4	526
121	23	21	24	659
232	37	35	38	1221
133	11	10	14	729
235	32	32	33	1377
104	4	2	8	550
166	0	0	35	920
157	7	7	41	869
116	15	14	22	633
237	52	52	54	1459
94	9	8	10	64
177	31	30	36	992
241	9	9	10	1513
48	17	13	18	259
55	12	9	16	290
128	1	0	2	563
229	19	18	24	1331
245	36	36	43	1607
233	11	9	12	1376
80	11	10	12	400
182	50	50	52	1014
141	12	11	13	734
214	1	0	7	1223
73	59	58	62	377
151	1	0	8	811
193	1	0	2	1113
183	34	34	35	1049
183	36	34	37	1046
152	19	19	20	822
241	0	0	26	1516
10	0	0	5	54
113	6	6	10	612
243	24	24	25	1546
181	1	0	2	1007
118	5	5	6	644
172	1	0	2	937
233	46	45	47	1403
37	8	7	9	64
93	3	3	4	284
57	9	6	10	299
223	5	5	6	1252
224	16	15	17	1265
198	4	4	5	1154
77	17	16	18	64
71	12	11	13	324
247	22	21	23	1347
19	0	0	1	99
92	22	22	24	496
171	24	24	26	279
173	18	17	19	972
11	15	15	18	61
132	24	24	28	182
77	42	40	43	410
243	53	53	54	1548
232	22	17	41	1377
18	0	0	1	88
247	31	30	32	1221
195	34	33	38	1132
140	1	0	2	767
227	28	27	35	1302
68	3	0	4	345
157	15	15	33	872
58	1	0	5	302
25	20	19	21	135
171	31	31	32	962
187	0	0	1	814
73	23	20	26	369
156	24	24	25	862
133	18	17	19	730
135	4	2	5	738
172	11	11	12	965
235	31	31	32	1435
117	4	2	5	637
105	24	22	25	404
157	11	10	41	870
121	2	1	24	660
111	34	33	35	106
98	26	24	27	440
212	1	0	20	1213
73	11	10	14	368
213	7	6	25	1220
111	22	21	23	191
214	12	10	13	1227
202	8	6	12	241
154	0	0	11	838
173	5	5	9	967
113	15	10	16	613
84	27	26	34	450
185	27	23	28	1062
187	14	14	15	1071
28	10	9	18	153
78	3	3	11	415
38	23	23	25	204
239	3	3	4	1496
69	29	29	30	313
235	4	4	8	1424
236	31	30	32	1453
77	32	31	33	400
198	11	9	12	1156
99	29	27	32	531
165	11	9	28	909
6	0	0	15	17
212	9	7	13	1215
195	17	16	72	1128
128	19	17	20	705
179	1	0	2	998
104	16	14	17	469
34	8	6	13	186
245	28	24	29	1604
183	29	26	41	1043
234	2	2	3	1406
44	5	4	6	218
162	1	0	4	895
234	11	9	38	1409
47	12	11	16	245
78	8	8	11	209
235	43	41	44	1440
248	1	1	3	1649
60	16	16	17	313
82	6	4	11	434
119	7	6	11	648
190	11	10	12	1096
137	0	0	1	733
156	26	21	28	860
121	15	11	16	662
195	5	4	9	1124
124	5	5	12	684
171	15	13	26	958
222	9	8	10	15
6	46	46	53	29
247	19	18	20	1640
143	11	9	12	778
53	3	3	4	284
26	7	6	8	139
51	13	12	21	270
59	10	9	11	309
95	4	0	5	438
248	6	6	8	1651
149	6	6	7	360
48	20	18	21	260
47	58	57	59	54
231	30	30	31	1365
106	9	9	14	559
186	3	0	4	1064
151	26	26	31	816
22	19	19	21	116
236	25	24	26	1451
26	9	9	13	140
152	32	30	33	808
45	16	15	23	239
236	54	52	55	1458
157	28	28	30	362
98	19	15	20	524
0	81	81	82	5
182	17	16	18	1021
119	4	2	5	637
73	53	52	62	376
48	0	0	6	258
153	34	33	35	105
113	20	18	33	614
154	10	8	11	843
76	22	22	24	387
171	2	0	6	956
133	13	13	15	727
168	8	8	11	939
176	10	7	11	984
231	27	25	28	1363
48	3	2	4	237
156	21	21	22	863
14	22	21	23	15
229	13	12	17	1329
31	15	15	16	158
225	13	12	20	1273
242	0	0	55	1528
165	0	0	1	332
200	8	5	9	1168
9	12	10	17	52
242	9	9	12	1532
210	7	6	8	1195
127	11	10	12	563
208	7	5	12	530
75	12	12	15	384
122	13	12	14	332
152	4	3	5	817
19	15	15	16	39
155	14	12	15	851
58	2	2	3	256
230	23	22	24	1349
246	4	4	5	1614
41	0	0	10	221
148	14	14	15	797
189	5	4	12	1091
185	16	14	20	1060
248	4	4	11	1650
48	1	1	2	256
112	12	10	15	608
119	16	13	19	649
113	29	27	30	372
235	9	9	10	1426
220	6	4	7	1232
84	30	29	34	451
233	29	28	36	1399
238	10	9	28	1486
88	20	19	21	64
153	15	12	20	833
187	6	4	20	1066
225	15	15	20	1274
245	20	20	21	797
243	37	35	42	1560
69	17	11	18	350
247	16	12	45	1638
78	1	0	11	414
157	31	31	33	876
19	28	27	29	105
118	0	0	1	641
231	50	49	51	1370
182	44	44	49	1031
140	4	3	9	768
24	2	0	3	126
238	21	20	22	1491
233	17	15	18	1394
173	3	0	4	966
135	16	15	17	106
187	9	7	20	1067
168	21	20	22	941
161	2	0	3	892
5	6	4	7	8
245	23	22	24	1603
153	36	36	37	512
130	5	4	8	711
183	27	27	28	650
195	52	50	53	1138
90	19	19	20	471
16	28	25	34	85
51	4	1	5	267
52	6	6	10	282
243	50	50	70	1564
230	6	6	13	1343
38	20	18	27	208
223	8	8	13	1258
18	16	14	20	95
130	15	14	16	715
110	24	23	28	595
232	16	15	17	1376
246	16	16	17	1620
62	7	5	8	323
151	10	9	31	812
12	14	14	17	66
107	15	12	18	572
230	18	14	26	1346
71	36	36	46	362
237	43	43	50	1478
231	0	0	1	1353
125	25	24	26	665
230	12	11	13	1295
171	22	22	26	959
229	21	20	22	1332
204	5	4	6	1180
17	16	13	17	89
135	8	6	14	739
7	0	0	1	40
243	41	38	42	1561
109	47	46	48	588
188	44	44	45	862
97	0	0	1	517
69	13	13	14	352
51	30	30	31	268
242	17	13	27	1534
47	20	19	21	241
175	12	11	22	978
106	2	0	5	564
126	14	12	15	699
121	12	12	15	604
132	0	0	1	711
6	29	27	45	24
105	5	4	6	556
212	5	2	13	1214
6	25	24	26	25
24	16	16	19	129
59	21	21	23	279
244	18	18	19	3
227	50	49	51	105
79	19	19	20	426
9	11	11	14	48
EOD
